# Copyright SRI International 1999-2016, Marine Biological Laboratory 1998-2001, DoubleTwist Inc 1998-1999.  All Rights Reserved.
#
# Authors:
#    Peter D. Karp
#    Ingrid Keseler
#    Carol Fulcher
#    Anamika Kothari
#    Suzanne Paley
#    Markus Krummenacker
#    Dan Weaver
#    Ian Paulsen
#    Amanda Mackie
#    Julio Collado-Vides
#    Cesar Bonavides-Martinez
#    Socorro Gama-Castro
#    Alberto Santos-Zavaleta
#    Verena Weiss
#    John L Ingraham
#    Robert Gunsalus
#    Robert LaRossa
#
# Please see the license agreement regarding the use of and distribution of this file.
# The format of this file is defined at http://bioinformatics.ai.sri.com/ptools/flatfile-format.html .
#
# Species: Escherichia coli K-12 substr. MG1655
# Database: EcoCyc
# Version: 20.0
# File Name: regulation.dat
# Date and time generated: April 18, 2016, 20:05:28
#
# Attributes:
#    UNIQUE-ID
#    TYPES
#    COMMON-NAME
#    ACCESSORY-PROTEINS
#    ANTI-ANTITERM-END-POS
#    ANTI-ANTITERM-START-POS
#    ANTITERMINATOR-END-POS
#    ANTITERMINATOR-START-POS
#    ASSOCIATED-BINDING-SITE
#    ASSOCIATED-RNASE
#    COMMENT
#    CREDITS
#    DATA-SOURCE
#    DOCUMENTATION
#    DOWNSTREAM-GENES-ONLY?
#    GROWTH-CONDITIONS
#    HIDE-SLOT?
#    INSTANCE-NAME-TEMPLATE
#    KI
#    MECHANISM
#    MEMBER-SORT-FN
#    MODE
#    PATHOLOGIC-NAME-MATCHER-EVIDENCE
#    PATHOLOGIC-PWY-EVIDENCE
#    PAUSE-END-POS
#    PAUSE-START-POS
#    PHYSIOLOGICALLY-RELEVANT?
#    REGULATED-ENTITY
#    REGULATOR
#    SYNONYMS
#
UNIQUE-ID - REG0-10828
TYPES - Regulation
CITATIONS - 20041203
CITATIONS - 20041203:EV-EXP-IMP:3491324080:shearer
COMMENT - MgrB interacts with PhoQ and in a currently unknown manner downregulates the activity of the PhoQP two-component system.
MODE - -
REGULATED-ENTITY - PHOQ-MONOMER
REGULATOR - G7002-MONOMER
//
UNIQUE-ID - REG0-10829
TYPES - Regulation
CITATIONS - 20041203
CITATIONS - 20041203:EV-EXP-IMP:3491324380:shearer
COMMENT - MgrB interacts with PhoQ and in a currently unknown manner downregulates the activity of the PhoQP two-component system.
MODE - -
REGULATED-ENTITY - PHOP-MONOMER
REGULATOR - G7002-MONOMER
//
UNIQUE-ID - REG0-5184
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6980
CITATIONS - 7601827
MODE - -
REGULATED-ENTITY - PM00353
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5556
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00217
CITATIONS - 6319708
MODE - +
REGULATED-ENTITY - PM00104
REGULATOR - CPLX-172
//
UNIQUE-ID - REG0-10543
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7799
CITATIONS - 7715459
MODE - -
REGULATED-ENTITY - PM00621
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5931
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00558
CITATIONS - 3304660
CITATIONS - 2571609
CITATIONS - 1943993
MODE - +
REGULATED-ENTITY - PM00312
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-6308
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3733
CITATIONS - 14731280
MODE - -
REGULATED-ENTITY - PM0-4241
REGULATOR - EG12386-MONOMER
//
UNIQUE-ID - REG0-11236
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8121
CITATIONS - 21908668
MODE - +
REGULATED-ENTITY - PM0-46155
REGULATOR - CPLX0-7672
//
UNIQUE-ID - REG0-12190
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8462
CITATIONS - 25375160
MODE - +
REGULATED-ENTITY - PM0-3665
REGULATOR - G6789-MONOMER
//
UNIQUE-ID - REG0-9063
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7417
CITATIONS - 18808381
CITATIONS - 17660422
MODE - +
REGULATED-ENTITY - PM0-5982
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-4795
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00035
CITATIONS - 1640456
CITATIONS - 17074904
MODE - -
REGULATED-ENTITY - PM00017
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-5168
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2082
CITATIONS - [10628873]
CITATIONS - 15368583
COMMENT - Compaction and bending of DNA were observed when Fis was bound to the <i>nuo</i> regulatory region |CITS:[15368583]|.
MODE - +
REGULATED-ENTITY - PM00593
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5540
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-921
CITATIONS - 1943694
CITATIONS - 6120934
MODE - -
REGULATED-ENTITY - PM00097
REGULATOR - PD00413
//
UNIQUE-ID - REG0-10511
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7786
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM0-10434
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5915
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00670
CITATIONS - 2826388
CITATIONS - 1715855
MODE - -
REGULATED-ENTITY - PM00337
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-6291
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2747
CITATIONS - 14651625
COMMENT - Fis binding to this site functions as an anti-activator of CRP.
MODE - -
REGULATED-ENTITY - PM0-3923
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-11209
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8108
CITATIONS - 21718532
MODE - +
REGULATED-ENTITY - PM00157
REGULATOR - PC00061
//
UNIQUE-ID - REG0-12124
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8444
CITATIONS - 25103863
MODE - +
REGULATED-ENTITY - TU0-13580
REGULATOR - CPLX0-2781
//
UNIQUE-ID - REG0-9039
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7385
CITATIONS - 17496099
MODE - -
REGULATED-ENTITY - PM00063
REGULATOR - CPLX0-8061
//
UNIQUE-ID - REG0-4779
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00018
CITATIONS - 1640456
CITATIONS - 17074904
MODE - -
REGULATED-ENTITY - PM00008
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-5152
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1843
CITATIONS - [9738023]
COMMENT - RtcR with its N terminal truncated activates the transcription of the <i>rtcBA</i> operon.
MODE - +
REGULATED-ENTITY - PM333
REGULATOR - EG12356-MONOMER
//
UNIQUE-ID - REG0-5527
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00728
MODE - -
REGULATED-ENTITY - PM00089
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10490
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7771
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM-8829
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5899
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3201
CITATIONS - 1460045
CITATIONS - 23029459
MODE - -
REGULATED-ENTITY - PM0-4428
REGULATOR - PD01520
//
UNIQUE-ID - REG0-11110
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8092
CITATIONS - 21460078
MODE - -
REGULATED-ENTITY - TU0-13640
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-12036
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8429
CITATIONS - 24720807
MODE - -
REGULATED-ENTITY - PM0-10544
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9007
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1661
CITATIONS - [11279109]
COMMENT - CRP activates the fisP1 promoter in the absence of FIS, but if FIS is present, together FIS and CRP repress <i>fis</i> gene transcription.
MODE - -
REGULATED-ENTITY - PM00028
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4763
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4502
CITATIONS - 1560456
MODE - -
REGULATED-ENTITY - PM00003
REGULATOR - CPLX-172
//
UNIQUE-ID - REG0-5136
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS184
CITATIONS - [7916011]
CITATIONS - [9515701]
MODE - +
REGULATED-ENTITY - PM242
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5511
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00727
CITATIONS - 17513476
MODE - +
REGULATED-ENTITY - PM00087
REGULATOR - MONOMER-47
//
UNIQUE-ID - REG0-10474
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7756
CITATIONS - 19633077
MODE - -
REGULATED-ENTITY - PM0-7561
REGULATOR - EG10087-MONOMER
//
UNIQUE-ID - REG0-5883
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7130
CITATIONS - 14741201
CITATIONS - 16621816
MODE - -
REGULATED-ENTITY - PM00151
REGULATOR - EG10694-MONOMER
//
UNIQUE-ID - REG0-11092
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8081
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00029
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6262
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4363
CITATIONS - 15375149
COMMENT - IHF (-48 site) is fully occupied at IHF concentrations lower than those for IHF (17 site).  The location of it is consistent with a role for IHF in bending DNA to bring NorR into contact with RNA polymerase.
/
MODE - +
REGULATED-ENTITY - PM0-4681
REGULATOR - PC00027
//
UNIQUE-ID - REG0-12001
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8411
CITATIONS - 24089053
COMMENT - HipB represses <i>relA</i> expression, and HipA enhances this repression through direct interaction with HipB, increasing its expression 36.8%, significantly higher than that by HipB alone |CITS: [24089053]|.
MODE - -
REGULATED-ENTITY - PM00427
REGULATOR - EG10442-MONOMER
//
UNIQUE-ID - REG0-8991
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00667
CITATIONS - 15520470
CITATIONS - 2826388
CITATIONS - 1715855
MODE - -
REGULATED-ENTITY - PM00337
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4746
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS402
CITATIONS - [8626344]
COMMENT - Under inducing conditions (growth on acetate), IHF activates <i>aceBAK</i> expression by opposing <i>IclR</i> repression. In contrast, IHF has little effect on <i>aceBAK</i> expression under repressing conditions (growth on glucose).
MODE - +
REGULATED-ENTITY - PM00001
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5118
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3563
CITATIONS - 15066032
COMMENT - ChbR and NagC appear to act as repressors for the <i>chbB</i> operon in the absence of the inducing sugar chitobiose |CITS:[15066032]|.
MODE - +
REGULATED-ENTITY - PM183
REGULATOR - CPLX0-8079
//
UNIQUE-ID - REG0-5494
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4561
CITATIONS - 2231717
MODE - +
REGULATED-ENTITY - PM00140
REGULATOR - CPLX-172
//
UNIQUE-ID - REG0-10456
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7740
CITATIONS - 11443092
MODE - -
REGULATED-ENTITY - PM0-8081
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5866
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6960
CITATIONS - 15659676
MODE - +
REGULATED-ENTITY - PM00146
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11076
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8070
CITATIONS - 21272324
MODE - +
REGULATED-ENTITY - PM687
REGULATOR - PD00197
//
UNIQUE-ID - REG0-6245
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4127
CITATIONS - 14593252
MODE - -
REGULATED-ENTITY - PM0-4922
REGULATOR - PD03585
//
UNIQUE-ID - REG0-11952
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7215
CITATIONS - 8631685
CITATIONS - 8631685:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3599430005:asantos
CITATIONS - 8631685:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3599430005:asantos
MODE - +
REGULATED-ENTITY - PM0-46300
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-8948
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7353
MODE - -
REGULATED-ENTITY - PM00326
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-4730
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00117
CITATIONS - 2538630
CITATIONS - 11013224
CITATIONS - 1824723
MODE - +
REGULATED-ENTITY - PM00047
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5102
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7139
CITATIONS - 9922259
CITATIONS - 9352908
CITATIONS - 9595659
MODE - -
REGULATED-ENTITY - PM00559
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5477
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-903
CITATIONS - 1938967
CITATIONS - 9324270
CITATIONS - 1904443
MODE - +
REGULATED-ENTITY - PM00132
REGULATOR - MONOMER0-162
//
UNIQUE-ID - REG0-10423
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7723
CITATIONS - 19376854
MODE - +
REGULATED-ENTITY - PM0-10370
REGULATOR - PD00406
//
UNIQUE-ID - REG0-5850
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7089
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM00142
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11059
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8054
CITATIONS - 21421764
MODE - +
REGULATED-ENTITY - PM00536
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6229
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3441
CITATIONS - 15073297
CITATIONS - 14996819
CITATIONS - 22101843
MODE - +
REGULATED-ENTITY - PM0-4802
REGULATOR - CPLX0-7721
//
UNIQUE-ID - REG0-11896
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8382
CITATIONS - 18177266
MODE - -
REGULATED-ENTITY - PM0-10229
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6604
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7177
CITATIONS - 16359331
MODE - +
REGULATED-ENTITY - PM0-9199
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-4714
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3622
CITATIONS - 15385551
CITATIONS - 12881519
CITATIONS - 9737918
CITATIONS - 16934214
CITATIONS - 1569008
CITATIONS - 3907860
CITATIONS - 1649816
COMMENT - The CRP-binding site controlling the <i>lacZ</>p1 promoter was enhanced up to 14-fold or abolished by varying the N<sub>6</sub> spacer sequence, which is part of the consensus sequence of the dimer that recognizes a 20-bp region through direct amino acid nucleotide interactions in the major groove of the two operator half-sites |CITS:[24387622]|.
/
/Crystal structure analyses revealed that the interaction results in two strong kinks at the TG/CA steps closest to the 6-bp spacer (N<sub>6</sub>), and the authors proposed that the underlying mechanism relies on N<sub>6</sub> deformability |CITS:[24387622]|.
MODE - +
REGULATED-ENTITY - PM00045
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5086
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2402
CITATIONS - 10760142
CITATIONS - 17233826
MODE - +
REGULATED-ENTITY - PM00547
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5460
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00246
CITATIONS - 23274360
MODE - +
REGULATED-ENTITY - PM00119
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-10338
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7706
CITATIONS - 19352034
MODE - +
REGULATED-ENTITY - PM0-9856
REGULATOR - PHOSPHO-EVGA
//
UNIQUE-ID - REG0-5834
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00786
MODE - +
REGULATED-ENTITY - PM00656
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-11035
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8042
CITATIONS - 8021189
MODE - -
REGULATED-ENTITY - PM0-8864
REGULATOR - EG10442-MONOMER
//
UNIQUE-ID - REG0-6213
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3814
CITATIONS - 9537375
CITATIONS - 9657988
MODE - -
REGULATED-ENTITY - PM0-5167
REGULATOR - PD03585
//
UNIQUE-ID - REG0-11816
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8366
CITATIONS - 23772072
MODE - +
REGULATED-ENTITY - PM0-46277
REGULATOR - PD01520
//
UNIQUE-ID - REG0-6588
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-11
CITATIONS - 3037486
COMMENT - The promoter region of the <i>recN</i> gene contains two 16-bp sequences, separated by 6 bp, that match the consensus sequence (SOS box) for binding LexA protein |CITS:[ 3037486]|.
MODE - -
REGULATED-ENTITY - PM0-3
REGULATOR - PC00010
//
UNIQUE-ID - REG0-4697
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6201
CITATIONS - 1556120
MODE - -
REGULATED-ENTITY - PM00039
REGULATOR - PD03576
//
UNIQUE-ID - REG0-5070
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1942
CITATIONS - [10537212]
MODE - -
REGULATED-ENTITY - PM197
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5444
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00312
MODE - +
REGULATED-ENTITY - PM00163
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10266
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7690
CITATIONS - 18586269
MODE - -
REGULATED-ENTITY - PM206
REGULATOR - PUTA-MONOMER
//
UNIQUE-ID - REG0-5818
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS82
CITATIONS - [8022285]
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM00199
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10990
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8029
CITATIONS - 18083817
CITATIONS - 18808381
CITATIONS - 12730179
MODE - +
REGULATED-ENTITY - PM928
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6197
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4082
CITATIONS - 12374842
CITATIONS - 14996803
MODE - -
REGULATED-ENTITY - PM0-5403
REGULATOR - G7854-MONOMER
//
UNIQUE-ID - REG0-11750
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8351
CITATIONS - 23274360
MODE - -
REGULATED-ENTITY - PM0-44353
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-6572
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6991
CITATIONS - 10542180
MODE - +
REGULATED-ENTITY - PM0-4
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-4681
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00094
CITATIONS - 1556120
MODE - -
REGULATED-ENTITY - PM00037
REGULATOR - PD03576
//
UNIQUE-ID - REG0-5054
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2346
CITATIONS - 10998176
CITATIONS - 12754220
CITATIONS - 16140031
MODE - +
REGULATED-ENTITY - PM439
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5428
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00588
MODE - -
REGULATED-ENTITY - PM00529
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10173
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7675
CITATIONS - 18648770
MODE - +
REGULATED-ENTITY - PM00014
REGULATOR - PC00061
//
UNIQUE-ID - REG0-5802
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00726
CITATIONS - 12754220
CITATIONS - 14766919
CITATIONS - 21272324
COMMENT - FNR binds to two sites upstream of the <i>ndh</i> promoter-like monomer, and both sites contribute to the anaerobic repression of <i>ndh</i> expression |CITS: [14766919]|.
MODE - -
REGULATED-ENTITY - PM00218
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10974
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8022
CITATIONS - 16980449
CITATIONS - 12446650
CITATIONS - 12730179
MODE - -
REGULATED-ENTITY - PM461
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6179
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00408
CITATIONS - 10972807
CITATIONS - 7665470
CITATIONS - 10463182
CITATIONS - 15621456
COMMENT - GcvA interacts with the RNA polymerase &sigma; subunit to activate gcvBp |CITS:[15621456]|.
MODE - +
REGULATED-ENTITY - PM0-6484
REGULATOR - PD00339
//
UNIQUE-ID - REG0-11667
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8336
CITATIONS - 23092251
MODE - +
REGULATED-ENTITY - PM00465
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-6551
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7052
CITATIONS - 15941987
MODE - +
REGULATED-ENTITY - PM-8783
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-4665
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00073
MODE - -
REGULATED-ENTITY - PM00033
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9881
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7647
CITATIONS - 18723630
MODE - -
REGULATED-ENTITY - PM0-10275
REGULATOR - CPLX0-7745
//
UNIQUE-ID - REG0-5038
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS463
CITATIONS - [8913296]
MODE - +
REGULATED-ENTITY - PM586
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5412
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00388
CITATIONS - 8230205
CITATIONS - 21115656
COMMENT - Even though the studies of FruR regulation of <i>fruBKA</i> were done in <i>Salmonella enterica</i> serovar Typhimurium, the inferences can be applied to <i>E. coli</i> also |CITS: [8230205]|. It was observed that in presence of fructose-1-phosphate FruR cannot bind to its <i>fruB</i> site, allowing its transcription. In addition, two FruR operators have been observed in the regulatory region of <i>fruBKA</i>, so a repression mechanism of  FruR for this operon has been proposed: as the two operators are distant, FruR binds to both sites and bends the DNA, avoiding the RNA polymerase  access to the promoter. For a discussion of the serovar Typhimurium evidence see |CITS: [8230205]|.
MODE - -
REGULATED-ENTITY - PM00221
REGULATOR - PC00061
//
UNIQUE-ID - REG0-10085
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7661
CITATIONS - 19007420
MODE - -
REGULATED-ENTITY - PM0-7421
REGULATOR - MONOMER-53
//
UNIQUE-ID - REG0-5786
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00473
CITATIONS - 12923080
CITATIONS - 2168848
CITATIONS - 8501030
CITATIONS - 8057356
CITATIONS - 9302020
MODE - +
REGULATED-ENTITY - PM00217
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-10956
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8011
CITATIONS - 16980449
CITATIONS - 12446650
MODE - +
REGULATED-ENTITY - PM450
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6163
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4341
CITATIONS - 12730174
COMMENT - |CITS:[12730174]| reported that  this site is  at -166.5,  but when identifying the sequence in the genome, it is centered at  -167.5. This site overlaps the putative -10 box of the divergently transcribed upstream <i>metY</i> gene.
MODE - +
REGULATED-ENTITY - PM0-5741
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11649
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8324
CITATIONS - 23071782
COMMENT - Yang et al. identified the binding site of PhoB |CITS:[ 23071782]| but did not identify the promoter regulated; therefore, there is a possibility that this binding site corresponds to another promoter, according to the function of PhoB. The binding site of this regulator, TTGTATGACAAATGTCACA, is located at bp -31 relative to the translation start site of <i>yegH</i> |CITS:[ 23071782]|.
MODE - +
REGULATED-ENTITY - PM0-10077
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-6535
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7127
CITATIONS - 15175316
MODE - +
REGULATED-ENTITY - PM0-8909
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-4649
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00403
MODE - -
REGULATED-ENTITY - PM00031
REGULATOR - PD03028
//
UNIQUE-ID - REG0-9605
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7635
CITATIONS - 9368369
MODE - -
REGULATED-ENTITY - PM0-10243
REGULATOR - PC00010
//
UNIQUE-ID - REG0-5022
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS443
CITATIONS - [8955407]
CITATIONS - [10216857]
MODE - -
REGULATED-ENTITY - PM561
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5396
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS116
CITATIONS - [8119409]
MODE - -
REGULATED-ENTITY - PM00214
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5770
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00399
CITATIONS - [2836368]
CITATIONS - [9575233]
CITATIONS - 12860393
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00207
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-10929
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7997
CITATIONS - 21034467
MODE - -
REGULATED-ENTITY - PM982
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6146
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7181
CITATIONS - 16140472
MODE - -
REGULATED-ENTITY - PM00500
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11630
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8308
CITATIONS - 23233451
MODE - +
REGULATED-ENTITY - PM0-46215
REGULATOR - G6444-MONOMER
//
UNIQUE-ID - REG0-6519
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4241
CITATIONS - 11932447
MODE - +
REGULATED-ENTITY - PM0-1303
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-4633
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2002
CITATIONS - [9335285]
COMMENT - Fis  site II  plays a predominant role in this repression.
MODE - -
REGULATED-ENTITY - PM00028
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-9584
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7619
CITATIONS - 18619465
MODE - +
REGULATED-ENTITY - PM0-10223
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5005
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1744
CITATIONS - [11976288]
CITATIONS - [12446650]
CITATIONS - 16980449
CITATIONS - 15795232
CITATIONS - 12730179
MODE - +
REGULATED-ENTITY - PM461
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-5380
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00602
CITATIONS - 8890170
CITATIONS - 9006049
MODE - +
REGULATED-ENTITY - PM00537
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5754
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00715
CITATIONS - 2000372
MODE - -
REGULATED-ENTITY - PM00235
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-10909
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7976
CITATIONS - 21070640
CITATIONS - 21070640:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3504435189:martin
COMMENT - This binding site was determined from  a computational prediction based on different statistical methods |CITS:[21070640]|. The function of the binding site was assigned according to the distance from the transcription start, with NagC as the transcriptional repressor.
MODE - -
REGULATED-ENTITY - PM00634
REGULATOR - PD00266
//
UNIQUE-ID - REG0-6130
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5523
CITATIONS - 15743943
MODE - -
REGULATED-ENTITY - PM0-7183
REGULATOR - G7678-MONOMER
//
UNIQUE-ID - REG0-11603
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8294
CITATIONS - 22752906
MODE - +
REGULATED-ENTITY - PM00146
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6503
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1062
CITATIONS - [9767573]
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM0-1301
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4617
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00172
CITATIONS - 23274360
MODE - +
REGULATED-ENTITY - PM00071
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-9553
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7603
CITATIONS - 18452510
CITATIONS - 21239586
MODE - -
REGULATED-ENTITY - PM00243
REGULATOR - PD00196
//
UNIQUE-ID - REG0-4987
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS327
CITATIONS - 10913096
MODE - -
REGULATED-ENTITY - PM449
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5364
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1321
CITATIONS - 10482502
MODE - +
REGULATED-ENTITY - PM0-1621
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5738
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00733
MODE - -
REGULATED-ENTITY - PM00229
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-10893
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7965
CITATIONS - 21115656
MODE - -
REGULATED-ENTITY - PM00295
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6114
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5641
CITATIONS - 15667305
CITATIONS - 17449618
MODE - +
REGULATED-ENTITY - PM0-7361
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11576
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8280
CITATIONS - 22442305
MODE - +
REGULATED-ENTITY - TU0-14345
REGULATOR - PHOSPHO-BASR
//
UNIQUE-ID - REG0-6486
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2485
CITATIONS - 12003934
MODE - +
REGULATED-ENTITY - PM0-1163
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-4599
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00159
MODE - -
REGULATED-ENTITY - PM00066
REGULATOR - PC00027
//
UNIQUE-ID - REG0-9471
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7590
CITATIONS - 18245262
CITATIONS - 20952573
MODE - -
REGULATED-ENTITY - PM0-5042
REGULATOR - EG11554-MONOMER
//
UNIQUE-ID - REG0-4971
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS472
CITATIONS - [8913296]
MODE - -
REGULATED-ENTITY - PM588
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5346
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3143
CITATIONS - 11357510
MODE - +
REGULATED-ENTITY - PM0-4427
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5721
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS603
CITATIONS - [8899705]
COMMENT - Repression of <i>mtl</i> transcription occurs only when both MtlR and Fis are expressed.
MODE - -
REGULATED-ENTITY - PM00272
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10859
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7950
CITATIONS - 20718955
MODE - -
REGULATED-ENTITY - PM00313
REGULATOR - G7003-MONOMER
//
UNIQUE-ID - REG0-6098
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5884
MODE - -
REGULATED-ENTITY - PM0-7541
REGULATOR - G7331-MONOMER
//
UNIQUE-ID - REG0-11528
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8260
CITATIONS - 16238633
MODE - -
REGULATED-ENTITY - PM00514
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-6470
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2569
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1349
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4582
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3081
MODE - -
REGULATED-ENTITY - PM00065
REGULATOR - PC00027
//
UNIQUE-ID - REG0-9422
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7576
CITATIONS - 18055596
MODE - +
REGULATED-ENTITY - PM0-9877
REGULATOR - PD00519
//
UNIQUE-ID - REG0-4955
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6997
CITATIONS - 15879709
MODE - +
REGULATED-ENTITY - PM643
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5330
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6971
CITATIONS - 15659676
MODE - +
REGULATED-ENTITY - PM00605
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5704
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS161
CITATIONS - 10760178
CITATIONS - 11742992
MODE - +
REGULATED-ENTITY - PM00175
REGULATOR - MONOMER0-161
//
UNIQUE-ID - REG0-10826
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7933
CITATIONS - 20659289
MODE - +
REGULATED-ENTITY - PM0-10544
REGULATOR - PD00519
//
UNIQUE-ID - REG0-6082
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6441
CITATIONS - 11101675
MODE - -
REGULATED-ENTITY - PM0-8042
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-11510
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7309
CITATIONS - 16115199
MODE - -
REGULATED-ENTITY - PM00578
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6454
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2545
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1343
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4565
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00153
CITATIONS - 2160397
MODE - +
REGULATED-ENTITY - PM00064
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9400
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7726
CITATIONS - 18997424
CITATIONS - 22101843
CITATIONS - 18997424:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3535223022:martin
CITATIONS - 18997424:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3535223022:martin
CITATIONS - 22101843:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3535223022:martin
CITATIONS - 22101843:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3535223022:martin
CITATIONS - 9701802
COMMENT - Three putative DpiA-binding sites, which are A+T-rich sequences,   are located upstream of the <i>citC</i> gene |CITS: [970182]|.
MODE - +
REGULATED-ENTITY - PM0-9889
REGULATOR - PHOSPHO-DPIA
//
UNIQUE-ID - REG0-4939
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2861
CITATIONS - 11071896
MODE - +
REGULATED-ENTITY - PM622
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5314
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS344
CITATIONS - [8002608]
CITATIONS - 1346534
MODE - -
REGULATED-ENTITY - PM00630
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5688
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00359
CITATIONS - 6296057
MODE - -
REGULATED-ENTITY - PM00201
REGULATOR - CPLX0-7714
//
UNIQUE-ID - REG0-10809
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7917
CITATIONS - 20466769
MODE - -
REGULATED-ENTITY - PM00536
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-6063
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6805
CITATIONS - 2543976
COMMENT - Both sites of the MetJ regulator in the intergenic region of <i>metE</i> and <i>metR</i> could negatively regulate both the metRp2 and metRp1 promoters.
MODE - -
REGULATED-ENTITY - PM0-8604
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-11492
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8236
CITATIONS - 18765794
CITATIONS - 22323519
MODE - -
REGULATED-ENTITY - PM450
REGULATOR - EG11356-MONOMER
//
UNIQUE-ID - REG0-6438
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5601
CITATIONS - 10419964
MODE - +
REGULATED-ENTITY - PM0-1441
REGULATOR - PD00406
//
UNIQUE-ID - REG0-4549
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2350
CITATIONS - 10972841
CITATIONS - 15225315
CITATIONS - 18757534
COMMENT - Although Fis and IHF repress  FNR-dependent  activation of the <i>nir</i> promoter, they do not prevent FNR binding.  Thus, Fis, IHF, andFNR can bind simultaneously.
MODE - -
REGULATED-ENTITY - PM00062
REGULATOR - PC00027
//
UNIQUE-ID - REG0-9379
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7540
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM321
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4923
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6082
CITATIONS - 9421904
COMMENT - Even though the FruR site has not been determined for the <i>acnA</i> gene, the FruR effect in its transcription is correlated. It has been proposed that FruR affects the acnAp2 promoter because this  is responsible for the basal level of <i>acnA</i> during exponential growth as well as redox stress |CITS: [9421904]|.	
MODE - +
REGULATED-ENTITY - PM262
REGULATOR - PC00061
//
UNIQUE-ID - REG0-5298
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7244
CITATIONS - 12395194
MODE - -
REGULATED-ENTITY - PM00543
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5672
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-19
CITATIONS - 9882673
MODE - +
REGULATED-ENTITY - PM00636
REGULATOR - PC00084
//
UNIQUE-ID - REG0-10784
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7901
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM0-9512
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6047
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS804
CITATIONS - [8381784]
CITATIONS - 16491024
CITATIONS - 21034467
COMMENT - Hns repress the <i>cadB</i> promoter at pH 8.0
MODE - -
REGULATED-ENTITY - PM00622
REGULATOR - PD00288
//
UNIQUE-ID - REG0-11476
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8223
CITATIONS - 22295907
MODE - -
REGULATED-ENTITY - PM0-46179
REGULATOR - PD00519
//
UNIQUE-ID - REG0-6420
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5484
CITATIONS - 12897000
CITATIONS - 9864311
MODE - -
REGULATED-ENTITY - PM0-1781
REGULATOR - G7678-MONOMER
//
UNIQUE-ID - REG0-4533
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6922
CITATIONS - 8057356
MODE - +
REGULATED-ENTITY - PM00061
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9362
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7524
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM461
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4906
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS581
CITATIONS - 10913096
MODE - +
REGULATED-ENTITY - PM692
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5282
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8193
CITATIONS - 10216857
CITATIONS - 8955407
MODE - -
REGULATED-ENTITY - PM00540
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5656
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00788
MODE - +
REGULATED-ENTITY - PM00674
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10756
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7889
CITATIONS - 12067348
MODE - +
REGULATED-ENTITY - PM262
REGULATOR - PD04418
//
UNIQUE-ID - REG0-6031
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-38
CITATIONS - 16140031
COMMENT - Under microaerobic conditions, ArcA activates <i>cydD</i> expression.
MODE - +
REGULATED-ENTITY - PM961
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11435
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8203
CITATIONS - 10074087
MODE - +
REGULATED-ENTITY - PM00233
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6404
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1601
CITATIONS - [11742080]
CITATIONS - 16677314
CITATIONS - 16824106
CITATIONS - 23075318
MODE - -
REGULATED-ENTITY - PM0-2061
REGULATOR - CPLX0-8083
//
UNIQUE-ID - REG0-4517
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS114
CITATIONS - 8057356
CITATIONS - 1528882
CITATIONS - 7050087
MODE - +
REGULATED-ENTITY - PM00060
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9335
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7506
CITATIONS - 17768236
MODE - +
REGULATED-ENTITY - PM0-1303
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4890
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS528
CITATIONS - 10572146
MODE - +
REGULATED-ENTITY - PM00279
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5266
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3881
CITATIONS - 12618441
COMMENT - IdnR negatively controls the <i>gntK</i> operon, presumably by binding to GntR-binding elements when GntR is released from the operator by interaction with gluconate.
MODE - -
REGULATED-ENTITY - PM00314
REGULATOR - MONOMER0-1301
//
UNIQUE-ID - REG0-5640
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00790
CITATIONS - 1690124
CITATIONS - 2145039
CITATIONS - 3317280
CITATIONS - 2207159
MODE - +
REGULATED-ENTITY - PM00659
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10720
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7871
CITATIONS - 15703297
MODE - +
REGULATED-ENTITY - PM0-8203
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-6015
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2641
CITATIONS - 11121068
MODE - +
REGULATED-ENTITY - PM326
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-11412
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8193
CITATIONS - 8955407
CITATIONS - 10216857
MODE - -
REGULATED-ENTITY - PM561
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6388
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2001
CITATIONS - [2670903]
CITATIONS - 17921503
COMMENT - The regulatory effect of Fur on the promoter exbBp is not yet known. However, we assigned a negative effect to this regulatory interaction based on two facts: (1) the protein's binding site overlaps the -35 box of the promoter; and (2) Fur is known to act, so far without exceptions, as a negative regulator.
MODE - -
REGULATED-ENTITY - PM0-2741
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4501
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00124
CITATIONS - 11448880
CITATIONS - 16515535
COMMENT - The regulatory effect of MetJ on the promoter metAp1 is as yet not known. However, we assigned a negative effect 
/to this regulatory interaction based on two facts: the protein's binding site is very close to the promoter, 
/and  MetJ is known to act, so far without exceptions, as a negative regulator.
MODE - -
REGULATED-ENTITY - PM00051
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-9317
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7494
CITATIONS - 17768236
MODE - +
REGULATED-ENTITY - PM0-1661
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4874
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3762
CITATIONS - 13129959
CITATIONS - 9696769
MODE - +
REGULATED-ENTITY - PM125
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-5249
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7269
CITATIONS - 17233899
MODE - -
REGULATED-ENTITY - PM00254
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5624
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3966
CITATIONS - 14702398
MODE - +
REGULATED-ENTITY - PM00590
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-10682
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7857
CITATIONS - 10644706
MODE - +
REGULATED-ENTITY - PM0-3284
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5999
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4942
CITATIONS - 10071223
MODE - -
REGULATED-ENTITY - PM324
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11376
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8180
CITATIONS - 22101843
MODE - -
REGULATED-ENTITY - PM0-10380
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6372
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1841
CITATIONS - 12748194
MODE - +
REGULATED-ENTITY - PM0-2582
REGULATOR - MONOMER0-1441
//
UNIQUE-ID - REG0-4484
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00232
CITATIONS - 8429549
CITATIONS - 2115869
CITATIONS - 2646291
CITATIONS - 8508774
CITATIONS - 8071194
CITATIONS - 8483418
CITATIONS - 8432705
CITATIONS - 12218014
CITATIONS - 3891724
CITATIONS - 1447135
MODE - +
REGULATED-ENTITY - PM00111
REGULATOR - PD00353
//
UNIQUE-ID - REG0-9281
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7482
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00207
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4857
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS146
CITATIONS - [3302614]
MODE - -
REGULATED-ENTITY - PM00360
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5233
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00704
CITATIONS - 2162467
CITATIONS - 1328649
CITATIONS - 9155036
MODE - -
REGULATED-ENTITY - PM00486
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5607
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7327
CITATIONS - 16115199
MODE - -
REGULATED-ENTITY - PM0-9569
REGULATOR - PC00061
//
UNIQUE-ID - REG0-10666
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7846
CITATIONS - 11443091
MODE - -
REGULATED-ENTITY - PM101
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5983
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1542
CITATIONS - [7608078]
CITATIONS - 9148912
MODE - -
REGULATED-ENTITY - PM00299
REGULATOR - CPLX0-7854
//
UNIQUE-ID - REG0-11335
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8168
CITATIONS - 2543976
CITATIONS - 2643109
CITATIONS - 7836282
CITATIONS - 2673243
MODE - +
REGULATED-ENTITY - PM0-8601
REGULATOR - CPLX0-7752
//
UNIQUE-ID - REG0-6356
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6341
CITATIONS - 10923791
CITATIONS - 14523115
MODE - +
REGULATED-ENTITY - PM0-3281
REGULATOR - PHOSPHO-EVGA
//
UNIQUE-ID - REG0-4467
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3486
CITATIONS - 14711822
CITATIONS - 16849788
MODE - -
REGULATED-ENTITY - PM00109
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-9264
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7468
CITATIONS - 17919280
MODE - -
REGULATED-ENTITY - PM0-2441
REGULATOR - PD01352
//
UNIQUE-ID - REG0-4841
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS755
CITATIONS - [11340070]
COMMENT - CRP has a positive effect on dgsAp2 transcription directed by &sigma;<sup>70</sup>. However, CRP has little effect on dgsAp2 transcription directed by &sigma;<sup>32</sup>.
MODE - +
REGULATED-ENTITY - PM935
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5216
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2430
CITATIONS - 8002608
CITATIONS - 11601842
MODE - -
REGULATED-ENTITY - PM00401
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5589
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00685
MODE - -
REGULATED-ENTITY - PM00184
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-10607
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7831
CITATIONS - 20015147
MODE - -
REGULATED-ENTITY - PM0-10490
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5967
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1148
CITATIONS - [11814655]
COMMENT - The sequence of this site was not shown in the report by |CITS:
/[11814655]|; the authors only mentioned its position. The sequence of
/the mentioned position is not very clear compared with the
/consensus Nac binding sequence.
MODE - -
REGULATED-ENTITY - PM00154
REGULATOR - G7072-MONOMER
//
UNIQUE-ID - REG0-11272
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8153
CITATIONS - 11350954
MODE - +
REGULATED-ENTITY - TU0-42470
REGULATOR - PHOSPHO-CREB
//
UNIQUE-ID - REG0-6340
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6441
CITATIONS - 11101675
CITATIONS - 11917098
MODE - -
REGULATED-ENTITY - PM0-3601
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-12321
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8493
CITATIONS - 25802297
MODE - +
REGULATED-ENTITY - PM0-46356
REGULATOR - PD01520
//
UNIQUE-ID - REG0-9167
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7450
CITATIONS - 17720788
MODE - +
REGULATED-ENTITY - PM0-9688
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-4824
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1284
CITATIONS - [8866483]
CITATIONS - [7961507]
MODE - +
REGULATED-ENTITY - PM164
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-5200
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6982
CITATIONS - 7601827
MODE - -
REGULATED-ENTITY - PM00354
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5572
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7101
CITATIONS - 15520470
CITATIONS - 3062173
MODE - +
REGULATED-ENTITY - PM00178
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10578
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7815
CITATIONS - 19843219
MODE - +
REGULATED-ENTITY - PM0-9632
REGULATOR - MONOMER0-4147
//
UNIQUE-ID - REG0-5951
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS462
CITATIONS - 1736096
CITATIONS - 8917437
MODE - -
REGULATED-ENTITY - PM00289
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-6324
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2341
CITATIONS - 11123679
COMMENT - Hns most strongly represses the cydAp4 promoter and has a moderate effect on cydAp1, cydAp2, and cydAp3 promoters. Hns regulates <i>cydAB</i> expression negatively in anaerobiosis and aerobiosis, but ArcA antagonizes its action in anaerobiosis.
MODE - -
REGULATED-ENTITY - PM0-3341
REGULATOR - PD00288
//
UNIQUE-ID - REG0-12227
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8478
CITATIONS - 25845847
MODE - -
REGULATED-ENTITY - PM0-46346
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-9112
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7433
CITATIONS - 17526711
MODE - +
REGULATED-ENTITY - PM0-9577
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4808
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00050
MODE - -
REGULATED-ENTITY - PM00024
REGULATOR - PD01196
//
UNIQUE-ID - REG0-9091
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7431
CITATIONS - 8416900
CITATIONS - 17630975
MODE - -
REGULATED-ENTITY - PM0-1041
REGULATOR - MONOMER-52
//
UNIQUE-ID - REG0-4805
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00047
CITATIONS - [9003304]
CITATIONS - 2982847
MODE - -
REGULATED-ENTITY - PM00023
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5181
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00579
CITATIONS - 9157253
CITATIONS - 15520470
COMMENT - The CRP-binding site is the same as the FNR-binding site, with a center position at  -41.5.
MODE - +
REGULATED-ENTITY - PM00353
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5553
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2922
CITATIONS - 11448880
COMMENT - The regulatory effect of MetJ on the promoter ahpCp is not yet known. However, we assigned a negative effect to this regulatory interaction based on two facts: the protein's binding site is very close to the promoter, and MetJ is known to act, so far without exceptions, as a negative regulator.
MODE - -
REGULATED-ENTITY - PM00102
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-10537
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7798
CITATIONS - 1715855
MODE - -
REGULATED-ENTITY - PM00337
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5928
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00461
CITATIONS - [8757744]
CITATIONS - [7608086]
CITATIONS - 8900067
CITATIONS - 8998977
MODE - +
REGULATED-ENTITY - PM00268
REGULATOR - CPLX0-7752
//
UNIQUE-ID - REG0-6305
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3041
CITATIONS - 11532138
COMMENT - H-NS modulate csiD expression by influencing activation by cAMP-CRP
MODE - +
REGULATED-ENTITY - PM0-4241
REGULATOR - PD00288
//
UNIQUE-ID - REG0-11222
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8117
CITATIONS - 11071896
CITATIONS - 11071896:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3523037529:martin
CITATIONS - 11071896:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3523037529:martin
CITATIONS - 11071896:EV-EXP-IMP-SITE-MUTATION:3523037529:martin
MODE - -
REGULATED-ENTITY - PM622
REGULATOR - EG10571-MONOMER
//
UNIQUE-ID - REG0-12187
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8459
CITATIONS - 25375160
MODE - +
REGULATED-ENTITY - PM0-10287
REGULATOR - G6789-MONOMER
//
UNIQUE-ID - REG0-9052
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7404
CITATIONS - 17616594
CITATIONS - 3025185
CITATIONS - 2883171
CITATIONS - 16153782
MODE - +
REGULATED-ENTITY - PM00155
REGULATOR - PHOSPHO-ATOC
//
UNIQUE-ID - REG0-4792
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00028
CITATIONS - 7961453
CITATIONS - 3001025
CITATIONS - 1530846
MODE - -
REGULATED-ENTITY - PM00013
REGULATOR - MONOMER0-162
//
UNIQUE-ID - REG0-5165
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7231
CITATIONS - 17185540
MODE - +
REGULATED-ENTITY - PM421
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5537
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4061
CITATIONS - 8613990
CITATIONS - 3050131
CITATIONS - 10518785
CITATIONS - 3315853
MODE - -
REGULATED-ENTITY - PM00094
REGULATOR - CPLX-125
//
UNIQUE-ID - REG0-10508
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7783
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM0-10144
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5912
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00795
CITATIONS - [8057842]
CITATIONS - [9868788]
CITATIONS - 15699038
COMMENT - The anaerobic repression is mediated by ArcA, as witnessed by the fivefold anaerobic derepression (and up to twofold aerobic derepression) in an <i>arcA</i> mutant.	
MODE - -
REGULATED-ENTITY - PM00326
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-6288
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2745
CITATIONS - 12923087
CITATIONS - 10894724
CITATIONS - 17630973
COMMENT - Activation of the acsp2 promoter absolutely requires a CRP site centered at position   -69.5, while optimal expression requires an additional site centered at position  -122.5.
MODE - +
REGULATED-ENTITY - PM0-3923
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11205
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8104
CITATIONS - 21571995
MODE - +
REGULATED-ENTITY - PM0-9828
REGULATOR - PHOSPHO-RCSB
//
UNIQUE-ID - REG0-12121
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8441
CITATIONS - 25103863
MODE - +
REGULATED-ENTITY - PM0-45513
REGULATOR - CPLX0-2781
//
UNIQUE-ID - REG0-9036
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7382
CITATIONS - 17557822
MODE - +
REGULATED-ENTITY - PM00320
REGULATOR - MONOMER0-162
//
UNIQUE-ID - REG0-4776
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00015
CITATIONS - 1640456
CITATIONS - 17074904
MODE - -
REGULATED-ENTITY - PM00006
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-5149
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS542
CITATIONS - [8899708]
CITATIONS - [10564485]
MODE - +
REGULATED-ENTITY - PM332
REGULATOR - PD00406
//
UNIQUE-ID - REG0-5524
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00198
CITATIONS - 17921503
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00089
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-10487
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7768
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM1001
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5896
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7091
CITATIONS - 15520470
CITATIONS - 23029459
MODE - +
REGULATED-ENTITY - PM0-4428
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11106
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8087
CITATIONS - 21460078
CITATIONS - 21460078:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3514125639:martin
CITATIONS - 21460078:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3514125639:martin
MODE - -
REGULATED-ENTITY - PM0-36235
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6275
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3403
CITATIONS - 8576032
CITATIONS - 10559180
MODE - -
REGULATED-ENTITY - PM0-4723
REGULATOR - G7821-MONOMER
//
UNIQUE-ID - REG0-12018
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8425
CITATIONS - 24659771
MODE - -
REGULATED-ENTITY - PM0-10155
REGULATOR - EG11084-MONOMER
//
UNIQUE-ID - REG0-9004
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00162
CITATIONS - [2656631]
CITATIONS - [2656704]
CITATIONS - [2553720]
CITATIONS - [9422609]
CITATIONS - 10698756
CITATIONS - 11158569
CITATIONS - 11812125
CITATIONS - 8175665
CITATIONS - 1648075
CITATIONS - 7557323
CITATIONS - 8113170
CITATIONS - 16618701
MODE - -
REGULATED-ENTITY - PM00066
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-4760
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00004
CITATIONS - 8510144
CITATIONS - 1848302
CITATIONS - 8980677
CITATIONS - 9600836
CITATIONS - 8516313
MODE - +
REGULATED-ENTITY - PM00003
REGULATOR - CPLX-172
//
UNIQUE-ID - REG0-5133
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS190
CITATIONS - [7916011]
CITATIONS - [9515701]
MODE - +
REGULATED-ENTITY - PM241
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5508
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4601
CITATIONS - 11073923
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM00087
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10471
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7753
CITATIONS - 19633077
MODE - -
REGULATED-ENTITY - PM0-8848
REGULATOR - EG10087-MONOMER
//
UNIQUE-ID - REG0-5880
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1302
CITATIONS - 11287152
COMMENT - The regulatory role of FlhDC in transcription of the <i>mdh</i> operon has been demonstrated
/only via microarray analysis |CITS: [11287152]|.
MODE - -
REGULATED-ENTITY - PM00150
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-11089
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8079
CITATIONS - 21272324
MODE - +
REGULATED-ENTITY - PM00379
REGULATOR - PD00197
//
UNIQUE-ID - REG0-6259
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3302
CITATIONS - 11139621
CITATIONS - 9469834
CITATIONS - 7934873
MODE - -
REGULATED-ENTITY - PM0-4621
REGULATOR - PD00266
//
UNIQUE-ID - REG0-11988
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8410
CITATIONS - 24335284
MODE - +
REGULATED-ENTITY - PM0-46308
REGULATOR - CPLX0-7916
//
UNIQUE-ID - REG0-8988
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00701
CITATIONS - 7715459
MODE - -
REGULATED-ENTITY - PM00620
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4743
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00118
CITATIONS - 2664421
MODE - +
REGULATED-ENTITY - PM00048
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-5115
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS154
CITATIONS - 1310090
MODE - -
REGULATED-ENTITY - PM221
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5491
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00282
CITATIONS - 2231717
CITATIONS - 1447222
MODE - +
REGULATED-ENTITY - PM00139
REGULATOR - CPLX-172
//
UNIQUE-ID - REG0-10453
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7739
CITATIONS - 9570400
MODE - -
REGULATED-ENTITY - PM331
REGULATOR - PD00196
//
UNIQUE-ID - REG0-5863
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS187
CITATIONS - [9209026]
MODE - -
REGULATED-ENTITY - PM00144
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11073
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8067
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00297
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6242
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4121
CITATIONS - 14593252
MODE - +
REGULATED-ENTITY - PM0-4922
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11949
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8395
CITATIONS - 24013633
MODE - +
REGULATED-ENTITY - PM0-46302
REGULATOR - G6706-MONOMER
//
UNIQUE-ID - REG0-8939
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7343
CITATIONS - 17209026
MODE - +
REGULATED-ENTITY - PM0-9593
REGULATOR - EG12094-MONOMER
//
UNIQUE-ID - REG0-4727
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5101
CITATIONS - 2664421
CITATIONS - 2538630
MODE - +
REGULATED-ENTITY - PM00047
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-5099
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2163
CITATIONS - 10766858
CITATIONS - 15159386
MODE - -
REGULATED-ENTITY - PM5
REGULATOR - CPLX0-7731
//
UNIQUE-ID - REG0-5474
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS756
CITATIONS - [9484893]
MODE - -
REGULATED-ENTITY - PM00129
REGULATOR - PD01896
//
UNIQUE-ID - REG0-10415
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7718
CITATIONS - 19220752
CITATIONS - 25375160
MODE - +
REGULATED-ENTITY - PM0-10349
REGULATOR - G6789-MONOMER
//
UNIQUE-ID - REG0-5847
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00349
CITATIONS - 7961413
MODE - -
REGULATED-ENTITY - PM00195
REGULATOR - PD00291
//
UNIQUE-ID - REG0-11056
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8051
CITATIONS - 21421764
MODE - +
REGULATED-ENTITY - PM00535
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6226
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7191
CITATIONS - 16377617
COMMENT - By making use of microarray analysis, Constantinidou et al. |CITS: [16377617]| concluded that FNR activates <i>uxaCA</i> operon expression. They also identified a putative FNR-binding site upstream of the operon, but the sequence was not reported.
MODE - +
REGULATED-ENTITY - PM0-5261
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11893
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8379
CITATIONS - 23874328
MODE - +
REGULATED-ENTITY - PM0-10349
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-6601
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7194
CITATIONS - 16377617
COMMENT - By making use of microarray analyses, Constantinidou et al. |CITS: [16377617]| concluded that FNR activates <i>yjiD</i> gene expression. They also identified a putative FNR-binding site upstream of the gene, but the sequence was not shown.
MODE - +
REGULATED-ENTITY - PM0-9061
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4711
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7156
CITATIONS - 16377617
MODE - +
REGULATED-ENTITY - PM00043
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5083
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7247
CITATIONS - 17233826
MODE - +
REGULATED-ENTITY - PM00547
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5457
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5182
CITATIONS - 12657056
MODE - +
REGULATED-ENTITY - PM00117
REGULATOR - PHOSPHO-TORR
//
UNIQUE-ID - REG0-10333
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7703
CITATIONS - 19245365
MODE - +
REGULATED-ENTITY - PM0-10357
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5831
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3161
CITATIONS - 8550494
CITATIONS - 8071201
MODE - -
REGULATED-ENTITY - PM00367
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11032
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8039
CITATIONS - 17170003
MODE - -
REGULATED-ENTITY - PM0-10318
REGULATOR - CPLX0-7929
//
UNIQUE-ID - REG0-6210
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7079
CITATIONS - 14701822
MODE - -
REGULATED-ENTITY - PM00134
REGULATOR - PD00365
//
UNIQUE-ID - REG0-11811
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8363
CITATIONS - 23564175
CITATIONS - 25246476
COMMENT - The regulation of CpxR on the <i>yqaE</i> gene has been demonstrated via <i>lacZ</i> reporter gene expression experiments, quantitative PCR analysis of cDNA, and by the identification of a consensus DNA-binding site of CpxR in the regulatory region of <i>yqaE</i> |CITS:[ 23564175]|. The identification of this DNA-binding site was only mentioned in the paper of Raivio et al. (2013), but the DNA sequence was not shown |CITS:[ 23564175]|.
MODE - +
REGULATED-ENTITY - PM0-10299
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-6585
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3352
CITATIONS - 16417519
MODE - -
REGULATED-ENTITY - PM0-9342
REGULATOR - EG12108-MONOMER
//
UNIQUE-ID - REG0-4694
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS105
CITATIONS - [1521763]
MODE - +
REGULATED-ENTITY - PM00039
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5067
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1141
CITATIONS - [9495755]
MODE - -
REGULATED-ENTITY - PM65
REGULATOR - G7072-MONOMER
//
UNIQUE-ID - REG0-5441
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7318
CITATIONS - 9582281
MODE - -
REGULATED-ENTITY - PM00161
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10262
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7687
CITATIONS - 18501926
MODE - -
REGULATED-ENTITY - PM0-9527
REGULATOR - CPLX0-7928
//
UNIQUE-ID - REG0-5815
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00360
CITATIONS - 2515108
MODE - -
REGULATED-ENTITY - PM00171
REGULATOR - PD03254
//
UNIQUE-ID - REG0-10987
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3862
CITATIONS - 14702398
CITATIONS - 12730179
CITATIONS - 18808381
CITATIONS - 18083817
COMMENT - GadX has a positive direct or indirect effect on the <i>hdeAB-yhiD</i> operon only in stationary-phase cells at pH 5.5, but it is a repressor in exponential growth phase at pH 7.0 |CITS: [18083817]|.
MODE - -
REGULATED-ENTITY - PM928
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6194
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4081
CITATIONS - 14996803
CITATIONS - 12374842
CITATIONS - 12644495
MODE - -
REGULATED-ENTITY - PM0-5402
REGULATOR - G7854-MONOMER
//
UNIQUE-ID - REG0-11747
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8348
CITATIONS - 23274360
MODE - +
REGULATED-ENTITY - PM0-2441
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-6568
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7032
CITATIONS - 15995204
MODE - -
REGULATED-ENTITY - PM0-8728
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-4678
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1303
CITATIONS - [11287152]
COMMENT - The regulatory effect of FlhDC in the <i>glpA</i> operon transcription has been proved only by microarray analysis by |CITS: [11287152]|.
MODE - +
REGULATED-ENTITY - PM00037
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-9997
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7650
CITATIONS - 18808381
MODE - -
REGULATED-ENTITY - PM0-10288
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-5051
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS321
CITATIONS - [8057841]
MODE - +
REGULATED-ENTITY - PM437
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5425
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2845
CITATIONS - 8253679
CITATIONS - 10856246
COMMENT - Lrp is not essential for osmotic induction of <i>osmY</i>.
MODE - -
REGULATED-ENTITY - PM00529
REGULATOR - PD00353
//
UNIQUE-ID - REG0-10135
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7673
CITATIONS - 12694615
CITATIONS - 19352034
MODE - +
REGULATED-ENTITY - PM0-10331
REGULATOR - PHOSPHO-EVGA
//
UNIQUE-ID - REG0-5799
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS747
CITATIONS - [9308170]
MODE - -
REGULATED-ENTITY - PM00218
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10971
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8021
CITATIONS - 12730179
MODE - -
REGULATED-ENTITY - PM00137
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6176
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7311
CITATIONS - 16885453
COMMENT - Based on genome-wide analysis, it was discovered that CRP downregulates the expression of the <i>mdtEF</i> gene cluster, and a novel uncharacterized physiological role for CRP in multidrug resistance has been described by Nishino et al. (2008). |CITS:[18503189]| .
MODE - -
REGULATED-ENTITY - PM0-5982
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11664
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8334
CITATIONS - 23092251
MODE - -
REGULATED-ENTITY - PM00465
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-6548
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7051
CITATIONS - 15941987
MODE - +
REGULATED-ENTITY - PM-8782
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-4662
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00074
CITATIONS - 9016640
CITATIONS - 14500788
CITATIONS - 15289461
COMMENT - In the total absence of galactose, HU and GalR repress the expression of the <i>gal</i> operon. But at a low concentration of galactose, GalR, bound to just a site at position -55.5,  activates the expression of the operon through the galp2 promoter |CITS: [16524589]|.
MODE - -
REGULATED-ENTITY - PM00033
REGULATOR - PD03028
//
UNIQUE-ID - REG0-9784
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7646
CITATIONS - 18673442
CITATIONS - 11321589
CITATIONS - 9473050
CITATIONS - 18673442:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3434400889:asantos
CITATIONS - 11321589:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3434400889:asantos
CITATIONS - 9473050:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3434400889:asantos
MODE - +
REGULATED-ENTITY - PM0-10259
REGULATOR - PD04418
//
UNIQUE-ID - REG0-5035
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS466
CITATIONS - [8913296]
MODE - +
REGULATED-ENTITY - PM586
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5409
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7320
CITATIONS - 2139473
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00228
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-10000
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7658
CITATIONS - 18808381
CITATIONS - 12730179
MODE - -
REGULATED-ENTITY - PM00137
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-5783
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS50
CITATIONS - 1629153
CITATIONS - 12923080
MODE - +
REGULATED-ENTITY - PM00217
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-10953
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8008
CITATIONS - 16980449
CITATIONS - 11976288
CITATIONS - 12446650
CITATIONS - 15795232
MODE - +
REGULATED-ENTITY - PM450
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6160
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4202
MODE - +
REGULATED-ENTITY - PM0-5642
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-11645
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8322
CITATIONS - 23071782
MODE - +
REGULATED-ENTITY - PM0-2002
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-6532
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5022
MODE - -
REGULATED-ENTITY - PM0-1122
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4646
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5704
MODE - -
REGULATED-ENTITY - PM00031
REGULATOR - PD03028
//
UNIQUE-ID - REG0-9602
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7628
CITATIONS - Suzuki03
CITATIONS - 2864330
MODE - -
REGULATED-ENTITY - PM00154
REGULATOR - CPLX0-7733
//
UNIQUE-ID - REG0-5019
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS423
CITATIONS - [9648752]
CITATIONS - 10216857
CITATIONS - 8955407
MODE - +
REGULATED-ENTITY - PM561
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5393
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1061
CITATIONS - [10206709]
COMMENT - A model has been proposed in which ModE-molybdate serves as a secondary transcriptional activator of both the <i>hyc</i> and <i>narXL</i> operons,  which  are activated primarily by the transcriptional activators FhlA and NarL, respectively.
MODE - +
REGULATED-ENTITY - PM00214
REGULATOR - CPLX0-6
//
UNIQUE-ID - REG0-5767
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6044
CITATIONS - 11115104
MODE - +
REGULATED-ENTITY - PM00202
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10926
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7994
CITATIONS - 21034467
MODE - -
REGULATED-ENTITY - PM0-9849
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6143
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7178
CITATIONS - 16140472
MODE - -
REGULATED-ENTITY - PM00500
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11627
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8305
CITATIONS - 23233451
MODE - -
REGULATED-ENTITY - PM00092
REGULATOR - G6444-MONOMER
//
UNIQUE-ID - REG0-6516
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1064
CITATIONS - [9767573]
COMMENT - The DgsA transcriptional repressor is inactivated by the cytoplasmic protein MtfA via a protein-protein interaction that prevents interaction of DgsA with its binding sites on the <i>ptsG</i> upstream region |CITS:[22178967]|.
MODE - -
REGULATED-ENTITY - PM0-1302
REGULATOR - PD01896
//
UNIQUE-ID - REG0-4630
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7241
CITATIONS - 1459953
MODE - -
REGULATED-ENTITY - PM00028
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-9578
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7616
CITATIONS - 11321589
MODE - -
REGULATED-ENTITY - PM00401
REGULATOR - EG12116-MONOMER
//
UNIQUE-ID - REG0-5002
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS340
CITATIONS - [8002608]
CITATIONS - 1346534
MODE - -
REGULATED-ENTITY - PM00631
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5377
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3472
CITATIONS - 14711822
MODE - -
REGULATED-ENTITY - PM00293
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5751
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00712
CITATIONS - 1433305
CITATIONS - 2000372
COMMENT - IHF binds to a site  immediately  upstream of glnHp2 and enhances  the activation of open complex formation by NRI phosphate.
MODE - +
REGULATED-ENTITY - PM00235
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10906
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7978
COMMENT - This binding site was determined from  a computational prediction based on different statistical methods |CITS:[21070640]|. The function of the binding site was assigned according to the distance from the transcription start, with NagC as the transcriptional repressor.
MODE - -
REGULATED-ENTITY - PM0-10244
REGULATOR - PD00266
//
UNIQUE-ID - REG0-6127
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5524
CITATIONS - 15743943
MODE - +
REGULATED-ENTITY - PM0-7183
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11590
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8291
CITATIONS - 6328431
CITATIONS - 6328431:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3554842022:asantos
MODE - -
REGULATED-ENTITY - PM00371
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6500
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3728
CITATIONS - 12588863
COMMENT - Fis binding to site I and II can coactivate ptsGp1 transcription with CRP.
MODE - +
REGULATED-ENTITY - PM0-1301
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4614
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7274
CITATIONS - 16861804
COMMENT - The consensus of this CpxR-binding site is not located in the same DNA strand as in the ycfSp promoter |CITS:[16861804]|.
MODE - +
REGULATED-ENTITY - PM0-9396
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-9546
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7600
CITATIONS - 18405378
MODE - -
REGULATED-ENTITY - PM00279
REGULATOR - PD00353
//
UNIQUE-ID - REG0-4984
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3929
CITATIONS - 7007313
MODE - -
REGULATED-ENTITY - PM101
REGULATOR - PD03270
//
UNIQUE-ID - REG0-5360
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7304
CITATIONS - 3025182
CITATIONS - 9765583
CITATIONS - 9209034
CITATIONS - 9209035
COMMENT - The TyrR-binding site at position 63.5 from the aroPp1 promoter is a weak TyrR box that is involved in the repression of <i>aroP</i> gene transcription |CITS:[10515932]|.
MODE - -
REGULATED-ENTITY - PM00014
REGULATOR - MONOMER0-162
//
UNIQUE-ID - REG0-5735
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00489
CITATIONS - 2539360
CITATIONS - 1640834
CITATIONS - 21572102
COMMENT - This PurR-binding site overlaps the  -35 box of the codBp ptomoter |CITS: [1640834]|.
MODE - -
REGULATED-ENTITY - PM00278
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-10890
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7962
CITATIONS - 21115656
MODE - -
REGULATED-ENTITY - PM0-3802
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6111
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6939
CITATIONS - 15667305
CITATIONS - 17449618
MODE - +
REGULATED-ENTITY - PM0-7361
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-11572
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8277
CITATIONS - 22685278
MODE - +
REGULATED-ENTITY - PM0-46197
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6483
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2503
CITATIONS - 12003934
COMMENT - ArgR enhances expression from  the astCp2 promoter but is not essential for its expression |CITS: [12003934]|.
MODE - +
REGULATED-ENTITY - PM0-1163
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-4596
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7033
CITATIONS - 16077119
CITATIONS - 23564175
COMMENT - Repression of <i>ompF</i> by CpxR could result from prevention of either OmpR or RNA polymerase binding |CITS: [16077119]|.
MODE - -
REGULATED-ENTITY - PM00066
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-9468
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7587
CITATIONS - 18368388
MODE - +
REGULATED-ENTITY - PM0-1301
REGULATOR - PD00406
//
UNIQUE-ID - REG0-4968
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS475
CITATIONS - [8913296]
MODE - -
REGULATED-ENTITY - PM588
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5343
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00700
CITATIONS - 7715459
MODE - -
REGULATED-ENTITY - PM00621
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5717
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS63
CITATIONS - 7551052
CITATIONS - 3135464
CITATIONS - 8195106
CITATIONS - 6309813
MODE - +
REGULATED-ENTITY - PM00272
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10855
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7946
CITATIONS - 20874755
COMMENT - The MlrA-<i>yrbA</i>p regulatory interaction was identified by sequence analysis reported by Ogasawara et al., and by a gel shift assay using purified transcription factor (data not provided) |CITS[20874755]|.
MODE - +
REGULATED-ENTITY - PM0-36160
REGULATOR - EG12008-MONOMER
//
UNIQUE-ID - REG0-6095
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6341
CITATIONS - 9532784
CITATIONS - 12694615
MODE - +
REGULATED-ENTITY - PM0-7921
REGULATOR - PHOSPHO-EVGA
//
UNIQUE-ID - REG0-11524
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8257
CITATIONS - 20923783
MODE - -
REGULATED-ENTITY - PM0-5261
REGULATOR - PD03270
//
UNIQUE-ID - REG0-6467
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5243
CITATIONS - 9632265
CITATIONS - 15686546
COMMENT - Paradoxically, even though H-NS is an inhibitor it drives the bound RNA 
/polymerase into open complexes |CITS: [15686546]|.
/
MODE - -
REGULATED-ENTITY - PM0-1347
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4579
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS330
CITATIONS - [8002608]
CITATIONS - 1346534
COMMENT - Binding of Lrp to one site enhances occupancy of the other Lrp sites  in the  ompCp1 promoter. Leucine does not abolish  DNA binding by the ligated Lrp but it may alter the affinity of Lrp for specific sites on DNA.
MODE - -
REGULATED-ENTITY - PM00065
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-9418
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7572
CITATIONS - 9422614
CITATIONS - 20952573
COMMENT - LeuO can fully antagonize the negative effect of H-NS on the <i>bglGFB</i> operon |CITS: [9422614]|.
MODE - +
REGULATED-ENTITY - PM0-5042
REGULATOR - PD00519
//
UNIQUE-ID - REG0-4952
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS506
CITATIONS - 3145340
MODE - -
REGULATED-ENTITY - PM00474
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5327
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1922
MODE - -
REGULATED-ENTITY - PM00598
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5701
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00318
CITATIONS - 2830238
MODE - +
REGULATED-ENTITY - PM00169
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10823
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7930
CITATIONS - 20622065
MODE - -
REGULATED-ENTITY - PM0-36147
REGULATOR - PD01520
//
UNIQUE-ID - REG0-6079
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6381
CITATIONS - 12460564
CITATIONS - 18957590
MODE - -
REGULATED-ENTITY - PM0-7982
REGULATOR - CPLX0-8071
//
UNIQUE-ID - REG0-11507
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8250
CITATIONS - 16115199
MODE - -
REGULATED-ENTITY - PM00577
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6451
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7142
CITATIONS - 16238633
MODE - -
REGULATED-ENTITY - PM0-1341
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-4562
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00151
CITATIONS - [8288532]
CITATIONS - [9819053]
MODE - +
REGULATED-ENTITY - PM00063
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-9393
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7554
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM70
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4936
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS765
CITATIONS - [9421904]
MODE - -
REGULATED-ENTITY - PM263
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5311
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2430
CITATIONS - [8002608]
CITATIONS - 1346534
MODE - -
REGULATED-ENTITY - PM00630
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5685
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3351
CITATIONS - 7934818
CITATIONS - 8830277
CITATIONS - 8437561
MODE - -
REGULATED-ENTITY - PM00191
REGULATOR - PD00288
//
UNIQUE-ID - REG0-10806
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7914
CITATIONS - 18383615
MODE - +
REGULATED-ENTITY - PM0-10021
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-6060
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6805
CITATIONS - 2543976
COMMENT - Both sites of the MetJ regulator in the intergenic region of <i>metE</i> and <i>metR</i> could negatively regulate both promoters metRp2 and metRp1.
MODE - -
REGULATED-ENTITY - PM0-8603
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-11489
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8233
CITATIONS - 22323519
MODE - -
REGULATED-ENTITY - PM0-5982
REGULATOR - EG11356-MONOMER
//
UNIQUE-ID - REG0-6435
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1145
CITATIONS - [9785451]
MODE - -
REGULATED-ENTITY - PM00379
REGULATOR - G7072-MONOMER
//
UNIQUE-ID - REG0-4546
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4208
CITATIONS - 15225315
COMMENT - The effect of Fis (-97 site) in the local nucleoprotein structure is not yet clear.
MODE - -
REGULATED-ENTITY - PM00062
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-9376
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7537
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM681
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4920
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7304
CITATIONS - 3025182
CITATIONS - 9765583
CITATIONS - 9209034
CITATIONS - 9209035
COMMENT - The TyrR-binding site at position bp 20.5 from the aroPp2 promoter is a strong TyrR box that is involved in the repression of <i>aroP</i> gene transcription |CITS:[10515932]|. This strong box, which is closest to the promoter, is critical for repression, due to the fact that this site is bound by TyrR as a dimer or as a hexamer. The weak box has a less significant role in aroPp2 repression |CITS:[10515932]|.
MODE - -
REGULATED-ENTITY - PM741
REGULATOR - MONOMER0-162
//
UNIQUE-ID - REG0-5295
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6623
CITATIONS - 15743955
MODE - +
REGULATED-ENTITY - PM0-8241
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5669
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7125
CITATIONS - 1640456
CITATIONS - 17074904
MODE - -
REGULATED-ENTITY - PM00152
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-10778
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS583
CITATIONS - 10913096
COMMENT - In 2000, Ibanez <i>et al</i> showed that transcription of the divergent operon <i>yiaJ</i>-<i>yiaKLMNO-lyxK-sgbHUE</i> depends on the YiaJ repressor. However, the authors suggested that this regulator binds a long region of 35 bp |CITS: [10913096]|. The alignment of this region with the orthologous sequence of <i>Klebsiella pneumoniae</i> showed a conserved palindrome of 21 bp |CITS: [18708499]|. The position and length of the YiaJ binding site have been changed to reflect this.
MODE - -
REGULATED-ENTITY - PM449
REGULATOR - EG12278-MONOMER
//
UNIQUE-ID - REG0-6044
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7172
CITATIONS - 8381784
CITATIONS - 16491024
CITATIONS - 21034467
COMMENT - Hns repress the <i>cadB</i> promoter at pH 8.0
MODE - -
REGULATED-ENTITY - PM00622
REGULATOR - PD00288
//
UNIQUE-ID - REG0-11473
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7556
CITATIONS - 15582999
CITATIONS - 15582999:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3545039504:martin
MODE - -
REGULATED-ENTITY - PM0-46179
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6417
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1382
CITATIONS - [11031114]
MODE - +
REGULATED-ENTITY - PM0-1729
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-4530
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6925
CITATIONS - 8057356
MODE - +
REGULATED-ENTITY - PM00061
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9359
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7521
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM461
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4903
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00418
CITATIONS - [9924977]
CITATIONS - [7715442]
MODE - -
REGULATED-ENTITY - PM00242
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5279
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00571
COMMENT - ArcA mediates anaerobic regulation of the <i>focA-pflB</i> operon. Its positive regulation shows a strong dependence on IHF. This ArcA-binding site overlaps the transcription start site of the focAp2 promoter. The binding of ArcA to this site may be required for the formation of a stable closed complex between Fnr and RNA polymerase at the focAp3 promoter. Clearly, it will be necessary to examine the occupancy of this site by ArcA in the presence of RNA polymerase and FNR before any speculation can be made as to the physiological relevance of this binding site, although <i>in vivo</i> studies using an <i>arcA</i> mutant have clearly established that ArcA is essential for transcription from the focAp3 promoter.
MODE - +
REGULATED-ENTITY - PM00517
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5653
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS303
CITATIONS - [10564497]
MODE - +
REGULATED-ENTITY - PM00528
REGULATOR - CPLX0-8062
//
UNIQUE-ID - REG0-10753
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7886
CITATIONS - 12067348
MODE - +
REGULATED-ENTITY - PM0-2281
REGULATOR - PD04418
//
UNIQUE-ID - REG0-6028
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS825
CITATIONS - [11101674]
MODE - -
REGULATED-ENTITY - PM1021
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11430
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8200
CITATIONS - 10463182
CITATIONS - 7665470
CITATIONS - 8188587
CITATIONS - 15621456
CITATIONS - 10972807
MODE - -
REGULATED-ENTITY - PM00234
REGULATOR - PD00339
//
UNIQUE-ID - REG0-6401
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1582
CITATIONS - [10564485]
CITATIONS - 11395452
CITATIONS - 21097628
MODE - +
REGULATED-ENTITY - PM0-2021
REGULATOR - PD00365
//
UNIQUE-ID - REG0-4514
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3281
CITATIONS - 9469834
CITATIONS - 1848637
CITATIONS - 11139621
CITATIONS - 7934873
COMMENT - CAP and NagC can bind simultaneously and produce a more stable complex than binary NagC-DNA complex.
MODE - -
REGULATED-ENTITY - PM00058
REGULATOR - PD00266
//
UNIQUE-ID - REG0-9330
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7501
CITATIONS - 17768236
MODE - +
REGULATED-ENTITY - PM00047
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4887
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS447
CITATIONS - [9924977]
CITATIONS - [7715442]
MODE - -
REGULATED-ENTITY - PM00241
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5263
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00623
CITATIONS - 8071234
MODE - +
REGULATED-ENTITY - PM00563
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5637
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00672
MODE - +
REGULATED-ENTITY - PM00597
REGULATOR - PD00288
//
UNIQUE-ID - REG0-10712
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7868
CITATIONS - 20156994
MODE - +
REGULATED-ENTITY - PM0-10539
REGULATOR - CPLX0-8048
//
UNIQUE-ID - REG0-6012
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS821
CITATIONS - [2575702]
CITATIONS - [1327747]
COMMENT - CRP and CytR bind cooperatively to cddp.
MODE - +
REGULATED-ENTITY - PM1001
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11407
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00229
CITATIONS - [8429549]
CITATIONS - 8508774
CITATIONS - 8071194
CITATIONS - 8483418
CITATIONS - 8429549:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537796067:martin
CITATIONS - 8429549:EV-EXP-IMP-SITE-MUTATION:3537796067:martin
CITATIONS - 8429549:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537796067:martin
CITATIONS - 8429549:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537796067:martin
CITATIONS - 2115869:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537796067:martin
CITATIONS - 2646291:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537796067:martin
CITATIONS - 8508774:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537796067:martin
CITATIONS - 8508774:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537796067:martin
CITATIONS - 8071194:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537796067:martin
CITATIONS - 8071194:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537796067:martin
CITATIONS - 8483418:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537796067:martin
CITATIONS - 8483418:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537796067:martin
CITATIONS - 8432705:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537796067:martin
CITATIONS - 8432705:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537796067:martin
CITATIONS - 12218014:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537796067:martin
CITATIONS - 12218014:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537796067:martin
CITATIONS - 3891724:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537796067:martin
CITATIONS - 1447135:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537796067:martin
MODE - -
REGULATED-ENTITY - PM00323
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6385
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1982
CITATIONS - [10411720]
MODE - -
REGULATED-ENTITY - PM0-2701
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4497
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS162
CITATIONS - 10760178
CITATIONS - 12060687
CITATIONS - 18346968
MODE - -
REGULATED-ENTITY - PM00050
REGULATOR - MONOMER0-161
//
UNIQUE-ID - REG0-9310
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7491
CITATIONS - 17768236
COMMENT - 4
MODE - +
REGULATED-ENTITY - PM00151
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4871
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS681
CITATIONS - [9294462]
MODE - +
REGULATED-ENTITY - PM821
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5246
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00440
CITATIONS - [9236118]
CITATIONS - 17233899
COMMENT - Lrp activates the <i>gltBDF</i> operon in a leucine-insensitive manner |CITS:[7901196]|, binding at three sites distant to the &sigma;<sup>70</sup> promoter. This is a strange way of regulating a &sigma;<sup>70</sup> promoter, since Lrp should bind close to the promoter in order to regulate, and so it is helped by IHF (the DNA-bending protein) binding between the proximal Lrp site and the promoter, bending this DNA region and getting Lrp closer to &sigma;<sup>70</sup> to activate the transcription |CITS:[11395454]|. (Lrp is just a modulator of the operon expression; it does not work as the common activators/repressors that switch the gene expression in an on/off manner. In addition, it is sometimes insensitive to the presence of leucine to have its modulator effect |CITS:[7968922]|.)
MODE - +
REGULATED-ENTITY - PM00254
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5621
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2602
CITATIONS - 12888342
CITATIONS - 11278071
CITATIONS - 9300053
MODE - +
REGULATED-ENTITY - PM00666
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10679
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7854
MODE - +
REGULATED-ENTITY - PM00243
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5996
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS41
CITATIONS - 9202484
MODE - +
REGULATED-ENTITY - PM324
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11373
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8179
CITATIONS - 18997424
CITATIONS - 22101843
MODE - +
REGULATED-ENTITY - PM0-10377
REGULATOR - PHOSPHO-DPIA
//
UNIQUE-ID - REG0-6369
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1821
CITATIONS - [11985712]
MODE - +
REGULATED-ENTITY - PM0-2522
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4481
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00229
CITATIONS - 8429549
CITATIONS - 2115869
CITATIONS - 2646291
CITATIONS - 8508774
CITATIONS - 8071194
CITATIONS - 8483418
CITATIONS - 8432705
CITATIONS - 12218014
CITATIONS - 3891724
CITATIONS - 1447135
MODE - +
REGULATED-ENTITY - PM00111
REGULATOR - PD00353
//
UNIQUE-ID - REG0-9278
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7479
CITATIONS - 17921503
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00089
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4854
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1501
CITATIONS - 12426353
CITATIONS - 14702328
COMMENT - HypF activates <i>hyf</i> operon transcription only when it is expressed from a heterologous promoter |CITS: [12426353] [14702328]|.
MODE - +
REGULATED-ENTITY - PM787
REGULATOR - G7308-MONOMER
//
UNIQUE-ID - REG0-5230
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00742
CITATIONS - 1987150
MODE - -
REGULATED-ENTITY - PM00449
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-5604
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7330
CITATIONS - 16115199
MODE - -
REGULATED-ENTITY - PM0-9576
REGULATOR - PC00061
//
UNIQUE-ID - REG0-10660
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7843
CITATIONS - 19889087
MODE - +
REGULATED-ENTITY - PM0-10505
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-5980
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3501
CITATIONS - 14711822
MODE - +
REGULATED-ENTITY - PM00299
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11326
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8166
CITATIONS - 9819050
CITATIONS - 21890697
MODE - +
REGULATED-ENTITY - PM00063
REGULATOR - CPLX0-7669
//
UNIQUE-ID - REG0-6353
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2101
CITATIONS - [8300522]
COMMENT - The regulatory effect of IHF on the promoter exbBp is as of yet not known. However, we assigned a negative effect to this regulatory interaction based on the fact that the protein's binding site is downstream of  the promoter (+21.5).
MODE - -
REGULATED-ENTITY - PM0-2921
REGULATOR - PC00027
//
UNIQUE-ID - REG0-12392
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8509
CITATIONS - 26549308
MODE - -
REGULATED-ENTITY - TU0-8628
REGULATOR - CPLX0-8210
//
UNIQUE-ID - REG0-9259
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7464
CITATIONS - 17416652
MODE - -
REGULATED-ENTITY - PM0-9587
REGULATOR - CPLX0-7756
//
UNIQUE-ID - REG0-4838
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS785
CITATIONS - [8858581]
COMMENT - The FruR site in the <i>pfkA</i> gene overlaps with the  -35 box, so it is proposed that FruR inhibits <i>pfkA</i> transcription, avoiding the RNA polymerase access to its binding site.
MODE - -
REGULATED-ENTITY - PM933
REGULATOR - PC00061
//
UNIQUE-ID - REG0-5213
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2422
CITATIONS - 10873449
CITATIONS - 11601842
MODE - +
REGULATED-ENTITY - PM00401
REGULATOR - PD00365
//
UNIQUE-ID - REG0-5586
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4381
CITATIONS - 12864862
COMMENT - The binding of the RcsAB heterodimer might sterically prevent the accessibility of the <i>flhDC</i> promoter to the RNA polymerase, or alternatively it might lead to premature transcription termination.
MODE - -
REGULATED-ENTITY - PM00184
REGULATOR - PC00084
//
UNIQUE-ID - REG0-10604
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7828
CITATIONS - 20015147
MODE - +
REGULATED-ENTITY - PM0-10490
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-5964
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00479
CITATIONS - 1316901
CITATIONS - 9312050
CITATIONS - 8932307
CITATIONS - 8168494
MODE - +
REGULATED-ENTITY - PM00282
REGULATOR - MONOMER0-46
//
UNIQUE-ID - REG0-11268
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8150
CITATIONS - 11350954
MODE - +
REGULATED-ENTITY - TU0-13837
REGULATOR - PHOSPHO-CREB
//
UNIQUE-ID - REG0-6337
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2521
CITATIONS - 11121068
MODE - +
REGULATED-ENTITY - PM0-3541
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-12298
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8490
CITATIONS - 26078445
MODE - -
REGULATED-ENTITY - PM00065
REGULATOR - G7947-MONOMER
//
UNIQUE-ID - REG0-9164
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7447
CITATIONS - 17720788
CITATIONS - 19245365
MODE - +
REGULATED-ENTITY - PM0-9688
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-4821
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00060
CITATIONS - 12079504
COMMENT - There are several putative NarL-binding sites, but only  three of them have a NarL consensus with only one 
/mismatch |CITS:[12079504]|.
MODE - -
REGULATED-ENTITY - PM00026
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5197
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00575
CITATIONS - 7601827
MODE - -
REGULATED-ENTITY - PM00354
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5569
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-24
CITATIONS - 2989817
CITATIONS - 8057377
MODE - -
REGULATED-ENTITY - PM00251
REGULATOR - PC00010
//
UNIQUE-ID - REG0-10575
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7812
CITATIONS - 19854903
MODE - +
REGULATED-ENTITY - PM00087
REGULATOR - CPLX-124
//
UNIQUE-ID - REG0-5944
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00487
CITATIONS - 8388874
MODE - -
REGULATED-ENTITY - PM00287
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-6321
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7016
CITATIONS - 12754220
COMMENT - By making use of microarray analysis, it was concluded that FNR activates <i>xdhA</i> gene expression under anaerobiosis. A putative FNR-binding site, which was not reported in the paper, was identified upstream of this gene |CITS: [12754220]|.
MODE - +
REGULATED-ENTITY - PM0-3325
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11253
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8137
CITATIONS - 11274153
MODE - +
REGULATED-ENTITY - PM0-4381
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-12224
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8474
CITATIONS - 25790494
CITATIONS - 25790494:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3641584606:asantos
CITATIONS - 25790494:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3641584606:asantos
CITATIONS - 25790494:EV-COMP-AINF:3641584606:asantos
MODE - -
REGULATED-ENTITY - PM0-46338
REGULATOR - G6976-MONOMER
//
UNIQUE-ID - REG0-11250
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8134
CITATIONS - 15686558
MODE - +
REGULATED-ENTITY - PM0-10482
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-12221
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8476
CITATIONS - 25790494
MODE - -
REGULATED-ENTITY - PM0-46339
REGULATOR - G6976-MONOMER
//
UNIQUE-ID - REG0-9082
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7428
CITATIONS - 17238917
MODE - +
REGULATED-ENTITY - PM00560
REGULATOR - PC00027
//
UNIQUE-ID - REG0-4802
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4722
CITATIONS - 11101675
CITATIONS - 17526711
MODE - -
REGULATED-ENTITY - PM00020
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-5178
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00570
COMMENT - ArcA positive regulation shows a strong dependence on IHF, and this ArcA-binding site is located upstream of the IHF-binding site. ArcA has a higher affinity for this ArcA-binding site than for the two other ArcA-binding sites.
MODE - +
REGULATED-ENTITY - PM00353
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5550
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00275
CITATIONS - 7937881
CITATIONS - 7868601
CITATIONS - 2648001
CITATIONS - 3139888
MODE - -
REGULATED-ENTITY - PM00101
REGULATOR - PD00230
//
UNIQUE-ID - REG0-10529
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7796
CITATIONS - 10347150
CITATIONS - 14499937
CITATIONS - 8626289
MODE - -
REGULATED-ENTITY - PM00179
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5925
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS449
CITATIONS - 15225313
CITATIONS - 7777530
CITATIONS - 8383113
CITATIONS - 7768850
CITATIONS - 11751765
COMMENT - Two MarR sites (-18 and +17) are required for full transcriptional repression, but either site alone permits partial repression |CITS:[15225313]|.
MODE - -
REGULATED-ENTITY - PM00265
REGULATOR - CPLX0-7710
//
UNIQUE-ID - REG0-6302
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2883
CITATIONS - 11292794
MODE - -
REGULATED-ENTITY - PM0-4141
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-11219
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8118
CITATIONS - 11071896
MODE - -
REGULATED-ENTITY - PM623
REGULATOR - CPLX0-1242
//
UNIQUE-ID - REG0-12154
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8456
CITATIONS - 25406449
MODE - -
REGULATED-ENTITY - PM00454
REGULATOR - G6745-MONOMER
//
UNIQUE-ID - REG0-9049
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7396
CITATIONS - 17608696
COMMENT - Localization at  -49.5 of CRP activating the <i>aer</i> promoter is unusual from any previously characterized CRP-activated promoter. However, this position is optimal for activation by &sigma;<sup>28</sup> |CITS:[19843224]|. In addition, CRP activates transcription of the <i>aer</i> promoter by recruitment of RNA polymerase |CITS:[19843224]|.
/
/Two &alpha;-CTD of E&sigma;<sup>28</sup> contact DNA both upstream and downstream of CRP |CITS:[19843224]|. A model for the organization of the CRP- E&sigma;<sup>28</sup>-DNA ternary complex at the <i>aer</i> promoter proposed by Hollands et al. (2009) differs substantially from the CRP- E&sigma;<sup>70</sup>-DNA complex at  the class I &sigma;<sup>70</sup>-dependent promoter |CITS:[19843224]|.
MODE - +
REGULATED-ENTITY - PM0-1727
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4789
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00026
CITATIONS - 3050131
CITATIONS - 8613990
CITATIONS - 10518785
CITATIONS - 3106331
CITATIONS - 3315853
MODE - -
REGULATED-ENTITY - PM00012
REGULATOR - CPLX-125
//
UNIQUE-ID - REG0-5162
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS304
CITATIONS - 10564497
COMMENT - CaiF and CRP bind cooperatively to the <i>cai-fix</i> intergenic region to activate the <i>fixA</i> promoter.
MODE - +
REGULATED-ENTITY - PM339
REGULATOR - CPLX0-8062
//
UNIQUE-ID - REG0-10505
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7781
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM00563
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5909
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00796
CITATIONS - [9720032]
CITATIONS - 9868788
COMMENT - Fis is a potential activator of <i>lpdA</i> gene expression. There is a potential Fis-binding site, GTTTAAAAATTGTTa, centered at  -29 in the <i>lpd</i> promoter region (coordinates 5770-5784). However, Fis binding at this position would be expected to repress, rather than activate, transcription |CITS: [9720032]|.
MODE - +
REGULATED-ENTITY - PM00326
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-6285
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2743
CITATIONS - 11929525
COMMENT - Fis binding to this site strongly represses the acsP1 promoter and weakly represses nrfAp, a promoter that is overlapping and divergent to acsP1.
MODE - -
REGULATED-ENTITY - PM0-3921
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-11202
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8101
CITATIONS - 21571995
MODE - +
REGULATED-ENTITY - PM928
REGULATOR - PHOSPHO-RCSB
//
UNIQUE-ID - REG0-12111
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8438
CITATIONS - 25176444
CITATIONS - 25176444:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3623599909:asantos
CITATIONS - 25176444:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3623599909:asantos
CITATIONS - 25176444:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3623599909:asantos
MODE - -
REGULATED-ENTITY - PM00297
REGULATOR - EG12116-MONOMER
//
UNIQUE-ID - REG0-9032
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7378
CITATIONS - 17020555
MODE - +
REGULATED-ENTITY - PM0-9640
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-4773
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00014
CITATIONS - 1640456
MODE - -
REGULATED-ENTITY - PM00005
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-5146
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3022
CITATIONS - 7768855
MODE - +
REGULATED-ENTITY - PM327
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5521
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS86
CITATIONS - 8412671
MODE - -
REGULATED-ENTITY - PM00089
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10484
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7766
CITATIONS - 19656291
CITATIONS - 20472787
MODE - -
REGULATED-ENTITY - PM00280
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5893
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6742
CITATIONS - 14731281
MODE - -
REGULATED-ENTITY - PM0-6882
REGULATOR - G7630-MONOMER
//
UNIQUE-ID - REG0-11103
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8088
CITATIONS - 21460078
CITATIONS - 21460078:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3514123168:martin
CITATIONS - 21460078:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3514123168:martin
MODE - +
REGULATED-ENTITY - PM0-36245
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6272
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3383
CITATIONS - 10762278
CITATIONS - 14645248
COMMENT - CdaR responds to the inducers d-glycerate, d-galactarate, d-glucarate, and 2-d-mannosyl-glycerate.
MODE - +
REGULATED-ENTITY - PM0-4701
REGULATOR - EG12335-MONOMER
//
UNIQUE-ID - REG0-12015
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8422
CITATIONS - 24659771
MODE - -
REGULATED-ENTITY - PM0-1101
REGULATOR - EG11084-MONOMER
//
UNIQUE-ID - REG0-9001
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00638
CITATIONS - 2139650
CITATIONS - 9767576
CITATIONS - 15520470
COMMENT - CRP alone activates <i>rpoH</i> transcription, but CytR and CRP act together  to repress transcription from the rpoHp5 promoter. A single CytR molecule binds between two CRP molecules. CRP-CytR-CRP.
MODE - -
REGULATED-ENTITY - PM00088
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4757
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00293
CITATIONS - 2964639
MODE - -
REGULATED-ENTITY - PM00001
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5130
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS663
CITATIONS - [2886490]
CITATIONS - [8898385]
CITATIONS - 9157242
CITATIONS - 10096084
COMMENT - IHF plays a dual role in controlling <i>fimA</i> expression: it is required both for inversion of the <i>fimA</i> control region and for efficient expression from the <i>fimA</i> promoter.
MODE - +
REGULATED-ENTITY - PM241
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5505
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2346
CITATIONS - [9302022]
CITATIONS - [1315704]
CITATIONS - [1851949]
CITATIONS - [9302022]
CITATIONS - 10998176
CITATIONS - 12754220
CITATIONS - 8824175
CITATIONS - 16140031
COMMENT - Under anaerobiosis, FNR represses <i>cydAB</i> operon expression |CITS: [12754220]|.
MODE - -
REGULATED-ENTITY - PM00141
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10466
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7750
CITATIONS - 20156994
MODE - +
REGULATED-ENTITY - PM0-10539
REGULATOR - CPLX0-8048
//
UNIQUE-ID - REG0-5877
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS58
CITATIONS - 16140031
CITATIONS - 9209047
CITATIONS - 15699038
CITATIONS - 25161193
MODE - -
REGULATED-ENTITY - PM00149
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11086
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8076
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00218
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6255
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7067
CITATIONS - 12492863
MODE - -
REGULATED-ENTITY - PM0-4528
REGULATOR - CPLX0-7605
//
UNIQUE-ID - REG0-11985
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8407
CITATIONS - 24335284
MODE - +
REGULATED-ENTITY - PM0-46307
REGULATOR - CPLX0-7916
//
UNIQUE-ID - REG0-8984
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS422
CITATIONS - 8955407
CITATIONS - 10216857
MODE - -
REGULATED-ENTITY - PM561
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4740
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4663
CITATIONS - 2664421
MODE - +
REGULATED-ENTITY - PM00048
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-5112
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS157
CITATIONS - 1885551
MODE - -
REGULATED-ENTITY - PM221
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5488
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00279
COMMENT - The AppY protein is also involved in anaerobic induction of the <i>hya</i> operon, which encodes hydrogenase 1 and is located immediately upstream  from  the <i>appCBA</i> operon. The AppY protein regulates AppA synthesis by activating transcription from the appCp promoter. Furthermore,  the <i>appY</i> gene might be autoregulated. Genetic analysis of the appCp promoter region indicates that the presence of sequences upstream  from  the -10 region are required for activation of the appCp promoter by AppY protein and anaerobiosis, suggesting that this region has an AppY-binding site.
MODE - +
REGULATED-ENTITY - PM00138
REGULATOR - PD00967
//
UNIQUE-ID - REG0-10437
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7736
CITATIONS - 18524933
CITATIONS - 7596361
MODE - -
REGULATED-ENTITY - PM0-10387
REGULATOR - PC00010
//
UNIQUE-ID - REG0-5860
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS144
CITATIONS - [8892825]
CITATIONS - [2964639]
MODE - -
REGULATED-ENTITY - PM00143
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11070
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8064
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00606
REGULATOR - PD00197
//
UNIQUE-ID - REG0-6239
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4129
CITATIONS - 14593252
MODE - -
REGULATED-ENTITY - PM0-4921
REGULATOR - PD03585
//
UNIQUE-ID - REG0-11923
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8392
CITATIONS - 23935044
MODE - -
REGULATED-ENTITY - PM0-46064
REGULATOR - G7678-MONOMER
//
UNIQUE-ID - REG0-6615
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7208
CITATIONS - 10850996
MODE - +
REGULATED-ENTITY - PM0-9299
REGULATOR - PD04418
//
UNIQUE-ID - REG0-4724
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6
CITATIONS - 7027255
CITATIONS - 8057377
MODE - -
REGULATED-ENTITY - PM00046
REGULATOR - PC00010
//
UNIQUE-ID - REG0-5096
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7095
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM00420
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5470
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00265
CITATIONS - 3062177
CITATIONS - 9556617
MODE - +
REGULATED-ENTITY - PM00128
REGULATOR - CPLX0-7715
//
UNIQUE-ID - REG0-10395
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7715
CITATIONS - 16857675
MODE - +
REGULATED-ENTITY - PM0-10021
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5844
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7306
CITATIONS - 7961413
MODE - +
REGULATED-ENTITY - PM00194
REGULATOR - MONOMER0-164
//
UNIQUE-ID - REG0-11053
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8048
CITATIONS - 21421764
CITATIONS - 21421764:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3513525532:martin
CITATIONS - 21421764:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3513525532:martin
CITATIONS - 21421764:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3513525532:martin
MODE - -
REGULATED-ENTITY - PM0-8720
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6223
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3883
CITATIONS - 9537375
MODE - +
REGULATED-ENTITY - PM0-5221
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11890
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8376
CITATIONS - 23873909
MODE - -
REGULATED-ENTITY - PM00063
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6598
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7291
CITATIONS - 16997959
CITATIONS - 18445167
MODE - +
REGULATED-ENTITY - PM0-8907
REGULATOR - MONOMER0-46
//
UNIQUE-ID - REG0-4707
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00096
CITATIONS - 6292893
COMMENT - An interesting characteristic of the regulation of the <i>ilvLBN</i> operon is that even though CRP can activate it,
/attenuation can trump any activation by CRP and absolutely stop <i>ilvLBN</i> transcription |CITS: [6095192]|.
/
MODE - +
REGULATED-ENTITY - PM00040
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5080
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7250
CITATIONS - 17233826
MODE - +
REGULATED-ENTITY - PM00547
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5454
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00537
MODE - +
REGULATED-ENTITY - PM00115
REGULATOR - PD00353
//
UNIQUE-ID - REG0-10330
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7700
CITATIONS - 19245365
MODE - +
REGULATED-ENTITY - PM0-10357
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5828
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00224
MODE - +
REGULATED-ENTITY - PM00107
REGULATOR - CPLX0-2781
//
UNIQUE-ID - REG0-11029
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8036
CITATIONS - 18501926
MODE - -
REGULATED-ENTITY - PM0-9527
REGULATOR - CPLX0-7791
//
UNIQUE-ID - REG0-6207
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3809
CITATIONS - 14702398
MODE - +
REGULATED-ENTITY - PM00134
REGULATOR - EG11544-MONOMER
//
UNIQUE-ID - REG0-11808
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8360
CITATIONS - 23564175
COMMENT - The regulation of CpxR on the <i>sbmA-yaiW</i> operon has been probed by quantitative PCR analysis of cDNA and by the identification of a consensus DNA-binding site of CpxR in the regulatory region of <i>sbmA-yaiW</i> |CITS:[ 23564175]|. The identification of this DNA-binding site was only mentioned in the paper of Raivio et al. (2013), but the DNA sequence was not shown |CITS:[ 23564175]|.
MODE - +
REGULATED-ENTITY - PM0-3626
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-6582
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7212
CITATIONS - 8021189
MODE - -
REGULATED-ENTITY - PM0-8864
REGULATOR - CPLX0-7425
//
UNIQUE-ID - REG0-4691
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00088
CITATIONS - 3045087
CITATIONS - 8955388
MODE - -
REGULATED-ENTITY - PM00038
REGULATOR - PD03576
//
UNIQUE-ID - REG0-5064
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-20
CITATIONS - 2509902
CITATIONS - 8057377
MODE - -
REGULATED-ENTITY - PM446
REGULATOR - PC00010
//
UNIQUE-ID - REG0-5438
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00754
CITATIONS - 9582281
COMMENT - This site essentially eliminates the effect of glucose.
MODE - +
REGULATED-ENTITY - PM00161
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10258
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7683
CITATIONS - 11115104
MODE - -
REGULATED-ENTITY - PM00202
REGULATOR - PD03270
//
UNIQUE-ID - REG0-5812
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7030
CITATIONS - 15995204
MODE - -
REGULATED-ENTITY - PM00220
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-10984
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8027
CITATIONS - 12446650
CITATIONS - 16980449
CITATIONS - 12730179
MODE - -
REGULATED-ENTITY - PM450
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6191
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3964
CITATIONS - 14702398
MODE - +
REGULATED-ENTITY - PM00399
REGULATOR - EG11544-MONOMER
//
UNIQUE-ID - REG0-11744
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8345
CITATIONS - 23274360
MODE - +
REGULATED-ENTITY - PM0-44765
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-6564
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6994
CITATIONS - 10850996
MODE - +
REGULATED-ENTITY - PM0-8715
REGULATOR - PD04418
//
UNIQUE-ID - REG0-4675
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00090
CITATIONS - 1556120
CITATIONS - 1372899
MODE - +
REGULATED-ENTITY - PM00037
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9987
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7655
CITATIONS - 16515535
MODE - -
REGULATED-ENTITY - PM0-10286
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-5048
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6682
CITATIONS - 7860604
CITATIONS - 17768236
COMMENT - Fis and RpoS inhibit <i>xylF</i> expression in an <i>rpoS fis</i> double mutant strain. The <i>rpoS</i> effects could be indirect |CITS: [7860604]|.
MODE - -
REGULATED-ENTITY - PM70
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5422
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1681
CITATIONS - [10986267]
MODE - -
REGULATED-ENTITY - PM0-2201
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10131
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7670
CITATIONS - 18083817
CITATIONS - 12730179
MODE - -
REGULATED-ENTITY - PM928
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-5796
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS543
CITATIONS - [8809757]
CITATIONS - 14766919
MODE - +
REGULATED-ENTITY - PM00218
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10968
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8019
CITATIONS - 21314918
MODE - -
REGULATED-ENTITY - PM00494
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6173
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4463
CITATIONS - 15489450
MODE - +
REGULATED-ENTITY - PM0-5982
REGULATOR - EG11544-MONOMER
//
UNIQUE-ID - REG0-11661
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8333
CITATIONS - 23092251
MODE - +
REGULATED-ENTITY - PM00465
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-6545
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7164
CITATIONS - 16677314
MODE - -
REGULATED-ENTITY - PM0-8917
REGULATOR - G7326-MONOMER
//
UNIQUE-ID - REG0-4659
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5941
CITATIONS - 8982002
MODE - +
REGULATED-ENTITY - PM00033
REGULATOR - MONOMER-53
//
UNIQUE-ID - REG0-9781
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7645
CITATIONS - 18673442
MODE - +
REGULATED-ENTITY - PM0-10219
REGULATOR - PD00406
//
UNIQUE-ID - REG0-5032
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7192
CITATIONS - 16377617
COMMENT - By making use of microarray analyses, Constantinidou et al. |CITS: [16377617]| concluded that FNR activates <i>garPLRK-rnpB</i> operon expression. They also identified a putative FNR-binding site upstream of the operon, but the sequence was not shown.
MODE - +
REGULATED-ENTITY - PM582
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5406
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6955
CITATIONS - 15659676
MODE - +
REGULATED-ENTITY - PM00228
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5780
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00684
COMMENT - CRP has a strong inhibitory effect on the proPp1 promoter because it binds to the almost-perfect consensus CRP-binding site located within the  35 box.
MODE - -
REGULATED-ENTITY - PM00212
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10948
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8005
CITATIONS - 20966094
MODE - +
REGULATED-ENTITY - PM0-36203
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6157
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7293
CITATIONS - 6264314
MODE - -
REGULATED-ENTITY - PM00424
REGULATOR - CPLX0-7541
//
UNIQUE-ID - REG0-11642
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8320
CITATIONS - 23071782
COMMENT - Yang et al. identified the binding site of PhoB |CITS:[ 23071782]| but did not identify the promoter regulated; therefore, there is a possibility that this binding site corresponds to another promoter, according to the function of PhoB. The binding site of this regulator, TCATTACAAAATTGTAATG, is located at bp -79 relative to the translation start site of <i>yedX</i> |CITS:[ 23071782]|.
MODE - +
REGULATED-ENTITY - PM0-45171
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-6529
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7323
CITATIONS - 10411720
CITATIONS - 17921503
CITATIONS - 15659676:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3409583335:martin
CITATIONS - 15659676:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3409583335:martin
CITATIONS - 10411720:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3409583335:martin
CITATIONS - 17921503:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3409583335:martin
CITATIONS - 17921503:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3409583335:martin
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00343
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4643
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00065
CITATIONS - 8057356
MODE - -
REGULATED-ENTITY - PM00030
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9599
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7629
CITATIONS - 3925152
CITATIONS - Suzuki03
MODE - +
REGULATED-ENTITY - PM00153
REGULATOR - CPLX0-7733
//
UNIQUE-ID - REG0-5016
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1305
CITATIONS - [11287152]
COMMENT - The regulatory effect of FlhDC in <i>hydN</i> operon transcription has been proved only by a microarray analysis by |CITS: [11287152]|.
MODE - +
REGULATED-ENTITY - PM526
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-5390
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00404
CITATIONS - 8982002
MODE - -
REGULATED-ENTITY - PM00231
REGULATOR - PD00261
//
UNIQUE-ID - REG0-5764
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00482
COMMENT - Purified OxyR and IHF proteins have also been shown to bind upstream  from  the <i>dps</i> promoter. OxyR and &sigma;<sup>S</sup> act independently to regulate the level of the Dps protein in the log and the stationary phases. Regulation of <i>dps</i> by &sigma;<sup>S</sup> and OxyR is independent <i>in vivo</i>, and OxyR probably does not activate &sigma;<sup>S</sup> holoenzyme. OxyR and IHF proteins may occupy the <i>dps</i> promoter simultaneously |CITS: [7984106]|.
MODE - +
REGULATED-ENTITY - PM00243
REGULATOR - PD00214
//
UNIQUE-ID - REG0-10923
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7991
CITATIONS - 21034467
MODE - -
REGULATED-ENTITY - PM00137
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6140
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7179
MODE - -
REGULATED-ENTITY - PM00499
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11624
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8303
CITATIONS - 23233451
MODE - +
REGULATED-ENTITY - TU0-8671
REGULATOR - G6444-MONOMER
//
UNIQUE-ID - REG0-6513
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3730
CITATIONS - 12588863
MODE - -
REGULATED-ENTITY - PM0-1302
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4627
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2005
CITATIONS - [9335285]
CITATIONS - [11847119]
MODE - +
REGULATED-ENTITY - PM00028
REGULATOR - PC00027
//
UNIQUE-ID - REG0-9575
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7613
CITATIONS - 9473050
CITATIONS - 11321589
CITATIONS - 18673442
MODE - +
REGULATED-ENTITY - PM0-10219
REGULATOR - PD00365
//
UNIQUE-ID - REG0-4999
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS387
CITATIONS - [8002608]
CITATIONS - 1346534
CITATIONS - 8521047
MODE - -
REGULATED-ENTITY - PM00631
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5374
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00764
MODE - +
REGULATED-ENTITY - PM00293
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5748
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00408
CITATIONS - 10463182
CITATIONS - 7665470
CITATIONS - 10972807
CITATIONS - 15621456
CITATIONS - 8188587
MODE - -
REGULATED-ENTITY - PM00234
REGULATOR - PD00339
//
UNIQUE-ID - REG0-10903
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7975
CITATIONS - 11115104
MODE - +
REGULATED-ENTITY - PM0-36188
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6124
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6781
CITATIONS - 2842314
MODE - -
REGULATED-ENTITY - PM00385
REGULATOR - PC00010
//
UNIQUE-ID - REG0-11587
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8291
CITATIONS - 6328431
MODE - +
REGULATED-ENTITY - PM00146
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6496
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1041
CITATIONS - [11092866]
MODE - +
REGULATED-ENTITY - PM0-1283
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4611
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7277
CITATIONS - 16861804
CITATIONS - 23564175
MODE - +
REGULATED-ENTITY - PM0-9401
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-9527
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7597
CITATIONS - 15878120
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00590
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4981
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS145
CITATIONS - [3083215]
MODE - +
REGULATED-ENTITY - PM101
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5357
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7001
CITATIONS - 15743952
MODE - -
REGULATED-ENTITY - PM00536
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-5732
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00650
CITATIONS - 9484892
COMMENT - A mutation in the <i>mlc</i> gene, encoding a homolog of  <i>nagC</i>, results in a threefold derepression of  <i>manX</i> expression, suggesting that this protein is a more important regulator of  <i>maX</i> expression than NagC. The Mlc protein binds to the NagC operators, binding preferentially to the promoter-proximal operator. Plasmids overproducing either the NagC protein or the Mlc protein repress the expression of <i>manX</i>, but the effect with the Mlc protein is stronger.  Mcl weakly protects this operator. The <i>manX</i> operator is only partially occupied under physiological concentrations of the Mlc protein.  CAP and NagC can bind simultaneously and produce a complex more stable than the binary NagC-DNA complex |CITS: [9484892]|.
MODE - -
REGULATED-ENTITY - PM00276
REGULATOR - PD01896
//
UNIQUE-ID - REG0-10887
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7960
CITATIONS - 20729367
MODE - -
REGULATED-ENTITY - PM0-10149
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-6108
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6184
CITATIONS - 12754220
COMMENT - Under anaerobiosis, FNR represses <i>rpsJ</i> gene expression, but it is not known if this regulation is direct or indirect  |CITS: [12754220]|.  We assigned this regulation to the <i>rrpsJ-rplCDWB-rpsS-rplV-rpsC-rplP-rpmC-rpsQ</i> operon because it is known that the <i>rpsJ</i>  gene  is transcribed as a part of this operon.
MODE - +
REGULATED-ENTITY - PM00444
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11566
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8274
CITATIONS - 16478729
MODE - -
REGULATED-ENTITY - PM0-8184
REGULATOR - PD04418
//
UNIQUE-ID - REG0-6480
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5242
CITATIONS - 9632265
CITATIONS - 15686546
COMMENT - Paradoxically, even though H-NS is an inhibitor, it drives the bound RNA 
/polymerase into open complexes |CITS: [15686546]|.
/
MODE - -
REGULATED-ENTITY - PM0-1351
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4593
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7036
CITATIONS - 16077119
CITATIONS - 23564175
COMMENT - Repression of <i>ompF</i> by CpxR could result from prevention of either OmpR or RNA polymerase binding |CITS: [16077119]|.
MODE - -
REGULATED-ENTITY - PM00066
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-9464
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7584
CITATIONS - 18227264
MODE - -
REGULATED-ENTITY - PM0-10196
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-4965
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS564
CITATIONS - 11053378
CITATIONS - 14996792
COMMENT - During anaerobic growth Fnr is important for <i>hlyE</i> expression. 
MODE - +
REGULATED-ENTITY - PM681
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5340
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00699
CITATIONS - 7715459
MODE - -
REGULATED-ENTITY - PM00620
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5714
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2041
CITATIONS - [10594821]
CITATIONS - 21276095
MODE - -
REGULATED-ENTITY - PM00192
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10850
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7943
CITATIONS - 20874755
COMMENT - BluF can interact with MlrA, antagonizing its effects <i>in vitro</i>, and when BluF is overexpressed <i>in vivo</i> it interferes with <i>csgD</i> expression |CITS: [22783906]|.
MODE - +
REGULATED-ENTITY - PM00536
REGULATOR - EG12008-MONOMER
//
UNIQUE-ID - REG0-6092
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6083
CITATIONS - 2542226
MODE - +
REGULATED-ENTITY - PM0-7741
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11521
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8255
CITATIONS - 17120142
MODE - -
REGULATED-ENTITY - PM0-9620
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6464
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2565
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1347
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4575
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2426
CITATIONS - 8002608
CITATIONS - 1346534
COMMENT - Binding of Lrp to one site enhances occupancy of the other Lrp sites  in the  ompCp1 promoter. Leucine does not abolish  DNA binding by the ligated Lrp but it may alter the affinity of Lrp for specific sites on DNA.
MODE - -
REGULATED-ENTITY - PM00065
REGULATOR - PD00353
//
UNIQUE-ID - REG0-9412
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7567
CITATIONS - 12904577
MODE - -
REGULATED-ENTITY - PM0-8710
REGULATOR - CPLX0-7680
//
UNIQUE-ID - REG0-4949
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS502
CITATIONS - [8900118]
COMMENT - The results of gel mobility experiments showed  that  Lrp forms three complexes with an <i>ilv</i> DNA fragment containing this site. In addition, this secondary site possess no sequence similarity to the Lrp consensus site.
MODE - -
REGULATED-ENTITY - PM00475
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5324
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7169
CITATIONS - 16677314
MODE - -
REGULATED-ENTITY - PM00598
REGULATOR - G7326-MONOMER
//
UNIQUE-ID - REG0-5698
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00428
MODE - +
REGULATED-ENTITY - PM00168
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10819
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7927
CITATIONS - 20435136
CITATIONS - 21571995
MODE - +
REGULATED-ENTITY - PM00137
REGULATOR - CPLX0-7852
//
UNIQUE-ID - REG0-6075
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6701
CITATIONS - 12951338
COMMENT - Through of overexpression analysis, BaeR and EvgA were shown to mediated &beta;B-lactam as a result of induction of the multidrug exporter <i>acrD</i> gene expression |CITS: [12951338]|.
MODE - +
REGULATED-ENTITY - PM0-8401
REGULATOR - PHOSPHO-EVGA
//
UNIQUE-ID - REG0-11504
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8247
CITATIONS - 1640456
CITATIONS - 17074904
MODE - -
REGULATED-ENTITY - PM0-8908
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-6448
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2543
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1341
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4559
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-942
CITATIONS - [9819053]
CITATIONS - 21890697
MODE - +
REGULATED-ENTITY - PM00063
REGULATOR - CPLX0-7669
//
UNIQUE-ID - REG0-9390
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7551
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM00518
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4933
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS768
CITATIONS - [9421904]
MODE - -
REGULATED-ENTITY - PM263
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5308
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00779
MODE - +
REGULATED-ENTITY - PM00665
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5682
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3342
CITATIONS - 8830277
MODE - +
REGULATED-ENTITY - PM00191
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10803
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7911
CITATIONS - 8034728
CITATIONS - 8034727
CITATIONS - 10848985
MODE - +
REGULATED-ENTITY - PM00210
REGULATOR - MONOMER0-183
//
UNIQUE-ID - REG0-6057
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6805
CITATIONS - 2543976
MODE - -
REGULATED-ENTITY - PM0-8601
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-11486
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8230
CITATIONS - 22326866
MODE - +
REGULATED-ENTITY - TU0-13312
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-6432
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1201
CITATIONS - [10589831]
MODE - +
REGULATED-ENTITY - PM0-1501
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-4543
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00149
CITATIONS - 15225315
CITATIONS - 11004182
CITATIONS - 9302020
COMMENT - The maximum <i>nirB</i> expression is achieved at high nitrate concentrations through the proteins NarL and NarP, which function independently of each other, but  NarL appears to be the main activator.  The nitrite is a less effective inductor of <i>nirB</i> expression |CITS: [11004182]|. 
/
/NarL counteracts the repressive effect of IHF (-88 site) and Fis (-142 site).  This site interferes with the binding of IHF (-88 site).  However, IHF cannot displace prebound NarL.  Browning et al. |CITS: [15225315]| suggested that NarL interferes with IHF (-88  binding site) at the <i>nir</i> promoter by distorting the minor groove at its target site, and they argued that the resulting activation by NarL results from remodeling of the local nucleoprotein structure to facilitate FNR-dependent transcription.
MODE - +
REGULATED-ENTITY - PM00062
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9373
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7534
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM681
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4917
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS625
CITATIONS - [9852003]
MODE - -
REGULATED-ENTITY - PM00625
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5292
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS443
CITATIONS - [8955407]
CITATIONS - [10216857]
MODE - -
REGULATED-ENTITY - PM00540
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5666
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7315
CITATIONS - 9582281
MODE - -
REGULATED-ENTITY - PM0-9554
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10775
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7897
CITATIONS - 20543070
MODE - +
REGULATED-ENTITY - PM0-36133
REGULATOR - G7563-MONOMER
//
UNIQUE-ID - REG0-6041
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1081
CITATIONS - [1370290]
CITATIONS - 16491024
MODE - +
REGULATED-ENTITY - PM00622
REGULATOR - PD00436
//
UNIQUE-ID - REG0-11469
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8217
CITATIONS - 17513476
REGULATED-ENTITY - PM00087
REGULATOR - PD00221
//
UNIQUE-ID - REG0-6414
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-31
CITATIONS - 10542180
CITATIONS - 11953442
MODE - -
REGULATED-ENTITY - PM0-1701
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-4527
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6928
CITATIONS - 8057356
MODE - +
REGULATED-ENTITY - PM00061
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9356
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7518
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM00026
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4900
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1124
CITATIONS - [9924977]
CITATIONS - [7715442]
MODE - -
REGULATED-ENTITY - PM00242
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5276
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00613
COMMENT - The positive effect of the cAMP-CRP complex  is seen only together with DsdC. Thus, CRP cannot act  by itself in this system.
MODE - +
REGULATED-ENTITY - PM00516
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5650
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3426
CITATIONS - 14711822
MODE - +
REGULATED-ENTITY - PM00528
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10735
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7883
CITATIONS - 20132443
CITATIONS - 20659289
MODE - -
REGULATED-ENTITY - PM0-10544
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6025
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS828
CITATIONS - [11101674]
COMMENT - <i>yeiL</i> expression is partly dependent on IHF in the absence of Fnr.
MODE - +
REGULATED-ENTITY - PM1021
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11424
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8198
CITATIONS - 10216857
CITATIONS - 10216857:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3538187343:martin
CITATIONS - 10216857:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3538187343:martin
CITATIONS - 10216857:EV-EXP-IMP-SITE-MUTATION:3538187343:martin
CITATIONS - 10216857:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3538187343:martin
CITATIONS - 8955407:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3538187343:martin
CITATIONS - 8955407:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3538187343:martin
MODE - -
REGULATED-ENTITY - PM562
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6398
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3353
CITATIONS - 11004187
CITATIONS - 15773991
MODE - +
REGULATED-ENTITY - PM0-2001
REGULATOR - MONOMER0-4180
//
UNIQUE-ID - REG0-4511
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6947
CITATIONS - 8107138
MODE - -
REGULATED-ENTITY - PM00055
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-9327
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7497
CITATIONS - 17768236
CITATIONS - 17768236:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3411310990:asantos
CITATIONS - 17768236:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3411310990:asantos
MODE - +
REGULATED-ENTITY - PM00039
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4884
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7122
CITATIONS - 16143461
COMMENT - Both, Hha and H-NS proteins form the Hha-H-NS complex, which negatively controls  the <i>htrA</i>'s osmoregulation |CITS: [16143461]|.
MODE - -
REGULATED-ENTITY - PM00327
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5260
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00620
CITATIONS - 14645248
MODE - -
REGULATED-ENTITY - PM00558
REGULATOR - PC00103
//
UNIQUE-ID - REG0-5634
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00657
CITATIONS - [8892825]
CITATIONS - 16140031
CITATIONS - 15699038
COMMENT - |CITS: [15699038]| identified another putative ArcA-binding site ~140 bp upstream of the <i>nuoA</i> gene, but the sequence was not reported.
MODE - -
REGULATED-ENTITY - PM00592
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10709
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7865
CITATIONS - 20156994
MODE - +
REGULATED-ENTITY - PM0-10539
REGULATOR - CPLX0-8048
//
UNIQUE-ID - REG0-6009
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7082
CITATIONS - 11918818
CITATIONS - 10506196
COMMENT - CysB appears to modulate in a negative manner the expression of the <i>ssu</i> operon rather than to be a strong repressor of the operon |CITS: [11918818]|.
MODE - -
REGULATED-ENTITY - PM169
REGULATOR - CPLX0-2781
//
UNIQUE-ID - REG0-11402
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00233
CITATIONS - [8429549]
CITATIONS - 8508774
CITATIONS - 8071194
CITATIONS - 8483418
CITATIONS - 1447135
CITATIONS - 8429549:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537794633:martin
CITATIONS - 8429549:EV-EXP-IMP-SITE-MUTATION:3537794633:martin
CITATIONS - 8429549:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537794633:martin
CITATIONS - 8429549:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537794633:martin
CITATIONS - 2115869:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537794633:martin
CITATIONS - 2115869:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537794633:martin
CITATIONS - 2646291:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537794633:martin
CITATIONS - 8508774:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537794633:martin
CITATIONS - 8508774:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537794633:martin
CITATIONS - 8071194:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537794633:martin
CITATIONS - 8071194:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537794633:martin
CITATIONS - 8483418:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537794633:martin
CITATIONS - 8483418:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537794633:martin
CITATIONS - 8432705:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537794633:martin
CITATIONS - 8432705:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537794633:martin
CITATIONS - 12218014:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537794633:martin
CITATIONS - 12218014:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537794633:martin
CITATIONS - 3891724:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537794633:martin
CITATIONS - 1447135:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537794633:martin
CITATIONS - :EV-EXP-IMP-SITE-MUTATION:3537794633:martin
CITATIONS - 1447135:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537794633:martin
MODE - -
REGULATED-ENTITY - PM00323
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6382
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6959
CITATIONS - 15659676
MODE - +
REGULATED-ENTITY - PM0-2701
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4494
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4623
CITATIONS - 10760178
CITATIONS - 10760179
CITATIONS - 16621812
MODE - +
REGULATED-ENTITY - PM00050
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9307
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7489
CITATIONS - 17768236
MODE - +
REGULATED-ENTITY - PM00151
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4867
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4423
CITATIONS - 8120010
CITATIONS - 8763946
CITATIONS - 11673423
MODE - -
REGULATED-ENTITY - PM00423
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5243
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3783
CITATIONS - 14702398
MODE - +
REGULATED-ENTITY - PM00254
REGULATOR - EG11544-MONOMER
//
UNIQUE-ID - REG0-5618
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7163
CITATIONS - 16377617
MODE - -
REGULATED-ENTITY - PM00546
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10676
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7851
CITATIONS - 11443092
MODE - -
REGULATED-ENTITY - PM0-8081
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5993
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00300
CITATIONS - Suzuki03
CITATIONS - 2864330
MODE - +
REGULATED-ENTITY - PM00153
REGULATOR - CPLX0-7733
//
UNIQUE-ID - REG0-11370
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8177
CITATIONS - 22101843
MODE - -
REGULATED-ENTITY - PM0-10380
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-6366
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1764
CITATIONS - [12446650]
MODE - -
REGULATED-ENTITY - PM0-2441
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-4478
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00585
CITATIONS - 23029459
MODE - +
REGULATED-ENTITY - PM00110
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9275
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7476
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00348
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4851
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4441
CITATIONS - 8808940
CITATIONS - 9197421
CITATIONS - 12093725
COMMENT - Nitric oxide (NO)  inactivates the FNR protein, so NO induces hmpA expression .
MODE - -
REGULATED-ENTITY - PM00415
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5227
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00739
CITATIONS - 1987150
CITATIONS - 23274360
MODE - +
REGULATED-ENTITY - PM00448
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-5599
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7114
CITATIONS - 15520470
CITATIONS - 19054084
COMMENT - CRP site 2 (-101.5) plays little or no role in CRP-dependent activation of the <i>malX</i> promoter. It might function synergistically with the downstream bound CRP, site 1 (-41.5) |CITS:[19054084]|.
MODE - +
REGULATED-ENTITY - PM00177
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10657
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7841
CITATIONS - 19897902
MODE - +
REGULATED-ENTITY - PM0-10266
REGULATOR - CPLX0-7745
//
UNIQUE-ID - REG0-5977
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00735
MODE - +
REGULATED-ENTITY - PM00298
REGULATOR - PHOSPHO-TORR
//
UNIQUE-ID - REG0-11323
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8163
CITATIONS - 21516113
MODE - -
REGULATED-ENTITY - PM00590
REGULATOR - G7571-MONOMER
//
UNIQUE-ID - REG0-6350
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6949
CITATIONS - 15009899
CITATIONS - 15101990
CITATIONS - 16824106
MODE - -
REGULATED-ENTITY - PM0-2801
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-12386
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8506
CITATIONS - 26527647
MODE - -
REGULATED-ENTITY - PM00004
REGULATOR - MONOMER0-165
//
UNIQUE-ID - REG0-9255
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7461
CITATIONS - 17892462
MODE - +
REGULATED-ENTITY - PM681
REGULATOR - G6882-MONOMER
//
UNIQUE-ID - REG0-4834
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3862
CITATIONS - 14702398
CITATIONS - 12730179
CITATIONS - 18808381
CITATIONS - 18083817
COMMENT - GadX has a positive direct or indirect effect on the <i>hdeAB-yhiD</i> operon only in stationary-phase cells at pH 5.5, but it is a repressor in exponential growth phase at pH 7.0 |CITS: [18083817]|.
MODE - +
REGULATED-ENTITY - PM928
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-5210
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3101
CITATIONS - 9192630
MODE - +
REGULATED-ENTITY - PM00401
REGULATOR - CPLX0-2021
//
UNIQUE-ID - REG0-5583
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00621
CITATIONS - 10601207
MODE - +
REGULATED-ENTITY - PM00184
REGULATOR - PD00288
//
UNIQUE-ID - REG0-10601
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7825
CITATIONS - 20015147
MODE - +
REGULATED-ENTITY - PM0-10490
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-5961
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2744
CITATIONS - 11929525
CITATIONS - 15978080
COMMENT - IHF binding to a site located  -55 bp from the promoter weakly represses the nrfAp promoter and strongly represses acsP1, a promoter that overlaps and is divergent to nrfAp. 
/
/NarL and IHF cannot bind together, contrary to other protein regulators that can bind together to form ternary complexes. Fis binds independently to FNR and IHF. |CITS: [15978080]| supposes that Fis blocks access of RNAP to the <i>nrf</i> promoter. Based on DNase footprinting |CITS:[15978080]|, it is suggested that IHF alters the binding of FNR without displacing it from its site. In addition, NarL binding prevents IHF binding but has little or no effect on FNR or Fis binding. Either Fis or IHF at  -55 can repress FNR-dependent open complex formation. NarL binding to its target reverses IHF-dependent repression but does not relieve Fis-dependent repression |CITS:[15978080]|.
/
MODE - -
REGULATED-ENTITY - PM00280
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11265
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8147
CITATIONS - 11350954
MODE - -
REGULATED-ENTITY - PM00047
REGULATOR - PHOSPHO-CREB
//
UNIQUE-ID - REG0-6334
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2481
CITATIONS - 12617754
COMMENT - The regulatory effect of Fis on the promoter ygjGp is not known |CITS: [12617754]|.
/
REGULATED-ENTITY - PM0-3521
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-12295
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8487
CITATIONS - 26078445
MODE - -
REGULATED-ENTITY - PM0-46352
REGULATOR - G7947-MONOMER
//
UNIQUE-ID - REG0-9161
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7444
CITATIONS - 17850814
MODE - -
REGULATED-ENTITY - PM0-8541
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-4818
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00057
CITATIONS - 11115116
CITATIONS - 8577745
CITATIONS - 12079504
COMMENT - The spacing between the FNR site and the RNA polymerase site  is critical in the expression of <i> dmsA</i> .
/FNR activates <i>dmsA</i>  expression under anaerobic environmental conditions |CITS:[12079504]|.
MODE - +
REGULATED-ENTITY - PM00026
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5194
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00573
COMMENT - FNR is absolutely necessary for pyruvate-mediated induction of the <i>focA-pflB</i> operon. This protein mediates anaerobic regulation of the <i>focA-pflB</i> operon.
MODE - +
REGULATED-ENTITY - PM00354
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5566
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7229
CITATIONS - 12123449
MODE - -
REGULATED-ENTITY - PM00308
REGULATOR - G7072-MONOMER
//
UNIQUE-ID - REG0-10572
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7809
CITATIONS - 19734316
MODE - -
REGULATED-ENTITY - PM0-10449
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5941
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1961
CITATIONS - 16404567
CITATIONS - 15347756
CITATIONS - 9871104
COMMENT - Both of the factors IHF and  -13C residue play an important role in the recognition and the transcription of pstSp by &sigma;<sup>S</sup> |CITS: [16404567]|. Unlike  all other PHO genes, which are under control of &sigma;<sup>D</sup>, the  -13C residue might confer specificity at the pstSp promoter to be transcribed by &sigma;<sup>S</sup> |CITS: [15347756]|.
MODE - +
REGULATED-ENTITY - PM00285
REGULATOR - PC00027
//
UNIQUE-ID - REG0-6318
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2681
CITATIONS - 11121068
MODE - +
REGULATED-ENTITY - PM0-3821
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-5938
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3354
CITATIONS - 11532153
MODE - -
REGULATED-ENTITY - PM00312
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6315
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5882
MODE - +
REGULATED-ENTITY - PM0-3802
REGULATOR - MONOMER0-2421
//
UNIQUE-ID - REG0-11244
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8129
CITATIONS - 11717281
MODE - -
REGULATED-ENTITY - PM00535
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-12214
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8473
CITATIONS - 25369000
MODE - -
REGULATED-ENTITY - TU0-8688
REGULATOR - CPLX0-7680
//
UNIQUE-ID - REG0-9078
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5522
CITATIONS - 15534208
CITATIONS - 17238917
MODE - +
REGULATED-ENTITY - PM00560
REGULATOR - G7678-MONOMER
//
UNIQUE-ID - REG0-4799
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00040
CITATIONS - 2644221
CITATIONS - 17526711
MODE - -
REGULATED-ENTITY - PM00019
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-5175
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00505
CITATIONS - [8825776]
CITATIONS - [10564485]
COMMENT - Stimulation of the nfop promoter was independent of the C-terminal domain of the RNA polymerase &alpha;-subunit. The binding site overlaps the -35 promoter hexamer.
MODE - +
REGULATED-ENTITY - PM00264
REGULATOR - PD00406
//
UNIQUE-ID - REG0-5547
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00211
CITATIONS - 6280873
MODE - -
REGULATED-ENTITY - PM00099
REGULATOR - PC00010
//
UNIQUE-ID - REG0-10518
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7793
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM0-10437
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5922
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-901
CITATIONS - [9393706]
COMMENT - Activation by Fis is dependent on the presence of MarA, SoxS, or Rob.
MODE - +
REGULATED-ENTITY - PM00265
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-6298
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2941
CITATIONS - 11448880
CITATIONS - 2419307
CITATIONS - 16515535
MODE - -
REGULATED-ENTITY - PM00490
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-11216
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8115
CITATIONS - 21622752
MODE - -
REGULATED-ENTITY - TU0-8628
REGULATOR - EG20249-MONOMER
//
UNIQUE-ID - REG0-12151
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8454
CITATIONS - 25406449
MODE - -
REGULATED-ENTITY - PM0-46335
REGULATOR - G6745-MONOMER
//
UNIQUE-ID - REG0-9046
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7391
CITATIONS - 17468243
CITATIONS - 20466769
MODE - -
REGULATED-ENTITY - PM00536
REGULATOR - PHOSPHO-RSTA
//
UNIQUE-ID - REG0-4786
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7278
CITATIONS - 16861804
MODE - +
REGULATED-ENTITY - PM00011
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-5159
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS127
CITATIONS - [8631699]
MODE - -
REGULATED-ENTITY - PM338
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5534
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00210
MODE - -
REGULATED-ENTITY - PM00091
REGULATOR - PC00010
//
UNIQUE-ID - REG0-10502
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7778
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM00201
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5906
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00766
CITATIONS - 7768815
MODE - -
REGULATED-ENTITY - PM00187
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-6282
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7011
CITATIONS - 15883881
MODE - +
REGULATED-ENTITY - PM0-3847
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-11117
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8097
CITATIONS - 15716448
MODE - +
REGULATED-ENTITY - TU-8382
REGULATOR - PHOSPHO-BAER
//
UNIQUE-ID - REG0-12106
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8436
CITATIONS - 9813115
COMMENT - The regulatory effect of NtrC on the promoter <i>patA</i>p is as yet not known |CITS: [12617754]|. However, we assigned a positive role to this regulatory interaction based on the facts that NtrC activates &sigma;<sup>54</sup> promoters and the promoter <i>patA</i>p is one of them.
MODE - +
REGULATED-ENTITY - PM0-3521
REGULATOR - GLNG-CPLX
//
UNIQUE-ID - REG0-9015
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3729
CITATIONS - 12588863
COMMENT - Fis binding to site I and II can coactivate ptsGp1 transcription with CRP.
MODE - -
REGULATED-ENTITY - PM0-1301
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4770
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4502
MODE - -
REGULATED-ENTITY - PM00004
REGULATOR - CPLX-172
//
UNIQUE-ID - REG0-5143
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS149
CITATIONS - [8057842]
CITATIONS - 15659676
MODE - +
REGULATED-ENTITY - PM00324
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5518
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00499
CITATIONS - [7896685]
MODE - +
REGULATED-ENTITY - PM00089
REGULATOR - PD04418
//
UNIQUE-ID - REG0-10481
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7763
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM0-46298
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5890
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5444
CITATIONS - 14731281
MODE - -
REGULATED-ENTITY - PM0-6881
REGULATOR - G7630-MONOMER
//
UNIQUE-ID - REG0-11100
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8089
CITATIONS - 21460078
MODE - +
REGULATED-ENTITY - PM0-36253
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6269
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4223
CITATIONS - 12586421
COMMENT - NarP or NarL repress the transcription of the <i>nor</i> operon when <i>Escherichia coli</i> is grown with nitrite, suggesting that NarL and NarP proteins are competing with a transcriptional activator which is activated by nitrite, and may bind to the nucleotide region in the vacinity of the putative NarL/NarP-binding site |CITS: [12586421]|.
MODE - -
REGULATED-ENTITY - PM0-4681
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-12009
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8419
CITATIONS - 24272779
MODE - -
REGULATED-ENTITY - PM00563
REGULATOR - PD01379
//
UNIQUE-ID - REG0-8998
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00663
CITATIONS - 2115441
CITATIONS - 8596434
CITATIONS - 15520470
COMMENT - In the absence of the other proteins, cAMP-CRP binds to three CRP targets centered at -92.5 (CRP2), -42.5 (CRP1), and +56 (CRPE).
/The <i>nupG</i> full repression complex contains CytR protein sandwiched between two cAMP-CRP complexes.
MODE - -
REGULATED-ENTITY - PM00173
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4753
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7060
CITATIONS - 12492863
CITATIONS - 8682810
MODE - -
REGULATED-ENTITY - PM00001
REGULATOR - CPLX0-7605
//
UNIQUE-ID - REG0-5127
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS326
CITATIONS - [8892825]
CITATIONS - 18263722
MODE - -
REGULATED-ENTITY - PM224
REGULATOR - EG11962-MONOMER
//
UNIQUE-ID - REG0-5502
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3482
CITATIONS - 14711822
CITATIONS - 16140031
CITATIONS - 16980446
MODE - +
REGULATED-ENTITY - PM00141
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10463
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7747
CITATIONS - 18309357
MODE - -
REGULATED-ENTITY - TU0-13273
REGULATOR - G7573-MONOMER
//
UNIQUE-ID - REG0-5874
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS53
CITATIONS - [3309132]
CITATIONS - [9720032]
CITATIONS - [8892825]
MODE - +
REGULATED-ENTITY - PM00148
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11083
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8074
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM0-36128
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6252
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3744
CITATIONS - 10760165
COMMENT - FIS-site I partially overlaps the CAP-binding site.
MODE - -
REGULATED-ENTITY - PM0-5042
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-11982
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8404
CITATIONS - 24335284
MODE - +
REGULATED-ENTITY - PM0-46313
REGULATOR - CPLX0-7916
//
UNIQUE-ID - REG0-8981
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS821
CITATIONS - [2575702]
CITATIONS - [1327747]
COMMENT - CRP and CytR bind cooperatively to cddp.
MODE - -
REGULATED-ENTITY - PM1001
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4737
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5102
MODE - +
REGULATED-ENTITY - PM00048
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-5109
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS165
CITATIONS - [9401024]
MODE - +
REGULATED-ENTITY - PM502
REGULATOR - CPLX0-2781
//
UNIQUE-ID - REG0-5484
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS784
CITATIONS - [8809748]
COMMENT - Lrp is a specific repressor for &sigma;<sup>38</sup>-dependent transcription of the <i>aidB</i> promoter. Activation of the <i>aidB</i> promoter by Ada is dominant over repression by Lrp <i>in vitro</i>.
MODE - -
REGULATED-ENTITY - PM00136
REGULATOR - PD00353
//
UNIQUE-ID - REG0-10434
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7733
CITATIONS - 18997424
MODE - +
REGULATED-ENTITY - PM00202
REGULATOR - PHOSPHO-DPIA
//
UNIQUE-ID - REG0-5857
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS141
MODE - +
REGULATED-ENTITY - PM00143
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11067
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8061
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00399
REGULATOR - PD00197
//
UNIQUE-ID - REG0-6236
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4126
CITATIONS - 14593252
MODE - +
REGULATED-ENTITY - PM0-4921
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11903
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8389
CITATIONS - 24025246
MODE - +
REGULATED-ENTITY - PM0-36236
REGULATOR - PD00406
//
UNIQUE-ID - REG0-6612
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7219
CITATIONS - 14523117
COMMENT - Since the CsgD-binding site overlaps the pepDp3 promoter and the transcription factor has a negative effect on the transcription of the <i>pepD</i> gene  |CITS: [14523117]|,  the regulatory effect of CsgD has been linked to  the pepDp3  promoter, although an effect of the protein on the other promoters has not been discarded.
MODE - -
REGULATED-ENTITY - PM0-9310
REGULATOR - PD01379
//
UNIQUE-ID - REG0-4721
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00104
MODE - -
REGULATED-ENTITY - PM00045
REGULATOR - PD00763
//
UNIQUE-ID - REG0-5093
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS241
MODE - +
REGULATED-ENTITY - PM341
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5467
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00260
CITATIONS - [3525516]
CITATIONS - [10197993]
CITATIONS - 7798138
CITATIONS - 15049824
COMMENT - The TyrR-binding site at position -41.5 from the promoter is a weak TyrR box that is involved in the repression of <i>tyrP</i> gene transcription. This, along  with another site (-64.5 from the promoter), is required for the repression of <i>tyrP</i> gene expression by the TyrR protein in the presence of ATP and tyrosine |CITS:[15049824]|.
MODE - -
REGULATED-ENTITY - PM00125
REGULATOR - MONOMER0-162
//
UNIQUE-ID - REG0-10392
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7712
CITATIONS - 16857675
MODE - +
REGULATED-ENTITY - PM0-10368
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5841
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7322
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00225
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-11050
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8048
CITATIONS - 21421764
CITATIONS - 21421764:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3513524528:martin
CITATIONS - 21421764:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3513524528:martin
CITATIONS - 21421764:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3513524528:martin
MODE - -
REGULATED-ENTITY - PM-8794
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6220
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3841
CITATIONS - 15516583
CITATIONS - 15520470
COMMENT - The gntP gene is subject to strong catabolite repression.
MODE - +
REGULATED-ENTITY - PM0-5201
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11825
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8373
CITATIONS - 23475967
MODE - -
REGULATED-ENTITY - PM404
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6595
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7085
CITATIONS - 16428390
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM-8829
REGULATOR - CPLX0-7756
//
UNIQUE-ID - REG0-4704
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00092
CITATIONS - 1556120
CITATIONS - 9179845
MODE - -
REGULATED-ENTITY - PM00039
REGULATOR - PD03576
//
UNIQUE-ID - REG0-5077
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5262
CITATIONS - 7512187
COMMENT - H-NS antagonizes the Fis-mediated activation  of the P1 promoter through conformational changes in the DNA |CITS: [7512187]|.
MODE - -
REGULATED-ENTITY - PM00514
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5451
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00637
MODE - -
REGULATED-ENTITY - PM00114
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10326
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7697
CITATIONS - 8830270
MODE - -
REGULATED-ENTITY - PM0-10354
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-5825
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7023
CITATIONS - 12754220
CITATIONS - 22152010
COMMENT - Based on microarray analysis it was concluded that anaerobiosis does not affect the expression of the <i>purMN</i> operon, although FNR appears to repress it. A putative FNR-binding site, which was not shown in the paper, was identified in this operon |CITS: [12754220]|.
MODE - -
REGULATED-ENTITY - PM00080
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11026
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8033
CITATIONS - 21441513
CITATIONS - 21890697
COMMENT - ArgP binds the <i>lysP</i>p promoter upstream region, with a <i>K<sub>d</sub></i> of  55 nM |CITS:[21890697]|.
MODE - +
REGULATED-ENTITY - PM340
REGULATOR - CPLX0-7669
//
UNIQUE-ID - REG0-6204
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6601
CITATIONS - 8455549
COMMENT - The H-NS site for the <i>hdeD</i> regulatory region hasn't been determined, but Yoshida93 suggested that H-NS  has two sites: one site near <i>hdeD</i> and the other one close to <i>hdeA</i> (the upstream operon in the opposite direction) and that H-NS represses transcription through the DNA binding to supercoil it or DNA already supercoiled. Futrher experiments are requiered to test this proposal.
MODE - -
REGULATED-ENTITY - PM0-5143
REGULATOR - PD00288
//
UNIQUE-ID - REG0-11757
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8358
CITATIONS - 23408903
MODE - -
REGULATED-ENTITY - PM0-8643
REGULATOR - PC00010
//
UNIQUE-ID - REG0-6579
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7183
CITATIONS - 8407793
MODE - -
REGULATED-ENTITY - PM0-8860
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4688
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS481
CITATIONS - 8955388
MODE - -
REGULATED-ENTITY - PM00038
REGULATOR - PD03576
//
UNIQUE-ID - REG0-5061
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1
CITATIONS - 13129959
MODE - -
REGULATED-ENTITY - PM444
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5435
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00690
CITATIONS - [8892825]
COMMENT - Several  putative ArcA-binding sites with one or two mismatches are located  within the <i>betT</i> promoter region.
MODE - -
REGULATED-ENTITY - PM00157
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10185
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7680
CITATIONS - 19074390
MODE - +
REGULATED-ENTITY - PM0-10338
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-5809
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS741
CITATIONS - [9852003]
CITATIONS - 15150239
COMMENT - The Crp effect is relatively weak.
MODE - +
REGULATED-ENTITY - PM00220
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10981
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8026
CITATIONS - 16980449
CITATIONS - 12446650
CITATIONS - 12730179
MODE - +
REGULATED-ENTITY - PM450
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6188
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3943
CITATIONS - 3934044
CITATIONS - 3079718
COMMENT - Expression of the regulated gene is affected as a result of mutating the regulatory protein. Note that this evidence does not eliminate the possiblity of an indirect effect of the regulator on the regulated gene.
MODE - -
REGULATED-ENTITY - PM0-5321
REGULATOR - EG20249-MONOMER
//
UNIQUE-ID - REG0-11701
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8342
CITATIONS - 22522900
CITATIONS - 19181795
CITATIONS - 18495664
MODE - -
REGULATED-ENTITY - PM0-10351
REGULATOR - EG12431-MONOMER
//
UNIQUE-ID - REG0-6558
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7046
CITATIONS - 15716448
CITATIONS - 17884222
MODE - +
REGULATED-ENTITY - PM-8764
REGULATOR - PHOSPHO-BAER
//
UNIQUE-ID - REG0-4672
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00078
CITATIONS - 2858855
MODE - -
REGULATED-ENTITY - PM00034
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-9984
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7652
CITATIONS - 16515535
MODE - -
REGULATED-ENTITY - PM0-10286
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-5045
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5321
CITATIONS - 9371449
MODE - +
REGULATED-ENTITY - PM70
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5419
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS801
CITATIONS - [8381784]
COMMENT - Hns repress adiAp promoter at pH 8.0
MODE - -
REGULATED-ENTITY - PM981
REGULATOR - PD00288
//
UNIQUE-ID - REG0-10095
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7668
CITATIONS - 19007420
MODE - -
REGULATED-ENTITY - PM0-7421
REGULATOR - PD00266
//
UNIQUE-ID - REG0-5793
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3464
CITATIONS - 14711822
CITATIONS - 22870390
MODE - -
REGULATED-ENTITY - PM00218
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10965
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8017
CITATIONS - 11976288
CITATIONS - 12446650
CITATIONS - 16980449
CITATIONS - 15795232
MODE - +
REGULATED-ENTITY - PM461
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6170
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4401
CITATIONS - 9315722
MODE - -
REGULATED-ENTITY - PM0-5862
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11658
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8331
CITATIONS - 23301696
MODE - -
REGULATED-ENTITY - PM0-44865
REGULATOR - G6664-MONOMER
//
UNIQUE-ID - REG0-6542
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7075
CITATIONS - 15941987
MODE - +
REGULATED-ENTITY - PM-8798
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-4656
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5061
CITATIONS - 9218807
CITATIONS - 10982882
CITATIONS - 9016640
CITATIONS - 14500788
COMMENT - GalR is required to bind HU.
MODE - -
REGULATED-ENTITY - PM00032
REGULATOR - CPLX0-2021
//
UNIQUE-ID - REG0-9638
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7642
CITATIONS - 18560382
MODE - +
REGULATED-ENTITY - PM0-10249
REGULATOR - PD02198
//
UNIQUE-ID - REG0-5029
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS443
CITATIONS - [8955407]
CITATIONS - [10216857]
MODE - -
REGULATED-ENTITY - PM562
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5403
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4802
CITATIONS - 10411720
CITATIONS - 11101675
CITATIONS - 2139473
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00226
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-5777
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00529
CITATIONS - 8034728
MODE - +
REGULATED-ENTITY - PM00209
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10937
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8003
CITATIONS - 12077137
COMMENT - The <i>ade</i> gene is repressed 10-fold by HNS. On the other hand, it was demonstrated that some insertion elements are able to eliminate the HNS-mediated silencing of <i>ade</i> |CITS:[ 12077137]|.
MODE - -
REGULATED-ENTITY - PM0-36195
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6153
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7117
CITATIONS - 9670013
MODE - +
REGULATED-ENTITY - PM00615
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-11638
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8316
CITATIONS - 23233451
MODE - +
REGULATED-ENTITY - PM0-44976
REGULATOR - G6444-MONOMER
//
UNIQUE-ID - REG0-6526
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6958
CITATIONS - 21272324
CITATIONS - 15659676
CITATIONS - 10411720
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00343
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4640
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6987
CITATIONS - 8057356
MODE - -
REGULATED-ENTITY - PM00030
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9596
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7626
CITATIONS - 18524927
MODE - -
REGULATED-ENTITY - PM00289
REGULATOR - PD00196
//
UNIQUE-ID - REG0-5012
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1746
CITATIONS - 16980449
CITATIONS - [12446650]
CITATIONS - 12730179
COMMENT - GadW regulates positively the expression of <i>gadA</i> in the absence of GadX only to pH 8 |CITS: [12446650]|.
MODE - -
REGULATED-ENTITY - PM461
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-5387
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00321
CITATIONS - 8416900
CITATIONS - 15520470
CITATIONS - 17608696
CITATIONS - 19054109
MODE - +
REGULATED-ENTITY - PM00231
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5761
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00679
CITATIONS - 1372899
COMMENT - This binding site is within the <i>glpK</i> coding region. The affinity of the repressor for this site is much lower than the affinity of it for the sites in the regulatory region.
MODE - -
REGULATED-ENTITY - PM00238
REGULATOR - PD03576
//
UNIQUE-ID - REG0-10920
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7988
CITATIONS - 21034467
MODE - +
REGULATED-ENTITY - PM461
REGULATOR - EG11966-MONOMER
//
UNIQUE-ID - REG0-6137
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6844
CITATIONS - 2556297
COMMENT - Most of the transcription of the <i>uvrC</i> gene begins at the uvrCp2 promoter |CITS:[2556297]|.
MODE - -
REGULATED-ENTITY - PM00389
REGULATOR - PC00010
//
UNIQUE-ID - REG0-11621
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8300
CITATIONS - 23028500
MODE - -
REGULATED-ENTITY - PM0-44722
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6510
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1063
CITATIONS - [9767573]
COMMENT - Mlc showed better repression of ptsGp1 in the presence of Fis.
/
/The DgsA transcriptional repressor is inactivated by the cytoplasmic protein MtfA via a protein-protein interaction that prevents interaction of DgsA with its binding sites on the <i>ptsG</i> upstream region |CITS:[22178967]|.
MODE - -
REGULATED-ENTITY - PM0-1301
REGULATOR - PD01896
//
UNIQUE-ID - REG0-4624
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00061
CITATIONS - 3079747
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00027
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-9571
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7610
CITATIONS - 18482579
MODE - +
REGULATED-ENTITY - PM0-10082
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4996
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2426
CITATIONS - [8002608]
CITATIONS - 1346534
MODE - -
REGULATED-ENTITY - PM00631
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5371
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00493
CITATIONS - 1304369
CITATIONS - 23651393
MODE - -
REGULATED-ENTITY - PM00290
REGULATOR - PD03867
//
UNIQUE-ID - REG0-5745
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00710
CITATIONS - 10217490
COMMENT - Lrp takes part in <i>gcv</i> operon regulation as a modulator of the GcvA effect. It bends the DNA upstream of the transcription start position to allow GcvA to function |CITS:[10217490]|.
MODE - +
REGULATED-ENTITY - PM00233
REGULATOR - PD00353
//
UNIQUE-ID - REG0-10900
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7972
CITATIONS - 21115656
MODE - -
REGULATED-ENTITY - PM0-1123
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6121
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6783
CITATIONS - 2842314
MODE - -
REGULATED-ENTITY - PM00386
REGULATOR - PC00010
//
UNIQUE-ID - REG0-11583
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8287
CITATIONS - 22442305
MODE - +
REGULATED-ENTITY - PM00560
REGULATOR - PHOSPHO-BASR
//
UNIQUE-ID - REG0-6493
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-981
CITATIONS - [9159399]
CITATIONS - [9159398]
CITATIONS - 16861804
MODE - +
REGULATED-ENTITY - PM0-1221
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-4608
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7273
CITATIONS - 16861804
CITATIONS - 23564175
MODE - +
REGULATED-ENTITY - PM0-9395
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-9521
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7594
CITATIONS - 9677290
MODE - -
REGULATED-ENTITY - PM0-10214
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-4978
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00504
CITATIONS - 7673113
CITATIONS - 9564045
MODE - -
REGULATED-ENTITY - PM00606
REGULATOR - PD04132
//
UNIQUE-ID - REG0-5354
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7078
CITATIONS - 16000739
MODE - -
REGULATED-ENTITY - PM00536
REGULATOR - PC00084
//
UNIQUE-ID - REG0-5729
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00721
CITATIONS - 1848637
CITATIONS - 15520470
COMMENT - This second very weak CAP site upstream from <i>manX</i> in the region -80 to -100 is detected only at very high CAP concentrations |CITS: [1848637], [15520470]|.
MODE - +
REGULATED-ENTITY - PM00276
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10884
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7957
CITATIONS - 21097627
CITATIONS - 12746439
MODE - -
REGULATED-ENTITY - PM0-36183
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6105
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6003
CITATIONS - 15988767
COMMENT - ArcA has a slightly positive effect on <i>ackA</i> expression |CITS:[15988767]|.
MODE - +
REGULATED-ENTITY - PM00524
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11538
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8270
CITATIONS - 6406797
MODE - -
REGULATED-ENTITY - PM0-5285
REGULATOR - EG20249-MONOMER
//
UNIQUE-ID - REG0-6477
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2552
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1351
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4589
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00161
CITATIONS - [2656631]
CITATIONS - [2656704]
CITATIONS - [2553720]
CITATIONS - [9422609]
CITATIONS - 10698756
CITATIONS - 11158569
CITATIONS - 11812125
CITATIONS - 11158569
CITATIONS - 16618701
MODE - +
REGULATED-ENTITY - PM00066
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-9461
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7581
CITATIONS - 18227264
MODE - -
REGULATED-ENTITY - PM0-10196
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-4962
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5341
CITATIONS - 11053378
CITATIONS - 14996792
CITATIONS - 17892462
COMMENT - Hns modulates the <i>hlyE</i> expression both positively and negatively; this protein enhances the CRP-mediated expression of <i>hlyE</i> , but it inhibits the FNR-mediated <i>hlyE</i> expression.
MODE - +
REGULATED-ENTITY - PM681
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5337
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00700
CITATIONS - 7715459
MODE - -
REGULATED-ENTITY - PM00619
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5711
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00346
COMMENT - CspA has been called CS7.4
MODE - +
REGULATED-ENTITY - PM00192
REGULATOR - PD03695
//
UNIQUE-ID - REG0-10842
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7940
CITATIONS - 20603130
MODE - -
REGULATED-ENTITY - PM0-9849
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-6089
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6503
CITATIONS - 12813061
CITATIONS - 15883881
COMMENT - This regulatory interaction was identified by means of PhoPQ-related microarray experiments, and the investigators checked for the presence of its regulatory motif in the promoter region |CITS: [15883881]|.
MODE - +
REGULATED-ENTITY - PM0-8164
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-11517
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8252
CITATIONS - 16115199
MODE - -
REGULATED-ENTITY - PM0-9575
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6461
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2556
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1346
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4572
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00361
CITATIONS - 6317653
MODE - +
REGULATED-ENTITY - PM00065
REGULATOR - PD00969
//
UNIQUE-ID - REG0-9407
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7564
CITATIONS - 18083817
MODE - -
REGULATED-ENTITY - PM928
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-4946
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS507
CITATIONS - [1703160]
CITATIONS - [1569580]
CITATIONS - [8577735]
CITATIONS - [8702758]
MODE - +
REGULATED-ENTITY - PM00475
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5321
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00772
CITATIONS - 7545108
MODE - -
REGULATED-ENTITY - PM00643
REGULATOR - PD00266
//
UNIQUE-ID - REG0-5695
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7154
CITATIONS - 16377617
MODE - +
REGULATED-ENTITY - PM00168
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10816
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7924
CITATIONS - 20466769
COMMENT - The site for IHF (-173.5), determined experimentally by DNase I footprinting, covers a region of 30 bp upstream of <i>csgD</i>p1 |CITS: [20466769]|]. It is likely that there are several sites for IHF, so the consensus sequence for this regulator is 13 bp.
MODE - +
REGULATED-ENTITY - PM00536
REGULATOR - PC00027
//
UNIQUE-ID - REG0-6070
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6661
CITATIONS - 15616579
COMMENT - Between the <i>dhaKLM</i> operon and the <i>dhaR</i> gene there is a 190-bp-long intergenic region that divergently transcribes them. DhaR is an (auto)repressor of the <i>dhaR</i> gene and an activator of the <i>dhaKLM</i> operon |CITS: [15616579]|.
MODE - -
REGULATED-ENTITY - PM0-8342
REGULATOR - G6628-MONOMER
//
UNIQUE-ID - REG0-11501
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8244
CITATIONS - 22422754
COMMENT - MatA-<i>fliA</i>p1 regulatory interaction was identified in <i>Escherichia coli</i> strain IHE 3034 |CITS:[ 22422754]|.
/
/MatA binds weakly to <i>fliA</i>p1 |CITS:[ 22422754]|.
MODE - -
REGULATED-ENTITY - PM00563
REGULATOR - G6165-MONOMER
//
UNIQUE-ID - REG0-6445
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7058
MODE - +
REGULATED-ENTITY - PM00604
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-4556
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7258
MODE - +
REGULATED-ENTITY - PM00063
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-9387
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7548
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM00061
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4930
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS771
CITATIONS - [9421904]
MODE - -
REGULATED-ENTITY - PM263
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5305
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00618
CITATIONS - 8102362
COMMENT - Isolated and studied mRNA from isogenic himA<sup>+</sup> and himA::Tn<i>10</i> (SR69 and SR1021) strains or from an <i>himD</i> mutant bacterial strain (SR1022). The primer extension results showed comparatively low levels of mRNA transcripts initiating from all three putative promoters. Thus, it is clear that functional IHF is needed for efficient transcription of the <i>ecp-htrE</i> operon.
MODE - +
REGULATED-ENTITY - PM00555
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5679
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3346
CITATIONS - 8830277
MODE - +
REGULATED-ENTITY - PM00191
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10800
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7908
CITATIONS - 11133959
CITATIONS - 9312050
CITATIONS - 1316901
CITATIONS - 8168494
REGULATED-ENTITY - PM00282
REGULATOR - MONOMER0-46
//
UNIQUE-ID - REG0-6054
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7332
CITATIONS - 17074904
CITATIONS - 17850814
MODE - -
REGULATED-ENTITY - PM0-8541
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-11483
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8228
CITATIONS - 22295907
MODE - -
REGULATED-ENTITY - PM0-46179
REGULATOR - PD00519
//
UNIQUE-ID - REG0-6428
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6972
CITATIONS - 15659676
MODE - -
REGULATED-ENTITY - PM00372
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4540
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-30
CITATIONS - 15225315
CITATIONS - 11004182
CITATIONS - 9302020
MODE - +
REGULATED-ENTITY - PM00062
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9369
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7531
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM167
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4914
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-22
CITATIONS - 9852003
MODE - -
REGULATED-ENTITY - PM00625
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5289
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS423
CITATIONS - [9648752]
COMMENT - 
/
/
MODE - +
REGULATED-ENTITY - PM00540
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5663
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7314
CITATIONS - 9582281
MODE - -
REGULATED-ENTITY - PM0-9556
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10763
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7893
CITATIONS - 10564497
MODE - +
REGULATED-ENTITY - PM00528
REGULATOR - CPLX0-8062
//
UNIQUE-ID - REG0-6038
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1644
CITATIONS - [9880556]
MODE - -
REGULATED-ENTITY - PM166
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11465
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8213
CITATIONS - 22422754
COMMENT - MatA-<i>flhD</i>p regulatory interaction was identified in <i>Escherichia coli</i> strain IHE 3034 |CITS:[ 22422754]|.
/
/MatA binds with higher affinity to <i>flhD</i>p than <i>flhD</i>p2 |CITS:[ 22422754]|.
/
MODE - -
REGULATED-ENTITY - PM00184
REGULATOR - G6165-MONOMER
//
UNIQUE-ID - REG0-6411
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3470
CITATIONS - 11741843
CITATIONS - 12392714
CITATIONS - 21097628
MODE - +
REGULATED-ENTITY - PM0-2281
REGULATOR - PD00406
//
UNIQUE-ID - REG0-4524
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00143
CITATIONS - 8682807
CITATIONS - 1528882
CITATIONS - 8419352
MODE - +
REGULATED-ENTITY - PM00060
REGULATOR - PC00027
//
UNIQUE-ID - REG0-9353
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7515
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM0-7321
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4897
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS567
CITATIONS - [8843440]
MODE - +
REGULATED-ENTITY - PM687
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-5273
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00758
CITATIONS - 2457575
CITATIONS - 15520470
COMMENT - CRP binds to the ptsHP1 promoter when there is a superhelicoidal  template <i>in vitro</i>.
MODE - +
REGULATED-ENTITY - PM00635
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5647
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7015
CITATIONS - 12754220
CITATIONS - 16377617
COMMENT - By making use of microarray analyses, it was concluded that FNR activates <i>cai</i> operon expression under anaerobiosis |CITS: [12754220], [16377617]|.
MODE - +
REGULATED-ENTITY - PM00528
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10731
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7879
CITATIONS - 19690171
MODE - -
REGULATED-ENTITY - PM0-10415
REGULATOR - G7571-MONOMER
//
UNIQUE-ID - REG0-6022
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6862
CITATIONS - 10760155
COMMENT - This site was determined by computational searches, and its inducibility was analyzed by Northern analysis in a variety of <i>lexA</i> backgrounds. The sequence of the site is  CTGTATTTGTCTCCAG, and its absolute position is 3719642.5. We have given the absolute position in the genome of <i>E. coli</i> for this site instead of the central position, since the +1 site of the transcription initiation has not yet been determined |CITS:[ 10760155]|.
MODE - -
REGULATED-ENTITY - PM0-8642
REGULATOR - PC00010
//
UNIQUE-ID - REG0-11421
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8194
CITATIONS - 10216857
CITATIONS - 8955407
CITATIONS - 8955407:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3538186972:martin
CITATIONS - 10216857:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3538186972:martin
CITATIONS - 10216857:EV-EXP-IMP-SITE-MUTATION:3538186972:martin
CITATIONS - 10216857:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3538186972:martin
CITATIONS - 10216857:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3538186972:martin
CITATIONS - 8955407:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3538186972:martin
CITATIONS - 8955407:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3538186972:martin
COMMENT - Changes in this site  significantly altered <i>dadAX</i> expression
MODE - -
REGULATED-ENTITY - PM562
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6395
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1521
CITATIONS - [7596833]
CITATIONS - [9302010]
COMMENT - IHF and PspF proteins bind cooperatively to regulate the <i>pspA</i> promoter.
MODE - +
REGULATED-ENTITY - PM0-1981
REGULATOR - PC00027
//
UNIQUE-ID - REG0-4508
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00133
MODE - -
REGULATED-ENTITY - PM00054
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-9324
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7500
CITATIONS - 17768236
CITATIONS - 17768236:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3411310391:asantos
CITATIONS - 17768236:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3411310391:asantos
MODE - +
REGULATED-ENTITY - PM00039
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4881
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7113
CITATIONS - 9159398
CITATIONS - 7883164
MODE - +
REGULATED-ENTITY - PM00327
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-5257
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00719
CITATIONS - 20141531
MODE - -
REGULATED-ENTITY - PM00260
REGULATOR - PD00361
//
UNIQUE-ID - REG0-5631
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00658
COMMENT - Upstream of -120, a sequence corresponding to the NarL consensus has been found. Other potential (but less-well-conserved) NarL consensus sites are located upstream of -260 and of -201.
MODE - +
REGULATED-ENTITY - PM00592
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-10701
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7863
CITATIONS - 17185552
CITATIONS - 21571995
MODE - +
REGULATED-ENTITY - PM450
REGULATOR - PHOSPHO-RCSB
//
UNIQUE-ID - REG0-6006
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7081
CITATIONS - 11918818
MODE - +
REGULATED-ENTITY - PM169
REGULATOR - G7071-MONOMER
//
UNIQUE-ID - REG0-11383
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8179
CITATIONS - 9701802
CITATIONS - 18997424
CITATIONS - 22101843
CITATIONS - 18997424:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3535302921:martin
CITATIONS - 18997424:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3535302921:martin
CITATIONS - 22101843:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3535302921:martin
CITATIONS - 22101843:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3535302921:martin
CITATIONS - 9701802:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3535302921:martin
CITATIONS - 9701802:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3535302921:martin
MODE - +
REGULATED-ENTITY - PM0-10380
REGULATOR - PHOSPHO-DPIA
//
UNIQUE-ID - REG0-6379
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7248
CITATIONS - 17233826
MODE - -
REGULATED-ENTITY - PM00550
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4491
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00121
CITATIONS - 7830577
MODE - +
REGULATED-ENTITY - PM00049
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-9291
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7487
CITATIONS - 17921503
CITATIONS - 17921503:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3409862238:martin
CITATIONS - 17921503:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3409862238:martin
MODE - -
REGULATED-ENTITY - PM0-4201
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4864
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4426
CITATIONS - 8120010
CITATIONS - 11673423
CITATIONS - 8763946
MODE - -
REGULATED-ENTITY - PM00423
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5240
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00642
COMMENT - Lrp binds to one or more sites within the region from -80 to -32 relative to the start point of <i>lrp</i> transcription. <i>In vitro</i> Lrp binds a region just upstream from the <i>lrp</i> promoter. With the deletion of this region, autogenous regulation by Lrp <i>in vivo</i> is lost. The region protected by Lrp from the DNase I cleavage is at 105 to -20 relative to the start point of <i>lrp</i> transcription. There are two sequences that match with the consensus of Lrp located at -67 to -53 and at +14 to +28. A cluster of single-base substitutions within the region -60 to -53 prevents binding of <i>lrp</i> <i>in vitro</i> and significantly reduces repression of <i>lrp</i> caused by <i>lrp 
/in vivo</i>.
MODE - -
REGULATED-ENTITY - PM00252
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5615
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1483
CITATIONS - [9663683]
COMMENT - Lrp affected the expression of osmCp2 since it activated the transcription of osmCp2. Lrp is an important factor in the shift of the effect on the transcription by E-sigma S of osmCp1 (repressor) and osmCp2 (activator) |CITS:[9663683]|.
MODE - +
REGULATED-ENTITY - PM00545
REGULATOR - PD00353
//
UNIQUE-ID - REG0-10673
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7849
CITATIONS - 11443092
CITATIONS - 17906139
CITATIONS - 1730735
CITATIONS - 2693740
CITATIONS - 8087856
MODE - +
REGULATED-ENTITY - PM00102
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5990
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00450
CITATIONS - [8626315]
CITATIONS - [8522515]
CITATIONS - [10564485]
CITATIONS - 10873449
MODE - +
REGULATED-ENTITY - PM00295
REGULATOR - PD00365
//
UNIQUE-ID - REG0-11354
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8173
CITATIONS - 22101843
MODE - -
REGULATED-ENTITY - PM0-10381
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-6363
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3963
CITATIONS - 14702398
MODE - +
REGULATED-ENTITY - PM0-2441
REGULATOR - EG11544-MONOMER
//
UNIQUE-ID - REG0-4475
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00581
CITATIONS - 8413182
MODE - -
REGULATED-ENTITY - PM00110
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-9272
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7474
CITATIONS - 12694615
CITATIONS - 19352034
MODE - +
REGULATED-ENTITY - PM0-9856
REGULATOR - PHOSPHO-EVGA
//
UNIQUE-ID - REG0-4848
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS758
CITATIONS - [8596446]
CITATIONS - [10648521]
MODE - -
REGULATED-ENTITY - PM168
REGULATOR - PHOSPHO-TORR
//
UNIQUE-ID - REG0-5224
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00758
CITATIONS - 2457575
COMMENT - CRP binds to the ptsHP2 promoter when there is a superhelicoidal  template <i>in vitro</i>.
MODE - -
REGULATED-ENTITY - PM00410
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5596
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4881
CITATIONS - 10601201
CITATIONS - 15520470
COMMENT - In the intergenic regulatory region the <i>fucPIK</i> and <i>fucAO</i> operons, there exist other potential CRP-binding sites, which are located at positions  -80.5,  -289.5,  -297.5, and -387.5 relative to the transcription start site.
MODE - +
REGULATED-ENTITY - PM00172
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10614
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7838
CITATIONS - 19906180
MODE - +
REGULATED-ENTITY - PM0-9890
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-5974
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3471
CITATIONS - 8226698
MODE - -
REGULATED-ENTITY - PM00297
REGULATOR - PD00406
//
UNIQUE-ID - REG0-11320
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8160
CITATIONS - 21441513
CITATIONS - 21890697
MODE - +
REGULATED-ENTITY - PM340
REGULATOR - CPLX0-7669
//
UNIQUE-ID - REG0-6347
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7168
CITATIONS - 16677314
CITATIONS - 16824106
CITATIONS - 21143317
MODE - +
REGULATED-ENTITY - PM0-2801
REGULATOR - G7326-MONOMER
//
UNIQUE-ID - REG0-12373
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8501
CITATIONS - 24212724
MODE - -
REGULATED-ENTITY - PM00536
REGULATOR - G7571-MONOMER
//
UNIQUE-ID - REG0-9239
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7458
CITATIONS - 17513468
MODE - -
REGULATED-ENTITY - PM0-9394
REGULATOR - EG11088-MONOMER
//
UNIQUE-ID - REG0-4831
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7096
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM924
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5207
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00155
CITATIONS - 11812125
CITATIONS - 2656704
CITATIONS - 16618701
MODE - +
REGULATED-ENTITY - PM00401
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-5580
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00527
CITATIONS - 2834341
MODE - +
REGULATED-ENTITY - PM00180
REGULATOR - CPLX0-7650
//
UNIQUE-ID - REG0-10594
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7822
CITATIONS - 8300537
MODE - -
REGULATED-ENTITY - PM00272
REGULATOR - PD00369
//
UNIQUE-ID - REG0-5958
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS69
CITATIONS - 11929525
CITATIONS - 9302020
CITATIONS - 7854119
CITATIONS - 8501030
CITATIONS - 11004182
COMMENT - At low levels of nitrate, NarL activates <i>nrfA</i> expression and  at high levels of nitrate NarL represses it.
MODE - +
REGULATED-ENTITY - PM00280
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-11260
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8144
CITATIONS - 21890697
MODE - +
REGULATED-ENTITY - TU0-13935
REGULATOR - CPLX0-7669
//
UNIQUE-ID - REG0-6331
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2264
CITATIONS - 10714981
MODE - +
REGULATED-ENTITY - PM0-3382
REGULATOR - PD00406
//
UNIQUE-ID - REG0-12292
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8484
CITATIONS - 26078445
MODE - -
REGULATED-ENTITY - PM0-46349
REGULATOR - G7947-MONOMER
//
UNIQUE-ID - REG0-9145
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6362
CITATIONS - 1577702
CITATIONS - 1577702:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3401042128:asantos
CITATIONS - 1577702:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3401042128:asantos
CITATIONS - 11065367
MODE - -
REGULATED-ENTITY - PM0-9680
REGULATOR - PC00010
//
UNIQUE-ID - REG0-4815
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00055
MODE - -
REGULATED-ENTITY - PM00025
REGULATOR - PD01196
//
UNIQUE-ID - REG0-5191
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00575
MODE - -
REGULATED-ENTITY - PM00353
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5563
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00535
CITATIONS - 8521047
MODE - -
REGULATED-ENTITY - PM00307
REGULATOR - PD00353
//
UNIQUE-ID - REG0-10564
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7806
CITATIONS - 9813115
MODE - +
REGULATED-ENTITY - PM0-10039
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10559
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7803
CITATIONS - 9767576
MODE - -
REGULATED-ENTITY - PM00114
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5935
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7220
CITATIONS - 16553838
MODE - +
REGULATED-ENTITY - PM00312
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-6312
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5283
CITATIONS - 11953442
COMMENT - This is an unusual site because it is 151 bp downstream of the psdp promoter.
MODE - -
REGULATED-ENTITY - PM0-3624
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-11240
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8125
CITATIONS - 21908668
MODE - -
REGULATED-ENTITY - PM0-46156
REGULATOR - CPLX0-7672
//
UNIQUE-ID - REG0-12197
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8466
CITATIONS - 25673659
MODE - +
REGULATED-ENTITY - PM00423
REGULATOR - PC00027
//
UNIQUE-ID - REG0-9074
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7425
CITATIONS - 17526711
MODE - +
REGULATED-ENTITY - PM00343
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5172
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00510
CITATIONS - 11395452
CITATIONS - 8522515
CITATIONS - 10564485
MODE - +
REGULATED-ENTITY - PM00262
REGULATOR - PD00406
//
UNIQUE-ID - REG0-5544
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7179
CITATIONS - 16140472
MODE - -
REGULATED-ENTITY - PM00098
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10515
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7790
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM0-10445
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5919
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4163
CITATIONS - 9537375
MODE - -
REGULATED-ENTITY - PM00315
REGULATOR - PD03585
//
UNIQUE-ID - REG0-6295
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2944
CITATIONS - 11448880
CITATIONS - 2419307
CITATIONS - 16515535
MODE - -
REGULATED-ENTITY - PM00490
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-11213
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8112
CITATIONS - 21559929
MODE - +
REGULATED-ENTITY - PM00536
REGULATOR - PC00061
//
UNIQUE-ID - REG0-12148
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8451
CITATIONS - 25246476
MODE - -
REGULATED-ENTITY - PM0-10223
REGULATOR - CPXR-MONOMER
//
UNIQUE-ID - REG0-9043
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7389
CITATIONS - 17496099
MODE - -
REGULATED-ENTITY - PM0-5023
REGULATOR - CPLX0-8061
//
UNIQUE-ID - REG0-4783
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00022
CITATIONS - 2857723
CITATIONS - 3041242
CITATIONS - 3294749
MODE - -
REGULATED-ENTITY - PM00010
REGULATOR - MONOMER0-162
//
UNIQUE-ID - REG0-5156
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS126
CITATIONS - [8631699]
COMMENT - Four other putative half sites for FNR were detected upstream of this site, but the functionality of these elements is puzzling because of  their location with respect to the transcription start site |CITS: [8631699]|.
/
MODE - +
REGULATED-ENTITY - PM338
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5531
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7180
CITATIONS - 16140472
MODE - -
REGULATED-ENTITY - PM00091
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10494
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7775
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM0-2801
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5903
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00340
CITATIONS - 7768815
MODE - +
REGULATED-ENTITY - PM00187
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6279
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3965
CITATIONS - 14702398
MODE - +
REGULATED-ENTITY - PM0-4386
REGULATOR - EG11544-MONOMER
//
UNIQUE-ID - REG0-11114
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5681
CITATIONS - 12754220
CITATIONS - 21272324
COMMENT - |CITS:[12754220]| identified a FNR-binding site in the <i>lpdA</i> regulatory region, but the sequence was not reported in the paper.
MODE - +
REGULATED-ENTITY - PM00326
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-12043
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8433
CITATIONS - 24814025
COMMENT - CRP box 2 (+13.5) represses <i>pck</i> expression only in the presence of high levels of cAMP-CRP |CITS:[24814025]|.
MODE - -
REGULATED-ENTITY - PM00193
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9012
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3303
CITATIONS - 11139621
CITATIONS - 7934873
CITATIONS - 9469834
CITATIONS - 1848637
MODE - -
REGULATED-ENTITY - PM0-4621
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4767
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00007
CITATIONS - 8980677
MODE - +
REGULATED-ENTITY - PM00004
REGULATOR - CPLX-172
//
UNIQUE-ID - REG0-5140
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6965
CITATIONS - 15659676
MODE - +
REGULATED-ENTITY - PM00324
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5515
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00641
CITATIONS - 9767576
COMMENT - CytR and CRP act  together to repress transcription from the rpoHp5 promoter. A single CytR molecule binds between two CRP molecules. CRP-CytR-CRP.
MODE - -
REGULATED-ENTITY - PM00088
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-10478
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7760
CITATIONS - 19633077
MODE - -
REGULATED-ENTITY - PM0-36231
REGULATOR - EG10087-MONOMER
//
UNIQUE-ID - REG0-5887
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3222
CITATIONS - 11274153
MODE - +
REGULATED-ENTITY - PM0-4436
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-11097
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8086
CITATIONS - 21460078
MODE - -
REGULATED-ENTITY - PM0-36225
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6266
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2
CITATIONS - 12586421
MODE - -
REGULATED-ENTITY - PM0-4681
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-12005
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8415
CITATIONS - 24089053
MODE - -
REGULATED-ENTITY - TU0-13634
REGULATOR - EG10442-MONOMER
//
UNIQUE-ID - REG0-8995
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00406
CITATIONS - 7665470
CITATIONS - 9802028
CITATIONS - 9611815
CITATIONS - 10463182
CITATIONS - 15621456
CITATIONS - 8188587
CITATIONS - 8423160
CITATIONS - 9733689
COMMENT - GcvA interacts with the RNA polymerase &alpha;-subunit to activate gcvTp |CITS:[15621456]|.
MODE - -
REGULATED-ENTITY - PM00233
REGULATOR - PD00339
//
UNIQUE-ID - REG0-4750
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7064
CITATIONS - 12492863
MODE - -
REGULATED-ENTITY - PM00001
REGULATOR - CPLX0-7605
//
UNIQUE-ID - REG0-5122
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3564
CITATIONS - 15066032
COMMENT - NagC and ChbR appear to act as repressors for the <i>chbB</i> operon in the absence of the inducing sugar chitobiose |CITS: [15066032]|.
MODE - -
REGULATED-ENTITY - PM183
REGULATOR - PD00266
//
UNIQUE-ID - REG0-5499
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3485
CITATIONS - 14711822
CITATIONS - 16140031
CITATIONS - 16980446
MODE - +
REGULATED-ENTITY - PM00141
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10460
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7744
CITATIONS - 11443092
MODE - +
REGULATED-ENTITY - PM0-10408
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5870
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00452
CITATIONS - 10873449
CITATIONS - 11395452
MODE - +
REGULATED-ENTITY - PM00147
REGULATOR - PD00365
//
UNIQUE-ID - REG0-11080
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8072
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00356
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6249
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3661
CITATIONS - 12923108
CITATIONS - 18683632
COMMENT - The operon <i>nrdDG</i> is induced under anaerobiosis in the stationary phase, and this induction is FNR dependent.
MODE - +
REGULATED-ENTITY - PM0-5023
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11979
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8401
CITATIONS - 24509317
COMMENT - CRP site II site is also called distal-promoter, and it plays a minor role in <i>cspD</i>p activation by CRP |CITS:[24509317]|.
MODE - +
REGULATED-ENTITY - PM00597
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-8959
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7368
CITATIONS - 16956381
CITATIONS - 17120142
CITATIONS - 19703465
CITATIONS - 21040754
COMMENT - Bound RcnR (RcnR transcriptional repressor) represses transcription |CITS:[16956381][17120142][19703465]|. RcnR interacts nonspecifically with the approximately 50 bp flanking the core binding site, resulting in DNA wrapping and the introduction of a single negative supercoil into plasmid DNA |CITS:[19703465]|.
MODE - -
REGULATED-ENTITY - PM0-9620
REGULATOR - G7137-MONOMER
//
UNIQUE-ID - REG0-4734
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4663
CITATIONS - 2664421
MODE - +
REGULATED-ENTITY - PM00047
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-5106
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS268
CITATIONS - [7559336]
CITATIONS - [10400599]
MODE - +
REGULATED-ENTITY - PM501
REGULATOR - CPLX0-7681
//
UNIQUE-ID - REG0-5481
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4064
CITATIONS - 10518785
CITATIONS - 2061290
CITATIONS - 1904443
MODE - -
REGULATED-ENTITY - PM00132
REGULATOR - CPLX-125
//
UNIQUE-ID - REG0-10431
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7730
CITATIONS - 18997424
MODE - +
REGULATED-ENTITY - PM00150
REGULATOR - PHOSPHO-DPIA
//
UNIQUE-ID - REG0-5854
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00377
CITATIONS - [1315704]
CITATIONS - [1957353]
CITATIONS - 12754220
CITATIONS - 16377617
CITATIONS - 21272324
COMMENT - Salmon et al  |CITS: [12754220]| did not find an FNR site in the <i>cyoA</i> promoter region. Therefore, they suggested that FNR-mediated repression of this promoter  under anaerobiosis  is indirect.
MODE - -
REGULATED-ENTITY - PM00142
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11064
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8058
CITATIONS - 21421764
MODE - +
REGULATED-ENTITY - PM0-10013
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6233
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3502
CITATIONS - 11397910
CITATIONS - 10816566
CITATIONS - 22210763
CITATIONS - 11397910:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3545467925:martin
CITATIONS - 22210763:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3545467925:martin
MODE - -
REGULATED-ENTITY - PM0-4882
REGULATOR - CPLX0-7680
//
UNIQUE-ID - REG0-11900
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8386
CITATIONS - 18177266
MODE - -
REGULATED-ENTITY - PM0-10228
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6609
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7195
CITATIONS - 16377617
COMMENT - By making use of microarray analysis, Constantinidou et al. |CITS: [16377617]| concluded that FNR represses <i>ompX</i> gene expression. They also identified a putative FNR-binding site upstream of the gene, but the sequence was not shown
MODE - -
REGULATED-ENTITY - PM0-9248
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4718
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5463
CITATIONS - 2160266
CITATIONS - 6379600
MODE - -
REGULATED-ENTITY - PM00045
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5090
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7251
CITATIONS - 17233826
MODE - -
REGULATED-ENTITY - PM00547
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5464
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00261
CITATIONS - [10197993]
CITATIONS - [3525516]
CITATIONS - 7798138
CITATIONS - 15049824
COMMENT - The TyrR-binding site at position -64.5 from the promoter is a strong TyrR box that is involved in the activation and repression of <i>tyrP</i> gene transcription. The TyrR protein with phenylalanine only binds to this site to activate transcription, whereas the protein with tyrosine binds to this and another weak site (-41.5 from the promoter) to repress the transcription |CITS:[15049824]|.
MODE - +
REGULATED-ENTITY - PM00125
REGULATOR - MONOMER0-163
//
UNIQUE-ID - REG0-10384
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7710
CITATIONS - 17068078
MODE - +
REGULATED-ENTITY - PM0-10365
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5838
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6957
CITATIONS - 15659676
MODE - +
REGULATED-ENTITY - PM00225
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11047
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8046
CITATIONS - 21421764
MODE - -
REGULATED-ENTITY - PM0-10131
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6217
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3815
CITATIONS - 14702398
MODE - +
REGULATED-ENTITY - PM00344
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-11822
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8370
CITATIONS - 23531166
MODE - +
REGULATED-ENTITY - PM0-46279
REGULATOR - G7072-MONOMER
//
UNIQUE-ID - REG0-6592
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7175
CITATIONS - 0010525738
MODE - +
REGULATED-ENTITY - PM0-9197
REGULATOR - PC00027
//
UNIQUE-ID - REG0-4701
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5722
CITATIONS - 9179845
MODE - -
REGULATED-ENTITY - PM00039
REGULATOR - PD03576
//
UNIQUE-ID - REG0-5074
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1162
CITATIONS - 7500958
CITATIONS - 8648646
CITATIONS - 9632265
CITATIONS - 9515922
COMMENT - Fis appears to have little or no effect on rrsBp1 as a result of the addition of amino acids to the growth medium |CITS:[16675089]|.
MODE - +
REGULATED-ENTITY - PM00514
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5448
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00236
CITATIONS - 21572102
CITATIONS - 2644189
CITATIONS - 2198266
CITATIONS - 2404765
MODE - -
REGULATED-ENTITY - PM00113
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-10271
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7694
CITATIONS - 8057377
MODE - -
REGULATED-ENTITY - PM0-10350
REGULATOR - PC00010
//
UNIQUE-ID - REG0-5822
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00358
CITATIONS - 7592420
MODE - +
REGULATED-ENTITY - PM00200
REGULATOR - CPLX0-7714
//
UNIQUE-ID - REG0-10994
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8031
CITATIONS - 18808381
MODE - -
REGULATED-ENTITY - PM0-6061
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6201
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4141
CITATIONS - 12535077
MODE - -
REGULATED-ENTITY - PM0-5561
REGULATOR - PD01520
//
UNIQUE-ID - REG0-11754
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8355
CITATIONS - 9813115
MODE - -
REGULATED-ENTITY - PM0-46264
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-6576
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6942
CITATIONS - 12480884
MODE - +
REGULATED-ENTITY - PM0-8710
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4685
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00288
CITATIONS - 2403539
MODE - -
REGULATED-ENTITY - PM00037
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5058
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7121
CITATIONS - 11287152
COMMENT - The regulatory effect of FlhDC in <i>napF</i> operon transcription has been proven only by microarray analysis by |CITS: [11287152]|.
MODE - +
REGULATED-ENTITY - PM444
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-5432
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS45
COMMENT - Several  putative ArcA-binding sites with one or two mismatches are located within the <i>betI</i> promoter region.
MODE - -
REGULATED-ENTITY - PM00156
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10182
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7677
CITATIONS - 19074390
MODE - +
REGULATED-ENTITY - PM0-10338
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-5806
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00605
CITATIONS - 9418241
CITATIONS - 2656658
COMMENT - Both proteins, FNR and ArcA,  activate the expression of <i>fumB</i> under anaerobiosis, but they act independently from each other. This site has eight identities with regard to the symmetrical consensus TTGATA--TATCAA proposed by Spiro and Guest for FNR |CITS:[1957353]|. There are also two half-sites with five and four identities. The significance of the potential FNR sites is difficult to assess, partly because their homologies with the consensus are not particularly strong.
MODE - +
REGULATED-ENTITY - PM00219
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10978
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8024
CITATIONS - 12446650
CITATIONS - 12730179
MODE - -
REGULATED-ENTITY - PM461
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6185
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3924
CITATIONS - 6406797
CITATIONS - 3929016
MODE - -
REGULATED-ENTITY - PM0-5285
REGULATOR - EG20249-MONOMER
//
UNIQUE-ID - REG0-11698
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8343
CITATIONS - 22522900
MODE - -
REGULATED-ENTITY - PM0-10033
REGULATOR - EG12431-MONOMER
//
UNIQUE-ID - REG0-6555
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7071
CITATIONS - 15941987
CITATIONS - 7961507
MODE - +
REGULATED-ENTITY - PM-8790
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-4669
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6932
CITATIONS - 2858855
MODE - -
REGULATED-ENTITY - PM00034
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-9980
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7649
CITATIONS - 18808381
MODE - +
REGULATED-ENTITY - PM0-6061
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-5042
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS269
CITATIONS - 9371449
MODE - +
REGULATED-ENTITY - PM68
REGULATOR - MONOMER0-165
//
UNIQUE-ID - REG0-5416
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00789
MODE - +
REGULATED-ENTITY - PM00658
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10089
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7665
CITATIONS - 19007420
MODE - -
REGULATED-ENTITY - PM0-7421
REGULATOR - MONOMER-53
//
UNIQUE-ID - REG0-5790
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3467
CITATIONS - 14711822
CITATIONS - 22870390
MODE - -
REGULATED-ENTITY - PM00218
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10960
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7418
CITATIONS - 18808381
CITATIONS - 17660422:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3510682681:martin
CITATIONS - 12730179:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3510682681:martin
CITATIONS - 18297445:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3510682681:martin
CITATIONS - 18808381:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3510682681:martin
CITATIONS - 18808381:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3510682681:martin
MODE - +
REGULATED-ENTITY - PM0-10349
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6167
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5661
CITATIONS - 15902464
COMMENT - ArcA repressed the  <i>ubiCA</i> operon under anaerobiosis conditions |CITS:[15902464]|.
MODE - -
REGULATED-ENTITY - PM0-5862
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11655
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8328
CITATIONS - 23065979
MODE - +
REGULATED-ENTITY - PM00598
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-6539
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7072
MODE - +
REGULATED-ENTITY - PM-8794
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-4653
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5473
CITATIONS - 2160266
MODE - -
REGULATED-ENTITY - PM00032
REGULATOR - PD00288
//
UNIQUE-ID - REG0-9619
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7639
CITATIONS - 18524933
MODE - -
REGULATED-ENTITY - PM0-10246
REGULATOR - PC00010
//
UNIQUE-ID - REG0-5026
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS423
CITATIONS - [9648752]
MODE - +
REGULATED-ENTITY - PM562
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5400
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7308
CITATIONS - 16849788
MODE - -
REGULATED-ENTITY - PM0-9520
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5774
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4181
CITATIONS - 12923080
COMMENT - NarL appears to bind two regions upstream of the <i>fdhF</i> promoter: one of them is  between position  -130 and position ?175  and the other one is between position -190 and position  -27 relative to the transcription start site. NarP appears to antagonize the ability of NarL to repress <i>fdhF</i> gene expression.
MODE - -
REGULATED-ENTITY - PM00208
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-10933
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8001
CITATIONS - 21034467
MODE - -
REGULATED-ENTITY - PM0-7921
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6150
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5448
CITATIONS - 14731281
MODE - -
REGULATED-ENTITY - PM0-6883
REGULATOR - G7630-MONOMER
//
UNIQUE-ID - REG0-11635
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8313
CITATIONS - 23233451
COMMENT - The curator assigned the possible central position of this binding site based on similarity to a consensus sequence (TTGTGTACA) identified by Shimada et al. in 2012 |CITS:[23233451]|.
MODE - +
REGULATED-ENTITY - PM0-1881
REGULATOR - G6444-MONOMER
//
UNIQUE-ID - REG0-6523
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7166
CITATIONS - 16677314
MODE - -
REGULATED-ENTITY - PM0-8920
REGULATOR - G7326-MONOMER
//
UNIQUE-ID - REG0-4637
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00063
CITATIONS - 17293415
MODE - -
REGULATED-ENTITY - PM00029
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-9592
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7623
CITATIONS - 18515344
MODE - -
REGULATED-ENTITY - PM0-10220
REGULATOR - PD01352
//
UNIQUE-ID - REG0-5009
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7162
CITATIONS - 16377617
MODE - -
REGULATED-ENTITY - PM461
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5384
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00652
MODE - -
REGULATED-ENTITY - PM00583
REGULATOR - PC00010
//
UNIQUE-ID - REG0-5758
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00676
CITATIONS - 1372899
COMMENT - GlpR perhaps binds cooperatively to  four adjacent operator sites.
MODE - -
REGULATED-ENTITY - PM00238
REGULATOR - PD03576
//
UNIQUE-ID - REG0-10917
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7985
CITATIONS - 21034467
MODE - +
REGULATED-ENTITY - PM0-9299
REGULATOR - CPLX0-7852
//
UNIQUE-ID - REG0-6134
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6001
CITATIONS - 8057842
CITATIONS - 15988767
COMMENT - FNR represses the aceEp promoter under anaerobic conditions.
MODE - -
REGULATED-ENTITY - PM00325
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11618
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8298
CITATIONS - 23028500
MODE - +
REGULATED-ENTITY - PM0-44722
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6507
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3732
CITATIONS - 12588863
MODE - -
REGULATED-ENTITY - PM0-1301
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4621
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00179
CITATIONS - 21572102
CITATIONS - 2198266
MODE - -
REGULATED-ENTITY - PM00078
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-9557
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7607
CITATIONS - 18405378
MODE - +
REGULATED-ENTITY - PM00254
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-4991
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6582
CITATIONS - 11238978
COMMENT - This potential site could belong to the CRP regulator since it possesses 9 of the 16 consensus nucleotides associated with CRP binding |CITS: [11238978]|. GadE and CRP bind to this site, controlling <i>gadB</i> expression during both growth under acidic conditions and in stationary phase.
MODE - -
REGULATED-ENTITY - PM450
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5368
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00785
MODE - +
REGULATED-ENTITY - PM00671
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5742
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7027
CITATIONS - 12754220
COMMENT - By making use of microarray analyses it was concluded that anarobiosis does not affect expression of the <i>gcv</i> operon, although FNR appears to activate it.  A putative FNR-binding site, which was not shown in the report, was identified upstream of this operon |CITS: [12754220]|.
MODE - +
REGULATED-ENTITY - PM00233
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10897
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7969
CITATIONS - 21115656
MODE - -
REGULATED-ENTITY - PM00491
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6118
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5703
CITATIONS - 8982002
CITATIONS - 19007420
MODE - -
REGULATED-ENTITY - PM0-7421
REGULATOR - PD03028
//
UNIQUE-ID - REG0-11580
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8284
CITATIONS - 22442305
MODE - +
REGULATED-ENTITY - PM0-9394
REGULATOR - PHOSPHO-BASR
//
UNIQUE-ID - REG0-6490
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3
CITATIONS - 10542180
CITATIONS - 16861804
CITATIONS - 23564175
MODE - +
REGULATED-ENTITY - PM0-1201
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-4605
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7281
CITATIONS - 16861804
MODE - +
REGULATED-ENTITY - PM0-9408
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-9508
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7593
CITATIONS - 2166165
CITATIONS - 6259624
CITATIONS - 1987134
COMMENT - The CRP-binding site controlling the <i>lacZ</>p1 promoter was enhanced up to 14-fold or abolished by varying the N<sub>6</sub> spacer sequence, which is part of the consensus sequence of the dimer that recognizes a 20-bp region through direct amino acid nucleotide interactions in the major groove of the two operator half-sites |CITS:[24387622]|.
/
/Crystal structure analyses revealed that the interaction results in two strong kinks at the TG/CA steps closest to the 6-bp spacer (N<sub>6</sub>), and the authors proposed that the underlying mechanism relies on N<sub>6</sub> deformability |CITS:[24387622]|.
MODE - +
REGULATED-ENTITY - PM00045
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4975
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS473
COMMENT - FIS represses the hupBp3 promoter only when CRP is absent.
MODE - -
REGULATED-ENTITY - PM589
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5350
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7087
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM00536
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5726
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7109
CITATIONS - 15520470
MODE - -
REGULATED-ENTITY - PM00274
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10881
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7954
CITATIONS - 21097627
CITATIONS - 24982304
COMMENT - There is communication over a distance of 200 bp between site I, associated with the <i>yqjI</i>p promoter, and site II, which is associated with the <i>yqjH</i>p promoter, that provides full YqjI-dependent regulation at two target promoters |CITS:[24982304]|.
/
/Extended footprinting analysis demonstrated that the <i>yqjI</i>p promoter (site II) is greater than 20 bp, which represents the length of the consensus sequences for the YqjI transcription factor |CITS:[24982304]|. Site I may contain only half of the full-length apo-YqjI operator, while site II contains the entire binding site |CITS:[24982304]|. YqjI had the highest affinity for site II, consist with this site containing the full-length operator rather than only a half-site |CITS:[24982304]|.
/ 
/There are two repetitive extragenic palindromic (REP) sequences within the <i>yqjH-yqjI</i> intergenic region; these REP sequences are not required for YqjI regulation |CITS:[24982304]|.
MODE - -
REGULATED-ENTITY - PM0-9094
REGULATOR - G7594-MONOMER
//
UNIQUE-ID - REG0-6102
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5882
CITATIONS - 15805526
MODE - -
REGULATED-ENTITY - PM0-7561
REGULATOR - MONOMER0-2421
//
UNIQUE-ID - REG0-11535
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8267
CITATIONS - 11121068
MODE - +
REGULATED-ENTITY - PM0-3847
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-6474
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2555
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1351
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4586
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6961
CITATIONS - 15659676
MODE - +
REGULATED-ENTITY - PM00066
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9426
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7578
CITATIONS - 18055596
CITATIONS - 18055596:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3414861137:asantos
MODE - -
REGULATED-ENTITY - PM0-9879
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4959
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS525
CITATIONS - [10601216]
COMMENT - Fnr can regulate <i>adhE</i> expression from the adhEp2 promoter only in the physical absence of the upstream promoter region.
MODE - +
REGULATED-ENTITY - PM646
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5334
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2842
CITATIONS - 7545153
COMMENT - This is the most strongly activated promoter by Fis that has been described. In addition to Fis and &sigma;<sup>38</sup>, sequences located over 108 bp upstream from the  proP2 transcription initiation site are required for efficient expression.
MODE - +
REGULATED-ENTITY - PM00611
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5708
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS158
CITATIONS - 10760178
CITATIONS - 16621812
MODE - -
REGULATED-ENTITY - PM00175
REGULATOR - PD00208
//
UNIQUE-ID - REG0-10834
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7937
CITATIONS - 8455549
CITATIONS - 20713450
MODE - -
REGULATED-ENTITY - PM0-9320
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6086
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6463
CITATIONS - 11101675
CITATIONS - 12475930
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM0-8081
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-11514
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8251
CITATIONS - 16115199
MODE - -
REGULATED-ENTITY - PM0-9569
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6458
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2559
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1346
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4569
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00154
CITATIONS - 2656704
CITATIONS - 11812125
CITATIONS - 12366850
CITATIONS - 16618701
MODE - +
REGULATED-ENTITY - PM00065
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-9404
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7561
CITATIONS - 18083817
MODE - -
REGULATED-ENTITY - PM928
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-4943
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1585
CITATIONS - [10564485]
CITATIONS - 11321589
MODE - +
REGULATED-ENTITY - PM624
REGULATOR - PD00365
//
UNIQUE-ID - REG0-5318
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS340
CITATIONS - [8002608]
CITATIONS - 1346534
MODE - -
REGULATED-ENTITY - PM00630
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5692
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00357
CITATIONS - 2115441
MODE - -
REGULATED-ENTITY - PM00173
REGULATOR - PD01196
//
UNIQUE-ID - REG0-10813
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7921
CITATIONS - 20466769
MODE - -
REGULATED-ENTITY - PM00536
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-6067
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6525
CITATIONS - 12813061
MODE - +
REGULATED-ENTITY - PM0-8186
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-11496
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8240
CITATIONS - 18765794
MODE - -
REGULATED-ENTITY - PM00535
REGULATOR - EG11356-MONOMER
//
UNIQUE-ID - REG0-6442
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1261
CITATIONS - [10564486]
MODE - +
REGULATED-ENTITY - PM0-1582
REGULATOR - PHOSPHO-RCSB
//
UNIQUE-ID - REG0-4553
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7261
CITATIONS - 8288532
MODE - +
REGULATED-ENTITY - PM00063
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-9383
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7544
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM0-1781
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4927
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS762
CITATIONS - [9421904]
MODE - +
REGULATED-ENTITY - PM263
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5302
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00772
CITATIONS - 7545108
MODE - +
REGULATED-ENTITY - PM00642
REGULATOR - PD00266
//
UNIQUE-ID - REG0-5676
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3816
CITATIONS - 14702398
MODE - +
REGULATED-ENTITY - PM00191
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-10788
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6464
CITATIONS - 11101675
CITATIONS - 17921503
CITATIONS - 11101675:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3488307703:asantos
CITATIONS - 11101675:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3488307703:asantos
CITATIONS - 12475930:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3488307703:asantos
CITATIONS - 17921503:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3488307703:asantos
CITATIONS - 17921503:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3488307703:asantos
MODE - -
REGULATED-ENTITY - PM0-10418
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6051
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00661
CITATIONS - 2826388
MODE - -
REGULATED-ENTITY - PM00338
REGULATOR - PD01196
//
UNIQUE-ID - REG0-11480
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8227
CITATIONS - 22295907
MODE - +
REGULATED-ENTITY - PM0-46179
REGULATOR - PD00519
//
UNIQUE-ID - REG0-6424
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1423
CITATIONS - [10368146]
MODE - +
REGULATED-ENTITY - PM0-1783
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4537
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00147
CITATIONS - 8577745
MODE - +
REGULATED-ENTITY - PM00061
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-9366
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7528
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM450
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4910
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS586
CITATIONS - [8825783]
CITATIONS - [9254708]
MODE - -
REGULATED-ENTITY - PM00465
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-5286
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8198
CITATIONS - 10216857
CITATIONS - 8955407
MODE - -
REGULATED-ENTITY - PM00540
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5660
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00641
COMMENT - CytR and CRP act in concert  to repress transcription from the rpoHp3 promoter. A single CytR molecule binds between two CRP molecules. CRP-CytR-CRP
MODE - -
REGULATED-ENTITY - PM00571
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-10760
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7893
CITATIONS - 10564497
MODE - +
REGULATED-ENTITY - PM339
REGULATOR - CPLX0-8062
//
UNIQUE-ID - REG0-6035
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1642
CITATIONS - [9880556]
MODE - +
REGULATED-ENTITY - PM166
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11455
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8207
CITATIONS - 22223481
CITATIONS - 23690622
MODE - +
REGULATED-ENTITY - PM0-9791
REGULATOR - CPLX0-8075
//
UNIQUE-ID - REG0-6408
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1704
CITATIONS - [11810262]
MODE - -
REGULATED-ENTITY - PM0-2221
REGULATOR - PC00027
//
UNIQUE-ID - REG0-4521
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS110
CITATIONS - 8057356
CITATIONS - 1528882
CITATIONS - 8736541
CITATIONS - 7050087
MODE - +
REGULATED-ENTITY - PM00060
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9350
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7512
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM0-7321
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4894
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-10
CITATIONS - 1744060
CITATIONS - 10601216
MODE - -
REGULATED-ENTITY - PM00279
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5270
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00753
CITATIONS - 1715982
CITATIONS - 15520470
CITATIONS - 9582281
MODE - +
REGULATED-ENTITY - PM00632
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5644
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00183
CITATIONS - 2211510
CITATIONS - 2404765
MODE - -
REGULATED-ENTITY - PM00081
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-10724
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7874
CITATIONS - 15703297
MODE - +
REGULATED-ENTITY - PM0-5141
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-6019
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7131
CITATIONS - 14594796
MODE - -
REGULATED-ENTITY - PM00525
REGULATOR - BCCP-CPLX
//
UNIQUE-ID - REG0-11417
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8198
CITATIONS - 10216857
CITATIONS - 8955407
MODE - -
REGULATED-ENTITY - PM561
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6392
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2902
CITATIONS - 11448880
COMMENT - The regulatory effect of MetJ on the promoter metKp is not yet known. However, we assigned a negative effect to this regulatory interaction based on two facts: the protein's binding site is very close to the promoter, and  MetJ is known to act, so far without exceptions, as a negative regulator.
MODE - -
REGULATED-ENTITY - PM0-1963
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-4505
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2964
CITATIONS - 11448880
MODE - -
REGULATED-ENTITY - PM00054
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-9321
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7498
CITATIONS - 17768236
MODE - +
REGULATED-ENTITY - PM00037
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4878
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3761
CITATIONS - 9696769
CITATIONS - 13129959
CITATIONS - 7643383
MODE - -
REGULATED-ENTITY - PM125
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5253
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00443
CITATIONS - 1729203
COMMENT - Lrp regulates the <i>livKHMGF</i> operon expression in a leucine-sensitive manner; it needs leucine for its repression effect |CITS:[1729203]|.
MODE - -
REGULATED-ENTITY - PM00257
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5628
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7123
CITATIONS - 16291649
MODE - -
REGULATED-ENTITY - PM00590
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10695
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7861
CITATIONS - 1730735
CITATIONS - 2471187
MODE - -
REGULATED-ENTITY - PM00067
REGULATOR - PD00214
//
UNIQUE-ID - REG0-6003
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS42
CITATIONS - 10071223
MODE - -
REGULATED-ENTITY - PM324
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11380
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8182
CITATIONS - 22101843
MODE - +
REGULATED-ENTITY - PM0-10381
REGULATOR - CPLX0-7721
//
UNIQUE-ID - REG0-6376
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1901
CITATIONS - [10464230]
CITATIONS - 12813061
CITATIONS - 15126461
MODE - +
REGULATED-ENTITY - PM171
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-4488
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7155
CITATIONS - 16377617
MODE - +
REGULATED-ENTITY - PM00049
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-9288
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7486
CITATIONS - 17921503
CITATIONS - 17921503:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3409862149:martin
CITATIONS - 17921503:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3409862149:martin
MODE - +
REGULATED-ENTITY - PM0-4201
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4861
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4429
CITATIONS - 8120010
CITATIONS - 8763946
CITATIONS - 11673423
MODE - -
REGULATED-ENTITY - PM00423
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5237
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00707
CITATIONS - 2836193
CITATIONS - 10411720
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00348
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-5612
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1481
CITATIONS - 11577158
CITATIONS - 12867437
MODE - +
REGULATED-ENTITY - PM00544
REGULATOR - MONOMER0-46
//
UNIQUE-ID - REG0-10670
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7848
CITATIONS - 9294462
MODE - +
REGULATED-ENTITY - PM821
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5987
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00554
CITATIONS - 8230210
CITATIONS - 7966303
CITATIONS - 10852886
CITATIONS - 11073923
CITATIONS - 15342598
CITATIONS - 10464186
CITATIONS - 17513476
COMMENT - Induction of <i>rhaBAD</i> involves a regulatory cascade in which the induction of <i>rhaSR</i> results in the accumulation of RhaS, which in turn induces <i>rhaBAD</i> expression.  The &alpha;-CTD is required for full <i>rhaBAD</i> activation.
MODE - +
REGULATED-ENTITY - PM00303
REGULATOR - CPLX-124
//
UNIQUE-ID - REG0-11351
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8170
CITATIONS - 22089859
COMMENT - The exact position where ComR binds to the <i>bhsA</i> gene is not known. However, it has been suggested that ComR binds to a 60 bp region upstream of the <i>bhsA</i> gene, based on analysis of PCR fragments |CITS: [22089859]|.
/
/Currently, it seems that <i>bhsA</i> is a unique gene of the nearly up- and downstream <i>comR</i>/<i>bhsA</i> region regulated by ComR |CITS: [22089859]|.
/
/Induction by copper is the principal regulation mechanism of the <i>bhsA</i> gene |CITS: [22089859]|.
/
MODE - -
REGULATED-ENTITY - PM0-36235
REGULATOR - G6569-MONOMER
//
UNIQUE-ID - REG0-6360
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3821
CITATIONS - 14702398
CITATIONS - 12730179
MODE - +
REGULATED-ENTITY - PM0-3303
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-4471
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00227
CITATIONS - 23029459
MODE - -
REGULATED-ENTITY - PM00110
REGULATOR - PD01520
//
UNIQUE-ID - REG0-9269
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7471
CITATIONS - 12694615
CITATIONS - 19352034
MODE - +
REGULATED-ENTITY - PM0-9849
REGULATOR - PHOSPHO-EVGA
//
UNIQUE-ID - REG0-4845
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4345
CITATIONS - 12730174
MODE - -
REGULATED-ENTITY - PM00672
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-5221
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00760
CITATIONS - [10464268]
CITATIONS - [7852310]
CITATIONS - [10469172]
COMMENT - Marginally stimulated by CRP-cAMP. When the template is linear, transcriptional initiation is switched from POa to POb, 3 bp farther upstream from POa, and transcription becomes more CRP dependent.
MODE - +
REGULATED-ENTITY - PM00409
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5593
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4661
MODE - +
REGULATED-ENTITY - PM00185
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-10611
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7835
CITATIONS - 20015147
MODE - -
REGULATED-ENTITY - PM0-10490
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5971
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2968
CITATIONS - 11555297
MODE - -
REGULATED-ENTITY - PM00296
REGULATOR - PD02198
//
UNIQUE-ID - REG0-11317
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8157
MODE - -
REGULATED-ENTITY - PM0-1501
REGULATOR - CPLX0-7671
//
UNIQUE-ID - REG0-6344
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2021
CITATIONS - [2162465]
COMMENT - The regulatory effect of Fur on the promoter for <i>fhuE</i> is as of yet not known. However, we assigned a negative effect to this regulatory interaction based on two facts: (1) the protein's binding site is  16 bp downstream of the transcription start site; and (2) Fur is known to act, so far without exceptions, as a negative regulator.
MODE - -
REGULATED-ENTITY - PM0-2761
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-12327
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8497
CITATIONS - 26010043
MODE - -
REGULATED-ENTITY - PM0-9849
REGULATOR - NARP-MONOMER
//
UNIQUE-ID - REG0-9171
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7454
CITATIONS - 16261196
MODE - +
REGULATED-ENTITY - PM-8827
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-4828
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4903
CITATIONS - 9171388
MODE - +
REGULATED-ENTITY - PM921
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5204
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6981
CITATIONS - 7601827
MODE - -
REGULATED-ENTITY - PM00354
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5577
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00738
CITATIONS - [8626289]
CITATIONS - [10347150]
CITATIONS - 14499937
CITATIONS - 8626289
CITATIONS - 15027196
MODE - +
REGULATED-ENTITY - PM00179
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10582
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7819
CITATIONS - 8596434
MODE - -
REGULATED-ENTITY - PM00173
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5955
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6989
CITATIONS - 11929525
CITATIONS - 11004182
CITATIONS - 7854119
CITATIONS - 9302020
CITATIONS - 15978080
CITATIONS - 8501030
MODE - +
REGULATED-ENTITY - PM00280
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-11257
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8141
CITATIONS - 21890697
MODE - +
REGULATED-ENTITY - PM179
REGULATOR - CPLX0-7669
//
UNIQUE-ID - REG0-6328
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2342
CITATIONS - 11123679
COMMENT - H-NS most strongly represses the cydAp4 promoter and has a moderate effect on cydAp1, cydAp2, and cydAp3 promoters. H-NS regulates <i>cydAB</i> expression negatively in anaerobiosis and aerobiosis, but ArcA antagonizes its action in anaerobiosis.
MODE - -
REGULATED-ENTITY - PM0-3342
REGULATOR - PD00288
//
UNIQUE-ID - REG0-12231
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8482
CITATIONS - 25568260
MODE - +
REGULATED-ENTITY - PM0-2002
REGULATOR - MONOMER0-4341
//
UNIQUE-ID - REG0-9134
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7437
CITATIONS - 2139473
MODE - -
REGULATED-ENTITY - PM00226
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4812
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7133
CITATIONS - 16205910
COMMENT - A with sequence different from the ModE consensus sequence (where adenines in TATAT-N7-TAYAT were replaced by guanines, TGTGT-N7-TGYGT) was found upstream of deoCp2, which overlaps with the -40.5 site of CRP |CITS: [16205910]|.
MODE - -
REGULATED-ENTITY - PM00025
REGULATOR - CPLX0-6
//
UNIQUE-ID - REG0-5188
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6976
CITATIONS - 7601827
MODE - -
REGULATED-ENTITY - PM00353
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5560
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7137
CITATIONS - 16205910
MODE - -
REGULATED-ENTITY - PM00306
REGULATOR - CPLX0-6
//
UNIQUE-ID - REG0-5185
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6979
CITATIONS - 7601827
MODE - -
REGULATED-ENTITY - PM00353
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5557
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00218
CITATIONS - 6319708
MODE - +
REGULATED-ENTITY - PM00104
REGULATOR - CPLX-172
//
UNIQUE-ID - REG0-10556
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7800
CITATIONS - 2162467
CITATIONS - 1328649
MODE - -
REGULATED-ENTITY - PM00486
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5932
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6932
CITATIONS - 12453212
MODE - +
REGULATED-ENTITY - PM00312
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-6309
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7151
CITATIONS - 16377617
MODE - +
REGULATED-ENTITY - PM00589
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11237
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8122
CITATIONS - 21908668
MODE - +
REGULATED-ENTITY - PM0-46155
REGULATOR - CPLX0-7672
//
UNIQUE-ID - REG0-12191
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8463
CITATIONS - 25375160
MODE - +
REGULATED-ENTITY - PM00137
REGULATOR - G6789-MONOMER
//
UNIQUE-ID - REG0-9064
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7418
CITATIONS - 17660422
CITATIONS - 12730179
CITATIONS - 18297445
CITATIONS - 18808381
CITATIONS - 19220752
MODE - +
REGULATED-ENTITY - PM0-5982
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-4796
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00036
CITATIONS - 1640456
CITATIONS - 17074904
MODE - -
REGULATED-ENTITY - PM00017
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-5169
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2081
CITATIONS - [10628873]
CITATIONS - 15368583
COMMENT - Compaction and bending of DNA were observed when Fis was bound to the <i>nuo</i> regulatory region |CITS:[15368583]|.
MODE - +
REGULATED-ENTITY - PM00593
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5541
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00209
CITATIONS - 3001057
CITATIONS - 6120934
MODE - -
REGULATED-ENTITY - PM00097
REGULATOR - PD00413
//
UNIQUE-ID - REG0-10512
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7787
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM0-9768
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5916
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00737
CITATIONS - 1715855
MODE - -
REGULATED-ENTITY - PM00337
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-6292
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7010
CITATIONS - 15883881
COMMENT - This regulatory interaction was identified by means of PhoPQ-related microarray experiments |CITS: [15883881]|.
MODE - +
REGULATED-ENTITY - PM00490
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-11210
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8109
CITATIONS - 21718532
MODE - +
REGULATED-ENTITY - PM00156
REGULATOR - PC00061
//
UNIQUE-ID - REG0-12125
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8445
CITATIONS - 25103863
MODE - +
REGULATED-ENTITY - PM0-45098
REGULATOR - CPLX0-2781
//
UNIQUE-ID - REG0-9040
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7386
CITATIONS - 17496099
MODE - -
REGULATED-ENTITY - PM0-1182
REGULATOR - CPLX0-8061
//
UNIQUE-ID - REG0-4780
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00019
CITATIONS - 1640456
CITATIONS - 17074904
MODE - -
REGULATED-ENTITY - PM00008
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-5153
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS522
CITATIONS - [10794600]
MODE - -
REGULATED-ENTITY - PM334
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5528
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00729
MODE - -
REGULATED-ENTITY - PM00089
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10491
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7772
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM-8829
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5900
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2581
CITATIONS - 11053370
CITATIONS - 10913075
CITATIONS - 8999880
COMMENT - Previous studies have supported a model in which membrane-localized UhpC binds external Glu6P and transmits a signal to UhpB, which subsequently converts UhpA to a form capable of activating transcription at the <i>uhpT</i> promoter. Each dimer binds to an inverted repeat of 24 bp |CITS:[11976297]|. UhpB inhibits UhpA action in the <i>uhpT</i> promoter |CITS:[11053370]|.
MODE - +
REGULATED-ENTITY - PM00174
REGULATOR - CPLX0-7754
//
UNIQUE-ID - REG0-6276
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3381
CITATIONS - 14645248
CITATIONS - 10762278
COMMENT - CdaR responds to the inducers D-glycerate, D-galactarate, D-glucarate, and 2-D-mannosyl-glycerate.
MODE - +
REGULATED-ENTITY - PM0-4741
REGULATOR - EG12335-MONOMER
//
UNIQUE-ID - REG0-11111
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8093
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM0-1303
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-12038
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8430
CITATIONS - 24593230
MODE - -
REGULATED-ENTITY - PM0-10382
REGULATOR - PD00266
//
UNIQUE-ID - REG0-9008
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00051
CITATIONS - 15520470
CITATIONS - 2170326
CITATIONS - 8969182
CITATIONS - 1962841
CITATIONS - 1661372
CITATIONS - 1647022
CITATIONS - 1655726
CITATIONS - 8221894
CITATIONS - 845188
CITATIONS - 8394345
CITATIONS - 11574471
CITATIONS - 12667072
MODE - -
REGULATED-ENTITY - PM00025
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4764
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00007
CITATIONS - 9600836
CITATIONS - 8980677
CITATIONS - 1848302
CITATIONS - 8510144
CITATIONS - 8516313
MODE - -
REGULATED-ENTITY - PM00003
REGULATOR - PC00003
//
UNIQUE-ID - REG0-5137
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS183
CITATIONS - [7510658]
CITATIONS - [9595659]
MODE - -
REGULATED-ENTITY - PM242
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5512
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00196
MODE - +
REGULATED-ENTITY - PM00088
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10475
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7757
CITATIONS - 19633077
MODE - -
REGULATED-ENTITY - PM0-7561
REGULATOR - EG10087-MONOMER
//
UNIQUE-ID - REG0-5884
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7129
CITATIONS - 14741201
CITATIONS - 16621816
CITATIONS - 21572102
MODE - -
REGULATED-ENTITY - PM00151
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-11093
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8082
CITATIONS - 21421764
MODE - +
REGULATED-ENTITY - PM0-10013
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6263
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4362
CITATIONS - 11751865
CITATIONS - 12142437
CITATIONS - 12529359
CITATIONS - 15375149
CITATIONS - 15694381
COMMENT - This NorR-binding site ( -132), which contains the inverse repeat GTCA-(N3)-TGAC, is considered to be of low affinity. 
/
/
MODE - +
REGULATED-ENTITY - PM0-4681
REGULATOR - EG12108-MONOMER
//
UNIQUE-ID - REG0-12002
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8412
CITATIONS - 24089053
COMMENT - HipB represses <i>relA</i> expression, and HipA enhances this repression through direct interaction with HipB, increasing its expression 36.8%, significantly higher than that by HipB alone |CITS: [24089053]|.
MODE - -
REGULATED-ENTITY - PM00427
REGULATOR - CPLX0-7425
//
UNIQUE-ID - REG0-8992
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3563
CITATIONS - 15066032
COMMENT - ChbR and NagC appear to act as repressors for the <i>chbB</i> operon in the absence of the inducing sugar chitobiose |CITS:[15066032]|.
MODE - -
REGULATED-ENTITY - PM183
REGULATOR - EG10143-MONOMER
//
UNIQUE-ID - REG0-4747
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS401
CITATIONS - [8626344]
COMMENT - Under inducing conditions (growth on acetate), IHF activates <i>aceBAK</i> expression by opposing <i>IclR</i> repression. In contrast, IHF has little effect on <i>aceBAK</i> expression under repressing conditions (growth on glucose).
MODE - +
REGULATED-ENTITY - PM00001
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5119
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3562
CITATIONS - 15066032
COMMENT - ChbR and NagC appear to act as repressors for the <i>chbB</i> operon in the absence of the inducing sugar chitobiose |CITS:[15066032]|.
MODE - +
REGULATED-ENTITY - PM183
REGULATOR - CPLX0-8079
//
UNIQUE-ID - REG0-5495
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00284
CITATIONS - 2231717
MODE - +
REGULATED-ENTITY - PM00140
REGULATOR - CPLX-172
//
UNIQUE-ID - REG0-10457
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7741
CITATIONS - 11443092
MODE - -
REGULATED-ENTITY - PM0-8081
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5867
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS185
CITATIONS - [7592392]
MODE - -
REGULATED-ENTITY - PM00146
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11077
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8070
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM687
REGULATOR - PD00197
//
UNIQUE-ID - REG0-6246
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3622
CITATIONS - 1649816
CITATIONS - 16934214
CITATIONS - 1569008
CITATIONS - 3907860
CITATIONS - 15385551
CITATIONS - 12881519
CITATIONS - 9737918
MODE - -
REGULATED-ENTITY - PM0-4941
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11953
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8398
CITATIONS - 24013633
MODE - +
REGULATED-ENTITY - PM0-46298
REGULATOR - G7072-MONOMER
//
UNIQUE-ID - REG0-8950
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7355
CITATIONS - 14711822
CITATIONS - 16980446
MODE - -
REGULATED-ENTITY - PM224
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-4731
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4664
CITATIONS - 2664421
CITATIONS - 1824723
CITATIONS - 11013224
MODE - +
REGULATED-ENTITY - PM00047
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5103
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2182
CITATIONS - 10766858
COMMENT - This site of IHF binding is also used to regulate the divergent paaAp promoter.
MODE - +
REGULATED-ENTITY - PM4
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5478
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00271
CITATIONS - 1938967
CITATIONS - 2061290
CITATIONS - 9324270
CITATIONS - 1904443
MODE - +
REGULATED-ENTITY - PM00132
REGULATOR - MONOMER0-162
//
UNIQUE-ID - REG0-10424
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7724
CITATIONS - 19376854
MODE - +
REGULATED-ENTITY - PM0-10370
REGULATOR - PD00365
//
UNIQUE-ID - REG0-5851
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3962
CITATIONS - 14702398
MODE - +
REGULATED-ENTITY - PM00142
REGULATOR - EG11544-MONOMER
//
UNIQUE-ID - REG0-11061
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8055
CITATIONS - 21421764
MODE - +
REGULATED-ENTITY - PM00536
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6230
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3502
CITATIONS - 11397910
CITATIONS - 10816566
MODE - -
REGULATED-ENTITY - PM0-4844
REGULATOR - CPLX0-7680
//
UNIQUE-ID - REG0-11897
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8383
CITATIONS - 18177266
MODE - -
REGULATED-ENTITY - PM0-10229
REGULATOR - EG11554-MONOMER
//
UNIQUE-ID - REG0-6605
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7176
CITATIONS - 16359331
MODE - +
REGULATED-ENTITY - PM0-9198
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-4715
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5469
CITATIONS - 2160266
CITATIONS - 6379600
MODE - -
REGULATED-ENTITY - PM00045
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5087
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2401
CITATIONS - 10760142
CITATIONS - 17233826
MODE - +
REGULATED-ENTITY - PM00547
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5461
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00247
CITATIONS - 23274360
MODE - +
REGULATED-ENTITY - PM00119
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-10339
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7707
CITATIONS - 7616564
MODE - -
REGULATED-ENTITY - PM0-10361
REGULATOR - EG10694-MONOMER
//
UNIQUE-ID - REG0-5835
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7334
CITATIONS - 17074904
CITATIONS - 17850814
MODE - -
REGULATED-ENTITY - PM0-9577
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-11036
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8043
CITATIONS - 8021189
MODE - -
REGULATED-ENTITY - PM0-8864
REGULATOR - EG10442-MONOMER
//
UNIQUE-ID - REG0-6214
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3812
CITATIONS - 9537375
CITATIONS - 9657988
MODE - +
REGULATED-ENTITY - PM0-5168
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11819
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8367
CITATIONS - 23651393
MODE - -
REGULATED-ENTITY - PM00078
REGULATOR - PD03867
//
UNIQUE-ID - REG0-6589
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-9
CITATIONS - 3037486
COMMENT - The promoter region of the <i>recN</i> gene contains two 16-bp sequences, separated by 6 bp, that match the consensus sequence (SOS box) for binding LexA protein |CITS:[ 3037486]|.
MODE - -
REGULATED-ENTITY - PM0-3
REGULATOR - PC00010
//
UNIQUE-ID - REG0-4698
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5741
CITATIONS - 9179845
MODE - -
REGULATED-ENTITY - PM00039
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5071
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1941
CITATIONS - [10537212]
MODE - -
REGULATED-ENTITY - PM197
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5445
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00313
CITATIONS - 2836193
MODE - +
REGULATED-ENTITY - PM00164
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10267
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7691
CITATIONS - 18586269
MODE - -
REGULATED-ENTITY - PM206
REGULATOR - PUTA-MONOMER
//
UNIQUE-ID - REG0-5819
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS81
CITATIONS - [8022285]
CITATIONS - 15520470
CITATIONS - 1645842
MODE - +
REGULATED-ENTITY - PM00199
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10991
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8029
CITATIONS - 18083817
CITATIONS - 18808381
CITATIONS - 12730179
MODE - -
REGULATED-ENTITY - PM928
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6198
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3982
CITATIONS - 14996803
CITATIONS - 12374842
MODE - -
REGULATED-ENTITY - PM0-5403
REGULATOR - G7854-MONOMER
//
UNIQUE-ID - REG0-11751
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8352
CITATIONS - 9813115
MODE - -
REGULATED-ENTITY - PM0-46264
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-6573
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3
CITATIONS - 10542180
MODE - +
REGULATED-ENTITY - PM0-4
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-4682
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00093
CITATIONS - 1556120
MODE - -
REGULATED-ENTITY - PM00037
REGULATOR - PD03576
//
UNIQUE-ID - REG0-5055
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS358
CITATIONS - [8892825]
CITATIONS - 16140031
CITATIONS - 16980446
MODE - +
REGULATED-ENTITY - PM439
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5429
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00591
CITATIONS - 8253679
CITATIONS - 21673794
MODE - -
REGULATED-ENTITY - PM00529
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10174
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7675
CITATIONS - 18648770
CITATIONS - 18648770:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3444053871:asantos
CITATIONS - 18648770:EV-COMP-AINF:3444053871:asantos
MODE - +
REGULATED-ENTITY - PM741
REGULATOR - PC00061
//
UNIQUE-ID - REG0-5803
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5362
CITATIONS - 9418241
COMMENT - Iron limitation  decreases <i>fumB</i> expression when Fur is present, this protein activates fumB promoter under anaerobiosis.
MODE - +
REGULATED-ENTITY - PM00219
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-10975
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8023
CITATIONS - 12446650
CITATIONS - 12730179
MODE - +
REGULATED-ENTITY - PM461
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6180
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5841
MODE - -
REGULATED-ENTITY - PM0-6541
REGULATOR - PC00010
//
UNIQUE-ID - REG0-11668
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8336
CITATIONS - 23092251
MODE - -
REGULATED-ENTITY - PM00465
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-6552
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7189
CITATIONS - 16377617
COMMENT - By making use of microarray analyses, Constantinidou et al. |CITS: [16377617]| concluded that FNR activates yecR  gene expression. They also identified a putative FNR-binding site upstream of the gene, but the sequence was not shown.
MODE - +
REGULATED-ENTITY - PM-8784
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4666
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00075
CITATIONS - 9016640
CITATIONS - 14500788
CITATIONS - 15289461
COMMENT - HU and GalR, binding two sites,  repress the expression of the <i>gal</i> operon in the total absence of galactose |CITS: [16524589]|.
MODE - -
REGULATED-ENTITY - PM00033
REGULATOR - PD03028
//
UNIQUE-ID - REG0-9882
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7648
CITATIONS - 18723630
MODE - +
REGULATED-ENTITY - PM0-10275
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5039
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1902
CITATIONS - 12813061
CITATIONS - 15126461
CITATIONS - 15883881
COMMENT - This regulatory interaction was identified by means of PhoPQ-related microarray experiments and the investigators checked for the presence of its regulatory motif in the promoter region |CITS: [15883881]|.
MODE - +
REGULATED-ENTITY - PM67
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-5413
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7339
CITATIONS - 17464064
MODE - +
REGULATED-ENTITY - PM0-9588
REGULATOR - PD00214
//
UNIQUE-ID - REG0-10086
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7662
CITATIONS - 19007420
MODE - -
REGULATED-ENTITY - PM0-7421
REGULATOR - MONOMER-52
//
UNIQUE-ID - REG0-5787
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6881
CITATIONS - 9302020
CITATIONS - 12923080
MODE - -
REGULATED-ENTITY - PM00217
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-10957
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8012
CITATIONS - 18808381
CITATIONS - 12730179
MODE - +
REGULATED-ENTITY - PM00137
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6164
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4345
CITATIONS - 12730174
CITATIONS - 1640456
CITATIONS - 17074904
MODE - -
REGULATED-ENTITY - PM0-5741
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-11650
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8325
CITATIONS - 23071782
MODE - -
REGULATED-ENTITY - PM0-46298
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-6536
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7126
CITATIONS - 1640456
CITATIONS - 17074904
MODE - -
REGULATED-ENTITY - PM0-8908
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-4650
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00073
MODE - +
REGULATED-ENTITY - PM00032
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9606
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7636
CITATIONS - 8682790
MODE - -
REGULATED-ENTITY - PM0-10244
REGULATOR - PC00010
//
UNIQUE-ID - REG0-5023
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS442
CITATIONS - [8955407]
CITATIONS - [10216857]
MODE - -
REGULATED-ENTITY - PM561
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5397
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7298
CITATIONS - 11118204
MODE - -
REGULATED-ENTITY - PM0-9517
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5771
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6921
CITATIONS - 12923080
COMMENT - NarP appears to be a mild antagonist of  NarL's ability  to repress <i>fdhF</i> gene expresion |CITS: [12923080]| .
MODE - +
REGULATED-ENTITY - PM00208
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-10930
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7998
CITATIONS - 21034467
MODE - -
REGULATED-ENTITY - PM0-36192
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6147
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5451
CITATIONS - 14731281
COMMENT - The AgaR operator sites farthest from the transcriptional start sites of <i>agaS</i> have not been experimentaly verified. They were inferred by computational analysis, based on similarity to the consensus sequence.
MODE - -
REGULATED-ENTITY - PM0-6883
REGULATOR - G7630-MONOMER
//
UNIQUE-ID - REG0-11631
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8309
CITATIONS - 23010927
MODE - +
REGULATED-ENTITY - PM0-46235
REGULATOR - PD00365
//
UNIQUE-ID - REG0-6520
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1065
CITATIONS - 9767578
CITATIONS - 11169114
CITATIONS - 11932447
CITATIONS - 15988767
MODE - +
REGULATED-ENTITY - PM0-1303
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4634
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00062
CITATIONS - [9335285]
COMMENT - Fis  site II  plays a predominant role in this repression.
MODE - -
REGULATED-ENTITY - PM00028
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-9587
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7620
CITATIONS - 16321939
CITATIONS - 19636340
CITATIONS - 23589368
MODE - -
REGULATED-ENTITY - PM0-10233
REGULATOR - CPLX0-8043
//
UNIQUE-ID - REG0-5006
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1743
CITATIONS - [11976288]
CITATIONS - [12446650]
CITATIONS - 16980449
CITATIONS - 15795232
CITATIONS - 12730179
MODE - +
REGULATED-ENTITY - PM461
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-5381
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00598
CITATIONS - 8890170
CITATIONS - 9006049
MODE - -
REGULATED-ENTITY - PM00537
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5755
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00681
CITATIONS - 1372899
MODE - +
REGULATED-ENTITY - PM00238
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10911
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7981
REGULATED-ENTITY - TU0-13636
REGULATOR - PD00266
//
UNIQUE-ID - REG0-6131
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5522
CITATIONS - 15743943
MODE - -
REGULATED-ENTITY - PM0-7183
REGULATOR - G7678-MONOMER
//
UNIQUE-ID - REG0-11604
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8295
CITATIONS - 22752906
MODE - +
REGULATED-ENTITY - PM00147
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6504
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4206
CITATIONS - 15252051
COMMENT - The addition of CRP decreased the ArcA-specific protection on binding sites -48 and -85 and the CRP specific protection was decreased, implying that ArcA and CRP compete with each other for  binding to the ptsGp1 promoter.
MODE - -
REGULATED-ENTITY - PM0-1301
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-4618
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00173
CITATIONS - 23071782
CITATIONS - 23274360
MODE - +
REGULATED-ENTITY - PM00072
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-9554
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7604
CITATIONS - 18452510
COMMENT - H-NS blocks <i>dps</i> transcription by displacing RNA polymerase |CITS:[18452510]|.
MODE - -
REGULATED-ENTITY - PM00243
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4988
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6581
CITATIONS - 12940989
CITATIONS - 11238978
CITATIONS - 16980449
CITATIONS - 19352034
COMMENT - GadE is required both for <i>gadA/gadBC</i> expression during exponential growth and stationary phase expression. GadE is an acid-induced regulator, since it is involved in the acid induction of <i>gadA/gadBC</i> operons during exponential growth. The expression of these operons is maybe one of the most intensively regulated systems in <i>Escherichia coli</i> since it is regulated by different factors. GadE and GadX could simultaneously bind to the GAD box region of <i>gadA/gadBC</i> and form a complex |CITS: [12940989]|.
MODE - +
REGULATED-ENTITY - PM450
REGULATOR - EG11544-MONOMER
//
UNIQUE-ID - REG0-5365
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1322
CITATIONS - [10482502]
MODE - -
REGULATED-ENTITY - PM0-1621
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5739
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7092
CITATIONS - 15520470
CITATIONS - 17608696
MODE - +
REGULATED-ENTITY - PM00232
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10894
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7966
CITATIONS - 21115656
MODE - -
REGULATED-ENTITY - PM0-8905
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6115
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5701
CITATIONS - 7934815
MODE - +
REGULATED-ENTITY - PM0-7421
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11577
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8281
CITATIONS - 22442305
CITATIONS - 15659689
CITATIONS - 15322361
MODE - +
REGULATED-ENTITY - TU0-13569
REGULATOR - PHOSPHO-BASR
//
UNIQUE-ID - REG0-6487
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2484
CITATIONS - 12003934
MODE - +
REGULATED-ENTITY - PM0-1163
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-4601
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2222
CITATIONS - 9324269
MODE - +
REGULATED-ENTITY - PM00067
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9478
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7591
CITATIONS - 2013578
MODE - +
REGULATED-ENTITY - PM0-3841
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4972
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS476
CITATIONS - [8913296]
MODE - +
REGULATED-ENTITY - PM589
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5347
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3142
CITATIONS - 11357510
MODE - +
REGULATED-ENTITY - PM0-4427
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5722
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS265
CITATIONS - [8577250]
MODE - -
REGULATED-ENTITY - PM00272
REGULATOR - PC00061
//
UNIQUE-ID - REG0-10863
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7951
CITATIONS - 20889740
MODE - -
REGULATED-ENTITY - PM00136
REGULATOR - CPLX0-7691
//
UNIQUE-ID - REG0-6099
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5884
CITATIONS - 15808934
MODE - +
REGULATED-ENTITY - PM0-7542
REGULATOR - MONOMER0-2081
//
UNIQUE-ID - REG0-11532
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8264
CITATIONS - 16238633
MODE - -
REGULATED-ENTITY - PM0-1341
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-6471
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2568
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1349
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4583
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6974
CITATIONS - 15659676
MODE - +
REGULATED-ENTITY - PM00066
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-9423
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7577
CITATIONS - 18055596
COMMENT - H-NS binds to the center region between the divergent promoters and to sites located distally from the two yjjQp and yjjPp promoters |CITS: [18055596]|.
MODE - -
REGULATED-ENTITY - PM0-9877
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4956
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6996
CITATIONS - 15879709
MODE - +
REGULATED-ENTITY - PM643
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5331
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4804
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00605
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-5705
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS160
CITATIONS - 10747919
CITATIONS - 10760178
CITATIONS - 12675795
CITATIONS - 16621812
MODE - +
REGULATED-ENTITY - PM00175
REGULATOR - MONOMER0-161
//
UNIQUE-ID - REG0-10827
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7934
CITATIONS - 20659289
MODE - +
REGULATED-ENTITY - PM0-10544
REGULATOR - PD00519
//
UNIQUE-ID - REG0-6083
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6462
CITATIONS - 11101675
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM0-8061
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-11511
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8250
CITATIONS - 16115199
MODE - -
REGULATED-ENTITY - PM00578
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6455
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7143
CITATIONS - 16238633
COMMENT - Based on studies of binding sites determined using gel shift and footprinting analyses with Lrp and H-NS regulator proteins, it was demonstrated that both proteins interact with obvious synergism in the repression of all seven <i>E. coli</i> <i>rrn</i> P1 promoter upstream regions; as a result, they help the efficient shutdown of rRNA synthesis.  Likewise, both proteins could be a transient heteromer via a protein-protein interaction interfering with the RNA polymerase, and this way they may  alter the DNA of the upstream regions of all seven ribosomal P1 promoters |CITS: [16238633]|.
MODE - -
REGULATED-ENTITY - PM0-1343
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-4566
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7039
CITATIONS - 16077119
MODE - +
REGULATED-ENTITY - PM00065
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-9401
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7558
CITATIONS - 9701802
COMMENT - A putative DpiA-binding site, which is an A+T-rich sequence,   is located upstream of the <i>appY</i> gene |CITS: [9701802]|.
MODE - -
REGULATED-ENTITY - PM0-8915
REGULATOR - PHOSPHO-DPIA
//
UNIQUE-ID - REG0-4940
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2861
CITATIONS - 11071896
MODE - +
REGULATED-ENTITY - PM623
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5315
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS343
CITATIONS - [8002608]
CITATIONS - 1346534
CITATIONS - 8521047
MODE - -
REGULATED-ENTITY - PM00630
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5689
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00326
CITATIONS - 8596434
COMMENT - In the absence of the other proteins, cAMP-CRP binds to three CRP targets centered at -92.5 , -42.5  and  +56.
MODE - +
REGULATED-ENTITY - PM00173
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10810
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7918
CITATIONS - 20466769
MODE - -
REGULATED-ENTITY - PM00536
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-6064
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6804
CITATIONS - 2543976
COMMENT - Both sites of the MetJ regulator in the intergenic region of <i>metE</i> and <i>metR</i> could negatively regulate both the metRp2 and metRp1 promoters.
MODE - -
REGULATED-ENTITY - PM0-8604
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-11493
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8237
CITATIONS - 22323519
CITATIONS - 18765794
MODE - -
REGULATED-ENTITY - TU0-14116
REGULATOR - EG11356-MONOMER
//
UNIQUE-ID - REG0-6439
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1182
CITATIONS - [10419964]
COMMENT - Induction of <i>fur</i> by OxyR is necessary to keep 
/the Fur regulon repressed under H<sub>2</sub>O<sub>2</sub> stress |CITS:[17462026]|.
MODE - +
REGULATED-ENTITY - PM0-1441
REGULATOR - PD00214
//
UNIQUE-ID - REG0-4550
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2349
CITATIONS - 10972841
CITATIONS - 15225315
COMMENT - Fis binds to this site and represses efficiently (less than FruR) the activity of FNR (-41.5 site) in the <i>nir</i> promoter.
MODE - -
REGULATED-ENTITY - PM00062
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-9380
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7541
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM321
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4924
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS759
CITATIONS - [9421904]
MODE - +
REGULATED-ENTITY - PM262
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5299
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7243
CITATIONS - 12395194
COMMENT - The transcriptional regulator Fis modulates the <i>osmE</i> gene expression under certain environmental conditions at a particular growth stage by reducing its transcription.  Fis can bind to three sites in the transcriptional region of osmEp, but the site centered at  -86 with respect to the +1 of the transcription initiation site is of major importance for efficient binding |CITS: [12395194]|.
/
MODE - -
REGULATED-ENTITY - PM00543
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5673
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3804
CITATIONS - 14702398
MODE - +
REGULATED-ENTITY - PM00636
REGULATOR - EG11544-MONOMER
//
UNIQUE-ID - REG0-10785
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7902
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM0-3601
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6048
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS263
CITATIONS - [8577250]
MODE - -
REGULATED-ENTITY - PM00313
REGULATOR - PC00061
//
UNIQUE-ID - REG0-11477
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8224
CITATIONS - 20659289
MODE - +
REGULATED-ENTITY - PM0-10544
REGULATOR - PD00519
//
UNIQUE-ID - REG0-6421
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5483
CITATIONS - 12897000
CITATIONS - 9864311
MODE - -
REGULATED-ENTITY - PM0-1781
REGULATOR - G7678-MONOMER
//
UNIQUE-ID - REG0-4534
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS66
CITATIONS - [1735706]
MODE - +
REGULATED-ENTITY - PM00061
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-9363
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7525
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM450
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4907
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS583
CITATIONS - 10913096
MODE - -
REGULATED-ENTITY - PM692
REGULATOR - EG12278-MONOMER
//
UNIQUE-ID - REG0-5283
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8194
CITATIONS - 10216857
CITATIONS - 8955407
MODE - -
REGULATED-ENTITY - PM00540
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5657
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00629
MODE - -
REGULATED-ENTITY - PM00571
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-10757
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7890
CITATIONS - 12067348
MODE - +
REGULATED-ENTITY - PM0-10041
REGULATOR - PD00365
//
UNIQUE-ID - REG0-6032
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS783
CITATIONS - [9335308]
MODE - +
REGULATED-ENTITY - PM961
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11441
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8204
CITATIONS - 22289118
MODE - +
REGULATED-ENTITY - PM0-46176
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6405
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7006
CITATIONS - 15883881
COMMENT - This regulatory interaction was identified by means of PhoPQ-related microarray experiments, and the analysis checked for the presence of the regulatory motif in the promoter region |CITS: [15883881]|. A repressor function for <i>dcuD</i> gene transcription can be clearly anticipated from the localization of the PhoP-binding site, very close to the dcuDp promoter core 
/region |CITS:[15883881]|.
MODE - -
REGULATED-ENTITY - PM0-2083
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-4518
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS113
CITATIONS - 8057356
CITATIONS - 1528882
CITATIONS - 7050087
MODE - +
REGULATED-ENTITY - PM00060
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9336
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7507
CITATIONS - 17768236
MODE - +
REGULATED-ENTITY - PM0-1303
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4891
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS527
CITATIONS - 10572146
MODE - +
REGULATED-ENTITY - PM00279
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5267
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3784
CITATIONS - 12618441
MODE - -
REGULATED-ENTITY - PM00314
REGULATOR - MONOMER0-1301
//
UNIQUE-ID - REG0-5641
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00792
MODE - +
REGULATED-ENTITY - PM00661
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10721
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7872
CITATIONS - 15703297
MODE - +
REGULATED-ENTITY - PM928
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-6016
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1203
CITATIONS - [8529872]
MODE - +
REGULATED-ENTITY - PM326
REGULATOR - CPLX0-2781
//
UNIQUE-ID - REG0-11413
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8194
CITATIONS - 8955407
CITATIONS - 10216857
MODE - -
REGULATED-ENTITY - PM561
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6389
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2004
CITATIONS - [2670903]
COMMENT - The regulatory effect of Fur on the promoter exbDp is as of yet not known. However, we assigned a negative effect to this regulatory interaction based on the fact that the protein Fur is known to act, so far without exceptions, as a negative regulator.
MODE - -
REGULATED-ENTITY - PM0-2743
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4502
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00125
CITATIONS - 11448880
CITATIONS - 16515535
COMMENT - The regulatory effect of MetJ on the promoter metAp1 is as yet not known. However, we assigned a negative effect 
/to this regulatory interaction based on two facts: the protein's binding site is very close to the promoter, 
/and  MetJ is known to act, so far without exceptions, as a negative regulator.
MODE - -
REGULATED-ENTITY - PM00051
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-9318
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7495
CITATIONS - 17768236
MODE - +
REGULATED-ENTITY - PM00037
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4875
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3763
CITATIONS - 12029041
CITATIONS - 13129959
MODE - +
REGULATED-ENTITY - PM125
REGULATOR - CPLX0-6
//
UNIQUE-ID - REG0-5250
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7184
CITATIONS - 16377617
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00254
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5625
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00654
COMMENT - This mechanism of regulation is not yet clearly elucidated. Lange and Hengge-Aronis have shown that the <i>rpoS</i> transcript is negatively regulated by the <i>cya</i> gene|CITS: [1849609]|. In contrast, McCann et al. reported that <i>rpoS</i> transcription was positively regulated by the <i>cya</i> gene product |CITS: [8458856]|.
REGULATED-ENTITY - PM00590
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10683
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7858
CITATIONS - 17464064
MODE - +
REGULATED-ENTITY - PM0-9588
REGULATOR - PD00214
//
UNIQUE-ID - REG0-6000
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4941
CITATIONS - 10071223
MODE - -
REGULATED-ENTITY - PM324
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11377
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8181
CITATIONS - 22101843
MODE - -
REGULATED-ENTITY - PM0-10380
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-6373
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1882
CITATIONS - [12123454]
CITATIONS - [10464230]
CITATIONS - 12366850
CITATIONS - 12813061
MODE - +
REGULATED-ENTITY - PM170
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-4485
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00233
CITATIONS - 8429549
CITATIONS - 2115869
CITATIONS - 2646291
CITATIONS - 8508774
CITATIONS - 8071194
CITATIONS - 8483418
CITATIONS - 8432705
CITATIONS - 12218014
CITATIONS - 3891724
CITATIONS - 1447135
MODE - +
REGULATED-ENTITY - PM00111
REGULATOR - PD00353
//
UNIQUE-ID - REG0-9285
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7486
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00227
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4858
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS147
CITATIONS - [3302614]
MODE - -
REGULATED-ENTITY - PM00360
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5234
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4901
CITATIONS - 2162467
CITATIONS - 1328649
MODE - +
REGULATED-ENTITY - PM00486
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5608
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7325
CITATIONS - 16115199
MODE - -
REGULATED-ENTITY - PM0-9567
REGULATOR - PC00061
//
UNIQUE-ID - REG0-10667
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7847
CITATIONS - 11443091
MODE - -
REGULATED-ENTITY - PM101
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5984
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1541
CITATIONS - [7608078]
CITATIONS - 9148912
MODE - -
REGULATED-ENTITY - PM00299
REGULATOR - CPLX0-7854
//
UNIQUE-ID - REG0-11336
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8168
CITATIONS - 2543976:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3532870659:martin
CITATIONS - 2543976:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3532870659:martin
CITATIONS - 2643109:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3532870659:martin
CITATIONS - 7836282:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3532870659:martin
CITATIONS - 2673243
MODE - -
REGULATED-ENTITY - PM0-8603
REGULATOR - CPLX0-7752
//
UNIQUE-ID - REG0-6357
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5024
MODE - -
REGULATED-ENTITY - PM00479
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4468
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00226
MODE - -
REGULATED-ENTITY - PM00109
REGULATOR - PD01520
//
UNIQUE-ID - REG0-9266
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7469
CITATIONS - 17919280
MODE - -
REGULATED-ENTITY - PM0-9823
REGULATOR - PD01352
//
UNIQUE-ID - REG0-4842
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS753
CITATIONS - [9484893]
CITATIONS - [11340070]
MODE - -
REGULATED-ENTITY - PM935
REGULATOR - PD01896
//
UNIQUE-ID - REG0-5217
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2427
CITATIONS - 8002608
CITATIONS - 11601842
MODE - -
REGULATED-ENTITY - PM00401
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-5590
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00686
MODE - -
REGULATED-ENTITY - PM00184
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-10608
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7832
CITATIONS - 20015147
MODE - -
REGULATED-ENTITY - PM0-10490
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5968
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1147
CITATIONS - [11814655]
COMMENT - The sequence of this site was not shown in the report by |CITS:
/[11814655]|; the authors only mentioned its position. The sequence of
/the mentioned position is not very clear compared with the
/consensus Nac binding sequence.
MODE - -
REGULATED-ENTITY - PM00154
REGULATOR - G7072-MONOMER
//
UNIQUE-ID - REG0-11294
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8154
CITATIONS - 22026739
MODE - -
REGULATED-ENTITY - PM0-9886
REGULATOR - CPLX0-7787
//
UNIQUE-ID - REG0-6341
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2572
CITATIONS - 11101675
CITATIONS - 11917098
MODE - -
REGULATED-ENTITY - PM0-3601
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-12322
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8494
CITATIONS - 25802297
MODE - +
REGULATED-ENTITY - PM0-46357
REGULATOR - PD01520
//
UNIQUE-ID - REG0-9168
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7451
CITATIONS - 16261196
MODE - +
REGULATED-ENTITY - PM-8827
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-4825
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS744
CITATIONS - [7934931]
CITATIONS - [10595554]
COMMENT - FNR upregulates nikABCDE in the absence of oxygen. This regulator is inactivated by O<sub>2</sub> |CITS:[16159764]|.	
MODE - +
REGULATED-ENTITY - PM881
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5201
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00577
CITATIONS - 7601827
MODE - -
REGULATED-ENTITY - PM00354
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5574
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00414
CITATIONS - 3062173
MODE - +
REGULATED-ENTITY - PM00178
REGULATOR - PD00345
//
UNIQUE-ID - REG0-10579
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7816
CITATIONS - 19843219
MODE - +
REGULATED-ENTITY - PM0-9632
REGULATOR - MONOMER0-4147
//
UNIQUE-ID - REG0-5952
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00490
CITATIONS - 2404765
CITATIONS - 21572102
MODE - -
REGULATED-ENTITY - PM00289
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-6325
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2265
CITATIONS - 10998176
CITATIONS - 12754220
CITATIONS - 16140031
COMMENT - Under anaerobiosis, FNR repress <i>cydAB</i> operon expression |CITS: [12754220]|.
MODE - -
REGULATED-ENTITY - PM0-3341
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-12228
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8479
CITATIONS - 25845847
MODE - -
REGULATED-ENTITY - PM0-46346
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-9113
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7434
CITATIONS - 17526711
MODE - -
REGULATED-ENTITY - PM00196
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4809
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS587
CITATIONS - [8899705]
MODE - +
REGULATED-ENTITY - PM00025
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5182
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6982
CITATIONS - 7601827
MODE - -
REGULATED-ENTITY - PM00353
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5554
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00215
MODE - +
REGULATED-ENTITY - PM00103
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10541
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7799
CITATIONS - 7715459
MODE - -
REGULATED-ENTITY - PM00619
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5929
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00716
CITATIONS - [8757744]
CITATIONS - [7608086]
CITATIONS - 8900067
CITATIONS - 8998977
MODE - +
REGULATED-ENTITY - PM00268
REGULATOR - CPLX0-7752
//
UNIQUE-ID - REG0-6306
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3002
CITATIONS - 9512707
COMMENT - Lrp protects at multiple sites extending at least between positions  -14 and  -102. The effects of cAMP-CRP and Lrp are additive.
MODE - +
REGULATED-ENTITY - PM0-4241
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-11223
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8118
CITATIONS - 11071896
CITATIONS - 11071896:EV-EXP-IMP-SITE-MUTATION:3523037684:martin
CITATIONS - 11071896:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3523037684:martin
CITATIONS - 11071896:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3523037684:martin
MODE - -
REGULATED-ENTITY - PM622
REGULATOR - CPLX0-1242
//
UNIQUE-ID - REG0-12188
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8460
CITATIONS - 25375160
MODE - +
REGULATED-ENTITY - PM00598
REGULATOR - G6789-MONOMER
//
UNIQUE-ID - REG0-9058
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7408
CITATIONS - 9852058
CITATIONS - 12475930
CITATIONS - 17024490
MODE - -
REGULATED-ENTITY - PM00415
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4793
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00029
CITATIONS - 7961453
CITATIONS - 3001025
CITATIONS - 1530846
MODE - -
REGULATED-ENTITY - PM00013
REGULATOR - MONOMER0-162
//
UNIQUE-ID - REG0-5166
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS360
CITATIONS - [8022271]
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM201
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5538
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00206
CITATIONS - 8613990
CITATIONS - 3050131
CITATIONS - 10518785
CITATIONS - 3315853
MODE - -
REGULATED-ENTITY - PM00094
REGULATOR - CPLX-125
//
UNIQUE-ID - REG0-10509
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7784
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM0-3623
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5913
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00662
CITATIONS - 15520470
CITATIONS - 2826388
CITATIONS - 1715855
MODE - +
REGULATED-ENTITY - PM00337
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6289
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2749
CITATIONS - 14651625
CITATIONS - 17630973
COMMENT - IHF binding to this site functions as an antiactivator of CRP.
MODE - -
REGULATED-ENTITY - PM0-3923
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11206
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8105
CITATIONS - 21571995
MODE - +
REGULATED-ENTITY - PM0-9849
REGULATOR - PHOSPHO-RCSB
//
UNIQUE-ID - REG0-12122
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8442
CITATIONS - 25103863
MODE - +
REGULATED-ENTITY - PM0-10368
REGULATOR - CPLX0-2781
//
UNIQUE-ID - REG0-9037
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7383
CITATIONS - 17557822
MODE - +
REGULATED-ENTITY - PM00320
REGULATOR - PC00027
//
UNIQUE-ID - REG0-4777
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00016
CITATIONS - 1640463
CITATIONS - 1640456
CITATIONS - 17074904
MODE - -
REGULATED-ENTITY - PM00007
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-5150
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5082
CITATIONS - 9738023
COMMENT - The regulatory effect of IHF on the <i>rtcB</i> promoter is not yet known. However, we assigned a positive effect to this regulatory interaction based on the protein's binding site, which is upstream of the promoter (62 bp upstream of the transcription start site).
MODE - +
REGULATED-ENTITY - PM333
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5525
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00199
CITATIONS - 17921503
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00089
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-10488
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7769
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM0-9342
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5897
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7290
CITATIONS - 16849788
MODE - -
REGULATED-ENTITY - PM0-4428
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11107
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8085
CITATIONS - 21460078
CITATIONS - 21460078:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3514126347:martin
CITATIONS - 21460078:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3514126347:martin
MODE - -
REGULATED-ENTITY - PM0-36222
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-12019
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8426
CITATIONS - 24272778
MODE - -
REGULATED-ENTITY - PM0-44963
REGULATOR - CPLX-172
//
UNIQUE-ID - REG0-9005
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6561
CITATIONS - 1848637
COMMENT - CAP and NagC can bind simultaneously and produce a  more stable complex than binary NagC-DNA complex. This is a weak CAP  binding site.
MODE - -
REGULATED-ENTITY - PM00058
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4761
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00005
CITATIONS - 1848302
CITATIONS - 2521619
CITATIONS - 9440505
MODE - +
REGULATED-ENTITY - PM00003
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5134
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS181
CITATIONS - [2886490]
CITATIONS - [8898385]
CITATIONS - 9157242
CITATIONS - 10096084
COMMENT - IHF plays a dual role in controlling <i>fimA</i> expression: it is required both for inversion of the <i>fimA</i> control region and for efficient expression from the <i>fimA</i> promoter.
MODE - +
REGULATED-ENTITY - PM241
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5509
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1202
CITATIONS - 11073923
MODE - +
REGULATED-ENTITY - PM00087
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10472
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7754
CITATIONS - 19633077
MODE - +
REGULATED-ENTITY - PM0-8848
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5881
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00297
CITATIONS - [8892825]
CITATIONS - 7592446
CITATIONS - 15699038
MODE - -
REGULATED-ENTITY - PM00150
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11090
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8080
CITATIONS - 21272324
MODE - +
REGULATED-ENTITY - PM00379
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6260
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3281
CITATIONS - 11139621
CITATIONS - 9469834
CITATIONS - 7934873
MODE - -
REGULATED-ENTITY - PM0-4621
REGULATOR - PD00266
//
UNIQUE-ID - REG0-11992
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3745
CITATIONS - 10792463
CITATIONS - 15520470
CITATIONS - 20952573
CITATIONS - 10792463:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3605883469:asantos
CITATIONS - 10792463:EV-EXP-IMP-SITE-MUTATION:3605883469:asantos
CITATIONS - 10792463:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3605883469:asantos
CITATIONS - 15520470:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3605883469:asantos
MODE - +
REGULATED-ENTITY - PM0-46317
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-8989
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00699
CITATIONS - 7715459
MODE - -
REGULATED-ENTITY - PM00619
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4744
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00120
CITATIONS - 2664421
MODE - +
REGULATED-ENTITY - PM00048
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-5116
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS154
CITATIONS - 1310090
MODE - +
REGULATED-ENTITY - PM222
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5492
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00322
CITATIONS - 2231717
CITATIONS - 1400237
CITATIONS - 10715008
MODE - +
REGULATED-ENTITY - PM00139
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10454
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7738
CITATIONS - 9570400
CITATIONS - 9570400:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3464622895:asantos
CITATIONS - 9570400:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3464622895:asantos
CITATIONS - 9570400:EV-EXP-IMP-SITE-MUTATION:3464622895:asantos
MODE - +
REGULATED-ENTITY - PM00654
REGULATOR - PD00196
//
UNIQUE-ID - REG0-5864
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00289
CITATIONS - [9209026]
MODE - -
REGULATED-ENTITY - PM00144
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11074
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8068
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM65
REGULATOR - PD00197
//
UNIQUE-ID - REG0-6243
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4129
CITATIONS - 14593252
MODE - -
REGULATED-ENTITY - PM0-4922
REGULATOR - PD03585
//
UNIQUE-ID - REG0-11950
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8396
CITATIONS - 24013633
MODE - +
REGULATED-ENTITY - PM0-46302
REGULATOR - G6706-MONOMER
//
UNIQUE-ID - REG0-8944
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7346
CITATIONS - 17449618
CITATIONS - 19656291
CITATIONS - 20533909
COMMENT - NsrR plays a major role while the effects of NarL and NarP are minimal in the regulation of the <i>hcp-hcr</i> operon by nitrate and nitrite |CITS: [20533909]|.
MODE - -
REGULATED-ENTITY - PM0-7361
REGULATOR - CPLX0-7756
//
UNIQUE-ID - REG0-4728
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5102
CITATIONS - 2538630
CITATIONS - 2016744
CITATIONS - 9000616
MODE - +
REGULATED-ENTITY - PM00047
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-5100
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3469
CITATIONS - 11395452
MODE - +
REGULATED-ENTITY - PM206
REGULATOR - PD00365
//
UNIQUE-ID - REG0-5475
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00270
CITATIONS - 21276098
MODE - +
REGULATED-ENTITY - PM00131
REGULATOR - PD01520
//
UNIQUE-ID - REG0-10417
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8014
CITATIONS - 18808381
CITATIONS - 17660422:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3510682258:martin
CITATIONS - 12730179:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3510682258:martin
CITATIONS - 18297445:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3510682258:martin
CITATIONS - 18808381:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3510682258:martin
CITATIONS - 18808381:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3510682258:martin
MODE - +
REGULATED-ENTITY - PM0-10349
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-5848
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00350
CITATIONS - 15255893
CITATIONS - 11038360
MODE - +
REGULATED-ENTITY - PM00196
REGULATOR - CPLX0-2781
//
UNIQUE-ID - REG0-11057
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8052
CITATIONS - 21421764
MODE - +
REGULATED-ENTITY - PM00535
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6227
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6044
CITATIONS - 11115104
CITATIONS - 20923783
MODE - +
REGULATED-ENTITY - PM0-5261
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11894
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8380
CITATIONS - 23874328
MODE - +
REGULATED-ENTITY - PM0-5141
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-6602
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7198
CITATIONS - 16377617
COMMENT - By making use of microarray analyses, Constantinidou et al. |CITS: [16377617]| concluded that FNR represses <i>ychO</i> gene expression. They also identified a putative FNR-binding site upstream of the gene, but the sequence was not shown.
MODE - -
REGULATED-ENTITY - PM0-9127
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4712
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00101
CITATIONS - 2183352
CITATIONS - 11443092
CITATIONS - 1730735
CITATIONS - 8087856
CITATIONS - 2693740
MODE - +
REGULATED-ENTITY - PM00043
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5084
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7246
CITATIONS - 17233826
MODE - +
REGULATED-ENTITY - PM00547
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5458
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00241
CITATIONS - 3902796
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM00117
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10334
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7704
CITATIONS - 19245365
MODE - -
REGULATED-ENTITY - PM0-9688
REGULATOR - PD00196
//
UNIQUE-ID - REG0-5832
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00782
MODE - +
REGULATED-ENTITY - PM00653
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-11033
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8040
CITATIONS - 17170003
MODE - -
REGULATED-ENTITY - PM0-10318
REGULATOR - CPLX0-7929
//
UNIQUE-ID - REG0-6211
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3812
CITATIONS - 9537375
MODE - +
REGULATED-ENTITY - PM0-5167
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11812
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8364
CITATIONS - 23564175
COMMENT - The regulation of CpxR on the <i>slt</i> gene has been probed by quantitative PCR analysis of cDNA and by the identification of a consensus DNA-binding site of CpxR in the regulatory region of <i>slt</i> |CITS:[ 23564175]|. The identification of this DNA-binding site was only mentioned in the paper of Raivio et al. (2013), but the DNA sequence was not shown |CITS:[ 23564175]|.
MODE - +
REGULATED-ENTITY - PM0-46112
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-6586
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4361
CITATIONS - 16417519
MODE - -
REGULATED-ENTITY - PM0-9342
REGULATOR - EG12108-MONOMER
//
UNIQUE-ID - REG0-4695
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00089
CITATIONS - 1556120
CITATIONS - 1372899
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM00039
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5068
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1944
CITATIONS - [10537212]
MODE - -
REGULATED-ENTITY - PM197
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5442
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7317
CITATIONS - 9582281
MODE - -
REGULATED-ENTITY - PM00161
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10263
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7688
CITATIONS - 18501926
MODE - -
REGULATED-ENTITY - PM0-9527
REGULATOR - CPLX0-7791
//
UNIQUE-ID - REG0-5816
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00352
COMMENT - The protein CysB regulates the expression of the <i>cysDNC</i> operon. This protein was previously indicated as involved in regulating the <i>cydD</i> and <i>cysNC</i> promoters. But the <i>cysNC</i> promoter has been eliminated from the database. See the note for the cysD promoter and the note for the transcription unit  <i>cysDNC</i>.
MODE - +
REGULATED-ENTITY - PM00198
REGULATOR - CPLX0-2781
//
UNIQUE-ID - REG0-10988
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8013
CITATIONS - 14702398
CITATIONS - 18808381
CITATIONS - 18083817
COMMENT - GadX has a positive direct or indirect effect on the <i>hdeAB-yhiD</i> operon only in stationary-phase cells at pH 5.5, but it is a repressor in exponential growth phase at pH 7.0 |CITS: [18083817]|.
MODE - -
REGULATED-ENTITY - PM928
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6195
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3981
CITATIONS - 14996803
CITATIONS - 12374842
CITATIONS - 12644495
MODE - -
REGULATED-ENTITY - PM0-5402
REGULATOR - G7854-MONOMER
//
UNIQUE-ID - REG0-11748
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8349
CITATIONS - 23274360
MODE - +
REGULATED-ENTITY - PM0-7682
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-6569
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7028
CITATIONS - 15995204
MODE - -
REGULATED-ENTITY - PM0-8728
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-4679
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00081
CITATIONS - 1556120
CITATIONS - 1372899
MODE - +
REGULATED-ENTITY - PM00037
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9998
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7657
CITATIONS - 12730179
CITATIONS - 18808381
MODE - +
REGULATED-ENTITY - PM00137
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-5052
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS324
CITATIONS - [8057841]
MODE - -
REGULATED-ENTITY - PM437
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-5426
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2844
CITATIONS - 8253679
CITATIONS - 10856246
COMMENT - Lrp is not essential for osmotic induction of <i>osmY</i>.
MODE - -
REGULATED-ENTITY - PM00529
REGULATOR - PD00353
//
UNIQUE-ID - REG0-10136
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7674
CITATIONS - 18723630
MODE - -
REGULATED-ENTITY - PM0-10275
REGULATOR - CPLX0-7745
//
UNIQUE-ID - REG0-5800
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS545
CITATIONS - [8809757]
CITATIONS - 14766919
COMMENT - The +51 Fis site has a small negative effect on <i>ndh</i> expression |CITS: [14766919]|.  
MODE - -
REGULATED-ENTITY - PM00218
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10972
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1746
CITATIONS - 16980449
CITATIONS - [12446650]
CITATIONS - 12730179
COMMENT - GadW regulates positively the expression of <i>gadA</i> in the absence of GadX only to pH 8 |CITS: [12446650]|.
MODE - +
REGULATED-ENTITY - PM461
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6177
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4782
CITATIONS - 15485810
MODE - +
REGULATED-ENTITY - PM0-6041
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11665
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8335
CITATIONS - 23092251
MODE - +
REGULATED-ENTITY - PM00465
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-6549
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7050
CITATIONS - 15941987
MODE - +
REGULATED-ENTITY - PM-8782
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-4663
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5943
MODE - -
REGULATED-ENTITY - PM00033
REGULATOR - PD00261
//
UNIQUE-ID - REG0-9785
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7613
CITATIONS - 9473050
CITATIONS - 11321589
CITATIONS - 18673442
CITATIONS - 9473050:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3434401642:asantos
CITATIONS - 9473050:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3434401642:asantos
CITATIONS - 11321589:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3434401642:asantos
CITATIONS - 18673442:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3434401642:asantos
MODE - +
REGULATED-ENTITY - PM0-10259
REGULATOR - PD00365
//
UNIQUE-ID - REG0-5036
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS465
CITATIONS - [8913296]
MODE - +
REGULATED-ENTITY - PM586
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5410
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6956
CITATIONS - 15659676
CITATIONS - 2139473
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00228
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-10001
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7659
CITATIONS - 18808381
CITATIONS - 18083817
CITATIONS - 12730179
MODE - +
REGULATED-ENTITY - PM928
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-5784
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS49
CITATIONS - 2168848
CITATIONS - 8501030
CITATIONS - 9302020
CITATIONS - 12923080
MODE - +
REGULATED-ENTITY - PM00217
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-10954
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8009
CITATIONS - 16980449
CITATIONS - 11976288
CITATIONS - 12446650
CITATIONS - 15795232
MODE - +
REGULATED-ENTITY - PM450
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6161
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4201
CITATIONS - 1918057
MODE - +
REGULATED-ENTITY - PM0-5642
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-11646
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00173
CITATIONS - 23071782
MODE - -
REGULATED-ENTITY - PM0-9646
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-6533
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7193
CITATIONS - 16377617
COMMENT - By making use of microarray analyses, Constantinidou et al. |CITS: [16377617]| concluded that FNR activates <i>pitA</i> gene expression. They also identified a putative FNR-binding site upstream of the gene, but the sequence was not shown.
MODE - +
REGULATED-ENTITY - PM0-8927
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4647
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00068
COMMENT - Based on the effect of various concentrations of GalS on the <i>gal</i> regulon promoter and mathematical models, it was determined that GalS has higher affinity for <i>galSOE</i>, which is at position  -61.5 on the <i>galS</i> promoter |CITS:[19429616]|. This effect is referred to as dominant negative autoregulation |CITS:[19429616]|.
MODE - -
REGULATED-ENTITY - PM00031
REGULATOR - PD00261
//
UNIQUE-ID - REG0-9603
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00300
MODE - -
REGULATED-ENTITY - PM00154
REGULATOR - CPLX0-7733
//
UNIQUE-ID - REG0-5020
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS445
CITATIONS - [8955407]
CITATIONS - [10216857]
MODE - -
REGULATED-ENTITY - PM561
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5394
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS150
CITATIONS - [8119409]
MODE - -
REGULATED-ENTITY - PM00214
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5768
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00363
CITATIONS - 11115104
MODE - -
REGULATED-ENTITY - PM00202
REGULATOR - PD03270
//
UNIQUE-ID - REG0-10927
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7995
CITATIONS - 21034467
MODE - -
REGULATED-ENTITY - PM0-5982
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6144
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7179
CITATIONS - 16140472
MODE - -
REGULATED-ENTITY - PM00500
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11628
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8306
CITATIONS - 23233451
MODE - -
REGULATED-ENTITY - PM00092
REGULATOR - G6444-MONOMER
//
UNIQUE-ID - REG0-6517
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7103
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM0-1303
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4631
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7240
CITATIONS - 1459953
MODE - -
REGULATED-ENTITY - PM00028
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-9581
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7617
CITATIONS - 18567656
COMMENT - The role for the <i>nemRA-gloA</i> operon is to sense electrophiles |CITS:[23506073]|.
/Bleach upregulates the NemR-controlled genes <i>gloA</i> and <i>nemA</i> and increases bacterial survival in bleach, and this finding provided the first evidence that resistance toward bleach relies on the ability of bacteria to detoxify methylglyoxal and reactive electrophiles |CITS:[23536188]|.
MODE - -
REGULATED-ENTITY - PM0-10220
REGULATOR - G6889-MONOMER
//
UNIQUE-ID - REG0-5003
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7043
CITATIONS - 15699038
COMMENT - ArcA appears to activate <i>gadAX</i> operon expression under anaerobiosis. A putative ArcA-binding site was  identified 567 bp upstream of this operon |CITS: [15699038]|, but the sequence was not shown.
MODE - +
REGULATED-ENTITY - PM461
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5378
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00599
CITATIONS - 8890170
CITATIONS - 9006049
MODE - +
REGULATED-ENTITY - PM00537
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5752
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00713
CITATIONS - 2000372
MODE - +
REGULATED-ENTITY - PM00235
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-10907
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7979
COMMENT - This binding site was determined from  a computational prediction based on different statistical methods |CITS:[21070640]|. The function of the binding site was assigned according to the distance from the transcription start, with NagC as the transcriptional repressor.
MODE - -
REGULATED-ENTITY - PM0-9849
REGULATOR - PD00266
//
UNIQUE-ID - REG0-6128
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5561
MODE - -
REGULATED-ENTITY - PM0-7183
REGULATOR - PD00266
//
UNIQUE-ID - REG0-11591
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8292
MODE - -
REGULATED-ENTITY - PM0-44963
REGULATOR - PD00266
//
UNIQUE-ID - REG0-6501
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3729
CITATIONS - 12588863
COMMENT - Fis binding to site I and II can coactivate ptsGp1 transcription with CRP.
MODE - +
REGULATED-ENTITY - PM0-1301
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4615
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7268
CITATIONS - 11520622
MODE - +
REGULATED-ENTITY - PM0-9374
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-9547
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7601
CITATIONS - 18405378
MODE - -
REGULATED-ENTITY - PM00279
REGULATOR - PD00353
//
UNIQUE-ID - REG0-4985
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3928
CITATIONS - 6281232
CITATIONS - 7007313
CITATIONS - 3929016
MODE - -
REGULATED-ENTITY - PM101
REGULATOR - EG20249-MONOMER
//
UNIQUE-ID - REG0-5361
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7303
CITATIONS - 9765583
CITATIONS - 3025182
CITATIONS - 9209034
CITATIONS - 9209035
COMMENT - The TyrR-binding site at position bp 40.5 from the aroPp1 promoter is a strong TyrR box that is involved in the repression of <i>aroP</i> gene transcription |CITS:[10515932]|.
MODE - -
REGULATED-ENTITY - PM00014
REGULATOR - MONOMER0-162
//
UNIQUE-ID - REG0-5736
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4803
CITATIONS - 17921503
MODE - +
REGULATED-ENTITY - PM00229
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-10891
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7963
CITATIONS - 21115656
MODE - -
REGULATED-ENTITY - PM00142
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6112
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5643
CITATIONS - 15667305
MODE - +
REGULATED-ENTITY - PM0-7361
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-11574
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8278
CITATIONS - 22442305
MODE - -
REGULATED-ENTITY - PM0-8161
REGULATOR - PHOSPHO-BASR
//
UNIQUE-ID - REG0-6484
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2502
CITATIONS - 12003934
COMMENT - ArgR enhances expression from  the astCp2 promoter but is not essential for its expression |CITS: [12003934]|.
MODE - +
REGULATED-ENTITY - PM0-1163
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-4597
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2781
CITATIONS - 8113170
CITATIONS - 8175665
CITATIONS - 1648075
CITATIONS - 12366850
CITATIONS - 16618701
MODE - -
REGULATED-ENTITY - PM00066
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-9469
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7588
CITATIONS - 18368388
CITATIONS - 12067348
MODE - +
REGULATED-ENTITY - PM180
REGULATOR - PD00406
//
UNIQUE-ID - REG0-4969
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS474
CITATIONS - [8913296]
MODE - -
REGULATED-ENTITY - PM588
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5344
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00190
CITATIONS - 1971621
CITATIONS - 21572102
COMMENT - When the CTP level within the cell is high relative to the level of GTP, the <i>pyrD</i> gene is transcribed from a start site that allows formation of a secondary structure within the 5' end of the mRNA.  This hairpin structure is thought to obscure the Shine-Dalgarno sequence, and it results in poor translation efficiency.  When the CTP level is low relative to the level of GTP, <i>pyrD</i> is transcribed from an alternate start site.  These shorter mRNAs are translated efficiently. The PurR protein, which represses the <i>pyrD</i> gene, is also regulated by the level of GTP, because this protein is active when GTP is present, but when PurR is active it repress the two genes, and  when  there is a high  level of GTP these genes are translated efficiently. Thus, the two  control systems can operate  in opposition to one another.
MODE - -
REGULATED-ENTITY - PM00084
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-5718
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS62
CITATIONS - 7551052
CITATIONS - 3135464
CITATIONS - 8195106
CITATIONS - 6309813
MODE - +
REGULATED-ENTITY - PM00272
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10856
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7947
CITATIONS - 20718955
MODE - -
REGULATED-ENTITY - PM404
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-6096
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6341
CITATIONS - 9532784
CITATIONS - 12694615
MODE - +
REGULATED-ENTITY - PM0-7941
REGULATOR - PHOSPHO-EVGA
//
UNIQUE-ID - REG0-11525
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8258
CITATIONS - 20923783
MODE - -
REGULATED-ENTITY - PM0-5261
REGULATOR - PD03270
//
UNIQUE-ID - REG0-6468
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2571
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1349
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4580
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS340
CITATIONS - 8002608
CITATIONS - 1346534
COMMENT - Binding of Lrp to one site enhances occupancy of the other Lrp sites  in the  ompCp1 promoter. Leucine does not abolish  DNA binding by the ligated Lrp but it may alter the affinity of Lrp for specific sites on DNA.
MODE - -
REGULATED-ENTITY - PM00065
REGULATOR - PD00353
//
UNIQUE-ID - REG0-9419
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7573
CITATIONS - 7836317
COMMENT - It is likely that LeuO binds directly to <i>cadC</i> promoter sequences to reduce <i>cadC</i> gene expression |CITS: [7836317]|.
MODE - -
REGULATED-ENTITY - PM00159
REGULATOR - PD00519
//
UNIQUE-ID - REG0-4953
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1562
CITATIONS - [10564485]
MODE - +
REGULATED-ENTITY - PM641
REGULATOR - PD00406
//
UNIQUE-ID - REG0-5328
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1921
MODE - -
REGULATED-ENTITY - PM00598
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5702
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4622
CITATIONS - 10760178
CITATIONS - 16621812
MODE - +
REGULATED-ENTITY - PM00175
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10824
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7931
CITATIONS - 20622065
CITATIONS - 16849788
MODE - -
REGULATED-ENTITY - PM0-36147
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-6080
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6382
CITATIONS - 12460564
CITATIONS - 18957590
MODE - -
REGULATED-ENTITY - PM0-7983
REGULATOR - CPLX0-8071
//
UNIQUE-ID - REG0-11508
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7309
CITATIONS - 16115199
MODE - -
REGULATED-ENTITY - PM00380
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6452
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2547
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1343
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4563
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00152
CITATIONS - [8288532]
CITATIONS - [9819053]
MODE - +
REGULATED-ENTITY - PM00063
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-9395
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8223
CITATIONS - 22295907
CITATIONS - 22295907:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3545039304:martin
CITATIONS - 22295907:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3545039304:martin
CITATIONS - 22295907:EV-IC:3545039304:martin
MODE - +
REGULATED-ENTITY - PM0-9884
REGULATOR - PD00519
//
UNIQUE-ID - REG0-4937
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS764
CITATIONS - [9421904]
MODE - -
REGULATED-ENTITY - PM263
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5312
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2426
CITATIONS - [8002608]
CITATIONS - 1346534
MODE - -
REGULATED-ENTITY - PM00630
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5686
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3349
CITATIONS - 8830277
CITATIONS - 7934818
CITATIONS - 8437561
MODE - -
REGULATED-ENTITY - PM00191
REGULATOR - PD00288
//
UNIQUE-ID - REG0-10807
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7915
CITATIONS - 20466769
MODE - -
REGULATED-ENTITY - PM00536
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-6061
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6804
CITATIONS - 2543976
COMMENT - Both sites of the MetJ regulator in the intergenic region of <i>metE</i> and <i>metR</i> could negatively regulate both promoters metRp2 and metRp1.
MODE - -
REGULATED-ENTITY - PM0-8603
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-11490
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8234
CITATIONS - 22323519
MODE - -
REGULATED-ENTITY - PM928
REGULATOR - EG11356-MONOMER
//
UNIQUE-ID - REG0-6436
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1144
CITATIONS - [9785451]
MODE - -
REGULATED-ENTITY - PM00379
REGULATOR - G7072-MONOMER
//
UNIQUE-ID - REG0-4547
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4207
CITATIONS - 15225315
CITATIONS - 18757534
COMMENT - IHF (-115 site)  increases  FNR-dependent  activation by decreasing the repression  mediated by IHF (-88 site) and Fis (-142 site).  It is a weak site.
MODE - +
REGULATED-ENTITY - PM00062
REGULATOR - PC00027
//
UNIQUE-ID - REG0-9377
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7538
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM00598
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4921
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7303
CITATIONS - 9209034
CITATIONS - 10515932
CITATIONS - 3025182
CITATIONS - 14614536
COMMENT - The TyrR binding site at position 20.5 bp from the aroPp2 promoter is a strong TyrR box that is involved in the repression of aroP gene transcription 
/|CITS:[10515932]|. This strong box, which is closest to the 
/promoter, is critical for repression, due to the fact that this site is 
/bound by TyrR as a dimer or as a hexamer. The weak box has a less 
/significant role in the aroPp2 repression |CITS:[10515932]|.
MODE - -
REGULATED-ENTITY - PM741
REGULATOR - MONOMER0-162
//
UNIQUE-ID - REG0-5296
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6621
CITATIONS - 15743955
CITATIONS - 19636340
MODE - -
REGULATED-ENTITY - PM0-8241
REGULATOR - CPLX0-8043
//
UNIQUE-ID - REG0-5670
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7008
CITATIONS - 15883881
COMMENT - This regulatory interaction was identified by means of PhoPQ-related microarray experiments, and the investigators checked for the presence of its regulatory motif in the promoter region |CITS: [15883881]|. A repressor function for <i>argD</i> gene transcription can be clearly anticipated from the localization of the PhoP-binding site,  very close to the argDp promoter core region.
MODE - -
REGULATED-ENTITY - PM00152
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-10782
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7899
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00306
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6045
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7171
CITATIONS - 16491024
CITATIONS - 8381784
CITATIONS - 21034467
COMMENT - Hns repress the <i>cadB</i> promoter at pH 8.0
MODE - -
REGULATED-ENTITY - PM00622
REGULATOR - PD00288
//
UNIQUE-ID - REG0-11474
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8222
CITATIONS - 22295907
MODE - -
REGULATED-ENTITY - PM0-46179
REGULATOR - EG11554-MONOMER
//
UNIQUE-ID - REG0-6418
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1381
CITATIONS - [11031114]
MODE - +
REGULATED-ENTITY - PM0-1730
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-4531
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6924
CITATIONS - 8057356
MODE - +
REGULATED-ENTITY - PM00061
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9360
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7522
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM461
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4904
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2821
CITATIONS - 10913096
COMMENT - Although Crp has been observed to bind to this site, its function remains unknown.
REGULATED-ENTITY - PM692
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5280
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00593
CITATIONS - 14523117
COMMENT - The CsgD protein-binding site overlaps the  -35 box of the  csgBp promoter, which is consistent with the location for an activator-binding site |CITS: [14523117]|.
MODE - +
REGULATED-ENTITY - PM00535
REGULATOR - PD01379
//
UNIQUE-ID - REG0-5654
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00586
CITATIONS - [9573142]
CITATIONS - [10564497]
CITATIONS - [7815937]
MODE - +
REGULATED-ENTITY - PM00528
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10754
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7887
CITATIONS - 12067348
MODE - +
REGULATED-ENTITY - PM262
REGULATOR - PD00406
//
UNIQUE-ID - REG0-6029
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7093
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM167
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11431
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8201
CITATIONS - 11065369
CITATIONS - 7665470
CITATIONS - 10463182
CITATIONS - 15621456
CITATIONS - 8188587
MODE - -
REGULATED-ENTITY - PM00233
REGULATOR - PD00339
//
UNIQUE-ID - REG0-6402
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1581
CITATIONS - [10564485]
CITATIONS - [10850996]
MODE - +
REGULATED-ENTITY - PM0-2021
REGULATOR - PD04418
//
UNIQUE-ID - REG0-4515
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3302
CITATIONS - 9469834
CITATIONS - 1848637
CITATIONS - 11139621
CITATIONS - 7934873
COMMENT - CAP and NagC can bind simultaneously and produce a more stable complex than binary NagC-DNA complex.
MODE - -
REGULATED-ENTITY - PM00058
REGULATOR - PD00266
//
UNIQUE-ID - REG0-9331
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7502
CITATIONS - 17768236
MODE - +
REGULATED-ENTITY - PM00047
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4888
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS446
CITATIONS - [9924977]
CITATIONS - [7715442]
MODE - -
REGULATED-ENTITY - PM00241
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5264
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00624
CITATIONS - 1324388
MODE - +
REGULATED-ENTITY - PM00567
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5638
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7256
CITATIONS - 1690124
CITATIONS - 3317280
CITATIONS - 2207159
MODE - +
REGULATED-ENTITY - PM00659
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10713
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7869
CITATIONS - 20421606
MODE - -
REGULATED-ENTITY - PM0-10541
REGULATOR - G7326-MONOMER
//
UNIQUE-ID - REG0-6013
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS824
CITATIONS - [2575702]
CITATIONS - [1327747]
CITATIONS - 1327747
CITATIONS - 9466254
CITATIONS - 20000490
COMMENT - CRP and CytR bind cooperatively to cddp.
MODE - -
REGULATED-ENTITY - PM1001
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-11408
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00230
CITATIONS - [8429549]
CITATIONS - 8508774
CITATIONS - 8071194
CITATIONS - 8483418
CITATIONS - 8429549:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537796233:martin
CITATIONS - 8429549:EV-EXP-IMP-SITE-MUTATION:3537796233:martin
CITATIONS - 8429549:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537796233:martin
CITATIONS - 2115869:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537796233:martin
CITATIONS - 2115869:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537796233:martin
CITATIONS - 2646291:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537796233:martin
CITATIONS - 8508774:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537796233:martin
CITATIONS - 8508774:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537796233:martin
CITATIONS - 8071194:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537796233:martin
CITATIONS - 8071194:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537796233:martin
CITATIONS - 8483418:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537796233:martin
CITATIONS - 8432705:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537796233:martin
CITATIONS - 8432705:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537796233:martin
CITATIONS - 12218014:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537796233:martin
CITATIONS - 12218014:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537796233:martin
CITATIONS - 3891724:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537796233:martin
CITATIONS - 1447135:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537796233:martin
MODE - -
REGULATED-ENTITY - PM00323
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6386
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1981
CITATIONS - [10411720]
MODE - -
REGULATED-ENTITY - PM0-2701
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4498
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS160
CITATIONS - 10760178
CITATIONS - 16621812
CITATIONS - 18346968
MODE - -
REGULATED-ENTITY - PM00050
REGULATOR - PD00208
//
UNIQUE-ID - REG0-9311
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7492
CITATIONS - 17768236
MODE - +
REGULATED-ENTITY - PM00151
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4872
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7120
CITATIONS - 11287152
COMMENT - The regulatory effect of FlhDC in <i>napF</i> operon transcription has been proved by microarray analysis by |CITS: [11287152]|
MODE - +
REGULATED-ENTITY - PM125
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-5247
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7271
CITATIONS - 17233899
MODE - -
REGULATED-ENTITY - PM00254
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-5622
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2601
CITATIONS - 12888342
CITATIONS - 11278071
CITATIONS - 9300053
MODE - +
REGULATED-ENTITY - PM00666
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10680
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7855
CITATIONS - 12029051
CITATIONS - 12644490
CITATIONS - 11972787
CITATIONS - 10692164
CITATIONS - 10094691
MODE - -
REGULATED-ENTITY - PM0-2881
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5997
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7160
CITATIONS - 16377617
MODE - -
REGULATED-ENTITY - PM324
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11374
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8178
CITATIONS - 22101843
CITATIONS - 18997424
CITATIONS - 22101843:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3535223225:martin
CITATIONS - 22101843:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3535223225:martin
CITATIONS - 18997424:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3535223225:martin
CITATIONS - 18997424:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3535223225:martin
CITATIONS - 9701802
MODE - +
REGULATED-ENTITY - PM0-9889
REGULATOR - PHOSPHO-DPIA
//
UNIQUE-ID - REG0-6370
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1802
MODE - -
REGULATED-ENTITY - PM0-2522
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-4482
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00230
CITATIONS - 8429549
CITATIONS - 2115869
CITATIONS - 2646291
CITATIONS - 8508774
CITATIONS - 8071194
CITATIONS - 8483418
CITATIONS - 8432705
CITATIONS - 12218014
CITATIONS - 3891724
CITATIONS - 1447135
MODE - +
REGULATED-ENTITY - PM00111
REGULATOR - PD00353
//
UNIQUE-ID - REG0-9279
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7480
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00605
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4855
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3701
CITATIONS - 14702328
COMMENT - It seems that Fnr repress the <i>hyf</i> operon expression when it is activated by HyfR.  Its is possible that binding of FNR  may minimize the binding of HyfR, whose binding site is only 25 bases upstream of the FNR-binding site |CITS: [14702328]|.
MODE - -
REGULATED-ENTITY - PM787
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5231
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00645
COMMENT - FadR represses <i>uspA</i> gene expression during log phase.
MODE - -
REGULATED-ENTITY - PM00451
REGULATOR - PD01520
//
UNIQUE-ID - REG0-5605
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7330
CITATIONS - 16115199
MODE - -
REGULATED-ENTITY - PM0-9575
REGULATOR - PC00061
//
UNIQUE-ID - REG0-10664
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7844
CITATIONS - 11443091
MODE - +
REGULATED-ENTITY - PM0-9365
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5981
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00692
CITATIONS - 7608078
COMMENT - The CRP function in the promoter for <i>treB</i> is not known, but  the  position of  the binding site on this promoter suggests that CRP is a repressor of this  promoter.
MODE - -
REGULATED-ENTITY - PM00299
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11327
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8167
CITATIONS - 9556617
CITATIONS - 3062177
MODE - +
REGULATED-ENTITY - PM00128
REGULATOR - PD00200
//
UNIQUE-ID - REG0-6354
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2102
CITATIONS - [8300522]
COMMENT - The regulatory effect of IHF on the promoter hemFp is not yet known. However, we assigned a negative effect to this regulatory interaction based on the fact that the protein's binding site overlaps with the promoter.
MODE - -
REGULATED-ENTITY - PM0-2922
REGULATOR - PC00027
//
UNIQUE-ID - REG0-12393
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8510
CITATIONS - 26673755
MODE - +
REGULATED-ENTITY - PM0-5001
REGULATOR - MONOMER0-1
//
UNIQUE-ID - REG0-9262
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7466
CITATIONS - 17919280
MODE - -
REGULATED-ENTITY - PM0-4261
REGULATOR - PD01352
//
UNIQUE-ID - REG0-4839
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS755
CITATIONS - 11340070
MODE - -
REGULATED-ENTITY - PM934
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5214
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3081
CITATIONS - 2203749
COMMENT - The regulatory effect of IHF on the promoter micFp1 is not yet known. However, we have assigned a negative effect to this regulatory interaction based on the fact that the protein's binding site overlaps the transcription start site of the promoter.
MODE - -
REGULATED-ENTITY - PM00401
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5587
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4281
CITATIONS - 10913108
MODE - -
REGULATED-ENTITY - PM00184
REGULATOR - EG11449-MONOMER
//
UNIQUE-ID - REG0-10605
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7829
CITATIONS - 20015147
MODE - +
REGULATED-ENTITY - PM0-10490
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-5965
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS602
CITATIONS - [8932307]
MODE - -
REGULATED-ENTITY - PM00282
REGULATOR - PD00288
//
UNIQUE-ID - REG0-11269
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8151
CITATIONS - 11350954
MODE - +
REGULATED-ENTITY - TU0-42468
REGULATOR - PHOSPHO-CREB
//
UNIQUE-ID - REG0-6338
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2550
CITATIONS - 11101675
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM0-3582
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-12312
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8491
CITATIONS - 17224606
MODE - -
REGULATED-ENTITY - PM0-9747
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-9165
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7448
CITATIONS - 17720788
MODE - +
REGULATED-ENTITY - PM0-9688
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-4822
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS722
CITATIONS - [8577250]
COMMENT - As an earlier study had described a negative effect in a <i>fruR</i> mutant of <i>S. enterica</i> serovar Typhimurium for the expression of <i>pckA</i> |CITS: [2496106]|,  it was inferred that FruR could activate <i>pckA</i> transcription. Now as the FruR site was found 145 bp upstream of the transcriptional start site (similar to the <i>ace</i> operon site), the suggestion is that FruR is able to activate gene expression at a considerable distance, possibly looping the DNA in order to contact the transcriptional initiation complex.
MODE - +
REGULATED-ENTITY - PM00193
REGULATOR - PC00061
//
UNIQUE-ID - REG0-5198
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6976
CITATIONS - 7601827
MODE - -
REGULATED-ENTITY - PM00354
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5570
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00437
CITATIONS - 2989817
CITATIONS - 8057377
MODE - -
REGULATED-ENTITY - PM00251
REGULATOR - PC00010
//
UNIQUE-ID - REG0-10576
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7813
CITATIONS - 19854903
MODE - +
REGULATED-ENTITY - PM00087
REGULATOR - CPLX-124
//
UNIQUE-ID - REG0-5945
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00488
CITATIONS - 8388874
MODE - -
REGULATED-ENTITY - PM00288
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-6322
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2347
CITATIONS - 11123679
CITATIONS - 10998176
CITATIONS - 16140031
CITATIONS - 16980446
MODE - +
REGULATED-ENTITY - PM0-3341
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11254
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8138
CITATIONS - 11274153
MODE - +
REGULATED-ENTITY - PM0-4436
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-12225
TYPES - Transcription-Factor-Binding
//
UNIQUE-ID - REG0-9109
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7432
CITATIONS - 7559363
CITATIONS - 9829921
MODE - +
REGULATED-ENTITY - PM00451
REGULATOR - PC00027
//
UNIQUE-ID - REG0-4806
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00048
MODE - -
REGULATED-ENTITY - PM00024
REGULATOR - PD01196
//
UNIQUE-ID - REG0-12222
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8476
CITATIONS - 25790494
CITATIONS - 25790494:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3641584369:asantos
CITATIONS - 25790494:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3641584369:asantos
CITATIONS - 25790494:EV-COMP-AINF:3641584369:asantos
MODE - -
REGULATED-ENTITY - PM0-46338
REGULATOR - G6976-MONOMER
//
UNIQUE-ID - REG0-9089
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7429
CITATIONS - 16824106
CITATIONS - 21143317
MODE - +
REGULATED-ENTITY - PM0-2801
REGULATOR - G7326-MONOMER
//
UNIQUE-ID - REG0-4803
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00040
CITATIONS - 2644221
CITATIONS - 11101675
CITATIONS - 17526711
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00020
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-5179
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00572
COMMENT - FNR is absolutely necessary for pyruvate-mediated induction of the <i>focA-pflB</i> operon. This protein mediates anaerobic regulation of the <i>focA-pflB</i> operon.
MODE - +
REGULATED-ENTITY - PM00353
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5551
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00214
CITATIONS - 2183352
CITATIONS - 17906139
CITATIONS - 11443092
CITATIONS - 1730735
CITATIONS - 2693740
CITATIONS - 8087856
MODE - +
REGULATED-ENTITY - PM00102
REGULATOR - PD00214
//
UNIQUE-ID - REG0-10530
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7797
CITATIONS - 1327747
CITATIONS - 9466254
CITATIONS - 20000490
MODE - -
REGULATED-ENTITY - PM1001
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5926
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00456
CITATIONS - 15225313
CITATIONS - 7777530
CITATIONS - 8383113
CITATIONS - 7768850
CITATIONS - 11751765
COMMENT - Two MarR sites (-18 and +17) are required for full transcriptional repression, but either site alone permits partial repression |CITS:[15225313]|.
MODE - -
REGULATED-ENTITY - PM00265
REGULATOR - CPLX0-7710
//
UNIQUE-ID - REG0-6303
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2967
CITATIONS - 11555297
COMMENT - The binding site of SdiA in the <i>ftsQ</i>p2 promoter seems insensitive to its autoinducer |CITS:[24598739]|.
MODE - +
REGULATED-ENTITY - PM00607
REGULATOR - PD02198
//
UNIQUE-ID - REG0-11220
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8119
CITATIONS - 11071896
MODE - -
REGULATED-ENTITY - PM623
REGULATOR - CPLX0-1242
//
UNIQUE-ID - REG0-12163
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8457
CITATIONS - 25568260
MODE - +
REGULATED-ENTITY - PM0-45171
REGULATOR - MONOMER0-4180
//
UNIQUE-ID - REG0-9050
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7397
CITATIONS - 17608696
MODE - +
REGULATED-ENTITY - PM0-9651
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4790
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4065
CITATIONS - 8613990
CITATIONS - 10518785
CITATIONS - 7961453
CITATIONS - 1530846
MODE - -
REGULATED-ENTITY - PM00013
REGULATOR - CPLX-125
//
UNIQUE-ID - REG0-5163
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS124
CITATIONS - [8631699]
CITATIONS - [9573142]
CITATIONS - [10564497]
COMMENT - CaiF and CRP bind cooperatively to the <i>cai-fix</i> intergenic region to activate the <i>fixA</i> promoter.
MODE - +
REGULATED-ENTITY - PM339
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10506
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7781
CITATIONS - 19656291
CITATIONS - 19656291:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3468096951:asantos
CITATIONS - 19656291:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3468096951:asantos
MODE - -
REGULATED-ENTITY - PM00626
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5910
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5681
CITATIONS - 12754220
CITATIONS - 21272324
COMMENT - |CITS:[12754220]| identified a FNR-binding site in the <i>lpdA</i> regulatory region, but the sequence was not reported in the paper.
MODE - -
REGULATED-ENTITY - PM00326
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-6286
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2750
CITATIONS - 14651625
COMMENT - The regulatory effect of this IHF site is as yet not known.
/
MODE - -
REGULATED-ENTITY - PM0-3923
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11203
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8102
CITATIONS - 21571995
MODE - +
REGULATED-ENTITY - PM0-5143
REGULATOR - PHOSPHO-RCSB
//
UNIQUE-ID - REG0-12118
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8439
CITATIONS - 24947454
MODE - +
REGULATED-ENTITY - PM0-46332
REGULATOR - PROTEIN-NRI
//
UNIQUE-ID - REG0-9033
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7379
CITATIONS - 17020555
MODE - +
REGULATED-ENTITY - PM0-9640
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-4774
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00015
CITATIONS - 1640456
CITATIONS - 17074904
MODE - -
REGULATED-ENTITY - PM00005
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-5147
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3021
CITATIONS - 8596457
MODE - +
REGULATED-ENTITY - PM327
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5522
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS85
CITATIONS - [8132465]
CITATIONS - 1565612
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00089
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10485
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7767
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM00325
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5894
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6741
CITATIONS - 14731281
MODE - -
REGULATED-ENTITY - PM0-6882
REGULATOR - G7630-MONOMER
//
UNIQUE-ID - REG0-11104
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8086
CITATIONS - 21460078
CITATIONS - 21460078:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3514125112:martin
CITATIONS - 21460078:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3514125112:martin
MODE - -
REGULATED-ENTITY - PM0-36224
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6273
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3384
CITATIONS - 10762278
CITATIONS - 14645248
COMMENT - CdaR responds to the inducers D-glycerate, D-galactarate, D-glucarate, and 2-D-mannosyl-glycerate.
MODE - +
REGULATED-ENTITY - PM0-4702
REGULATOR - EG12335-MONOMER
//
UNIQUE-ID - REG0-12016
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8423
CITATIONS - 24659771
MODE - -
REGULATED-ENTITY - PM0-10155
REGULATOR - EG11084-MONOMER
//
UNIQUE-ID - REG0-9002
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00637
CITATIONS - 2139650
CITATIONS - 9767576
CITATIONS - 15520470
COMMENT - CRP alone activates <i>rpoH</i> transcription, but CytR and CRP act in concert  to repress transcription from  the rpoHp5 promoter. A single CytR molecule binds between two CRP molecules, CRP-CytR-CRP.
MODE - -
REGULATED-ENTITY - PM00088
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4758
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00002
CITATIONS - [3009022]
CITATIONS - 9188491
CITATIONS - 7937881
CITATIONS - 7868601
CITATIONS - 2648001
CITATIONS - 3009022
CITATIONS - 1494347
COMMENT - Ada activates <i>alkA</i> transcription via direct interaction with &sigma;<sup>70</sup> region 4 |CITS:[10049384]|.
MODE - +
REGULATED-ENTITY - PM00002
REGULATOR - PD00230
//
UNIQUE-ID - REG0-5131
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS193
CITATIONS - [9515701]
MODE - +
REGULATED-ENTITY - PM241
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5506
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2265
CITATIONS - [9302022]
CITATIONS - [1315704]
CITATIONS - 10998176
CITATIONS - 12754220
CITATIONS - 8824175
CITATIONS - 16140031
MODE - -
REGULATED-ENTITY - PM00141
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10467
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7368
CITATIONS - 19703465
CITATIONS - 16956381:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3466280544:asantos
CITATIONS - 17120142:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3466280544:asantos
CITATIONS - 16956381:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3466280544:asantos
CITATIONS - 19703465:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3466280544:asantos
CITATIONS - 19703465:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3466280544:asantos
MODE - -
REGULATED-ENTITY - PM0-9621
REGULATOR - G7137-MONOMER
//
UNIQUE-ID - REG0-5878
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00296
CITATIONS - 9209047
CITATIONS - 16140031
CITATIONS - 15699038
CITATIONS - 25161193
MODE - -
REGULATED-ENTITY - PM00149
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11087
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8077
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00295
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6257
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6561
CITATIONS - 1848637
MODE - +
REGULATED-ENTITY - PM0-4621
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11986
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8408
CITATIONS - 24335284
MODE - +
REGULATED-ENTITY - PM0-46310
REGULATOR - CPLX0-7916
//
UNIQUE-ID - REG0-8985
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7227
CITATIONS - 12354237
MODE - -
REGULATED-ENTITY - PM00501
REGULATOR - EG10125-MONOMER
//
UNIQUE-ID - REG0-4741
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00115
CITATIONS - 2664421
MODE - +
REGULATED-ENTITY - PM00048
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5113
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS156
CITATIONS - 1885551
MODE - -
REGULATED-ENTITY - PM221
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5489
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4541
CITATIONS - 1447222
CITATIONS - 2231717
MODE - +
REGULATED-ENTITY - PM00139
REGULATOR - CPLX-172
//
UNIQUE-ID - REG0-10451
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7737
CITATIONS - 9570400
MODE - -
REGULATED-ENTITY - PM331
REGULATOR - PD00196
//
UNIQUE-ID - REG0-5861
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00287
CITATIONS - [9383149]
CITATIONS - [2964639]
MODE - -
REGULATED-ENTITY - PM00143
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11071
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8065
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00606
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6240
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4126
CITATIONS - 14593252
MODE - +
REGULATED-ENTITY - PM0-4922
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11924
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8393
CITATIONS - 23935044
MODE - -
REGULATED-ENTITY - PM0-46064
REGULATOR - G7678-MONOMER
//
UNIQUE-ID - REG0-8934
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7341
CITATIONS - 15522088
CITATIONS - 17209026
COMMENT - Autoregulation of SgrR is not affected by stress |CITS:[17209026]|.
MODE - -
REGULATED-ENTITY - PM0-9592
REGULATOR - EG12094-MONOMER
//
UNIQUE-ID - REG0-4725
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00107
MODE - -
REGULATED-ENTITY - PM00046
REGULATOR - PC00010
//
UNIQUE-ID - REG0-5097
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2182
CITATIONS - 10766858
COMMENT - This site of IHF binding is also used to regulate the divergent paaZp promoter.
MODE - +
REGULATED-ENTITY - PM5
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5472
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS282
CITATIONS - [7751276]
MODE - +
REGULATED-ENTITY - PM00129
REGULATOR - PD00353
//
UNIQUE-ID - REG0-10396
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7716
CITATIONS - 16857675
MODE - +
REGULATED-ENTITY - PM0-10021
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5845
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00348
CITATIONS - 7961413
MODE - +
REGULATED-ENTITY - PM00194
REGULATOR - MONOMER0-164
//
UNIQUE-ID - REG0-11054
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8049
CITATIONS - 21421764
MODE - +
REGULATED-ENTITY - PM0-36218
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6224
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3882
MODE - -
REGULATED-ENTITY - PM0-5221
REGULATOR - PD03585
//
UNIQUE-ID - REG0-11891
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8377
CITATIONS - 23873909
MODE - -
REGULATED-ENTITY - PM00063
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6599
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7200
CITATIONS - 16377617
COMMENT - By making use of micro arrays analyseis, Constantinidou et al. |CITS: [16377617]| concluded that FNR represses <i>ysgA</i> gene expression. They also identified a putative FNR- binding site upstream of the gene, but the sequence was not shown.
MODE - -
REGULATED-ENTITY - PM0-9097
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4709
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00265
CITATIONS - 9556617
CITATIONS - 3062177
MODE - -
REGULATED-ENTITY - PM00041
REGULATOR - CPLX0-7715
//
UNIQUE-ID - REG0-5081
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7249
CITATIONS - 17233826
MODE - +
REGULATED-ENTITY - PM00547
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5455
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00239
CITATIONS - 1917830
COMMENT - Lrp regulates the <i>tdh-kbl</i> operon in a leucine-dependent manner |CITS: [1917830]|.
MODE - +
REGULATED-ENTITY - PM00115
REGULATOR - PD00353
//
UNIQUE-ID - REG0-10331
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7701
CITATIONS - 19245365
MODE - +
REGULATED-ENTITY - PM0-10357
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5829
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3181
CITATIONS - 8071201
MODE - +
REGULATED-ENTITY - PM00367
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11030
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8037
CITATIONS - 18501926
MODE - -
REGULATED-ENTITY - PM0-9527
REGULATOR - CPLX0-7791
//
UNIQUE-ID - REG0-6208
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7300
CITATIONS - 8106311
CITATIONS - 21572102
MODE - -
REGULATED-ENTITY - PM00134
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-11809
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8361
CITATIONS - 23564175
COMMENT - The regulation of CpxR on the <i>ygaU</i> gene has been probed by quantitative PCR analysis of cDNA and by the identification of a consensus DNA-binding site of CpxR in the regulatory region of <i>ygaU</i> |CITS:[ 23564175]|. The identification of this DNA-binding site was only mentioned in the paper of Raivio et al. (2013), but the DNA sequence was not shown |CITS:[ 23564175]|.
MODE - +
REGULATED-ENTITY - PM0-45451
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-6583
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7211
CITATIONS - 8021189
MODE - -
REGULATED-ENTITY - PM0-8864
REGULATOR - CPLX0-7425
//
UNIQUE-ID - REG0-4692
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6222
CITATIONS - 1521763
MODE - +
REGULATED-ENTITY - PM00039
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5065
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS328
CITATIONS - [7651327]
MODE - -
REGULATED-ENTITY - PM446
REGULATOR - PC00010
//
UNIQUE-ID - REG0-5439
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7316
CITATIONS - 9582281
MODE - -
REGULATED-ENTITY - PM00161
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10259
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7684
CITATIONS - 11115104
MODE - +
REGULATED-ENTITY - PM00202
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5813
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7029
CITATIONS - 15995204
MODE - -
REGULATED-ENTITY - PM00220
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-10985
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8028
CITATIONS - 12730179
CITATIONS - 16980449
CITATIONS - 12446650
MODE - +
REGULATED-ENTITY - PM450
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6192
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4102
CITATIONS - 14996803
CITATIONS - 12644495
MODE - +
REGULATED-ENTITY - PM0-5402
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11745
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8346
CITATIONS - 23274360
MODE - +
REGULATED-ENTITY - PM0-36186
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-6566
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7021
CITATIONS - 12754220
COMMENT - By making use of microarray analyses it was concluded that FNR activates <i>acrEF</i> operon expression under anaerobiosis. A putative FNR-binding site, which was not reported in the paper, was identified upstream of this operon |CITS: [12754220]|.
MODE - +
REGULATED-ENTITY - PM0-8727
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4676
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00089
CITATIONS - 1556120
CITATIONS - 1372899
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM00037
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9993
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7656
CITATIONS - 15313253
MODE - -
REGULATED-ENTITY - PM0-1881
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5049
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6182
CITATIONS - 12754220
COMMENT - FNR represses the <i>rplM-rps</i> operon expression under anaerobiosis. A putative FNR-binding site, which was not shown in the paper, was identified upstream of this operon |CITS: [12754220]|.
MODE - -
REGULATED-ENTITY - PM404
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5423
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2847
CITATIONS - 8253679
CITATIONS - 21673794
COMMENT - CRP is not essential for osmotic induction of <i>osmY</i>.
MODE - -
REGULATED-ENTITY - PM00529
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10132
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7671
CITATIONS - 18083817
CITATIONS - 14702398
COMMENT - GadE is the main activator of the <i>hdeAB-yhiD</i> operon. Both H-NS and GadE are involved in increasing the <i>hdeAB-yhiD</i> repression levels by MarA that occur as the cell enters the stationary phase |CITS: [18083817]|.
MODE - +
REGULATED-ENTITY - PM928
REGULATOR - EG11544-MONOMER
//
UNIQUE-ID - REG0-5797
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS749
CITATIONS - [9308170]
MODE - -
REGULATED-ENTITY - PM00218
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10969
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8020
CITATIONS - 21314918	
MODE - -
REGULATED-ENTITY - PM00494
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6174
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4462
CITATIONS - 15489450
MODE - +
REGULATED-ENTITY - PM0-5982
REGULATOR - EG11544-MONOMER
//
UNIQUE-ID - REG0-11662
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8333
CITATIONS - 23092251
MODE - -
REGULATED-ENTITY - PM00465
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-6546
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7049
CITATIONS - 16194231
MODE - +
REGULATED-ENTITY - PM-8770
REGULATOR - MONOMER0-2741
//
UNIQUE-ID - REG0-4660
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00074
CITATIONS - 9016640
CITATIONS - 14500788
CITATIONS - 15289461
COMMENT - In the total absence of galactose, HU and GalR repress the expression of the <i>gal</i> operon. But at low concentrations of galactose, GalR, bound to just one site at position -55.5,  activates the expression of the operon through the galp2 promoter |CITS: [16524589]|.
MODE - +
REGULATED-ENTITY - PM00033
REGULATOR - MONOMER-52
//
UNIQUE-ID - REG0-9782
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7646
CITATIONS - 18673442
MODE - +
REGULATED-ENTITY - PM0-10219
REGULATOR - PD04418
//
UNIQUE-ID - REG0-5033
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3382
CITATIONS - 10762278
CITATIONS - 14645248
COMMENT - CdaR responds to the inducers D-glycerate, D-galactarate, D-glucarate, and 2-D-mannosyl-glycerate.
MODE - +
REGULATED-ENTITY - PM582
REGULATOR - EG12335-MONOMER
//
UNIQUE-ID - REG0-5407
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6954
CITATIONS - 15659676
MODE - +
REGULATED-ENTITY - PM00228
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5781
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS325
CITATIONS - 12923080
CITATIONS - 2168848
CITATIONS - 8501030
CITATIONS - 9302020
MODE - +
REGULATED-ENTITY - PM00217
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-10949
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8006
CITATIONS - 21239586
MODE - -
REGULATED-ENTITY - PM00243
REGULATOR - CPLX0-7672
//
UNIQUE-ID - REG0-6158
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6321
CITATIONS - 1629168
CITATIONS - 1577702
COMMENT - The <i>dinG</i> sequence breaks the pattern of the binding site for the LexA repressor, since it takes the form TTG(N10)CAG instead of CTG(N10)CAG.
MODE - -
REGULATED-ENTITY - PM0-6601
REGULATOR - PC00010
//
UNIQUE-ID - REG0-11643
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8321
CITATIONS - 23071782
MODE - +
REGULATED-ENTITY - PM0-10045
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-6530
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-861
CITATIONS - [9573216]
CITATIONS - 11101675
CITATIONS - 15659676
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00343
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4644
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00066
CITATIONS - 8057356
MODE - -
REGULATED-ENTITY - PM00030
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9600
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7630
CITATIONS - 2864330
CITATIONS - Suzuki03
MODE - +
REGULATED-ENTITY - PM00153
REGULATOR - CPLX0-7733
//
UNIQUE-ID - REG0-5017
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS404
CITATIONS - 8661925
MODE - +
REGULATED-ENTITY - PM526
REGULATOR - MONOMER0-183
//
UNIQUE-ID - REG0-5391
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7340
CITATIONS - 16952953
COMMENT - The regulation of CpxR on the rpoHp1 promoter was observed under the stress condition caused by the introduction of the R1-16 plasmid that encodes the type V secretion system (T4S machinery) in the cell |CITS:[16952953]|.
MODE - +
REGULATED-ENTITY - PM00570
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-5765
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-13
CITATIONS - 15686558
MODE - +
REGULATED-ENTITY - PM0-8261
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-10924
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7992
CITATIONS - 21034467
MODE - -
REGULATED-ENTITY - PM0-36140
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6141
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7181
CITATIONS - 16140472
MODE - -
REGULATED-ENTITY - PM00499
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11625
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8303
CITATIONS - 23233451
MODE - -
REGULATED-ENTITY - TU0-13069
REGULATOR - G6444-MONOMER
//
UNIQUE-ID - REG0-6514
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3729
CITATIONS - 12588863
COMMENT - Fis binding to site I and II can coactivate ptsGp1 transcription with CRP.
MODE - -
REGULATED-ENTITY - PM0-1302
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4628
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1661
CITATIONS - [11279109]
COMMENT - CRP activates the fisP1 promoter in the absence of FIS, but if FIS is present, together FIS and CRP repress <i>fis</i> gene transcription.
MODE - +
REGULATED-ENTITY - PM00028
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9576
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7614
CITATIONS - 11321589
MODE - -
REGULATED-ENTITY - PM437
REGULATOR - CPLX0-7418
//
UNIQUE-ID - REG0-5000
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS342
CITATIONS - [8002608]
CITATIONS - 1346534
MODE - -
REGULATED-ENTITY - PM00631
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5375
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3474
CITATIONS - 14711822
MODE - -
REGULATED-ENTITY - PM00293
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5749
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00409
CITATIONS - 2000372
MODE - +
REGULATED-ENTITY - PM00235
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-10904
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7976
COMMENT - This binding site was determined from  a computational prediction based on different statistical methods |CITS:[21070640]|. The function of the binding site was assigned according to the distance from the transcription start, with NagC as the transcriptional repressor.
MODE - -
REGULATED-ENTITY - PM00633
REGULATOR - PD00266
//
UNIQUE-ID - REG0-6125
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5501
CITATIONS - 1848300
CITATIONS - 12867454
CITATIONS - 2163388
MODE - +
REGULATED-ENTITY - PM0-7163
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11588
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8289
CITATIONS - 6397402
CITATIONS - 6397402:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3554841652:asantos
MODE - +
REGULATED-ENTITY - PM00371
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6497
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5921
MODE - -
REGULATED-ENTITY - PM0-1283
REGULATOR - CPLX0-7708
//
UNIQUE-ID - REG0-4612
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7276
CITATIONS - 16861804
CITATIONS - 23564175
MODE - +
REGULATED-ENTITY - PM0-9400
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-9532
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7598
CITATIONS - 11350954
CITATIONS - 18375564
MODE - +
REGULATED-ENTITY - PM0-10215
REGULATOR - PHOSPHO-CREB
//
UNIQUE-ID - REG0-4982
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6041
CITATIONS - 7007313
MODE - -
REGULATED-ENTITY - PM101
REGULATOR - PD03270
//
UNIQUE-ID - REG0-5358
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7000
CITATIONS - 15743952
CITATIONS - 20466769
MODE - -
REGULATED-ENTITY - PM00536
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-5733
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00651
CITATIONS - 1848637
CITATIONS - 9484892
COMMENT - Previously, two binding sites for the NagC repressor were detected upstream  from  <i>manX</i>, but a mutation in <i>nagC</i> had very little effect on <i>manX</i> expression. Plasmids overproducing either the NagC protein or the Mlc protein repress the expression of <i>manX</i>, but the effect on  the  Mlc protein is stronger. NagC binds more tightly to the  -79 position than to the  -13 position |CITS: [1848637], [9484892]|.
MODE - -
REGULATED-ENTITY - PM00276
REGULATOR - PD00266
//
UNIQUE-ID - REG0-10888
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7961
CITATIONS - 21115656
MODE - -
REGULATED-ENTITY - PM0-9591
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6109
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7042
CITATIONS - 15699038
COMMENT - Salmon et al. |CITS: [15699038]| identified a putative ArcA-binding site  upstream of the rpsJp promoter, but the sequence was not reported.
MODE - -
REGULATED-ENTITY - PM00444
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11567
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8275
CITATIONS - 16478729
MODE - -
REGULATED-ENTITY - PM0-8184
REGULATOR - PD00406
//
UNIQUE-ID - REG0-6481
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5201
MODE - +
REGULATED-ENTITY - PM0-1123
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4594
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7035
CITATIONS - 16077119
CITATIONS - 23564175
COMMENT - Repression of <i>ompF</i> by CpxR could result from prevention of either OmpR or RNA polymerase binding |CITS: [16077119]|.
MODE - -
REGULATED-ENTITY - PM00066
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-9465
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7585
CITATIONS - 18227264
MODE - -
REGULATED-ENTITY - PM0-10196
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-4966
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS563
CITATIONS - 11053378
CITATIONS - 14996792
MODE - +
REGULATED-ENTITY - PM681
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5341
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00700
CITATIONS - 7715459
MODE - -
REGULATED-ENTITY - PM00620
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5715
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS65
CITATIONS - 7551052
CITATIONS - 8195106
CITATIONS - 3135464
CITATIONS - 6309813
MODE - +
REGULATED-ENTITY - PM00272
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10853
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7944
CITATIONS - 20874755
COMMENT - The MlrA-<i>cadC</i>p regulatory interaction was identified by sequence analysis reported by Ogasawara et al., and by a gel shift assay using purified transcription factor (data not provided) |CITS[20874755]|.
MODE - +
REGULATED-ENTITY - PM00159
REGULATOR - EG12008-MONOMER
//
UNIQUE-ID - REG0-6093
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6101
CITATIONS - 9023215
CITATIONS - 21115656
MODE - -
REGULATED-ENTITY - PM0-7761
REGULATOR - PC00061
//
UNIQUE-ID - REG0-11522
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8256
CITATIONS - 17120142
MODE - -
REGULATED-ENTITY - PM0-9620
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6465
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2564
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1347
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4576
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2425
CITATIONS - 8002608
CITATIONS - 1346534
COMMENT - Binding of Lrp to one site enhances occupancy of the other Lrp sites  in the  ompCp1 promoter. Leucine does not abolish  DNA binding by the ligated Lrp but it may alter the affinity of Lrp for specific sites on DNA.
MODE - -
REGULATED-ENTITY - PM00065
REGULATOR - PD00353
//
UNIQUE-ID - REG0-9413
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7568
CITATIONS - 12904577
MODE - -
REGULATED-ENTITY - PM0-9892
REGULATOR - CPLX0-7680
//
UNIQUE-ID - REG0-4950
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS501
CITATIONS - [8900118]
COMMENT - L-Leucine inhibits but does not abolish Lrp binding to its primary and secondary sites in the leader region of the ilvLG_1G_2MEDA.
MODE - -
REGULATED-ENTITY - PM00475
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5325
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1924
MODE - -
REGULATED-ENTITY - PM00598
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-5699
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00511
COMMENT - TdcA is able to activate in <i>trans</i> and might play a dominant  role over TdcR in transcriptional regulation of the <i>tdc</i> genes. TdcA might form stable dimers (or multimers) without TdcR.
MODE - +
REGULATED-ENTITY - PM00168
REGULATOR - PD00268
//
UNIQUE-ID - REG0-10820
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7928
CITATIONS - 2180912
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00089
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6076
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6361
CITATIONS - 1577702
COMMENT - The <i>polB </i> (<i> dinA</i>) regulatory region contains both a perfect match to the LexA-binding site and sequences with the extended dyad symmetry (CTGT....ACAG) seen in the consensus sequence for LexA operators.
MODE - -
REGULATED-ENTITY - PM0-7961
REGULATOR - PC00010
//
UNIQUE-ID - REG0-11505
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8248
CITATIONS - 8824175
MODE - +
REGULATED-ENTITY - PM0-3343
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6449
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2542
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1341
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4560
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-941
CITATIONS - [9819053]
CITATIONS - 21890697
MODE - +
REGULATED-ENTITY - PM00063
REGULATOR - CPLX0-7669
//
UNIQUE-ID - REG0-9391
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7552
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM00084
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4934
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS767
CITATIONS - [9421904]
MODE - -
REGULATED-ENTITY - PM263
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5309
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00656
CITATIONS - 21572102
CITATIONS - 3058704
CITATIONS - 3058703
CITATIONS - 2198266
CITATIONS - 2404765
MODE - -
REGULATED-ENTITY - PM00629
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-5683
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3341
CITATIONS - 8830277
MODE - +
REGULATED-ENTITY - PM00191
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10804
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7912
CITATIONS - 8034727
MODE - +
REGULATED-ENTITY - PM00208
REGULATOR - MONOMER0-183
//
UNIQUE-ID - REG0-6058
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6804
CITATIONS - 2543976
MODE - -
REGULATED-ENTITY - PM0-8601
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-11487
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8231
CITATIONS - 22323519
CITATIONS - 18765794
MODE - -
REGULATED-ENTITY - PM0-36161
REGULATOR - EG11356-MONOMER
//
UNIQUE-ID - REG0-6433
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7221
CITATIONS - 2465204
COMMENT - A putative CRP-bindig site was identified at bp  -32.5 upstream of  gdhAp. The regulatory effect of this possible interaction of CRP with the site is not known. However, we assigned a negative effect to this regulatory interaction based on the fact that the position of the site is not optimal for activation of transcription by CRP.  This site is located between the  -10 and  -35 boxes of  the promoter |CITS: [2465204]|.
MODE - -
REGULATED-ENTITY - PM00379
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4544
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7108
CITATIONS - 15520470
MODE - -
REGULATED-ENTITY - PM00062
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9374
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7535
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM681
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4918
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS624
CITATIONS - [9852003]
MODE - -
REGULATED-ENTITY - PM00625
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5293
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS442
CITATIONS - [8955407]
CITATIONS - [10216857]
MODE - -
REGULATED-ENTITY - PM00540
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5667
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7314
CITATIONS - 9582281
MODE - -
REGULATED-ENTITY - PM0-9554
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10776
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7898
CITATIONS - 20543070
MODE - +
REGULATED-ENTITY - PM0-36133
REGULATOR - G7563-MONOMER
//
UNIQUE-ID - REG0-6042
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7174
CITATIONS - 16491024
CITATIONS - 3163049
CITATIONS - 21034467
COMMENT - Hns repress the <i>cadB</i> promoter at pH 8.0
MODE - -
REGULATED-ENTITY - PM00622
REGULATOR - PD00288
//
UNIQUE-ID - REG0-11470
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8218
CITATIONS - 17513476
REGULATED-ENTITY - PM00293
REGULATOR - PD00221
//
UNIQUE-ID - REG0-6415
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7152
CITATIONS - 16377617
MODE - +
REGULATED-ENTITY - PM0-1727
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4528
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6927
CITATIONS - 8057356
MODE - +
REGULATED-ENTITY - PM00061
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9357
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7519
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM00026
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4901
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1123
CITATIONS - [9924977]
CITATIONS - [7715442]
MODE - -
REGULATED-ENTITY - PM00242
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5277
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00614
COMMENT - The positive effect of the cAMP-CRP complex is seen only  together  with DsdC. Thus, CRP cannot act on its own in this system.
MODE - +
REGULATED-ENTITY - PM00516
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5651
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3425
CITATIONS - 14711822
MODE - +
REGULATED-ENTITY - PM00528
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10751
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7884
CITATIONS - 12067348
CITATIONS - 21097628
MODE - +
REGULATED-ENTITY - PM0-2281
REGULATOR - PD00406
//
UNIQUE-ID - REG0-6026
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS827
CITATIONS - [11101674]
COMMENT - <i>yeiL</i> expression is partly dependent on IHF in the absence of Fnr.
MODE - +
REGULATED-ENTITY - PM1021
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11425
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8199
CITATIONS - 10216857
CITATIONS - 8955407:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3538187392:martin
CITATIONS - 8955407:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3538187392:martin
CITATIONS - 10216857:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3538187392:martin
CITATIONS - 10216857:EV-EXP-IMP-SITE-MUTATION:3538187392:martin
CITATIONS - 10216857:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3538187392:martin
CITATIONS - 10216857:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3538187392:martin
MODE - -
REGULATED-ENTITY - PM562
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6399
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3353
CITATIONS - 15773991
MODE - +
REGULATED-ENTITY - PM0-2002
REGULATOR - MONOMER0-4180
//
UNIQUE-ID - REG0-4512
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6561
CITATIONS - 1848637
COMMENT - CAP and NagC can bind simultaneously and produce a  more stable complex than binary NagC-DNA complex. This is a weak CAP  binding site.
MODE - +
REGULATED-ENTITY - PM00058
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9328
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7496
CITATIONS - 17768236
CITATIONS - 17768236:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3411311065:asantos
CITATIONS - 17768236:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3411311065:asantos
MODE - +
REGULATED-ENTITY - PM00039
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4885
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5943
CITATIONS - 8982002
MODE - -
REGULATED-ENTITY - PM00032
REGULATOR - PD00261
//
UNIQUE-ID - REG0-5261
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7056
CITATIONS - 15941987
CITATIONS - 7961507
CITATIONS - 21685294
MODE - +
REGULATED-ENTITY - PM00563
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-5635
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00659
CITATIONS - 12754220
CITATIONS - 21272324
COMMENT - |CITS: [12754220]| did not find an FNR site in the <i>nuo</i> promoter region, but  Bongaerts et al. |CITS: [7565112]| did. Therefore, we do not know if  the FNR-mediated repression of this promoter under anaerobiosis is direct or indirect.
MODE - -
REGULATED-ENTITY - PM00592
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10710
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7866
CITATIONS - 20156994
MODE - +
REGULATED-ENTITY - PM0-10539
REGULATOR - CPLX0-8048
//
UNIQUE-ID - REG0-6010
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS841
CITATIONS - [8444794]
CITATIONS - 23274360
MODE - +
REGULATED-ENTITY - PM00362
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-11403
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00234
CITATIONS - [8429549]
CITATIONS - 8508774
CITATIONS - 8071194
CITATIONS - 8483418
CITATIONS - 8429549:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537794855:martin
CITATIONS - 8429549:EV-EXP-IMP-SITE-MUTATION:3537794855:martin
CITATIONS - 8429549:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537794855:martin
CITATIONS - 8429549:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537794855:martin
CITATIONS - 2115869:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537794855:martin
CITATIONS - 2115869:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537794855:martin
CITATIONS - 2646291:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537794855:martin
CITATIONS - 8508774:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537794855:martin
CITATIONS - 8508774:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537794855:martin
CITATIONS - 8071194:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537794855:martin
CITATIONS - 8071194:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537794855:martin
CITATIONS - 8483418:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537794855:martin
CITATIONS - 8483418:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537794855:martin
CITATIONS - 8432705:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537794855:martin
CITATIONS - 8432705:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537794855:martin
CITATIONS - 12218014:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537794855:martin
CITATIONS - 12218014:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537794855:martin
CITATIONS - 3891724:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537794855:martin
CITATIONS - 1447135:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537794855:martin
MODE - -
REGULATED-ENTITY - PM00323
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6383
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1984
CITATIONS - [10411720]
MODE - -
REGULATED-ENTITY - PM0-2701
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4495
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4622
CITATIONS - 10760178
CITATIONS - 11742992
CITATIONS - 15520470
CITATIONS - 16621812
MODE - +
REGULATED-ENTITY - PM00050
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9308
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2743
CITATIONS - 11929525
CITATIONS - 15978080
CITATIONS - 14651625
MODE - -
REGULATED-ENTITY - PM0-3923
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4868
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4422
CITATIONS - 8120010
CITATIONS - 11673423
CITATIONS - 8763946
MODE - -
REGULATED-ENTITY - PM00423
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5244
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS55
CITATIONS - [3326786]
CITATIONS - [9236118]
CITATIONS - 17233899
COMMENT - Lrp activates the <i>gltBDF</i> operon in a leucine-insensitive manner |CITS:[7901196]|, binding at three sites distant to the &sigma;<sup>70</sup> promoter. This is a strange way of regulating a &sigma;<sup>70</sup> promoter, since Lrp should bind close to the promoter in order to regulate, and so it is helped by IHF (the DNA-bending protein) binding between the proximal Lrp site and the promoter, bending this DNA region and getting Lrp closer to &sigma;<sup>70</sup> to activate the transcription |CITS:[11395454]|. (Lrp is just a modulator of the operon expression; it does not work as the common activators/repressors that switch the gene expression in an on/off manner. In addition, it is sometimes insensitive to the presence of leucine to have its modulator effect |CITS:[7968922]|.)
MODE - +
REGULATED-ENTITY - PM00254
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5619
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00616
CITATIONS - 8102362
COMMENT - mRNA from isogenic himA<sup>+</sup> and <i>himA</i>::Tn<i>10</i> (SR69 and SR1021) strains or from <i>himD</i> mutant bacteria (SR1022) was isolated and studied. The primer extension results showed comparatively low levels of mRNA transcripts initiating from all three putative promoters. Thus, it is clear that functional IHF is needed for efficient transcription of the <i>ecp-htrE</i> operon.
MODE - +
REGULATED-ENTITY - PM00553
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10677
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7852
CITATIONS - 11443092
MODE - -
REGULATED-ENTITY - PM0-8081
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5994
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1461
CITATIONS - [10102373]
CITATIONS - [8709966]
CITATIONS - [10564485]
MODE - +
REGULATED-ENTITY - PM181
REGULATOR - PD00406
//
UNIQUE-ID - REG0-11371
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8177
CITATIONS - 22101843
CITATIONS - 22101843:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3535222653:asantos
MODE - -
REGULATED-ENTITY - PM0-10377
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-6367
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1766
CITATIONS - [12169620]
CITATIONS - [12218041]
CITATIONS - 16515535
MODE - -
REGULATED-ENTITY - PM0-2482
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-4479
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7285
CITATIONS - 9837718
MODE - +
REGULATED-ENTITY - PM0-9414
REGULATOR - PC00027
//
UNIQUE-ID - REG0-9276
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7477
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00229
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4852
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3681
CITATIONS - 14702328
COMMENT - CRP and anaerobiosis are required for  the hyf operon expression when the HyfR protein is the activator |CITS: [14702328]|.
MODE - +
REGULATED-ENTITY - PM787
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5228
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00741
MODE - +
REGULATED-ENTITY - PM00449
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5602
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00720
CITATIONS - 19054084
CITATIONS - 20141531
COMMENT - CRP site 2 (-101.5) plays little or no role in CRP-dependent activation of the <i>malX</i> promoter. It might function synergistically with the downstream bound CRP, site 1 (-41.5) |CITS:[19054084]|.
MODE - +
REGULATED-ENTITY - PM00177
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10658
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7841
CITATIONS - 19897902
MODE - -
REGULATED-ENTITY - PM0-10266
REGULATOR - CPLX0-7745
//
UNIQUE-ID - REG0-5978
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00736
MODE - +
REGULATED-ENTITY - PM00298
REGULATOR - PHOSPHO-TORR
//
UNIQUE-ID - REG0-11324
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8164
CITATIONS - 9819053
MODE - +
REGULATED-ENTITY - PM00063
REGULATOR - CPLX0-7669
//
UNIQUE-ID - REG0-6351
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2061
CITATIONS - [11972787]
CITATIONS - [10094691]
CITATIONS - [12644490]
CITATIONS - [10692164]
CITATIONS - 12029051
MODE - -
REGULATED-ENTITY - PM0-2881
REGULATOR - PD00214
//
UNIQUE-ID - REG0-12387
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8507
CITATIONS - 26527647
MODE - -
REGULATED-ENTITY - PM00004
REGULATOR - MONOMER0-165
//
UNIQUE-ID - REG0-9256
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7462
CITATIONS - 17892462
MODE - +
REGULATED-ENTITY - PM681
REGULATOR - G6882-MONOMER
//
UNIQUE-ID - REG0-4836
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7080
CITATIONS - 14701822
COMMENT - MarA plays a very important role in the complex negative regulation of the <i>hdeAB-yhiD</i> operon during the stationary phase and acid resistance that depends on the growth conditions, on other regulators of <i>hdeAB-yhiD</i> expression, and on the degree of induction of <i>marA</i> expression. MarA also controls it, by modifying the effects of the other regulators. This transcriptional regulator binds to a \ marbox\  partially overlapping the -35 box of the hdeAp promoter, competing with the RNA polymerase for DNA binding and/or direct interactions between MarA and &sigma;<sup>70</sup>, &sigma;<sup>38</sup>, or other subunits of RNA polymerase. In addition, several putative binding sites are located near the \ marbox\ . MarA reduces the repression caused by GadX and Lrp during exponential phase and it helps H-NS repression, although it is not clear how. On the other hand, MarA reduces the ability of GadE to activate the <i>hdeAB-yhiD</i> operon during the stationary phase, since they compete for DNA binding or for interacting. This regulator also reduces the repression caused by GadW during stationary phase. Finally, MarA seems to compete functionally with GadX, GadW, RpoS, and Lrp under some conditions, which might ensure that <i>hdeAB-yhiD</i> expression is not repressed more than necessary |CITS: [18083817]|.
MODE - -
REGULATED-ENTITY - PM928
REGULATOR - PD00365
//
UNIQUE-ID - REG0-5211
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2429
CITATIONS - 8034583
CITATIONS - 11601842
MODE - +
REGULATED-ENTITY - PM00401
REGULATOR - PD00406
//
UNIQUE-ID - REG0-5584
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00687
CITATIONS - 7642497
MODE - -
REGULATED-ENTITY - PM00184
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10602
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7826
CITATIONS - 20015147
MODE - +
REGULATED-ENTITY - PM0-10490
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-5962
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2743
CITATIONS - 11929525
CITATIONS - 15978080
COMMENT - Fis binding to this site weakly represses the nrfAp promoter and strongly represses acsP1, a promoter that overlaps and is divergent to nrfAp. 
/
/Either IHF or Fis can repress FNR-dependent open complex formation. NarL binding to its target reverses IHF-dependent repression but does not relieve Fis-dependent repression |CITS: [15978080]|.
MODE - -
REGULATED-ENTITY - PM00280
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-11266
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8148
CITATIONS - 11350954
MODE - +
REGULATED-ENTITY - PM0-10095
REGULATOR - PHOSPHO-CREB
//
UNIQUE-ID - REG0-6335
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2462
CITATIONS - 12617754
CITATIONS - 23531166
COMMENT - The regulatory effect of NtrC on the promoter <i>patA</i>p is as yet not known |CITS: [12617754]|. However, we assigned a positive role to this regulatory interaction based on the facts that NtrC activates &sigma;<sup>54</sup> promoters and the promoter <i>patA</i>p is one of them.
MODE - +
REGULATED-ENTITY - PM0-3521
REGULATOR - GLNG-CPLX
//
UNIQUE-ID - REG0-12296
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8488
CITATIONS - 26078445
MODE - -
REGULATED-ENTITY - PM0-46352
REGULATOR - G7947-MONOMER
//
UNIQUE-ID - REG0-9162
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7445
CITATIONS - 17850814
MODE - -
REGULATED-ENTITY - PM0-9577
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-4819
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00058
CITATIONS - 12079504
COMMENT - There are several putative NarL-binding sites, but only  three of them have a NarL consensus with only one 
/mismatch |CITS:[12079504]|.
MODE - -
REGULATED-ENTITY - PM00026
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5195
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6975
CITATIONS - 7601827
MODE - -
REGULATED-ENTITY - PM00354
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5567
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS154
CITATIONS - 1310090
MODE - +
REGULATED-ENTITY - PM00247
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10573
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7810
CITATIONS - 19734316
MODE - -
REGULATED-ENTITY - PM0-10449
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5942
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00485
CITATIONS - 23274360
MODE - +
REGULATED-ENTITY - PM00285
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-6319
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2682
CITATIONS - 11121068
MODE - +
REGULATED-ENTITY - PM0-3822
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-11251
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8135
CITATIONS - 15686558
MODE - +
REGULATED-ENTITY - PM0-10482
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-6316
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5862
MODE - +
REGULATED-ENTITY - PM0-3802
REGULATOR - MONOMER0-2421
//
UNIQUE-ID - REG0-11245
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8130
CITATIONS - 11953442
MODE - -
REGULATED-ENTITY - PM00535
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-12219
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8474
CITATIONS - 25790494
MODE - -
REGULATED-ENTITY - PM0-46339
REGULATOR - G6976-MONOMER
//
UNIQUE-ID - REG0-9079
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5523
CITATIONS - 15534208
CITATIONS - 17238917
MODE - +
REGULATED-ENTITY - PM00560
REGULATOR - G7678-MONOMER
//
UNIQUE-ID - REG0-4800
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00041
CITATIONS - 2644221
CITATIONS - 11101675
CITATIONS - 17526711
MODE - -
REGULATED-ENTITY - PM00019
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-5176
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00798
MODE - +
REGULATED-ENTITY - PM00350
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5548
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00212
MODE - -
REGULATED-ENTITY - PM00100
REGULATOR - PC00010
//
UNIQUE-ID - REG0-10519
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7794
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM0-10441
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5923
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS450
CITATIONS - [8636021]
CITATIONS - [10564485]
COMMENT - This site also  can  be activated by MarA. Sequences between  -91 to  -74  play an \ accesory\  role in MarR and SoxS transcriptional activation and MarA binding  to the <i>marR</i> promoter.
MODE - +
REGULATED-ENTITY - PM00265
REGULATOR - PD00406
//
UNIQUE-ID - REG0-6300
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2882
CITATIONS - 11292794
MODE - +
REGULATED-ENTITY - PM0-4141
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11217
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8116
CITATIONS - 11071896
MODE - -
REGULATED-ENTITY - PM623
REGULATOR - EG10571-MONOMER
//
UNIQUE-ID - REG0-12152
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8453
CITATIONS - 25406449
MODE - -
REGULATED-ENTITY - TU0-8702
REGULATOR - G6745-MONOMER
//
UNIQUE-ID - REG0-9047
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7392
CITATIONS - 17468243
MODE - -
REGULATED-ENTITY - PM00066
REGULATOR - PHOSPHO-RSTA
//
UNIQUE-ID - REG0-4787
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00025
CITATIONS - 1970563
MODE - -
REGULATED-ENTITY - PM00011
REGULATOR - MONOMER0-163
//
UNIQUE-ID - REG0-5160
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7149
CITATIONS - 16377617
CITATIONS - 12754220
MODE - +
REGULATED-ENTITY - PM339
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5535
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00203
MODE - -
REGULATED-ENTITY - PM00092
REGULATOR - PC00010
//
UNIQUE-ID - REG0-10503
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7779
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM00252
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5907
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00767
CITATIONS - 7768815
MODE - -
REGULATED-ENTITY - PM00187
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-6283
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2701
CITATIONS - 11121068
MODE - +
REGULATED-ENTITY - PM0-3847
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-11118
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8098
CITATIONS - 16377617
COMMENT - By making use of microarray analyses, Constantinidou et al. |CITS:[16377617]|
/concluded that FNR represses ycaC gene expression. They also identified a putative FNR-binding site upstream of the gene, but the sequence was not reported.
/
MODE - -
REGULATED-ENTITY - TU-8382
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-12109
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8437
CITATIONS - 25176444
MODE - -
REGULATED-ENTITY - PM00265
REGULATOR - EG12116-MONOMER
//
UNIQUE-ID - REG0-9016
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3728
CITATIONS - 12588863
COMMENT - Fis binding to site I and II can coactivate ptsGp1 transcription with CRP.
MODE - -
REGULATED-ENTITY - PM0-1301
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4771
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4503
CITATIONS - 9409145
MODE - -
REGULATED-ENTITY - PM00004
REGULATOR - CPLX-172
//
UNIQUE-ID - REG0-5144
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS118
CITATIONS - [8057842]
CITATIONS - 12754220
CITATIONS - 16377617
COMMENT - FNR affects pdhRp promoter under anaerobic conditions.
MODE - +
REGULATED-ENTITY - PM00324
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5519
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00506
CITATIONS - [8825776]
CITATIONS - 21097628
COMMENT - Stimulation of this promoter was independent of the C-terminal domain of the RNA polymerase &alpha;-subunit. The binding site overlaps the  -35 promoter hexamer.
MODE - +
REGULATED-ENTITY - PM00089
REGULATOR - PD00406
//
UNIQUE-ID - REG0-10482
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7764
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM00415
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5891
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5443
CITATIONS - 14731281
MODE - -
REGULATED-ENTITY - PM0-6881
REGULATOR - G7630-MONOMER
//
UNIQUE-ID - REG0-11101
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8089
CITATIONS - 21460078
CITATIONS - 21460078:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3514118949:martin
CITATIONS - 21460078:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3514118949:martin
MODE - -
REGULATED-ENTITY - PM0-36254
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6270
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4222
CITATIONS - 12586421
COMMENT - NarP or NarL represses the transcription of the <i>nor</i> operon when <i>Escherichia coli</i> is grown with nitrite, which suggests that NarL and NarP proteins are competing with a transcriptional activator which is activated by nitrite and may binds to the nucleotide region in the vicinity of the putative NarL/NarP-binding site |CITS:[12586421]|.
MODE - -
REGULATED-ENTITY - PM0-4681
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-12013
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8420
CITATIONS - 24659771
MODE - -
REGULATED-ENTITY - PM0-1101
REGULATOR - EG11084-MONOMER
//
UNIQUE-ID - REG0-8999
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00664
CITATIONS - 8596434
COMMENT - In the absence of the other proteins, cAMP-CRP binds to three CRP targets centered at -92.5 (CRP2), -42.5 (CRP1), and +56 (CRPE). The importance of CRPE located  within the <i>nupG</i> coding region is at present unknown.
MODE - -
REGULATED-ENTITY - PM00173
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4755
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6953
CITATIONS - 15659676
MODE - -
REGULATED-ENTITY - PM00001
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5128
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3488
CITATIONS - 8892825
CITATIONS - 16980446
MODE - -
REGULATED-ENTITY - PM224
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5503
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS47
CITATIONS - [9302022]
CITATIONS - [8892825]
CITATIONS - [1315704]
CITATIONS - 14711822
CITATIONS - 16140031
CITATIONS - 16980446
MODE - +
REGULATED-ENTITY - PM00141
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10464
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7748
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM00563
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5875
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00319
MODE - +
REGULATED-ENTITY - PM00148
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11084
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8075
CITATIONS - 21272324
MODE - +
REGULATED-ENTITY - PM0-36128
REGULATOR - PD00197
//
UNIQUE-ID - REG0-6253
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3743
CITATIONS - 10760165
COMMENT - FIS-site II overlaps the -35 box.
MODE - -
REGULATED-ENTITY - PM0-5042
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-11983
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8405
CITATIONS - 24335284
MODE - +
REGULATED-ENTITY - PM0-46312
REGULATOR - CPLX0-7916
//
UNIQUE-ID - REG0-8982
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS562
CITATIONS - 11053378
CITATIONS - 14996792
CITATIONS - 17892462
COMMENT - Hns modulates the <i>hlyE</i> expression both positively and negatively; this protein enhances the CRP-mediated expression of <i>hlyE</i> , but it inhibits the FNR-mediated <i>hlyE</i> expression.
/
MODE - -
REGULATED-ENTITY - PM681
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4738
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5101
MODE - +
REGULATED-ENTITY - PM00048
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-5110
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS164
CITATIONS - [9401024]
MODE - +
REGULATED-ENTITY - PM502
REGULATOR - CPLX0-2781
//
UNIQUE-ID - REG0-5486
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2201
CITATIONS - 11094278
CITATIONS - 7836283
MODE - -
REGULATED-ENTITY - PM00137
REGULATOR - PD00365
//
UNIQUE-ID - REG0-10435
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7734
CITATIONS - 19251855
MODE - -
REGULATED-ENTITY - PM0-5721
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5858
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00319
CITATIONS - 15659676
CITATIONS - 15520470
COMMENT - Early work with an <i>sdh-galk</i> fusion indicates that <i>crp</i> and <i>cya</i> are required for maximum expression, and S1 mapping studies not only confirmed that <i>sdh</i> transcription is severely repressed by glucose but indicated that there is a potential CRP-binding site at  -80 in the <i>sdh</i> promoter region.
/This promoter and its CRP-binding site are responsible for the coordinate expression and the glucose-mediated repression of ODH and SCS synthesis. 
MODE - +
REGULATED-ENTITY - PM00143
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11068
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8062
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00147
REGULATOR - PD00197
//
UNIQUE-ID - REG0-6237
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4127
CITATIONS - 14593252
MODE - -
REGULATED-ENTITY - PM0-4921
REGULATOR - PD03585
//
UNIQUE-ID - REG0-11904
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8390
CITATIONS - 24025246
MODE - +
REGULATED-ENTITY - PM0-36236
REGULATOR - PD00406
//
UNIQUE-ID - REG0-6613
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7218
CITATIONS - 14523117
CITATIONS - 21421764
MODE - +
REGULATED-ENTITY - PM0-9308
REGULATOR - PD01379
//
UNIQUE-ID - REG0-4722
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00105
MODE - -
REGULATED-ENTITY - PM00045
REGULATOR - PD00763
//
UNIQUE-ID - REG0-5094
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4022
CITATIONS - 14612240
COMMENT - FNR activates <i>hypB</i> transcription under anaerobiosis.
MODE - +
REGULATED-ENTITY - PM00574
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5468
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00261
CITATIONS - [10197993]
CITATIONS - [3525516]
CITATIONS - 7798138
CITATIONS - 15049824
COMMENT - The TyrR-binding site at position -64.5 from the promoter is a strong TyrR box that is involved in the activation and repression of <i>tyrP</i> gene transcription. The TyrR protein with phenylalanine only binds to this site to activate transcription, whereas the protein with tyrosine binds to this and another weak site (-41.5 from the promoter) to repress the transcription |CITS:[15049824]|.
MODE - -
REGULATED-ENTITY - PM00125
REGULATOR - PD00413
//
UNIQUE-ID - REG0-10393
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7713
CITATIONS - 16857675
MODE - +
REGULATED-ENTITY - PM0-10368
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5842
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6958
CITATIONS - 15659676
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00225
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-11051
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8047
CITATIONS - 21421764
CITATIONS - 21421764:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3513524726:martin
CITATIONS - 21421764:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3513524726:martin
CITATIONS - 21421764:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3513524726:martin
MODE - -
REGULATED-ENTITY - PM-8794
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6221
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3928
MODE - -
REGULATED-ENTITY - PM0-5201
REGULATOR - EG20249-MONOMER
//
UNIQUE-ID - REG0-11826
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8374
CITATIONS - 23475967
MODE - +
REGULATED-ENTITY - PM0-10188
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6596
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7083
CITATIONS - 16428390
CITATIONS - 17449618
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM-8827
REGULATOR - CPLX0-7756
//
UNIQUE-ID - REG0-4705
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00093
CITATIONS - 1556120
CITATIONS - 9179845
MODE - -
REGULATED-ENTITY - PM00039
REGULATOR - PD03576
//
UNIQUE-ID - REG0-5078
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5261
CITATIONS - 7512187
COMMENT - H-NS antagonizes the Fis-mediated activation  of the P1 promoter through conformational changes in the DNA |CITS: [7512187]|.
MODE - -
REGULATED-ENTITY - PM00514
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5452
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00638
MODE - -
REGULATED-ENTITY - PM00114
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10327
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7698
CITATIONS - 8830270
MODE - -
REGULATED-ENTITY - PM0-10354
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-5826
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00181
CITATIONS - 21572102
CITATIONS - 2404765
CITATIONS - 3015935
CITATIONS - 22152010
MODE - -
REGULATED-ENTITY - PM00080
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-11027
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8034
CITATIONS - 21441513
MODE - +
REGULATED-ENTITY - PM340
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6205
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7309
CITATIONS - 16115199
MODE - -
REGULATED-ENTITY - PM00577
REGULATOR - PC00061
//
UNIQUE-ID - REG0-11758
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8359
CITATIONS - 23341772
MODE - -
REGULATED-ENTITY - PM0-46271
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-6580
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7209
CITATIONS - 8021189
MODE - +
REGULATED-ENTITY - PM0-8864
REGULATOR - PC00027
//
UNIQUE-ID - REG0-4689
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS189
CITATIONS - 2403539
MODE - -
REGULATED-ENTITY - PM00038
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5062
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3761
CITATIONS - 13129959
COMMENT - The napFp2 promoter is inhibited by NarL in response to nitrate.
MODE - -
REGULATED-ENTITY - PM444
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5436
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7158
CITATIONS - 16377617
MODE - +
REGULATED-ENTITY - PM00159
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10186
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7681
CITATIONS - 19074390
MODE - +
REGULATED-ENTITY - PM0-10338
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-5810
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00385
CITATIONS - 1957353
COMMENT - This is a weak FNR site.
MODE - +
REGULATED-ENTITY - PM00220
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10982
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8026
CITATIONS - 16980449
CITATIONS - 12446650
CITATIONS - 12730179
MODE - -
REGULATED-ENTITY - PM450
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6189
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3942
CITATIONS - 3934044
CITATIONS - 3079718
COMMENT - Expression of the regulated gene is affected as a result of mutating the regulatory protein. Note that this evidence does not eliminate the possibility of an indirect effect of the regulator on the regulated gene.
MODE - -
REGULATED-ENTITY - PM0-5321
REGULATOR - G6867-MONOMER
//
UNIQUE-ID - REG0-11702
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8343
CITATIONS - 22522900
CITATIONS - 18495664
CITATIONS - 19181795
MODE - -
REGULATED-ENTITY - PM0-10351
REGULATOR - EG12431-MONOMER
//
UNIQUE-ID - REG0-6561
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7022
CITATIONS - 12754220
COMMENT - By making use of microarray analyses, it was concluded that FNR activates <i>bcsBZ</i> operon expression under anaerobiosis. A putative FNR-binding site, which is not shown in the paper, was identified upstream of this operon |CITS: [12754220]|.
MODE - +
REGULATED-ENTITY - PM0-8735
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4673
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00079
CITATIONS - 6148334
MODE - -
REGULATED-ENTITY - PM00035
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-9985
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7653
CITATIONS - 16515535
MODE - -
REGULATED-ENTITY - PM0-10286
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-5046
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS272
CITATIONS - 9371449
MODE - +
REGULATED-ENTITY - PM70
REGULATOR - MONOMER0-165
//
UNIQUE-ID - REG0-5420
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1683
CITATIONS - [10986267]
MODE - +
REGULATED-ENTITY - PM0-2201
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-10099
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7669
CITATIONS - 17170003
MODE - -
REGULATED-ENTITY - PM0-10318
REGULATOR - CPLX0-3781
//
UNIQUE-ID - REG0-5794
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3463
CITATIONS - 14711822
CITATIONS - 22870390
MODE - -
REGULATED-ENTITY - PM00218
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10966
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8015
CITATIONS - 18808381
MODE - -
REGULATED-ENTITY - PM0-10288
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6171
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4482
CITATIONS - 15489450
MODE - +
REGULATED-ENTITY - PM0-5982
REGULATOR - G6789-MONOMER
//
UNIQUE-ID - REG0-11659
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8332
CITATIONS - 23028867
MODE - -
REGULATED-ENTITY - PM0-46242
REGULATOR - EG10226-MONOMER
//
UNIQUE-ID - REG0-6543
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7074
CITATIONS - 15941987
MODE - +
REGULATED-ENTITY - PM-8798
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-4657
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00074
CITATIONS - 9016640
CITATIONS - 14500788
CITATIONS - 8982002
CITATIONS - 15289461
COMMENT - HU and GalR, binding two sites,  repress the expression of the <i>gal</i> operon in the total absence of galactose |CITS: [16524589]|.
MODE - -
REGULATED-ENTITY - PM00032
REGULATOR - PD03028
//
UNIQUE-ID - REG0-9639
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7643
CITATIONS - 18658270
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM0-46300
REGULATOR - CPLX0-7756
//
UNIQUE-ID - REG0-5030
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS442
CITATIONS - [8955407]
CITATIONS - [10216857]
MODE - -
REGULATED-ENTITY - PM562
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5404
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00397
CITATIONS - 2139473
CITATIONS - 10411720
CITATIONS - 11101675
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00226
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-5778
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00373
CITATIONS - [8034728]
CITATIONS - [8034727]
CITATIONS - 10848985
MODE - +
REGULATED-ENTITY - PM00210
REGULATOR - MONOMER0-183
//
UNIQUE-ID - REG0-10938
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8004
CITATIONS - 11243806
MODE - +
REGULATED-ENTITY - PM923
REGULATOR - PHOSPHO-HYDG
//
UNIQUE-ID - REG0-6154
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7116
CITATIONS - 9670013
MODE - +
REGULATED-ENTITY - PM00615
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-11639
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8317
CITATIONS - 23233451
COMMENT - The curator assigned the possible central position of this binding site based on similarity to a consensus sequence (TTGTGTACA) identified by Shimada et al. in 2012 |CITS:[23233451]|.
MODE - -
REGULATED-ENTITY - PM0-44418
REGULATOR - G6444-MONOMER
//
UNIQUE-ID - REG0-6527
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7324
CITATIONS - 10411720
CITATIONS - 17921503
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00343
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4641
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6986
CITATIONS - 8057356
MODE - -
REGULATED-ENTITY - PM00030
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9597
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7627
CITATIONS - 18524927
MODE - -
REGULATED-ENTITY - PM00289
REGULATOR - PD00196
//
UNIQUE-ID - REG0-5013
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1745
CITATIONS - [11976288]
CITATIONS - [12446650]
CITATIONS - 15795232
COMMENT - Two large footprinting regions for Hns binding, which are necessary for full repression, were identified around the regulatory region of the gadAp promoter (from +43 to -55 and from -86 to -133). These regions may contain sites for several Hns molecules, but these specific sites have not been identified |CITS:[15795232]|. 
/
/The RNA polymerase binding to the gadAp promoter can be prevented by the Hns protein which binds around the promoter region. Also, on the same region GadX can bind, competing with Hns for the same site; even GadX can remove the already-bound Hns |CITS:[15795232]| .
MODE - -
REGULATED-ENTITY - PM461
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5388
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5961
CITATIONS - 8982002
MODE - -
REGULATED-ENTITY - PM00231
REGULATOR - PD03028
//
UNIQUE-ID - REG0-5762
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00680
CITATIONS - 1372899
COMMENT - This binding site is within the <i>glpK</i> coding region. The affinity of the repressor for this site is much lower than the affinity of it for the sites in the regulatory region.
MODE - -
REGULATED-ENTITY - PM00238
REGULATOR - PD03576
//
UNIQUE-ID - REG0-10921
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7989
CITATIONS - 21034467
MODE - +
REGULATED-ENTITY - PM450
REGULATOR - EG11966-MONOMER
//
UNIQUE-ID - REG0-6138
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6843
CITATIONS - 2556297
MODE - -
REGULATED-ENTITY - PM00388
REGULATOR - PC00010
//
UNIQUE-ID - REG0-11622
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8301
CITATIONS - 23233451
MODE - +
REGULATED-ENTITY - TU0-8671
REGULATOR - G6444-MONOMER
//
UNIQUE-ID - REG0-6511
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3732
CITATIONS - 12588863
MODE - -
REGULATED-ENTITY - PM0-1302
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4625
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7105
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM00028
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9573
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7611
CITATIONS - 14973023
MODE - -
REGULATED-ENTITY - PM0-8727
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4997
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2425
CITATIONS - [8002608]
CITATIONS - 1346534
MODE - -
REGULATED-ENTITY - PM00631
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5372
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4581
CITATIONS - 8757746
CITATIONS - 17513476
MODE - +
REGULATED-ENTITY - PM00293
REGULATOR - CPLX-124
//
UNIQUE-ID - REG0-5746
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00407
CITATIONS - 11065369
CITATIONS - 7665470
CITATIONS - 10463182
CITATIONS - 15621456
CITATIONS - 8188587
MODE - -
REGULATED-ENTITY - PM00233
REGULATOR - PD00339
//
UNIQUE-ID - REG0-10901
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7973
COMMENT - This binding site was determined from  a computational prediction based on different statistical methods |CITS:[21070640]|. The function of the binding site was assigned according to the distance from the transcription start, with NagC as the transcriptional repressor.
MODE - -
REGULATED-ENTITY - PM0-10382
REGULATOR - PD00266
//
UNIQUE-ID - REG0-6122
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5902
CITATIONS - 15659677
MODE - -
REGULATED-ENTITY - PM00382
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-11585
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8289
CITATIONS - 6397402
MODE - +
REGULATED-ENTITY - PM00146
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6494
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1022
CITATIONS - [9466267]
MODE - -
REGULATED-ENTITY - PM0-1282
REGULATOR - PC00027
//
UNIQUE-ID - REG0-4609
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7279
CITATIONS - 16861804
MODE - +
REGULATED-ENTITY - PM0-9403
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-9525
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7595
CITATIONS - 15878120
MODE - +
REGULATED-ENTITY - PM00043
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4979
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7215
CITATIONS - 8631685
MODE - +
REGULATED-ENTITY - PM0-46298
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5355
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7003
CITATIONS - 15743952
CITATIONS - 20466769
MODE - -
REGULATED-ENTITY - PM00536
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-5730
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00470
CITATIONS - 9484892
CITATIONS - 1848637
COMMENT - Previously, two binding sites for the NagC repressor were detected upstream of <i>manX</i>, but a mutation in <i>nagC</i> has very little effect on <i>manX</i> expression. Plasmids overproducing either the NagC protein or the Mlc protein repress the expression of <i>manX</i>, but the effect of the Mlc protein is stronger |CITS: [9484892], [1848637]|.
MODE - -
REGULATED-ENTITY - PM00276
REGULATOR - PD00266
//
UNIQUE-ID - REG0-10885
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7958
CITATIONS - 21097627
CITATIONS - 12746439
MODE - -
REGULATED-ENTITY - PM0-36183
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6106
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6062
CITATIONS - 11466284
CITATIONS - 12029030
MODE - -
REGULATED-ENTITY - PM0-7661
REGULATOR - CPLX0-7672
//
UNIQUE-ID - REG0-11539
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8271
CITATIONS - 6406797
MODE - -
REGULATED-ENTITY - PM0-5285
REGULATOR - EG20249-MONOMER
//
UNIQUE-ID - REG0-6478
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2551
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1351
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4590
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00162
CITATIONS - [2656631]
CITATIONS - [2656704]
CITATIONS - [2553720]
CITATIONS - [9422609]
CITATIONS - 10698756
CITATIONS - 11158569
CITATIONS - 11812125
CITATIONS - 8175665
CITATIONS - 1648075
CITATIONS - 7557323
CITATIONS - 8113170
CITATIONS - 16618701
MODE - +
REGULATED-ENTITY - PM00066
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-9462
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7582
CITATIONS - 18227264
MODE - -
REGULATED-ENTITY - PM0-10196
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-4963
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS562
CITATIONS - 11053378
CITATIONS - 14996792
CITATIONS - 17892462
COMMENT - Hns modulates the <i>hlyE</i> expression both positively and negatively; this protein enhances the CRP-mediated expression of <i>hlyE</i> , but it inhibits the FNR-mediated <i>hlyE</i> expression.
/
MODE - +
REGULATED-ENTITY - PM681
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5338
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00701
CITATIONS - 7715459
MODE - -
REGULATED-ENTITY - PM00619
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5712
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00717
COMMENT - CspA has been called CS7.4
MODE - +
REGULATED-ENTITY - PM00192
REGULATOR - PD03695
//
UNIQUE-ID - REG0-10843
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7941
CITATIONS - 20603130
MODE - -
REGULATED-ENTITY - PM0-9828
REGULATOR - G6789-MONOMER
//
UNIQUE-ID - REG0-6090
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6522
CITATIONS - 12813061
MODE - +
REGULATED-ENTITY - PM0-8182
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-11518
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8252
CITATIONS - 16115199
MODE - -
REGULATED-ENTITY - PM0-9576
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6462
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7148
CITATIONS - 16238633
COMMENT - Based on studies of binding sites determined using gel shift and footprinting analyses with Lrp and H-NS regulator proteins, it was demonstrated that both proteins interact with obvious synergism in the repression of all seven <i>E. coli</i> <i>rrn</i> P1 promoter upstream regions; as a result, they help the efficient shutdown of rRNA synthesis. Likewise, both proteins could be a transient heteromer via a protein-protein interaction interfering with the RNA polymerase, and this way they may alter the DNA of the upstream regions of all seven ribosomal P1 promoters |CITS: [16238633]|. 
/
/In a DNase I footprinting analysis of the rrnEp region, several regions of Lrp protection were observed to extend from position  -100 upstream into the downstream transcription region. Specific central positions for the Lrp transcriptional regulator were not determined. It is important to note that the same sequence is strongly protected by the H-NS-DNA complex |CITS: [16238633]|.
/
MODE - -
REGULATED-ENTITY - PM0-1346
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-4573
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS348
CITATIONS - 8002608
CITATIONS - 1346534
COMMENT - Binding of Lrp to one site enhances occupancy of the other Lrp sites  in the  ompCp1 promoter. Leucine does not abolish  DNA binding by the ligated Lrp but it may alter the affinity of Lrp for specific sites on DNA.
MODE - -
REGULATED-ENTITY - PM00065
REGULATOR - PD00353
//
UNIQUE-ID - REG0-9408
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7565
CITATIONS - 18083817
MODE - -
REGULATED-ENTITY - PM928
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-4947
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS506
CITATIONS - [1703160]
CITATIONS - [8702758]
MODE - +
REGULATED-ENTITY - PM00475
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5322
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00673
CITATIONS - [10464194]
COMMENT - AppY actives the transcription of the <i>hyaABCDEF</i> operon during anaerobic growth.
MODE - +
REGULATED-ENTITY - PM00598
REGULATOR - PD00967
//
UNIQUE-ID - REG0-5696
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7153
CITATIONS - 16377617
MODE - +
REGULATED-ENTITY - PM00168
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10817
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7925
CITATIONS - 20466769
MODE - +
REGULATED-ENTITY - PM00536
REGULATOR - PC00027
//
UNIQUE-ID - REG0-6071
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6681
CITATIONS - 15616579
COMMENT - Between the <i>dhaKLM</i> operon and the <i>dhaR</i> gene there is a 190-bp-long intergenic region that divergently transcribes them. DhaR is an (auto)repressor of the <i>dhaR</i> gene and an activator of the <i>dhaKLM</i> operon |CITS: [15616579]|.
MODE - +
REGULATED-ENTITY - PM0-8361
REGULATOR - G6628-MONOMER
//
UNIQUE-ID - REG0-11502
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8245
CITATIONS - 22422754
COMMENT - MatA-<i>fliC</i>p regulatory interaction was identified in <i>Escherichia coli</i> strain IHE 3034 |CITS:[ 22422754]|.
/
/MatA binds weakly to <i>fliC</i>p |CITS:[ 22422754]|.
MODE - -
REGULATED-ENTITY - PM0-1681
REGULATOR - G6165-MONOMER
//
UNIQUE-ID - REG0-6446
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7057
MODE - +
REGULATED-ENTITY - PM00604
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-4557
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7099
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM00063
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9388
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7549
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM00529
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4931
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS770
CITATIONS - [9421904]
MODE - -
REGULATED-ENTITY - PM263
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5306
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00776
MODE - +
REGULATED-ENTITY - PM00662
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5680
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3344
CITATIONS - 8830277
MODE - +
REGULATED-ENTITY - PM00191
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10801
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7909
CITATIONS - 9312050
CITATIONS - 11133959
CITATIONS - 8168494
CITATIONS - 1316901
REGULATED-ENTITY - PM00282
REGULATOR - MONOMER0-46
//
UNIQUE-ID - REG0-6055
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7333
CITATIONS - 17074904
CITATIONS - 17850814
MODE - -
REGULATED-ENTITY - PM0-8542
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-11484
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8229
CITATIONS - 22295907
MODE - +
REGULATED-ENTITY - PM0-46179
REGULATOR - PD00519
//
UNIQUE-ID - REG0-6430
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2441
CITATIONS - 10850997
COMMENT - IHF slightly represses the sodBp promoter.
MODE - -
REGULATED-ENTITY - PM00372
REGULATOR - PC00027
//
UNIQUE-ID - REG0-4541
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6806
CITATIONS - 15225315
CITATIONS - 11004182
CITATIONS - 9302020
CITATIONS - 9302020
COMMENT - NarP appears to antagonize the activation of <i>nirB</i> by NarL at low nitrate concentrations, but not when nitrite is present |CITS: [11004182]|.
MODE - +
REGULATED-ENTITY - PM00062
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-9370
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7532
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM167
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4915
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS627
CITATIONS - [9852003]
MODE - -
REGULATED-ENTITY - PM00625
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5290
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS445
CITATIONS - [8955407]
CITATIONS - [10216857]
MODE - -
REGULATED-ENTITY - PM00540
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5664
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7313
CITATIONS - 9582281
MODE - -
REGULATED-ENTITY - PM0-9556
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10766
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7895
CITATIONS - 20487274
MODE - -
REGULATED-ENTITY - PM00063
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-6039
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3961
CITATIONS - 14702398
CITATIONS - 20435136
MODE - +
REGULATED-ENTITY - PM00622
REGULATOR - CPLX0-7852
//
UNIQUE-ID - REG0-11466
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8214
CITATIONS - 22422754
COMMENT - MatA-<i>flhD</i>p2 regulatory interaction was identified in <i>Escherichia coli</i> strain IHE 3034 |CITS:[ 22422754]|.
/
/MatA binds with higher affinity to <i>flhD</i>p than <i>flhD</i>p2 |CITS:[ 22422754]|.
MODE - -
REGULATED-ENTITY - PM0-10472
REGULATOR - G6165-MONOMER
//
UNIQUE-ID - REG0-6412
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4261
CITATIONS - 11872702
MODE - +
REGULATED-ENTITY - PM0-1681
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4525
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00144
CITATIONS - 8057356
CITATIONS - 1528882
CITATIONS - 8736541
CITATIONS - 7050087
MODE - +
REGULATED-ENTITY - PM00060
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9354
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7516
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM0-7321
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4898
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1126
CITATIONS - [9924977]
CITATIONS - [7715442]
MODE - -
REGULATED-ENTITY - PM00242
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5274
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00757
CITATIONS - 21115656
COMMENT - A high concentration of FruR was needed for ptsHP1b repression <i>in vitro</i>. FruR could repress pstHP1b transcription by displacing CRP-cAMP from its binding site, thus restoring P1a activity from CRP-cAMP inhibition |CITS: [7852310]|.
MODE - -
REGULATED-ENTITY - PM00635
REGULATOR - PC00061
//
UNIQUE-ID - REG0-5648
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3428
CITATIONS - 14711822
MODE - +
REGULATED-ENTITY - PM00528
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10732
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7880
CITATIONS - 19690171
MODE - -
REGULATED-ENTITY - PM0-10415
REGULATOR - G7571-MONOMER
//
UNIQUE-ID - REG0-6023
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6863
CITATIONS - 10760155
CITATIONS - 23408903
MODE - -
REGULATED-ENTITY - PM0-8643
REGULATOR - PC00010
//
UNIQUE-ID - REG0-11422
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8195
CITATIONS - 10216857
CITATIONS - 10216857:EV-EXP-IMP-SITE-MUTATION:3538187090:martin
CITATIONS - 10216857:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3538187090:martin
CITATIONS - 10216857:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3538187090:martin
CITATIONS - 10216857:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3538187090:martin
CITATIONS - 8955407:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3538187090:martin
CITATIONS - 8955407:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3538187090:martin
MODE - -
REGULATED-ENTITY - PM562
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6396
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5821
CITATIONS - 9260970
MODE - -
REGULATED-ENTITY - PM0-1983
REGULATOR - EG12344-MONOMER
//
UNIQUE-ID - REG0-4509
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00134
MODE - -
REGULATED-ENTITY - PM00054
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-9325
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7499
CITATIONS - 17768236
CITATIONS - 17768236:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3411310679:asantos
CITATIONS - 17768236:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3411310679:asantos
MODE - +
REGULATED-ENTITY - PM00039
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4882
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1001
CITATIONS - 9159398
CITATIONS - 7883164
MODE - +
REGULATED-ENTITY - PM00327
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-5258
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00720
CITATIONS - 19054084
CITATIONS - 20141531
COMMENT - CRP binding to site 2 (+17.5) causes little or no repression on the <i>malI</i> promoter, while CRP binding to site 1 (-43.5) causes only weak activation. It could be that <i>malI</i> has an unusual organization of its peculiar sequence |CITS:[19054084]|.
MODE - +
REGULATED-ENTITY - PM00260
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5632
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2085
CITATIONS - [10628873]
CITATIONS - [7565112]
MODE - -
REGULATED-ENTITY - PM00592
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10703
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00620
CITATIONS - [7805834]
CITATIONS - 14645248
CITATIONS - 7805834:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3480865621:asantos
CITATIONS - 14645248:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3480865621:asantos
MODE - -
REGULATED-ENTITY - PM0-4722
REGULATOR - PC00103
//
UNIQUE-ID - REG0-6007
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7025
CITATIONS - 12754220
COMMENT - By making use of microarray analyses it was concluded that anarobiosis does not affect expression of the <i>ssu</i> operon, although FNR appears to activate  it.  A putative FNR-binding site, which was not shown in the report, was identified in this operon |CITS: [12754220]|.
MODE - +
REGULATED-ENTITY - PM169
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11384
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8184
CITATIONS - 22168595
MODE - -
REGULATED-ENTITY - PM166
REGULATOR - EG11088-MONOMER
//
UNIQUE-ID - REG0-6380
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7247
CITATIONS - 17233826
MODE - -
REGULATED-ENTITY - PM00550
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4492
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00122
CITATIONS - 7830577
MODE - +
REGULATED-ENTITY - PM00049
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-9292
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7488
CITATIONS - 17921503
CITATIONS - 17921503:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3409862291:martin
CITATIONS - 17921503:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3409862291:martin
MODE - +
REGULATED-ENTITY - PM0-4201
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4865
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4425
CITATIONS - 8120010
CITATIONS - 8763946
CITATIONS - 11673423
MODE - -
REGULATED-ENTITY - PM00423
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5241
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7235
CITATIONS - 11395454
CITATIONS - 17233899
MODE - +
REGULATED-ENTITY - PM00254
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5616
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6842
CITATIONS - 9663683
COMMENT - When H-NS was absent, transcription from osmCp2 was stimulated but remained totally &sigma;<sup>S</sup> dependent. 
MODE - -
REGULATED-ENTITY - PM00545
REGULATOR - PD00288
//
UNIQUE-ID - REG0-10674
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7850
CITATIONS - 11443092
MODE - +
REGULATED-ENTITY - PM0-10408
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5991
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00502
CITATIONS - [8626315]
CITATIONS - [7896685]
COMMENT - Rob binding to zwf  induced a bend of ~30&deg;.
MODE - +
REGULATED-ENTITY - PM00295
REGULATOR - PD04418
//
UNIQUE-ID - REG0-11366
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8174
CITATIONS - 22101843
MODE - -
REGULATED-ENTITY - PM0-9889
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-6364
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7161
CITATIONS - 16377617
MODE - -
REGULATED-ENTITY - PM0-2441
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4476
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00582
CITATIONS - 8413182
MODE - -
REGULATED-ENTITY - PM00110
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-9273
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7475
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00228
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4849
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS773
CITATIONS - [2454912]
MODE - -
REGULATED-ENTITY - PM00483
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5225
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00787
CITATIONS - 2207159
MODE - +
REGULATED-ENTITY - PM00440
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5597
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00324
CITATIONS - 10601201
COMMENT - In the intergenic regulatory region the <i>fucPIK</i> and <i>fucAO</i> operons, there exist other potential CRP-binding sites, which are located at positions  -80.5,  -289.5,  -297.5, and -387.5 relative to the transcription start site.
MODE - +
REGULATED-ENTITY - PM00172
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10654
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7839
CITATIONS - 11395466
MODE - -
REGULATED-ENTITY - PM0-10501
REGULATOR - PD00519
//
UNIQUE-ID - REG0-5975
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS757
MODE - +
REGULATED-ENTITY - PM00298
REGULATOR - PHOSPHO-TORR
//
UNIQUE-ID - REG0-11321
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8161
CITATIONS - 8825783
CITATIONS - 9254708
CITATIONS - 21890697
CITATIONS - 8995231
MODE - +
REGULATED-ENTITY - PM00466
REGULATOR - CPLX0-7669
//
UNIQUE-ID - REG0-6348
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6948
CITATIONS - 15009899
COMMENT - It is suggested that IHF bends the DNA to facilitate the interaction between OxyR and the promoter-bound complex |CITS: [15009899]|.
/
MODE - +
REGULATED-ENTITY - PM0-2801
REGULATOR - PC00027
//
UNIQUE-ID - REG0-12374
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8502
CITATIONS - 26350134
COMMENT - <i>tcyP</i> transcription is activated by CysB when cysteine is scarce |CITS:[ 26350134]|. There is a likely CysB-binding site 100 bp upstream of the promoter |CITS:[ 26350134]|.
MODE - +
REGULATED-ENTITY - PM0-46362
REGULATOR - PD00232
//
UNIQUE-ID - REG0-9240
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7459
CITATIONS - 17513468
MODE - -
REGULATED-ENTITY - PM0-8186
REGULATOR - EG11088-MONOMER
//
UNIQUE-ID - REG0-4832
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS751
CITATIONS - [11243806]
COMMENT - ZraR activates the zraSp promoter in the presence of high Zn<sup>2+</sup> and Pb<sup>2+</sup> concentrations|CITS: [11243806]|.
MODE - +
REGULATED-ENTITY - PM924
REGULATOR - PHOSPHO-HYDG
//
UNIQUE-ID - REG0-5208
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00156
CITATIONS - 11812125
CITATIONS - 11158569
CITATIONS - 16618701
MODE - +
REGULATED-ENTITY - PM00401
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-5581
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4382
CITATIONS - 11929534
MODE - +
REGULATED-ENTITY - PM00184
REGULATOR - MONOMER0-2741
//
UNIQUE-ID - REG0-10595
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7823
CITATIONS - 19943910
MODE - -
REGULATED-ENTITY - PM0-9802
REGULATOR - PC00010
//
UNIQUE-ID - REG0-5959
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS67
CITATIONS - 9302020
CITATIONS - 15978080
COMMENT - <i>nrf</i> regulation is totally dependent on FNR at this site (-41.5) under anaerobic conditions. FNR and NarL/NarP act by promoting the open complex formation by RNA polymerase at the <i>nrf</i> promoter. Although it seems that NarL and FNR can bind to their targets independently, NarL is unable to activate the <i>nrf</i> promoter in the absence of FNR |CITS: [15978080]|. Based on DNase I footprinting |CITS: [15978080]| suggest that IHF alters the binding of FNR without displacing it from its site. In adittion, NarL binding prevents IHF binding but has little or no effect on FNR or Fis binding.
MODE - +
REGULATED-ENTITY - PM00280
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11261
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8145
CITATIONS - 15686558
MODE - +
REGULATED-ENTITY - PM0-10482
REGULATOR - PHOSPHO-BAER
//
UNIQUE-ID - REG0-6332
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2263
CITATIONS - 10714981
CITATIONS - 12067348
MODE - +
REGULATED-ENTITY - PM0-3382
REGULATOR - PD00406
//
UNIQUE-ID - REG0-12293
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8485
CITATIONS - 26078445
MODE - -
REGULATED-ENTITY - PM0-46350
REGULATOR - G7947-MONOMER
//
UNIQUE-ID - REG0-9159
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7442
CITATIONS - 17884222
MODE - +
REGULATED-ENTITY - PM-8764
REGULATOR - PHOSPHO-BAER
//
UNIQUE-ID - REG0-4816
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00056
MODE - -
REGULATED-ENTITY - PM00025
REGULATOR - PD01196
//
UNIQUE-ID - REG0-5192
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00576
CITATIONS - 7601827
MODE - -
REGULATED-ENTITY - PM00353
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5564
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00536
CITATIONS - [11985712]
MODE - +
REGULATED-ENTITY - PM00308
REGULATOR - PD00353
//
UNIQUE-ID - REG0-10565
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7807
CITATIONS - 17768236
MODE - +
REGULATED-ENTITY - PM0-10039
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5939
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00484
CITATIONS - 2155195
CITATIONS - 1840580
CITATIONS - 23274360
MODE - +
REGULATED-ENTITY - PM00284
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-10560
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7803
CITATIONS - 9767576
MODE - -
REGULATED-ENTITY - PM00571
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5936
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4642
CITATIONS - 3304660
CITATIONS - 2571609
CITATIONS - 1943993
MODE - +
REGULATED-ENTITY - PM00312
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-6313
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5282
CITATIONS - 11953442
MODE - +
REGULATED-ENTITY - PM0-3625
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-11241
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8126
CITATIONS - 21840983
MODE - -
REGULATED-ENTITY - PM0-9871
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-12198
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8467
CITATIONS - 25667010
COMMENT - OmpR-P represses biofilm production by direct interaction of the <i>pgaABCD</i> operon through acetyl phosphate as the phosphodonor |CITS:[25667010]|.
MODE - -
REGULATED-ENTITY - PM0-8907
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-9076
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5541
CITATIONS - 15534208
CITATIONS - 17238917
MODE - +
REGULATED-ENTITY - PM00560
REGULATOR - PD00266
//
UNIQUE-ID - REG0-5173
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00454
CITATIONS - [10564485]
CITATIONS - [8522515]
MODE - +
REGULATED-ENTITY - PM00264
REGULATOR - PD00365
//
UNIQUE-ID - REG0-5545
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7178
CITATIONS - 16140472
MODE - -
REGULATED-ENTITY - PM00098
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10516
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7791
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM0-10442
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5920
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7097
CITATIONS - 15520470
CITATIONS - 20211899
MODE - +
REGULATED-ENTITY - PM00265
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6296
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2943
CITATIONS - 11448880
CITATIONS - 2419307
CITATIONS - 16515535
MODE - -
REGULATED-ENTITY - PM00490
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-11214
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8113
CITATIONS - 21559929
MODE - +
REGULATED-ENTITY - PM00536
REGULATOR - PC00061
//
UNIQUE-ID - REG0-12149
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8452
CITATIONS - 25246476
MODE - +
REGULATED-ENTITY - PM0-9596
REGULATOR - CPXR-MONOMER
//
UNIQUE-ID - REG0-9044
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7390
CITATIONS - 17468243
MODE - +
REGULATED-ENTITY - PM0-1881
REGULATOR - PHOSPHO-RSTA
//
UNIQUE-ID - REG0-4784
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00023
CITATIONS - 2857723
CITATIONS - 3041242
CITATIONS - 2857723
MODE - -
REGULATED-ENTITY - PM00010
REGULATOR - MONOMER0-162
//
UNIQUE-ID - REG0-5157
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS125
CITATIONS - [8631699]
MODE - +
REGULATED-ENTITY - PM338
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5532
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7179
CITATIONS - 16140472
MODE - -
REGULATED-ENTITY - PM00091
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10495
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7776
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM0-2801
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5904
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00376
CITATIONS - 7768815
MODE - -
REGULATED-ENTITY - PM00187
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-6280
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3223
CITATIONS - 11274153
MODE - +
REGULATED-ENTITY - PM0-4386
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-11115
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8095
CITATIONS - 7511582
MODE - +
REGULATED-ENTITY - TU0-13688
REGULATOR - PD02850
//
UNIQUE-ID - REG0-12094
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8434
CITATIONS - 24923415
MODE - +
REGULATED-ENTITY - PM00161
REGULATOR - PC00061
//
UNIQUE-ID - REG0-9013
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6561
CITATIONS - 1848637
MODE - -
REGULATED-ENTITY - PM0-4621
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4768
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00005
MODE - +
REGULATED-ENTITY - PM00004
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5141
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6964
CITATIONS - 15659676
MODE - +
REGULATED-ENTITY - PM00324
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5516
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00764
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM00089
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10479
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7761
CITATIONS - 19633077
MODE - -
REGULATED-ENTITY - PM00340
REGULATOR - EG10087-MONOMER
//
UNIQUE-ID - REG0-5888
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00034
MODE - -
REGULATED-ENTITY - PM00015
REGULATOR - MONOMER-48
//
UNIQUE-ID - REG0-11098
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8087
CITATIONS - 21460078
MODE - -
REGULATED-ENTITY - PM0-36234
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6267
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-0
CITATIONS - 12586421
MODE - -
REGULATED-ENTITY - PM0-4681
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-12006
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8416
CITATIONS - 24272779
MODE - -
REGULATED-ENTITY - PM0-1725
REGULATOR - PD01379
//
UNIQUE-ID - REG0-8996
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00709
CITATIONS - 7665470
CITATIONS - 9802028
CITATIONS - 9611815
CITATIONS - 10463182
CITATIONS - 8188587
CITATIONS - 8423160
CITATIONS - 15621456
CITATIONS - 9733689
COMMENT - GcvA interacts with the RNA polymerase &alpha;-subunit to activate gcvTp |CITS:[15621456]|.
MODE - -
REGULATED-ENTITY - PM00233
REGULATOR - PD00339
//
UNIQUE-ID - REG0-4751
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7063
CITATIONS - 12492863
MODE - -
REGULATED-ENTITY - PM00001
REGULATOR - CPLX0-7605
//
UNIQUE-ID - REG0-5123
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7098
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM521
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5500
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3484
CITATIONS - 14711822
CITATIONS - 16140031
CITATIONS - 16980446
MODE - +
REGULATED-ENTITY - PM00141
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10461
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7745
CITATIONS - 19240136
MODE - -
REGULATED-ENTITY - PM0-10543
REGULATOR - G6602-MONOMER
//
UNIQUE-ID - REG0-5872
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00509
CITATIONS - [8522515]
CITATIONS - 11395452
CITATIONS - 12392714
COMMENT - SoxS binding to <i>fumC</i> induced a bend of ~50&deg;. 
/
/SoxS is a regulator that participates in controlling several genes involved in the response to oxidative stress, including <i>fumC</i>. SoxS facilitates the binding of RNA polymerase to some promoters during low iron availability |CITS [11470373]|.
/
MODE - +
REGULATED-ENTITY - PM00147
REGULATOR - PD00406
//
UNIQUE-ID - REG0-11081
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8073
CITATIONS - 21272324
MODE - +
REGULATED-ENTITY - PM00356
REGULATOR - PD00197
//
UNIQUE-ID - REG0-6250
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3745
CITATIONS - 10792463
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM0-5042
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11980
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8402
CITATIONS - 24335284
MODE - +
REGULATED-ENTITY - PM0-10
REGULATOR - CPLX0-7916
//
UNIQUE-ID - REG0-8960
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7370
CITATIONS - 16956381
CITATIONS - 17120142
CITATIONS - 19703465
CITATIONS - 21040754
COMMENT - Bound RcnR (RcnR transcriptional repressor) represses transcription |CITS:[16956381][17120142][19703465]|. RcnR interacts nonspecifically with the approximately 50 bp flanking the core binding site, resulting in DNA wrapping and the introduction of a single negative supercoil into plasmid DNA |CITS:[19703465]|.
MODE - -
REGULATED-ENTITY - PM0-9620
REGULATOR - G7137-MONOMER
//
UNIQUE-ID - REG0-4735
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00118
CITATIONS - 2538630
CITATIONS - 2016744
CITATIONS - 9000616
MODE - +
REGULATED-ENTITY - PM00047
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-5107
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS267
CITATIONS - [7559336]
CITATIONS - [10400599]
MODE - +
REGULATED-ENTITY - PM501
REGULATOR - CPLX0-7681
//
UNIQUE-ID - REG0-5482
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00272
CITATIONS - 10518785
CITATIONS - 2061290
CITATIONS - 1904443
MODE - -
REGULATED-ENTITY - PM00132
REGULATOR - CPLX-125
//
UNIQUE-ID - REG0-10432
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7731
CITATIONS - 18997424
MODE - +
REGULATED-ENTITY - PM0-10371
REGULATOR - PHOSPHO-DPIA
//
UNIQUE-ID - REG0-5855
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6970
CITATIONS - 15659676
CITATIONS - 21272324
MODE - +
REGULATED-ENTITY - PM00143
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-11065
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8059
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00254
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6234
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4121
CITATIONS - 14973046
CITATIONS - 14593252
MODE - +
REGULATED-ENTITY - PM0-4921
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11901
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8387
CITATIONS - 18177266
MODE - -
REGULATED-ENTITY - PM0-10228
REGULATOR - EG11554-MONOMER
//
UNIQUE-ID - REG0-6610
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7226
CITATIONS - 3911021
MODE - -
REGULATED-ENTITY - PM0-9327
REGULATOR - EG10226-MONOMER
//
UNIQUE-ID - REG0-4719
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5462
CITATIONS - 2160266
CITATIONS - 6379600
MODE - -
REGULATED-ENTITY - PM00045
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5091
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7227
CITATIONS - 12354237
MODE - +
REGULATED-ENTITY - PM00501
REGULATOR - EG10125-MONOMER
//
UNIQUE-ID - REG0-5465
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7236
CITATIONS - 8892849
MODE - -
REGULATED-ENTITY - PM00125
REGULATOR - CPLX0-2021
//
UNIQUE-ID - REG0-10388
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7695
CITATIONS - 16857675
CITATIONS - 16857675:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3454271150:asantos
MODE - -
REGULATED-ENTITY - PM0-10033
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5839
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7324
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00225
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-11048
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8047
CITATIONS - 21421764
MODE - -
REGULATED-ENTITY - PM-8797
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6218
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7094
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM0-5201
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11823
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8371
CITATIONS - 23475967
COMMENT - CRP regulates positively the activation of the <i>rmf</i> gene for formation of 100S ribosome dimers |CITS: [23475967]|. <i>rmf</i>p expression is increased during the transition from exponential- to stationary-phase growth |CITS: [2181444][11168583][23475967]|.
MODE - +
REGULATED-ENTITY - PM0-46188
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6593
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7086
CITATIONS - 16428390
CITATIONS - 19656291
COMMENT - NsrR  has only a small effect on tehAp promoter activity |CITS: [16428390]|.
MODE - -
REGULATED-ENTITY - PM-8830
REGULATOR - CPLX0-7756
//
UNIQUE-ID - REG0-4702
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5721
CITATIONS - 9179845
MODE - -
REGULATED-ENTITY - PM00039
REGULATOR - PD03576
//
UNIQUE-ID - REG0-5075
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1161
CITATIONS - 9515922
CITATIONS - 9632265
CITATIONS - 8648646
CITATIONS - 7500958
COMMENT - Fis appears to have little or no effect on rrsBp1 as a result of the addition of amino acids to the growth medium |CITS:[16675089]|.
MODE - +
REGULATED-ENTITY - PM00514
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5449
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00238
MODE - -
REGULATED-ENTITY - PM00114
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-10272
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7695
CITATIONS - 16857675
MODE - -
REGULATED-ENTITY - PM0-10351
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5823
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7341
CITATIONS - 15522088
CITATIONS - 17209026
CITATIONS - 20971900
MODE - +
REGULATED-ENTITY - PM0-9591
REGULATOR - EG12094-MONOMER
//
UNIQUE-ID - REG0-10995
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8031
CITATIONS - 18808381
MODE - -
REGULATED-ENTITY - PM0-10288
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6202
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8013
CITATIONS - 18808381
CITATIONS - 14702398:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3511015134:martin
CITATIONS - 12730179:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3511015134:martin
CITATIONS - 18808381:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3511015134:martin
CITATIONS - 18808381:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3511015134:martin
COMMENT - Microarray analyses have shown that the <i>hdeD</i> gene is activated by the transcriptional regulator GadX, but it is not known if the effect of the regulator on the gene is direct or indirect. The positive regulation of <i>hdeD</i> by GadX is positively influenced by  the transcriptional regulator GadW |CITS: [12730179]|.
MODE - +
REGULATED-ENTITY - PM0-5143
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-11755
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8356
CITATIONS - 23139412
MODE - -
REGULATED-ENTITY - PM0-1962
REGULATOR - PD00214
//
UNIQUE-ID - REG0-6577
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6941
CITATIONS - 12480884
COMMENT - The induction of yodA by cadmiun is SoxS and Fur dependent |CITS:[12480884]|.
MODE - +
REGULATED-ENTITY - PM0-8710
REGULATOR - PD00406
//
UNIQUE-ID - REG0-4686
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS541
CITATIONS - 3045087
CITATIONS - 1372899
MODE - +
REGULATED-ENTITY - PM00038
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5059
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3763
CITATIONS - 13129959
MODE - +
REGULATED-ENTITY - PM444
REGULATOR - CPLX0-6
//
UNIQUE-ID - REG0-5433
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS45
CITATIONS - [8626294]
MODE - -
REGULATED-ENTITY - PM00157
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10183
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7678
CITATIONS - 19074390
MODE - +
REGULATED-ENTITY - PM0-10338
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-5807
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00606
CITATIONS - 9418241
CITATIONS - 2656658
COMMENT - Both proteins, FNR and ArcA,  activate the expression of <i>fumB</i> under anaerobiosis, but they act independently from each other. This site has eight identities with regard to the symmetrical consensus TTGATA--TATCAA proposed by Spiro and Guest for FNR |CITS:[1957353]|. There are also two half-sites with five and four identities. The significance of the potential FNR sites is difficult to assess, partly because their homologies with the consensus are not particularly strong.
MODE - +
REGULATED-ENTITY - PM00219
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10979
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8025
CITATIONS - 16980449
CITATIONS - 12446650
CITATIONS - 12730179
MODE - +
REGULATED-ENTITY - PM450
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6186
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3926
CITATIONS - 6808145
MODE - -
REGULATED-ENTITY - PM0-5286
REGULATOR - PD03270
//
UNIQUE-ID - REG0-11699
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8344
CITATIONS - 22522900
MODE - -
REGULATED-ENTITY - PM0-10033
REGULATOR - EG12431-MONOMER
//
UNIQUE-ID - REG0-6556
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7070
CITATIONS - 15941987
CITATIONS - 7961507
MODE - +
REGULATED-ENTITY - PM-8790
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-4670
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00558
CITATIONS - 2858855
MODE - -
REGULATED-ENTITY - PM00034
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-9981
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7650
CITATIONS - 18808381
MODE - -
REGULATED-ENTITY - PM0-6061
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-5043
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7076
CITATIONS - 11953442
MODE - -
REGULATED-ENTITY - PM361
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-5417
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS803
CITATIONS - [8704970]
MODE - +
REGULATED-ENTITY - PM981
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10090
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7666
CITATIONS - 19007420
MODE - -
REGULATED-ENTITY - PM0-7421
REGULATOR - MONOMER-52
//
UNIQUE-ID - REG0-5791
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3466
CITATIONS - 14711822
CITATIONS - 22870390
MODE - -
REGULATED-ENTITY - PM00218
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10963
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8015
CITATIONS - 18808381
MODE - +
REGULATED-ENTITY - PM0-6061
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6168
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5662
CITATIONS - 15902464
COMMENT - NarL repressed the <i>ubiCA</i> operon under anaerobiosis.
MODE - -
REGULATED-ENTITY - PM0-5862
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-11656
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8329
CITATIONS - 23222720
MODE - +
REGULATED-ENTITY - PM0-46200
REGULATOR - MONOMER0-4288
//
UNIQUE-ID - REG0-6540
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7072
MODE - +
REGULATED-ENTITY - PM-8797
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-4654
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5472
CITATIONS - 2160266
MODE - -
REGULATED-ENTITY - PM00032
REGULATOR - PD00288
//
UNIQUE-ID - REG0-9620
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7640
CITATIONS - 18524933
CITATIONS - 20718955
MODE - -
REGULATED-ENTITY - PM0-10248
REGULATOR - PC00010
//
UNIQUE-ID - REG0-5027
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS445
CITATIONS - [8955407]
CITATIONS - [10216857]
MODE - -
REGULATED-ENTITY - PM562
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5401
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7301
CITATIONS - 12057976
MODE - -
REGULATED-ENTITY - PM0-9520
REGULATOR - PD01520
//
UNIQUE-ID - REG0-5775
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS805
CITATIONS - 10206709
COMMENT - A model has been proposed in which ModE-molybdate serves as a secondary transcriptional activator of both the <i>hyc</i> and <i>narXL</i> operons,  which  are activated primarily by the transcriptional activators FhlA and NarL, respectively. Both ModE and MoeA are needed for maximal expression of the <i>hyc</i> operon. MoeA does not bind DNA |CITS:[9851041]|, and  it was suggested that  it activates molybdenum by sulfurylation |CITS:[9515915]|.
MODE - +
REGULATED-ENTITY - PM00209
REGULATOR - CPLX0-6
//
UNIQUE-ID - REG0-10934
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8002
CITATIONS - 21034467
MODE - -
REGULATED-ENTITY - PM0-7941
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6151
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5447
CITATIONS - 14731281
MODE - -
REGULATED-ENTITY - PM0-6883
REGULATOR - G7630-MONOMER
//
UNIQUE-ID - REG0-11636
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8314
CITATIONS - 23233451
COMMENT - The curator assigned the possible central position of this binding site based on similarity to a consensus sequence (TTGTGTACA) identified by Shimada et al. in 2012 |CITS:[23233451]|.
MODE - +
REGULATED-ENTITY - PM0-1881
REGULATOR - G6444-MONOMER
//
UNIQUE-ID - REG0-6524
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7159
CITATIONS - 8655536
COMMENT - The <i>appY</i> promoter region contains a curved DNA which could be specific for the recognition of H-NS.  However, it is possible that there might be more than one H-NS-binding site in the <i>appY</i> promoter region.  H-NS plays a role in the thermoregulation of the <i>appY</i> gene |CITS: [8655536]|.
MODE - -
REGULATED-ENTITY - PM0-8915
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4638
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1341
CITATIONS - [9765574]
CITATIONS - [9973351]
CITATIONS - 14996819
CITATIONS - 15073297
COMMENT - DcuR regulates the expression of the <i>frd</i> promoter in response to external C4-dicarboxylates.
MODE - +
REGULATED-ENTITY - PM00030
REGULATOR - CPLX0-7721
//
UNIQUE-ID - REG0-9593
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7624
CITATIONS - 18515344
MODE - -
REGULATED-ENTITY - PM00226
REGULATOR - PD01352
//
UNIQUE-ID - REG0-5010
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6622
CITATIONS - 11238978
COMMENT - This potential site could belong to the CRP regulator, since it possesses 9 of the 16 consensus nucleotides associated with CRP binding |CITS: [11238978]|. GadE and CRP bind to this site, controlling <i>gadA</i> expression during growth both under acidic conditions and in stationary phase.
MODE - -
REGULATED-ENTITY - PM461
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5385
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00775
MODE - +
REGULATED-ENTITY - PM00646
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5759
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00677
CITATIONS - 1372899
COMMENT - GlpR perhaps binds cooperatively to  four adjacent operator sites.
MODE - -
REGULATED-ENTITY - PM00238
REGULATOR - PD03576
//
UNIQUE-ID - REG0-10918
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7986
CITATIONS - 21034467
MODE - +
REGULATED-ENTITY - PM0-36192
REGULATOR - CPLX0-7852
//
UNIQUE-ID - REG0-6135
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6183
CITATIONS - 12754220
COMMENT - Under anaerobiosis, FNR repress <i>rplT</i> gene expression, but it is not known if this regulation is direct or indirect  |CITS: [12754220]|.
MODE - -
REGULATED-ENTITY - PM00375
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11619
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8299
CITATIONS - 23028500
MODE - -
REGULATED-ENTITY - PM0-44722
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-6508
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3731
CITATIONS - 12588863
MODE - -
REGULATED-ENTITY - PM0-1301
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4622
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00180
CITATIONS - 21572102
CITATIONS - 2198266
MODE - -
REGULATED-ENTITY - PM00079
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-9566
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7608
CITATIONS - 16078372
CITATIONS - 4349027
MODE - -
REGULATED-ENTITY - PM0-9995
REGULATOR - CPLX0-7975
//
UNIQUE-ID - REG0-4994
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS348
CITATIONS - [8002608]
CITATIONS - 1346534
MODE - -
REGULATED-ENTITY - PM00631
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5369
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00631
CITATIONS - 9922253
COMMENT - Activation of the <i>icd</i> gene is proposed to be via Cra bending the DNA region of the promoter icdAp2. Transcription is activated only when Cra and RNA polymerase bind to opposite faces of the DNA helix (similar to the ppsA promoter). Cra would compensate for the absence of an upstream (UP) element in icdp2, changing the structure of proximal DNA so as to make it operate like a UP module |CITS: [9922253]|.
MODE - +
REGULATED-ENTITY - PM00575
REGULATOR - PC00061
//
UNIQUE-ID - REG0-5743
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00406
CITATIONS - 7665470
CITATIONS - 9802028
CITATIONS - 9611815
CITATIONS - 10463182
CITATIONS - 15621456
CITATIONS - 8188587
CITATIONS - 8423160
CITATIONS - 9733689
COMMENT - GcvA interacts with the RNA polymerase &alpha;-subunit to activate gcvTp |CITS:[15621456]|.
MODE - +
REGULATED-ENTITY - PM00233
REGULATOR - PD00339
//
UNIQUE-ID - REG0-10898
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7970
CITATIONS - 21115656
MODE - -
REGULATED-ENTITY - PM00221
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6119
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5702
CITATIONS - 8982002
CITATIONS - 19007420
MODE - -
REGULATED-ENTITY - PM0-7421
REGULATOR - PD03028
//
UNIQUE-ID - REG0-11581
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8285
CITATIONS - 22442305
MODE - -
REGULATED-ENTITY - PM206
REGULATOR - PHOSPHO-BASR
//
UNIQUE-ID - REG0-6491
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6991
CITATIONS - 10542180:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3526909297:martin
CITATIONS - 23564175
MODE - +
REGULATED-ENTITY - PM0-1201
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-4606
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7257
CITATIONS - 11489853
MODE - -
REGULATED-ENTITY - PM0-9366
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-9509
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7593
CITATIONS - 2166165
CITATIONS - 6259624
CITATIONS - 1987134
MODE - -
REGULATED-ENTITY - PM0-4941
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4976
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS472
CITATIONS - [8913296]
COMMENT - FIS represses the hupBp3 promoter only when CRP is absent.
MODE - -
REGULATED-ENTITY - PM589
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5351
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00596
CITATIONS - 21421764
MODE - +
REGULATED-ENTITY - PM00536
REGULATOR - PD01379
//
UNIQUE-ID - REG0-5727
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00467
MODE - -
REGULATED-ENTITY - PM00274
REGULATOR - CPLX0-7975
//
UNIQUE-ID - REG0-10882
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7955
CITATIONS - 21097627
CITATIONS - 24982304
COMMENT - There is communication over a distance of 200 bp between site I, associated with the <i>yqjI</i>p promoter, and site II, which is associated with the <i>yqjH</i>p promoter, that provides full YqjI-dependent regulation at two target promoters |CITS:[24982304]|.
/ 
/There are two repetitive extragenic palindromic (REP) sequences within the <i>yqjH-yqjI</i> intergenic region; these REP sequences are not required for YqjI regulation |CITS:[24982304]|.
MODE - -
REGULATED-ENTITY - PM0-36183
REGULATOR - G7594-MONOMER
//
UNIQUE-ID - REG0-6103
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5901
MODE - -
REGULATED-ENTITY - PM00384
REGULATOR - G7003-MONOMER
//
UNIQUE-ID - REG0-11536
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8268
CITATIONS - 11121068
MODE - +
REGULATED-ENTITY - PM0-3822
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-6475
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2554
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1351
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4587
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2801
CITATIONS - 6317653
MODE - +
REGULATED-ENTITY - PM00066
REGULATOR - PD00969
//
UNIQUE-ID - REG0-9431
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7579
CITATIONS - 16513732
MODE - +
REGULATED-ENTITY - PM0-9521
REGULATOR - PD01379
//
UNIQUE-ID - REG0-4960
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-10
CITATIONS - 10601216
MODE - -
REGULATED-ENTITY - PM646
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5335
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2841
CITATIONS - 7545153
COMMENT - In addition to Fis and &sigma;<sup>38</sup>, sequences located over 108 bp upstream of the proP2 transcription initiation site are required for efficient expression.
MODE - +
REGULATED-ENTITY - PM00611
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5709
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS160
CITATIONS - 10747919
CITATIONS - 10760178
CITATIONS - 12675795
CITATIONS - 16621812
MODE - -
REGULATED-ENTITY - PM00175
REGULATOR - PD00208
//
UNIQUE-ID - REG0-10840
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7938
CITATIONS - 20603130
MODE - -
REGULATED-ENTITY - PM0-9828
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-6087
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6501
CITATIONS - 12813061
CITATIONS - 15883881
COMMENT - This regulatory interaction was identified by means of PhoPQ-related microarray experiments and the investigators checked for the presence of its regulatory motif in the promoter region |CITS: [15883881]|.
MODE - +
REGULATED-ENTITY - PM0-8161
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-11515
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7325
CITATIONS - 16115199
MODE - -
REGULATED-ENTITY - PM0-9568
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6459
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2558
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1346
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4570
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00155
CITATIONS - 11812125
CITATIONS - 2656704
CITATIONS - 12366850
CITATIONS - 16618701
MODE - +
REGULATED-ENTITY - PM00065
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-9405
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7562
CITATIONS - 18083817
MODE - -
REGULATED-ENTITY - PM928
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-4944
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7004
CITATIONS - 15883881
COMMENT - This regulatory interaction was identified by means of PhoPQ-related microarray experiments, and it was checked for the presence of the regulatory motif in the promoter region |CITS: [15883881]|. A repressor function for <i>acrAB</i> operon transcription can be clearly anticipated from the localization of the PhoP-binding site, very close to the acrAp promoter core region.
MODE - -
REGULATED-ENTITY - PM624
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-5319
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3081
MODE - -
REGULATED-ENTITY - PM00630
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5693
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00665
CITATIONS - 8596434
COMMENT - The <i>nupG</i> full repression complex contains the CytR protein sandwiched between two cAMP-CRP complexes. Binding of CytR to its target excludes binding of cAMP-CRP to CRP1 and promotes binding of cAMP-CRP to CRP0, therefore allowing cooperative binding of the two protein species.
MODE - -
REGULATED-ENTITY - PM00173
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10814
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7922
CITATIONS - 20466769
MODE - -
REGULATED-ENTITY - PM00536
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-6068
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6541
CITATIONS - 15126461
MODE - +
REGULATED-ENTITY - PM0-8201
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-11498
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8242
CITATIONS - 18765794
CITATIONS - 22323519
MODE - -
REGULATED-ENTITY - PM00529
REGULATOR - EG11356-MONOMER
//
UNIQUE-ID - REG0-6443
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2901
CITATIONS - 11566998
CITATIONS - 21276098
MODE - +
REGULATED-ENTITY - PM00407
REGULATOR - PD01520
//
UNIQUE-ID - REG0-4554
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7260
CITATIONS - 8288532
MODE - +
REGULATED-ENTITY - PM00063
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-9385
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7546
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM00060
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4928
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6241
CITATIONS - 9421904
COMMENT - Direct FruR binding to <i>acnB</i> has been determined, even though a repressive effect is observed. The different effect of FruR on <i>acnA</i> (activating) and <i>acnB</i> (repressing) is yet unclear. It may be related to the preferential use of one of the two enzymes in the citric and glyoxylate cycles or stress response (see |CITS: [9421904]|).
MODE - -
REGULATED-ENTITY - PM263
REGULATOR - PC00061
//
UNIQUE-ID - REG0-5303
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00791
MODE - +
REGULATED-ENTITY - PM00675
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5677
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3348
CITATIONS - 8830277
MODE - +
REGULATED-ENTITY - PM00191
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10789
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6463
CITATIONS - 11101675
CITATIONS - 17921503
CITATIONS - 11101675:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3488308206:asantos
CITATIONS - 11101675:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3488308206:asantos
CITATIONS - 12475930:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3488308206:asantos
CITATIONS - 17921503:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3488308206:asantos
CITATIONS - 17921503:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3488308206:asantos
MODE - -
REGULATED-ENTITY - PM0-10418
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6052
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-17
CITATIONS - 9882673
MODE - +
REGULATED-ENTITY - PM00291
REGULATOR - PC00084
//
UNIQUE-ID - REG0-11481
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8227
CITATIONS - 22295907
MODE - -
REGULATED-ENTITY - PM0-46179
REGULATOR - PD00519
//
UNIQUE-ID - REG0-6425
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1422
CITATIONS - [10368146]
MODE - +
REGULATED-ENTITY - PM0-1783
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4538
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00549
CITATIONS - 1429433
CITATIONS - 8057356
MODE - +
REGULATED-ENTITY - PM00061
REGULATOR - PC00027
//
UNIQUE-ID - REG0-9367
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7529
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM167
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4912
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS622
CITATIONS - [9852003]
MODE - +
REGULATED-ENTITY - PM00625
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5287
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8199
CITATIONS - 10216857
CITATIONS - 8955407
MODE - -
REGULATED-ENTITY - PM00540
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5661
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7316
CITATIONS - 9582281
MODE - -
REGULATED-ENTITY - PM0-9556
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10761
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7894
CITATIONS - 10564497
MODE - +
REGULATED-ENTITY - PM339
REGULATOR - CPLX0-8062
//
UNIQUE-ID - REG0-6036
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1645
CITATIONS - [9880556]
MODE - +
REGULATED-ENTITY - PM166
REGULATOR - MONOMER0-562
//
UNIQUE-ID - REG0-11456
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8208
CITATIONS - 22223481
CITATIONS - 23690622
MODE - +
REGULATED-ENTITY - PM00490
REGULATOR - CPLX0-8075
//
UNIQUE-ID - REG0-6409
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1704
CITATIONS - [11810262]
MODE - +
REGULATED-ENTITY - PM0-2222
REGULATOR - PC00027
//
UNIQUE-ID - REG0-4522
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS109
CITATIONS - [7050087]
CITATIONS - [8501030]
CITATIONS - [9302020]
CITATIONS - 8057356
CITATIONS - 1528882
CITATIONS - 8736541
MODE - +
REGULATED-ENTITY - PM00060
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9351
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7513
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM0-7321
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4895
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00567
CITATIONS - 9371462
CITATIONS - 18648770
COMMENT - The effect of FruR repression of the <i>adhE</i> gene was studied under aerobic and anaerobic growth conditions, and stronger repression was observed during aerobic growth. Neither respiratory condition implies direct regulation, but they may reflect a difference of fructose or fructose-1,6-diphosphate levels |CITS: [9371462]|. Later, the FruR site was localized downstream of the promoter,  and it has been proposed as a repressor site |CITS: [12083772]| (as it has been observed that other FruR repressor sites are overlapping or downstream of the promoter) (see |CITS: [8655535]|).
MODE - -
REGULATED-ENTITY - PM00279
REGULATOR - PC00061
//
UNIQUE-ID - REG0-5271
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00754
CITATIONS - 9582281
MODE - -
REGULATED-ENTITY - PM00632
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5645
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00034
MODE - -
REGULATED-ENTITY - PM00016
REGULATOR - MONOMER-48
//
UNIQUE-ID - REG0-10729
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7877
CITATIONS - 20105222
MODE - -
REGULATED-ENTITY - PM00597
REGULATOR - G7571-MONOMER
//
UNIQUE-ID - REG0-6020
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7138
CITATIONS - 9352908
CITATIONS - 9595659
CITATIONS - 9922259
MODE - -
REGULATED-ENTITY - PM00560
REGULATOR - PD00288
//
UNIQUE-ID - REG0-11418
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8199
CITATIONS - 8955407
CITATIONS - 10216857
MODE - -
REGULATED-ENTITY - PM561
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6393
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5821
CITATIONS - 9878422
CITATIONS - 9302010
MODE - +
REGULATED-ENTITY - PM0-1981
REGULATOR - EG12344-MONOMER
//
UNIQUE-ID - REG0-4506
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2963
CITATIONS - 11448880
MODE - -
REGULATED-ENTITY - PM00054
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-9322
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7499
CITATIONS - 17768236
MODE - +
REGULATED-ENTITY - PM00037
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4879
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2185
CITATIONS - 10802181
MODE - -
REGULATED-ENTITY - PM00527
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-5254
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00444
CITATIONS - 6411928
MODE - +
REGULATED-ENTITY - PM00258
REGULATOR - PD00360
//
UNIQUE-ID - REG0-5629
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00655
CITATIONS - 9851989
MODE - +
REGULATED-ENTITY - PM00591
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10696
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7860
CITATIONS - 8087856
CITATIONS - 7868602
MODE - +
REGULATED-ENTITY - PM0-10525
REGULATOR - PD00214
//
UNIQUE-ID - REG0-6004
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7287
CITATIONS - 10506196
COMMENT - We have assigned the positive function for these sites (-77, -134) since IHF normally activates at this distance.
MODE - +
REGULATED-ENTITY - PM169
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11381
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8183
CITATIONS - 22101843
MODE - +
REGULATED-ENTITY - PM0-10381
REGULATOR - CPLX0-7721
//
UNIQUE-ID - REG0-6377
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7250
CITATIONS - 17233826
MODE - -
REGULATED-ENTITY - PM00550
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4489
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4702
MODE - +
REGULATED-ENTITY - PM00049
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-9289
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7486
CITATIONS - 17921503
CITATIONS - 17921503:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3409862169:martin
CITATIONS - 17921503:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3409862169:martin
MODE - -
REGULATED-ENTITY - PM0-4201
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4862
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4428
CITATIONS - 8120010
CITATIONS - 11673423
CITATIONS - 8763946
MODE - -
REGULATED-ENTITY - PM00423
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5238
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3808
CITATIONS - 14702398
MODE - +
REGULATED-ENTITY - PM00252
REGULATOR - EG11544-MONOMER
//
UNIQUE-ID - REG0-5613
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6841
CITATIONS - 9663683
COMMENT - |CITS:[9663683]| mentioned that they do not know if the inhibitory effect of H-NS on transcription from osmCp1 is direct or indirect. The effect on osmCp1 was independent of &sigma;<sup>S</sup>.
MODE - -
REGULATED-ENTITY - PM00544
REGULATOR - PD00288
//
UNIQUE-ID - REG0-10671
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7848
CITATIONS - 9294462
CITATIONS - 11443091
MODE - -
REGULATED-ENTITY - PM0-2281
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5988
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00555
CITATIONS - 8230210
MODE - +
REGULATED-ENTITY - PM00303
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11352
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8171
CITATIONS - 22059728
MODE - +
REGULATED-ENTITY - PM0-46172
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6361
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2203
CITATIONS - 10915804
CITATIONS - 15773991
MODE - +
REGULATED-ENTITY - PM0-3304
REGULATOR - CPLX0-7708
//
UNIQUE-ID - REG0-4472
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00228
CITATIONS - 23029459
MODE - -
REGULATED-ENTITY - PM00110
REGULATOR - PD01520
//
UNIQUE-ID - REG0-9270
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7472
CITATIONS - 12694615
CITATIONS - 19352034
MODE - +
REGULATED-ENTITY - PM0-9855
REGULATOR - PHOSPHO-EVGA
//
UNIQUE-ID - REG0-4846
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4341
CITATIONS - 12730174
COMMENT - CRP binds in just one site and activates <i>argG</i> gene expresion and represses the expression of the divergent operon, <i>metY-yhbC-nusA-infB</i>.
MODE - -
REGULATED-ENTITY - PM00672
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5222
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1523
CITATIONS - [10464268]
CITATIONS - [10469172]
MODE - -
REGULATED-ENTITY - PM00409
REGULATOR - PD01896
//
UNIQUE-ID - REG0-5594
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00338
COMMENT - This region contains a possible cAMP/CAP-binding site. Because the site is far upstream of the promoter and occurs only as a single copy, in contrast to the three copies in a typical cAMP/CAP-controlled <i>mal</i> promoter, it is unlikely that it is functional in the expression of <i>malS</i>.
MODE - +
REGULATED-ENTITY - PM00185
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10612
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7836
CITATIONS - 19906180
MODE - +
REGULATED-ENTITY - PM0-9890
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-5972
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00503
CITATIONS - 11555297
MODE - -
REGULATED-ENTITY - PM00296
REGULATOR - PD02198
//
UNIQUE-ID - REG0-11318
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8158
CITATIONS - 10600368
MODE - -
REGULATED-ENTITY - PM0-1501
REGULATOR - CPLX0-7671
//
UNIQUE-ID - REG0-6345
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2043
CITATIONS - [10594821]
CITATIONS - 21276095
MODE - -
REGULATED-ENTITY - PM00457
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-12328
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8498
CITATIONS - 26010043
MODE - +
REGULATED-ENTITY - PM0-9849
REGULATOR - MONOMER0-1
//
UNIQUE-ID - REG0-9229
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7456
CITATIONS - 17513468
MODE - -
REGULATED-ENTITY - PM00218
REGULATOR - EG11088-MONOMER
//
UNIQUE-ID - REG0-4829
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7233
CITATIONS - 8018734
COMMENT - It is important to note that the CRP site position at the <i>serC-aroA</i> operon is unusual for this regulator |CITS: [9171388]|.
MODE - -
REGULATED-ENTITY - PM921
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5205
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6980
MODE - -
REGULATED-ENTITY - PM00354
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5578
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00356
CITATIONS - 14499937
CITATIONS - 10347150
CITATIONS - 8626289
CITATIONS - 12391883
MODE - -
REGULATED-ENTITY - PM00179
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-10592
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7820
CITATIONS - 20023096
MODE - -
REGULATED-ENTITY - PM68
REGULATOR - CPLX-172
//
UNIQUE-ID - REG0-5956
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6821
CITATIONS - 11929525
CITATIONS - 11004182
CITATIONS - 7854119
CITATIONS - 9302020
CITATIONS - 15978080
CITATIONS - 8501030
COMMENT - NarP appears to weakly antagonize the activation of <i>nrfA</i> by  NarL at low  nitrate concentrations  |CITS:[11004182]|. 
/
/<i>nrf</i> expression is increased in response to nitrite or nitrate ions by NarL or NarP. FNR and NarL/NarP act by promoting open complex formation by RNAP at the <i>nrf</i> promoter. Although it seems that NarL and FNR can bind to their targets independently, NarL is unable to activate the <i>nrf</i> promoter in the absence of FNR |CITS: [15978080]|. NarL and IHF cannot bind together, and the other protein regulator can bind together to form ternary complexes. Fis binds independently of FNR and IHF. |CITS: [15978080]| supposed that Fis block access of RNAP to the <i>nrf</i> promoter.
/
MODE - +
REGULATED-ENTITY - PM00280
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-11258
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8142
CITATIONS - 21890697
MODE - +
REGULATED-ENTITY - PM00258
REGULATOR - CPLX0-7669
//
UNIQUE-ID - REG0-6329
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2265
CITATIONS - 10998176
CITATIONS - 12754220
CITATIONS - 16140031
COMMENT - Under anaerobiosis, FNR repress <i>cydAB</i> operon expression |CITS: [12754220]|.
MODE - -
REGULATED-ENTITY - PM0-3342
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-12232
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8482
CITATIONS - 25568260
CITATIONS - 25568260:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3642105879:asantos
MODE - +
REGULATED-ENTITY - PM0-2001
REGULATOR - MONOMER0-4341
//
UNIQUE-ID - REG0-9135
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7438
CITATIONS - 2139473
MODE - -
REGULATED-ENTITY - PM00228
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4813
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00053
CITATIONS - 2170326
CITATIONS - 8969182
CITATIONS - 1649947
CITATIONS - 1661372
CITATIONS - 1647022
CITATIONS - 1655726
CITATIONS - 8221894
CITATIONS - 845188
CITATIONS - 8394345
CITATIONS - 11574471
CITATIONS - 12667072
MODE - -
REGULATED-ENTITY - PM00025
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5189
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6975
CITATIONS - 7601827
MODE - -
REGULATED-ENTITY - PM00353
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5561
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7041
CITATIONS - 15699038
COMMENT - ArcA  represses <i>oppA</i> gene expression under anaerobiosis. Three putative ArcA-binding sites were  identified  upstream of this gene, but their sequence  was not reported |CITS: [15699038]|.
MODE - -
REGULATED-ENTITY - PM00306
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5558
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00219
CITATIONS - 6319708
MODE - +
REGULATED-ENTITY - PM00104
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10557
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7801
CITATIONS - 2162467
CITATIONS - 1328649
MODE - -
REGULATED-ENTITY - PM00486
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5933
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6933
CITATIONS - 12453212
MODE - +
REGULATED-ENTITY - PM00312
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-6310
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3221
CITATIONS - 11274153
MODE - +
REGULATED-ENTITY - PM0-4381
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-11238
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8123
CITATIONS - 21908668
MODE - +
REGULATED-ENTITY - PM0-46155
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-12192
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8464
CITATIONS - 25375160
MODE - +
REGULATED-ENTITY - TU0-14299
REGULATOR - G6789-MONOMER
//
UNIQUE-ID - REG0-9066
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7419
CITATIONS - 17616594
MODE - +
REGULATED-ENTITY - PM00155
REGULATOR - PC00027
//
UNIQUE-ID - REG0-4797
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00542
MODE - +
REGULATED-ENTITY - PM00019
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5170
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1002
CITATIONS - [9159398]
CITATIONS - 12366850
CITATIONS - 16861804
MODE - +
REGULATED-ENTITY - PM00618
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-5542
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7181
CITATIONS - 16140472
MODE - -
REGULATED-ENTITY - PM00098
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10513
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7788
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM0-10435
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5917
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3812
CITATIONS - 9537375
CITATIONS - 9657988
MODE - +
REGULATED-ENTITY - PM00315
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6293
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2962
CITATIONS - 11448880
CITATIONS - 16515535
CITATIONS - 2419307
MODE - -
REGULATED-ENTITY - PM00490
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-11211
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8110
CITATIONS - 21559929
MODE - +
REGULATED-ENTITY - PM00536
REGULATOR - PC00061
//
UNIQUE-ID - REG0-12127
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8446
CITATIONS - 25103863
MODE - +
REGULATED-ENTITY - TU0-42593
REGULATOR - CPLX0-2781
//
UNIQUE-ID - REG0-9041
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7387
CITATIONS - 17496099
MODE - -
REGULATED-ENTITY - PM0-1182
REGULATOR - CPLX0-8061
//
UNIQUE-ID - REG0-4781
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00020
CITATIONS - 1640463
CITATIONS - 1640456
CITATIONS - 17074904
MODE - -
REGULATED-ENTITY - PM00009
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-5154
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS521
CITATIONS - [10794600]
MODE - -
REGULATED-ENTITY - PM334
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5529
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00730
MODE - -
REGULATED-ENTITY - PM00089
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10492
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7773
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM00372
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5901
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00327
CITATIONS - 11976297
MODE - +
REGULATED-ENTITY - PM00174
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6277
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3402
CITATIONS - 9401019
COMMENT - It was not identified which of two promoters of the <i>als</i> operon was repressed by AlsR, but we inferred that both are repressed, because they are very closed.
MODE - -
REGULATED-ENTITY - PM0-4742
REGULATOR - G7821-MONOMER
//
UNIQUE-ID - REG0-11112
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8094
CITATIONS - 21272324
MODE - +
REGULATED-ENTITY - PM00326
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-12039
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8431
CITATIONS - 24593230
MODE - +
REGULATED-ENTITY - PM0-10382
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9009
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7228
CITATIONS - 12354237
CITATIONS - 21464593
MODE - -
REGULATED-ENTITY - PM0-9218
REGULATOR - EG10125-MONOMER
//
UNIQUE-ID - REG0-4765
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00006
CITATIONS - 8980677
CITATIONS - 9600836
CITATIONS - 1848302
MODE - -
REGULATED-ENTITY - PM00003
REGULATOR - PC00003
//
UNIQUE-ID - REG0-5138
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6967
CITATIONS - 15659676
MODE - +
REGULATED-ENTITY - PM00324
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5513
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00637
CITATIONS - 2139650
CITATIONS - 9767576
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM00088
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10476
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7758
CITATIONS - 19633077
MODE - -
REGULATED-ENTITY - PM0-7561
REGULATOR - EG10087-MONOMER
//
UNIQUE-ID - REG0-5885
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7128
CITATIONS - 16621816
MODE - -
REGULATED-ENTITY - PM00151
REGULATOR - EG10694-MONOMER
//
UNIQUE-ID - REG0-11094
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8083
CITATIONS - 21421764
MODE - +
REGULATED-ENTITY - PM0-10013
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6264
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4361
CITATIONS - 11751865
CITATIONS - 12142437
CITATIONS - 12529359
CITATIONS - 15375149
CITATIONS - 15694381
COMMENT - This NorR-binding site  ( -111), which contains the inverted repeat GTCA-(N3)-CGAC, is considered to be of low -affinity. 
MODE - +
REGULATED-ENTITY - PM0-4681
REGULATOR - EG12108-MONOMER
//
UNIQUE-ID - REG0-12003
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8413
CITATIONS - 24089053
MODE - -
REGULATED-ENTITY - TU0-13634
REGULATOR - EG10442-MONOMER
//
UNIQUE-ID - REG0-8993
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3562
CITATIONS - 15066032
COMMENT - ChbR and NagC appear to act as repressors for the <i>chbB</i> operon in the absence of the inducing sugar chitobiose |CITS:[15066032]|.
MODE - -
REGULATED-ENTITY - PM183
REGULATOR - EG10143-MONOMER
//
UNIQUE-ID - REG0-4748
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7066
CITATIONS - 12492863
MODE - -
REGULATED-ENTITY - PM00001
REGULATOR - CPLX0-7605
//
UNIQUE-ID - REG0-5120
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3561
CITATIONS - 15066032
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM183
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5496
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00325
CITATIONS - 2231717
MODE - +
REGULATED-ENTITY - PM00140
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10458
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7742
CITATIONS - 12029030
CITATIONS - 19400769
MODE - +
REGULATED-ENTITY - PM0-7661
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5868
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00291
CITATIONS - [7592392]
MODE - -
REGULATED-ENTITY - PM00146
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11078
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8071
CITATIONS - 21272324
MODE - +
REGULATED-ENTITY - PM687
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6247
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3622
CITATIONS - 1649816
CITATIONS - 16934214
CITATIONS - 1569008
CITATIONS - 3907860
CITATIONS - 15385551
CITATIONS - 12881519
CITATIONS - 9737918
MODE - -
REGULATED-ENTITY - PM0-4942
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11961
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8399
CITATIONS - 24078635
MODE - +
REGULATED-ENTITY - PM0-44438
REGULATOR - G6175-MONOMER
//
UNIQUE-ID - REG0-8951
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7356
CITATIONS - 10760155
MODE - -
REGULATED-ENTITY - PM0-9611
REGULATOR - PC00010
//
UNIQUE-ID - REG0-4732
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00115
CITATIONS - 2538630
CITATIONS - 1824723
CITATIONS - 11013224
MODE - +
REGULATED-ENTITY - PM00047
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5104
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2181
CITATIONS - 10766858
COMMENT - This site of CRP binding is also used to regulate the divergent paaAp promoter.
MODE - +
REGULATED-ENTITY - PM4
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5479
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7237
CITATIONS - 8892849
MODE - -
REGULATED-ENTITY - PM00132
REGULATOR - CPLX0-2021
//
UNIQUE-ID - REG0-10426
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7726
CITATIONS - 18997424
CITATIONS - 22101843
CITATIONS - 9701802
CITATIONS - 9701802:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3535301930:martin
CITATIONS - 9701802:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3535301930:martin
CITATIONS - 18997424:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3535301930:martin
CITATIONS - 18997424:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3535301930:martin
CITATIONS - 22101843:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3535301930:martin
CITATIONS - 22101843:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3535301930:martin
MODE - +
REGULATED-ENTITY - PM0-10380
REGULATOR - PHOSPHO-DPIA
//
UNIQUE-ID - REG0-5852
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6945
CITATIONS - 8107138
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00142
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-11062
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8056
CITATIONS - 21421764
MODE - +
REGULATED-ENTITY - PM0-9416
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6231
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3521
CITATIONS - 10608803
CITATIONS - 10048032
COMMENT - <i>zntA</i> expression is controlled by the ZntR transcriptional activator in the presence of nanomolar levels of intracellular zinc <i>in vivo</i>|CITS:[22459916]|.
MODE - +
REGULATED-ENTITY - PM0-4863
REGULATOR - CPLX0-7678
//
UNIQUE-ID - REG0-11898
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8384
CITATIONS - 18177266
MODE - -
REGULATED-ENTITY - PM0-10229
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-6607
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7216
CITATIONS - 9043126
CITATIONS - 24013633
MODE - +
REGULATED-ENTITY - PM0-46300
REGULATOR - G6706-MONOMER
//
UNIQUE-ID - REG0-4716
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5468
CITATIONS - 2160266
CITATIONS - 6379600
MODE - -
REGULATED-ENTITY - PM00045
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5088
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7253
CITATIONS - 17233826
MODE - -
REGULATED-ENTITY - PM00547
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5462
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00258
CITATIONS - 12207706
CITATIONS - 3308851
COMMENT - The TyrR-binding site at position bp 19.5 downstream of the promoter is a weak TyrR box that is involved in the repression of <i>tyrB</i> gene transcription. For this repression, it is necessary that TyrR, with tyrosine or phenylalanine, binds to this site and another strong site located 42.5 bp downstream from the promoter |CITS:[12207706]|.
MODE - -
REGULATED-ENTITY - PM00124
REGULATOR - MONOMER0-162
//
UNIQUE-ID - REG0-10382
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7708
CITATIONS - 17068078
MODE - +
REGULATED-ENTITY - PM0-10364
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5836
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00777
MODE - +
REGULATED-ENTITY - PM00647
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-11037
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8044
CITATIONS - 8021189
MODE - -
REGULATED-ENTITY - PM0-8864
REGULATOR - EG10442-MONOMER
//
UNIQUE-ID - REG0-6215
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4163
CITATIONS - 9537375
CITATIONS - 9657988
MODE - -
REGULATED-ENTITY - PM0-5168
REGULATOR - PD03585
//
UNIQUE-ID - REG0-11820
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8368
CITATIONS - 23651393
MODE - +
REGULATED-ENTITY - PM0-45010
REGULATOR - MONOMER-60
//
UNIQUE-ID - REG0-6590
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8
CITATIONS - 8593953
COMMENT - OxyR regulates <i>gor</i> gene expression in response to H<sub>2</sub>O<sub>2</sub> during the exponential phase. This gene was induced by <i>rpoS</i> in stationary phase |CITS:[8593953]|.
MODE - +
REGULATED-ENTITY - PM0-15
REGULATOR - PD00214
//
UNIQUE-ID - REG0-4699
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5724
CITATIONS - 9179845
MODE - -
REGULATED-ENTITY - PM00039
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5072
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3817
CITATIONS - 14702398
MODE - +
REGULATED-ENTITY - PM00511
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-5446
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00707
CITATIONS - 2836193
CITATIONS - 10411720
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00164
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-10268
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7692
CITATIONS - 18586269
MODE - -
REGULATED-ENTITY - PM103
REGULATOR - PUTA-MONOMER
//
UNIQUE-ID - REG0-5820
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00354
COMMENT - Although no CytR-binding sites have been identified, it was suggested that the CytR protein could bind cooperatively to a region between the two CRP-binding sites, as in the regulatory regions of the <i>deo</i> and <i>cdd</i> operons |CITS: [8022285]|.
MODE - -
REGULATED-ENTITY - PM00199
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-10992
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7672
CITATIONS - 18083817
CITATIONS - 12730179
MODE - +
REGULATED-ENTITY - PM928
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6199
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7223
CITATIONS - 11844765
MODE - +
REGULATED-ENTITY - PM0-5441
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-11752
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8353
CITATIONS - 9813115
MODE - -
REGULATED-ENTITY - PM0-46264
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-6574
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-33
CITATIONS - 10542180
MODE - -
REGULATED-ENTITY - PM0-8
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-4683
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00092
CITATIONS - 1556120
MODE - -
REGULATED-ENTITY - PM00037
REGULATOR - PD03576
//
UNIQUE-ID - REG0-5056
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2343
CITATIONS - 11123679
COMMENT - Hns most strongly represses the cydAp4 promoter and has a moderate effect on cydAp1, cydAp2, and cydAp3 promoters. Hns regulates <i>cydAB</i> expression negatively in anaerobiosis and aerobiosis, but ArcA antagonizes its action in anaerobiosis.
MODE - -
REGULATED-ENTITY - PM439
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5430
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS44
CITATIONS - [8626294]
CITATIONS - [8892825]
MODE - -
REGULATED-ENTITY - PM00156
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10175
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7676
CITATIONS - 18648770
MODE - -
REGULATED-ENTITY - PM00276
REGULATOR - PC00061
//
UNIQUE-ID - REG0-5804
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5361
CITATIONS - 9418241
COMMENT - Both proteins, FNR and ArcA,  activate the expression of <i>fumB</i> under anaerobiosis, but they act independently from each other. Salmon et al. |CITS: [15699038]| identified five putative ArcA-binding sites at positions bp 242, 260, 370, 376, and 381 upstream of the <i>fumB</i> gene, but the sequences of them were not reported.
MODE - +
REGULATED-ENTITY - PM00219
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10976
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8023
CITATIONS - 12446650
CITATIONS - 12730179
MODE - -
REGULATED-ENTITY - PM461
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6183
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3927
CITATIONS - 6281232
MODE - +
REGULATED-ENTITY - PM0-5285
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11695
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8340
CITATIONS - 22522900
MODE - -
REGULATED-ENTITY - PM0-10033
REGULATOR - EG12431-MONOMER
//
UNIQUE-ID - REG0-6553
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7055
CITATIONS - 15941987
MODE - +
REGULATED-ENTITY - PM-8784
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-4667
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00076
CITATIONS - 2858855
MODE - +
REGULATED-ENTITY - PM00034
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9883
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7648
CITATIONS - 18723630
CITATIONS - 18723630:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3435415204:asantos
CITATIONS - 18723630:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3435415204:asantos
CITATIONS - 18723630:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3435415204:asantos
MODE - +
REGULATED-ENTITY - PM0-10276
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5040
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5321
CITATIONS - 9371449
MODE - +
REGULATED-ENTITY - PM68
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5414
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7338
CITATIONS - 17464064
MODE - +
REGULATED-ENTITY - PM0-9588
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10087
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7663
CITATIONS - 19007420
MODE - -
REGULATED-ENTITY - PM0-7421
REGULATOR - MONOMER-53
//
UNIQUE-ID - REG0-5788
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6882
CITATIONS - 9302020
CITATIONS - 12923080
MODE - -
REGULATED-ENTITY - PM00217
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-10958
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8013
CITATIONS - 14702398
CITATIONS - 18808381
CITATIONS - 18083817
COMMENT - GadX has a positive direct or indirect effect on the <i>hdeAB-yhiD</i> operon only in stationary-phase cells at pH 5.5, but it is a repressor in exponential growth phase at pH 7.0 |CITS: [18083817]|.
MODE - +
REGULATED-ENTITY - PM928
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6165
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4346
CITATIONS - 12730174
CITATIONS - 1640456
CITATIONS - 17074904
MODE - -
REGULATED-ENTITY - PM0-5741
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-11651
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8326
CITATIONS - 23071782
MODE - -
REGULATED-ENTITY - PM0-7561
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-6537
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7170
CITATIONS - 16677314
MODE - +
REGULATED-ENTITY - PM0-8918
REGULATOR - G7326-MONOMER
//
UNIQUE-ID - REG0-4651
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5941
CITATIONS - 8982002
MODE - -
REGULATED-ENTITY - PM00032
REGULATOR - PD00261
//
UNIQUE-ID - REG0-9607
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7637
CITATIONS - 8709849
MODE - -
REGULATED-ENTITY - PM0-10074
REGULATOR - PC00010
//
UNIQUE-ID - REG0-5024
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS441
CITATIONS - [8955407]
CITATIONS - [10216857]
MODE - -
REGULATED-ENTITY - PM561
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5398
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7297
CITATIONS - 11118204
MODE - -
REGULATED-ENTITY - PM0-9516
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5772
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6261
CITATIONS - 12754220
COMMENT - Under anaerobiosis, FNR activates <i>fdhF</i> gene expression, but it is not known if this regulation is direct or indirect  |CITS: [12754220]|.
/
/This regulatory interaction was determined only by microarray analysis.
MODE - +
REGULATED-ENTITY - PM00208
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10931
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7999
CITATIONS - 21034467
MODE - -
REGULATED-ENTITY - PM0-10288
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6148
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5450
CITATIONS - 14731281
COMMENT - The AgaR operator sites farthest from the transcriptional start sites of <i>agaS</i> have not been experimentaly verified. They were inferred by computational analysis, based on similarity to the consensus sequence.
MODE - -
REGULATED-ENTITY - PM0-6883
REGULATOR - G7630-MONOMER
//
UNIQUE-ID - REG0-11632
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8310
CITATIONS - 23010927
MODE - +
REGULATED-ENTITY - PM0-46235
REGULATOR - PD00406
//
UNIQUE-ID - REG0-6521
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4243
CITATIONS - 11932447
COMMENT - PdhR is a weak repressor of <i>yfiD</i> expression.
MODE - -
REGULATED-ENTITY - PM0-1303
REGULATOR - EG11088-MONOMER
//
UNIQUE-ID - REG0-4635
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5981
CITATIONS - 15988767
COMMENT - The negative effect of ArcA on <i>fnr</i> expression is slight; this was found using QRT-PCR.
MODE - -
REGULATED-ENTITY - PM00029
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-9588
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7824
CITATIONS - 15743955
CITATIONS - 15743955:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3487970175:asantos
CITATIONS - 15743955:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3487970175:asantos
CITATIONS - 15743955:EV-EXP-IMP-SITE-MUTATION:3487970175:asantos
MODE - +
REGULATED-ENTITY - PM0-10233
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5007
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1742
CITATIONS - [11976288]
CITATIONS - [12446650]
CITATIONS - 16980449
CITATIONS - 15795232
CITATIONS - 12730179
MODE - +
REGULATED-ENTITY - PM461
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-5382
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00773
MODE - +
REGULATED-ENTITY - PM00644
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5756
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00682
CITATIONS - 1372899
MODE - +
REGULATED-ENTITY - PM00238
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10912
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7982
COMMENT - J. Oberto in 2010 identified a possible binding site for NagC, GGTAATTCACTATTCGAATTATA, in the upstream region of the <i>feoA</i> gene. The demonstration was based on different statistical methods |CITS:[21070640]|. In this case the regulator requires two binding sites to repress the transcription of the <i>feoA</i> gene, and for this reason the function of this binding site cannot be predicted.
REGULATED-ENTITY - PM0-8860
REGULATOR - PD00266
//
UNIQUE-ID - REG0-6132
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5521
CITATIONS - 15743943
MODE - -
REGULATED-ENTITY - PM0-7183
REGULATOR - G7678-MONOMER
//
UNIQUE-ID - REG0-11605
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8296
CITATIONS - 22752906
REGULATED-ENTITY - PM00147
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6505
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4204
CITATIONS - 15252051
MODE - -
REGULATED-ENTITY - PM0-1301
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-4619
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00177
CITATIONS - 2198266
CITATIONS - 21572102
MODE - -
REGULATED-ENTITY - PM00076
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-9555
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7605
CITATIONS - 18405378
MODE - -
REGULATED-ENTITY - PM00252
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-4989
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1762
CITATIONS - 16980449
CITATIONS - [11976288]
CITATIONS - [12446650]
CITATIONS - 15795232
CITATIONS - 12730179
MODE - +
REGULATED-ENTITY - PM450
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-5366
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00223
MODE - -
REGULATED-ENTITY - PM00106
REGULATOR - PC00040
//
UNIQUE-ID - REG0-5740
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7040
CITATIONS - 15699038
COMMENT - ArcA  represses <i>gatY</i> gene expression under anaerobiosis. Two putative ArcA-binding sites were  identified upstream of this gene, but their sequence was not shown |CITS: [15699038]|.
MODE - -
REGULATED-ENTITY - PM00232
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10895
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7967
CITATIONS - 21115656
MODE - -
REGULATED-ENTITY - PM167
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6116
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5966
CITATIONS - 8982002
CITATIONS - 19007420
MODE - -
REGULATED-ENTITY - PM0-7421
REGULATOR - PD00261
//
UNIQUE-ID - REG0-11578
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8282
MODE - +
REGULATED-ENTITY - TU0-42498
REGULATOR - PHOSPHO-BASR
//
UNIQUE-ID - REG0-6488
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2483
CITATIONS - 12003934
MODE - +
REGULATED-ENTITY - PM0-1163
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-4603
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7239
CITATIONS - 17159291
COMMENT - Although H-NS cannot activate relAp2 by itself, it can positively regulate relAp2 activity together with CRP, since H-NS induces conformational changes in the relAp2 transcriptional region that facilitate the CRP binding |CITS: [17159291]|.
MODE - +
REGULATED-ENTITY - PM0-9355
REGULATOR - PD00288
//
UNIQUE-ID - REG0-9479
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7592
CITATIONS - 18263722
MODE - +
REGULATED-ENTITY - PM224
REGULATOR - CPLX0-7689
//
UNIQUE-ID - REG0-4973
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS475
CITATIONS - [8913296]
COMMENT - FIS represses the hupBp3 promoter only when CRP is absent.
MODE - -
REGULATED-ENTITY - PM589
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5348
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3141
CITATIONS - 11357510
MODE - -
REGULATED-ENTITY - PM0-4427
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5724
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00466
CITATIONS - [8729576]
CITATIONS - [10464228]
CITATIONS - 16078372
CITATIONS - 4349027
MODE - -
REGULATED-ENTITY - PM00273
REGULATOR - CPLX0-7975
//
UNIQUE-ID - REG0-10877
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7952
CITATIONS - 21029047
COMMENT - It  was demonstrated that PhoP is able to activate the expression of each gene in the operon |CITS:[21029047]|.
MODE - +
REGULATED-ENTITY - PM0-36176
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-6100
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5842
CITATIONS - 15805526
CITATIONS - 19633077
MODE - +
REGULATED-ENTITY - PM0-7561
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11533
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8265
CITATIONS - 11121068
MODE - +
REGULATED-ENTITY - PM0-3781
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-6472
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7147
CITATIONS - 16238633
COMMENT - Based on studies of binding sites with gel shift and footprinting with Lrp and H-NS regulator proteins, it was demonstrated that both proteins interact with obvious synergism in the repression of all seven <i>E. coli</i> <i>rrn</i> P1 promoter upstream regions; as a result, they help the efficient shutdown of rRNA synthesis.  Likewise, both proteins could be a transient heteromer via a protein-protein interaction that interferes with the RNA polymerase, and in this way it alters the DNA of the upstream regions of all seven ribosomal P1 promoters |CITS: [16238633]|.
/
/
MODE - -
REGULATED-ENTITY - PM0-1349
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-4584
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6963
CITATIONS - 15659676
MODE - +
REGULATED-ENTITY - PM00066
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9424
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7578
CITATIONS - 18055596
COMMENT - H-NS binds to the center region between the divergent promoters and to sites located distally from the two yjjQp and yjjPp promoters |CITS: [18055596]|.
MODE - -
REGULATED-ENTITY - PM0-9877
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4957
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6995
CITATIONS - 15879709
MODE - +
REGULATED-ENTITY - PM643
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5332
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-881
CITATIONS - [9575233]
CITATIONS - 15659676
MODE - -
REGULATED-ENTITY - PM00605
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-5706
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4623
CITATIONS - 16621812
MODE - +
REGULATED-ENTITY - PM00175
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10832
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7935
CITATIONS - 20713450
COMMENT - McbR activates &sigma;<sup>S</sup>-dependent transcription at <i>yciG</i>p by countering the negative effect of H-NS |CITS:[20713450]|, i.e., &sigma;<sup>S</sup> induces expression of the <i>yciGFE</i> operon only when H-NS-mediated repression is relieved. Repression of <i>yciGFE</i> by H-NS is inversely correlated with &sigma;<sup>S</sup> levels |CITS:[20713450]|.
MODE - +
REGULATED-ENTITY - PM0-9320
REGULATOR - G6761-MONOMER
//
UNIQUE-ID - REG0-6084
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6461
CITATIONS - 11101675
MODE - -
REGULATED-ENTITY - PM0-8061
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-11512
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7309
CITATIONS - 16115199
MODE - -
REGULATED-ENTITY - PM00579
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6456
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5241
CITATIONS - 9632265
CITATIONS - 15686546
COMMENT - Paradoxically, even though H-NS is an inhibitor, it drives the bound RNA polymerase into open complexes |CITS: [15686546]|.
MODE - -
REGULATED-ENTITY - PM0-1343
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4567
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7038
CITATIONS - 16077119
MODE - +
REGULATED-ENTITY - PM00065
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-9402
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7559
CITATIONS - 17504942
CITATIONS - 21890697
CITATIONS - 19906180
CITATIONS - 18502871
COMMENT - The transcription of <i>argO</i>  is induced by ArgP when it is bound  to arginine, but it is inhibited when lysine is bound to ArgP |CITS: [17504942]|.
/
/ArgP regulates the <i>argO</i> operon by a mechanism involving active trapping at the <i>argO</i>p promoter by ArgP of RNA polymerase, which is then prevented from being released and engaging in productive transcription |CITS:[17504942][21890697]|.  
/
/
MODE - +
REGULATED-ENTITY - PM0-9890
REGULATOR - CPLX0-7671
//
UNIQUE-ID - REG0-4941
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7132
CITATIONS - 12791142
COMMENT - Rob regulates <i>acrAB</i> operon expression in response to decanoate, but the specific mechanism remains to be investigated |CITS: [12791142]|. The Rob induction complements the MarA and SoxS effects in this operon.
MODE - +
REGULATED-ENTITY - PM624
REGULATOR - PD04418
//
UNIQUE-ID - REG0-5316
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS342
CITATIONS - [8002608]
CITATIONS - 1346534
MODE - -
REGULATED-ENTITY - PM00630
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5690
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00663
CITATIONS - 2115441
CITATIONS - 8596434
CITATIONS - 15520470
COMMENT - In the absence of the other proteins, cAMP-CRP binds to three CRP targets centered at -92.5 (CRP2), -42.5 (CRP1), and +56 (CRPE).
/The <i>nupG</i> full repression complex contains CytR protein sandwiched between two cAMP-CRP complexes.
MODE - +
REGULATED-ENTITY - PM00173
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10811
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7919
CITATIONS - 20466769
MODE - -
REGULATED-ENTITY - PM00536
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-6065
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7077
CITATIONS - 16478729
COMMENT - MarA represses <i>rob</i> by steric hindrance |CITS:[20453091]|. This mar box has a backward orientation |CITS:[20453091]|.
MODE - -
REGULATED-ENTITY - PM0-8184
REGULATOR - PD00365
//
UNIQUE-ID - REG0-11494
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8238
CITATIONS - 18765794
CITATIONS - 22323519
MODE - -
REGULATED-ENTITY - PM0-9649
REGULATOR - EG11356-MONOMER
//
UNIQUE-ID - REG0-6440
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1181
CITATIONS - [10419964]
CITATIONS - [10564485]
CITATIONS - 11395452
MODE - +
REGULATED-ENTITY - PM0-1442
REGULATOR - PD00406
//
UNIQUE-ID - REG0-4551
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1121
CITATIONS - [9484902]
CITATIONS - 15225315
CITATIONS - 18757534
COMMENT - Although Fis and IHF repress FNR-dependent  activation of the <i>nir</i> promoter, they do not prevent FNR binding.  Thus, Fis, IHF, and FNR can bind simultaneously.
MODE - -
REGULATED-ENTITY - PM00062
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-9381
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7542
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM0-1781
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4925
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS761
CITATIONS - [9421904]
MODE - -
REGULATED-ENTITY - PM262
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5300
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00607
CITATIONS - 7565114
COMMENT - IHF inhibits osmEp expression at low osmolarity.
MODE - -
REGULATED-ENTITY - PM00543
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5674
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00761
CITATIONS - 10702265
COMMENT - The effect of RcsB on <i>rcsA</i> expression depends on the presence of the RcsA protein. There is a putative Rcs box (RcsA-RcsB)-binding site in the <i>rcsA</i> promoter region. Direct interaction of RcsB and/or RcsA in the <i>E. coli</i> <i>rcsA</i> promoter region remains to be shown. The RcsB effect on <i>rcsA</i> expression can be overcome by excess RcsA, indicating that RcsB functions as an auxiliary factor in <i>rcsA</i> expression.
MODE - +
REGULATED-ENTITY - PM00636
REGULATOR - PC00084
//
UNIQUE-ID - REG0-10786
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7903
CITATIONS - 17921503
CITATIONS - 12475930
CITATIONS - 11101675
MODE - -
REGULATED-ENTITY - PM0-8081
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6049
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00559
CITATIONS - 1624451
MODE - -
REGULATED-ENTITY - PM00313
REGULATOR - PD03585
//
UNIQUE-ID - REG0-11478
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8225
CITATIONS - 20659289
MODE - +
REGULATED-ENTITY - PM0-10544
REGULATOR - PD00519
//
UNIQUE-ID - REG0-6422
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5482
CITATIONS - 9864311
CITATIONS - 12897000
MODE - -
REGULATED-ENTITY - PM0-1781
REGULATOR - G7678-MONOMER
//
UNIQUE-ID - REG0-4535
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00145
CITATIONS - 1474901
CITATIONS - 8057356
MODE - +
REGULATED-ENTITY - PM00061
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9364
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7526
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM450
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4908
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS584
CITATIONS - [9254708]
CITATIONS - [8825783]
CITATIONS - 21890697
CITATIONS - 8995231
COMMENT - It has been shown that the <i>dnaAN-recF</i> operon is not regulated <i>in vivo</i> by ArgP |CITS:[21890697]|. However, ArgP slightly binds to the regulatory regions of <i>dnaA</i>p1 <i>in vitro</i>, as it exhibits low-affinity binding to ArgP |CITS:[21890697]|.
MODE - +
REGULATED-ENTITY - PM00466
REGULATOR - CPLX0-7669
//
UNIQUE-ID - REG0-5284
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8195
CITATIONS - 10216857
CITATIONS - 8955407
MODE - -
REGULATED-ENTITY - PM00540
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5658
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00637
COMMENT - CytR and CRP act  together  to repress transcription from the rpoHp3 promoter. A single CytR molecule binds between two CRP molecules. CRP-CytR-CRP.
MODE - -
REGULATED-ENTITY - PM00571
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10758
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7891
CITATIONS - 12067348
CITATIONS - 21097628
MODE - +
REGULATED-ENTITY - PM0-4864
REGULATOR - PD00406
//
UNIQUE-ID - REG0-6033
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS782
CITATIONS - [9335308]
MODE - +
REGULATED-ENTITY - PM961
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-11453
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8205
CITATIONS - 22223481
MODE - +
REGULATED-ENTITY - PM00141
REGULATOR - CPLX0-8075
//
UNIQUE-ID - REG0-6406
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1621
CITATIONS - [12446648]
CITATIONS - 11121068
MODE - +
REGULATED-ENTITY - PM0-2101
REGULATOR - G7072-MONOMER
//
UNIQUE-ID - REG0-4519
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS112
CITATIONS - 8057356
CITATIONS - 1528882
CITATIONS - 7050087
MODE - +
REGULATED-ENTITY - PM00060
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9348
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7510
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM00430
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4892
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS526
CITATIONS - 10572146
MODE - +
REGULATED-ENTITY - PM00279
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5268
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3782
CITATIONS - 12618441
MODE - -
REGULATED-ENTITY - PM00314
REGULATOR - PD03585
//
UNIQUE-ID - REG0-5642
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6943
CITATIONS - 8107138
MODE - -
REGULATED-ENTITY - PM00081
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-10722
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7873
CITATIONS - 15703297
MODE - +
REGULATED-ENTITY - PM0-10288
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-6017
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1282
CITATIONS - [12123461]
MODE - +
REGULATED-ENTITY - PM00576
REGULATOR - EG12123-MONOMER
//
UNIQUE-ID - REG0-11414
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8195
CITATIONS - 10216857
CITATIONS - 8955407
MODE - -
REGULATED-ENTITY - PM561
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6390
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7106
CITATIONS - 15520470
MODE - -
REGULATED-ENTITY - PM0-1963
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4503
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2966
CITATIONS - 11448880
MODE - -
REGULATED-ENTITY - PM00054
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-9319
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7496
CITATIONS - 17768236
MODE - +
REGULATED-ENTITY - PM00037
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4876
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS108
CITATIONS - 9696769
CITATIONS - 13129959
MODE - +
REGULATED-ENTITY - PM125
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5251
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2643
CITATIONS - 11121068
MODE - -
REGULATED-ENTITY - PM00254
REGULATOR - G7072-MONOMER
//
UNIQUE-ID - REG0-5626
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00653
COMMENT - This mechanism of regulation is not yet clearly elucidated. Lange and Hengge-Aronis have shown that the <i>rpoS</i> transcript is negatively regulated by the <i>cya</i> gene|CITS: [1849609]|. In contrast, McCann et al. reported that <i>rpoS</i> transcription was positively regulated by the <i>cya</i> gene product |CITS: [8458856]|.
REGULATED-ENTITY - PM00590
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10684
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7859
CITATIONS - 2183352
CITATIONS - 11443092
CITATIONS - 1730735
CITATIONS - 8087856
CITATIONS - 2693740
MODE - +
REGULATED-ENTITY - PM00043
REGULATOR - PD00214
//
UNIQUE-ID - REG0-6001
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3261
CITATIONS - 11160809
COMMENT - It seems that DnaA bound first at a site between the transcription start site and the  -10 sequence on the upper strand triggered the cooperative binding upon an increase of the number of bound molecules.
MODE - -
REGULATED-ENTITY - PM324
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-11378
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8180
CITATIONS - 22101843
CITATIONS - 22101843:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3535224000:asantos
MODE - -
REGULATED-ENTITY - PM0-10377
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6374
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1882
CITATIONS - [12123454]
MODE - -
REGULATED-ENTITY - PM0-2622
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-4486
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00234
CITATIONS - 8429549
CITATIONS - 2115869
CITATIONS - 2646291
CITATIONS - 8508774
CITATIONS - 8071194
CITATIONS - 8483418
CITATIONS - 8432705
CITATIONS - 12218014
CITATIONS - 3891724
CITATIONS - 1447135
MODE - +
REGULATED-ENTITY - PM00111
REGULATOR - PD00353
//
UNIQUE-ID - REG0-9286
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7487
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00227
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4859
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS661
CITATIONS - 11673423
CITATIONS - 8120010
MODE - -
REGULATED-ENTITY - PM00421
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5235
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00643
CITATIONS - 1999392
MODE - +
REGULATED-ENTITY - PM00493
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5610
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00316
CITATIONS - 3021588
MODE - -
REGULATED-ENTITY - PM00167
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10668
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7847
CITATIONS - 11443091
MODE - -
REGULATED-ENTITY - PM0-5201
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5985
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4602
CITATIONS - 11073923
MODE - +
REGULATED-ENTITY - PM00303
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11337
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8168
CITATIONS - 2543976:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3532870847:martin
CITATIONS - 2543976:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3532870847:martin
CITATIONS - 2643109:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3532870847:martin
CITATIONS - 7836282:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3532870847:martin
CITATIONS - 2673243
MODE - -
REGULATED-ENTITY - PM0-8604
REGULATOR - CPLX0-7752
//
UNIQUE-ID - REG0-6358
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2186
CITATIONS - 10644706
MODE - +
REGULATED-ENTITY - PM0-3284
REGULATOR - PD00214
//
UNIQUE-ID - REG0-4469
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7009
CITATIONS - 15883881
COMMENT - This regulatory interaction was identified by means of PhoPQ-related microarray experiments and it was checked for the presence of its regulatory motif in the promoter region |CITS: [15883881]|.
MODE - +
REGULATED-ENTITY - PM00110
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-9267
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7469
CITATIONS - 17919280
CITATIONS - 18515344
COMMENT - The site of the RutR-regulating <i>rutABCDEFG</i> may hinder contact between NtrC and &sigma;<sup>54</sup> by stiffening the DNA between the enhancer and the promoter |CITS:[1776167]|.
MODE - -
REGULATED-ENTITY - PM0-3847
REGULATOR - PD01352
//
UNIQUE-ID - REG0-4843
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4347
CITATIONS - 12730174
MODE - -
REGULATED-ENTITY - PM00672
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-5218
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2426
CITATIONS - 8002608
CITATIONS - 11601842
MODE - -
REGULATED-ENTITY - PM00401
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5591
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7005
CITATIONS - 15883881
COMMENT - This regulatory interaction was identified by means of PhoPQ-related microarray experiments, which checked for the presence of the regulatory motif in the promoter region |CITS: [15883881]|.
MODE - +
REGULATED-ENTITY - PM00185
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-10609
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7833
CITATIONS - 20015147
MODE - -
REGULATED-ENTITY - PM0-10490
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5969
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7630
CITATIONS - Suzuki03
CITATIONS - 2864330
MODE - -
REGULATED-ENTITY - PM00154
REGULATOR - CPLX0-7733
//
UNIQUE-ID - REG0-11295
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8155
CITATIONS - 19210620
MODE - -
REGULATED-ENTITY - PM0-10350
REGULATOR - CPLX0-7787
//
UNIQUE-ID - REG0-6342
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2548
CITATIONS - 11101675
MODE - -
REGULATED-ENTITY - PM0-3603
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-12323
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8495
CITATIONS - 25802297
MODE - +
REGULATED-ENTITY - PM00526
REGULATOR - PD01520
//
UNIQUE-ID - REG0-9169
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7452
CITATIONS - 16261196
MODE - +
REGULATED-ENTITY - PM-8827
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-4826
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7
CITATIONS - 16159764
COMMENT - NikR and NarLX repress the synthesis of NikABCDE in the presence of nitrate. NarL is phosphorylated by NarX in the presence of NO<sup>3 </sup> |CITS:[16159764]|.
MODE - -
REGULATED-ENTITY - PM881
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5202
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6978
CITATIONS - 7601827
MODE - -
REGULATED-ENTITY - PM00354
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5575
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00415
CITATIONS - 3062173
MODE - -
REGULATED-ENTITY - PM00178
REGULATOR - PD00283
//
UNIQUE-ID - REG0-10580
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7817
CITATIONS - 19843219
CITATIONS - 20965974
MODE - +
REGULATED-ENTITY - PM0-9632
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5953
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2749
CITATIONS - 16936015
CITATIONS - 14651625
COMMENT - IHF, located at -127 from the nrfAp promoter, is necessary to activate the  FNR-dependent  transcription of the <i>nrfABCDEFG</i> operon , but only in the absence of NarL/NarP |CITS:[16936015]|.
MODE - +
REGULATED-ENTITY - PM00280
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11255
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8139
CITATIONS - 11274153
MODE - +
REGULATED-ENTITY - PM0-4436
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-6326
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2348
CITATIONS - 10998176
CITATIONS - 11123679
CITATIONS - 16140031
CITATIONS - 16980446
MODE - +
REGULATED-ENTITY - PM0-3342
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-12229
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8480
CITATIONS - 25568260
MODE - +
REGULATED-ENTITY - PM00142
REGULATOR - MONOMER0-4180
//
UNIQUE-ID - REG0-9114
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7435
CITATIONS - 17526711
MODE - -
REGULATED-ENTITY - PM582
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4810
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00051
CITATIONS - 15520470
CITATIONS - 2170326
CITATIONS - 8969182
CITATIONS - 1962841
CITATIONS - 1661372
CITATIONS - 1647022
CITATIONS - 1655726
CITATIONS - 8221894
CITATIONS - 845188
CITATIONS - 8394345
CITATIONS - 11574471
CITATIONS - 12667072
MODE - +
REGULATED-ENTITY - PM00025
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5186
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6978
CITATIONS - 7601827
MODE - -
REGULATED-ENTITY - PM00353
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5183
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6981
CITATIONS - 7601827
MODE - -
REGULATED-ENTITY - PM00353
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5555
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00216
MODE - +
REGULATED-ENTITY - PM00103
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10542
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7799
CITATIONS - 7715459:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3471879379:martin
CITATIONS - 7715459
CITATIONS - :EV-IC:3471879379:martin
MODE - -
REGULATED-ENTITY - PM00620
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5930
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00491
CITATIONS - [8757744]
CITATIONS - [1490614]
CITATIONS - [7608086]
CITATIONS - 21572102
MODE - -
REGULATED-ENTITY - PM00268
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-6307
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3001
CITATIONS - 11532138
CITATIONS - 9512707
MODE - +
REGULATED-ENTITY - PM0-4241
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11224
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8119
CITATIONS - 11071896
CITATIONS - 11071896:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3523037772:martin
CITATIONS - 11071896:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3523037772:martin
CITATIONS - 11071896:EV-EXP-IMP-SITE-MUTATION:3523037772:martin
MODE - -
REGULATED-ENTITY - PM622
REGULATOR - CPLX0-1242
//
UNIQUE-ID - REG0-12189
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8461
CITATIONS - 25375160
MODE - +
REGULATED-ENTITY - PM00138
REGULATOR - G6789-MONOMER
//
UNIQUE-ID - REG0-9059
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00461
CITATIONS - 9767577
MODE - +
REGULATED-ENTITY - PM00415
REGULATOR - CPLX0-7759
//
UNIQUE-ID - REG0-4794
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00030
CITATIONS - 10518785
CITATIONS - 1530846
CITATIONS - 8613990
CITATIONS - 7961453
MODE - -
REGULATED-ENTITY - PM00013
REGULATOR - CPLX-125
//
UNIQUE-ID - REG0-5167
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2083
CITATIONS - [10628873]
CITATIONS - 15368583
COMMENT - Compaction and bending of DNA were observed when Fis was bound to the <i>nuo</i> regulatory region |CITS:[15368583]|.
MODE - +
REGULATED-ENTITY - PM00593
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5539
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00207
CITATIONS - 10518785
CITATIONS - 3050131
CITATIONS - 8613990
CITATIONS - 7012834
CITATIONS - 3315853
MODE - -
REGULATED-ENTITY - PM00095
REGULATOR - CPLX-125
//
UNIQUE-ID - REG0-10510
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7785
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM0-10444
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5914
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00667
CITATIONS - 15520470
CITATIONS - 2826388
CITATIONS - 1715855
MODE - +
REGULATED-ENTITY - PM00337
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6290
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2748
CITATIONS - 14651625
COMMENT - Fis binding to this site functions as an anti-activator of CRP.
MODE - -
REGULATED-ENTITY - PM0-3923
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-11207
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8106
CITATIONS - 21718532
MODE - +
REGULATED-ENTITY - PM641
REGULATOR - PC00061
//
UNIQUE-ID - REG0-12123
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8443
CITATIONS - 25103863
MODE - +
REGULATED-ENTITY - PM0-9401
REGULATOR - CPLX0-2781
//
UNIQUE-ID - REG0-9038
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7384
CITATIONS - 17496099
MODE - -
REGULATED-ENTITY - PM00063
REGULATOR - CPLX0-8061
//
UNIQUE-ID - REG0-4778
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00017
CITATIONS - 7997172
CITATIONS - 1640456
CITATIONS - 17074904
MODE - -
REGULATED-ENTITY - PM00007
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-5151
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5081
CITATIONS - 9738023
COMMENT - The regulatory effect of IHF on the <i>rtcB</i> promoter is as yet not known. However, we assigned a positive effect to this regulatory interaction based on the protein's binding site being upstream of the promoter (52 bp upstream of the transcription start site).		
MODE - +
REGULATED-ENTITY - PM333
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5526
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00419
MODE - -
REGULATED-ENTITY - PM00089
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10489
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7770
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM00218
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5898
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3202
CITATIONS - 1460045
CITATIONS - 23029459
MODE - -
REGULATED-ENTITY - PM0-4428
REGULATOR - PD01520
//
UNIQUE-ID - REG0-11108
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8091
CITATIONS - 21460078
MODE - -
REGULATED-ENTITY - PM0-36247
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-12020
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8427
CITATIONS - 24272778
MODE - -
REGULATED-ENTITY - TU0-14166
REGULATOR - PD00242
//
UNIQUE-ID - REG0-9006
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3303
CITATIONS - 9469834
CITATIONS - 7934873
CITATIONS - 1848637
COMMENT - CAP and NagC can bind simultaneously and produce a more stable complex than binary NagC-DNA complex.
MODE - -
REGULATED-ENTITY - PM00058
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4762
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4503
CITATIONS - 1560456
MODE - -
REGULATED-ENTITY - PM00003
REGULATOR - CPLX-172
//
UNIQUE-ID - REG0-5135
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7141
CITATIONS - 16207912
COMMENT - By means of gene expression and mutation analysis, it was determined that the LrhA protein regulator positively regulates <i>fimE</i> expression, leading the repression of the <i>fimA</i> operon through the on/off switch at <i>fimA</i> |CITS:  [16207912]|.
MODE - +
REGULATED-ENTITY - PM242
REGULATOR - EG12123-MONOMER
//
UNIQUE-ID - REG0-5510
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00195
CITATIONS - 17513476
MODE - +
REGULATED-ENTITY - PM00087
REGULATOR - MONOMER-47
//
UNIQUE-ID - REG0-10473
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7755
CITATIONS - 19633077
MODE - -
REGULATED-ENTITY - PM0-7561
REGULATOR - EG10087-MONOMER
//
UNIQUE-ID - REG0-5882
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00421
CITATIONS - 8455562
CITATIONS - 16621816
MODE - +
REGULATED-ENTITY - PM00151
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11091
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8080
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00379
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6261
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3321
CITATIONS - 11254141
MODE - -
REGULATED-ENTITY - PM0-4684
REGULATOR - CPLX0-2021
//
UNIQUE-ID - REG0-11993
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7575
CITATIONS - 20952573
CITATIONS - 24335284
CITATIONS - 16207917:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3605884863:asantos
CITATIONS - 8725214:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3605884863:asantos
CITATIONS - 20952573:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3605884863:asantos
CITATIONS - 20952573:EV-EXP-IMP-SITE-MUTATION:3605884863:asantos
CITATIONS - 20952573:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3605884863:asantos
CITATIONS - 24335284:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3605884863:asantos
CITATIONS - 24335284:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3605884863:asantos
COMMENT - Venkatesh et al. in 2010 showed that the formation of heterodimers between RcsB and the BglJ stabilizes the interaction with the distant binding site to the <i>bglG</i> operon. They also determined that the binding target for the RcsB-BglJ heterodimer consists of a 14-nucleotide sequence (TTTATAAATTCCTA), and they suggested that RcsB is a regulator that may interact with the right half (ATTCCTA) of this binding site while BglJ interacts with the left half (TTTATAA) of the same binding site |CITS:[20952573]|.
/
/The RcsB-BglJ heteromer activates transcription of <i>bglG<i/> synergistically with CRP, where it shifts the transcription start by 20 bp from a position typical for class I CRP-dependent promoters (<i>bglG<i/>p) to a position typical for class II CRP-dependent promoters (<i>bglG<i/>p2) |CITS:[24335284]|. 
/
/Activation of <i>bglG<i/>p2 by RcsB-BglJ is CRP dependent, and the AR2 region of CRP is not involved in coactivation of this promoter by either regulator |CITS:[24335284]|. BglJ-RcsB and CRP synergistically activate the <i>bglG<i/>p2 promoter and relieve repression by HNS and StpA.
/
/
MODE - +
REGULATED-ENTITY - PM0-46317
REGULATOR - CPLX0-7916
//
UNIQUE-ID - REG0-8990
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00662
CITATIONS - 15520470
CITATIONS - 2826388
CITATIONS - 1715855
MODE - -
REGULATED-ENTITY - PM00337
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4745
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00392
CITATIONS - 8230205
CITATIONS - 21718532
COMMENT - FruR cannot bind to its site in the <i>aceBAK</i> regulatory region in the presence of fructose-1-phosphate,  and the inference of the positive effect of FruR for the activation of this operon was proved for <i>S. typhimurium</i> (by gene expression analysis) by |CITS: [2496106]|, and just confirmed for <i>E. coli</i> by |CITS: [8230205]|, providing further evidence of  its localization in the regulatory region of the <i>aceBAK</i> operon.
MODE - +
REGULATED-ENTITY - PM00001
REGULATOR - PC00061
//
UNIQUE-ID - REG0-5117
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS154
CITATIONS - 1310090
MODE - -
REGULATED-ENTITY - PM223
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5493
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00746
CITATIONS - 2231717
CITATIONS - 1447222
MODE - +
REGULATED-ENTITY - PM00139
REGULATOR - CPLX-172
//
UNIQUE-ID - REG0-10455
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7737
CITATIONS - 9570400
CITATIONS - 9570400:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3464623803:asantos
CITATIONS - 9570400:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3464623803:asantos
CITATIONS - 9570400:EV-EXP-IMP-SITE-MUTATION:3464623803:asantos
MODE - +
REGULATED-ENTITY - PM00654
REGULATOR - PD00196
//
UNIQUE-ID - REG0-5865
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00797
COMMENT - Expression from the <i>suc</i> promoter was repressed by IHF. The consequences of inactivating other potential regulators showed that IHF performs a major role in repressing the <i>suc</i> promoter may be initiated by &sigma;<sup>38</sup>.
MODE - -
REGULATED-ENTITY - PM00144
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11075
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8069
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM65
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6244
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4128
CITATIONS - 14593252
MODE - -
REGULATED-ENTITY - PM0-4922
REGULATOR - PD03585
//
UNIQUE-ID - REG0-11951
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8397
CITATIONS - 24013633
MODE - +
REGULATED-ENTITY - PM0-46300
REGULATOR - G6706-MONOMER
//
UNIQUE-ID - REG0-8946
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7348
CITATIONS - 17449618
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM00280
REGULATOR - CPLX0-7756
//
UNIQUE-ID - REG0-4729
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5103
CITATIONS - 2538630
CITATIONS - 1824723
MODE - +
REGULATED-ENTITY - PM00047
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5101
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3541
CITATIONS - 11294639
CITATIONS - 1618807
CITATIONS - 18586269
MODE - -
REGULATED-ENTITY - PM206
REGULATOR - PUTA-MONOMER
//
UNIQUE-ID - REG0-5476
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1361
CITATIONS - [11859088]
CITATIONS - [11160901]
CITATIONS - 21276098
MODE - -
REGULATED-ENTITY - PM00131
REGULATOR - EG11394-MONOMER
//
UNIQUE-ID - REG0-10419
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7722
CITATIONS - 19220752
MODE - +
REGULATED-ENTITY - PM0-5141
REGULATOR - EG11544-MONOMER
//
UNIQUE-ID - REG0-5849
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7090
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM00142
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11058
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8053
CITATIONS - 21421764
MODE - +
REGULATED-ENTITY - PM00536
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6228
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00363
CITATIONS - [6357945]
CITATIONS - 11115104
MODE - -
REGULATED-ENTITY - PM0-5261
REGULATOR - PD03270
//
UNIQUE-ID - REG0-11895
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8381
CITATIONS - 18177266
MODE - -
REGULATED-ENTITY - PM0-10229
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6603
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7228
CITATIONS - 12354237
CITATIONS - 21464593
MODE - +
REGULATED-ENTITY - PM0-9218
REGULATOR - EG10125-MONOMER
//
UNIQUE-ID - REG0-4713
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00102
CITATIONS - 1630316
CITATIONS - 22291906
MODE - +
REGULATED-ENTITY - PM00044
REGULATOR - CPLX0-7795
//
UNIQUE-ID - REG0-5085
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2403
CITATIONS - 10760142
CITATIONS - 17233826
MODE - +
REGULATED-ENTITY - PM00547
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5459
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00245
CITATIONS - 23274360
MODE - +
REGULATED-ENTITY - PM00119
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-10335
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7705
CITATIONS - 19245365
MODE - -
REGULATED-ENTITY - PM0-9688
REGULATOR - PD00196
//
UNIQUE-ID - REG0-5833
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7739
CITATIONS - 9570400
CITATIONS - 9570400:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3464622404:asantos
CITATIONS - 9570400:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3464622404:asantos
CITATIONS - 9570400:EV-EXP-IMP-SITE-MUTATION:3464622404:asantos
MODE - +
REGULATED-ENTITY - PM00654
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-11034
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8041
CITATIONS - 8021189
MODE - -
REGULATED-ENTITY - PM0-8864
REGULATOR - EG10442-MONOMER
//
UNIQUE-ID - REG0-6212
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4163
CITATIONS - 9537375
CITATIONS - 9657988
MODE - -
REGULATED-ENTITY - PM0-5167
REGULATOR - PD03585
//
UNIQUE-ID - REG0-11813
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8365
CITATIONS - 23719730
COMMENT - The cAMP-CRP complex inhibits the <i>puuDRCBE</i> operon in the presence of 0.04% (2.22 mM) glucose |CITS:[23719730]|.
MODE - -
REGULATED-ENTITY - PM0-10033
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6587
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4362
CITATIONS - 16417519
MODE - -
REGULATED-ENTITY - PM0-9342
REGULATOR - EG12108-MONOMER
//
UNIQUE-ID - REG0-4696
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00090
CITATIONS - 1556120
CITATIONS - 1372899
MODE - +
REGULATED-ENTITY - PM00039
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5069
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1943
CITATIONS - [10537212]
MODE - -
REGULATED-ENTITY - PM197
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5443
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00753
CITATIONS - 9582281
COMMENT - Glucose lowers the level of <i>crp</i> mRNA without affecting its stability.
MODE - -
REGULATED-ENTITY - PM00161
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10264
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7689
CITATIONS - 18501926
MODE - -
REGULATED-ENTITY - PM0-9527
REGULATOR - CPLX0-7791
//
UNIQUE-ID - REG0-5817
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2642
CITATIONS - 11121068
MODE - +
REGULATED-ENTITY - PM00199
REGULATOR - G7072-MONOMER
//
UNIQUE-ID - REG0-10989
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7659
CITATIONS - 18808381
CITATIONS - 18083817
CITATIONS - 12730179
MODE - -
REGULATED-ENTITY - PM928
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6196
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4104
CITATIONS - 14996803
MODE - -
REGULATED-ENTITY - PM0-5403
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11749
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8350
CITATIONS - 23274360
MODE - +
REGULATED-ENTITY - PM0-46012
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-6571
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7206
CITATIONS - 1630307
CITATIONS - 19633077
MODE - -
REGULATED-ENTITY - PM0-8848
REGULATOR - EG10087-MONOMER
//
UNIQUE-ID - REG0-4680
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6201
CITATIONS - 1556120
MODE - -
REGULATED-ENTITY - PM00037
REGULATOR - PD03576
//
UNIQUE-ID - REG0-5053
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS323
CITATIONS - [8057841]
MODE - -
REGULATED-ENTITY - PM437
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5427
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2843
CITATIONS - 8253679
CITATIONS - 10856246
COMMENT - IHF is not essential for osmotic induction of <i>osmY</i>.
MODE - -
REGULATED-ENTITY - PM00529
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10137
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7674
CITATIONS - 18723630
CITATIONS - 18723630:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3442751951:asantos
CITATIONS - 18723630:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3442751951:asantos
CITATIONS - 18723630:EV-COMP-AINF:3442751951:asantos
MODE - -
REGULATED-ENTITY - PM0-10276
REGULATOR - CPLX0-7745
//
UNIQUE-ID - REG0-5801
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00383
CITATIONS - 12754220
CITATIONS - 14766919
CITATIONS - 21272324
COMMENT - FNR binds to two sites upstream of the <i>ndh</i> promoter-like monomer, and both sites contribute to the anaerobic repression of <i>ndh</i> expression |CITS: [14766919]|.
MODE - -
REGULATED-ENTITY - PM00218
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10973
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8022
CITATIONS - 16980449
CITATIONS - 12446650
CITATIONS - 12730179
MODE - +
REGULATED-ENTITY - PM461
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6178
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4781
CITATIONS - 15485810
MODE - +
REGULATED-ENTITY - PM0-6041
REGULATOR - EG12344-MONOMER
//
UNIQUE-ID - REG0-11666
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8335
CITATIONS - 23092251
MODE - -
REGULATED-ENTITY - PM00465
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-6550
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7053
CITATIONS - 15941987
MODE - +
REGULATED-ENTITY - PM-8783
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-4664
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5062
CITATIONS - 9218807
CITATIONS - 10982882
CITATIONS - 9016640
CITATIONS - 14500788
COMMENT - GalR is required to facilitate HU binding.
MODE - -
REGULATED-ENTITY - PM00033
REGULATOR - CPLX0-2021
//
UNIQUE-ID - REG0-9815
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4901
CITATIONS - 2162467
CITATIONS - 1328649
MODE - -
REGULATED-ENTITY - PM00486
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5037
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS464
CITATIONS - [8913296]
MODE - +
REGULATED-ENTITY - PM586
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5411
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00400
CITATIONS - 15659676
MODE - -
REGULATED-ENTITY - PM00228
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-10084
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7660
CITATIONS - 19007420
MODE - -
REGULATED-ENTITY - PM0-7421
REGULATOR - MONOMER-52
//
UNIQUE-ID - REG0-5785
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00382
CITATIONS - 1629153
MODE - +
REGULATED-ENTITY - PM00217
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10955
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8010
CITATIONS - 16980449
CITATIONS - 12446650
MODE - +
REGULATED-ENTITY - PM450
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6162
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7187
CITATIONS - 16377617
CITATIONS - 19251855
MODE - +
REGULATED-ENTITY - PM0-5721
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11648
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8323
CITATIONS - 23071782
COMMENT - Yang et al. identified the binding site of PhoB |CITS:[ 23071782]| but did not identify the promoter regulated; therefore, there is a possibility that this binding site corresponds to another promoter, according to the function of PhoB. The binding site of this regulator, gCATGACAACATTGTGAAA, is located at bp -21 relative to the translation start site of <i>yhjC</i> |CITS:[ 23071782]|.
MODE - +
REGULATED-ENTITY - PM0-10468
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-6534
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7185
CITATIONS - 16377617
COMMENT - By making use of microarray analyses, Constantinidou et al. |CITS: [16377617]| concluded that FNR activates <i>pepT</i> gene expression. They also identified a putative FNR-binding site upstream of the <i>pepT</i> gene, but the sequence was not shown.
MODE - +
REGULATED-ENTITY - PM0-8926
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4648
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00069
MODE - -
REGULATED-ENTITY - PM00031
REGULATOR - PD00261
//
UNIQUE-ID - REG0-9604
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7634
CITATIONS - 8002613
MODE - -
REGULATED-ENTITY - PM0-10242
REGULATOR - PC00010
//
UNIQUE-ID - REG0-5021
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS444
CITATIONS - [8955407]
CITATIONS - [10216857]
MODE - -
REGULATED-ENTITY - PM561
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5395
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS117
CITATIONS - [2657652]
CITATIONS - [8119409]
MODE - -
REGULATED-ENTITY - PM00214
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5769
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3542
CITATIONS - 11114913
CITATIONS - 12860393
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00207
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-10928
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7996
CITATIONS - 21034467
MODE - -
REGULATED-ENTITY - PM0-9843
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6145
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7180
MODE - -
REGULATED-ENTITY - PM00500
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11629
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8307
CITATIONS - 23233451
MODE - +
REGULATED-ENTITY - PM0-46215
REGULATOR - G6444-MONOMER
//
UNIQUE-ID - REG0-6518
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4242
CITATIONS - 11932447
COMMENT - It is suggested that ArcA relieves the repression mediated by the far upstream FNR dimer by competing for occupation of the -94 site of the <i>yfiD</i> 
/promoter |CITS:[11932447]|.
MODE - +
REGULATED-ENTITY - PM0-1303
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-4632
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2003
CITATIONS - [9335285]
MODE - -
REGULATED-ENTITY - PM00028
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-9583
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7618
CITATIONS - 11321589
MODE - +
REGULATED-ENTITY - PM0-10221
REGULATOR - PD00365
//
UNIQUE-ID - REG0-5004
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3781
CITATIONS - 14702398
CITATIONS - 12940989
CITATIONS - 16980449
CITATIONS - 19352034
CITATIONS - 20189963
CITATIONS - 21571995
COMMENT - GadE is required both for <i>gadA/gadBC</i> expression during exponential growth and stationary-phase expression. GadE is an acid-induced regulator since it is involved in the acid induction of <i>gadA/gadBC</i> operons during exponential growth. The expression of these operons may be one of the most intensively regulated systems in <i>Escherichia coli</i>, since it is regulated by different factors. GadE and GadX may simultaneously bind to the GAD box region of <i>gadA/gadBC</i> and form a complex |CITS: [12940989]|.
MODE - +
REGULATED-ENTITY - PM461
REGULATOR - CPLX0-7852
//
UNIQUE-ID - REG0-5379
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00600
CITATIONS - 8890170
CITATIONS - 9006049
MODE - +
REGULATED-ENTITY - PM00537
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5753
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00714
CITATIONS - 2000372
MODE - -
REGULATED-ENTITY - PM00235
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-10908
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7976
CITATIONS - 21070640
CITATIONS - 21070640:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3504434923:martin
COMMENT - This binding site was determined from  a computational prediction based on different statistical methods |CITS:[21070640]|. The function of the binding site was assigned according to the distance from the transcription start, with NagC as the transcriptional repressor.
MODE - -
REGULATED-ENTITY - PM00409
REGULATOR - PD00266
//
UNIQUE-ID - REG0-6129
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5541
CITATIONS - 15743943
MODE - -
REGULATED-ENTITY - PM0-7183
REGULATOR - PD00266
//
UNIQUE-ID - REG0-11592
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8293
MODE - -
REGULATED-ENTITY - PM0-44963
REGULATOR - PD00266
//
UNIQUE-ID - REG0-6502
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3721
CITATIONS - 12588863
MODE - +
REGULATED-ENTITY - PM0-1301
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4616
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7267
CITATIONS - 11520622
MODE - +
REGULATED-ENTITY - PM0-9373
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-9552
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7602
CITATIONS - 18452510
CITATIONS - 21239586
COMMENT - The FisI (-26) binding site has a relatively low affinity for its cognate factor, which ensures that it is only occupied during rapid growth |CITS:[18452510]|.
MODE - -
REGULATED-ENTITY - PM00243
REGULATOR - PD00196
//
UNIQUE-ID - REG0-4986
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4981
CITATIONS - 10913096
COMMENT - The regulatory effect of IHF on the promoter yiaJp is not yet known. However, we assigned a negative effect to this regulatory interaction based on the fact that the protein-binding site is very close to the promoter (4 bp upstream from the transcription start site).
MODE - -
REGULATED-ENTITY - PM449
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5363
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1342
CITATIONS - [9973351]
CITATIONS - [10482502]
CITATIONS - 14996819
CITATIONS - 15073297
COMMENT - DcuR regulates the expression of dctAp in response to external C4-dicarboxylates |CITS: [10482502] [997335]|.
/
MODE - +
REGULATED-ENTITY - PM0-1621
REGULATOR - CPLX0-7721
//
UNIQUE-ID - REG0-5737
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00401
CITATIONS - 17921503
COMMENT - Fur binds DNA at a site between the -10 and -35 regions of the tonB promoter under aerobic and anaerobic conditions, but only when iron is present in excess .
MODE - -
REGULATED-ENTITY - PM00229
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-10892
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7964
CITATIONS - 21115656
MODE - -
REGULATED-ENTITY - PM00265
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6113
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5642
CITATIONS - 15667305
CITATIONS - 17449618
MODE - +
REGULATED-ENTITY - PM0-7361
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-11575
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8279
CITATIONS - 22442305
MODE - +
REGULATED-ENTITY - PM00536
REGULATOR - PHOSPHO-BASR
//
UNIQUE-ID - REG0-6485
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2501
CITATIONS - 12003934
COMMENT - ArgR enhances expression from  the astCp2 promoter but is not essential for its expression |CITS: [12003934]|.
MODE - +
REGULATED-ENTITY - PM0-1163
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-4598
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00157
MODE - -
REGULATED-ENTITY - PM00066
REGULATOR - PC00027
//
UNIQUE-ID - REG0-9470
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7589
CITATIONS - 18245262
MODE - -
REGULATED-ENTITY - PM00537
REGULATOR - EG11554-MONOMER
//
UNIQUE-ID - REG0-4970
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS473
CITATIONS - [8913296]
MODE - -
REGULATED-ENTITY - PM588
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5345
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3144
CITATIONS - 11357510
MODE - +
REGULATED-ENTITY - PM0-4427
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5719
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS61
CITATIONS - 7551052
CITATIONS - 3135464
CITATIONS - 8195106
CITATIONS - 6309813
MODE - +
REGULATED-ENTITY - PM00272
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10858
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7949
CITATIONS - 20718955
MODE - +
REGULATED-ENTITY - PM00106
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-6097
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5781
CITATIONS - 15901715
MODE - +
REGULATED-ENTITY - PM0-7481
REGULATOR - PHOSPHO-RCSB
//
UNIQUE-ID - REG0-11527
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8259
CITATIONS - 16238633
MODE - -
REGULATED-ENTITY - PM00514
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-6469
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2570
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1349
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4581
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS387
CITATIONS - 8002608
CITATIONS - 1346534
CITATIONS - 8521047
COMMENT - Binding of Lrp to one site enhances occupancy of the other Lrp sites  in the  ompCp1 promoter. Leucine does not abolish  DNA binding by the ligated Lrp but it may alter the affinity of Lrp for specific sites on DNA.
MODE - -
REGULATED-ENTITY - PM00065
REGULATOR - PD00353
//
UNIQUE-ID - REG0-9421
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7575
CITATIONS - 16207917
CITATIONS - 8725214
CITATIONS - 20952573
COMMENT - BglJ induces <i>bgl</i> operon expression via unknown mechanisms |CITS:[8725214][16207917]|. A modest effect was observed on expression of the <i>bglGFB</i> operon during the stationary phase by the BglJ transcriptional regulator in the absence of <i>rpoS/crl</i> |CITS:[18793199]|.
/
/The response regulator RcsB can form heterodimers with RcsA |CITS:[9341681]|  and GadE |CITS:[20189963]| and it forms heterodimers with BglJ to activate the transcription of the <i>bgl</i> operon |CITS:[20952573]|.
/
/The RcsB-BglJ heteromer activates transcription of <i>bglG<i/> synergistically with CRP, where it shifts the transcription start by 20 bp from a position typical for class I CRP-dependent promoters (<i>bglG<i/>p) to a position typical for class II CRP-dependent promoters (<i>bglG<i/>p2) |CITS:[24335284]|. 
/
/Activation of <i>bglG<i/>p2 by RcsB-BglJ is CRP dependent, and the AR2 region of CRP is not involved in coactivation of this promoter by either regulator |CITS:[24335284]|. BglJ-RcsB and CRP synergistically activate the <i>bglG<i/>p2 promoter and relieve repression by HNS and StpA.
MODE - +
REGULATED-ENTITY - PM0-5042
REGULATOR - CPLX0-7916
//
UNIQUE-ID - REG0-4954
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1561
CITATIONS - [10564485]
MODE - +
REGULATED-ENTITY - PM641
REGULATOR - PD00365
//
UNIQUE-ID - REG0-5329
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7312
CITATIONS - 17214507
MODE - +
REGULATED-ENTITY - PM00605
REGULATOR - EG11088-MONOMER
//
UNIQUE-ID - REG0-5703
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS162
CITATIONS - 10760178
CITATIONS - 11742992
MODE - +
REGULATED-ENTITY - PM00175
REGULATOR - MONOMER0-161
//
UNIQUE-ID - REG0-10825
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7932
CITATIONS - 20622065
MODE - +
REGULATED-ENTITY - PM0-36147
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6081
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6401
CITATIONS - 12460564
MODE - +
REGULATED-ENTITY - PM0-8002
REGULATOR - MONOMER0-2221
//
UNIQUE-ID - REG0-11509
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8250
CITATIONS - 16115199
MODE - -
REGULATED-ENTITY - PM00380
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6453
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2546
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1343
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4564
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7337
CITATIONS - 16796689
MODE - -
REGULATED-ENTITY - PM0-9579
REGULATOR - PD00288
//
UNIQUE-ID - REG0-9399
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7556
CITATIONS - 15582999
COMMENT - H-NS acts as <i>trans</i>-acting factor upstream of the <i>leuO</i> gene, and it is responsible for the transcriptional repression mediated by a gene silencer. Chen et al. (2005) concluded that the gene silencer site is important for the relay mechanism and that there must be an H-NS nucleation site for its propagation, rather than an ordinary H-NS-preferred DNA-binding sequence |CITS: [15582999]|.
MODE - -
REGULATED-ENTITY - PM0-9884
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4938
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS763
CITATIONS - [9421904]
MODE - -
REGULATED-ENTITY - PM263
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5313
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2425
CITATIONS - [8002608]
CITATIONS - 1346534
MODE - -
REGULATED-ENTITY - PM00630
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5687
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00416
CITATIONS - 8830277
CITATIONS - 8437561
COMMENT - Autoregulation of <i>hns</i> expression is particularly pronounced during log phase.
MODE - -
REGULATED-ENTITY - PM00191
REGULATOR - PD00288
//
UNIQUE-ID - REG0-10808
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7916
CITATIONS - 20466769
MODE - -
REGULATED-ENTITY - PM00536
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-6062
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6803
CITATIONS - 2543976
CITATIONS - 2643109
CITATIONS - 2673243
MODE - -
REGULATED-ENTITY - PM0-8604
REGULATOR - CPLX0-7752
//
UNIQUE-ID - REG0-11491
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8235
CITATIONS - 22323519
MODE - -
REGULATED-ENTITY - PM00184
REGULATOR - EG11356-MONOMER
//
UNIQUE-ID - REG0-6437
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1143
CITATIONS - [9785451]
MODE - -
REGULATED-ENTITY - PM00379
REGULATOR - G7072-MONOMER
//
UNIQUE-ID - REG0-4548
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2351
CITATIONS - 10972841
CITATIONS - 15225315
COMMENT - Hns binds to this site and represses efficiently (less than FruR) the activity of FNR (-41.5 site) in the <i>nir</i> promoter.
MODE - -
REGULATED-ENTITY - PM00062
REGULATOR - PD00288
//
UNIQUE-ID - REG0-9378
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7539
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM00378
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4922
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS641
CITATIONS - [9106210]
COMMENT - The stimulatory effect of DnaA on <i>polA</i> genes was only observed in stationary phase.
MODE - +
REGULATED-ENTITY - PM761
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-5297
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7245
CITATIONS - 12395194
MODE - -
REGULATED-ENTITY - PM00543
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5671
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00299
CITATIONS - 1640456
CITATIONS - 17074904
MODE - -
REGULATED-ENTITY - PM00152
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-10783
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7900
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM582
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6046
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3421
CITATIONS - 14711822
MODE - -
REGULATED-ENTITY - PM00622
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11475
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8223
CITATIONS - 22295907
MODE - +
REGULATED-ENTITY - PM0-46179
REGULATOR - PD00519
//
UNIQUE-ID - REG0-6419
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5481
CITATIONS - 12897000
MODE - +
REGULATED-ENTITY - PM0-1781
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4532
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6923
CITATIONS - 8057356
MODE - +
REGULATED-ENTITY - PM00061
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9361
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7523
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM461
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4905
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS327
CITATIONS - 10913096
MODE - +
REGULATED-ENTITY - PM692
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5281
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1222
CITATIONS - [11717281]
CITATIONS - 11953442
MODE - -
REGULATED-ENTITY - PM00535
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-5655
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00587
CITATIONS - 7815937
MODE - -
REGULATED-ENTITY - PM00528
REGULATOR - PD00288
//
UNIQUE-ID - REG0-10755
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7888
CITATIONS - 12067348
MODE - +
REGULATED-ENTITY - PM262
REGULATOR - PD00365
//
UNIQUE-ID - REG0-6030
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1645
CITATIONS - [9880556]
MODE - -
REGULATED-ENTITY - PM167
REGULATOR - MONOMER0-562
//
UNIQUE-ID - REG0-11434
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8202
CITATIONS - 10074087
MODE - +
REGULATED-ENTITY - PM00233
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6403
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7165
CITATIONS - 16677314
CITATIONS - 16824106
CITATIONS - 23075318
MODE - -
REGULATED-ENTITY - PM0-2061
REGULATOR - CPLX0-8083
//
UNIQUE-ID - REG0-4516
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS115
CITATIONS - 8057356
CITATIONS - 1528882
CITATIONS - 7050087
MODE - +
REGULATED-ENTITY - PM00060
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9334
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7505
CITATIONS - 17768236
MODE - +
REGULATED-ENTITY - PM0-1303
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4889
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00417
CITATIONS - [9924977]
CITATIONS - [7715442]
COMMENT - This site has low affinity for IHF. The low affinity of IHF binding suggests a simple mechanism for the negative autoregulation of IHF, in which IHF acts as a repressor of transcription initiation only when its level in the cell is high. The increase in the level of IHF as the cell enters the stationary phase is partly caused by the increase in the mRNA level of the two IHF genes.
MODE - -
REGULATED-ENTITY - PM00241
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5265
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00563
CITATIONS - 9135111
MODE - +
REGULATED-ENTITY - PM00314
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5639
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7255
CITATIONS - 1690124
CITATIONS - 2207159
MODE - +
REGULATED-ENTITY - PM00659
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10714
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7870
CITATIONS - 20209085
COMMENT - UspE regulates positively the transcription of the <i>gadX</i> gene in an unknown way, and GadX induces the transcription of <i>uspE</i> |CITS:[ 20209085]|.
MODE - +
REGULATED-ENTITY - PM0-10036
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6014
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS823
CITATIONS - [2575702]
CITATIONS - [1327747]
COMMENT - CRP and CytR bind cooperatively to cddp.
MODE - -
REGULATED-ENTITY - PM1001
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11409
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00231
CITATIONS - [8429549]
CITATIONS - 8508774
CITATIONS - 8071194
CITATIONS - 8483418
CITATIONS - 8429549:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537796397:martin
CITATIONS - 8429549:EV-EXP-IMP-SITE-MUTATION:3537796397:martin
CITATIONS - 8429549:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537796397:martin
CITATIONS - 8429549:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537796397:martin
CITATIONS - 2115869:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537796397:martin
CITATIONS - 2115869:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537796397:martin
CITATIONS - 2646291:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537796397:martin
CITATIONS - 8508774:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537796397:martin
CITATIONS - 8508774:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537796397:martin
CITATIONS - 8071194:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537796397:martin
CITATIONS - 8071194:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537796397:martin
CITATIONS - 8483418:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537796397:martin
CITATIONS - 8483418:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537796397:martin
CITATIONS - 8432705:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537796397:martin
CITATIONS - 8432705:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537796397:martin
CITATIONS - 12218014:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537796397:martin
CITATIONS - 3891724:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537796397:martin
CITATIONS - 1447135:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537796397:martin
MODE - -
REGULATED-ENTITY - PM00323
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6387
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4801
MODE - -
REGULATED-ENTITY - PM0-2741
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4499
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS158
CITATIONS - 10760178
CITATIONS - 16621812
CITATIONS - 18346968
COMMENT - Binding of MelR to a fifth site (R) that overlaps the <i>melR</i> promoter has been shown to downregulate expression from the <i>melR</i> promoter |CITS[10760179], [10760178], [16621812]|. 
/
/Helix-turn-helix 2 of MelR contacts the downstream part of site +1.5 at the bp 5 and 13 of the consensus sequence |CITS:[ 12675795][18346968]|.
MODE - -
REGULATED-ENTITY - PM00050
REGULATOR - PD00208
//
UNIQUE-ID - REG0-9312
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7493
CITATIONS - 17768236
MODE - +
REGULATED-ENTITY - PM00109
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4873
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-23
CITATIONS - 13129959
CITATIONS - 9696769
MODE - +
REGULATED-ENTITY - PM125
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-5248
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7270
CITATIONS - 17233899
MODE - -
REGULATED-ENTITY - PM00254
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-5623
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00780
CITATIONS - 11278071
CITATIONS - 12888342
CITATIONS - 9300053
MODE - +
REGULATED-ENTITY - PM00666
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10681
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7856
CITATIONS - 19400769
CITATIONS - 12029030
MODE - +
REGULATED-ENTITY - PM0-7661
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5998
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4943
CITATIONS - 10071223
MODE - -
REGULATED-ENTITY - PM324
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11375
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8179
CITATIONS - 18997424
CITATIONS - 22101843
CITATIONS - 18997424:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3535223313:martin
CITATIONS - 18997424:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3535223313:martin
CITATIONS - 22101843:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3535223313:martin
CITATIONS - 22101843:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3535223313:martin
CITATIONS - 9701802
MODE - +
REGULATED-ENTITY - PM0-9889
REGULATOR - PHOSPHO-DPIA
//
UNIQUE-ID - REG0-6371
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1842
CITATIONS - [12748194]
COMMENT - CRP binds to the mhpAp promoter only if MhpR is present |CITS:[12748194]|.
MODE - +
REGULATED-ENTITY - PM0-2582
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4483
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00231
CITATIONS - 8429549
CITATIONS - 2115869
CITATIONS - 2646291
CITATIONS - 8508774
CITATIONS - 8071194
CITATIONS - 8483418
CITATIONS - 8432705
CITATIONS - 12218014
CITATIONS - 3891724
CITATIONS - 1447135
MODE - +
REGULATED-ENTITY - PM00111
REGULATOR - PD00353
//
UNIQUE-ID - REG0-9280
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7481
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00207
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4856
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS148
CITATIONS - [3302614]
MODE - -
REGULATED-ENTITY - PM00360
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5232
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00647
COMMENT - FadR represses <i>uspA</i> gene expression during log phase. This site shows some weak FadR binding, and it exhibits little homology to other FarR-binding sites.
MODE - -
REGULATED-ENTITY - PM00451
REGULATOR - PD01520
//
UNIQUE-ID - REG0-5606
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7330
CITATIONS - 16115199
MODE - -
REGULATED-ENTITY - PM0-9574
REGULATOR - PC00061
//
UNIQUE-ID - REG0-10665
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7845
CITATIONS - 11443091
CITATIONS - 15101990
CITATIONS - 16824106
CITATIONS - 15009899
CITATIONS - 21143317
MODE - +
REGULATED-ENTITY - PM0-2801
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5982
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00691
CITATIONS - 7608078
CITATIONS - 15520470
COMMENT - The CRP function in the promoter for <i>treB</i> is not known.
REGULATED-ENTITY - PM00299
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11328
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8167
CITATIONS - 9556617
CITATIONS - 3062177
MODE - -
REGULATED-ENTITY - PM00041
REGULATOR - PD00200
//
UNIQUE-ID - REG0-6355
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7026
CITATIONS - 12754220
COMMENT - By making use of microarray analyses it was concluded that anarobiosis does not affect the expression of the <i>purMN</i> operon, although FNR appears to activate it.  A putative FNR-binding site, which is not shown in the paper, was identified upstream of this operon |CITS: [12754220]|.
MODE - +
REGULATED-ENTITY - PM0-3281
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-12394
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8511
CITATIONS - 26673755
MODE - +
REGULATED-ENTITY - PM0-5062
REGULATOR - MONOMER0-1
//
UNIQUE-ID - REG0-9263
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7467
CITATIONS - 17919280
CITATIONS - 18515344
MODE - +
REGULATED-ENTITY - PM00151
REGULATOR - PD01352
//
UNIQUE-ID - REG0-4840
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS753
CITATIONS - 9484893
CITATIONS - 11340070
MODE - -
REGULATED-ENTITY - PM934
REGULATOR - PD01896
//
UNIQUE-ID - REG0-5215
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3061
CITATIONS - 11029695
CITATIONS - 11601842
MODE - -
REGULATED-ENTITY - PM00401
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5588
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1281
CITATIONS - [12123461]
MODE - -
REGULATED-ENTITY - PM00184
REGULATOR - EG12123-MONOMER
//
UNIQUE-ID - REG0-10606
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7830
CITATIONS - 20015147
MODE - -
REGULATED-ENTITY - PM0-10490
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5966
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1149
CITATIONS - [11814655]
COMMENT - The sequence of this site was not shown in the report by |CITS:
/[11814655]|; the authors only mentioned its position. The sequence of
/the mentioned position is not very clear compared with the
/consensus Nac binding sequence.
MODE - -
REGULATED-ENTITY - PM00154
REGULATOR - G7072-MONOMER
//
UNIQUE-ID - REG0-11271
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8152
CITATIONS - 11350954
MODE - +
REGULATED-ENTITY - TU0-14026
REGULATOR - PHOSPHO-CREB
//
UNIQUE-ID - REG0-6339
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2549
CITATIONS - 11101675
MODE - -
REGULATED-ENTITY - PM0-3582
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-12320
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8492
CITATIONS - 25802297
MODE - +
REGULATED-ENTITY - PM0-46358
REGULATOR - PD01520
//
UNIQUE-ID - REG0-9166
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7449
CITATIONS - 17720788
CITATIONS - 19245365
MODE - +
REGULATED-ENTITY - PM0-9688
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-4823
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7069
CITATIONS - 15941987
CITATIONS - 7961507
MODE - +
REGULATED-ENTITY - PM164
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-5199
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6977
CITATIONS - 7601827
MODE - -
REGULATED-ENTITY - PM00354
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5571
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7102
CITATIONS - 15520470
CITATIONS - 3062173
MODE - +
REGULATED-ENTITY - PM00178
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10577
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7814
CITATIONS - 19843219
MODE - +
REGULATED-ENTITY - PM0-9632
REGULATOR - MONOMER0-4147
//
UNIQUE-ID - REG0-5950
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS523
CITATIONS - 19633076
MODE - +
REGULATED-ENTITY - PM00289
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6323
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2346
CITATIONS - 10998176
CITATIONS - 12754220
CITATIONS - 16140031
MODE - -
REGULATED-ENTITY - PM0-3341
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-12226
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8477
CITATIONS - 10074084
CITATIONS - 9023186
MODE - +
REGULATED-ENTITY - PM0-46344
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9110
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7432
CITATIONS - 9829921
MODE - -
REGULATED-ENTITY - PM0-1358
REGULATOR - PC00027
//
UNIQUE-ID - REG0-4807
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00049
MODE - -
REGULATED-ENTITY - PM00024
REGULATOR - PD01196
//
UNIQUE-ID - REG0-9090
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7430
CITATIONS - 16824106
CITATIONS - 21143317
MODE - +
REGULATED-ENTITY - PM0-2801
REGULATOR - G7326-MONOMER
//
UNIQUE-ID - REG0-4804
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00041
CITATIONS - 2644221
CITATIONS - 11101675
CITATIONS - 17526711
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00020
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-5180
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00574
COMMENT - This IHF-binding site located between two putative FNR- binding sites is absolutely necessary for pyruvate-mediated induction of the <i>focA-pflB</i> operon. IHF also has a positive role in the anaerobic induction mediated by ArcA of the <i>focA-pflB</i> operon |CITS: [8376324]|.
MODE - +
REGULATED-ENTITY - PM00353
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5552
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2923
CITATIONS - 11448880
COMMENT - he regulatory effect of MetJ on the promoter ahpCp is not yet known. However, we assigned a negative effect to this regulatory interaction based on two facts: the protein's binding site is very close to the promoter, and MetJ is known to act, so far without exceptions, as a negative regulator.
MODE - -
REGULATED-ENTITY - PM00102
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-10536
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00738
CITATIONS - [8626289]
CITATIONS - [10347150]
CITATIONS - 14499937
CITATIONS - 8626289
CITATIONS - 15027196
MODE - -
REGULATED-ENTITY - PM00179
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5927
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00460
CITATIONS - [8898382]
CITATIONS - [8729576]
MODE - -
REGULATED-ENTITY - PM00267
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-6304
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5041
CITATIONS - 12367523
CITATIONS - 11222606
CITATIONS - 17921503
COMMENT - Generally Fur binds to 19 bp in DNA, but in this case it binds to 25 bp upstream from entSp1 promoter.
MODE - +
REGULATED-ENTITY - PM0-4201
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-11221
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8116
CITATIONS - 11071896
CITATIONS - 11071896:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3523037378:martin
CITATIONS - 11071896:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3523037378:martin
CITATIONS - 11071896:EV-EXP-IMP-SITE-MUTATION:3523037378:martin
MODE - -
REGULATED-ENTITY - PM622
REGULATOR - EG10571-MONOMER
//
UNIQUE-ID - REG0-12172
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8458
CITATIONS - 25568260
MODE - +
REGULATED-ENTITY - PM0-45171
REGULATOR - MONOMER0-4341
//
UNIQUE-ID - REG0-9051
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7398
CITATIONS - 17618229
MODE - +
REGULATED-ENTITY - PM0-9653
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4791
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00027
CITATIONS - 3001025
CITATIONS - 7961453
CITATIONS - 1530846
MODE - -
REGULATED-ENTITY - PM00013
REGULATOR - MONOMER0-162
//
UNIQUE-ID - REG0-5164
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS121
CITATIONS - [8631699]
CITATIONS - [9573142]
CITATIONS - [10564497]
COMMENT - CaiF and CRP bind cooperatively to the <i>cai-fix</i> intergenic region to activate the <i>fixA</i> promoter.
MODE - +
REGULATED-ENTITY - PM339
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5536
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4062
CITATIONS - 8613990
CITATIONS - 3050131
CITATIONS - 10518785
CITATIONS - 3315853
MODE - -
REGULATED-ENTITY - PM00094
REGULATOR - CPLX-125
//
UNIQUE-ID - REG0-10507
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7782
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM0-8891
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5911
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00794
CITATIONS - 15659676
MODE - -
REGULATED-ENTITY - PM00326
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6287
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2746
CITATIONS - 12923087
CITATIONS - 10894724
CITATIONS - 17630973
COMMENT - Activation of the acsp2 promoter absolutely requires a CRP site centered at position   -69.5, while optimal expression requires an additional site centered at position  -122.5.
MODE - +
REGULATED-ENTITY - PM0-3923
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11204
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8103
CITATIONS - 21571995
MODE - +
REGULATED-ENTITY - PM0-6061
REGULATOR - PHOSPHO-RCSB
//
UNIQUE-ID - REG0-12120
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8440
CITATIONS - 25103863
MODE - +
REGULATED-ENTITY - PM0-46333
REGULATOR - CPLX0-2781
//
UNIQUE-ID - REG0-9035
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7381
CITATIONS - 17557822
MODE - +
REGULATED-ENTITY - PM00320
REGULATOR - MONOMER0-162
//
UNIQUE-ID - REG0-4775
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00014
CITATIONS - 1640456
CITATIONS - 17074904
MODE - -
REGULATED-ENTITY - PM00006
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-5148
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1584
CITATIONS - [10564485]
CITATIONS - 21097628
MODE - +
REGULATED-ENTITY - PM332
REGULATOR - PD00365
//
UNIQUE-ID - REG0-5523
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00197
CITATIONS - 8412671
MODE - -
REGULATED-ENTITY - PM00089
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10486
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7762
CITATIONS - 19656291
CITATIONS - 19656291:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3466391490:martin
CITATIONS - 19656291:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3466391490:martin
MODE - -
REGULATED-ENTITY - PM00210
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5895
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6683
CITATIONS - 7860604
COMMENT - Both Fis and RpoS negatively regulated <i>mglA</i> in a gene expression analysis. The RpoS effect could be indirect |CITS: [7860604]|.
MODE - -
REGULATED-ENTITY - PM0-8281
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-11105
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8090
CITATIONS - 21460078
CITATIONS - 21460078:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3514125410:martin
CITATIONS - 21460078:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3514125410:martin
CITATIONS - 15520470:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3514125410:martin
MODE - +
REGULATED-ENTITY - PM0-36231
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6274
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00619
CITATIONS - [7805834]
CITATIONS - 14645248
CITATIONS - 7805834:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3480864877:asantos
CITATIONS - 14645248:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3480864877:asantos
MODE - -
REGULATED-ENTITY - PM0-4722
REGULATOR - PC00103
//
UNIQUE-ID - REG0-12017
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8424
CITATIONS - 24659771
MODE - -
REGULATED-ENTITY - PM0-10155
REGULATOR - EG11084-MONOMER
//
UNIQUE-ID - REG0-9003
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00163
CITATIONS - [2656631]
CITATIONS - [2656704]
CITATIONS - [2553720]
CITATIONS - [1736095]
CITATIONS - [9422609]
CITATIONS - 10698756
CITATIONS - 11158569
CITATIONS - 11812125
CITATIONS - 7557323
CITATIONS - 12366850
CITATIONS - 16618701
MODE - -
REGULATED-ENTITY - PM00066
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-4759
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00007
CITATIONS - 9600836
CITATIONS - 8980677
CITATIONS - 1848302
CITATIONS - 8510144
CITATIONS - 8516313
MODE - +
REGULATED-ENTITY - PM00003
REGULATOR - CPLX-172
//
UNIQUE-ID - REG0-5132
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS191
CITATIONS - [7916011]
CITATIONS - [9515701]
MODE - +
REGULATED-ENTITY - PM241
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5507
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00193
CITATIONS - 7027255
MODE - -
REGULATED-ENTITY - PM00086
REGULATOR - PC00010
//
UNIQUE-ID - REG0-10468
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7370
CITATIONS - 19703465
CITATIONS - 16956381:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3466280823:asantos
CITATIONS - 16956381:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3466280823:asantos
CITATIONS - 17120142:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3466280823:asantos
CITATIONS - 19703465:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3466280823:asantos
CITATIONS - 19703465:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3466280823:asantos
MODE - -
REGULATED-ENTITY - PM0-9621
REGULATOR - G7137-MONOMER
//
UNIQUE-ID - REG0-5879
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS60
CITATIONS - [3322223]
MODE - +
REGULATED-ENTITY - PM00150
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11088
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8078
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00295
REGULATOR - PD00197
//
UNIQUE-ID - REG0-6258
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3303
CITATIONS - 11139621
CITATIONS - 7934873
CITATIONS - 9469834
CITATIONS - 1848637
MODE - +
REGULATED-ENTITY - PM0-4621
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11987
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8409
CITATIONS - 24335284
MODE - +
REGULATED-ENTITY - PM0-46309
REGULATOR - CPLX0-7916
//
UNIQUE-ID - REG0-8987
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS118
CITATIONS - [8057842]
CITATIONS - 12754220
CITATIONS - 16377617
COMMENT - FNR affects the pdhRp promoter under anaerobic conditions.
MODE - -
REGULATED-ENTITY - PM00324
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4742
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00117
CITATIONS - 2664421
MODE - +
REGULATED-ENTITY - PM00048
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5114
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS155
CITATIONS - 1885551
MODE - -
REGULATED-ENTITY - PM221
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5490
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4521
CITATIONS - 2231717
CITATIONS - 1447222
MODE - +
REGULATED-ENTITY - PM00139
REGULATOR - CPLX-172
//
UNIQUE-ID - REG0-10452
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7738
CITATIONS - 9570400
MODE - -
REGULATED-ENTITY - PM331
REGULATOR - PD00196
//
UNIQUE-ID - REG0-5862
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00386
CITATIONS - 21272324
CITATIONS - 7783618
MODE - -
REGULATED-ENTITY - PM00143
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11072
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8066
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00297
REGULATOR - PD00197
//
UNIQUE-ID - REG0-6241
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3803
CITATIONS - 14593252
CITATIONS - 9658018
MODE - +
REGULATED-ENTITY - PM0-4922
REGULATOR - MONOMER0-1301
//
UNIQUE-ID - REG0-11939
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8394
CITATIONS - 24062463
COMMENT - BasR contributes to <i>qseBC</i> transcription in the absence of QseC in uropathogenic <i>Escherichia coli</i> (UPEC) |CITS:[24062463]|. Cross-regulation between the QseBC and BasSR two-component systems (TCSs) has been suggested |CITS:[24062463]|.
MODE - +
REGULATED-ENTITY - PM-8770
REGULATOR - PHOSPHO-BASR
//
UNIQUE-ID - REG0-8937
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7351
CITATIONS - 16553864
MODE - -
REGULATED-ENTITY - PM-8827
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4726
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00108
MODE - -
REGULATED-ENTITY - PM00046
REGULATOR - PC00010
//
UNIQUE-ID - REG0-5098
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2181
CITATIONS - 10766858
COMMENT - This site of CRP binding is also used to regulate the divergent paaZp promoter.
MODE - +
REGULATED-ENTITY - PM5
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5473
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00267
CITATIONS - [8952481]
CITATIONS - [2832158]
CITATIONS - 9256428
CITATIONS - 9484893
CITATIONS - 6315676
MODE - +
REGULATED-ENTITY - PM00129
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10397
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7717
CITATIONS - 16857675
MODE - +
REGULATED-ENTITY - PM0-10021
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5846
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00348
CITATIONS - 7961413
MODE - -
REGULATED-ENTITY - PM00195
REGULATOR - PD00291
//
UNIQUE-ID - REG0-11055
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8050
CITATIONS - 21421764
MODE - +
REGULATED-ENTITY - PM00535
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6225
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3901
MODE - +
REGULATED-ENTITY - PM0-5241
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11892
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8378
CITATIONS - 23873909
MODE - -
REGULATED-ENTITY - PM0-5023
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6600
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7190
CITATIONS - 16377617
COMMENT - By making use of microarray analyses,  |CITS: [16377617]| concluded that FNR activates <i>yqjI</i> gene expression. They also identified a putative FNR-binding site upstream of the gene, but the sequence was not shown.
MODE - +
REGULATED-ENTITY - PM0-9094
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4710
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7157
CITATIONS - 16377617
MODE - +
REGULATED-ENTITY - PM00043
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5082
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7248
CITATIONS - 17233826
MODE - +
REGULATED-ENTITY - PM00547
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5456
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5183
CITATIONS - 12657056
MODE - +
REGULATED-ENTITY - PM00117
REGULATOR - PHOSPHO-TORR
//
UNIQUE-ID - REG0-10332
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7702
CITATIONS - 19245365
MODE - +
REGULATED-ENTITY - PM0-10357
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5830
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3162
CITATIONS - 8550494
CITATIONS - 8071201
MODE - +
REGULATED-ENTITY - PM00367
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11031
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8038
CITATIONS - 17170003
MODE - -
REGULATED-ENTITY - PM0-10318
REGULATOR - CPLX0-3781
//
UNIQUE-ID - REG0-6209
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7299
CITATIONS - 8106311
CITATIONS - 21572102
MODE - -
REGULATED-ENTITY - PM00134
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-11810
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8362
CITATIONS - 23564175
COMMENT - The regulation of CpxR on the <i>yjfN</i> gene has been demonstrated via <i>lacZ</i> reporter gene expression experiments, quantitative PCR analysis of cDNA, and by the identification of a consensus DNA-binding site of CpxR in the regulatory region of <i>yjfN</i> |CITS:[ 23564175]|. The identification of this DNA-binding site was only mentioned in the paper of Raivio et al. (2013), but the DNA sequence was not shown |CITS:[ 23564175]|.
MODE - +
REGULATED-ENTITY - TU0-14155
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-6584
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7210
CITATIONS - 8021189
MODE - -
REGULATED-ENTITY - PM0-8864
REGULATOR - CPLX0-7425
//
UNIQUE-ID - REG0-4693
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00081
CITATIONS - 1556120
CITATIONS - 1372899
MODE - +
REGULATED-ENTITY - PM00039
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5066
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1142
CITATIONS - [9495755]
MODE - +
REGULATED-ENTITY - PM65
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-5440
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7319
CITATIONS - 9582281
MODE - -
REGULATED-ENTITY - PM00161
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10261
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7686
CITATIONS - 18501926
MODE - -
REGULATED-ENTITY - PM0-9527
REGULATOR - CPLX0-7928
//
UNIQUE-ID - REG0-5814
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00323
CITATIONS - 2515108
MODE - +
REGULATED-ENTITY - PM00171
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10986
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8028
CITATIONS - 12730179
CITATIONS - 16980449
CITATIONS - 12446650
MODE - -
REGULATED-ENTITY - PM450
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6193
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4101
CITATIONS - 14996803
MODE - -
REGULATED-ENTITY - PM0-5402
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11746
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8347
CITATIONS - 23274360
MODE - +
REGULATED-ENTITY - PM00066
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-6567
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7020
CITATIONS - 12754220
COMMENT - By making use of microarray analyses, it was concluded that FNR activates <i>dcuSR</i> operon expression under anaerobiosis. A putative FNR-binding site, which was not shown in the paper, was identified upstream of this operon |CITS: [12754220]|.
MODE - +
REGULATED-ENTITY - PM0-8728
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4677
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS105
CITATIONS - 6363389
CITATIONS - 2403539
MODE - +
REGULATED-ENTITY - PM00037
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-9996
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7649
CITATIONS - 18808381
MODE - -
REGULATED-ENTITY - PM0-10288
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-5050
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS322
CITATIONS - [8057841]
MODE - +
REGULATED-ENTITY - PM437
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5424
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2846
CITATIONS - 8253679
CITATIONS - 21673794
COMMENT - CRP is not essential for osmotic induction of <i>osmY</i>.
MODE - -
REGULATED-ENTITY - PM00529
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10133
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7672
CITATIONS - 18083817
CITATIONS - 12730179
MODE - -
REGULATED-ENTITY - PM928
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-5798
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS748
CITATIONS - [9308170]
MODE - -
REGULATED-ENTITY - PM00218
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10970
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3862
CITATIONS - 18808381
CITATIONS - 14702398:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3511015733:martin
CITATIONS - 12730179:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3511015733:martin
CITATIONS - 18808381:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3511015733:martin
CITATIONS - 18808381:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3511015733:martin
COMMENT - Microarray analyses have shown that the <i>hdeD</i> gene is activated by the transcriptional regulator GadX, but it is not known if the effect of the regulator on the gene is direct or indirect. The positive regulation of <i>hdeD</i> by GadX is positively influenced by  the transcriptional regulator GadW |CITS: [12730179]|.
MODE - +
REGULATED-ENTITY - PM0-5143
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6175
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4461
CITATIONS - 15489450
MODE - +
REGULATED-ENTITY - PM0-5982
REGULATOR - EG11544-MONOMER
//
UNIQUE-ID - REG0-11663
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8334
CITATIONS - 23092251
MODE - +
REGULATED-ENTITY - PM00465
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-6547
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7048
CITATIONS - 16194231
MODE - +
REGULATED-ENTITY - PM-8770
REGULATOR - MONOMER0-2741
//
UNIQUE-ID - REG0-4661
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5941
CITATIONS - 8982002
MODE - -
REGULATED-ENTITY - PM00033
REGULATOR - PD00261
//
UNIQUE-ID - REG0-9783
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7645
CITATIONS - 18673442
CITATIONS - 11321589
CITATIONS - 9473050
CITATIONS - 18673442:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3434400677:asantos
CITATIONS - 11321589:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3434400677:asantos
CITATIONS - 9473050:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3434400677:asantos
MODE - +
REGULATED-ENTITY - PM0-10259
REGULATOR - PD00406
//
UNIQUE-ID - REG0-5034
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS467
CITATIONS - [8913296]
MODE - +
REGULATED-ENTITY - PM586
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5408
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7321
CITATIONS - 2139473
MODE - -
REGULATED-ENTITY - PM00228
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-5782
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS51
CITATIONS - 1629153
MODE - +
REGULATED-ENTITY - PM00217
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10950
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8007
CITATIONS - 21338418
MODE - +
REGULATED-ENTITY - PM0-1182
REGULATOR - G7326-MONOMER
//
UNIQUE-ID - REG0-6159
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4203
MODE - +
REGULATED-ENTITY - PM0-5642
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-11644
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8322
CITATIONS - 23071782
MODE - +
REGULATED-ENTITY - PM0-2001
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-6531
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5021
MODE - -
REGULATED-ENTITY - PM0-1121
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4645
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00067
CITATIONS - 8416900
CITATIONS - 7934815
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM00031
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9601
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7629
CITATIONS - 3925152
CITATIONS - Suzuki03
MODE - -
REGULATED-ENTITY - PM00154
REGULATOR - CPLX0-7733
//
UNIQUE-ID - REG0-5018
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS422
CITATIONS - 8955407
CITATIONS - 10216857
MODE - +
REGULATED-ENTITY - PM561
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5392
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7295
CITATIONS - 11118204
MODE - -
REGULATED-ENTITY - PM0-9512
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5766
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6641
CITATIONS - 12107133
CITATIONS - 15686558
CITATIONS - 15716448
MODE - +
REGULATED-ENTITY - PM0-8261
REGULATOR - PHOSPHO-BAER
//
UNIQUE-ID - REG0-10925
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7993
CITATIONS - 21034467
MODE - -
REGULATED-ENTITY - PM00159
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6142
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7180
CITATIONS - 16140472
MODE - -
REGULATED-ENTITY - PM00499
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11626
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8304
CITATIONS - 22972332
COMMENT - Based on a reduced genome of <i>Escherichia coli</i> W3110red (MGF-01) and shift assay analysis, it was determined that YdfH is a transcriptional repressor of the <i>rspAB</i> operon |CITS:[22972332]|.
MODE - -
REGULATED-ENTITY - TU0-13333
REGULATOR - G6814-MONOMER
//
UNIQUE-ID - REG0-6515
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3728
CITATIONS - 12588863
COMMENT - Fis binding to site I and II can coactivate ptsGp1 transcription with CRP.
MODE - -
REGULATED-ENTITY - PM0-1302
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4629
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7242
CITATIONS - 1459953
MODE - -
REGULATED-ENTITY - PM00028
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-9577
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7615
CITATIONS - 11321589
MODE - -
REGULATED-ENTITY - PM624
REGULATOR - CPLX0-7418
//
UNIQUE-ID - REG0-5001
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS341
CITATIONS - [8002608]
CITATIONS - 1346534
MODE - -
REGULATED-ENTITY - PM00631
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5376
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3473
CITATIONS - 14711822
MODE - -
REGULATED-ENTITY - PM00293
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5750
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00427
CITATIONS - 2000372
CITATIONS - 1447969
MODE - +
REGULATED-ENTITY - PM00235
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10905
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7977
COMMENT - This binding site was determined from  a computational prediction based on different statistical methods |CITS:[21070640]|. The function of the binding site was assigned according to the distance from the transcription start, with NagC as the transcriptional repressor.
MODE - -
REGULATED-ENTITY - PM00603
REGULATOR - PD00266
//
UNIQUE-ID - REG0-6126
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7282
CITATIONS - 14663078
CITATIONS - 12892888
MODE - -
REGULATED-ENTITY - PM0-9409
REGULATOR - CPLX0-2781
//
UNIQUE-ID - REG0-11589
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8290
CITATIONS - 6328431
CITATIONS - 6328431:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3554841906:asantos
MODE - -
REGULATED-ENTITY - PM00371
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6498
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7136
CITATIONS - 9044285
COMMENT - Based on MoaA gel shift assays and <i>moaA-lacZ</i> operon fusions , molybdate had no effect on ModE binding to moaAp2 |CITS: [9044285]|.
MODE - +
REGULATED-ENTITY - PM0-1284
REGULATOR - CPLX0-6
//
UNIQUE-ID - REG0-4613
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7275
CITATIONS - 16861804
CITATIONS - 23564175
MODE - -
REGULATED-ENTITY - PM0-9399
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-9545
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7599
CITATIONS - 18405378
MODE - -
REGULATED-ENTITY - PM00279
REGULATOR - PD00353
//
UNIQUE-ID - REG0-4983
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4861
MODE - -
REGULATED-ENTITY - PM101
REGULATOR - EG20249-MONOMER
//
UNIQUE-ID - REG0-5359
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6999
CITATIONS - 15743952
MODE - -
REGULATED-ENTITY - PM00536
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-5734
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2583
CITATIONS - 12700271
CITATIONS - 11121068
COMMENT - In a footprinting analysis the Nac protein of <i>Klebsiella pneumoniae</i> was used.
MODE - +
REGULATED-ENTITY - PM00278
REGULATOR - G7072-MONOMER
//
UNIQUE-ID - REG0-10889
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7675
CITATIONS - 21115656
CITATIONS - 18648770
MODE - -
REGULATED-ENTITY - PM00324
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6110
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6940
CITATIONS - 15667305
MODE - +
REGULATED-ENTITY - PM0-7361
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-11571
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8276
CITATIONS - 22685278
MODE - +
REGULATED-ENTITY - PM0-46197
REGULATOR - MONOMER0-4276
//
UNIQUE-ID - REG0-6482
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2504
CITATIONS - 12003934
COMMENT - ArgR enhances expression from  the astCp2 promoter but is not essential for its expression |CITS: [12003934]|.
MODE - +
REGULATED-ENTITY - PM0-1163
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-4595
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7034
CITATIONS - 16077119
CITATIONS - 23564175
COMMENT - Repression of <i>ompF</i> by CpxR could result from prevention of either OmpR or RNA polymerase binding |CITS: [16077119]|.
MODE - -
REGULATED-ENTITY - PM00066
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-9466
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7586
CITATIONS - 18227264
COMMENT - Although this site (-42 heptamer) had significant contribution in <i>in vivo</i> assays, no clear protection by NarL was detected in DNase footprint analyses. However, this suggests that there are other factors <i>in vivo</i> that lead to occupation of the -42 heptamer by NarL in the presence of nitrate |CITS: [18227264]|.
MODE - -
REGULATED-ENTITY - PM0-10196
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-4967
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS561
CITATIONS - [10027972]
CITATIONS - 14996792
CITATIONS - 11053378
CITATIONS - 8861216
CITATIONS - 17892462
COMMENT - The almost-to-40-bp size of the footprinting suggests that two dimers of SlyA are binding. 
MODE - +
REGULATED-ENTITY - PM681
REGULATOR - G6882-MONOMER
//
UNIQUE-ID - REG0-5342
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00699
CITATIONS - 7715459
MODE - -
REGULATED-ENTITY - PM00621
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5716
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS64
CITATIONS - 7551052
CITATIONS - 8288055
CITATIONS - 8195106
CITATIONS - 6309813
MODE - +
REGULATED-ENTITY - PM00272
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10854
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7945
CITATIONS - 20874755
COMMENT - The MlrA-<i>rplU</i>p regulatory interaction was identified by sequence analysis reported by Ogasawara et al., and by a gel shift assay using purified transcription factor (data not provided) |CITS[20874755]|.
MODE - +
REGULATED-ENTITY - PM0-36158
REGULATOR - EG12008-MONOMER
//
UNIQUE-ID - REG0-6094
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6185
CITATIONS - 12754220
COMMENT - Under anaerobiosis, FNR represses  <i>rplS</i> and <i>trmD</i>  gene expression, but it is not known if this regulation is direct or indirect  |CITS: [12754220]|.  We assigned this regulation to the <i>rpsP-rimM-trmD-rplS</i>  operon because it is known that  the <i>rplS</i> and <i>trmD</i> genes  are transcribed as a part of this operon.
MODE - -
REGULATED-ENTITY - PM0-7821
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11523
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7683
CITATIONS - 11115104
CITATIONS - 20923783
MODE - -
REGULATED-ENTITY - PM0-5261
REGULATOR - PD03270
//
UNIQUE-ID - REG0-6466
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7146
CITATIONS - 16238633
COMMENT - Based on studies of binding sites with gel shift and footprinting with Lrp and H-NS regulator proteins, it was demonstrated that both proteins interact with obvious synergism in the repression of all seven <i>E. coli</i> <i>rrn</i> P1 promoter upstream regions; as a result, they help the efficient shutdown of rRNA synthesis.  Likewise, both proteins could be a transient heteromer via protein-protein interaction interfering with the RNA polymerase, and this way it alters the DNA of the upstream regions of all seven ribosomal P1 promoters |CITS: [16238633]|.
MODE - -
REGULATED-ENTITY - PM0-1347
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-4578
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS342
CITATIONS - 8002608
CITATIONS - 1346534
COMMENT - Binding of Lrp to one site enhances occupancy of the other Lrp sites  in the  ompCp1 promoter. Leucine does not abolish  DNA binding by the ligated Lrp but it may alter the affinity of Lrp for specific sites on DNA.
MODE - -
REGULATED-ENTITY - PM00065
REGULATOR - PD00353
//
UNIQUE-ID - REG0-9414
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7569
CITATIONS - 17630975
MODE - -
REGULATED-ENTITY - PM0-1041
REGULATOR - MONOMER-53
//
UNIQUE-ID - REG0-4951
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS507
CITATIONS - 3145340
MODE - -
REGULATED-ENTITY - PM00474
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5326
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1923
MODE - -
REGULATED-ENTITY - PM00598
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-5700
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00512
MODE - +
REGULATED-ENTITY - PM00168
REGULATOR - PD03292
//
UNIQUE-ID - REG0-10821
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7929
CITATIONS - 18176545
MODE - -
REGULATED-ENTITY - PM00083
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6077
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6381
CITATIONS - 12460564
CITATIONS - 18957590
MODE - -
REGULATED-ENTITY - PM0-7981
REGULATOR - CPLX0-8071
//
UNIQUE-ID - REG0-11506
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8249
CITATIONS - 8824175
MODE - +
REGULATED-ENTITY - PM0-3343
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6450
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2541
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1341
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4561
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00150
CITATIONS - 8288532
MODE - +
REGULATED-ENTITY - PM00063
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-9392
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7553
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM70
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4935
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS766
CITATIONS - [9421904]
MODE - -
REGULATED-ENTITY - PM263
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5310
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS348
CITATIONS - [8002608]
CITATIONS - 1346534
MODE - -
REGULATED-ENTITY - PM00630
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5684
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00345
CITATIONS - 11278076
MODE - +
REGULATED-ENTITY - PM00191
REGULATOR - PD03695
//
UNIQUE-ID - REG0-10805
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7913
CITATIONS - 18383615
CITATIONS - 21193607
MODE - +
REGULATED-ENTITY - PM0-10021
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-6059
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6803
CITATIONS - 2543976
CITATIONS - 2643109
CITATIONS - 2673243
MODE - -
REGULATED-ENTITY - PM0-8603
REGULATOR - CPLX0-7752
//
UNIQUE-ID - REG0-11488
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8232
CITATIONS - 22323519
CITATIONS - 18765794
MODE - -
REGULATED-ENTITY - PM0-4261
REGULATOR - EG11356-MONOMER
//
UNIQUE-ID - REG0-6434
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1146
CITATIONS - [9785451]
MODE - -
REGULATED-ENTITY - PM00379
REGULATOR - G7072-MONOMER
//
UNIQUE-ID - REG0-4545
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7107
CITATIONS - 15520470
MODE - -
REGULATED-ENTITY - PM00062
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9375
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7536
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM681
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4919
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS623
CITATIONS - [9852003]
MODE - -
REGULATED-ENTITY - PM00625
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5294
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS441
CITATIONS - [8955407]
CITATIONS - [10216857]
MODE - -
REGULATED-ENTITY - PM00540
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5668
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7313
CITATIONS - 9582281
MODE - -
REGULATED-ENTITY - PM0-9554
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10777
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6623
CITATIONS - 15743955
CITATIONS - 15743955:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3487970397:asantos
CITATIONS - 15743955:EV-EXP-IMP-SITE-MUTATION:3487970397:asantos
CITATIONS - 15743955:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3487970397:asantos
MODE - +
REGULATED-ENTITY - PM0-10233
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6043
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7173
CITATIONS - 8381784
CITATIONS - 16491024
CITATIONS - 21034467
COMMENT - Hns repress the <i>cadB</i> promoter at pH 8.0
MODE - -
REGULATED-ENTITY - PM00622
REGULATOR - PD00288
//
UNIQUE-ID - REG0-11472
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8220
CITATIONS - 22295907
MODE - +
REGULATED-ENTITY - PM0-46179
REGULATOR - CPLX0-7916
//
UNIQUE-ID - REG0-6416
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7188
CITATIONS - 16377617
COMMENT - By making use of microarray analyses, Constantinidou et al. |CITS: [16377617]| concluded that FNR activates <i>tar-tap-cheRBYZ</i> operon expression. They also identified a putative FNR-binding site upstream of the operon, but the sequence was not reported.
MODE - +
REGULATED-ENTITY - PM0-1728
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4529
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6926
CITATIONS - 8057356
MODE - +
REGULATED-ENTITY - PM00061
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9358
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7520
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM00026
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4902
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1122
CITATIONS - [9924977]
CITATIONS - [7715442]
MODE - -
REGULATED-ENTITY - PM00242
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5278
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00615
COMMENT - The DsdC activator can act independently and is absolutely required for the transcription activation of the <i>dsdXA</i> promoter. 
/
/Expression from this promoter can be futher enhanced (about seven fold) in the presence of the cAMP-CRP complex, leading to a more than 200-fold activation of transcription.
/
MODE - +
REGULATED-ENTITY - PM00516
REGULATOR - CPLX0-7714
//
UNIQUE-ID - REG0-5652
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS304
CITATIONS - [10564497]
MODE - +
REGULATED-ENTITY - PM00528
REGULATOR - CPLX0-8062
//
UNIQUE-ID - REG0-10752
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7885
CITATIONS - 12067348
CITATIONS - 21097628
MODE - +
REGULATED-ENTITY - PM0-2281
REGULATOR - PD00365
//
UNIQUE-ID - REG0-6027
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS826
CITATIONS - [11101674]
MODE - +
REGULATED-ENTITY - PM1021
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-11429
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8200
CITATIONS - 10463182
CITATIONS - 7665470
CITATIONS - 15621456
CITATIONS - 10972807
MODE - +
REGULATED-ENTITY - PM0-6484
REGULATOR - PD00339
//
UNIQUE-ID - REG0-6400
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1583
CITATIONS - [10564485]
CITATIONS - 11395452
CITATIONS - 21097628
MODE - +
REGULATED-ENTITY - PM0-2021
REGULATOR - PD00406
//
UNIQUE-ID - REG0-4513
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3303
CITATIONS - 9469834
CITATIONS - 7934873
CITATIONS - 1848637
COMMENT - CAP and NagC can bind simultaneously and produce a more stable complex than binary NagC-DNA complex.
MODE - +
REGULATED-ENTITY - PM00058
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9329
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7495
CITATIONS - 17768236
CITATIONS - 17768236:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3411311191:asantos
CITATIONS - 17768236:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3411311191:asantos
MODE - +
REGULATED-ENTITY - PM00039
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4886
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5801
CITATIONS - 15838058
MODE - +
REGULATED-ENTITY - PM00531
REGULATOR - PHOSPHO-RCSB
//
UNIQUE-ID - REG0-5262
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1283
CITATIONS - [8866483]
CITATIONS - [7961507]
CITATIONS - 15941987
CITATIONS - 21685294
MODE - +
REGULATED-ENTITY - PM00563
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-5636
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00660
CITATIONS - [7565112]
CITATIONS - [10628873]
MODE - -
REGULATED-ENTITY - PM00592
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10711
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7867
CITATIONS - 20156994
MODE - +
REGULATED-ENTITY - PM0-10539
REGULATOR - CPLX0-8048
//
UNIQUE-ID - REG0-6011
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS822
CITATIONS - [2575702]
CITATIONS - [1327747]
MODE - +
REGULATED-ENTITY - PM1001
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11404
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00232
CITATIONS - [8429549]
CITATIONS - 8508774
CITATIONS - 8071194
CITATIONS - 8483418
CITATIONS - 8429549:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537795018:martin
CITATIONS - 8429549:EV-EXP-IMP-SITE-MUTATION:3537795018:martin
CITATIONS - 8429549:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537795018:martin
CITATIONS - 8429549:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537795018:martin
CITATIONS - 2115869:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537795018:martin
CITATIONS - 2115869:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537795018:martin
CITATIONS - 2646291:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537795018:martin
CITATIONS - 8508774:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537795018:martin
CITATIONS - 8508774:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537795018:martin
CITATIONS - 8071194:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537795018:martin
CITATIONS - 8071194:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537795018:martin
CITATIONS - 8483418:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537795018:martin
CITATIONS - 8483418:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3537795018:martin
CITATIONS - 8432705:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537795018:martin
CITATIONS - 8432705:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3537795018:martin
CITATIONS - 12218014:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537795018:martin
CITATIONS - 12218014:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3537795018:martin
CITATIONS - 3891724:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537795018:martin
CITATIONS - 1447135:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3537795018:martin
MODE - -
REGULATED-ENTITY - PM00323
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6384
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1983
CITATIONS - [10411720]
MODE - -
REGULATED-ENTITY - PM0-2701
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4496
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS161
CITATIONS - 10760178
CITATIONS - 12060687
CITATIONS - 18346968
MODE - -
REGULATED-ENTITY - PM00050
REGULATOR - MONOMER0-161
//
UNIQUE-ID - REG0-9309
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2744
CITATIONS - 11929525
CITATIONS - 15978080
MODE - -
REGULATED-ENTITY - PM0-3923
REGULATOR - PC00027
//
UNIQUE-ID - REG0-4869
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4421
CITATIONS - 8120010
CITATIONS - 8763946
CITATIONS - 11673423
MODE - -
REGULATED-ENTITY - PM00423
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5245
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS54
CITATIONS - [3326786]
CITATIONS - [9236118]
CITATIONS - 17233899
COMMENT - Lrp activates the <i>gltBDF</i> operon in a leucine-insensitive manner |CITS:[7901196]|, binding at three sites distant to the &sigma;<sup>70</sup> promoter. This is a strange way of regulating a &sigma;<sup>70</sup> promoter, since Lrp should bind close to the promoter in order to regulate, and so it is helped by IHF (the DNA-bending protein) binding between the proximal Lrp site and the promoter, bending this DNA region and getting Lrp closer to &sigma;<sup>70</sup> to activate the transcription |CITS:[11395454]|. (Lrp is just a modulator of the operon expression; it does not work as the common activators/repressors that switch the gene expression in an on/off manner. In addition, it is sometimes insensitive to the presence of leucine to have its modulator effect |CITS:[7968922]|.)
MODE - +
REGULATED-ENTITY - PM00254
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5620
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00617
CITATIONS - 8102362
COMMENT - Isolated mRNA from isogenic himA<sup>+</sup> and himA::Tn<i>10</i> (SR69 and SR1021) strains or from <i>himD</i> mutant bacteria (SR1022) has been studied. The primer extension results showed comparatively low levels of mRNA transcripts initiating from all three putative promoters. Thus, it is clear that functional IHF is needed for efficient transcription of the <i>ecp-htrE</i> operon.
MODE - +
REGULATED-ENTITY - PM00554
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10678
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7853
CITATIONS - 10419964
MODE - +
REGULATED-ENTITY - PM0-1441
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5995
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS360
CITATIONS - [8022271]
COMMENT - Shalel-Levanon et al.  |CITS: [15988767]| suggested that FNR has a minor positive effect or no effect on <i>arcA</i> expression under the conditions that they used.
MODE - +
REGULATED-ENTITY - PM195
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11372
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8178
CITATIONS - 22101843
CITATIONS - 18997424
MODE - +
REGULATED-ENTITY - PM0-10377
REGULATOR - PHOSPHO-DPIA
//
UNIQUE-ID - REG0-6368
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1765
CITATIONS - 12169620
CITATIONS - 16515535
MODE - -
REGULATED-ENTITY - PM0-2482
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-4480
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7284
CITATIONS - 17379715
MODE - +
REGULATED-ENTITY - PM0-9414
REGULATOR - PC00084
//
UNIQUE-ID - REG0-9277
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7478
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00020
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4853
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1502
CITATIONS - 12426353
CITATIONS - 14702328
COMMENT - Only  FhlA mutants can activate the transcription of the <i>hyf</i> operon.   The HycA protein acts as an antiactivator of FhlA |CITS:[12426353]|.
MODE - +
REGULATED-ENTITY - PM787
REGULATOR - MONOMER0-183
//
UNIQUE-ID - REG0-5229
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4923
CITATIONS - 1987150
MODE - -
REGULATED-ENTITY - PM00449
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-5603
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00646
CITATIONS - 20141531
MODE - -
REGULATED-ENTITY - PM00177
REGULATOR - PD00361
//
UNIQUE-ID - REG0-10659
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7842
CITATIONS - 19889087
MODE - +
REGULATED-ENTITY - PM0-10504
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-5979
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00471
CITATIONS - 3035558
MODE - -
REGULATED-ENTITY - PM00298
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-11325
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8165
CITATIONS - 9819053
CITATIONS - 21890697
MODE - +
REGULATED-ENTITY - PM00063
REGULATOR - CPLX0-7669
//
UNIQUE-ID - REG0-6352
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6946
CITATIONS - 8107138
MODE - -
REGULATED-ENTITY - PM00488
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-12391
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8508
CITATIONS - 26549308
MODE - -
REGULATED-ENTITY - PM0-46099
REGULATOR - CPLX0-8210
//
UNIQUE-ID - REG0-9257
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7463
CITATIONS - 17892462
MODE - +
REGULATED-ENTITY - PM681
REGULATOR - G6882-MONOMER
//
UNIQUE-ID - REG0-4837
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6482
CITATIONS - 10383761
CITATIONS - 8455549
CITATIONS - 16204188
COMMENT - H-NS represses transcription through the binding to supercoiled DNA |CITS: [8455549]|. H-NS represses the transcription initiation at <i>hdeAp</i> by &sigma;<sup>70</sup>, but not by &sigma;<sup>38</sup>. This repression is not through a direct interaction with &sigma;<sup>70</sup>; instead, it acts as a cofactor for DNA looping. H-NS bound at  118 laterally extends to the promoter downstream sequence and wraps the DNA around &sigma;<sup>70</sup> through the cooperative recruitment of other H-NS molecules |CITS: [16204188]|. 
/
/H-NS is the main repressor of the <i>hdeAB-yhiD</i> operon. Both H-NS and GadE are involved in increasing the <i>hdeAB-yhiD</i> repression levels by MarA that occur as the cell enters the stationary phase |CITS: [18083817]|.
/
MODE - -
REGULATED-ENTITY - PM928
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5212
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2428
CITATIONS - 8034583
CITATIONS - 11601842
MODE - +
REGULATED-ENTITY - PM00401
REGULATOR - PD00406
//
UNIQUE-ID - REG0-5585
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6944
CITATIONS - 8107138
MODE - -
REGULATED-ENTITY - PM00184
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-10603
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7827
CITATIONS - 20015147
MODE - +
REGULATED-ENTITY - PM0-10490
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-5963
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS68
CITATIONS - 11929525
CITATIONS - 11004182
CITATIONS - 8501030
CITATIONS - 7854119
CITATIONS - 9302020
COMMENT - The  -22 and  -50  NarL sites are needed for optimal repression of <i>nrfA</i> expression. At high  nitrate concentrations NarL can repress <i>nrfA</i> expression, but NarP cannot |CITS:[11004182] |.
MODE - -
REGULATED-ENTITY - PM00280
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-11267
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8149
CITATIONS - 11350954
MODE - +
REGULATED-ENTITY - TU0-8301
REGULATOR - PHOSPHO-CREB
//
UNIQUE-ID - REG0-6336
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2461
CITATIONS - 12617754
CITATIONS - 23531166
COMMENT - The regulatory effect of NtrC on the promoter <i>patA</i>p is as yet not known |CITS: [12617754]|. However, we assigned a positive to this regulatory interaction based on the facts that NtrC activates sigma54 promoters and the promoter <i>patA</i>p is one of them.
MODE - +
REGULATED-ENTITY - PM0-3521
REGULATOR - GLNG-CPLX
//
UNIQUE-ID - REG0-12297
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8489
CITATIONS - 26078445
MODE - -
REGULATED-ENTITY - PM00184
REGULATOR - G7947-MONOMER
//
UNIQUE-ID - REG0-9163
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7446
CITATIONS - 17720788
MODE - -
REGULATED-ENTITY - PM0-9688
REGULATOR - CPLX0-7756
//
UNIQUE-ID - REG0-4820
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00059
CITATIONS - 12079504
COMMENT - There are several putative NarL-binding sites, but only  three of them have a NarL consensus with only one 
/mismatch |CITS:[12079504]|.
MODE - -
REGULATED-ENTITY - PM00026
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5196
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00576
CITATIONS - 7601827
MODE - -
REGULATED-ENTITY - PM00354
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5568
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00436
CITATIONS - 11121424
MODE - +
REGULATED-ENTITY - PM00250
REGULATOR - PD00519
//
UNIQUE-ID - REG0-10574
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7811
CITATIONS - 19734316
MODE - +
REGULATED-ENTITY - PM0-10451
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5943
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00688
CITATIONS - 23274360
MODE - +
REGULATED-ENTITY - PM00285
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-6320
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2683
CITATIONS - 11121068
MODE - +
REGULATED-ENTITY - PM0-3823
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-11252
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8136
CITATIONS - 15686558
MODE - +
REGULATED-ENTITY - PM0-8261
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-12223
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8475
CITATIONS - 25790494
CITATIONS - 25790494:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3641584529:asantos
CITATIONS - 25790494:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3641584529:asantos
CITATIONS - 25790494:EV-COMP-AINF:3641584529:asantos
MODE - -
REGULATED-ENTITY - PM0-46338
REGULATOR - G6976-MONOMER
//
UNIQUE-ID - REG0-11249
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8133
CITATIONS - 15686558
MODE - +
REGULATED-ENTITY - PM0-10482
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-12220
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8475
CITATIONS - 25790494
MODE - -
REGULATED-ENTITY - PM0-46339
REGULATOR - G6976-MONOMER
//
UNIQUE-ID - REG0-9080
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5521
CITATIONS - 15534208
CITATIONS - 17238917
MODE - +
REGULATED-ENTITY - PM00560
REGULATOR - G7678-MONOMER
//
UNIQUE-ID - REG0-4801
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00543
CITATIONS - 2160948
MODE - +
REGULATED-ENTITY - PM00020
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5177
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00571
COMMENT - ArcA regulation in this promoter shows a strong dependence on IHF . This ArcA-binding site straddles the transcription start site of the focAp1 promoter and it may be required for formation of a stable closed complex between Fnr and RNA polymerase at the focAp1 promoter.
MODE - +
REGULATED-ENTITY - PM00353
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5549
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00213
CITATIONS - [8676855]
CITATIONS - [2648001]
CITATIONS - 3139888
CITATIONS - 3009022
CITATIONS - 7868601
CITATIONS - 7937881
CITATIONS - 8468304
CITATIONS - 7556074
CITATIONS - 7713936
MODE - +
REGULATED-ENTITY - PM00101
REGULATOR - PD00230
//
UNIQUE-ID - REG0-10528
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7795
CITATIONS - 10347150
CITATIONS - 14499937
CITATIONS - 12391883
CITATIONS - 8626289
MODE - -
REGULATED-ENTITY - PM00179
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5924
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS448
CITATIONS - [10564485]
CITATIONS - [8636021]
CITATIONS - 10873449
CITATIONS - 11395452
COMMENT - This site also can be activated by SoxS. Sequences between  -91 and  -74  play an \ accessory\  role in MarR and SoxS transcriptional activation and MarA binding  to the <i>marR</i> promoter.
MODE - +
REGULATED-ENTITY - PM00265
REGULATOR - PD00365
//
UNIQUE-ID - REG0-6301
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2881
CITATIONS - 11292794
MODE - +
REGULATED-ENTITY - PM0-4141
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-11218
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8117
CITATIONS - 11071896
MODE - -
REGULATED-ENTITY - PM623
REGULATOR - EG10571-MONOMER
//
UNIQUE-ID - REG0-12153
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8455
CITATIONS - 25406449
MODE - -
REGULATED-ENTITY - PM00563
REGULATOR - G6745-MONOMER
//
UNIQUE-ID - REG0-9048
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7393
CITATIONS - 12366850
MODE - +
REGULATED-ENTITY - PM00060
REGULATOR - PHOSPHO-RSTA
//
UNIQUE-ID - REG0-4788
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4063
CITATIONS - 8613990
CITATIONS - 3050131
CITATIONS - 10518785
CITATIONS - 3106331
CITATIONS - 3315853
MODE - -
REGULATED-ENTITY - PM00012
REGULATOR - CPLX-125
//
UNIQUE-ID - REG0-5161
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS303
CITATIONS - 10564497
COMMENT - CaiF and CRP bind cooperatively to the <i>cai-fix</i> intergenic region to activate the <i>fixA</i> promoter.
MODE - +
REGULATED-ENTITY - PM339
REGULATOR - CPLX0-8062
//
UNIQUE-ID - REG0-10504
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7780
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM00626
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5908
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00768
CITATIONS - 7768815
MODE - -
REGULATED-ENTITY - PM00187
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-6284
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2744
CITATIONS - 11929525
COMMENT - IHF binding to this site strongly represses the acsp1 promoter and weakly represses nrfAp, a promoter that is overlapping and divergent to acsp1.
MODE - -
REGULATED-ENTITY - PM0-3921
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11119
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8099
CITATIONS - 12754220
COMMENT - By making use of microarray analysis it was concluded that anaerobiosis does not affect expression of the <i>gapC</i> operon, although FNR appears to repress  it.  A putative FNR-binding site, which was not shown in the report, was identified upstream of this operon |CITS: [12754220]|.
MODE - -
REGULATED-ENTITY - TU0-8359
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-12110
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8438
CITATIONS - 25176444
MODE - -
REGULATED-ENTITY - PM00606
REGULATOR - EG12116-MONOMER
//
UNIQUE-ID - REG0-9031
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7377
CITATIONS - 17020555
MODE - +
REGULATED-ENTITY - PM00391
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-4772
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00006
MODE - -
REGULATED-ENTITY - PM00004
REGULATOR - PC00003
//
UNIQUE-ID - REG0-5145
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS201
CITATIONS - [8057842]
CITATIONS - [7783622]
CITATIONS - 22168595
MODE - -
REGULATED-ENTITY - PM00324
REGULATOR - EG11088-MONOMER
//
UNIQUE-ID - REG0-5520
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4582
CITATIONS - 8412671
MODE - -
REGULATED-ENTITY - PM00089
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10483
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7765
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM00415
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5892
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5442
CITATIONS - 14731281
MODE - -
REGULATED-ENTITY - PM0-6881
REGULATOR - G7630-MONOMER
//
UNIQUE-ID - REG0-11102
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8090
CITATIONS - 21460078
CITATIONS - 15520470
MODE - -
REGULATED-ENTITY - PM0-8714
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6271
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4221
CITATIONS - 12586421
MODE - -
REGULATED-ENTITY - PM0-4681
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-12014
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8421
CITATIONS - 24659771
MODE - -
REGULATED-ENTITY - PM0-1101
REGULATOR - EG11084-MONOMER
//
UNIQUE-ID - REG0-9000
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00421
CITATIONS - 8455562
CITATIONS - 16621816
MODE - -
REGULATED-ENTITY - PM00151
REGULATOR - PC00027
//
UNIQUE-ID - REG0-4756
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00001
CITATIONS - 12492863
CITATIONS - 8682810
MODE - -
REGULATED-ENTITY - PM00001
REGULATOR - CPLX0-7605
//
UNIQUE-ID - REG0-5129
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS182
CITATIONS - [9749677]
MODE - +
REGULATED-ENTITY - PM241
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5504
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2344
CITATIONS - 11123679
COMMENT - H-NS most strongly represses the cydAp4 promoter and has a moderate effect on cydAp1, cydAp2, and cydAp3 promoters. H-NS regulates <i>cydAB</i> expression negatively in anaerobiosis and aerobiosis, but ArcA antagonizes its action in anaerobiosis.
MODE - -
REGULATED-ENTITY - PM00141
REGULATOR - PD00288
//
UNIQUE-ID - REG0-10465
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7749
CITATIONS - 19661178
MODE - +
REGULATED-ENTITY - PM0-10540
REGULATOR - CPLX0-8048
//
UNIQUE-ID - REG0-5876
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00295
CITATIONS - 2201868
CITATIONS - 8051021
CITATIONS - 8892825
CITATIONS - 16140031
CITATIONS - 15699038
MODE - -
REGULATED-ENTITY - PM00148
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11085
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8075
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM0-36128
REGULATOR - PD00197
//
UNIQUE-ID - REG0-6254
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3242
CITATIONS - 8755903
MODE - +
REGULATED-ENTITY - PM0-4528
REGULATOR - PD01520
//
UNIQUE-ID - REG0-11984
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8406
CITATIONS - 24335284
MODE - +
REGULATED-ENTITY - PM0-46311
REGULATOR - CPLX0-7916
//
UNIQUE-ID - REG0-8983
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5341
CITATIONS - 11053378
CITATIONS - 14996792
CITATIONS - 17892462
COMMENT - Hns modulates the <i>hlyE</i> expression both positively and negatively; this protein enhances the CRP-mediated expression of <i>hlyE</i> , but it inhibits the FNR-mediated <i>hlyE</i> expression.
MODE - -
REGULATED-ENTITY - PM681
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4739
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4664
CITATIONS - 2664421
MODE - +
REGULATED-ENTITY - PM00048
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5111
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS163
CITATIONS - [9401024]
MODE - +
REGULATED-ENTITY - PM502
REGULATOR - CPLX0-2781
//
UNIQUE-ID - REG0-5487
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-12
CITATIONS - 8626281
MODE - +
REGULATED-ENTITY - PM00138
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10436
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7735
CITATIONS - 19251855
MODE - -
REGULATED-ENTITY - PM0-5721
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5859
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS143
CITATIONS - [9383149]
MODE - -
REGULATED-ENTITY - PM00143
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11069
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8063
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00147
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6238
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4128
CITATIONS - 14593252
MODE - -
REGULATED-ENTITY - PM0-4921
REGULATOR - PD03585
//
UNIQUE-ID - REG0-11922
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8391
CITATIONS - 23935044
MODE - -
REGULATED-ENTITY - PM0-46064
REGULATOR - G7678-MONOMER
//
UNIQUE-ID - REG0-6614
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7217
CITATIONS - 14523117
COMMENT - The CsgD protein is bound to two sites (-47 and -64) upstream of the adrAp promoter. Together, these sites form an inverted repeat, suggesting that CsgD binds  to this region as a dimer.  In other regulatory regions,  the CsgD protein binds  to just one site |CITS: [14523117]|.
MODE - +
REGULATED-ENTITY - PM0-9308
REGULATOR - PD01379
//
UNIQUE-ID - REG0-4723
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00106
MODE - -
REGULATED-ENTITY - PM00045
REGULATOR - PD00763
//
UNIQUE-ID - REG0-5095
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS57
CITATIONS - 14612240
COMMENT - FNR activates <i>hypB</i> transcription under anaerobiosis.
MODE - +
REGULATED-ENTITY - PM00574
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5469
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00749
CITATIONS - 8388874
COMMENT - We have assumed that PurR negatively regulates these two promoters, but in the paper of He et al., 1993, this was not clear  |CITS:  [8388874]|.
MODE - -
REGULATED-ENTITY - PM00127
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-10394
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7714
CITATIONS - 16857675
MODE - +
REGULATED-ENTITY - PM0-10368
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5843
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-861
CITATIONS - 11101675
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00225
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-11052
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8047
CITATIONS - 21421764
CITATIONS - 21421764:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3513525325:martin
CITATIONS - 21421764:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3513525325:martin
CITATIONS - 21421764:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3513525325:martin
MODE - -
REGULATED-ENTITY - PM0-8720
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6222
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4861
CITATIONS - 15516583
MODE - -
REGULATED-ENTITY - PM0-5201
REGULATOR - EG20249-MONOMER
//
UNIQUE-ID - REG0-11831
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8375
CITATIONS - 16264194
COMMENT - Although the <i>ptrA</i>p promoter lacks a canonical LexA sequence, it is recognized by LexA based on ChIP-chip analysis and  mutation site experiments |CITS: [16264194]|. This aberrant version of the LexA motif suggests that another transcription factor could be involved in the regulation of the <i>ptrA</i>p promoter <i>in vivo</i> |CITS: [16264194]|.
MODE - -
REGULATED-ENTITY - PM00428
REGULATOR - PC00010
//
UNIQUE-ID - REG0-6597
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7292
CITATIONS - 16997959
CITATIONS - 18445167
MODE - +
REGULATED-ENTITY - PM0-8907
REGULATOR - MONOMER0-46
//
UNIQUE-ID - REG0-4706
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00094
CITATIONS - 1556120
CITATIONS - 9179845
MODE - -
REGULATED-ENTITY - PM00039
REGULATOR - PD03576
//
UNIQUE-ID - REG0-5079
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1164
CITATIONS - 7512187
COMMENT - H-NS antagonizes the Fis-mediated activation  of the P1 promoter through conformational changes in the DNA |CITS: [7512187]|.
MODE - -
REGULATED-ENTITY - PM00514
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5453
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00641
MODE - -
REGULATED-ENTITY - PM00114
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-10329
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7699
CITATIONS - 19245365
MODE - -
REGULATED-ENTITY - PM0-10357
REGULATOR - PD00196
//
UNIQUE-ID - REG0-5827
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7283
CITATIONS - 9613586
COMMENT - |CITS: [9613586]| demonstrated that IHF was necessary for full expression of the positively regulated <i>cysJp</i> promoter during stationary growth. In addition, they mentioned that IHF could act as a positive accessory factor, harnessing the effect of CysB under the transcription of <i>cysJIH</i>.
/
MODE - +
REGULATED-ENTITY - PM00107
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11028
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8035
CITATIONS - 21441513
MODE - +
REGULATED-ENTITY - PM00622
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6206
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6761
CITATIONS - 8300536
MODE - +
REGULATED-ENTITY - PM00578
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11759
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8359
CITATIONS - 23341772
CITATIONS - 23341772:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3577933570:asantos
CITATIONS - 23341772:EV-EXP-IMP-SITE-MUTATION:3577933570:asantos
CITATIONS - 23341772:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3577933570:asantos
CITATIONS - 23341772:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3577933570:asantos
MODE - -
REGULATED-ENTITY - PM0-46270
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-6581
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7213
CITATIONS - 8021189
MODE - -
REGULATED-ENTITY - PM0-8864
REGULATOR - CPLX0-7425
//
UNIQUE-ID - REG0-4690
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00087
CITATIONS - 3045087
CITATIONS - 8955388
MODE - -
REGULATED-ENTITY - PM00038
REGULATOR - PD03576
//
UNIQUE-ID - REG0-5063
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3762
CITATIONS - 13129959
COMMENT - The napFp2 promoter is inhibited by NarP in response to nitrate.
MODE - -
REGULATED-ENTITY - PM444
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-5437
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00306
CITATIONS - 1370290
MODE - +
REGULATED-ENTITY - PM00159
REGULATOR - PD00436
//
UNIQUE-ID - REG0-10187
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7682
CITATIONS - 19074390
MODE - +
REGULATED-ENTITY - PM0-10338
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-5811
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7031
CITATIONS - 15995204
MODE - -
REGULATED-ENTITY - PM00220
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-10983
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8027
CITATIONS - 12446650
CITATIONS - 16980449
CITATIONS - 12730179
MODE - +
REGULATED-ENTITY - PM450
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6190
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3941
CITATIONS - 3934044
MODE - -
REGULATED-ENTITY - PM0-5322
REGULATOR - G6867-MONOMER
//
UNIQUE-ID - REG0-11703
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8344
CITATIONS - 22522900
CITATIONS - 18495664
CITATIONS - 19181795
MODE - -
REGULATED-ENTITY - PM0-10351
REGULATOR - EG12431-MONOMER
//
UNIQUE-ID - REG0-6563
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6993
CITATIONS - 10850996
COMMENT - Rob is a transcriptional regulator related to the increase in resistance to antibiotics and is expressed constitutively. Bennik et al. have shown that this regulator activates  the transcription of the <i>ybiS</i> gene |CITS [ 10850996 ]|.
MODE - +
REGULATED-ENTITY - PM0-8714
REGULATOR - PD04418
//
UNIQUE-ID - REG0-4674
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6222
CITATIONS - 6363389
CITATIONS - 2403539
MODE - +
REGULATED-ENTITY - PM00037
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-9986
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7654
CITATIONS - 16515535
MODE - -
REGULATED-ENTITY - PM0-10286
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-5047
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS271
CITATIONS - 9371449
MODE - +
REGULATED-ENTITY - PM70
REGULATOR - MONOMER0-165
//
UNIQUE-ID - REG0-5421
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1682
CITATIONS - [10986267]
MODE - +
REGULATED-ENTITY - PM0-2201
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-10130
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7670
CITATIONS - 18083817
CITATIONS - 12730179
MODE - +
REGULATED-ENTITY - PM928
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-5795
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3462
CITATIONS - 14711822
CITATIONS - 22870390
MODE - -
REGULATED-ENTITY - PM00218
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10967
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8018
CITATIONS - 21314918
MODE - -
REGULATED-ENTITY - PM00494
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6172
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4481
CITATIONS - 15489450
MODE - +
REGULATED-ENTITY - PM0-5982
REGULATOR - PHOSPHO-EVGA
//
UNIQUE-ID - REG0-11660
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8332
CITATIONS - 23028867
COMMENT - The complex of CnuK9E (a variant of Cnu) and HNS antagonizes DNA binding of DicA, causing temperature-dependent filamentous growth at 37<sup>o</sup>C |CITS:[23028867]|. DicA binds better at 25<sup>o</sup>C than at 37<sup>o</sup>C |CITS:[23028867]|.
MODE - +
REGULATED-ENTITY - TU0-13328
REGULATOR - EG10226-MONOMER
//
UNIQUE-ID - REG0-6544
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7167
CITATIONS - 16677314
MODE - -
REGULATED-ENTITY - PM0-8916
REGULATOR - G7326-MONOMER
//
UNIQUE-ID - REG0-4658
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00075
CITATIONS - 9016640
CITATIONS - 14500788
CITATIONS - 8982002
CITATIONS - 15289461
COMMENT - HU and GalR, binding two sites,  repress the expression of the <i>gal</i> operon in the total absence of galactose |CITS: [16524589]|.
MODE - -
REGULATED-ENTITY - PM00032
REGULATOR - PD03028
//
UNIQUE-ID - REG0-9754
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7644
CITATIONS - 14523115
MODE - +
REGULATED-ENTITY - PM0-10257
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-5031
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS441
CITATIONS - [8955407]
CITATIONS - [10216857]
MODE - -
REGULATED-ENTITY - PM562
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5405
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5041
CITATIONS - 11222606:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3409861047:martin
CITATIONS - 12367523:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3409861047:martin
CITATIONS - 12367523:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3409861047:martin
CITATIONS - 12367523
CITATIONS - 11222606
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00227
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-5779
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00529
MODE - +
REGULATED-ENTITY - PM00210
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10939
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8004
CITATIONS - 11243806
CITATIONS - 11243806:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3505215933:martin
CITATIONS - 11243806:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3505215933:martin
CITATIONS - 11243806:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3505215933:martin
MODE - +
REGULATED-ENTITY - PM924
REGULATOR - PHOSPHO-HYDG
//
UNIQUE-ID - REG0-6155
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7115
CITATIONS - 9670013
MODE - +
REGULATED-ENTITY - PM00615
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-11640
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8318
CITATIONS - 23071782
MODE - +
REGULATED-ENTITY - PM0-10060
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-6528
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7322
CITATIONS - 15659676
CITATIONS - 21272324
CITATIONS - 10411720
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00343
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4642
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6983
CITATIONS - 8057356
MODE - -
REGULATED-ENTITY - PM00030
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9598
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7628
CITATIONS - 2864330
CITATIONS - Suzuki03
MODE - +
REGULATED-ENTITY - PM00153
REGULATOR - CPLX0-7733
//
UNIQUE-ID - REG0-5015
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS541
CITATIONS - [8955387]
CITATIONS - [9524241]
MODE - +
REGULATED-ENTITY - PM503
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5389
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1301
CITATIONS - 11287152
COMMENT - The regulatory effect of FlhDC in <i>mglB</i> operon transcription has been proved by microarray analysis by |CITS: [11287152]|
MODE - -
REGULATED-ENTITY - PM00231
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-5763
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00420
COMMENT - Purified OxyR and IHF proteins have also been shown to bind upstream of the <i>dps</i> promoter. IHF is required for the &sigma;<sup>S</sup>-dependent promoter. <i>dps</i> is induced in stationary phase. OxyR and IHF proteins may occupy the <i>dps</i> promoter simultaneously |CITS: [7984106]|.
MODE - +
REGULATED-ENTITY - PM00243
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10922
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7990
CITATIONS - 21034467
MODE - +
REGULATED-ENTITY - PM00254
REGULATOR - EG11966-MONOMER
//
UNIQUE-ID - REG0-6139
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7178
CITATIONS - 16140472
MODE - -
REGULATED-ENTITY - PM00499
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11623
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8301
CITATIONS - 23233451
MODE - -
REGULATED-ENTITY - TU0-13069
REGULATOR - G6444-MONOMER
//
UNIQUE-ID - REG0-6512
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3731
CITATIONS - 12588863
MODE - -
REGULATED-ENTITY - PM0-1302
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4626
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7104
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM00028
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9574
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7612
CITATIONS - 18502871
CITATIONS - 21890697
COMMENT - Based on EMSE, it was demonstrated that His<sub>6</sub>-ArgP has an apparent <i>K<sub>d</sub></i> of 35 nM for the binding of ArgP to the <i>dapB</i> regulatory region |CITS:[18502871]|.
MODE - +
REGULATED-ENTITY - PM00318
REGULATOR - CPLX0-7669
//
UNIQUE-ID - REG0-4998
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS344
CITATIONS - [8002608]
CITATIONS - 1346534
MODE - -
REGULATED-ENTITY - PM00631
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5373
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00496
CITATIONS - 8757746
CITATIONS - 17513476
COMMENT - <i>rhaT</i> is under the RhaR-RhaS cascade for induction by L-rhamnose.
MODE - +
REGULATED-ENTITY - PM00293
REGULATOR - CPLX-124
//
UNIQUE-ID - REG0-5747
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00711
CITATIONS - 7665470
CITATIONS - 21572102
MODE - -
REGULATED-ENTITY - PM00233
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-10902
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7974
CITATIONS - 6357945
CITATIONS - 6296052
MODE - -
REGULATED-ENTITY - PM0-36188
REGULATOR - PD03270
//
UNIQUE-ID - REG0-6123
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6782
MODE - -
REGULATED-ENTITY - PM00385
REGULATOR - PC00010
//
UNIQUE-ID - REG0-11586
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8290
CITATIONS - 6328431
MODE - +
REGULATED-ENTITY - PM00146
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6495
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1021
CITATIONS - [9466267]
MODE - -
REGULATED-ENTITY - PM0-1282
REGULATOR - CPLX0-6
//
UNIQUE-ID - REG0-4610
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7272
CITATIONS - 16861804
MODE - +
REGULATED-ENTITY - PM0-9394
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-9526
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7596
CITATIONS - 15878120
MODE - +
REGULATED-ENTITY - PM00378
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4980
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3841
MODE - +
REGULATED-ENTITY - PM101
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5356
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7002
CITATIONS - 15743952
CITATIONS - 11717281
MODE - -
REGULATED-ENTITY - PM00536
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-5731
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00649
CITATIONS - 9484892
COMMENT - A mutation in the <i>mlc</i> gene, encoding a homolog of  <i>nagC</i>, results in a threefold derepression of  <i>manX</i> expression, suggesting that this protein is a more important regulator of  <i>maX</i> expression than NagC. The Mlc protein binds to the NagC operators, binding preferentially to the promoter-proximal operator. Plasmids overproducing either the NagC protein or the mlc protein repress the expression of <i>manX</i>, but the effect to the Mlc protein is stronger.  Mcl weakly protects this operator. The <i>manX</i> operator is only partially occupied under physiological concentrations of the Mlc protein.  CAP and NagC can bind simultaneously and produce a complex more stable than the binary NagC-DNA complex |CITS: [9484892]|.
MODE - -
REGULATED-ENTITY - PM00276
REGULATOR - PD01896
//
UNIQUE-ID - REG0-10886
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7959
CITATIONS - 20729367
MODE - -
REGULATED-ENTITY - PM0-45322
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-6107
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6061
CITATIONS - 11466284
CITATIONS - 12029030
COMMENT - Iron  represses <i>mntH</i> expression. This repression is mediated by Fur, a transcriptional regulator that binds 59 nt upstream of the <i>mntH</i> gene start |CITS: [11466284]|.
MODE - -
REGULATED-ENTITY - PM0-7661
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-11552
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8272
CITATIONS - 22563052
MODE - +
REGULATED-ENTITY - PM0-46189
REGULATOR - PHOSPHO-RCSB
//
UNIQUE-ID - REG0-6479
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7144
CITATIONS - 16238633
COMMENT - Based on studies of binding sites using gel shift and footprinting with Lrp and H-NS regulator proteins, it was demonstrated that both proteins interact with obvious synergism in the repression of all seven <i>E. coli</i> rrn P1 promoter upstream regions; as a result, they help the efficient shutdown of rRNA synthesis.  Likewise, both proteins could be a transient heteromer via protein-protein interactions interfering with the RNA polymerase, and this way it may alter the DNA of the upstream regions of all seven ribosomal P1 promoters |CITS: [16238633]|.
MODE - -
REGULATED-ENTITY - PM0-1351
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-4591
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00163
CITATIONS - [2656631]
CITATIONS - [2656704]
CITATIONS - [2553720]
CITATIONS - [1736095]
CITATIONS - [9422609]
CITATIONS - 10698756
CITATIONS - 11158569
CITATIONS - 11812125
CITATIONS - 7557323
CITATIONS - 12366850
CITATIONS - 16618701
MODE - +
REGULATED-ENTITY - PM00066
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-9463
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7583
CITATIONS - 18227264
MODE - -
REGULATED-ENTITY - PM0-10196
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-4964
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4301
CITATIONS - 10027972
CITATIONS - 14996792
CITATIONS - 17892462
MODE - +
REGULATED-ENTITY - PM681
REGULATOR - G6882-MONOMER
//
UNIQUE-ID - REG0-5339
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00701
CITATIONS - 7715459
MODE - +
REGULATED-ENTITY - PM00620
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5713
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00718
COMMENT - CspA has been called CS7.4
MODE - +
REGULATED-ENTITY - PM00192
REGULATOR - PD03695
//
UNIQUE-ID - REG0-10848
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7942
CITATIONS - 20683441
COMMENT - The ArcAB two-component system represses <i>arcZ</i> expression under anaerobic growth |CITS:[20683441]|. Thus, ArcA represses <i>rpoS</i> translation through ArcZ |CITS:[20683441]|.
MODE - -
REGULATED-ENTITY - PM0-9687
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-6091
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6522
CITATIONS - 12813061
MODE - -
REGULATED-ENTITY - PM0-8183
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-11519
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8253
CITATIONS - 8626315
CITATIONS - 22465792
MODE - +
REGULATED-ENTITY - PM0-46187
REGULATOR - PD04418
//
UNIQUE-ID - REG0-6463
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2566
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1347
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4574
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2430
CITATIONS - 8002608
CITATIONS - 1346534
COMMENT - Binding of Lrp to one site enhances occupancy of the other Lrp sites  in the  ompCp1 promoter. Leucine does not abolish  DNA binding by the ligated Lrp but it may alter the affinity of Lrp for specific sites on DNA.
MODE - -
REGULATED-ENTITY - PM00065
REGULATOR - PD00353
//
UNIQUE-ID - REG0-9409
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7566
CITATIONS - 18083817
COMMENT - TorR shows no significant effect in the expression of <i>hdeAB-yhiD</i>, which suggests that TorR only regulates the <i>hdeAB-yhiD</i> operon after induction of the TorRS system by trimethylamine, <i>N</i>-oxide, and anaerobiosis |CITS: [12657056] [18083817]|. Two predicted sites have been reported |CITS: [18083817]|.
MODE - +
REGULATED-ENTITY - PM928
REGULATOR - CPLX0-2821
//
UNIQUE-ID - REG0-4948
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS503
CITATIONS - [8900118]
MODE - -
REGULATED-ENTITY - PM00475
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-5323
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00674
CITATIONS - [10537212]
COMMENT - ArcA actives the transcription of the <i>hyaABCDEF</i> operon during anaerobic growth.
MODE - +
REGULATED-ENTITY - PM00598
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5697
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00317
MODE - +
REGULATED-ENTITY - PM00168
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10818
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7926
CITATIONS - 20435136
MODE - +
REGULATED-ENTITY - PM0-46012
REGULATOR - CPLX0-7852
//
UNIQUE-ID - REG0-6072
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6684
CITATIONS - 7860604
COMMENT - Fis negatively regulates <i>glnQ</i> gene expression, and RpoS lightly regulates its expression |CITS: [7860604]|.
MODE - -
REGULATED-ENTITY - PM0-8381
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-11503
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8246
CITATIONS - 22539721
MODE - +
REGULATED-ENTITY - PM0-7361
REGULATOR - PD00214
//
UNIQUE-ID - REG0-6447
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2544
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1341
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4558
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-943
CITATIONS - [9819053]
MODE - +
REGULATED-ENTITY - PM00063
REGULATOR - CPLX0-7669
//
UNIQUE-ID - REG0-9389
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7550
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM00529
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4932
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS769
CITATIONS - [9421904]
MODE - -
REGULATED-ENTITY - PM263
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5307
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00778
MODE - +
REGULATED-ENTITY - PM00664
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5681
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3343
CITATIONS - 8830277
MODE - +
REGULATED-ENTITY - PM00191
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10802
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7910
CITATIONS - 8034727
CITATIONS - 8034728
CITATIONS - 10848985
MODE - +
REGULATED-ENTITY - PM00209
REGULATOR - MONOMER0-183
//
UNIQUE-ID - REG0-6056
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6803
CITATIONS - 2543976
CITATIONS - 2643109
CITATIONS - 7836282
CITATIONS - 2673243
MODE - +
REGULATED-ENTITY - PM0-8601
REGULATOR - CPLX0-7752
//
UNIQUE-ID - REG0-11485
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8229
CITATIONS - 22295907
MODE - -
REGULATED-ENTITY - PM0-46179
REGULATOR - PD00519
//
UNIQUE-ID - REG0-6431
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1441
CITATIONS - [10094685]
MODE - +
REGULATED-ENTITY - PM0-1881
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-4542
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00148
CITATIONS - [2845227]
CITATIONS - [2677602]
CITATIONS - [8437517]
CITATIONS - 15225315
CITATIONS - 18757534
COMMENT - The <i>nir</i> promoter is 100% dependent on FNR.  If there is no FNR, there is no activity.  This activity can be efficiently repressed  by FruR (-16.5 site) and less efficiently by HNS and Fis (+23 site). FNR-dependent activation of the <i>nir</i> promoter is repressed by IHF (-88 site) and Fis (-142 site), DNA-binding proteins that play a role in shaping the folded bacterial chromosome.  Although Fis and IHF repress FNR-dependent activation of the <i>nir</i> promoter, they do not prevent FNR binding.  Thus, Fis, IHF, and FNR can bind simultaneously.
MODE - +
REGULATED-ENTITY - PM00062
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-9372
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7533
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM681
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4916
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS626
CITATIONS - [9852003]
MODE - -
REGULATED-ENTITY - PM00625
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5291
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS444
CITATIONS - [8955407]
CITATIONS - [10216857]
MODE - -
REGULATED-ENTITY - PM00540
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5665
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7316
CITATIONS - 9582281
MODE - -
REGULATED-ENTITY - PM0-9554
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10767
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7896
CITATIONS - 20522491
MODE - +
REGULATED-ENTITY - PM0-36132
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-6040
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3861
CITATIONS - 14702398
MODE - +
REGULATED-ENTITY - PM00622
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-11467
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8215
CITATIONS - 22422754
COMMENT - MatA-<i>matB</i>p5 regulatory interaction was identified in <i>Escherichia coli</i> strain IHE 3034 |CITS:[ 22422754]|.
/
/MatA binds weakly to <i>matB</i>p |CITS:[ 22422754]|.
MODE - +
REGULATED-ENTITY - PM0-44426
REGULATOR - G6165-MONOMER
//
UNIQUE-ID - REG0-6413
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3807
CITATIONS - 14702398
MODE - +
REGULATED-ENTITY - PM0-1681
REGULATOR - EG11544-MONOMER
//
UNIQUE-ID - REG0-4526
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6988
CITATIONS - 8057356
MODE - +
REGULATED-ENTITY - PM00061
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9355
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7517
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM0-7321
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4899
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1125
CITATIONS - [9924977]
CITATIONS - [7715442]
MODE - -
REGULATED-ENTITY - PM00242
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5275
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00176
CITATIONS - 1729205
CITATIONS - 21572102
MODE - -
REGULATED-ENTITY - PM00515
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-5649
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3427
CITATIONS - 14711822
MODE - +
REGULATED-ENTITY - PM00528
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10734
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7882
CITATIONS - 20126629
MODE - +
REGULATED-ENTITY - PM0-10288
REGULATOR - PD02198
//
UNIQUE-ID - REG0-6024
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS829
CITATIONS - 10702265
MODE - +
REGULATED-ENTITY - PM1021
REGULATOR - EG12031-MONOMER
//
UNIQUE-ID - REG0-11423
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8197
CITATIONS - 10216857
CITATIONS - 8955407
CITATIONS - 8955407:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3538187207:martin
CITATIONS - 8955407:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3538187207:martin
CITATIONS - 10216857:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3538187207:martin
CITATIONS - 10216857:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3538187207:martin
CITATIONS - 10216857:EV-EXP-IMP-SITE-MUTATION:3538187207:martin
CITATIONS - 10216857:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3538187207:martin
CITATIONS - 8955407:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3538187207:martin
MODE - -
REGULATED-ENTITY - PM562
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6397
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1522
CITATIONS - 9260970
MODE - -
REGULATED-ENTITY - PM0-1983
REGULATOR - EG12344-MONOMER
//
UNIQUE-ID - REG0-4510
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00135
CITATIONS - 2543976
CITATIONS - 2185137
CITATIONS - 2673243
CITATIONS - 7836282
MODE - +
REGULATED-ENTITY - PM00055
REGULATOR - CPLX0-7759
//
UNIQUE-ID - REG0-9326
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7498
CITATIONS - 17768236
CITATIONS - 17768236:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3411310759:asantos
CITATIONS - 17768236:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3411310759:asantos
MODE - +
REGULATED-ENTITY - PM00039
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4883
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-961
CITATIONS - 7883164
CITATIONS - 9159398
CITATIONS - 16861804
MODE - +
REGULATED-ENTITY - PM00327
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-5259
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00619
CITATIONS - 14645248
MODE - -
REGULATED-ENTITY - PM00558
REGULATOR - PC00103
//
UNIQUE-ID - REG0-5633
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2084
CITATIONS - [10628873]
CITATIONS - [7565112]
MODE - -
REGULATED-ENTITY - PM00592
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10706
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7864
CITATIONS - 20189963
CITATIONS - 17185552
CITATIONS - 20435136
MODE - -
REGULATED-ENTITY - PM461
REGULATOR - PHOSPHO-RCSB
//
UNIQUE-ID - REG0-6008
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7288
CITATIONS - 10506196
COMMENT - We have assigned a negative function for this site (+33), since IHF normally represses at this distance.
MODE - -
REGULATED-ENTITY - PM169
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11385
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8185
CITATIONS - 22168595
MODE - -
REGULATED-ENTITY - PM0-1101
REGULATOR - EG11088-MONOMER
//
UNIQUE-ID - REG0-6381
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7246
CITATIONS - 17233826
MODE - -
REGULATED-ENTITY - PM00550
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4493
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00457
COMMENT - MelR binding to site 2' (-194.5) occurs only in the presence of melibiose |CITS:[12060687]| and relieves MelR-dependent repression of the <i>melR</i> promoter |CITS:[12060687], [10760179], [10747919], [1445208], [10760178]|.
MODE - +
REGULATED-ENTITY - PM00050
REGULATOR - MONOMER0-161
//
UNIQUE-ID - REG0-9293
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7488
CITATIONS - 17921503
CITATIONS - 17921503:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3409862291:martin
CITATIONS - 17921503:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3409862291:martin
MODE - -
REGULATED-ENTITY - PM0-4201
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4866
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4424
CITATIONS - 8120010
CITATIONS - 11673423
CITATIONS - 8763946
MODE - -
REGULATED-ENTITY - PM00423
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5242
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7234
CITATIONS - 11395454
CITATIONS - 17233899
MODE - +
REGULATED-ENTITY - PM00254
REGULATOR - PC00027
//
UNIQUE-ID - REG0-5617
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00608
COMMENT - In the intergenic region between <i>dppA</i> and <i>dppC</i> there is an IHF site. Abouhamad et al. |CITS: [7536291]|  suggest  that IHF affects transcription of <i>dppABCDF</i>. That seems unlikely given its position downstream of the gene.
MODE - +
REGULATED-ENTITY - PM00546
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10675
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00214
CITATIONS - [2183352]
CITATIONS - 11443092
MODE - +
REGULATED-ENTITY - PM0-10406
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5992
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00744
CITATIONS - [8825776]
CITATIONS - [10564485]
CITATIONS - [7896696]
CITATIONS - 11395452
COMMENT - SoxS binding to <i>zwf</i> induced a bend of ~50&deg;.
MODE - +
REGULATED-ENTITY - PM00295
REGULATOR - PD00406
//
UNIQUE-ID - REG0-11368
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8174
CITATIONS - 22101843
CITATIONS - 22101843:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3535221744:asantos
MODE - +
REGULATED-ENTITY - PM0-10380
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-6365
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6483
CITATIONS - 11298273
CITATIONS - 15795232
COMMENT - Two large footprinting regions for Hns binding, which are necessary for full repression, were identified around the regulatory region of the gadXp promoter (from +1 to -67 and from -86 to -153 ) . These regions may contain sites for several Hns molecules, but these specific sites have
/not been identified |CITS:[15795232]|.
/
/The RNA polymerase binding to the gadXp promoter can be prevented by Hns protein that binds around the promoter  region |CITS:[15795232]|.
MODE - -
REGULATED-ENTITY - PM0-2441
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4477
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00583
CITATIONS - 8413182
MODE - -
REGULATED-ENTITY - PM00110
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-9274
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7476
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00164
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4850
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7084
CITATIONS - 16428390
MODE - -
REGULATED-ENTITY - PM00415
REGULATOR - CPLX0-7756
//
UNIQUE-ID - REG0-5226
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4923
CITATIONS - 1987150
CITATIONS - 1987150:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3510451887:martin
CITATIONS - 23274360
MODE - +
REGULATED-ENTITY - PM00448
REGULATOR - PHOSPHO-PHOB
//
UNIQUE-ID - REG0-5598
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00393
CITATIONS - 10601201
MODE - +
REGULATED-ENTITY - PM00172
REGULATOR - CPLX0-7650
//
UNIQUE-ID - REG0-10655
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7840
CITATIONS - 20075074
MODE - +
REGULATED-ENTITY - PM0-10502
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5976
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS758
MODE - +
REGULATED-ENTITY - PM00298
REGULATOR - PHOSPHO-TORR
//
UNIQUE-ID - REG0-11322
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8162
CITATIONS - 8825783
CITATIONS - 8995231
CITATIONS - 9254708
CITATIONS - 21890697
MODE - +
REGULATED-ENTITY - PM00466
REGULATOR - CPLX0-7669
//
UNIQUE-ID - REG0-6349
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4961
CITATIONS - 15009899
CITATIONS - 16824106
CITATIONS - 15101990
CITATIONS - 11443091
CITATIONS - 21143317
MODE - +
REGULATED-ENTITY - PM0-2801
REGULATOR - PD00214
//
UNIQUE-ID - REG0-12375
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8503
CITATIONS - 26350134
MODE - +
REGULATED-ENTITY - PM0-9795
REGULATOR - PD00232
//
UNIQUE-ID - REG0-9254
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7460
CITATIONS - 17892462
MODE - +
REGULATED-ENTITY - PM681
REGULATOR - G6882-MONOMER
//
UNIQUE-ID - REG0-4833
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5181
CITATIONS - 12657056
CITATIONS - 18083817
COMMENT - TorR shows no significant effect in the expression of <i>hdeAB-yhiD</i>, which suggests that TorR only regulates the <i>hdeAB-yhiD</i> operon after induction of the TorRS system by trimethylamine, <i>N</i>-oxide, and anaerobiosis |CITS: [12657056] [18083817]|. Two predicted sites have been reported |CITS: [18083817]|.
MODE - +
REGULATED-ENTITY - PM928
REGULATOR - CPLX0-2821
//
UNIQUE-ID - REG0-5209
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3121
CITATIONS - 10802742
MODE - +
REGULATED-ENTITY - PM00401
REGULATOR - PD04418
//
UNIQUE-ID - REG0-5582
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00337
CITATIONS - [8729576]
CITATIONS - [10601207]
MODE - +
REGULATED-ENTITY - PM00184
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10599
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7824
CITATIONS - 15743955
MODE - +
REGULATED-ENTITY - PM0-8241
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5960
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00476
CITATIONS - 11929525
CITATIONS - 11004182
CITATIONS - 7854119
CITATIONS - 9302020
CITATIONS - 15978080
CITATIONS - 8501030
COMMENT - The maximum <i>nrfA</i> expression is achieved at low nitrate concentrations through NarP and mainly through NarL. Wang and Gunsalus |CITS: [11004182]| reported that the nitrite is a less effective inductor of <i>nrfA</i> expression, although in a earlier report Page et al. |CITS: [2173895]| reported  that this molecule was the primary signal. The sites at -70 and -79  are recognized by NarL and NarP, but NarL has the highest affinity for them.
/ 
/<i>nrf</i> expression is increased in response to nitrite or nitrate ions by NarL or NarP. FNR and NarL/NarP act by promoting open complex formation by RNAP at the <i>nrf</i> promoter. Although it seems that NarL and FNR can bind to their targets independently, NarL is unable to activate the <i>nrf</i> promoter in the absence of FNR |CITS: [15978080]|. NarL and IHF cannot bind together; the other protein regulators can bind together to form ternary complexes. Fis binds independently of FNR and IHF. |CITS: [15978080]| supposed that Fis blocks access of RNAP to the <i>nrf</i> promoter.
MODE - +
REGULATED-ENTITY - PM00280
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-11264
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8146
CITATIONS - 18576672
MODE - -
REGULATED-ENTITY - PM0-44483
REGULATOR - PD01520
//
UNIQUE-ID - REG0-6333
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2482
CITATIONS - 12617754
COMMENT - The regulatory effect of IHF on the promoter ygjGp is not known |CITS: [12617754]|.
REGULATED-ENTITY - PM0-3521
REGULATOR - PC00027
//
UNIQUE-ID - REG0-12294
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8486
CITATIONS - 26078445
MODE - -
REGULATED-ENTITY - PM0-46351
REGULATOR - G7947-MONOMER
//
UNIQUE-ID - REG0-9160
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7443
CITATIONS - 17850814
MODE - -
REGULATED-ENTITY - PM0-8542
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-4817
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00748
CITATIONS - 2170326
CITATIONS - 8969182
CITATIONS - 1649947
CITATIONS - 1661372
CITATIONS - 1647022
CITATIONS - 1655726
CITATIONS - 8221894
CITATIONS - 845188
CITATIONS - 8394345
CITATIONS - 11574471
CITATIONS - 12667072
MODE - -
REGULATED-ENTITY - PM00025
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5193
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00577
MODE - -
REGULATED-ENTITY - PM00353
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5565
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7230
CITATIONS - 12123449
MODE - -
REGULATED-ENTITY - PM00308
REGULATOR - G7072-MONOMER
//
UNIQUE-ID - REG0-10566
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7808
CITATIONS - 17768236
MODE - +
REGULATED-ENTITY - PM0-10039
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5940
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7019
CITATIONS - 12754220
COMMENT - By making use of microarray analyses it was concluded that FNR activates <i>pst</i> operon expression under anaerobiosis. A putative FNR-binding site, which was not shown in the paper, was identified upstream of this operon |CITS: [12754220]|.
MODE - +
REGULATED-ENTITY - PM00285
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-6317
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5842
CITATIONS - 15805526
MODE - +
REGULATED-ENTITY - PM0-3802
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5937
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3355
CITATIONS - 11532153
MODE - -
REGULATED-ENTITY - PM00312
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6314
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2661
CITATIONS - 11121068
MODE - +
REGULATED-ENTITY - PM0-3781
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-11243
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8128
CITATIONS - 7603430
MODE - -
REGULATED-ENTITY - PM00252
REGULATOR - PD00288
//
UNIQUE-ID - REG0-12208
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8469
MODE - +
REGULATED-ENTITY - PM0-46336
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9077
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5561
CITATIONS - 15534208
MODE - +
REGULATED-ENTITY - PM00560
REGULATOR - PD00266
//
UNIQUE-ID - REG0-5174
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00501
CITATIONS - [10564485]
CITATIONS - [7896685]
MODE - +
REGULATED-ENTITY - PM00264
REGULATOR - PD04418
//
UNIQUE-ID - REG0-5546
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00210
MODE - -
REGULATED-ENTITY - PM00098
REGULATOR - PC00010
//
UNIQUE-ID - REG0-10517
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7792
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM0-10442
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5921
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-902
CITATIONS - [10564485]
CITATIONS - [9393706]
CITATIONS - [10850996]
MODE - +
REGULATED-ENTITY - PM00265
REGULATOR - PD04418
//
UNIQUE-ID - REG0-6297
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2942
CITATIONS - 11448880
CITATIONS - 2419307
CITATIONS - 16515535
MODE - -
REGULATED-ENTITY - PM00490
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-11215
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8115
CITATIONS - 21622752:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3523010762:martin
MODE - -
REGULATED-ENTITY - PM0-46099
REGULATOR - CPLX0-8209
//
UNIQUE-ID - REG0-12150
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8453
CITATIONS - 25406449
MODE - +
REGULATED-ENTITY - PM0-46335
REGULATOR - G6745-MONOMER
//
UNIQUE-ID - REG0-9045
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7391
CITATIONS - 17468243
COMMENT - RstA activates <i>csgDEFG</i> only under acidic conditions at low pH |CITS: [20466769]|.
MODE - -
REGULATED-ENTITY - PM0-9649
REGULATOR - PHOSPHO-RSTA
//
UNIQUE-ID - REG0-4785
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00024
CITATIONS - 3001025
CITATIONS - 3294794
CITATIONS - 3041242
CITATIONS - 2857723
MODE - -
REGULATED-ENTITY - PM00010
REGULATOR - MONOMER0-162
//
UNIQUE-ID - REG0-5158
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6901
CITATIONS - 8631699
MODE - -
REGULATED-ENTITY - PM338
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5533
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7178
CITATIONS - 16140472
MODE - -
REGULATED-ENTITY - PM00091
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10501
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7777
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM0-9640
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5905
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00765
CITATIONS - 7768815
MODE - -
REGULATED-ENTITY - PM00187
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-6281
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7045
CITATIONS - 15699038
COMMENT - ArcA  activates  <i>ycdG</i> gene expression, although  oxygen does not appear to regulate the gene |CITS: [15699038]|.	
MODE - +
REGULATED-ENTITY - PM0-3847
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11116
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8096
CITATIONS - 12754220
COMMENT - By making use of microarray analysis, it was concluded that FNR activates <i>sbm-argK-ygfGH</i> operon expression under anaerobiosis. A putative FNR-binding site, which was not described in this report, was identified upstream of this operon |CITS: [12754220]|.
MODE - +
REGULATED-ENTITY - TU0-8343
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-12095
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8435
CITATIONS - 24983528
MODE - -
REGULATED-ENTITY - PM7
REGULATOR - CPLX0-7731
//
UNIQUE-ID - REG0-9014
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1065
CITATIONS - 9767578
CITATIONS - 11169114
CITATIONS - 11932447
CITATIONS - 15988767
MODE - -
REGULATED-ENTITY - PM0-1303
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4769
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00007
CITATIONS - 8980677
MODE - -
REGULATED-ENTITY - PM00004
REGULATOR - PC00003
//
UNIQUE-ID - REG0-5142
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS202
CITATIONS - [8057842]
CITATIONS - 15659676
MODE - +
REGULATED-ENTITY - PM00324
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5517
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00455
CITATIONS - [8522515]
CITATIONS - [10564485]
CITATIONS - 21097628
MODE - +
REGULATED-ENTITY - PM00089
REGULATOR - PD00365
//
UNIQUE-ID - REG0-10480
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7762
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM00209
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5889
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5445
CITATIONS - 14731281
COMMENT - The CRP-binding site is class I, which is determined by its localization, centered at position  -60.5, with respect to the kbaZp transcriptional start site.
MODE - +
REGULATED-ENTITY - PM0-6881
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11099
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8088
CITATIONS - 21460078
MODE - +
REGULATED-ENTITY - PM0-36246
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6268
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4364
CITATIONS - 15375149
COMMENT - IHF (17 site) is considered a low-affinity IHF-binding site. Based on its position, it is inferred that it causes a negative 
/effect |CITS:[15375149]|.
MODE - -
REGULATED-ENTITY - PM0-4681
REGULATOR - PC00027
//
UNIQUE-ID - REG0-12007
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8417
CITATIONS - 24272779
MODE - -
REGULATED-ENTITY - PM0-1725
REGULATOR - PD01379
//
UNIQUE-ID - REG0-8997
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS51
CITATIONS - 1629153
MODE - -
REGULATED-ENTITY - PM00217
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4752
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7061
CITATIONS - 12492863
CITATIONS - 8682810
MODE - -
REGULATED-ENTITY - PM00001
REGULATOR - CPLX0-7605
//
UNIQUE-ID - REG0-5124
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1023
CITATIONS - [10446207]
MODE - -
REGULATED-ENTITY - PM521
REGULATOR - CPLX0-6
//
UNIQUE-ID - REG0-5501
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3483
CITATIONS - 14711822
CITATIONS - 9302022
CITATIONS - 8892825
CITATIONS - 1315704
CITATIONS - 16140031
CITATIONS - 16980446
MODE - +
REGULATED-ENTITY - PM00141
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10462
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7746
CITATIONS - 18309357
MODE - -
REGULATED-ENTITY - PM0-44629
REGULATOR - G6761-MONOMER
//
UNIQUE-ID - REG0-5873
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00292
MODE - -
REGULATED-ENTITY - PM00147
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11082
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8073
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00356
REGULATOR - PD00197
//
UNIQUE-ID - REG0-6251
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3742
CITATIONS - 15066043
CITATIONS - 8710516
CITATIONS - 9422614
CITATIONS - 20952573
COMMENT - Hns is necessary but is not sufficient for repression of the <i>bglB</i> gene, and it was suggested that other cellular factors are involved in the repression of this gene. 
/
/Repression at this site requires the termination factor Rho and is reduced by translation of the <i>bglG</i> mRNA |CITS: [15066043]|.
/
MODE - -
REGULATED-ENTITY - PM0-5042
REGULATOR - PD00288
//
UNIQUE-ID - REG0-11981
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8403
CITATIONS - 24335284
MODE - +
REGULATED-ENTITY - PM0-46314
REGULATOR - CPLX0-7916
//
UNIQUE-ID - REG0-8961
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7371
CITATIONS - 17120142
MODE - -
REGULATED-ENTITY - PM0-9620
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4736
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5103
MODE - +
REGULATED-ENTITY - PM00048
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5108
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS166
CITATIONS - [9401024]
MODE - +
REGULATED-ENTITY - PM502
REGULATOR - G7071-MONOMER
//
UNIQUE-ID - REG0-5483
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00277
CITATIONS - 7713936
CITATIONS - 7556074
CITATIONS - 8002588
COMMENT - Evidence supports the existence of a regulatory element controlling induction under oxygen-limiting conditions in <i>aidB</i>. The <i>aidB</i> mRNA start site is identical whether induction occurs via Ada-dependent or Ada-independent pathway.
MODE - +
REGULATED-ENTITY - PM00136
REGULATOR - PD00230
//
UNIQUE-ID - REG0-10433
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7732
CITATIONS - 18997424
MODE - +
REGULATED-ENTITY - PM0-10375
REGULATOR - PHOSPHO-DPIA
//
UNIQUE-ID - REG0-5856
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS142
CITATIONS - [9383149]
MODE - +
REGULATED-ENTITY - PM00143
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11066
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8060
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00399
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6235
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3803
CITATIONS - 14593252
MODE - +
REGULATED-ENTITY - PM0-4921
REGULATOR - G7891-MONOMER
//
UNIQUE-ID - REG0-11902
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8388
CITATIONS - 18177266
MODE - +
REGULATED-ENTITY - PM0-10228
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-6611
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7225
CITATIONS - 8455549
CITATIONS - 20713450
MODE - -
REGULATED-ENTITY - PM0-9320
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4720
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5461
CITATIONS - 2160266
CITATIONS - 6379600
MODE - -
REGULATED-ENTITY - PM00045
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5092
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1902
CITATIONS - [10464230]
CITATIONS - 12813061
CITATIONS - 15126461
CITATIONS - 15883881
COMMENT - This regulatory interaction was identified by means of PhoPQ-related microarray experiments and the investigators checked for the presence of its regulatory motif in the promoter region |CITS: [15883881]|.
MODE - -
REGULATED-ENTITY - PM66
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-5466
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS601
CITATIONS - 8892849
MODE - -
REGULATED-ENTITY - PM00125
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10391
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7711
CITATIONS - 16857675
MODE - +
REGULATED-ENTITY - PM0-10367
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5840
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7323
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00225
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-11049
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8048
CITATIONS - 21421764
MODE - -
REGULATED-ENTITY - PM-8797
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6219
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS145
MODE - +
REGULATED-ENTITY - PM0-5201
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11824
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8372
CITATIONS - 23475967
MODE - +
REGULATED-ENTITY - PM0-9839
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6594
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7197
CITATIONS - 16377617
COMMENT - By making use of microarray analyses, Constantinidou et al. |CITS: [16377617]| concluded that FNR represses <i>ygbA</i> gene expression. They also identified a putative FNR-binding site upstream of the gene, but the sequence was not shown.
MODE - -
REGULATED-ENTITY - PM-8829
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4703
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00091
CITATIONS - 9179845
CITATIONS - 1556120
MODE - -
REGULATED-ENTITY - PM00039
REGULATOR - PD03576
//
UNIQUE-ID - REG0-5076
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7140
CITATIONS - 16238633
MODE - -
REGULATED-ENTITY - PM00514
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-5450
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00629
MODE - -
REGULATED-ENTITY - PM00114
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-10273
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7696
CITATIONS - 16857675
MODE - -
REGULATED-ENTITY - PM0-10351
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5824
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00749
CITATIONS - 8388874
COMMENT - We have assumed that PurR negatively regulates these two promoters, but in the paper of He et al., 1993, this was not clear  |CITS:  [8388874]|.
MODE - -
REGULATED-ENTITY - PM00627
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-10996
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8032
CITATIONS - 18808381
CITATIONS - 17660422
MODE - +
REGULATED-ENTITY - PM0-5982
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6203
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7671
CITATIONS - 18083817
CITATIONS - 18083817:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3510954858:martin
CITATIONS - 18083817:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3510954858:martin
CITATIONS - 14702398:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3510954858:martin
CITATIONS - 14702398:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3510954858:martin
COMMENT - GadE is the main activator of the <i>hdeAB-yhiD</i> operon. Both H-NS and GadE are involved in increasing the <i>hdeAB-yhiD</i> repression levels by MarA that occur as the cell enters the stationary phase |CITS: [18083817]|.
MODE - +
REGULATED-ENTITY - PM0-5143
REGULATOR - EG11544-MONOMER
//
UNIQUE-ID - REG0-11756
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8357
CITATIONS - 23139412
MODE - -
REGULATED-ENTITY - PM0-1962
REGULATOR - PD00214
//
UNIQUE-ID - REG0-6578
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7182
CITATIONS - 8407793
MODE - +
REGULATED-ENTITY - PM0-8860
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4687
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS482
CITATIONS - 8955388
COMMENT - Although the internal operators required sites at +1 and +20 for repression <i>in vivo</i>,  these sites were not required  to demonstrate the binding of GlpR to sites +415.5 and +456.5.
MODE - -
REGULATED-ENTITY - PM00038
REGULATOR - PD03576
//
UNIQUE-ID - REG0-5060
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-23
CITATIONS - 13129959
MODE - -
REGULATED-ENTITY - PM444
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-5434
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00304
COMMENT - BetI  is a repressor that regulates the <i>betT</i> promoter in response to the inducer choline.
MODE - -
REGULATED-ENTITY - PM00157
REGULATOR - PD00251
//
UNIQUE-ID - REG0-10184
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7679
CITATIONS - 19074390
MODE - +
REGULATED-ENTITY - PM0-10338
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-5808
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5381
CITATIONS - 9418241
COMMENT - During anaerobiosis, a <i>fis</i> mutation enhances <i>fumB</i> expression about 30% compared with the wild type.	
MODE - -
REGULATED-ENTITY - PM00219
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10980
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8025
CITATIONS - 16980449
CITATIONS - 12446650
CITATIONS - 12730179
MODE - -
REGULATED-ENTITY - PM450
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6187
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3944
CITATIONS - 3934044
MODE - +
REGULATED-ENTITY - PM0-5321
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-11700
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8340
CITATIONS - 22522900
CITATIONS - 18495664
CITATIONS - 19181795
MODE - -
REGULATED-ENTITY - PM0-10351
REGULATOR - EG12431-MONOMER
//
UNIQUE-ID - REG0-6557
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7266
CITATIONS - 12354228
CITATIONS - 10972835
CITATIONS - 16861804
CITATIONS - 23564175
COMMENT - The consensus of this CpxR-binding site is not located in the same DNA strand as in the spyp promoter |CITS:[16861804]|.
MODE - +
REGULATED-ENTITY - PM-8764
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-4671
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4642
CITATIONS - 2858855
MODE - -
REGULATED-ENTITY - PM00034
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-9983
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7651
CITATIONS - 12410838
MODE - +
REGULATED-ENTITY - PM0-9596
REGULATOR - PHOSPHO-RCSB
//
UNIQUE-ID - REG0-5044
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7044
CITATIONS - 15699038
COMMENT - ArcA  activates  <i>xylR</i> gene expression under anaerobiosis. A putative ArcA-binding site 112 bp upstream of this gene was identified, but the sequence of it was not shown |CITS: [15699038]|.
MODE - +
REGULATED-ENTITY - PM69
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5418
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS802
CITATIONS - [8704970]
CITATIONS - 21034467
COMMENT - The effect of AdiY on <i>adiA</i> expression is most readily detected at pH 8.0.
MODE - +
REGULATED-ENTITY - PM981
REGULATOR - EG11966-MONOMER
//
UNIQUE-ID - REG0-10091
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7667
CITATIONS - 19007420
MODE - -
REGULATED-ENTITY - PM0-7421
REGULATOR - MONOMER-53
//
UNIQUE-ID - REG0-5792
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3465
CITATIONS - 14711822
CITATIONS - 22870390
MODE - -
REGULATED-ENTITY - PM00218
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10964
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8016
CITATIONS - 11976288
CITATIONS - 12446650
CITATIONS - 16980449
CITATIONS - 15795232
MODE - +
REGULATED-ENTITY - PM461
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6169
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4402
CITATIONS - 9315722
MODE - -
REGULATED-ENTITY - PM0-5862
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11657
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8330
CITATIONS - 23222720
MODE - +
REGULATED-ENTITY - PM0-46200
REGULATOR - MONOMER0-4288
//
UNIQUE-ID - REG0-6541
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7073
MODE - +
REGULATED-ENTITY - PM-8797
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-4655
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5471
CITATIONS - 2160266
MODE - -
REGULATED-ENTITY - PM00032
REGULATOR - PD00288
//
UNIQUE-ID - REG0-9621
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7641
CITATIONS - 18524933
MODE - -
REGULATED-ENTITY - PM0-10247
REGULATOR - PC00010
//
UNIQUE-ID - REG0-5028
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS444
CITATIONS - [8955407]
CITATIONS - [10216857]
MODE - -
REGULATED-ENTITY - PM562
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5402
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00389
CITATIONS - 8230205
CITATIONS - 18648770
CITATIONS - 21115656
CITATIONS - 21718532
COMMENT - FruR is unable to bind to its <i>ppsA</i> site in the presence of fructose-1-phosphate (during glycolysis), in which case the <i>ppsA</i> transcription activation is avoided |CITS: [8230205]|.
MODE - +
REGULATED-ENTITY - PM00222
REGULATOR - PC00061
//
UNIQUE-ID - REG0-5776
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00372
CITATIONS - 8034728
CITATIONS - 8034727
CITATIONS - 10689164
CITATIONS - 10848985
MODE - +
REGULATED-ENTITY - PM00209
REGULATOR - MONOMER0-183
//
UNIQUE-ID - REG0-10936
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7913
CITATIONS - 18383615
CITATIONS - 18383615:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3505070753:asantos
CITATIONS - 18383615:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3505070753:asantos
CITATIONS - 21193607:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3505070753:asantos
MODE - +
REGULATED-ENTITY - PM0-36194
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-6152
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5446
CITATIONS - 14731281
MODE - -
REGULATED-ENTITY - PM0-6883
REGULATOR - G7630-MONOMER
//
UNIQUE-ID - REG0-11637
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8315
CITATIONS - 23233451
COMMENT - DNase I digestion patterns showed that RcdA binds within the sequence between -192 and -308 of the transcription start site of <i>csgD</i> |CITS: [23233451]|. According to this evidence and electrophoretic mobility shift assay results |CITS: [23233451]|, the curator assigned one possible binding site of 10 bp for RcdA, located at -298.5 relative to the transcription start site of <i>csgD</i>. The curator assigned the possible central position of this binding site based on similarity to a consensus sequence (TTGTGTACA) identified by Shimada et al. in 2012 |CITS:[23233451]|.
MODE - +
REGULATED-ENTITY - PM00536
REGULATOR - G6444-MONOMER
//
UNIQUE-ID - REG0-6525
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7150
CITATIONS - 16377617
MODE - +
REGULATED-ENTITY - PM00343
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4639
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00064
CITATIONS - 8437517
CITATIONS - 14996819
CITATIONS - 15988767
CITATIONS - 3298218
MODE - +
REGULATED-ENTITY - PM00030
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-9595
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7625
CITATIONS - 18524927
MODE - -
REGULATED-ENTITY - PM00289
REGULATOR - PD00196
//
UNIQUE-ID - REG0-5011
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5161
CITATIONS - 12657056
MODE - -
REGULATED-ENTITY - PM461
REGULATOR - CPLX0-2821
//
UNIQUE-ID - REG0-5386
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00799
CITATIONS - 8550429
COMMENT - The FruR effect for <i>pykF</i> was tested in the presence of different glycolytic and gluconeogenic substrates. It was found that FruR binds to its control region, downstream of the putative promoter, to repress it during gluconeogenesis. During glycolysis, when fructose or fructose-1,6-diphosphate is available, FruR unbinds the <i>pykF</i> site |CITS: [8550429]|.
MODE - -
REGULATED-ENTITY - PM00585
REGULATOR - PC00061
//
UNIQUE-ID - REG0-5760
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00678
CITATIONS - 1372899
COMMENT - GlpR perhaps binds cooperatively to  four adjacent operator sites.
MODE - -
REGULATED-ENTITY - PM00238
REGULATOR - PD03576
//
UNIQUE-ID - REG0-10919
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7987
CITATIONS - 21034467
MODE - +
REGULATED-ENTITY - PM00254
REGULATOR - EG11449-MONOMER
//
UNIQUE-ID - REG0-6136
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6081
CITATIONS - 15576781
COMMENT - <i>ung</i> transcription is negatively regulated by CpxR in the stationary phase.  The affinity of CpxR to the CpxR box of the <i>ung</i> promoter region is increased by phosphorylation. This site was previously predicted  by |CITS:[11953442]|. 
/
/Near the <i>ung</i> promoter, in the CpxR box, there is an AT-rich sequence corresponding to the UP element. It is probable that CpxR binding to the <i>ung</i> promoter represses its transcription by interfering with the ability  of the &alpha;-CTD to bind to the UP element.
/
MODE - -
REGULATED-ENTITY - PM00417
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-11620
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8300
CITATIONS - 23028500
MODE - +
REGULATED-ENTITY - PM0-44722
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6509
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3730
CITATIONS - 12588863
MODE - -
REGULATED-ENTITY - PM0-1301
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4623
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00189
CITATIONS - 1971621
CITATIONS - 1971620
COMMENT - When the CTP level within the cell is high relative to the level of GTP, the <i>pyrC</i> gene is transcribed from a start site that allows formation of a secondary structure within the 5' end of the mRNA.  This hairpin structure is thought to obscure the Shine-Dalgarno sequence, and it results in poor translation efficiency.  When the CTP level is low relative to the level of GTP, <i>pyrC</i> is transcribed from an alternate start site.  This shorter mRNA is translated efficiently. The PurR protein, which represses the <i>pyrC</i> gene, is also regulated by the level of GTP, because this protein is active when GTP is present.
MODE - -
REGULATED-ENTITY - PM00083
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-9570
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7609
CITATIONS - 18567659
MODE - -
REGULATED-ENTITY - PM624
REGULATOR - EG11741-MONOMER
//
UNIQUE-ID - REG0-4995
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2430
CITATIONS - [8002608]
CITATIONS - 1346534
MODE - -
REGULATED-ENTITY - PM00631
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5370
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS84
CITATIONS - 15520470
CITATIONS - 3011793
MODE - +
REGULATED-ENTITY - PM00290
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5744
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00709
CITATIONS - 7665470
CITATIONS - 9802028
CITATIONS - 9611815
CITATIONS - 10463182
CITATIONS - 8188587
CITATIONS - 8423160
CITATIONS - 15621456
CITATIONS - 9733689
COMMENT - GcvA interacts with the RNA polymerase &alpha;-subunit to activate gcvTp |CITS:[15621456]|.
MODE - +
REGULATED-ENTITY - PM00233
REGULATOR - PD00339
//
UNIQUE-ID - REG0-10899
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7971
CITATIONS - 21115656
MODE - -
REGULATED-ENTITY - PM0-10170
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6120
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6784
MODE - -
REGULATED-ENTITY - PM00386
REGULATOR - PC00010
//
UNIQUE-ID - REG0-11582
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8286
CITATIONS - 22442305
MODE - +
REGULATED-ENTITY - PM0-7321
REGULATOR - PHOSPHO-BASR
//
UNIQUE-ID - REG0-6492
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4
CITATIONS - 10542180
CITATIONS - 16861804
CITATIONS - 23564175
MODE - +
REGULATED-ENTITY - PM0-1201
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-4607
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7254
CITATIONS - 11443091
MODE - +
REGULATED-ENTITY - PM0-9365
REGULATOR - PD00214
//
UNIQUE-ID - REG0-9510
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7593
CITATIONS - 2166165
CITATIONS - 6259624
CITATIONS - 1987134
MODE - -
REGULATED-ENTITY - PM0-4942
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4977
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS523
CITATIONS - [10856643]
MODE - -
REGULATED-ENTITY - PM591
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5352
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00597
CITATIONS - [11717281]
CITATIONS - COLISALII
CITATIONS - 15743952
CITATIONS - 20466769
MODE - +
REGULATED-ENTITY - PM00536
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-5728
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00648
CITATIONS - 9484892
CITATIONS - 1848637
COMMENT - A Class II promoter. CAP and NagC can bind simultaneously and produce a complex more stable than the binary NagC-DNA complex |CITS: [9484892]|.
MODE - +
REGULATED-ENTITY - PM00276
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10883
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7956
CITATIONS - 21097627
CITATIONS - 12746439
MODE - -
REGULATED-ENTITY - PM0-36183
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6104
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6004
CITATIONS - 15988767
COMMENT - The positive effect of ArcA and FNR on <i>ackA</i> expression is independent |CITS:[15988767]|.
MODE - +
REGULATED-ENTITY - PM00524
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11537
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8269
CITATIONS - 12657056
MODE - -
REGULATED-ENTITY - PM461
REGULATOR - CPLX0-2821
//
UNIQUE-ID - REG0-6476
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2553
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1351
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4588
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00158
MODE - +
REGULATED-ENTITY - PM00066
REGULATOR - PC00027
//
UNIQUE-ID - REG0-9460
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7580
CITATIONS - 18227264
MODE - +
REGULATED-ENTITY - PM0-10196
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4961
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS524
CITATIONS - 10601216
MODE - -
REGULATED-ENTITY - PM646
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5336
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00699
CITATIONS - 7715459
MODE - +
REGULATED-ENTITY - PM00619
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5710
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS403
CITATIONS - [8655515]
MODE - +
REGULATED-ENTITY - PM00192
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10841
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7939
CITATIONS - 20603130
MODE - -
REGULATED-ENTITY - PM0-9828
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-6088
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6502
CITATIONS - 12813061
MODE - +
REGULATED-ENTITY - PM0-8163
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-11516
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8252
CITATIONS - 16115199
MODE - -
REGULATED-ENTITY - PM0-9574
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6460
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2557
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1346
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4571
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00156
CITATIONS - 11812125
CITATIONS - 11158569
CITATIONS - 12366850
CITATIONS - 16618701
MODE - +
REGULATED-ENTITY - PM00065
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-9406
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7563
CITATIONS - 18083817
MODE - -
REGULATED-ENTITY - PM928
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-4945
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6935
CITATIONS - 8821940
CITATIONS - 17644067
CITATIONS - 25176444
COMMENT - The <i>acrR</i> gene, which is located upstream of and in the opposite direction of <i>acrAB</i>, encodes AcrR, a negative DNA-binding transcriptional regulator for a multidrug efflux pump. The presence of <i>acrR</i> upstream of the  <i>acrAB</i> operon in <i>E. coli</i> suggests that the operon may be controlled at the level of transcription by this regulator |CITS [ 8821940]|.
MODE - -
REGULATED-ENTITY - PM624
REGULATOR - EG12116-MONOMER
//
UNIQUE-ID - REG0-5320
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00771
CITATIONS - 7545108
MODE - -
REGULATED-ENTITY - PM00643
REGULATOR - PD00266
//
UNIQUE-ID - REG0-5694
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00666
CITATIONS - 8596434
COMMENT - The <i>nupG</i> full repression complex contains the CytR protein sandwiched between two cAMP-CRP complexes. Binding of CytR to its target excludes binding of cAMP-CRP to CRP1 and promotes binding of cAMP-CRP to CRP0, therefore allowing cooperative binding of the two protein species.
MODE - -
REGULATED-ENTITY - PM00173
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-10815
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7923
CITATIONS - 20466769
MODE - -
REGULATED-ENTITY - PM00536
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-6069
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6542
CITATIONS - 15126461
MODE - +
REGULATED-ENTITY - PM0-8202
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-11500
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8243
CITATIONS - 22422754
COMMENT - MatA-<i>matA</i>p1 regulatory interaction was identified in <i>Escherichia coli</i> strain IHE 3034 |CITS:[ 22422754]|.
MODE - +
REGULATED-ENTITY - PM0-44427
REGULATOR - G6165-MONOMER
//
UNIQUE-ID - REG0-6444
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1362
CITATIONS - [11859088]
CITATIONS - [11160901]
CITATIONS - 21276098
MODE - -
REGULATED-ENTITY - PM00407
REGULATOR - EG11394-MONOMER
//
UNIQUE-ID - REG0-4555
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7259
CITATIONS - 8288532
MODE - +
REGULATED-ENTITY - PM00063
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-9386
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7547
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM00060
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4929
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS772
CITATIONS - [9421904]
MODE - -
REGULATED-ENTITY - PM263
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5304
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00793
CITATIONS - [10368169]
MODE - +
REGULATED-ENTITY - PM00676
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5678
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3347
CITATIONS - 8830277
MODE - +
REGULATED-ENTITY - PM00191
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10797
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7905
CITATIONS - 8168494
CITATIONS - 11133959
CITATIONS - 9312050
CITATIONS - 1316901
MODE - +
REGULATED-ENTITY - PM00282
REGULATOR - MONOMER0-46
//
UNIQUE-ID - REG0-6053
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00494
CITATIONS - 10702265
CITATIONS - 1943696
CITATIONS - 8763957
COMMENT - RcsB is apparently essential for <i>cps</i> expression. As a matter of fact, both RcsA and RcsB are required for optimal <i>cps</i> expression, since <i>cps</i> expression in an <i>rcsB</i> strain is low and <i>cps</i> expression cannot be activated by RcsA in the absence of RcsB, suggesting an auxiliary role in cps expression. But RcsA is not absolutely dependent on RcsB. There are no <i>in vitro</i> data that demonstrate RcsA binding to the <i>cps</i> promoter region. Thus, direct interaction of RcsB and/or RcsA in the <i>E. coli</i> <i>cps</i> promoter region remains to be shown. RcsA and RcsB are proposed to form heterodimers in order to be functional in the activation of <i>cps</i>. Multicopy RcsB can overcome the absence of RcsA to activate <i>cps</i> expression. Osmotic shock has been shown to be dependent on RcsA, RcsB, RcsC, and MdoH. Several global regulators bind and repress cps, such as CRP and H-NS.
MODE - +
REGULATED-ENTITY - PM00291
REGULATOR - PC00084
//
UNIQUE-ID - REG0-11482
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8228
CITATIONS - 22295907
MODE - +
REGULATED-ENTITY - PM0-46179
REGULATOR - PD00519
//
UNIQUE-ID - REG0-6426
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1421
CITATIONS - [10368146]
MODE - +
REGULATED-ENTITY - PM0-1783
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4539
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-32
CITATIONS - 15225315
CITATIONS - 11004182
CITATIONS - 9302020
MODE - +
REGULATED-ENTITY - PM00062
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-9368
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7530
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM167
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4913
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS621
CITATIONS - [9852003]
COMMENT - An unknown factor  other  than Fnr also contributes to anaerobic induction of <i>dcuB</i>.
MODE - +
REGULATED-ENTITY - PM00625
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5288
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS424
MODE - +
REGULATED-ENTITY - PM00540
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5662
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7315
CITATIONS - 9582281
MODE - -
REGULATED-ENTITY - PM0-9556
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10762
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7894
CITATIONS - 10564497
MODE - +
REGULATED-ENTITY - PM00528
REGULATOR - CPLX0-8062
//
UNIQUE-ID - REG0-6037
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3487
CITATIONS - 14711822
CITATIONS - 9880556
MODE - -
REGULATED-ENTITY - PM166
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11457
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8209
CITATIONS - 22223481
CITATIONS - 23690622
MODE - -
REGULATED-ENTITY - PM00605
REGULATOR - CPLX0-8075
//
UNIQUE-ID - REG0-6410
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1703
CITATIONS - [8419307]
CITATIONS - [11810262]
MODE - -
REGULATED-ENTITY - PM0-2222
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4523
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00142
CITATIONS - 11115116
CITATIONS - 8577745
CITATIONS - 8577745
MODE - +
REGULATED-ENTITY - PM00060
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-9352
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7514
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM0-7321
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4896
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3822
CITATIONS - 14702398
MODE - +
REGULATED-ENTITY - PM687
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-5272
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00760
CITATIONS - 10469172
COMMENT - When the template is linear, transcriptional initiation is switched from POa to POb, 3 bp farther upstream from POa, and transcription becomes more CRP dependent. There is no PO expression in the absence of CRP or cAMP in the cell, unless glucose is present.
MODE - +
REGULATED-ENTITY - PM00633
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5646
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7149
CITATIONS - 12754220
CITATIONS - 16377617
MODE - +
REGULATED-ENTITY - PM00528
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10730
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7878
CITATIONS - 20105222
MODE - -
REGULATED-ENTITY - PM00597
REGULATOR - G7571-MONOMER
//
UNIQUE-ID - REG0-6021
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6861
CITATIONS - 10760155
MODE - -
REGULATED-ENTITY - PM0-8641
REGULATOR - PC00010
//
UNIQUE-ID - REG0-11420
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8193
CITATIONS - 10216857
CITATIONS - 10216857:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3538186829:martin
CITATIONS - 10216857:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3538186829:martin
CITATIONS - 10216857:EV-EXP-IMP-SITE-MUTATION:3538186829:martin
CITATIONS - 10216857:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3538186829:martin
CITATIONS - 8955407:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3538186829:martin
CITATIONS - 8955407:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3538186829:martin
MODE - -
REGULATED-ENTITY - PM562
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6394
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1522
CITATIONS - [9878422]
CITATIONS - [9302010]
MODE - +
REGULATED-ENTITY - PM0-1981
REGULATOR - EG12344-MONOMER
//
UNIQUE-ID - REG0-4507
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00132
MODE - -
REGULATED-ENTITY - PM00054
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-9323
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7500
CITATIONS - 17768236
MODE - +
REGULATED-ENTITY - PM00037
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4880
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS701
CITATIONS - [7768855]
MODE - -
REGULATED-ENTITY - PM00527
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5255
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00445
CITATIONS - 6350602
MODE - -
REGULATED-ENTITY - PM00259
REGULATOR - PD00360
//
UNIQUE-ID - REG0-5630
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS264
CITATIONS - [8577250]
MODE - -
REGULATED-ENTITY - PM00591
REGULATOR - PC00061
//
UNIQUE-ID - REG0-10697
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7861
CITATIONS - 7868602
CITATIONS - 8087856
MODE - +
REGULATED-ENTITY - PM0-10525
REGULATOR - PD00214
//
UNIQUE-ID - REG0-6005
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7286
CITATIONS - 10506196
COMMENT -  We have assigned the positive function for these sites (-177, -134) since IHF normally activates at this distance.
/
MODE - +
REGULATED-ENTITY - PM169
REGULATOR - PC00027
//
UNIQUE-ID - REG0-11382
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8178
CITATIONS - 9701802
CITATIONS - 22101843:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3535302154:martin
CITATIONS - 22101843:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3535302154:martin
CITATIONS - 18997424:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3535302154:martin
CITATIONS - 18997424:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3535302154:martin
CITATIONS - 9701802:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3535302154:martin
CITATIONS - 9701802:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3535302154:martin
MODE - +
REGULATED-ENTITY - PM0-10380
REGULATOR - PHOSPHO-DPIA
//
UNIQUE-ID - REG0-6378
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7249
CITATIONS - 17233826
MODE - -
REGULATED-ENTITY - PM00550
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4490
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4701
CITATIONS - 7830577
MODE - +
REGULATED-ENTITY - PM00049
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-9290
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7487
CITATIONS - 17921503
CITATIONS - 17921503:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3409862227:martin
CITATIONS - 17921503:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3409862227:martin
MODE - +
REGULATED-ENTITY - PM0-4201
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4863
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4427
CITATIONS - 8120010
CITATIONS - 8763946
CITATIONS - 11673423
MODE - -
REGULATED-ENTITY - PM00423
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5239
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00438
MODE - -
REGULATED-ENTITY - PM00252
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5614
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1483
CITATIONS - [9663683]
COMMENT - Lrp affected the expression of osmCp1 since it repressed the transcription of osmCp1. This regulator hampers E-sigma S action on osmCp1. Lrp is an important factor in the shift of the effect on the transcription by E-sigma S of osmCp1 (repressor) and osmCp2 (activator) |CITS:[9663683]|.
MODE - -
REGULATED-ENTITY - PM00544
REGULATOR - PD00353
//
UNIQUE-ID - REG0-10672
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS681
CITATIONS - 9294462
CITATIONS - 11443091
MODE - -
REGULATED-ENTITY - PM0-2281
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5989
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00531
MODE - -
REGULATED-ENTITY - PM00305
REGULATOR - PD00353
//
UNIQUE-ID - REG0-11353
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8172
CITATIONS - 22059728
MODE - +
REGULATED-ENTITY - PM0-46172
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6362
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2221
CITATIONS - 10760150
COMMENT - There is a curved region upstream of the chiAp promoter, and it could be the Hns- binding site.
MODE - -
REGULATED-ENTITY - PM0-3321
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4474
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00580
MODE - -
REGULATED-ENTITY - PM00110
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-9271
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7473
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00228
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4847
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS757
CITATIONS - [8596446]
CITATIONS - [10648521]
MODE - -
REGULATED-ENTITY - PM168
REGULATOR - PHOSPHO-TORR
//
UNIQUE-ID - REG0-5223
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00757
COMMENT - FruR could repress ptsHP1b transcription by displacing CRP-cAMP from its binding site, thus restoring ptsHp2 activity from CRP-cAMP inhibition |CITS: [7852310]|.
MODE - +
REGULATED-ENTITY - PM00410
REGULATOR - PC00061
//
UNIQUE-ID - REG0-5595
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00449
COMMENT - This site has 80% homology to the MalT consensus.
MODE - +
REGULATED-ENTITY - PM00185
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-10613
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7837
CITATIONS - 19906180
MODE - +
REGULATED-ENTITY - PM0-9890
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-5973
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00504
CITATIONS - [7673113]
CITATIONS - [9564045]
MODE - +
REGULATED-ENTITY - PM00297
REGULATOR - PD04132
//
UNIQUE-ID - REG0-11319
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8159
CITATIONS - 19906180
CITATIONS - 17504942
CITATIONS - 21890697
CITATIONS - 15150242
MODE - +
REGULATED-ENTITY - PM0-9890
REGULATOR - CPLX0-7671
//
UNIQUE-ID - REG0-6346
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2042
CITATIONS - [10594821]
CITATIONS - 21276095
MODE - -
REGULATED-ENTITY - PM00457
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-12329
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8499
CITATIONS - 26010043
MODE - +
REGULATED-ENTITY - PM00174
REGULATOR - MONOMER0-1
//
UNIQUE-ID - REG0-9230
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7457
CITATIONS - 17513468
MODE - -
REGULATED-ENTITY - PM00142
REGULATOR - EG11088-MONOMER
//
UNIQUE-ID - REG0-4830
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS751
CITATIONS - 11243806
COMMENT - ZraR activates the zraPp promoter in the presence of high Zn<sup>2+</sup> and Pb<sup>2+</sup> concentrations |CITS: [11243806]|.
MODE - +
REGULATED-ENTITY - PM923
REGULATOR - PHOSPHO-HYDG
//
UNIQUE-ID - REG0-5206
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00154
CITATIONS - 2656704
CITATIONS - 11812125
CITATIONS - 16618701
MODE - +
REGULATED-ENTITY - PM00401
REGULATOR - PHOSPHO-OMPR
//
UNIQUE-ID - REG0-5579
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00333
CITATIONS - 2834341
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM00180
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10593
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7821
CITATIONS - 20023096
MODE - -
REGULATED-ENTITY - PM68
REGULATOR - CPLX-172
//
UNIQUE-ID - REG0-5957
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1304
CITATIONS - [11287152]
COMMENT - The regulatory effect of FlhDC in <i>nrfA</i> operon transcription has been proved only by microarray analysis by |CITS: [11287152]|.
MODE - +
REGULATED-ENTITY - PM00280
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-11259
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8143
CITATIONS - 21890697
MODE - +
REGULATED-ENTITY - PM00328
REGULATOR - CPLX0-7669
//
UNIQUE-ID - REG0-6330
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2242
CITATIONS - 10991887
MODE - -
REGULATED-ENTITY - PM00613
REGULATOR - CPLX0-7418
//
UNIQUE-ID - REG0-12291
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8483
CITATIONS - 26121029
MODE - -
REGULATED-ENTITY - TU0-13439
REGULATOR - EG12860-MONOMER
//
UNIQUE-ID - REG0-9142
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7439
CITATIONS - 2676977
CITATIONS - 9614967
MODE - -
REGULATED-ENTITY - PM0-9678
REGULATOR - PC00010
//
UNIQUE-ID - REG0-4814
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00054
MODE - -
REGULATED-ENTITY - PM00025
REGULATOR - PD01196
//
UNIQUE-ID - REG0-5190
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00569
CITATIONS - 1592804
CITATIONS - 8376324
CITATIONS - 7934836
CITATIONS - 7565118
MODE - +
REGULATED-ENTITY - PM00353
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5562
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00534
MODE - -
REGULATED-ENTITY - PM00306
REGULATOR - PD00353
//
UNIQUE-ID - REG0-10561
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7804
CITATIONS - 2170326
CITATIONS - 8969182
CITATIONS - 1649947
CITATIONS - 1661372
CITATIONS - 1647022
CITATIONS - 1655726
CITATIONS - 8221894
CITATIONS - 845188
CITATIONS - 8394345
CITATIONS - 11574471
CITATIONS - 12667072
MODE - -
REGULATED-ENTITY - PM00025
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-10558
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7802
CITATIONS - 9767576
MODE - -
REGULATED-ENTITY - PM00088
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5934
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00078
CITATIONS - 2871943
CITATIONS - 3304660
CITATIONS - 2571609
MODE - +
REGULATED-ENTITY - PM00312
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-6311
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5281
CITATIONS - 11953442
MODE - -
REGULATED-ENTITY - PM0-3623
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-11239
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8124
CITATIONS - 21908668
MODE - -
REGULATED-ENTITY - PM0-46156
REGULATOR - CPLX0-7672
//
UNIQUE-ID - REG0-12196
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8465
CITATIONS - 25673659
MODE - +
REGULATED-ENTITY - PM00423
REGULATOR - PC00027
//
UNIQUE-ID - REG0-9067
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7420
CITATIONS - 17616594
MODE - +
REGULATED-ENTITY - PM00155
REGULATOR - PC00027
//
UNIQUE-ID - REG0-4798
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4722
CITATIONS - 11101675
CITATIONS - 17526711
MODE - -
REGULATED-ENTITY - PM00019
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-5171
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00451
CITATIONS - 10873449
MODE - +
REGULATED-ENTITY - PM00262
REGULATOR - PD00365
//
UNIQUE-ID - REG0-5543
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7180
CITATIONS - 16140472
MODE - -
REGULATED-ENTITY - PM00098
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10514
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7789
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM0-10438
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5918
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3814
CITATIONS - 9537375
MODE - -
REGULATED-ENTITY - PM00315
REGULATOR - PD03585
//
UNIQUE-ID - REG0-6294
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2961
CITATIONS - 11448880
CITATIONS - 2419307
CITATIONS - 16515535
MODE - -
REGULATED-ENTITY - PM00490
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-11212
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8111
CITATIONS - 21559929
MODE - +
REGULATED-ENTITY - PM00536
REGULATOR - PC00061
//
UNIQUE-ID - REG0-12140
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8449
CITATIONS - 25294881
MODE - +
REGULATED-ENTITY - PM00265
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-9042
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7388
CITATIONS - 17496099
MODE - -
REGULATED-ENTITY - PM0-5023
REGULATOR - CPLX0-8061
//
UNIQUE-ID - REG0-4782
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00021
CITATIONS - 1640463
CITATIONS - 1640456
CITATIONS - 17074904
MODE - -
REGULATED-ENTITY - PM00009
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-5155
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7331
CITATIONS - 8764681
CITATIONS - 12829264
MODE - -
REGULATED-ENTITY - PM336
REGULATOR - CPLX0-7734
//
UNIQUE-ID - REG0-5530
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7181
CITATIONS - 16140472
MODE - -
REGULATED-ENTITY - PM00091
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10493
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7774
CITATIONS - 19656291
MODE - -
REGULATED-ENTITY - PM-8830
REGULATOR - CPLX0-8047
//
UNIQUE-ID - REG0-5902
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00517
CITATIONS - 10512697
CITATIONS - 8999880
CITATIONS - 11976297
CITATIONS - 12107138
COMMENT - Previous studies have supported a model in which membrane-localized UhpC binds external Glu6P and transmits a signal to UhpB, which subsequently converts UhpA to a form capable of activating transcription at the <i>uhpT</i> promoter. Each dimer binds to an inverted repeat of 24 bp |CITS:[11976297]|. UhpB inhibits UhpA action in the <i>uhpT</i> promoter |CITS:[11053370]|.
MODE - +
REGULATED-ENTITY - PM00174
REGULATOR - CPLX0-7754
//
UNIQUE-ID - REG0-6278
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3401
CITATIONS - 9401019
COMMENT - It was not identified which of two promoters of the <i>als</i> operon was repressed by AlsR, but we inferred that both are repressed, because they are very closed.
MODE - -
REGULATED-ENTITY - PM0-4744
REGULATOR - G7821-MONOMER
//
UNIQUE-ID - REG0-11113
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8094
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM00326
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-12042
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8432
CITATIONS - 24814025
COMMENT - CRP box 1 (-90.5) activates <i>pck</i> expression only in the presence of low levels of cAMP-CRP |CITS:[24814025]|. However, the activation of <i>pck</i> by CRP is not clear, based on <i>in vitro</i> experiments. It is possible that there is a yet-unidentified supporting factor for transcription activation <i>in vivo</i> of the <i>pck</i> gene, as in the case of Cra, which positively regulates the expression of <i>pck</i> |CITS:[ 8577250]|.
MODE - +
REGULATED-ENTITY - PM00193
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9010
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5041
CITATIONS - 12367523
CITATIONS - 11222606
CITATIONS - 17921503
COMMENT - Generally, Fur binds to 19 bp in DNA, but in this case it binds to 25 bp upstream from the entSp1 promoter.
MODE - -
REGULATED-ENTITY - PM0-4201
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4766
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00004
CITATIONS - 3041410
CITATIONS - 8980677
MODE - +
REGULATED-ENTITY - PM00004
REGULATOR - CPLX-172
//
UNIQUE-ID - REG0-5139
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6966
CITATIONS - 15659676
MODE - +
REGULATED-ENTITY - PM00324
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5514
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00638
CITATIONS - 2139650
CITATIONS - 9767576
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM00088
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10477
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7759
CITATIONS - 19633077
MODE - -
REGULATED-ENTITY - PM0-7561
REGULATOR - EG10087-MONOMER
//
UNIQUE-ID - REG0-5886
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00302
CITATIONS - 17616594
CITATIONS - 16153782
CITATIONS - 3025185
CITATIONS - 2883171
MODE - +
REGULATED-ENTITY - PM00155
REGULATOR - PHOSPHO-ATOC
//
UNIQUE-ID - REG0-11096
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8085
CITATIONS - 21460078
MODE - +
REGULATED-ENTITY - PM0-36221
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6265
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3352
CITATIONS - 11751865
CITATIONS - 12142437
CITATIONS - 12529359
CITATIONS - 15375149
CITATIONS - 15667300
CITATIONS - 15694381
COMMENT - This NorR-binding site( -87), which is considered to be of high affinity, facilitates further binding of NorR to the adjacent site(s). In addition, it is primarily required for NorR-dependent <i>norVW</i> regulation, while one or both of the lower-affinity sites are involved in <i>norR</i> autoregulation. It contains the inverted repeat GTCA-(N3)-TGAC |CITS: [15375149]||CITS: [15667300]|.
/
MODE - +
REGULATED-ENTITY - PM0-4681
REGULATOR - EG12108-MONOMER
//
UNIQUE-ID - REG0-12004
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8414
CITATIONS - 24089053
MODE - -
REGULATED-ENTITY - PM0-36147
REGULATOR - EG10442-MONOMER
//
UNIQUE-ID - REG0-8994
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS69
CITATIONS - 11929525
CITATIONS - 9302020
CITATIONS - 7854119
CITATIONS - 8501030
CITATIONS - 11004182
COMMENT - At low levels of nitrate, NarL activates <i>nrfA</i> expression and  at high levels of nitrate NarL represses it.
MODE - -
REGULATED-ENTITY - PM00280
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-4749
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7065
CITATIONS - 12492863
MODE - -
REGULATED-ENTITY - PM00001
REGULATOR - CPLX0-7605
//
UNIQUE-ID - REG0-5121
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3565
CITATIONS - 15066032
COMMENT - NagC and ChbR appear to act as repressors for the <i>chbB</i> operon in the absence of the inducing sugar chitobiose |CITS: [15066032]|.
MODE - -
REGULATED-ENTITY - PM183
REGULATOR - PD00266
//
UNIQUE-ID - REG0-5497
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00702
CITATIONS - 2231717
MODE - -
REGULATED-ENTITY - PM00140
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10459
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7849
CITATIONS - 11443092
MODE - +
REGULATED-ENTITY - PM0-10406
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5869
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6934
CITATIONS - 11470373
MODE - +
REGULATED-ENTITY - PM00147
REGULATOR - PD04132
//
UNIQUE-ID - REG0-11079
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8071
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM687
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6248
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3662
CITATIONS - 12923108
CITATIONS - 18683632
COMMENT - The operon <i>nrdDG</i> is induced under anaerobiosis in the stationary phase, and this induction is FNR dependent.
MODE - +
REGULATED-ENTITY - PM0-5023
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-11978
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8400
CITATIONS - 24509317
COMMENT - CRP site I is also called promoter-proximal, and it plays a major role in <i>cspD</i>p activation by CRP |CITS:[24509317]|.
MODE - +
REGULATED-ENTITY - PM00597
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-8952
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7357
CITATIONS - 10760155
MODE - -
REGULATED-ENTITY - PM0-8641
REGULATOR - PC00010
//
UNIQUE-ID - REG0-4733
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00120
CITATIONS - 2664421
CITATIONS - 2538630
MODE - +
REGULATED-ENTITY - PM00047
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-5105
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2183
CITATIONS - 10766858
CITATIONS - 15159386
MODE - -
REGULATED-ENTITY - PM4
REGULATOR - CPLX0-7731
//
UNIQUE-ID - REG0-5480
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5063
CITATIONS - 8892849
MODE - -
REGULATED-ENTITY - PM00132
REGULATOR - PC00027
//
UNIQUE-ID - REG0-10427
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7726
CITATIONS - 18997424
CITATIONS - 22101843
MODE - +
REGULATED-ENTITY - PM0-10377
REGULATOR - PHOSPHO-DPIA
//
UNIQUE-ID - REG0-5853
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00286
CITATIONS - [8892825]
CITATIONS - [1315704]
CITATIONS - 15699038
COMMENT - Salmon et al. |CITS: [15699038]| identified four putative ArcA-binding sites upstream of the cyoAp promoter, but the sequences were not reported.
MODE - -
REGULATED-ENTITY - PM00142
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11063
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8057
CITATIONS - 21421764
MODE - +
REGULATED-ENTITY - PM0-9416
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6232
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3522
CITATIONS - 12100559
CITATIONS - 12067348
COMMENT - There are four putative sites to bind MarA, but just one at position  -43.5 is necessary to activate the  transcription of <i>nfnB</i>. <i>In vitro</i>, but not <i>in vivo</i>, the proteins Rob and SoxS activate the transcription of  <i>nfnB</i> and they bind to  the MarA-binding site when they are present in a high concentration.
MODE - +
REGULATED-ENTITY - PM0-4864
REGULATOR - PD00365
//
UNIQUE-ID - REG0-11899
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8385
CITATIONS - 18177266
MODE - -
REGULATED-ENTITY - PM0-10228
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6608
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7186
COMMENT - By making use of microarray analyses, Constantinidou et al. |CITS: [16377617]| concluded that FNR activates <i>ompW</i> gene expression. They also identified a putative FNR-binding site upstream of the gene, but the sequence was not shown.
MODE - +
REGULATED-ENTITY - PM0-9249
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4717
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5467
CITATIONS - 2160266
CITATIONS - 6379600
MODE - -
REGULATED-ENTITY - PM00045
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5089
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7252
CITATIONS - 17233826
MODE - -
REGULATED-ENTITY - PM00547
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5463
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00259
CITATIONS - 12207706
CITATIONS - 3308851
COMMENT - The TyrR-binding site at position bp 42.5 downstream of the promoter is a strong TyrR box that is involved in repression of <i>tyrB</i> gene transcription. For this repression, it is necessary that TyrR, with tyrosine or phenylalanine, binds this site and another weak site located 19.5 bp downstream from the promoter |CITS:[12207706]|.
MODE - -
REGULATED-ENTITY - PM00124
REGULATOR - MONOMER0-162
//
UNIQUE-ID - REG0-10383
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7709
CITATIONS - 17068078
MODE - +
REGULATED-ENTITY - PM0-10365
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5837
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00781
MODE - +
REGULATED-ENTITY - PM00652
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-11046
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8045
CITATIONS - 21421764
MODE - -
REGULATED-ENTITY - PM0-10131
REGULATOR - PD01379
//
UNIQUE-ID - REG0-6216
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3814
CITATIONS - 9537375
CITATIONS - 9358057
CITATIONS - 9657988
MODE - -
REGULATED-ENTITY - PM0-5168
REGULATOR - PD03585
//
UNIQUE-ID - REG0-11821
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8369
CITATIONS - 23651393
COMMENT - The site for the RbsR transcriptional regulator in the <i>udk-dcd</i> operon was identified based on genomic Selex analysis |CITS:[23651393]|.
MODE - +
REGULATED-ENTITY - TU00370
REGULATOR - MONOMER-60
//
UNIQUE-ID - REG0-6591
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-14
CITATIONS - 10760155
MODE - -
REGULATED-ENTITY - PM0-10
REGULATOR - PC00010
//
UNIQUE-ID - REG0-4700
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5723
CITATIONS - 9179845
MODE - -
REGULATED-ENTITY - PM00039
REGULATOR - PD03576
//
UNIQUE-ID - REG0-5073
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1163
CITATIONS - 7500958
CITATIONS - 8648646
CITATIONS - 9515922
CITATIONS - 9632265
COMMENT - Fis appears to have little or no effect on rrsBp1 as a result of the addition of amino acids to the growth medium |CITS:[16675089]|.
MODE - +
REGULATED-ENTITY - PM00514
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5447
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00314
CITATIONS - 2468650
MODE - +
REGULATED-ENTITY - PM00165
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10269
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7693
CITATIONS - 18586269
MODE - -
REGULATED-ENTITY - PM103
REGULATOR - PUTA-MONOMER
//
UNIQUE-ID - REG0-5821
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00336
CITATIONS - 1899415
MODE - +
REGULATED-ENTITY - PM00200
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10993
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8030
CITATIONS - 12446650
CITATIONS - 14702398
CITATIONS - 18808381
MODE - +
REGULATED-ENTITY - PM0-2441
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6200
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7307
CITATIONS - 16849788
MODE - -
REGULATED-ENTITY - PM0-5561
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11753
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8354
CITATIONS - 9813115
MODE - -
REGULATED-ENTITY - PM0-46264
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-6575
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6935
CITATIONS - 17644067
CITATIONS - 8821940:EV-EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS:3504951620:martin
CITATIONS - 8821940:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3504951620:martin
CITATIONS - 17644067:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3504951620:martin
CITATIONS - 17644067:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3504951620:martin
CITATIONS - 11321589:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3504951620:martin
COMMENT - The <i>acrR</i> gene, which is located upstream of and in the opposite direction of <i>acrAB</i>, encodes AcrR, a negative DNA-binding transcriptional regulator for a multidrug efflux pump. The presence of <i>acrR</i> upstream of the  <i>acrAB</i> operon in <i>E. coli</i> suggests that the operon may be controlled at the level of transcription by this regulator |CITS [ 8821940]|.
MODE - -
REGULATED-ENTITY - PM0-8705
REGULATOR - EG12116-MONOMER
//
UNIQUE-ID - REG0-4684
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00091
CITATIONS - 1556120
MODE - -
REGULATED-ENTITY - PM00037
REGULATOR - PD03576
//
UNIQUE-ID - REG0-5057
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2265
CITATIONS - 10998176
CITATIONS - 12754220
CITATIONS - 16140031
COMMENT - Under anaerobiosis, FNR repress <i>cydAB</i> operon expression |CITS: [12754220]|.
MODE - -
REGULATED-ENTITY - PM439
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-5431
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00304
COMMENT - BetI  is a repressor that regulates the betIp  promoter in response to the inducer choline.
MODE - -
REGULATED-ENTITY - PM00156
REGULATOR - PD00251
//
UNIQUE-ID - REG0-10181
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7114
CITATIONS - 15520470
CITATIONS - 19054084
CITATIONS - 15520470:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3444487605:asantos
CITATIONS - 15520470:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3444487605:asantos
CITATIONS - 19054084:EV-EXP-IMP-SITE-MUTATION:3444487605:asantos
CITATIONS - 19054084:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3444487605:asantos
CITATIONS - 19054084:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3444487605:asantos
COMMENT - CRP binding to site 2 (+17.5) causes little or no repression on the <i>malI</i> promoter, while CRP binding to site 1 (-43.5) causes only weak activation. It could be that <i>malI</i> has an unusual organization of its peculiar sequence |CITS:[19054084]|.
MODE - -
REGULATED-ENTITY - PM00260
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5805
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00384
CITATIONS - 9418241
CITATIONS - 2656658
CITATIONS - 1957353
COMMENT - Both proteins, FNR and ArcA,  activate the expression of <i>fumB</i> under anaerobiosis, but they act independently from each other. This site has eight identities with regard to the symmetrical consensus TTGATA--TATCAA proposed by Spiro and Guest for FNR |CITS:[1957353]|. There are also two half-sites with five and four identities. The significance of the potential FNR sites is difficult to assess, partly because their homologies with the consensus are not particularly strong.
MODE - +
REGULATED-ENTITY - PM00219
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-10977
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8024
CITATIONS - 12446650
CITATIONS - 12730179
MODE - +
REGULATED-ENTITY - PM461
REGULATOR - EG12242-MONOMER
//
UNIQUE-ID - REG0-6184
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3925
CITATIONS - 6406797
CITATIONS - 3929016
MODE - -
REGULATED-ENTITY - PM0-5285
REGULATOR - PD03270
//
UNIQUE-ID - REG0-11697
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8342
CITATIONS - 22522900
MODE - -
REGULATED-ENTITY - PM0-10033
REGULATOR - EG12431-MONOMER
//
UNIQUE-ID - REG0-6554
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7054
CITATIONS - 15941987
MODE - +
REGULATED-ENTITY - PM-8784
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-4668
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6933
CITATIONS - 2858855
MODE - -
REGULATED-ENTITY - PM00034
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-9884
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7647
CITATIONS - 18723630:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3435415509:asantos
CITATIONS - 18723630:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3435415509:asantos
CITATIONS - 18723630
MODE - -
REGULATED-ENTITY - PM0-10276
REGULATOR - CPLX0-7745
//
UNIQUE-ID - REG0-5041
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS270
CITATIONS - 9371449
MODE - +
REGULATED-ENTITY - PM68
REGULATOR - MONOMER0-165
//
UNIQUE-ID - REG0-5415
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7336
CITATIONS - 16796689
MODE - -
REGULATED-ENTITY - PM0-9580
REGULATOR - PD00288
//
UNIQUE-ID - REG0-10088
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7664
CITATIONS - 19007420
MODE - -
REGULATED-ENTITY - PM0-7421
REGULATOR - MONOMER-52
//
UNIQUE-ID - REG0-5789
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS544
CITATIONS - [8809757]
CITATIONS - 14766919
MODE - +
REGULATED-ENTITY - PM00218
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-10959
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8014
CITATIONS - 17660422
CITATIONS - 12730179
CITATIONS - 18297445
CITATIONS - 18808381
CITATIONS - 19220752
MODE - +
REGULATED-ENTITY - PM0-5982
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-6166
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4347
CITATIONS - 12730174
CITATIONS - 1640456
CITATIONS - 17074904
MODE - -
REGULATED-ENTITY - PM0-5741
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-11654
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8327
CITATIONS - 23065979
MODE - -
REGULATED-ENTITY - PM00598
REGULATOR - G7326-MONOMER
//
UNIQUE-ID - REG0-6538
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7073
MODE - +
REGULATED-ENTITY - PM-8794
REGULATOR - CPLX0-3930
//
UNIQUE-ID - REG0-4652
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5474
CITATIONS - 2160266
MODE - -
REGULATED-ENTITY - PM00032
REGULATOR - PD00288
//
UNIQUE-ID - REG0-9608
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7638
CITATIONS - 8709849
CITATIONS - 19054109
MODE - +
REGULATED-ENTITY - PM0-10074
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5025
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS422
CITATIONS - [9648752]
CITATIONS - 10216857
CITATIONS - 8955407:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3555840984:martin
CITATIONS - :EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3555840984:martin
CITATIONS - :EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3555840984:martin
CITATIONS - 10216857:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3555840984:martin
CITATIONS - 10216857:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3555840984:martin
COMMENT - This site  probably plays little or no role in dadAX expression.
MODE - +
REGULATED-ENTITY - PM562
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5399
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7296
CITATIONS - 11118204
MODE - -
REGULATED-ENTITY - PM0-9513
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5773
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00371
CITATIONS - [8034727]
MODE - +
REGULATED-ENTITY - PM00208
REGULATOR - MONOMER0-183
//
UNIQUE-ID - REG0-10932
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8000
CITATIONS - 21034467
MODE - -
REGULATED-ENTITY - PM0-36193
REGULATOR - PD00288
//
UNIQUE-ID - REG0-6149
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5449
CITATIONS - 14731281
MODE - -
REGULATED-ENTITY - PM0-6883
REGULATOR - G7630-MONOMER
//
UNIQUE-ID - REG0-11633
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8311
CITATIONS - 23010927
MODE - +
REGULATED-ENTITY - PM0-46235
REGULATOR - PD04418
//
UNIQUE-ID - REG0-6522
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1066
CITATIONS - 11169114
CITATIONS - 9767578
CITATIONS - 11932447
CITATIONS - 21272324
MODE - -
REGULATED-ENTITY - PM0-1303
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-4636
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS52
CITATIONS - 17293415
MODE - +
REGULATED-ENTITY - PM00029
REGULATOR - PC00027
//
UNIQUE-ID - REG0-9589
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7622
CITATIONS - 14996819
CITATIONS - 15073297
CITATIONS - 22101843
MODE - +
REGULATED-ENTITY - PM0-4802
REGULATOR - CPLX0-7721
//
UNIQUE-ID - REG0-5008
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1741
CITATIONS - [11976288]
CITATIONS - [12446650]
CITATIONS - 16980449
CITATIONS - 15795232
CITATIONS - 12730179
MODE - +
REGULATED-ENTITY - PM461
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-5383
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00774
MODE - +
REGULATED-ENTITY - PM00645
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5757
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00675
CITATIONS - 1372899
COMMENT - GlpR perhaps binds cooperatively to  four adjacent operator sites.
MODE - -
REGULATED-ENTITY - PM00238
REGULATOR - PD03576
//
UNIQUE-ID - REG0-10915
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7984
CITATIONS - 20965974
MODE - +
REGULATED-ENTITY - PM0-9632
REGULATOR - PC00027
//
UNIQUE-ID - REG0-6133
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6002
CITATIONS - 15988767
COMMENT - It appears that the negative effects of ArcA and Fnr on <i>aceE</i> are not additive |CITS:[15988767]|.
MODE - -
REGULATED-ENTITY - PM00325
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11617
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8297
CITATIONS - 23026122
MODE - +
REGULATED-ENTITY - PM0-10352
REGULATOR - MONOMER-51
//
UNIQUE-ID - REG0-6506
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4205
CITATIONS - 15252051
COMMENT - The addition of CRP decreased the ArcA-specific protection on binding sites -48 and -85 and the CRP-specific protection was decreased, implying that ArcA and CRP compete with each other for  binding to the ptsGp1 promoter.
MODE - -
REGULATED-ENTITY - PM0-1301
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-4620
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7007
CITATIONS - 15883881
COMMENT - This regulatory interaction was identified by means of PhoPQ-related microarray experiments, and it was investigated to determine the presence of its regulatory motif in the promoter region |CITS: [15883881]|.
MODE - +
REGULATED-ENTITY - PM00078
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-9556
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7606
CITATIONS - 18405378
MODE - -
REGULATED-ENTITY - PM00252
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-4990
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1761
CITATIONS - 16980449
CITATIONS - [11976288]
CITATIONS - [12446650]
CITATIONS - 15795232
CITATIONS - 12730179
MODE - +
REGULATED-ENTITY - PM450
REGULATOR - EG12243-MONOMER
//
UNIQUE-ID - REG0-5367
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00783
MODE - +
REGULATED-ENTITY - PM00669
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5741
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00405
CITATIONS - 8955298
MODE - -
REGULATED-ENTITY - PM00232
REGULATOR - PC00063
//
UNIQUE-ID - REG0-10896
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7968
CITATIONS - 21115656
MODE - -
REGULATED-ENTITY - PM0-10151
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6117
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5963
CITATIONS - 8982002
CITATIONS - 19007420
MODE - -
REGULATED-ENTITY - PM0-7421
REGULATOR - PD00261
//
UNIQUE-ID - REG0-11579
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8283
CITATIONS - 21463370
MODE - +
REGULATED-ENTITY - PM0-36261
REGULATOR - PHOSPHO-BASR
//
UNIQUE-ID - REG0-6489
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2548
CITATIONS - 11101675
CITATIONS - 21338418
MODE - -
REGULATED-ENTITY - PM0-1182
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4604
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7238
CITATIONS - 17159291
MODE - +
REGULATED-ENTITY - PM0-9355
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9480
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7592
CITATIONS - 18263722
MODE - -
REGULATED-ENTITY - PM224
REGULATOR - EG11962-MONOMER
//
UNIQUE-ID - REG0-4974
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS474
COMMENT - FIS represses the hupBp3 promoter only when CRP is absent.
MODE - -
REGULATED-ENTITY - PM589
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5349
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7088
CITATIONS - 15520470
MODE - +
REGULATED-ENTITY - PM00536
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5725
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS-7110
CITATIONS - 15520470
MODE - -
REGULATED-ENTITY - PM00274
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10878
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7953
CITATIONS - 21029047
MODE - +
REGULATED-ENTITY - PM0-36178
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-6101
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5862
MODE - -
REGULATED-ENTITY - PM0-7561
REGULATOR - MONOMER0-2421
//
UNIQUE-ID - REG0-11534
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8266
CITATIONS - 11121068
MODE - +
REGULATED-ENTITY - PM0-3823
REGULATOR - PROTEIN-NRIP
//
UNIQUE-ID - REG0-6473
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-5244
CITATIONS - 9632265
CITATIONS - 15686546
COMMENT - Paradoxically, even though H-NS is an inhibitor it drives the bound RNA 
/polymerase into open complexes |CITS: [15686546]|.
/
MODE - -
REGULATED-ENTITY - PM0-1349
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4585
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6962
CITATIONS - 15659676
MODE - +
REGULATED-ENTITY - PM00066
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-9425
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7577
CITATIONS - 18055596
CITATIONS - 18055596:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3414861073:asantos
MODE - -
REGULATED-ENTITY - PM0-9879
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4958
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6998
CITATIONS - 15879709
COMMENT - The presence of this site could reduce Fis activation and cause inhibition at high Fis concentrations. Nevertheless, the authors did not discard the possibility that this effect was due to impurities in the protein preparation |CITS: [15879709]|.
MODE - -
REGULATED-ENTITY - PM643
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-5333
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6937
CITATIONS - 10894725
MODE - +
REGULATED-ENTITY - PM00611
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5707
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00457
CITATIONS - 10760178
CITATIONS - 10747919
CITATIONS - 12675795
CITATIONS - 16621812
COMMENT - 
/MelR binding to the site 2'(-42.5) occurs only in the presence of melibiose and is absolutely required for expression of <i>melAB</i> |CITS [12060687]|. Improvement of the base sequence of site 2' removes the requirement for sites 1 and 1' and for melobiose |CITS[10747919], [10760178]|.
MODE - +
REGULATED-ENTITY - PM00175
REGULATOR - MONOMER0-161
//
UNIQUE-ID - REG0-10833
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7936
CITATIONS - 20713450
MODE - +
REGULATED-ENTITY - PM0-9320
REGULATOR - G6761-MONOMER
//
UNIQUE-ID - REG0-6085
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6464
CITATIONS - 11101675
CITATIONS - 12475930
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM0-8081
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-11513
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8250
CITATIONS - 16115199
MODE - -
REGULATED-ENTITY - PM00579
REGULATOR - PC00061
//
UNIQUE-ID - REG0-6457
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2560
CITATIONS - 11591675
MODE - +
REGULATED-ENTITY - PM0-1346
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4568
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7037
CITATIONS - 16077119
MODE - +
REGULATED-ENTITY - PM00065
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-9403
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7560
CITATIONS - 18083817
MODE - -
REGULATED-ENTITY - PM928
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-4942
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1586
CITATIONS - [10564485]
MODE - +
REGULATED-ENTITY - PM624
REGULATOR - PD00406
//
UNIQUE-ID - REG0-5317
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS341
CITATIONS - [8002608]
CITATIONS - 1346534
MODE - -
REGULATED-ENTITY - PM00630
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5691
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00664
CITATIONS - 8596434
COMMENT - In the absence of the other proteins, cAMP-CRP binds to three CRP targets centered at -92.5 (CRP2), -42.5 (CRP1), and +56 (CRPE). The importance of CRPE located  within the <i>nupG</i> coding region is at present unknown.
MODE - +
REGULATED-ENTITY - PM00173
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10812
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7920
CITATIONS - 20466769
MODE - -
REGULATED-ENTITY - PM00536
REGULATOR - PHOSPHO-CPXR
//
UNIQUE-ID - REG0-6066
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6524
CITATIONS - 12813061
MODE - +
REGULATED-ENTITY - PM0-8185
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-11495
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8239
CITATIONS - 22323519
CITATIONS - 18765794
MODE - -
REGULATED-ENTITY - PM00536
REGULATOR - EG11356-MONOMER
//
UNIQUE-ID - REG0-6441
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-3489
CITATIONS - 14711822
MODE - -
REGULATED-ENTITY - PM0-1581
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-4552
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS746
CITATIONS - 9382703
CITATIONS - 15225315
COMMENT - FruR represses the <i>nirB</i> operon in the absence of glucose binding to its promoter. It is suggested that Cra probably interferes with RNA polymerase binding to its site or with the RNA polymerase interaction with FNR and other components for transcription initiation.
MODE - -
REGULATED-ENTITY - PM00062
REGULATOR - PC00061
//
UNIQUE-ID - REG0-9382
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7543
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM0-1781
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4926
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS760
CITATIONS - [9421904]
MODE - -
REGULATED-ENTITY - PM262
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-5301
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00771
CITATIONS - 7545108
MODE - +
REGULATED-ENTITY - PM00642
REGULATOR - PD00266
//
UNIQUE-ID - REG0-5675
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00762
CITATIONS - 26403574
COMMENT - Beyond the silencing of <i>rcsA</i> expression by H-NS and the multicopy effect of DsrA on H-NS, little is known about the regulation of <i>rscA</i> expression.
MODE - -
REGULATED-ENTITY - PM00636
REGULATOR - PD00288
//
UNIQUE-ID - REG0-10787
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7904
CITATIONS - 17921503
CITATIONS - 12475930
CITATIONS - 11101675
MODE - -
REGULATED-ENTITY - PM0-8081
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-6050
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00560
CITATIONS - 1624451
MODE - -
REGULATED-ENTITY - PM00313
REGULATOR - PD03585
//
UNIQUE-ID - REG0-11479
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8226
CITATIONS - 9422614
CITATIONS - 20952573
COMMENT - LeuO can fully antagonize the negative effect of H-NS on the <i>bglGFB</i> operon |CITS: [9422614]|.
MODE - +
REGULATED-ENTITY - PM0-5042
REGULATOR - PD00519
//
UNIQUE-ID - REG0-6423
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1424
CITATIONS - [10368146]
MODE - +
REGULATED-ENTITY - PM0-1783
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-4536
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00146
CITATIONS - 8057356
MODE - +
REGULATED-ENTITY - PM00061
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9365
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7527
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM450
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4909
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS586
CITATIONS - [8825783]
CITATIONS - [9254708]
MODE - -
REGULATED-ENTITY - PM00466
REGULATOR - MONOMER0-160
//
UNIQUE-ID - REG0-5285
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8197
CITATIONS - 10216857
CITATIONS - 8955407
MODE - -
REGULATED-ENTITY - PM00540
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5659
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00638
COMMENT - CytR and CRP act  together to repress transcription from the rpoHp3 promoter. A single CytR molecule binds between two CRP molecules. CRP-CytR-CRP.
MODE - -
REGULATED-ENTITY - PM00571
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10759
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7892
CITATIONS - 12067348
MODE - +
REGULATED-ENTITY - PM0-4864
REGULATOR - PD04418
//
UNIQUE-ID - REG0-6034
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS781
CITATIONS - [9335308]
MODE - +
REGULATED-ENTITY - PM961
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-11454
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8206
CITATIONS - 22223481
CITATIONS - 23690622
MODE - +
REGULATED-ENTITY - PM0-2482
REGULATOR - CPLX0-8075
//
UNIQUE-ID - REG0-6407
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1703
CITATIONS - [11810262]
MODE - +
REGULATED-ENTITY - PM0-2221
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-4520
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS111
CITATIONS - 8057356
CITATIONS - 1528882
CITATIONS - 8736541
CITATIONS - 7050087
MODE - +
REGULATED-ENTITY - PM00060
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-9349
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7511
CITATIONS - 17768236
MODE - -
REGULATED-ENTITY - PM00430
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4893
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS524
CITATIONS - 10601216
CITATIONS - 1744060
MODE - -
REGULATED-ENTITY - PM00279
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5269
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00561
CITATIONS - 12618441
MODE - -
REGULATED-ENTITY - PM00314
REGULATOR - PD03585
//
UNIQUE-ID - REG0-5643
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00182
CITATIONS - 21572102
CITATIONS - 2404765
CITATIONS - 2211510
MODE - -
REGULATED-ENTITY - PM00081
REGULATOR - CPLX-123
//
UNIQUE-ID - REG0-10723
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7872
CITATIONS - 15703297
CITATIONS - 15703297:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3482610172:asantos
CITATIONS - 15703297:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3482610172:asantos
CITATIONS - 15703297:EV-COMP-HINF-SIMILAR-TO-CONSENSUS:3482610172:asantos
MODE - +
REGULATED-ENTITY - PM0-5143
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-6018
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS842
CITATIONS - [1508713]
MODE - +
REGULATED-ENTITY - PM00336
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-11416
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8197
CITATIONS - 8955407
CITATIONS - 10216857
MODE - -
REGULATED-ENTITY - PM561
REGULATOR - PD00353
//
UNIQUE-ID - REG0-6391
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2921
CITATIONS - 11448880
COMMENT - The regulatory effect of MetJ on the promoter metKp is not yet known. However, we assigned a negative effect to this regulatory interaction based on two facts: the protein's binding site is very close to the promoter, and  MetJ is known to act, so far without exceptions, as a negative regulator.
MODE - -
REGULATED-ENTITY - PM0-1963
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-4504
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2965
CITATIONS - 11448880
MODE - -
REGULATED-ENTITY - PM00054
REGULATOR - CPLX0-7796
//
UNIQUE-ID - REG0-9320
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7497
CITATIONS - 17768236
MODE - +
REGULATED-ENTITY - PM00037
REGULATOR - CPLX0-7705
//
UNIQUE-ID - REG0-4877
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1
CITATIONS - 9696769
CITATIONS - 7643383
CITATIONS - 13129959
MODE - -
REGULATED-ENTITY - PM125
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5252
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00442
CITATIONS - 7751276
CITATIONS - 1729203
CITATIONS - 1532173
CITATIONS - 8521047
COMMENT - Lrp regulates <i>livJ</i> gene expression in a leucine-sensitive manner; it needs leucine to results in this repression effect |CITS:[1729203]|.
MODE - -
REGULATED-ENTITY - PM00256
REGULATOR - MONOMER0-155
//
UNIQUE-ID - REG0-5627
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7124
CITATIONS - 16291649
MODE - -
REGULATED-ENTITY - PM00590
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-10694
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7860
CITATIONS - 8087856
CITATIONS - 2471187
CITATIONS - 1730735
MODE - -
REGULATED-ENTITY - PM00067
REGULATOR - PD00214
//
UNIQUE-ID - REG0-6002
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS43
CITATIONS - 10071223
MODE - -
REGULATED-ENTITY - PM324
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-11379
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8181
CITATIONS - 22101843
CITATIONS - 22101843:EV-COMP-AINF-SIMILAR-TO-CONSENSUS:3535224069:asantos
MODE - -
REGULATED-ENTITY - PM0-10377
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-6375
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-1882
CITATIONS - 12123454
MODE - -
REGULATED-ENTITY - PM0-2623
REGULATOR - PHOSPHO-PHOP
//
UNIQUE-ID - REG0-4487
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7232
CITATIONS - 8152423
COMMENT - It has been proven that HNS has regulatory effects for the <i>ilvIH</i> operon under high osmolarity conditions, decreasing the Lrp action; these effects superimpose the Lrp activation of the operon |CITS:[8152423]|.
MODE - -
REGULATED-ENTITY - PM00111
REGULATOR - PD00288
//
UNIQUE-ID - REG0-9287
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7488
CITATIONS - 17921503
MODE - -
REGULATED-ENTITY - PM00227
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-4860
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4430
CITATIONS - 8120010
CITATIONS - 11673423
CITATIONS - 8763946
MODE - -
REGULATED-ENTITY - PM00423
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5236
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00313
CITATIONS - 2836193
MODE - +
REGULATED-ENTITY - PM00348
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5611
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2862
CITATIONS - 11566985
CITATIONS - 15901715
MODE - +
REGULATED-ENTITY - PM00544
REGULATOR - PHOSPHO-RCSB
//
UNIQUE-ID - REG0-10669
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7846
CITATIONS - 11443091
MODE - -
REGULATED-ENTITY - PM0-5201
REGULATOR - PD00214
//
UNIQUE-ID - REG0-5986
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00539
CITATIONS - 8230210
CITATIONS - 17513476
COMMENT - Induction of <i>rhaBAD</i> involves a regulatory cascade in which the induction of <i>rhaSR</i> results in the accumulation of RhaS, which in turn induces <i>rhaBAD</i> expression.  The &alpha;-CTD is required for full <i>rhaBAD</i> activation.
MODE - +
REGULATED-ENTITY - PM00303
REGULATOR - CPLX-124
//
UNIQUE-ID - REG0-11347
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00461
CITATIONS - [8757744]
CITATIONS - [7608086]
CITATIONS - 8900067
CITATIONS - 8998977
MODE - -
REGULATED-ENTITY - PM00268
REGULATOR - CPLX0-7752
//
UNIQUE-ID - REG0-6359
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2202
CITATIONS - 10915804
CITATIONS - 11167016
CITATIONS - 15773991
MODE - +
REGULATED-ENTITY - PM172
REGULATOR - CPLX0-7708
//
UNIQUE-ID - REG0-4470
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7310
MODE - -
REGULATED-ENTITY - PM00110
REGULATOR - PHOSPHO-ARCA
//
UNIQUE-ID - REG0-9268
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7470
CITATIONS - 12694615
CITATIONS - 17998538
CITATIONS - 19352034
MODE - +
REGULATED-ENTITY - PM0-9828
REGULATOR - PHOSPHO-EVGA
//
UNIQUE-ID - REG0-4844
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4346
CITATIONS - 12730174
MODE - -
REGULATED-ENTITY - PM00672
REGULATOR - CPLX0-228
//
UNIQUE-ID - REG0-5219
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2425
CITATIONS - 8002608
CITATIONS - 11601842
MODE - -
REGULATED-ENTITY - PM00401
REGULATOR - PD00353
//
UNIQUE-ID - REG0-5592
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4662
MODE - +
REGULATED-ENTITY - PM00185
REGULATOR - MONOMER0-158
//
UNIQUE-ID - REG0-10610
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7834
CITATIONS - 20015147
MODE - -
REGULATED-ENTITY - PM0-10490
REGULATOR - PD00288
//
UNIQUE-ID - REG0-5970
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2967
CITATIONS - 11555297
MODE - -
REGULATED-ENTITY - PM00296
REGULATOR - PD02198
//
UNIQUE-ID - REG0-11310
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8156
CITATIONS - 21926233
MODE - +
REGULATED-ENTITY - PM0-9885
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-6343
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-4821
COMMENT - The regulatory effect of Fur on the promoter for <i>fhuE</i> is as of yet not known. However, we assigned a negative effect to this regulatory interaction based on two facts: (1) the protein's binding site is  16 bp downstream of the transcription start site; and (2) Fur is known to act, so far without exceptions, as a negative regulator.
MODE - -
REGULATED-ENTITY - PM0-2761
REGULATOR - CPLX0-7639
//
UNIQUE-ID - REG0-12326
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8496
CITATIONS - 26010043
MODE - +
REGULATED-ENTITY - PM0-9849
REGULATOR - NARL-MONOMER
//
UNIQUE-ID - REG0-9170
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7453
CITATIONS - 16261196
MODE - +
REGULATED-ENTITY - PM-8827
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-4827
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2721
CITATIONS - 10787413
CITATIONS - 10595554
CITATIONS - 22971172
COMMENT - The N-terminal domain of NikR is responsible for DNA recognition. 
/
/NikR and NarLX repress the synthesis of NikABCDE in the presence of nitrate. NikR also represses NikABCDE expression at higher nickel concentrations. This regulator is activated by Ni<sup>2+</sup>, and its function is inhibited by one or more formate-inducible hydrogenase assembly components  |CITS:[16159764]|.
MODE - -
REGULATED-ENTITY - PM881
REGULATOR - CPLX0-7707
//
UNIQUE-ID - REG0-5203
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6979
CITATIONS - 7601827
MODE - -
REGULATED-ENTITY - PM00354
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5576
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00332
CITATIONS - [8626289]
CITATIONS - [10347150]
CITATIONS - 14499937
CITATIONS - 8626289
CITATIONS - 12391883
CITATIONS - 15027196
MODE - +
REGULATED-ENTITY - PM00179
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-10581
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7818
CITATIONS - 8596434
MODE - -
REGULATED-ENTITY - PM00173
REGULATOR - CPLX0-7740
//
UNIQUE-ID - REG0-5954
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6990
CITATIONS - 11929525
CITATIONS - 11004182
CITATIONS - 7854119
CITATIONS - 9302020
CITATIONS - 15978080
CITATIONS - 8501030
MODE - +
REGULATED-ENTITY - PM00280
REGULATOR - PHOSPHO-NARP
//
UNIQUE-ID - REG0-11256
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8140
CITATIONS - 21890697
MODE - +
REGULATED-ENTITY - PM00379
REGULATOR - CPLX0-7669
//
UNIQUE-ID - REG0-6327
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-2346
CITATIONS - 10998176
CITATIONS - 12754220
CITATIONS - 16140031
MODE - -
REGULATED-ENTITY - PM0-3342
REGULATOR - CPLX0-7797
//
UNIQUE-ID - REG0-12230
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-8481
CITATIONS - 25568260
MODE - -
REGULATED-ENTITY - PM00142
REGULATOR - MONOMER0-4341
//
UNIQUE-ID - REG0-9115
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-7436
CITATIONS - 17526711
MODE - +
REGULATED-ENTITY - PM00178
REGULATOR - PD00288
//
UNIQUE-ID - REG0-4811
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00052
CITATIONS - 2170326
CITATIONS - 8969182
CITATIONS - 1962841
CITATIONS - 1649947
CITATIONS - 1661372
CITATIONS - 1647022
CITATIONS - 1655726
CITATIONS - 8221894
CITATIONS - 845188
CITATIONS - 8394345
CITATIONS - 12667072
MODE - +
REGULATED-ENTITY - PM00025
REGULATOR - CPLX0-226
//
UNIQUE-ID - REG0-5187
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS0-6977
CITATIONS - 7601827
MODE - -
REGULATED-ENTITY - PM00353
REGULATOR - PHOSPHO-NARL
//
UNIQUE-ID - REG0-5559
TYPES - Transcription-Factor-Binding
ASSOCIATED-BINDING-SITE - BS00225
MODE - +
REGULATED-ENTITY - PM00108
REGULATOR - CPLX0-2781
//
UNIQUE-ID - REG0-12324
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 25749694
CITATIONS - 25749694:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3652022287:asantos
GROWTH-CONDITIONS - NIL
MODE - -
REGULATED-ENTITY - PM0-46360
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-12218
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 25365487
CITATIONS - 25365487:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3641299010:asantos
COMMENT - Upon amino acid starvation, <i>rpsB</i>p is negatively regulated by ppGpp due to the presence of the GC-rich discriminator, whose substitution for the AT-rich element abolished stringent control |CITS:[25365487]|.
GROWTH-CONDITIONS - Amino acid starvation
MODE - -
REGULATED-ENTITY - PM0-9963
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-12217
TYPES - Allosteric-Regulation-of-RNAP
GROWTH-CONDITIONS - NIL
//
UNIQUE-ID - REG0-11948
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 23772072
CITATIONS - 23772072:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3599405504:asantos
GROWTH-CONDITIONS - stringent response
MODE - -
REGULATED-ENTITY - PM0-10352
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11947
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 23772072
CITATIONS - 8649995
CITATIONS - 23772072:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3599405036:asantos
CITATIONS - 8649995:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3599405215:asantos
COMMENT - ppGpp and its cofactor, DksA, inhibit in two ways the transcription of <i>fabH</i>p: 1) they directly inhibit its transcription, and 2) they inhibit <i>fadR</i> expression, which is an activator of the <i>fabHDG</i> operon |CITS:[23772072]|.
GROWTH-CONDITIONS - stringent response
MODE - -
REGULATED-ENTITY - PM0-46277
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11944
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 8253685
CITATIONS - 8253685:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3599403216:asantos
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM00590
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11943
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 10760563
CITATIONS - 10760563:EV-EXP-IMP:3599402011:asantos
GROWTH-CONDITIONS - amino acid starvation
MODE - +
REGULATED-ENTITY - PM00480
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11941
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 10760563
CITATIONS - 10760563:EV-EXP-IMP:3599401748:asantos
GROWTH-CONDITIONS - amino acid starvation
MODE - +
REGULATED-ENTITY - PM00479
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11652
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 22907080
CITATIONS - 22907080:EV-EXP-IMP:3568498035:asantos
COMMENT - The positive effect of ppGpp on RelA is through its effect on the <i>k</i><sub>cat'</sub> and not the <i>K<sub>m</sub></i>. This effect is amplified by ribosomal protein L11 and deacylated RNA<sup>Phe</sup> and mRNA |CITS:[22907080]|.
GROWTH-CONDITIONS - NIL
MODE - +
REGULATED-ENTITY - PM0-9355
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11388
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 22200485
CITATIONS - 22200485:EV-EXP-IDA:3558206836:paley
MODE - +
REGULATED-ENTITY - PM0-7141
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11386
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 22200485
CITATIONS - 22200485:EV-EXP-IDA-PURIFIED-PROTEIN:3558206891:paley
MODE - +
REGULATED-ENTITY - PM00249
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11187
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IMP:3515978370:paley
CITATIONS - 15294157:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515978370:paley
CITATIONS - 15294157:EV-EXP-IDA-PURIFIED-PROTEIN:3515978370:paley
COMMENT - DskA amplifies the magnitude of inhibition effects of ppGpp from <i>rrnB</i>p1 and all rRNAP1 promoters |CITS:[15294157][21402902]|. A model reflecting the contribution of DksA under regulation of rRNA expression has been developed |CITS:[15294157]|.
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM00514
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11186
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IMP:3515978370:paley
CITATIONS - 15294157:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515978370:paley
CITATIONS - 15294157:EV-EXP-IDA-PURIFIED-PROTEIN:3515978370:paley
COMMENT - DskA amplifies the magnitude of inhibition effects of ppGpp from <i>rrnB</i>p1 and all rRNAP1 promoters |CITS:[15294157][21402902]|. A model reflecting the contribution of DksA under regulation of rRNA expression has been developed |CITS:[15294157]|.
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-1349
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11185
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IMP:3515978370:paley
CITATIONS - 15294157:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515978370:paley
CITATIONS - 15294157:EV-EXP-IDA-PURIFIED-PROTEIN:3515978370:paley
COMMENT - DskA amplifies the magnitude of inhibition effects of ppGpp from <i>rrnB</i>p1 and all rRNAP1 promoters |CITS:[15294157][21402902]|. A model reflecting the contribution of DksA under regulation of rRNA expression has been developed |CITS:[15294157]|.
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-1347
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11184
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IMP:3515978370:paley
CITATIONS - 15294157:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515978370:paley
CITATIONS - 15294157:EV-EXP-IDA-PURIFIED-PROTEIN:3515978370:paley
COMMENT - DskA amplifies the magnitude of inhibition effects of ppGpp from <i>rrnB</i>p1 and all rRNAP1 promoters |CITS:[15294157][21402902]|. A model reflecting the contribution of DksA under regulation of rRNA expression has been developed |CITS:[15294157]|.
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-1346
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11183
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IMP:3515978370:paley
CITATIONS - 15294157:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515978370:paley
CITATIONS - 15294157:EV-EXP-IDA-PURIFIED-PROTEIN:3515978370:paley
COMMENT - DskA amplifies the magnitude of inhibition effects of ppGpp from <i>rrnB</i>p1 and all rRNAP1 promoters |CITS:[15294157][21402902]|. A model reflecting the contribution of DksA under regulation of rRNA expression has been developed |CITS:[15294157]|.
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-1351
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11182
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IMP:3515978370:paley
CITATIONS - 15294157:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515978370:paley
CITATIONS - 15294157:EV-EXP-IDA-PURIFIED-PROTEIN:3515978370:paley
COMMENT - DskA amplifies the magnitude of inhibition effects of ppGpp from <i>rrnB</i>p1 and all rRNAP1 promoters |CITS:[15294157][21402902]|. A model reflecting the contribution of DksA under regulation of rRNA expression has been developed |CITS:[15294157]|.
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-1343
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11181
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21402902:EV-EXP-IMP:3515955600:paley
CITATIONS - 21402902:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515955600:paley
CITATIONS - 21402902:EV-EXP-IDA-PURIFIED-PROTEIN:3515955600:paley
COMMENT - Together ppGpp and DksA can inhibit more strongly the transcription initiation from the ribosomal protein promoter <i>in vitro</i> and <i>in vivo</i> |CITS:[21402902]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM00434
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11180
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21402902:EV-EXP-IMP:3515955600:paley
CITATIONS - 21402902:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515955600:paley
CITATIONS - 21402902:EV-EXP-IDA-PURIFIED-PROTEIN:3515955600:paley
COMMENT - Together ppGpp and DksA can inhibit more strongly the transcription initiation from the ribosomal protein promoter <i>in vitro</i> and <i>in vivo</i> |CITS:[21402902]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM00497
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11179
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21402902:EV-EXP-IMP:3515955600:paley
CITATIONS - 21402902:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515955600:paley
CITATIONS - 21402902:EV-EXP-IDA-PURIFIED-PROTEIN:3515955600:paley
COMMENT - Together ppGpp and DksA can inhibit more strongly the transcription initiation from the ribosomal protein promoter <i>in vitro</i> and <i>in vivo</i> |CITS:[21402902]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-10343
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11178
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21402902:EV-EXP-IMP:3515955600:paley
CITATIONS - 21402902:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515955600:paley
CITATIONS - 21402902:EV-EXP-IDA-PURIFIED-PROTEIN:3515955600:paley
COMMENT - Together ppGpp and DksA can inhibit more strongly the transcription initiation from the ribosomal protein promoter <i>in vitro</i> and <i>in vivo</i> |CITS:[21402902]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-9339
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11177
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21402902:EV-EXP-IMP:3515955600:paley
CITATIONS - 21402902:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515955600:paley
CITATIONS - 21402902:EV-EXP-IDA-PURIFIED-PROTEIN:3515955600:paley
COMMENT - Together ppGpp and DksA can inhibit more strongly the transcription initiation from the ribosomal protein promoter <i>in vitro</i> and <i>in vivo</i> |CITS:[21402902]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-3485
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11176
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21402902:EV-EXP-IMP:3515955600:paley
CITATIONS - 21402902:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515955600:paley
CITATIONS - 21402902:EV-EXP-IDA-PURIFIED-PROTEIN:3515955600:paley
COMMENT - Together ppGpp and DksA can inhibit more strongly the transcription initiation from the ribosomal protein promoter <i>in vitro</i> and <i>in vivo</i> |CITS:[21402902]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM00376
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11175
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21402902:EV-EXP-IMP:3515955600:paley
CITATIONS - 21402902:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515955600:paley
CITATIONS - 21402902:EV-EXP-IDA-PURIFIED-PROTEIN:3515955600:paley
COMMENT - Together ppGpp and DksA can inhibit more strongly the transcription initiation from the ribosomal protein promoter <i>in vitro</i> and <i>in vivo</i> |CITS:[21402902]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-8891
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11174
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21402902:EV-EXP-IMP:3515955600:paley
CITATIONS - 21402902:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515955600:paley
CITATIONS - 21402902:EV-EXP-IDA-PURIFIED-PROTEIN:3515955600:paley
COMMENT - Together ppGpp and DksA can inhibit more strongly the transcription initiation from the ribosomal protein promoter <i>in vitro</i> and <i>in vivo</i> |CITS:[21402902]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-8224
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11173
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21402902:EV-EXP-IMP:3515955600:paley
CITATIONS - 21402902:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515955600:paley
CITATIONS - 21402902:EV-EXP-IDA-PURIFIED-PROTEIN:3515955600:paley
COMMENT - Together ppGpp and DksA can inhibit more strongly the transcription initiation from the ribosomal protein promoter <i>in vitro</i> and <i>in vivo</i> |CITS:[21402902]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-8222
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11172
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21402902:EV-EXP-IMP:3515955600:paley
CITATIONS - 21402902:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515955600:paley
CITATIONS - 21402902:EV-EXP-IDA-PURIFIED-PROTEIN:3515955600:paley
COMMENT - Together ppGpp and DksA can inhibit more strongly the transcription initiation from the ribosomal protein promoter <i>in vitro</i> and <i>in vivo</i> |CITS:[21402902]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-7821
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11171
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21402902:EV-EXP-IMP:3515955600:paley
CITATIONS - 21402902:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515955600:paley
CITATIONS - 21402902:EV-EXP-IDA-PURIFIED-PROTEIN:3515955600:paley
COMMENT - Together ppGpp and DksA can inhibit more strongly the transcription initiation from the ribosomal protein promoter <i>in vitro</i> and <i>in vivo</i> |CITS:[21402902]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM00355
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11170
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21402902:EV-EXP-IMP:3515955600:paley
CITATIONS - 21402902:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515955600:paley
CITATIONS - 21402902:EV-EXP-IDA-PURIFIED-PROTEIN:3515955600:paley
COMMENT - Together ppGpp and DksA can inhibit more strongly the transcription initiation from the ribosomal protein promoter <i>in vitro</i> and <i>in vivo</i> |CITS:[21402902]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM664
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11169
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21402902:EV-EXP-IMP:3515955600:paley
CITATIONS - 21402902:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515955600:paley
CITATIONS - 21402902:EV-EXP-IDA-PURIFIED-PROTEIN:3515955600:paley
COMMENT - Together ppGpp and DksA can inhibit more strongly the transcription initiation from the ribosomal protein promoter <i>in vitro</i> and <i>in vivo</i> |CITS:[21402902]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM00445
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11168
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21402902:EV-EXP-IMP:3515955600:paley
CITATIONS - 21402902:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515955600:paley
CITATIONS - 21402902:EV-EXP-IDA-PURIFIED-PROTEIN:3515955600:paley
COMMENT - Together ppGpp and DksA can inhibit more strongly the transcription initiation from the ribosomal protein promoter <i>in vitro</i> and <i>in vivo</i> |CITS:[21402902]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM406
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11167
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21402902:EV-EXP-IMP:3515955600:paley
CITATIONS - 21402902:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515955600:paley
CITATIONS - 21402902:EV-EXP-IDA-PURIFIED-PROTEIN:3515955600:paley
COMMENT - Together ppGpp and DksA can inhibit more strongly the transcription initiation from the ribosomal protein promoter <i>in vitro</i> and <i>in vivo</i> |CITS:[21402902]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM00496
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11166
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21402902:EV-EXP-IMP:3515955600:paley
CITATIONS - 21402902:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515955600:paley
CITATIONS - 21402902:EV-EXP-IDA-PURIFIED-PROTEIN:3515955600:paley
COMMENT - Together ppGpp and DksA can inhibit more strongly the transcription initiation from the ribosomal protein promoter <i>in vitro</i> and <i>in vivo</i> |CITS:[21402902]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM00444
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11164
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21496125:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515958744:paley
CITATIONS - 21496125:EV-EXP-IMP:3515958874:paley
CITATIONS - 21496125:EV-EXP-IDA-PURIFIED-PROTEIN:3515958874:paley
GROWTH-CONDITIONS - stringent condition and changes in the growth rate
MODE - -
REGULATED-ENTITY - PM0-10207
REGULATOR - EG10230-MONOMER
//
UNIQUE-ID - REG0-11163
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21496125:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515958744:paley
CITATIONS - 21496125:EV-EXP-IMP:3515958874:paley
CITATIONS - 21496125:EV-EXP-IDA-PURIFIED-PROTEIN:3515958874:paley
GROWTH-CONDITIONS - stringent condition and changes in the growth rate
MODE - -
REGULATED-ENTITY - PM0-10207
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11162
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21496125:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515958744:paley
GROWTH-CONDITIONS - stringent condition and changes in the growth rate
MODE - -
REGULATED-ENTITY - PM0-10207
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11161
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15335888:EV-EXP-IMP:3515957914:paley
CITATIONS - 8407846:EV-EXP-IMP:3515957914:paley
COMMENT - <i>ftsQ</i>p1, <i>ftsZ</i>p4, and <i>ftsZ</i>p3 are attractive candidates for ppGpp activation, since they exhibit inverse growth rate regulation. Even so, the effect of ppGpp on the <i>ftsZ</i> gene could be indirect |CITS:[8407846]|.
GROWTH-CONDITIONS - stringent response
MODE - +
REGULATED-ENTITY - PM00296
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11160
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15335888:EV-EXP-IMP:3515957914:paley
CITATIONS - 8407846:EV-EXP-IMP:3515957914:paley
COMMENT - <i>ftsQ</i>p1, <i>ftsZ</i>p4, and <i>ftsZ</i>p3 are attractive candidates for ppGpp activation, since they exhibit inverse growth rate regulation. Even so, the effect of ppGpp on the <i>ftsZ</i> gene could be indirect |CITS:[8407846]|.
GROWTH-CONDITIONS - stringent response
MODE - +
REGULATED-ENTITY - PM00610
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11159
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15335888:EV-EXP-IMP:3515957914:paley
CITATIONS - 8407846:EV-EXP-IMP:3515957914:paley
COMMENT - <i>ftsQ</i>p1, <i>ftsZ</i>p4, and <i>ftsZ</i>p3 are attractive candidates for ppGpp activation, since they exhibit inverse growth rate regulation. Even so, the effect of ppGpp on the <i>ftsZ</i> gene could be indirect |CITS:[8407846]|.
GROWTH-CONDITIONS - stringent response
MODE - +
REGULATED-ENTITY - PM00609
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11158
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 11006083:EV-EXP-IMP:3515979580:paley
CITATIONS - 11006083:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515979580:paley
COMMENT - <i>leuO</i> expression is induced indirectly via an increase in the cellular Lrp level in response to a ppGpp level increase, which is caused by the slow growth rate as cells enter stationary phase |CITS:[11006083]|.
GROWTH-CONDITIONS - Transition from exponential phase to Stationary phase
MODE - +
REGULATED-ENTITY - PM0-9884
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11157
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 2468650:EV-EXP-IMP:3515957559:paley
GROWTH-CONDITIONS - Transition from exponential phase to Stationary phase
MODE - +
REGULATED-ENTITY - PM00623
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11156
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 2468650:EV-EXP-IMP:3515957559:paley
GROWTH-CONDITIONS - Transition from exponential phase to Stationary phase
MODE - +
REGULATED-ENTITY - PM00165
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11155
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 1889138:EV-EXP-IMP:3515957447:paley
CITATIONS - 1889138:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515957447:paley
COMMENT - ppGpp regulates the expression of the <i>grxB</i> gene together with &sigma;<sup>S</sup> and &sigma;<sup>70</sup> during the exponential and stationary phases, respectively |CITS:[11889138]|.
GROWTH-CONDITIONS - stationary phase
MODE - +
REGULATED-ENTITY - PM0-36215
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11154
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 11162084:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515957210:paley
GROWTH-CONDITIONS - amino acid starvation
MODE - +
REGULATED-ENTITY - PM00256
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11153
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 11162084:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515957210:paley
GROWTH-CONDITIONS - amino acid starvation
MODE - +
REGULATED-ENTITY - PM00008
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11152
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 19820090:EV-EXP-IMP:3515956771:paley
CITATIONS - 19820090:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515956771:paley
GROWTH-CONDITIONS - exponential phase
MODE - +
REGULATED-ENTITY - PM0-9061
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11151
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 19820090:EV-EXP-IMP:3515956771:paley
CITATIONS - 19820090:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515956771:paley
GROWTH-CONDITIONS - stringent response
GROWTH-CONDITIONS - Transition from exponential phase to stationary phase
MODE - +
REGULATED-ENTITY - PM0-10448
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11149
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 17640895:EV-EXP-IMP:3515956436:paley
CITATIONS - 17640895:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515956436:paley
GROWTH-CONDITIONS - phosphate starvation
MODE - +
REGULATED-ENTITY - PM0-9521
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11148
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 20700605:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515953315:paley
COMMENT - ppGpp is the main negative regulator of <i>pcnBp4</i> (pS2) <i>in vivo</i>. DksA had little effect in inhibiting the activity of <i>pcnBp4</i>(pS2). However, DksA enhanced the inhibitory effect of ppGpp |CITS:[20700605]|.
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-36157
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11147
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 20700605:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515953315:paley
CITATIONS - 20700605:EV-EXP-IDA-PURIFIED-PROTEIN:3515953315:paley
COMMENT - DksA weakly inhibited <i>pcnBp3</i> (pB) transcription |CITS:[20700605]|. Pronounced impairment of <i>pcnBp3</i> (pB) activity was caused by ppGpp |CITS:[20700605]|. A dramatic decrease in the level of <i>pcnBp3</i> (pB)-derived transcripts was observed when both DksA and ppGpp were present in the reaction mixture |CITS:[20700605]|.
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-2523
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11146
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 16885445:EV-EXP-IMP:3515952765:paley
CITATIONS - 16885445:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515952848:paley
CITATIONS - 16885445:EV-EXP-IDA-PURIFIED-PROTEIN:3515952765:paley
COMMENT - ppGpp and DksA act directly and synergistically to negatively control <i>dusB</i>p transcription <i>in vitro</i>, reducing the lifetime of the competitor-resistant complex with RNA polymerase |CITS:[16885445]|. DksA is required for inhibition of <i>dusB </i>p transcription during mid- and late log growth and in stationary phase |CITS:[16885445]|. DksA negatively controls <i>dusB</i>p for normal growth-phase-dependent regulation of <i>dusB-fis</i>operon |CITS:[16885445]|. Moreover, DksA inhibits transcription, in part by further destabilizing intrinsically unstable promoter complexes |CITS:[16885445]|. Finally, it was shown that DksA not only amplifies the sensitivity of <i>dusB-fis</i> operon to ppGpp but also it increases the concentration of the initiating NTP required for transcription |CITS:[16885445]|.
GROWTH-CONDITIONS - steady-state growth
MODE - -
REGULATED-ENTITY - PM00028
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11145
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IMP:3515978370:paley
CITATIONS - 15294157:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515978370:paley
CITATIONS - 15294157:EV-EXP-IDA-PURIFIED-PROTEIN:3515978370:paley
COMMENT - DskA amplifies the magnitude of inhibition effects of ppGpp from <i>rrnB</i>p1 and all rRNAP1 promoters |CITS:[15294157][21402902]|. A model reflecting the contribution of DksA under regulation of rRNA expression has been developed |CITS:[15294157]|.
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-1341
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11144
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 21402902:EV-EXP-IMP:3515955600:paley
CITATIONS - 21402902:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515955600:paley
CITATIONS - 21402902:EV-EXP-IDA-PURIFIED-PROTEIN:3515955600:paley
COMMENT - Together ppGpp and DksA can inhibit more strongly the transcription initiation from the ribosomal protein promoter <i>in vitro</i> and <i>in vivo</i> |CITS:[21402902]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM00443
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11143
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515954904:paley
CITATIONS - 15294157:EV-EXP-IDA-PURIFIED-PROTEIN:3515954904:paley
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-1349
REGULATOR - EG10230-MONOMER
//
UNIQUE-ID - REG0-11142
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515954904:paley
CITATIONS - 15294157:EV-EXP-IDA-PURIFIED-PROTEIN:3515954904:paley
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-1347
REGULATOR - EG10230-MONOMER
//
UNIQUE-ID - REG0-11141
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515954904:paley
CITATIONS - 15294157:EV-EXP-IDA-PURIFIED-PROTEIN:3515954904:paley
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-1346
REGULATOR - EG10230-MONOMER
//
UNIQUE-ID - REG0-11140
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515954904:paley
CITATIONS - 15294157:EV-EXP-IDA-PURIFIED-PROTEIN:3515954904:paley
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-1351
REGULATOR - EG10230-MONOMER
//
UNIQUE-ID - REG0-11139
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515954712:paley
CITATIONS - 15294157:EV-EXP-IDA-PURIFIED-PROTEIN:3515954712:paley
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-1343
REGULATOR - EG10230-MONOMER
//
UNIQUE-ID - REG0-11138
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515954572:paley
CITATIONS - 15294157:EV-EXP-IDA-PURIFIED-PROTEIN:3515954572:paley
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM00514
REGULATOR - EG10230-MONOMER
//
UNIQUE-ID - REG0-11137
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515954363:paley
CITATIONS - 15294157:EV-EXP-IDA-PURIFIED-PROTEIN:3515954363:paley
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-1341
REGULATOR - EG10230-MONOMER
//
UNIQUE-ID - REG0-11136
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 19820090:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515954172:paley
CITATIONS - 19820090:EV-EXP-IMP:3515954172:paley
GROWTH-CONDITIONS - exponential phase
MODE - -
REGULATED-ENTITY - PM0-9061
REGULATOR - EG10230-MONOMER
//
UNIQUE-ID - REG0-11135
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 19820090:EV-EXP-IMP:3515954024:paley
CITATIONS - 19820090:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515954024:paley
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-10448
REGULATOR - EG10230-MONOMER
//
UNIQUE-ID - REG0-11134
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 4370496:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515953625:paley
CITATIONS - 4370496:EV-EXP-IMP:3515953625:paley
GROWTH-CONDITIONS - amino acid starvation
MODE - -
REGULATED-ENTITY - PM00167
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11133
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 8650219:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515953499:paley
CITATIONS - 16390452:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515953499:paley
GROWTH-CONDITIONS - amino acid starvation
MODE - -
REGULATED-ENTITY - PM622
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11132
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 20700605:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515953315:paley
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-2523
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11131
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 20700605:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515953193:paley
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-36157
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11130
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 1699940:EV-EXP-IMP:3515953052:paley
CITATIONS - 1699940:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515953052:paley
COMMENT - <i>pyrL</i>p2 (<i>pyrB</i>p2) contains a G+C-rich sequence immediately dowstream of the _10 region that is similar to the discriminator sequence found in stringently controlled promoters |CITS:[1699940]|.
GROWTH-CONDITIONS - stringent conditions
MODE - -
REGULATED-ENTITY - PM00503
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11129
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 16885445:EV-EXP-IMP:3515952765:paley
CITATIONS - 16885445:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3515952848:paley
COMMENT - ppGpp is able to inhibit <i>dusB</i>p (<i>fis</i>p) expression slightly in the absence of DksA |CITS:[15294157]|. However, ppGpp and DksA are required for normal stringent control of <i>dusB</i>p. Both act directly and synergistically to negatively control <i>dusB</i>p transcription <i>in vitro</i> |CITS:[16885445]|.
GROWTH-CONDITIONS - steady-state growth
MODE - -
REGULATED-ENTITY - PM00028
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11128
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IMP:3515952539:paley
COMMENT - ppGpp binds RNA polymerase (RNAP) near the catalytic center in the secondary channel |CITS:[15109491]|. Its binding is proposed to be stabilized by DskA. If the demand for rRNA is low, transcription can be inhibited by high levels of ppGpp or low levels of NTPs. RNAP is a direct target of ppGpp action. There are three proposed mechanisms through which ppGpp binding inhibits rRNA transcription: 1) ppGpp binds with the initiating NTP for the active site, 2) ppGpp pairs with a cytosine residue(s) just upstream of the transcription start site, 3) ppGpp decreases the lifetime of the open complex formed at all rRNA promoters |CITS:[15109491]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-1349
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11127
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IMP:3515952389:paley
COMMENT - ppGpp binds RNA polymerase (RNAP) near the catalytic center in the secondary channel |CITS:[15109491]|. Its binding is proposed to be stabilized by DskA. If the demand for rRNA is low, transcription can be inhibited by high levels of ppGpp or low levels of NTPs. RNAP is a direct target of ppGpp action. There are three proposed mechanisms through which ppGpp binding inhibits rRNA transcription: 1) ppGpp binds with the initiating NTP for the active site, 2) ppGpp pairs with a cytosine residue(s) just upstream of the transcription start site, 3) ppGpp decreases the lifetime of the open complex formed at all rRNA promoters |CITS:[15109491]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-1347
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11126
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IMP:3515952231:paley
COMMENT - ppGpp binds RNA polymerase (RNAP) near the catalytic center in the secondary channel |CITS:[15109491]|. Its binding is proposed to be stabilized by DskA. If the demand for rRNA is low, transcription can be inhibited by high levels of ppGpp or low levels of NTPs. RNAP is a direct target of ppGpp action. There are three proposed mechanisms through which ppGpp binding inhibits rRNA transcription: 1) ppGpp binds with the initiating NTP for the active site, 2) ppGpp pairs with a cytosine residue(s) just upstream of the transcription start site, 3) ppGpp decreases the lifetime of the open complex formed at all rRNA promoters |CITS:[15109491]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-1346
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11125
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IMP:3515952094:paley
COMMENT - ppGpp binds RNA polymerase (RNAP) near the catalytic center in the secondary channel |CITS:[15109491]|. Its binding is proposed to be stabilized by DskA. If the demand for rRNA is low, transcription can be inhibited by high levels of ppGpp or low levels of NTPs. RNAP is a direct target of ppGpp action. There are three proposed mechanisms through which ppGpp binding inhibits rRNA transcription: 1) ppGpp binds with the initiating NTP for the active site, 2) ppGpp pairs with a cytosine residue(s) just upstream of the transcription start site, 3) ppGpp decreases the lifetime of the open complex formed at all rRNA promoters |CITS:[15109491]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-1351
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11124
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IMP:3515951876:paley
COMMENT - ppGpp binds RNA polymerase (RNAP) near the catalytic center in the secondary channel |CITS:[15109491]|. Its binding is proposed to be stabilized by DskA. If the demand for rRNA is low, transcription can be inhibited by high levels of ppGpp or low levels of NTPs. RNAP is a direct target of ppGpp action. There are three proposed mechanisms through which ppGpp binding inhibits rRNA transcription: 1) ppGpp binds with the initiating NTP for the active site, 2) ppGpp pairs with a cytosine residue(s) just upstream of the transcription start site, 3) ppGpp decreases the lifetime of the open complex formed at all rRNA promoters |CITS:[15109491]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-1343
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11123
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IMP:3515951647:paley
COMMENT - ppGpp binds RNA polymerase (RNAP) near the catalytic center in the secondary channel |CITS:[15109491]|. Its binding is proposed to be stabilized by DskA. If the demand for rRNA is low, transcription can be inhibited by high levels of ppGpp or low levels of NTPs. RNAP is a direct target of ppGpp action. There are three proposed mechanisms through which ppGpp binding inhibits rRNA transcription: 1) ppGpp binds with the initiating NTP for the active site, 2) ppGpp pairs with a cytosine residue(s) just upstream of the transcription start site, 3) ppGpp decreases the lifetime of the open complex formed at all rRNA promoters |CITS:[15109491]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM00514
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11122
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15294157:EV-EXP-IMP:3515947078:paley
COMMENT - ppGpp binds RNA polymerase (RNAP) near the catalytic center in the secondary channel |CITS:[15109491]|. Its binding is proposed to be stabilized by DskA. If the demand for rRNA is low, transcription can be inhibited by high levels of ppGpp or low levels of NTPs. RNAP is a direct target of ppGpp action. There are three proposed mechanisms through which ppGpp binding inhibits rRNA transcription: 1) ppGpp binds with the initiating NTP for the active site, 2) ppGpp pairs with a cytosine residue(s) just upstream of the transcription start site, 3) ppGpp decreases the lifetime of the open complex formed at all rRNA promoters |CITS:[15109491]|.
GROWTH-CONDITIONS - amino acid starvation
GROWTH-CONDITIONS - changes in the growth rate
GROWTH-CONDITIONS - stationary phase
MODE - -
REGULATED-ENTITY - PM0-1341
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-11121
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15899978:EV-EXP-IDA-PURIFIED-PROTEIN:3515948491:paley
CITATIONS - 15899978:EV-EXP-IMP:3515946708:paley
CITATIONS - 22200485
GROWTH-CONDITIONS - amino acid starvation
MODE - +
REGULATED-ENTITY - PM00256
REGULATOR - CPLX0-8070
//
UNIQUE-ID - REG0-11120
TYPES - Allosteric-Regulation-of-RNAP
CITATIONS - 15899978:EV-EXP-IMP:3515939878:paley
CITATIONS - 15899978:EV-EXP-IDA-PURIFIED-PROTEIN:3515939878:paley
GROWTH-CONDITIONS - Amino acid starvation
MODE - +
REGULATED-ENTITY - PM00008
REGULATOR - CPLX0-8070
SYNONYMS - Amino acid starvation
//
UNIQUE-ID - REG0-9565
TYPES - Transcriptional-Attenuation
CITATIONS - 6300835
CITATIONS - 7517939
CITATIONS - 7517939:EV-EXP-IDA:3426883044:shearer
CITATIONS - 6300835:EV-EXP-IDA:3426883044:shearer
COMMENT - When UTP is not abundant, the RNA polymerase pauses at the poly-T sequence preceding this terminator. This pause in turn
/lets the ribosome catch up with the polymerase, preventing formation of a terminator and thus blocking premature
/termination. When UTP is abundant, the polymerase does not pause, allowing formation of this terminator and
/premature termination.
MODE - -
REGULATED-ENTITY - TERM0-1081
REGULATOR - UTP
//
UNIQUE-ID - REG0-9248
TYPES - Ribosome-Mediated-Attenuation
CITATIONS - 1709279:EV-EXP-IDA:3407262846:shearer
MODE - -
REGULATED-ENTITY - TERM0-1059
REGULATOR - |Charged-THR-tRNAs|
//
UNIQUE-ID - REG0-9185
TYPES - Ribosome-Mediated-Attenuation
CITATIONS - 372752:EV-EXP:3401821306:shearer
CITATIONS - 6154938:EV-EXP:3401821306:shearer
COMMENT - Valine-based attenuation acts via two pause sites within the first half of the early terminator loop,
/comprising a doublet and a triplet of valine codons. A lack of valine causes ribosomal pausing in this region.
/This pausing then allows formation of an alternate RNA secondary structure that allows continued transcription.
MODE - -
PAUSE-END-POS - 3948395
PAUSE-START-POS - 3948375
REGULATED-ENTITY - TERM0-1054
REGULATOR - |Charged-VAL-tRNAs|
//
UNIQUE-ID - REG0-9084
TYPES - Ribosome-Mediated-Attenuation
CITATIONS - 7038627
CITATIONS - 2409288:EV-EXP-IDA:3406045658:shearer
MODE - -
PAUSE-END-POS - 1321074
PAUSE-START-POS - 1321079
REGULATED-ENTITY - TERM0-1057
REGULATOR - |Charged-TRP-tRNAs|
//
UNIQUE-ID - REG0-9586
TYPES - Ribosome-Mediated-Attenuation
CITATIONS - 6171647:EV-AS-HYPO:3427833643:shearer
COMMENT - Based on the sequence around this area, observed transcription termination <i>in vitro</i>, and demonstrated
/regulation by attenuation of the similar <i>Salmonella</i> operon, this site is presumed to allow regulation by
/attenuation of <i>leuLABCD</I> in response to leucine abundance.
MODE - -
REGULATED-ENTITY - TERM0-1090
REGULATOR - |Charged-LEU-tRNAs|
//
UNIQUE-ID - REG0-9249
TYPES - Ribosome-Mediated-Attenuation
CITATIONS - 1709279:EV-EXP-IDA:3407263069:shearer
MODE - -
REGULATED-ENTITY - TERM0-1059
REGULATOR - |Charged-ILE-tRNAs|
//
UNIQUE-ID - REG0-9186
TYPES - Ribosome-Mediated-Attenuation
CITATIONS - 372752:EV-EXP:3401822972:shearer
CITATIONS - 6154938:EV-EXP:3401822972:shearer
COMMENT - Leucine-based attenuation acts via a doublet of leucine codons within the first half
/of the early terminator loop. A lack of leucine causes ribosomal pausing in this region. This pausing
/then allows formation of an alternate RNA secondary structure that allows continued transcription.
MODE - -
PAUSE-END-POS - 3948359
PAUSE-START-POS - 3948354
REGULATED-ENTITY - TERM0-1054
REGULATOR - |Charged-LEU-tRNAs|
//
UNIQUE-ID - REG0-9088
TYPES - Ribosome-Mediated-Attenuation
MODE - -
REGULATED-ENTITY - PHEM-T3
REGULATOR - |Charged-PHE-tRNAs|
//
UNIQUE-ID - REG0-9250
TYPES - Ribosome-Mediated-Attenuation
COMMENT - This attenuation interaction is presumed to exist based on the presence of <i>ivbL</i> and the terminator |CITS: [6292893]|.
MODE - -
REGULATED-ENTITY - TERM0-1055
REGULATOR - |Charged-LEU-tRNAs|
//
UNIQUE-ID - REG0-9246
TYPES - Ribosome-Mediated-Attenuation
CITATIONS - 6166940:EV-EXP-IDA:3406919571:shearer
MODE - -
PAUSE-END-POS - 2088061
PAUSE-START-POS - 2088041
REGULATED-ENTITY - TERM0-1058
REGULATOR - |Charged-HIS-tRNAs|
//
UNIQUE-ID - REG0-9184
TYPES - Ribosome-Mediated-Attenuation
CITATIONS - 372752:EV-EXP:3401820376:shearer
CITATIONS - 6154938:EV-EXP:3401820376:shearer
COMMENT - Isoleucine-based attenuation acts via a triplet of isoleucine codons within the first half
/of the early terminator loop. A lack of isoleucine causes ribosomal pausing in this region. This pausing
/then allows formation of an alternate RNA secondary structure that allows continued transcription.
MODE - -
PAUSE-END-POS - 3948404
PAUSE-START-POS - 3948396
REGULATED-ENTITY - TERM0-1054
REGULATOR - |Charged-ILE-tRNAs|
//
UNIQUE-ID - REG0-9251
TYPES - Ribosome-Mediated-Attenuation
COMMENT - This attenuation reaction is presumed to exist based on the presence of <i>ivbL</i> and the terminator |CITS: [6292893]|.
MODE - -
REGULATED-ENTITY - TERM0-1055
REGULATOR - |Charged-VAL-tRNAs|
//
UNIQUE-ID - REG0-10780
TYPES - Small-Molecule-Mediated-Attenuation
CITATIONS - 6207018
CITATIONS - 6098450:EV-EXP-IEP:3488130918:keseler
MODE - -
REGULATED-ENTITY - TERM0-1095
REGULATOR - UTP
//
UNIQUE-ID - REG0-11193
TYPES - Small-Molecule-Mediated-Attenuation
CITATIONS - 21665928
CITATIONS - 21665928:EV-EXP-IEP:3517833889:keseler
MODE - -
REGULATED-ENTITY - TU0-8529
REGULATOR - S-ADENOSYLMETHIONINE
//
UNIQUE-ID - REG0-12170
TYPES - Small-Molecule-Mediated-Attenuation
ASSOCIATED-BINDING-SITE - RBS0-176
CITATIONS - 22431636
CITATIONS - 25661987
CITATIONS - 22431636:EV-EXP-IDA:3635768637:keseler
CITATIONS - 25661987:EV-EXP-IDA:3635776775:keseler
COMMENT - FMN stimulates premature transcription termination |CITS: [22431636]|.  Reports differ on whether |CITS: [22431636]| or not |CITS: [25661987]| termination is Rho-dependent.
MODE - -
REGULATED-ENTITY - TERM0-1195
REGULATOR - FMN
//
UNIQUE-ID - REG0-9585
TYPES - Rho-Blocking-Antitermination
CITATIONS - 3902796
CITATIONS - 17293419
CITATIONS - 3902796:EV-EXP-IDA:3427820946:shearer
CITATIONS - 11050101:EV-EXP-IDA:3427820946:shearer
MODE - +
PAUSE-END-POS - 3886536
PAUSE-START-POS - 3886536
REGULATED-ENTITY - TERM0-1089
REGULATOR - TRP
//
UNIQUE-ID - REG0-9567
TYPES - Protein-Mediated-Attenuation
CITATIONS - 2423505
CITATIONS - 2423505:EV-EXP-IDA:3426963906:shearer
MODE - -
REGULATED-ENTITY - TERM0-1082
REGULATOR - EG10845-MONOMER
//
UNIQUE-ID - REG0-12022
TYPES - Protein-Mediated-Attenuation
//
UNIQUE-ID - REG0-9568
TYPES - Protein-Mediated-Attenuation
CITATIONS - 2423505
CITATIONS - 2423505:EV-EXP-IDA:3426963945:shearer
MODE - -
REGULATED-ENTITY - TERM0-1083
REGULATOR - EG10845-MONOMER
//
UNIQUE-ID - REG0-9085
TYPES - Protein-Mediated-Attenuation
CITATIONS - 2846278:EV-EXP-IDA:3406571586:shearer
MODE - +
REGULATED-ENTITY - TERM0344
REGULATOR - CPLX0-8117
//
UNIQUE-ID - REG0-10869
TYPES - Protein-Mediated-Attenuation
CITATIONS - 18713317
CITATIONS - 18713317:EV-EXP-IEP:3500656631:keseler
MODE - -
REGULATED-ENTITY - TU0-13064
REGULATOR - CPLX0-7956
//
UNIQUE-ID - REG0-9241
TYPES - Protein-Mediated-Attenuation
CITATIONS - 2846278:EV-EXP-IDA:3406571742:shearer
MODE - +
REGULATED-ENTITY - TERM0564
REGULATOR - CPLX0-8117
//
UNIQUE-ID - REG0-12021
TYPES - Protein-Mediated-Attenuation
//
UNIQUE-ID - REG0-9455
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3886014
MODE - -
REGULATED-ENTITY - XANPRIBOSYLTRAN-ENZRXN
REGULATOR - CPD-5721
//
UNIQUE-ID - REG0-11772
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6383480
MODE - -
REGULATED-ENTITY - GLYCEROL-3-P-ACYLTRANSFER-ENZRXN
REGULATOR - DIACETYL
//
UNIQUE-ID - REG0-6697
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4945113]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ALDOSE1EPIM-ENZRXN
REGULATOR - MANNOSE
//
UNIQUE-ID - REG0-7288
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2164013]
CITATIONS - [1316760]
COMMENT - Mg++ was the best activator. |CITS: [1316760]| 
MODE - +
REGULATED-ENTITY - PPK-ENZRXN
REGULATOR - MN+2
//
UNIQUE-ID - REG0-7871
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13794771
CITATIONS - 15358357
MODE - -
REGULATED-ENTITY - GLUCUROISOM-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-8493
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7592873
COMMENT - Acyl-ACP most likely inhibits enoyl-ACP reductase through product inhibition.
/|CITS: [8567624]|
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ENOYL-ACP-REDUCT-NADH-ENZRXN
REGULATOR - ACYL-ACP
//
UNIQUE-ID - REG0-10179
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13844669
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - AMYLOMALT-ENZRXN
REGULATOR - CPD0-1667
//
UNIQUE-ID - REG0-9396
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18245280
MODE - -
REGULATED-ENTITY - ENZRXN0-1702
REGULATOR - CO-A
//
UNIQUE-ID - REG0-11743
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21957966
MODE - +
REGULATED-ENTITY - ORNDECARBOXDEG-ENZRXN
REGULATOR - GTP
//
UNIQUE-ID - REG0-6670
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6282821]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ACID-PHOSPHAT-ENZRXN
REGULATOR - |NaF|
//
UNIQUE-ID - REG0-7268
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10572016]
COMMENT - Inactivation occurs by deprotonation of a single ionizable group.
MODE - -
REGULATED-ENTITY - HOMSUCTRAN-ENZRXN
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7844
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4861885
MODE - -
REGULATED-ENTITY - NAG6PDEACET-ENZRXN
REGULATOR - FRUCTOSE-6P
//
UNIQUE-ID - REG0-8472
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15582453
MODE - -
REGULATED-ENTITY - ASPS-ENZRXN
REGULATOR - CPD0-916
//
UNIQUE-ID - REG0-10150
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [2495789]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - CPD0-1584
//
UNIQUE-ID - REG0-9304
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4581499
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - MANNONDEHYDRAT-ENZRXN
REGULATOR - CPD0-1655
//
UNIQUE-ID - REG0-11690
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17167539
MODE - -
REGULATED-ENTITY - ENZRXN0-7445
REGULATOR - CPD-15291
//
UNIQUE-ID - REG0-6649
TYPES - Regulation-of-Enzyme-Activity
COMMENT - Shows competitive inhibition in the fumarate reduction reaction.  |CITS: [10486141]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - FUMARATE-REDN-ENZRXN
REGULATOR - |Ubiquinol-Analogues|
//
UNIQUE-ID - REG0-7231
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [357906]
COMMENT - competitive with PRPP
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ADENPRIBOSYLTRAN-ENZRXN
REGULATOR - MG+2
//
UNIQUE-ID - REG0-7828
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3301828]
COMMENT - inhibits at both substrate sites
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYANLY-ENZRXN
REGULATOR - FORMATE
//
UNIQUE-ID - REG0-8451
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9334229
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - GLYCOPHOSPHORYL-ENZRXN
REGULATOR - PTSH-MONOMER
//
UNIQUE-ID - REG0-10126
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12952
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DAHPSYNPHE-ENZRXN
REGULATOR - CPD0-1555
//
UNIQUE-ID - REG0-9211
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9150206
MODE - NIL
REGULATED-ENTITY - MENF-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-11672
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24449932
MODE - -
REGULATED-ENTITY - ENZRXN0-7682
REGULATOR - CO+2
//
UNIQUE-ID - REG0-6625
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14982633
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6343
REGULATOR - LYS
//
UNIQUE-ID - REG0-7208
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6363415]
MODE - -
REGULATED-ENTITY - DIENOYLCOAREDUCT-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-7812
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1646790
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - LEUAMINOTRANS-ENZRXN
REGULATOR - 2-KETO-ISOVALERATE
//
UNIQUE-ID - REG0-8434
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10500145
MODE - +
REGULATED-ENTITY - ENZRXN0-4441
REGULATOR - HCO3
//
UNIQUE-ID - REG0-10103
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6337635
MODE - -
REGULATED-ENTITY - CHORISMATEMUT2-ENZRXN
REGULATOR - CPD-381
//
UNIQUE-ID - REG0-9187
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8676381
CITATIONS - FESSNER96
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - FUCPALDOL-ENZRXN
REGULATOR - CPD0-1102
//
UNIQUE-ID - REG0-11600
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 23075985
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - TRANS-ENZRXN-305
REGULATOR - |D-Glucose|
//
UNIQUE-ID - REG0-12467
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7012144]
MODE - -
REGULATED-ENTITY - ENZRXN0-8286
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-7185
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6749853
MODE - -
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - PHENYLHYDRAZINE
//
UNIQUE-ID - REG0-7786
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [237196]
MODE - -
REGULATED-ENTITY - RHAMNULPALDOL-ENZRXN
REGULATOR - CPD-8819
//
UNIQUE-ID - REG0-8407
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1915361
COMMENT - with
/respect to fructose 6-phosphate  |CITS: [1915361]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - L-GLN-FRUCT-6-P-AMINOTRANS-ENZRXN
REGULATOR - PYRIDOXAL_PHOSPHATE
//
UNIQUE-ID - REG0-10066
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5327100]
CITATIONS - [5327101]
KI - 1300
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DSERDEAM-ENZRXN
REGULATOR - CPD0-1507
//
UNIQUE-ID - REG0-9137
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7774707
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - TRANS-ENZRXN-130
REGULATOR - CPD-9939
//
UNIQUE-ID - REG0-11559
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7011812
CITATIONS - 4384985
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ENZRXN0-1306
REGULATOR - NADH
//
UNIQUE-ID - REG0-9973
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3081491
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - AGMATIN-ENZRXN
REGULATOR - L-ORNITHINE
//
UNIQUE-ID - REG0-12451
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8265
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7152
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - FUM
//
UNIQUE-ID - REG0-7749
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1577828]
MODE - -
REGULATED-ENTITY - KDOTRANS-ENZRXN
REGULATOR - KDO2-LIPID-IVA
//
UNIQUE-ID - REG0-8385
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4365537
MODE - -
REGULATED-ENTITY - N-ACETYLGLUTPREDUCT-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-10048
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7035170]
MODE - -
REGULATED-ENTITY - GLUTSEMIALDEHYDROG-ENZRXN
REGULATOR - NI+2
//
UNIQUE-ID - REG0-9108
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4580841]
CITATIONS - [374983]
MODE - -
REGULATED-ENTITY - THI-P-SYN-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-11445
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 340460
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6416
REGULATOR - CPD-67
//
UNIQUE-ID - REG0-9916
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7002918
MODE - -
REGULATED-ENTITY - ENZRXN0-4761
REGULATOR - MGCL2
//
UNIQUE-ID - REG0-12435
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8257
REGULATOR - TRIS-HYDROCHLORIDE
//
UNIQUE-ID - REG0-7110
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3071721]
MODE - -
REGULATED-ENTITY - ACETOLACTSYNIII-ENZRXN
REGULATOR - CPD0-1692
//
UNIQUE-ID - REG0-7723
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4893578]
CITATIONS - [4866293]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GSDEADENYLATION-ENZRXN
REGULATOR - GLN
//
UNIQUE-ID - REG0-8367
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [189701]
MODE - -
REGULATED-ENTITY - GMP-SYN-GLUT-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-10028
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12980976
MODE - -
REGULATED-ENTITY - DEOXYRIBOSE-P-ALD-ENZRXN
REGULATOR - CPD0-1476
//
UNIQUE-ID - REG0-9056
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10833389
MODE - +
REGULATED-ENTITY - 1PFRUCTPHOSPHN-ENZRXN
REGULATOR - KCL
//
UNIQUE-ID - REG0-11356
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 372191
CITATIONS - 8120039
MECHANISM - :ALLOSTERIC
MODE - -
REGULATED-ENTITY - PRPPAMIDOTRANS-ENZRXN
REGULATOR - GMP
//
UNIQUE-ID - REG0-9896
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 359325
MODE - -
REGULATED-ENTITY - PSII-ENZRXN
REGULATOR - CPD0-1414
//
UNIQUE-ID - REG0-12389
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19824612
MODE - +
REGULATED-ENTITY - ENZRXN0-6613
REGULATOR - CPLX0-3964
//
UNIQUE-ID - REG0-7091
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1576149
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - INOPHOSPHOR-ENZRXN
REGULATOR - CPD0-1653
//
UNIQUE-ID - REG0-7695
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329757
MODE - -
REGULATED-ENTITY - ICITDEHKINASE-ENZRXN
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-8342
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6463
COMMENT - inhibited both the forward
/and reverse reactions |CITS: [6463]|
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - 3-METHYL-2-OXOBUT-OHCH3XFER-ENZRXN
REGULATOR - PANTOTHENATE
//
UNIQUE-ID - REG0-10010
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4878694]
CITATIONS - [4878695]
MODE - -
REGULATED-ENTITY - GLYCOPHOSPHORYL-ENZRXN
REGULATOR - CPD0-1463
//
UNIQUE-ID - REG0-8973
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8155731
MODE - +
REGULATED-ENTITY - 4OHBENZOATE-OCTAPRENYLTRANSFER-ENZRXN
REGULATOR - CPD0-1088
//
UNIQUE-ID - REG0-11313
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4388614]
CITATIONS - [4388615]
CITATIONS - 7016178
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - MALIC-NADP-ENZRXN
REGULATOR - NADP
//
UNIQUE-ID - REG0-9863
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7929323
MODE - -
REGULATED-ENTITY - RIBONUCLEOSIDE-TRIP-REDUCT-ENZRXN
REGULATOR - CPD0-1391
//
UNIQUE-ID - REG0-12350
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 25655354
MODE - -
REGULATED-ENTITY - PYRIDOXKIN-ENZRXN
REGULATOR - PYRIDOXAL
//
UNIQUE-ID - REG0-7072
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11336655
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - CTPSYN-ENZRXN
REGULATOR - L-GLUTAMATE_GAMMA-SEMIALDEHYDE
//
UNIQUE-ID - REG0-7662
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [380648]
MODE - -
REGULATED-ENTITY - CFA-ENZRXN
REGULATOR - PHMB
//
UNIQUE-ID - REG0-8302
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7918411]
MODE - -
REGULATED-ENTITY - ENZRXN0-803
REGULATOR - NAIR
//
UNIQUE-ID - REG-14666
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1646603]
CITATIONS - 6389524
CREDITS - SRI
CREDITS - |caspi|
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ENZRXN-22535
REGULATOR - PYRUVATE
//
UNIQUE-ID - REG0-8916
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8940025
MODE - +
REGULATED-ENTITY - ENZRXN0-5861
REGULATOR - EDTA
//
UNIQUE-ID - REG0-11293
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1444446
MODE - -
REGULATED-ENTITY - AKBLIG-ENZRXN
REGULATOR - DIACETYL
//
UNIQUE-ID - REG0-9840
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3157043]
CITATIONS - 6351843
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - S-ADENOSYLMETHIONINAMINE
//
UNIQUE-ID - REG0-12307
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - CHEN09WORDJMICRO
CITATIONS - 8226676
MODE - +
REGULATED-ENTITY - ENZRXN0-4502
REGULATOR - MN+2
//
UNIQUE-ID - REG0-7054
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4557653]
MODE - -
REGULATED-ENTITY - GLYCOLATEDEHYDRO-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-7643
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [11488932]
CITATIONS - [3025169]
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - NAD-KIN-ENZRXN
REGULATOR - NADPH
//
UNIQUE-ID - REG0-8281
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3291954
COMMENT - Competitive with respect to isocitrate.  |CITS: [3291954]| 
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ISOCITLYASE-ENZRXN
REGULATOR - OXALATE
//
UNIQUE-ID - REG0-8898
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - HandEnzInh
CITATIONS - 2889829
COMMENT - Exhibits mixed noncompetitive inhibition versus L-glutamate.
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - GLUTAMINESYN-ENZRXN
REGULATOR - CPD0-1650
//
UNIQUE-ID - REG0-11230
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 368067
KI - 1
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - GLYC3PDEHYDROGBIOSYN-ENZRXN
REGULATOR - PALMITYL-COA
//
UNIQUE-ID - REG0-9823
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SUCCINATE-OXN-ENZRXN
REGULATOR - CPD0-1367
//
UNIQUE-ID - REG0-12281
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2201947
KI - 7
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-1625
REGULATOR - ADENOSYL-HOMO-CYS
//
UNIQUE-ID - REG0-7020
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3131312
COMMENT - The activity of the enzyme is strongly
/activated in vitro by monovalent ions. KCl, potassium glutamate, LiCl,
/and NaCl all served as activators.  |CITS: [3131312]|
MODE - +
REGULATED-ENTITY - TREHALOSE6PSYN-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-7616
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4388614]
CITATIONS - [SpinaBiochem193794]
MODE - +
REGULATED-ENTITY - MALIC-NADP-ENZRXN
REGULATOR - AMMONIUM
//
UNIQUE-ID - REG0-8251
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3291856]
MODE - -
REGULATED-ENTITY - ACP-S-ACETYLTRANSFER-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-8843
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12133
KI - 600
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PYRROLINECARBREDUCT-ENZRXN
REGULATOR - NADP
//
UNIQUE-ID - REG0-11045
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4904482
MODE - -
REGULATED-ENTITY - HOMOCYSMET-ENZRXN
REGULATOR - CPD0-1474
//
UNIQUE-ID - REG0-9796
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2188649]
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - PYRUVATEDEH-ENZRXN
REGULATOR - CPD0-1354
//
UNIQUE-ID - REG0-12262
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16569861
MODE - -
REGULATED-ENTITY - ENZRXN0-7969
REGULATOR - CPD-12301
//
UNIQUE-ID - REG0-6996
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [2188649]
MODE - -
REGULATED-ENTITY - PYRUVATEDEH-ENZRXN
REGULATOR - PYRUVATE
//
UNIQUE-ID - REG0-7582
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [346589]
COMMENT - complete inhibition at 2mM, 85% at
/0.5mM
MODE - -
REGULATED-ENTITY - DUTP-PYROP-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-8228
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10739946
COMMENT - The addition of pyruvate increases the degradation rate of
/L-selenocysteine and 3-sulfinoalanine but not L-cysteine.
/ |CITS: [10739946]| 
MODE - +
REGULATED-ENTITY - ENZRXN0-257
REGULATOR - PYRUVATE
//
UNIQUE-ID - REG0-8821
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4992818
MODE - -
REGULATED-ENTITY - D-PPENTOMUT
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-11016
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21467222
MODE - -
REGULATED-ENTITY - ENZRXN0-7454
REGULATOR - CD+2
//
UNIQUE-ID - REG0-9772
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3905407]
MODE - -
REGULATED-ENTITY - UDP-NACMURALGLDAPLIG-ENZRXN
REGULATOR - CPD0-1329
//
UNIQUE-ID - REG0-12245
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14693515
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - CPD-12294
//
UNIQUE-ID - REG0-6961
TYPES - Regulation-of-Enzyme-Activity
COMMENT - competitive with L-ornithine, induces cooperative interactions between subunits of the
/enzyme.  |CITS: [7048313] [KuoPNAS80,3243]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ORNCARBAMTRANSFERI-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7558
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4581499
MODE - +
REGULATED-ENTITY - MANNONDEHYDRAT-ENZRXN
REGULATOR - D-GALACTURONATE
//
UNIQUE-ID - REG0-8194
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [WallenfelsTheEnzymes7-617]
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - ETHANOL-AMINE
//
UNIQUE-ID - REG0-8796
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3122832
MODE - -
REGULATED-ENTITY - NADH-DHI-ENZRXN
REGULATOR - CPD0-1689
//
UNIQUE-ID - REG0-10945
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7492556
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-1641
REGULATOR - FMPP
//
UNIQUE-ID - REG0-9755
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3535805]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - URPHOS-ENZRXN
REGULATOR - |Benzylacylouridines|
//
UNIQUE-ID - REG0-12209
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17567577
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - F16BDEPHOS-ENZRXN
REGULATOR - GLC-6-P
//
UNIQUE-ID - REG0-6937
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11945670
CITATIONS - 4563643
COMMENT - competitive with respect to
/glycerone phosphate |CITS: [4563643] [6093685]|
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - METHGLYSYN-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-7538
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14063305
MODE - -
REGULATED-ENTITY - GMP-SYN-NH3-ENZRXN
REGULATOR - CPD0-1033
//
UNIQUE-ID - REG0-8168
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6349612
COMMENT - An activator only at low Mg<SUP>+2</SUP> and Ca<SUP>+2</SUP> concentrations,
/otherwise it is an inhibitor.  |CITS: [6349612]| 
MODE - +
REGULATED-ENTITY - PEPDEPHOSI-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-8771
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3096379]
CITATIONS - [HandEnzInh]
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ORNDECARBOX-BIO-ENZRXN
REGULATOR - CPD-3728
//
UNIQUE-ID - REG0-10867
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20236319
MODE - -
REGULATED-ENTITY - PHOSACETYLTRANS-ENZRXN
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-9734
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4947657]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - CPD0-1303
//
UNIQUE-ID - REG0-12168
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8836102
MODE - +
REGULATED-ENTITY - F16ALDOLASE-ENZRXN-CLASSII
REGULATOR - AMMONIUM
//
UNIQUE-ID - REG0-6913
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10739481]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - INORGPYROPHOSPHAT-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-7517
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3518793]
MODE - -
REGULATED-ENTITY - THREODEHYD-ENZRXN
REGULATOR - CPD-1486
//
UNIQUE-ID - REG0-8147
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7034777
COMMENT - inhibit the enzyme by competing
/for both the NAD+ and CoA binding sites.  |CITS: [7034777]|
MODE - -
REGULATED-ENTITY - ACETALD-DEHYDROG-ENZRXN
REGULATOR - ADENOSINE_DIPHOSPHATE_RIBOSE
//
UNIQUE-ID - REG0-8746
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [776970]
MODE - -
REGULATED-ENTITY - GLUTAMINB-ENZRXN
REGULATOR - NAD
//
UNIQUE-ID - REG0-10764
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20522491
MODE - +
REGULATED-ENTITY - ENZRXN0-7381
REGULATOR - MN+2
//
UNIQUE-ID - REG0-9716
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - CPD0-1272
//
UNIQUE-ID - REG0-12135
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2139607
MODE - -
REGULATED-ENTITY - NITRATREDUCTZ-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-6893
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7848303
COMMENT - The
/enzyme is sensitive to thiol-blocking reagents.  Activity blocked by
/p-hydroxymercuribenzoate or 5,5'-dithiobis-(2-nitrobenzoate) could be
/restored by addition of dithiothreitol, 2-mercaptoethanol or GSH.
/|CITS: [7848303]|
MODE - -
REGULATED-ENTITY - GLYOXIII-ENZRXN
REGULATOR - DITHIO-NITROBENZOATE
//
UNIQUE-ID - REG0-7500
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9904]
MODE - -
REGULATED-ENTITY - ACETYL-COA-ACETYLTRANSFER-ENZRXN
REGULATOR - ACETOACETYL-COA
//
UNIQUE-ID - REG0-8120
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [MethEnz17A-708]
MODE - -
REGULATED-ENTITY - ASP-SEMIALDEHYDE-DEHYDROGENASE-ENZRXN
REGULATOR - NA+
//
UNIQUE-ID - REG0-8720
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4630409]
MODE - -
REGULATED-ENTITY - GALACTOACETYLTRAN-ENZRXN
REGULATOR - CPD0-1609
//
UNIQUE-ID - REG0-10708
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5332197]
CITATIONS - 12805358
CITATIONS - 20039350
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - DARAB5PISOM-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-9700
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1577828]
MODE - -
REGULATED-ENTITY - KDOTRANS-ENZRXN
REGULATOR - CPD0-1281
//
UNIQUE-ID - REG0-12096
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 25139244
MODE - -
REGULATED-ENTITY - ENZRXN0-7897
REGULATOR - L-CYSTATHIONINE
//
UNIQUE-ID - REG0-6873
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8083170]
COMMENT - weak inhibitor
MODE - -
REGULATED-ENTITY - GLUCOSAMINE1PACETYL-ENZRXN
REGULATOR - NACMUR
//
UNIQUE-ID - REG0-7474
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4229913
MECHANISM - :ALLOSTERIC
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - 6PFRUCTPHOS-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-8093
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10673432
COMMENT - GDP-fucose is competitive with respect to GDP-mannose.
/GDP-L-beta-fucose is the end product of the pathway. 
/GDP-L-alpha-fucose had no inhibitory effect suggesting 
/a specific mechanism of feedback inhibition.
/|CITS: [9257704] [10673432]|
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GDPMANDEHYDRA-ENZRXN
REGULATOR - GUANOSINE_DIPHOSPHATE_FUCOSE
//
UNIQUE-ID - REG0-8692
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [FishMethEnz9-529]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - CPD-377
//
UNIQUE-ID - REG0-10638
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7665468
MODE - -
REGULATED-ENTITY - GUANOSINEKIN-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-9684
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - CPD0-1265
//
UNIQUE-ID - REG0-11998
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 37899
KI - 100
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ARGS-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-6855
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7929099
MODE - -
REGULATED-ENTITY - ENZRXN0-5762
REGULATOR - ADP-D-GLUCOSE
//
UNIQUE-ID - REG0-7450
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14004226
MODE - +
REGULATED-ENTITY - PYROXALTRANSAM-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-8069
TYPES - Regulation-of-Enzyme-Activity
COMMENT - Respiration-linked inactivation requiring the presence of molybdenum
/cofactor.  |CITS: [2182384]|
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - CITLY-ENZRXN
REGULATOR - CPD-8123
//
UNIQUE-ID - REG0-8666
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 779849
MODE - -
REGULATED-ENTITY - ENZRXN0-2142
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-10598
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4552899
MODE - -
REGULATED-ENTITY - CHORISMATEMUT1-ENZRXN
REGULATOR - PREPHENATE
//
UNIQUE-ID - REG0-9664
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - UDP-NACMURALGLDAPAALIG-ENZRXN
REGULATOR - |UDP-NAcMur-Peptides|
//
UNIQUE-ID - REG0-11959
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3908101
KI - 530
MECHANISM - :MIXED
MODE - -
REGULATED-ENTITY - DCYSDESULF-ENZRXN
REGULATOR - CYS
//
UNIQUE-ID - REG0-6833
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [11120740]
MECHANISM - :UNCOMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-285
REGULATOR - GLYCEROL
//
UNIQUE-ID - REG0-7426
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7592346
MODE - -
REGULATED-ENTITY - TRANSALDOLB-ENZRXN
REGULATOR - TRIS
//
UNIQUE-ID - REG0-8043
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12627979
MODE - -
REGULATED-ENTITY - SERINE-O-ACETTRAN-ENZRXN
REGULATOR - L-ALPHA-ALANINE
//
UNIQUE-ID - REG0-8637
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14243758
COMMENT - The inhibitory effect was almost completely reversed by the addition of cysteine. |CITS:[14243758]|
MODE - -
REGULATED-ENTITY - RHAMNISOM-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-10449
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19815542
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CPM-KDOSYNTH-ENZRXN
REGULATOR - CMP
//
UNIQUE-ID - REG0-9642
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [776969]
MODE - +
REGULATED-ENTITY - GLUTAMINB-ENZRXN
REGULATOR - BORATE
//
UNIQUE-ID - REG0-11926
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 22411989
MODE - -
REGULATED-ENTITY - ENZRXN0-3802
REGULATOR - HYDROGEN-PEROXIDE
//
UNIQUE-ID - REG0-6801
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [12147680]
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - ENZRXN0-1105
REGULATOR - EGTA
//
UNIQUE-ID - REG0-7407
TYPES - Regulation-of-Enzyme-Activity
COMMENT - competitive at high concentrations with
/respect to glucose-1-P and vice versa |CITS: [RayJBC239,1228]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PHOSPHOGLUCMUT-ENZRXN
REGULATOR - GLC-1-P
//
UNIQUE-ID - REG0-8009
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7896726
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ASPAMINOTRANS-ENZRXN
REGULATOR - MALEATE
//
UNIQUE-ID - REG0-8607
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3908101
CITATIONS - 11527960
COMMENT - Showed substrate inhibition
/at high concentrations.  |CITS: [3908101]|
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - DCYSDESULF-ENZRXN
REGULATOR - D-CYSTEINE
//
UNIQUE-ID - REG0-10370
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - DIACYLGLYKIN-ENZRXN
REGULATOR - CPD0-1763
//
UNIQUE-ID - REG0-9622
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6102911
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ASP-SEMIALDEHYDE-DEHYDROGENASE-ENZRXN
REGULATOR - CPD0-1224
//
UNIQUE-ID - REG0-11907
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24214977
KI - 71
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7809
REGULATOR - CPD0-2060
//
UNIQUE-ID - REG0-6772
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [13563461]
MODE - -
REGULATED-ENTITY - DGTPTRIPHYDRO-ENZRXN
REGULATOR - GDP
//
UNIQUE-ID - REG0-7384
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 235552
CITATIONS - 11301327
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GTP-CYCLOHYDRO-II-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-7975
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4554913]
MODE - -
REGULATED-ENTITY - THIOESTERII-ENZRXN
REGULATOR - CPD0-1625
//
UNIQUE-ID - REG0-8570
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - MALEATE
//
UNIQUE-ID - REG0-10278
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8941345
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6633
REGULATOR - 5-P-NITROPHENYLTHIOADENOSINE
//
UNIQUE-ID - REG0-9559
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4291828
MODE - +
REGULATED-ENTITY - NICONUCADENYLYLTRAN-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-11834
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15489502
MODE - -
REGULATED-ENTITY - ENZRXN0-5221
REGULATOR - TTP
//
UNIQUE-ID - REG0-6739
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :ALLOSTERIC
MODE - -
REGULATED-ENTITY - CITSYN-ENZRXN
REGULATOR - OXALACETIC_ACID
//
UNIQUE-ID - REG0-7368
TYPES - Regulation-of-Enzyme-Activity
COMMENT - The vanadate inhibition is enhanced by phenol.  |CITS: [3280015]| 
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ALKAPHOSPHA-ENZRXN
REGULATOR - CPD-4584
//
UNIQUE-ID - REG0-7926
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7559576]
COMMENT - Apo-ACP shows substrate inhibition. This inhibition can
/be overcome by high concentrations of NaCl. The effect
/is due to the Na<SUP>+</SUP> cation rather than the
/Cl<SUP>-</SUP> anion.  |CITS: [10625633]| 
MODE - -
REGULATED-ENTITY - HOLO-ACP-SYNTH-ENZRXN
REGULATOR - EG50003-MONOMER
//
UNIQUE-ID - REG0-8536
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10600526
COMMENT - Competitive with respect to ATP.  |CITS: [10600526]| 
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - BIOTIN-CARBOXYL-ENZRXN
REGULATOR - CPD-764
//
UNIQUE-ID - REG0-10244
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2194570]
MODE - -
REGULATED-ENTITY - BADH-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-9507
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12119303
MODE - -
REGULATED-ENTITY - ENZRXN0-6535
REGULATOR - CPD-4584
//
UNIQUE-ID - REG0-11798
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19460094
KI - 44
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6592
REGULATOR - C-DI-GMP
//
UNIQUE-ID - REG0-6717
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6365902]
CITATIONS - 359547
MODE - -
REGULATED-ENTITY - AMINOPROPDEHYDROG-ENZRXN
REGULATOR - MN+2
//
UNIQUE-ID - REG0-7342
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 213023
CITATIONS - 16460038
COMMENT - 30% inhibition  |CITS: [213023]|
MODE - -
REGULATED-ENTITY - SUPEROX-DISMUTMN-ENZRXN
REGULATOR - CPD-2841
//
UNIQUE-ID - REG0-7897
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6305942]
COMMENT - 40% inhibition at 1 mM
MODE - -
REGULATED-ENTITY - XANPRIBOSYLTRAN-ENZRXN
REGULATOR - IMP
//
UNIQUE-ID - REG0-8515
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6988389
MODE - -
REGULATED-ENTITY - KDO-8PSYNTH-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-10211
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2007545
MODE - -
REGULATED-ENTITY - 7-ALPHA-HYDROXYSTEROID-DEH-ENZRXN
REGULATOR - CPD0-1695
//
UNIQUE-ID - REG0-10206
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6368527
MODE - +
REGULATED-ENTITY - PEPCARBOX-ENZRXN
REGULATOR - CPD0-1682
//
UNIQUE-ID - REG0-9438
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6338013
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - CHORISMATEMUT1-ENZRXN
REGULATOR - TYR
//
UNIQUE-ID - REG0-11769
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6383480
MECHANISM - :MIXED
MODE - -
REGULATED-ENTITY - GLYCEROL-3-P-ACYLTRANSFER-ENZRXN
REGULATOR - CPD0-2099
//
UNIQUE-ID - REG0-6694
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3117785]
MODE - -
REGULATED-ENTITY - AKBLIG-ENZRXN
REGULATOR - CD+2
//
UNIQUE-ID - REG0-7284
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2164013]
MODE - -
REGULATED-ENTITY - PPK-ENZRXN
REGULATOR - KCL
//
UNIQUE-ID - REG0-7868
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13794771
MODE - -
REGULATED-ENTITY - GLUCUROISOM-ENZRXN
REGULATOR - CYS
//
UNIQUE-ID - REG0-8488
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3519603
MODE - -
REGULATED-ENTITY - FPPSYN-ENZRXN
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-10170
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - HANDENZINH
CITATIONS - 3291954
MODE - -
REGULATED-ENTITY - ISOCITLYASE-ENZRXN
REGULATOR - DITHIO-NITROBENZOATE
//
UNIQUE-ID - REG0-9345
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - NIL
REGULATED-ENTITY - ENOYL-COA-DELTA-ISOM-ENZRXN
REGULATOR - TRIS-HYDROCHLORIDE
//
UNIQUE-ID - REG0-11740
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21957966
MODE - +
REGULATED-ENTITY - ORNDECARBOXDEG-ENZRXN
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-6664
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2007545
MODE - -
REGULATED-ENTITY - 7-ALPHA-HYDROXYSTEROID-DEH-ENZRXN
REGULATOR - DIETHYLPYROCARBONATE
//
UNIQUE-ID - REG0-7841
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4337557]
MODE - -
REGULATED-ENTITY - ENTF-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-8469
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4362677]
MODE - -
REGULATED-ENTITY - H2NEOPTERINP3PYROPHOSPHOHYDRO-ENZRXN
REGULATOR - TTP
//
UNIQUE-ID - REG0-10147
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6363415
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIENOYLCOAREDUCT-ENZRXN
REGULATOR - T2-C4-DECADIENYL-COA
//
UNIQUE-ID - REG0-9301
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4351435]
CITATIONS - [195622]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - MANNONOXIDOREDUCT-ENZRXN
REGULATOR - NAD
//
UNIQUE-ID - REG0-11687
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16540431
MODE - -
REGULATED-ENTITY - ENZRXN0-7445
REGULATOR - CAFFEOYLQUINATE
//
UNIQUE-ID - REG0-6645
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3298234
MODE - +
REGULATED-ENTITY - ENZRXN0-6244
REGULATOR - AMMONIUM
//
UNIQUE-ID - REG0-7228
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4328693
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ADENPRIBOSYLTRAN-ENZRXN
REGULATOR - |Ribonucleoside-Triphosphates|
//
UNIQUE-ID - REG0-7825
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3301828]
COMMENT - inhibits at both substrate sites
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYANLY-ENZRXN
REGULATOR - BR-
//
UNIQUE-ID - REG0-8447
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4878694]
CITATIONS - [4878695]
MODE - -
REGULATED-ENTITY - GLYCOPHOSPHORYL-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-10123
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1646603]
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ACNEULY-ENZRXN
REGULATOR - CPD0-1551
//
UNIQUE-ID - REG0-9207
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3308886
MODE - -
REGULATED-ENTITY - GLYCOLALD-DEHYDROG-ENZRXN
REGULATOR - GLYCOLALDEHYDE
//
UNIQUE-ID - REG0-11669
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13844669
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - AMYLOMALT-ENZRXN
REGULATOR - CPD-3582
//
UNIQUE-ID - REG0-6621
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3516220
MODE - -
REGULATED-ENTITY - ENZRXN0-6375
REGULATOR - CPD0-1354
//
UNIQUE-ID - REG0-7200
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6991069]
MODE - -
REGULATED-ENTITY - PEPCARBOXYKIN-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-7804
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [350870]
MODE - -
REGULATED-ENTITY - METHYLENETHFDEHYDROG-NADP-ENZRXN
REGULATOR - GTP
//
UNIQUE-ID - REG0-8431
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [369600]
MODE - +
REGULATED-ENTITY - DLACTDEHYDROGFAD-ENZRXN
REGULATOR - |Phospholipids|
//
UNIQUE-ID - REG0-10081
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12886052
MODE - -
REGULATED-ENTITY - ENZRXN0-6573
REGULATOR - faropenem
//
UNIQUE-ID - REG0-9179
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4616949
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - ENZRXN0-6440
REGULATOR - HCN
//
UNIQUE-ID - REG0-11597
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 22984449
MODE - -
REGULATED-ENTITY - ENZRXN0-7608
REGULATOR - CA+2
//
UNIQUE-ID - REG0-12464
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - -
REGULATED-ENTITY - ENZRXN0-8285
REGULATOR - TRIS
//
UNIQUE-ID - REG0-7169
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3910996]
MODE - +
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - F
//
UNIQUE-ID - REG0-7782
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4975916
COMMENT - strictly competitive with K+.
/|CITS: [4975916]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - RHAMNULPALDOL-ENZRXN
REGULATOR - LI+
//
UNIQUE-ID - REG0-8401
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13658662
COMMENT - These are
/inhibitors of glucokinase from strain E. coli A.  |CITS:
/[13658662]|
MODE - -
REGULATED-ENTITY - GLUCOKIN-ENZRXN
REGULATOR - GLUCOSAMINE
//
UNIQUE-ID - REG0-10063
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [FishMethEnz9-529]
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - |Tetraric-Acids|
//
UNIQUE-ID - REG0-9131
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7547881
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - L-GLN-FRUCT-6-P-AMINOTRANS-ENZRXN
REGULATOR - CPD-280
//
UNIQUE-ID - REG0-11546
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11825618
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CHORPYRLY-ENZRXN
REGULATOR - 4-HYDROXYBENZALDEHYDE
//
UNIQUE-ID - REG0-9969
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4571773
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ARGDECARBOXBIO-ENZRXN
REGULATOR - PUTRESCINE
//
UNIQUE-ID - REG0-12448
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8264
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7138
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - CPD-183
//
UNIQUE-ID - REG0-7746
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3149742
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUTDEHYD-ENZRXN
REGULATOR - D-GLT
//
UNIQUE-ID - REG0-8381
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5333666]
MODE - +
REGULATED-ENTITY - GUANYL-KIN-ENZRXN
REGULATOR - AMMONIUM
//
UNIQUE-ID - REG0-10043
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1033766]
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - IMP-DEHYDROG-ENZRXN
REGULATOR - CPD0-1492
//
UNIQUE-ID - REG0-9105
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4580841]
CITATIONS - [374983]
MODE - -
REGULATED-ENTITY - THI-P-SYN-ENZRXN
REGULATOR - GTP
//
UNIQUE-ID - REG0-11410
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8909293
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - FUMARC-ENZRXN
REGULATOR - CIT
//
UNIQUE-ID - REG0-9913
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1391
MODE - -
REGULATED-ENTITY - ENZRXN0-4761
REGULATOR - CEPHALOSPORIN-C
//
UNIQUE-ID - REG0-12432
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8256
REGULATOR - TRIS-HYDROCHLORIDE
//
UNIQUE-ID - REG0-7107
TYPES - Regulation-of-Enzyme-Activity
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ACETOLACTSYNIII-ENZRXN
REGULATOR - LEU
//
UNIQUE-ID - REG0-7720
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4365537]
MODE - -
REGULATED-ENTITY - ARGSUCCINLYA-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-8364
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9890911
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GMP-SYN-GLUT-ENZRXN
REGULATOR - CPD0-1035
//
UNIQUE-ID - REG0-10024
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4904482
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - HOMOCYSMET-ENZRXN
REGULATOR - CPD0-1473
//
UNIQUE-ID - REG0-9025
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14245401
COMMENT - inhibited strongly |CITS: [14245401]|
MODE - -
REGULATED-ENTITY - THIOREDOXIN-REDUCT-NADPH-ENZRXN
REGULATOR - CPD-7388
//
UNIQUE-ID - REG0-11348
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10601247
KI - 35
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DSERDEAM-ENZRXN
REGULATOR - |23-Diaminopropanoate|
//
UNIQUE-ID - REG0-9893
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [355248]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PROLDEHYDROG-ENZRXN
REGULATOR - CPD0-1104
//
UNIQUE-ID - REG0-12382
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18714089
KI - 37
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - MALATESYN-ENZRXN
REGULATOR - OXALATE
//
UNIQUE-ID - REG0-7088
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15857829
CITATIONS - [7711027]
KI - 154
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - UMPKI-ENZRXN
REGULATOR - UTP
//
UNIQUE-ID - REG0-7691
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329757
MODE - -
REGULATED-ENTITY - ICITDEHKINASE-ENZRXN
REGULATOR - NADP
//
UNIQUE-ID - REG0-8339
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6463
COMMENT - inhibited the forward reaction  |CITS:
/[6463]|
MODE - -
REGULATED-ENTITY - 3-METHYL-2-OXOBUT-OHCH3XFER-ENZRXN
REGULATOR - PYRUVATE
//
UNIQUE-ID - REG0-10004
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17018556
MODE - -
REGULATED-ENTITY - ENZRXN0-6272
REGULATOR - CPD0-1455
//
UNIQUE-ID - REG0-8970
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8290655
MODE - -
REGULATED-ENTITY - ASPARTATEKINIII-ENZRXN
REGULATOR - LEU
//
UNIQUE-ID - REG0-11309
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17557829
MODE - +
REGULATED-ENTITY - MALIC-NADP-ENZRXN
REGULATOR - L-ASPARTATE
//
UNIQUE-ID - REG0-9859
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [WallenfelsTheEnzymes7-617]
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - |Chelators|
//
UNIQUE-ID - REG0-12347
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 25139244
MODE - +
REGULATED-ENTITY - ENZRXN0-7897
REGULATOR - D-CYSTEINE
//
UNIQUE-ID - REG0-7069
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1303749
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - CTPSYN-ENZRXN
REGULATOR - CPD0-1038
//
UNIQUE-ID - REG0-7659
TYPES - Regulation-of-Enzyme-Activity
COMMENT - An antifungal drug.
MODE - -
REGULATED-ENTITY - CFA-ENZRXN
REGULATOR - CPD0-1631
//
UNIQUE-ID - REG0-8298
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 342522
MODE - +
REGULATED-ENTITY - ENZRXN0-5101
REGULATOR - AMMONIUM
//
UNIQUE-ID - REG-14663
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1646603]
CITATIONS - 6389524
CREDITS - SRI
CREDITS - |caspi|
MODE - -
REGULATED-ENTITY - ENZRXN-22535
REGULATOR - N-BROMOSUCCINIMIDE
//
UNIQUE-ID - REG0-8913
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3013841
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - GLUC1PADENYLTRANS-ENZRXN
REGULATOR - CPD0-967
//
UNIQUE-ID - REG0-11290
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1444446
MODE - -
REGULATED-ENTITY - AKBLIG-ENZRXN
REGULATOR - CPD-13890
//
UNIQUE-ID - REG0-9836
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4934072
CITATIONS - 16054140
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SERS-ENZRXN
REGULATOR - CPD0-1378
//
UNIQUE-ID - REG0-12303
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19558329
MODE - -
REGULATED-ENTITY - ENZRXN0-4502
REGULATOR - CPD0-2067
//
UNIQUE-ID - REG0-7047
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 46
COMMENT - KCl is a better inhibitor than
/NaCl.  |CITS: [46]|
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - NA+
//
UNIQUE-ID - REG0-7632
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3297044
COMMENT - irreversible inhibitor  |CITS: [3297044] [HandEnzInh]|
MODE - -
REGULATED-ENTITY - ARGDECARBOXBIO-ENZRXN
REGULATOR - CPD0-1659
//
UNIQUE-ID - REG0-8277
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8494895]
MODE - -
REGULATED-ENTITY - GLUTAMIDOTRANS-ENZRXN
REGULATOR - MN+2
//
UNIQUE-ID - REG0-8868
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - 4OH2OXOGLUTARALDOL-ENZRXN
REGULATOR - IODOACETATE
//
UNIQUE-ID - REG0-11227
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3512553
MODE - -
REGULATED-ENTITY - GLYOHMETRANS-ENZRXN
REGULATOR - D-ALANINE
//
UNIQUE-ID - REG0-9819
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7034777]
MODE - +
REGULATED-ENTITY - ACETALD-DEHYDROG-ENZRXN
REGULATOR - CPD0-1364
//
UNIQUE-ID - REG0-12275
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21764913
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - NACMURLALAAMI1-ENZRXN
REGULATOR - EG12297-MONOMER
//
UNIQUE-ID - REG0-7014
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 361681
MODE - -
REGULATED-ENTITY - TYRAMINOTRANS-ENZRXN
REGULATOR - LEU
//
UNIQUE-ID - REG0-7611
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4388614]
CITATIONS - [4388615]
CITATIONS - 17557829
MECHANISM - :ALLOSTERIC
MODE - -
REGULATED-ENTITY - MALIC-NADP-ENZRXN
REGULATOR - OXALACETIC_ACID
//
UNIQUE-ID - REG0-8247
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12639950
COMMENT - Ba++, Zn++, and Mn++ stimulated
/the reaction to a lesser extent.   |CITS: [6246070]|
MODE - +
REGULATED-ENTITY - KDO-8PPHOSPHAT-ENZRXN
REGULATOR - CO+2
//
UNIQUE-ID - REG0-8840
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5337593
COMMENT - competitive with the substrate |CITS: [5337593]|
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - UDPSUGARHYDRO-ENZRXN
REGULATOR - CDP-D-GLUCOSE
//
UNIQUE-ID - REG0-11042
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20014435
KI - 1.9    
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYSTATHIONINE-BETA-LYASE-ENZRXN
REGULATOR - CPD-13353
//
UNIQUE-ID - REG0-9792
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2188649]
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - PYRUVATEDEH-ENZRXN
REGULATOR - CPD0-1352
//
UNIQUE-ID - REG0-12259
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7001458
MODE - -
REGULATED-ENTITY - ENZRXN0-7969
REGULATOR - CPD-12245
//
UNIQUE-ID - REG0-6990
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7005225
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PYRUVATEDEH-ENZRXN
REGULATOR - 3-BROMOPYRUVATE
//
UNIQUE-ID - REG0-7579
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7961955]
MODE - +
REGULATED-ENTITY - LYXK-ENZRXN
REGULATOR - GLUTATHIONE
//
UNIQUE-ID - REG0-8221
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4921568
COMMENT - ADP is competitive with ATP.
/|CITS: [4921568]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DETHIOBIOTIN-SYN-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-8818
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4992818
MODE - -
REGULATED-ENTITY - D-PPENTOMUT
REGULATOR - SULFATE
//
UNIQUE-ID - REG0-11013
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3157043]
CITATIONS - 6351843
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - CPD0-1397
//
UNIQUE-ID - REG0-9769
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3513846
CITATIONS - YATAVK12
KI - 13
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - URACIL-PRIBOSYLTRANS-ENZRXN
REGULATOR - CPD0-1327
//
UNIQUE-ID - REG0-12242
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14693515
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - CPD0-2069
//
UNIQUE-ID - REG0-6950
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16890
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - N-ACETYLTRANSFER-ENZRXN
REGULATOR - ARG
//
UNIQUE-ID - REG0-7553
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4581499]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - MANNONDEHYDRAT-ENZRXN
REGULATOR - SORBITOL
//
UNIQUE-ID - REG0-8184
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [SaikusaAgBioChem51-1893]
MODE - +
REGULATED-ENTITY - METHYLGLYREDUCT-ENZRXN
REGULATOR - GLUTATHIONE
//
UNIQUE-ID - REG0-8790
TYPES - Regulation-of-Enzyme-Activity
COMMENT - Acyl-ACP was competitive with respect to malonyl-ACP. |CITS: [8631920]|
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - 3-OXOACYL-ACP-COA-SYNTHIII-ENZRXN
REGULATOR - ACYL-ACP
//
UNIQUE-ID - REG0-10942
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9055203
MODE - -
REGULATED-ENTITY - ENZRXN0-1641
REGULATOR - DITHIO-NITROBENZOATE
//
UNIQUE-ID - REG0-9751
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2186813
MODE - -
REGULATED-ENTITY - UDPGLUCEPIM-ENZRXN
REGULATOR - CPD0-1315
//
UNIQUE-ID - REG0-12185
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17306798
MODE - +
REGULATED-ENTITY - ENZRXN0-5803
REGULATOR - GLUCOSE-16-DIPHOSPHATE
//
UNIQUE-ID - REG0-6934
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6349639]
CITATIONS - 9339543
MODE - -
REGULATED-ENTITY - LDC2-ENZRXN
REGULATOR - PUTRESCINE
//
UNIQUE-ID - REG0-7531
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - CHEN09WORDJMICRO
CITATIONS - 8226676
MODE - -
REGULATED-ENTITY - ENZRXN0-4502
REGULATOR - NI+2
//
UNIQUE-ID - REG0-8165
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2653362
CITATIONS - 4588693
COMMENT - high concentrations of Mg+2 and ADP |CITS:[2653362]|
MODE - -
REGULATED-ENTITY - PEPDEPHOSI-ENZRXN
REGULATOR - SUC-COA
//
UNIQUE-ID - REG0-8768
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [15587]
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ORNDECARBOX-BIO-ENZRXN
REGULATOR - PUTRESCINE
//
UNIQUE-ID - REG0-10864
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21046341
MODE - +
REGULATED-ENTITY - ENZRXN0-7425
REGULATOR - PYRUVATE
//
UNIQUE-ID - REG0-9731
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6811114]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - CPD0-1299
//
UNIQUE-ID - REG0-12165
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 348198
MODE - +
REGULATED-ENTITY - F16ALDOLASE-ENZRXN-CLASSI
REGULATOR - 2-KETOGLUTARATE
//
UNIQUE-ID - REG0-6907
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4094]
COMMENT - The activity of adenyltransferase is
/modulated by a small regulatory protin, PII, which can also undergo
/reversible covalent modification. Stimulated by PIIA (the unmodified
/form of PII), adenylyltransferase carries out the adenylylation of
/glutamine synthetase, whereas in the presence of PIID (the
/uridylylated form of PII), ATase catalyzes the deadenylylation.
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GSADENYLATION-ENZRXN
REGULATOR - PROTEIN-PII
//
UNIQUE-ID - REG0-7514
TYPES - Regulation-of-Enzyme-Activity
COMMENT - exhibits mixed
/noncompetitive inhibition  |CITS: [3056527]|
MODE - -
REGULATED-ENTITY - THREODEHYD-ENZRXN
REGULATOR - 2-MERCAPTOETHANOL
//
UNIQUE-ID - REG0-8142
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3516690]
MODE - -
REGULATED-ENTITY - FORMHYDROG2-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-8743
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [776970]
MODE - -
REGULATED-ENTITY - GLUTAMINB-ENZRXN
REGULATOR - NADPH
//
UNIQUE-ID - REG0-10747
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19261245
MODE - -
REGULATED-ENTITY - NADH-DHI-ENZRXN
REGULATOR - CPD0-2356
//
UNIQUE-ID - REG0-9713
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - CPD0-1262
//
UNIQUE-ID - REG0-12132
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24338017
MODE - +
REGULATED-ENTITY - PFLACTENZ-ENZRXN
REGULATOR - PYRUVATE
//
UNIQUE-ID - REG0-6886
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [40950]
COMMENT - for the reaction in both directions
MODE - +
REGULATED-ENTITY - GLYCDEH-ENZRXN
REGULATOR - AMMONIUM
//
UNIQUE-ID - REG0-7497
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4861610]
CITATIONS - [357898]
COMMENT - at high concentrations
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - THYKI-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-8116
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14726201
MODE - -
REGULATED-ENTITY - ASP-SEMIALDEHYDE-DEHYDROGENASE-ENZRXN
REGULATOR - CYSTINE
//
UNIQUE-ID - REG0-8717
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7040602
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - THREDEHYDSYN-ENZRXN
REGULATOR - VAL
//
UNIQUE-ID - REG0-10704
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3072022
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - ORNCARBAMTRANSFERI-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-9697
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1577828]
MODE - -
REGULATED-ENTITY - KDOTRANS-ENZRXN
REGULATOR - BISOHMYR-GLC
//
UNIQUE-ID - REG0-12034
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3934143
MODE - -
REGULATED-ENTITY - VALINE-PYRUVATE-AMINOTRANSFER-ENZRXN
REGULATOR - CHLORALAN-CPD
//
UNIQUE-ID - REG0-6870
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8083170]
COMMENT - potent inhibitor
MODE - -
REGULATED-ENTITY - GLUCOSAMINE1PACETYL-ENZRXN
REGULATOR - UDP-N-ACETYLMURAMATE
//
UNIQUE-ID - REG0-7466
TYPES - Regulation-of-Enzyme-Activity
MODE - +
REGULATED-ENTITY - ASPARTASE-ENZRXN
REGULATOR - CPD-302
//
UNIQUE-ID - REG0-8090
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1628835]
MODE - +
REGULATED-ENTITY - ACETYLORNDEACET-ENZRXN
REGULATOR - GLUTATHIONE
//
UNIQUE-ID - REG0-8689
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12374823
MODE - +
REGULATED-ENTITY - ENZRXN0-2041
REGULATOR - HCN
//
UNIQUE-ID - REG0-10635
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1107044
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-3381
REGULATOR - CPD-12164
//
UNIQUE-ID - REG0-9681
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - CPD0-1263
//
UNIQUE-ID - REG0-11974
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 193572
MODE - +
REGULATED-ENTITY - PEPDEPHOSII-ENZRXN
REGULATOR - |Glucose-6-phosphate|
//
UNIQUE-ID - REG0-6852
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2118386
COMMENT - competitive with respect to NADH |CITS: [2118386]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-4721
REGULATOR - DICOUMAROL
//
UNIQUE-ID - REG0-7447
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14004226
COMMENT - inhibits the initial rate of transamination
MODE - -
REGULATED-ENTITY - PYROXALTRANSAM-ENZRXN
REGULATOR - L-ASPARTATE
//
UNIQUE-ID - REG0-8065
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10480878
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6061
REGULATOR - GUANOSINE_DIPHOSPHATE_FUCOSE
//
UNIQUE-ID - REG0-8659
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3027079
MODE - +
REGULATED-ENTITY - TETRAACYLDISACC4KIN-ENZRXN
REGULATOR - CARDIOLIPIN
//
UNIQUE-ID - REG0-10571
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 210911
MODE - -
REGULATED-ENTITY - PEPSYNTH-ENZRXN
REGULATOR - OXALATE
//
UNIQUE-ID - REG0-9661
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1967948]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTAMINESYN-ENZRXN
REGULATOR - CPD-9035
//
UNIQUE-ID - REG0-11956
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3908101
MODE - -
REGULATED-ENTITY - ALADEHYDCHLORO-ENZRXN
REGULATOR - CPD-7702
//
UNIQUE-ID - REG0-6827
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3888977
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-2710
REGULATOR - GLOBOMYCIN
//
UNIQUE-ID - REG0-7423
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7592346
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - TRANSALDOLB-ENZRXN
REGULATOR - L-GLYCERALDEHYDE
//
UNIQUE-ID - REG0-8038
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 348236
MODE - -
REGULATED-ENTITY - PREPHENATEDEHYDRAT-ENZRXN
REGULATOR - CHORISMATE
//
UNIQUE-ID - REG0-8631
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4591623
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - HISS-ENZRXN
REGULATOR - HISTIDINOL
//
UNIQUE-ID - REG0-10414
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 391265
CITATIONS - 229891
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - UDPGLUCEPIM-ENZRXN
REGULATOR - CPD0-1326
//
UNIQUE-ID - REG0-9637
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3132968
CITATIONS - [2111163]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - L-GLN-FRUCT-6-P-AMINOTRANS-ENZRXN
REGULATOR - CPD0-1236
//
UNIQUE-ID - REG0-11920
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24214977
KI - 370
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7337
REGULATOR - HYPOXANTHINE
//
UNIQUE-ID - REG0-6792
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9287300]
MODE - -
REGULATED-ENTITY - ENZRXN-203
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7404
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3294837]
COMMENT - Cerulenin and thiolactomycin are antibiotics
MODE - -
REGULATED-ENTITY - 3-OXOACYL-ACP-SYNTHII-ENZRXN
REGULATOR - CPD-6901
//
UNIQUE-ID - REG0-7989
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7868604]
MODE - +
REGULATED-ENTITY - FORMYLTHFDEFORMYL-ENZRXN
REGULATOR - MET
//
UNIQUE-ID - REG0-8593
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7033218
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - L-ASPARTATE-OXID-ENZRXN
REGULATOR - CPD-8829
//
UNIQUE-ID - REG0-10366
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - DIACYLGLYKIN-ENZRXN
REGULATOR - CPD0-1811
//
UNIQUE-ID - REG0-9616
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [40956]
MODE - -
REGULATED-ENTITY - LACTALDREDUCT-ENZRXN
REGULATOR - CPD0-1223
//
UNIQUE-ID - REG0-11889
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24210219
MODE - -
REGULATED-ENTITY - ENZRXN0-7799
REGULATOR - GTP
//
UNIQUE-ID - REG0-6765
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1993184]
KI - 8.9    
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DALADALALIGA-ENZRXN
REGULATOR - CPD-2482
//
UNIQUE-ID - REG0-7381
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [189806]
CITATIONS - [4358555]
MECHANISM - :ALLOSTERIC
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - CARBPSYN-ENZRXN
REGULATOR - IMP
//
UNIQUE-ID - REG0-7968
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2185038
MODE - +
REGULATED-ENTITY - GST-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-8566
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - PHTHALATE
//
UNIQUE-ID - REG0-10270
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329756
MODE - +
REGULATED-ENTITY - ICITDEHDEPHOSPH-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-9549
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8561507
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - QUINOPRIBOTRANS-ENZRXN
REGULATOR - PHTHALATE
//
UNIQUE-ID - REG0-11830
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 23844911
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7782
REGULATOR - FORMATE
//
UNIQUE-ID - REG0-6736
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - CITSYN-ENZRXN
REGULATOR - 2-KETOGLUTARATE
//
UNIQUE-ID - REG0-7365
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3280015]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ALKAPHOSPHA-ENZRXN
REGULATOR - TUNGSTATE
//
UNIQUE-ID - REG0-7923
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4290215]
COMMENT - Shows slight inhibition.
MODE - -
REGULATED-ENTITY - NAD-SYNTH-NH3-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-8533
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8060125]
MODE - -
REGULATED-ENTITY - CROBETREDUCT-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-10240
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 779849
MODE - -
REGULATED-ENTITY - ENZRXN0-2142
REGULATOR - HG+2
//
UNIQUE-ID - REG0-9499
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18459799
MODE - -
REGULATED-ENTITY - ENZRXN0-2801
REGULATOR - MN+2
//
UNIQUE-ID - REG0-11788
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 381306
MODE - +
REGULATED-ENTITY - UDPMANNACADEHYDROG-ENZRXN
REGULATOR - AMMONIUM
//
UNIQUE-ID - REG0-6714
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6365902]
COMMENT - completely blocked activity
MODE - -
REGULATED-ENTITY - AMINOPROPDEHYDROG-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-7333
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13844669
MODE - -
REGULATED-ENTITY - AMYLOMALT-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-7894
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7929317]
COMMENT - for CTP and UTP reduction
MECHANISM - :ALLOSTERIC
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - RIBONUCLEOSIDE-TRIP-REDUCT-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-8512
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6988389
COMMENT - with respect
/to D-arabinose-5-phosphate  |CITS: [6988389]|
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - KDO-8PSYNTH-ENZRXN
REGULATOR - RIBOSE-5P
//
UNIQUE-ID - REG0-7891
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1460049
COMMENT - in high concentrations |CITS: [1460049]|
MODE - -
REGULATED-ENTITY - RIBONUCLEOSIDE-TRIP-REDUCT-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-8508
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2856144]
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - CYT-O-UBIOX-ENZRXN
REGULATOR - HYDROXYLAMINE
//
UNIQUE-ID - REG0-10202
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2194570
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - BADH-ENZRXN
REGULATOR - CPD-7031
//
UNIQUE-ID - REG0-9435
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18328504
MODE - -
REGULATED-ENTITY - ENZRXN0-6517
REGULATOR - ATP
//
UNIQUE-ID - REG0-6691
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3117785]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - AKBLIG-ENZRXN
REGULATOR - GLUTATHIONE
//
UNIQUE-ID - REG0-7281
TYPES - Regulation-of-Enzyme-Activity
COMMENT - Pyrophosphate is competitive with ATP. It inhibits
/polyphosphate synthesis and the NDK reaction but
/stimulates ppppG synthesis.  |CITS: [2164013] [10660553]| 
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PPK-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-7863
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8155731
MODE - -
REGULATED-ENTITY - 4OHBENZOATE-OCTAPRENYLTRANSFER-ENZRXN
REGULATOR - CPD-7988
//
UNIQUE-ID - REG0-8482
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [214126]
COMMENT - where GDP is the variable substrate,
/ATP fixed and GTP is at varying concentrations, non-competitive
/inhibition is observed between GTP and GDP
MODE - -
REGULATED-ENTITY - NUCLEOSIDE-DIP-KIN-ENZRXN
REGULATOR - GTP
//
UNIQUE-ID - REG0-10166
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15066985
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ACETYL-COA-CARBOXYLTRANSFER-ENZRXN
REGULATOR - CPD0-1598
//
UNIQUE-ID - REG0-9342
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - NIL
REGULATED-ENTITY - ENOYL-COA-HYDRAT-ENZRXN
REGULATOR - TRIS-HYDROCHLORIDE
//
UNIQUE-ID - REG0-11735
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - MORGAN97
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - UDPGLCNACEPIM-ENZRXN
REGULATOR - UDP-N-ACETYL-D-GLUCOSAMINE
//
UNIQUE-ID - REG0-6660
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16216582
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6179
REGULATOR - GTP
//
UNIQUE-ID - REG0-7265
TYPES - Regulation-of-Enzyme-Activity
COMMENT - allosterically inhibited in a synergistic way, representing
/cooperative effects of end products of a branched pathway |CITS: [5333667]|
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - HOMSUCTRAN-ENZRXN
REGULATOR - MET
//
UNIQUE-ID - REG0-7838
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9148919
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-1627
REGULATOR - ADP
//
UNIQUE-ID - REG0-8462
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6251075]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - S-ADENMETSYN-ENZRXN
REGULATOR - CPD0-1054
//
UNIQUE-ID - REG0-10144
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14343156
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIAMINOPIMDECARB-ENZRXN
REGULATOR - CPD0-1578
//
UNIQUE-ID - REG0-9231
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7512955
MODE - -
REGULATED-ENTITY - ENZRXN0-6499
REGULATOR - HG+2
//
UNIQUE-ID - REG0-11682
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10806332
COMMENT - Salicylic acid is competitive with o-aminobenzoic acid 
/and non-competitive with acetyl-CoA.  |CITS: [10806332]| 
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7688
REGULATOR - CPD-110
//
UNIQUE-ID - REG0-6640
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7896726
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6321
REGULATOR - MALEATE
//
UNIQUE-ID - REG0-7225
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [BlumenthalMethEnz9-660]
MODE - -
REGULATED-ENTITY - GLUCARDEHYDRA-ENZRXN
REGULATOR - CPD-5401
//
UNIQUE-ID - REG0-7822
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3301828]
COMMENT - competitive with respect to
/cyanate
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYANLY-ENZRXN
REGULATOR - CPD-2841
//
UNIQUE-ID - REG0-8444
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4878694]
CITATIONS - [4878695]
MODE - -
REGULATED-ENTITY - GLYCOPHOSPHORYL-ENZRXN
REGULATOR - CPD-1486
//
UNIQUE-ID - REG0-10119
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4904235
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ANTHRANSYN-ENZRXN
REGULATOR - CPD0-1544
//
UNIQUE-ID - REG0-9203
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10446288
MODE - -
REGULATED-ENTITY - ENZRXN0-6461
REGULATOR - CHOLINE
//
UNIQUE-ID - REG0-11616
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15948139
KI - 1.100e-2
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-4241
REGULATOR - PROTAMINE
//
UNIQUE-ID - REG0-12477
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - ENZRXN0-8297
REGULATOR - HSCN
//
UNIQUE-ID - REG0-7196
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4297266
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - DLACTDEHYDROGNAD-ENZRXN
REGULATOR - PYRUVATE
//
UNIQUE-ID - REG0-7801
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6377306]
CITATIONS - 13897943
MECHANISM - :ALLOSTERIC
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ASPCARBTRANS-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-8423
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [MethEnzV-794]
MODE - -
REGULATED-ENTITY - IGPSYN-ENZRXN
REGULATOR - ANTHRANILATE
//
UNIQUE-ID - REG0-10078
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18250190
MODE - -
REGULATED-ENTITY - ENZRXN0-6573
REGULATOR - doripenem
//
UNIQUE-ID - REG0-9176
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4616949
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - ENZRXN0-6440
REGULATOR - CPD-8179
//
UNIQUE-ID - REG0-11594
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9011040
MODE - -
REGULATED-ENTITY - APHA-ENZRXN
REGULATOR - |Nucleosides|
//
UNIQUE-ID - REG0-9992
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10359647
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6603
REGULATOR - CPD-6001
//
UNIQUE-ID - REG0-12461
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7012144]
MODE - -
REGULATED-ENTITY - ENZRXN0-8284
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-7166
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7767
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2985605
COMMENT - noncompetitive inhibitor |CITS:[2985605]|
MODE - -
REGULATED-ENTITY - FOLYLPOLYGLUTAMATESYNTH-ENZRXN
REGULATOR - 7-8-DIHYDROPTEROATE
//
UNIQUE-ID - REG0-8397
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - CooperMethEnz13309
CITATIONS - 4572511
MODE - -
REGULATED-ENTITY - PEPSYNTH-ENZRXN
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-10060
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [FishMethEnz9-529]
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - |Hexuronates|
//
UNIQUE-ID - REG0-9125
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7005223
COMMENT - Free ACP exerted a selective effect in that
/it was a more potent inhibitor of acyl transfer from palmitoyl-CoA
/than from palmitoyl-ACP.  |CITS: [7005223]|
MODE - -
REGULATED-ENTITY - 1-ACYLGLYCEROL-3-P-ACYLTRANSFER-ENZRXN
REGULATOR - |apo-ACP|
//
UNIQUE-ID - REG0-11526
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 318639
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ENZRXN0-6001
REGULATOR - SELENOMETHIONINE
//
UNIQUE-ID - REG0-9928
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14742205
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PHES-ENZRXN
REGULATOR - CPD0-1433
//
UNIQUE-ID - REG0-12445
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8262
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7131
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [239942]
CITATIONS - [7961766]
CITATIONS - [7629080]
CITATIONS - 9737855
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - URITRANS-ENZRXN
REGULATOR - GLN
//
UNIQUE-ID - REG0-7742
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5328735
COMMENT - Stimulation by NH4Cl is greatest. |CITS: [5328735]|
MODE - +
REGULATED-ENTITY - GLYOCARBOLIG-ENZRXN
REGULATOR - NH4CL
//
UNIQUE-ID - REG0-8377
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5333666]
COMMENT - may be competing at
/both the ATP and  GMP sites
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GUANYL-KIN-ENZRXN
REGULATOR - DGTP
//
UNIQUE-ID - REG0-10040
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [MethEnzV-794]
MODE - -
REGULATED-ENTITY - IGPSYN-ENZRXN
REGULATOR - CPD0-1489
//
UNIQUE-ID - REG0-9102
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4580841]
CITATIONS - [374983]
COMMENT - uncompetitive for either HMP-PP or THZ-P
MODE - -
REGULATED-ENTITY - THI-P-SYN-ENZRXN
REGULATOR - ACETYL-P
//
UNIQUE-ID - REG0-11398
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8226748
MODE - -
REGULATED-ENTITY - FUMARA-ENZRXN
REGULATOR - SUPER-OXIDE
//
UNIQUE-ID - REG0-9910
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1391
MODE - -
REGULATED-ENTITY - ENZRXN0-4761
REGULATOR - CPD-9195
//
UNIQUE-ID - REG0-12429
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - ENZRXN0-8177
REGULATOR - CPD0-1385
//
UNIQUE-ID - REG0-7104
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8380170]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PPX-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-7712
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7607225]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - TRANSKETOI-ENZRXN
REGULATOR - ARABINOSE-5P
//
UNIQUE-ID - REG0-8361
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4890761
KI - 300
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ARGS-ENZRXN
REGULATOR - CANAVANINE
//
UNIQUE-ID - REG0-10020
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - PPK-ENZRXN
REGULATOR - CPD0-1470
//
UNIQUE-ID - REG0-9021
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6393625
COMMENT - marked inhibition at high concentrations |CITS: [6393625]|
MODE - -
REGULATED-ENTITY - GLUTATHIONE-REDUCT-NADPH-ENZRXN
REGULATOR - NADPH
//
UNIQUE-ID - REG0-11338
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20580719
MODE - +
REGULATED-ENTITY - ENZRXN0-7401
REGULATOR - MG+2
//
UNIQUE-ID - REG0-9888
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16740960
CITATIONS - 4917899
KI - 200
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PYRIDOXKIN-ENZRXN
REGULATOR - CPD0-1408
//
UNIQUE-ID - REG0-12379
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8856065
MODE - +
REGULATED-ENTITY - URACIL-PRIBOSYLTRANS-ENZRXN
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-7085
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4584822]
MODE - -
REGULATED-ENTITY - MALONYL-COA-ACP-TRANSACYL-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-7688
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329757
MODE - -
REGULATED-ENTITY - ICITDEHKINASE-ENZRXN
REGULATOR - GLYOX
//
UNIQUE-ID - REG0-8334
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7918616
COMMENT - slightly stimulatory |CITS:
/[7918616]|
MODE - +
REGULATED-ENTITY - CARDIOLIPSYN-ENZRXN
REGULATOR - |L-1-phosphatidyl-inositols|
//
UNIQUE-ID - REG-15077
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8550422
COMMENT - inhibits
/the reductase activity  |CITS: [8550422]|
CREDITS - SRI
CREDITS - |caspi|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN-23884
REGULATOR - 2-HYDROXYGLUTARIC_ACID
//
UNIQUE-ID - REG0-8931
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9724711]
CITATIONS - 10915782
MODE - -
REGULATED-ENTITY - ENZRXN-802
REGULATOR - HCN
//
UNIQUE-ID - REG0-11306
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7765483
MODE - -
REGULATED-ENTITY - AMINEPHEN-ENZRXN
REGULATOR - CPD-7656
//
UNIQUE-ID - REG0-9855
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - ACYLCOASYN-ENZRXN
REGULATOR - HSCN
//
UNIQUE-ID - REG0-12336
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9748330
KI - 6600
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ASNSYNB-ENZRXN
REGULATOR - CPD-18649
//
UNIQUE-ID - REG0-7065
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 30751
COMMENT - In the presence
/of Triton digitonin acted as a stimulator, but in the absence of Triton
/it caused slight inhibition. |CITS: [30751]|
MODE - +
REGULATED-ENTITY - CDPDIGLYSYN-ENZRXN
REGULATOR - CPD0-1629
//
UNIQUE-ID - REG0-7656
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16104732
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CFA-ENZRXN
REGULATOR - BORATE
//
UNIQUE-ID - REG0-8295
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3291954
COMMENT - Poor inhibitor  |CITS: [3291954]| 
MODE - -
REGULATED-ENTITY - ISOCITLYASE-ENZRXN
REGULATOR - CPD-546
//
UNIQUE-ID - REG-14660
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1646603]
CITATIONS - 6389524
CREDITS - SRI
CREDITS - |caspi|
MODE - -
REGULATED-ENTITY - ENZRXN-22535
REGULATOR - CU+2
//
UNIQUE-ID - REG0-8908
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15958189
MODE - -
REGULATED-ENTITY - ACETOLACTSYNII-ENZRXN
REGULATOR - GLYOX
//
UNIQUE-ID - REG0-11287
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21957966
MODE - -
REGULATED-ENTITY - LDC2-ENZRXN
REGULATOR - GDP-TP
//
UNIQUE-ID - REG0-9833
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3157043]
CITATIONS - 6406265
CITATIONS - 3091070
MODE - -
REGULATED-ENTITY - SPERMIDINESYN-ENZRXN
REGULATOR - CPD0-1375
//
UNIQUE-ID - REG0-12300
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21436141
MODE - -
REGULATED-ENTITY - ENZRXN0-4263
REGULATOR - CARDIOLIPIN
//
UNIQUE-ID - REG0-7044
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [46]
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - MG+2
//
UNIQUE-ID - REG0-7629
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3297044
COMMENT - irreversible inhibitor  |CITS: [3297044] [HandEnzInh]|
MODE - -
REGULATED-ENTITY - ARGDECARBOXBIO-ENZRXN
REGULATOR - CPD0-1662
//
UNIQUE-ID - REG0-8265
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14982633
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - TRANS-ENZRXN-68
REGULATOR - PUTRESCINE
//
UNIQUE-ID - REG0-8864
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - 4OH2OXOGLUTARALDOL-ENZRXN
REGULATOR - ACETALD
//
UNIQUE-ID - REG0-11201
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2162151
CITATIONS - 21741429
MODE - +
REGULATED-ENTITY - GLUC1PADENYLTRANS-ENZRXN
REGULATOR - PYRIDOXAL_PHOSPHATE
//
UNIQUE-ID - REG0-9808
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10753862
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - ENZRXN0-3841
REGULATOR - CPD0-1363
//
UNIQUE-ID - REG0-12272
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 25953817
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - CPD-18165
//
UNIQUE-ID - REG0-7011
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4567662
MODE - +
REGULATED-ENTITY - THI-P-KIN-ENZRXN
REGULATOR - AMMONIUM
//
UNIQUE-ID - REG0-7604
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329756
MODE - +
REGULATED-ENTITY - ICITDEHDEPHOSPH-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-8244
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6246070]
MODE - -
REGULATED-ENTITY - KDO-8PPHOSPHAT-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-8833
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10879466]
MODE - +
REGULATED-ENTITY - GUANOSINEKIN-ENZRXN
REGULATOR - UMP
//
UNIQUE-ID - REG0-11038
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17302437
MODE - -
REGULATED-ENTITY - HOMSUCTRAN-ENZRXN
REGULATOR - DIETHYLPYROCARBONATE
//
UNIQUE-ID - REG0-9789
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4861610]
CITATIONS - [357898]
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - THYKI-ENZRXN
REGULATOR - CPD0-1346
//
UNIQUE-ID - REG0-12255
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14693515
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - ristocetin
//
UNIQUE-ID - REG0-6973
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [793612]
MODE - -
REGULATED-ENTITY - PHOSPHAGLYPSYN-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-7576
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 782527
MODE - +
REGULATED-ENTITY - 3-OCTPRNL-4-OHBENZOATE-DECARBOX-ENZRXN
REGULATOR - METOH
//
UNIQUE-ID - REG0-8212
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4312205
CITATIONS - 20236319
COMMENT - noncompetitive with respect to CoA
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - PHOSACETYLTRANS-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-8815
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16670087
MODE - +
REGULATED-ENTITY - F16BDEPHOS-ENZRXN
REGULATOR - SULFATE
//
UNIQUE-ID - REG0-11010
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3091070
MODE - -
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - CPD0-1403
//
UNIQUE-ID - REG0-9765
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 210796
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - UDPGLUCEPIM-ENZRXN
REGULATOR - CPD-13245
//
UNIQUE-ID - REG0-12239
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8436562
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - FK037
//
UNIQUE-ID - REG0-6947
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16890
MODE - -
REGULATED-ENTITY - N-ACETYLTRANSFER-ENZRXN
REGULATOR - CD+2
//
UNIQUE-ID - REG0-7550
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10625642
MODE - +
REGULATED-ENTITY - ENZRXN0-5583
REGULATOR - K+
//
UNIQUE-ID - REG0-8181
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [SaikusaAgBioChem51-1893]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - METHYLGLYREDUCT-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-8786
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14245396
MODE - -
REGULATED-ENTITY - 3-NUCLEOTID-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-10914
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20530482
MODE - -
REGULATED-ENTITY - GSPAMID-ENZRXN
REGULATOR - HYDROGEN-PEROXIDE
//
UNIQUE-ID - REG0-9744
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - 4OH2OXOGLUTARALDOL-ENZRXN
REGULATOR - CPD0-1309
//
UNIQUE-ID - REG0-12182
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10373427
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7928
REGULATOR - CPD0-2574
//
UNIQUE-ID - REG0-6930
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4310089]
MODE - -
REGULATED-ENTITY - LACTALDDEHYDROG-ENZRXN
REGULATOR - IODOACETATE
//
UNIQUE-ID - REG0-7528
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 385340
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - ENZRXN0-4501
REGULATOR - MG+2
//
UNIQUE-ID - REG0-8162
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7049234]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYSTATHIONINE-BETA-LYASE-ENZRXN
REGULATOR - CYS
//
UNIQUE-ID - REG0-8760
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 776970
MODE - +
REGULATED-ENTITY - GLUTAMINB-ENZRXN
REGULATOR - MG+2
//
UNIQUE-ID - REG0-10860
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20961145
MODE - -
REGULATED-ENTITY - BIOTIN-SYN-ENZRXN
REGULATOR - ADENOSYL-HOMO-CYS
//
UNIQUE-ID - REG0-9728
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - CPD0-1294
//
UNIQUE-ID - REG0-12160
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 46
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - BA+2
//
UNIQUE-ID - REG0-6903
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4920894]
COMMENT - High levels of glycolytic and TCA cycle intermediates result in strong 
/inhibition of the adenylyltransferase reaction.  Pyruvate, glutarate, succinate
/and fumarate also inhibit to a lesser degree.  |CITS: [4920894]| 
MODE - -
REGULATED-ENTITY - GSADENYLATION-ENZRXN
REGULATOR - CO-A
//
UNIQUE-ID - REG0-7510
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2681195]
MODE - -
REGULATED-ENTITY - THREODEHYD-ENZRXN
REGULATOR - 23-PENTANEDIONE
//
UNIQUE-ID - REG0-8139
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4402996]
MODE - +
REGULATED-ENTITY - MANNONOXIDOREDUCT-ENZRXN
REGULATOR - MG+2
//
UNIQUE-ID - REG0-8732
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [821948]
KI - 0.25    
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GTP-CYCLOHYDRO-I-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-10744
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17307338
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PGLUCISOM-ENZRXN
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-9710
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - CPD-7673
//
UNIQUE-ID - REG0-12119
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4991605
MODE - -
REGULATED-ENTITY - ENZRXN0-6154
REGULATOR - |All-tRNAs|
//
UNIQUE-ID - REG0-6883
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [40950]
MODE - -
REGULATED-ENTITY - GLYCDEH-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-7492
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4861610]
CITATIONS - [357898]
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - THYKI-ENZRXN
REGULATOR - DADP
//
UNIQUE-ID - REG0-8113
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - MethEnz17A-708
CITATIONS - HandEnzInh
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ASP-SEMIALDEHYDE-DEHYDROGENASE-ENZRXN
REGULATOR - IODOACETATE
//
UNIQUE-ID - REG0-8706
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [FishMethEnz9-529]
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - ACET
//
UNIQUE-ID - REG0-10687
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14245401
MODE - -
REGULATED-ENTITY - THIOREDOXIN-REDUCT-NADPH-ENZRXN
REGULATOR - HCN
//
UNIQUE-ID - REG0-9694
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - CPD0-1276
//
UNIQUE-ID - REG0-12030
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24914049
MODE - +
REGULATED-ENTITY - ENZRXN0-7856
REGULATOR - DITHIOTHREITOL
//
UNIQUE-ID - REG0-6867
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11448178
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - GALPMUT-ENZRXN
REGULATOR - CPD0-1053
//
UNIQUE-ID - REG0-7463
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [4584395]
MODE - -
REGULATED-ENTITY - ASPARTASE-ENZRXN
REGULATOR - PHMB
//
UNIQUE-ID - REG0-8086
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [VogelAdvEnzym40-71]
MODE - -
REGULATED-ENTITY - ACETYLORNDEACET-ENZRXN
REGULATOR - NI+2
//
UNIQUE-ID - REG0-8686
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4565085
MODE - -
REGULATED-ENTITY - GLUTAMATESYN-ENZRXN
REGULATOR - L-ASPARTATE
//
UNIQUE-ID - REG0-10624
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2194570
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - BADH-ENZRXN
REGULATOR - CPD-7679
//
UNIQUE-ID - REG0-9678
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [33657]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ETHAMLY-ENZRXN
REGULATOR - CPD0-1260
//
UNIQUE-ID - REG0-11970
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 368072
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-282
REGULATOR - NAD
//
UNIQUE-ID - REG0-6849
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7988883
MODE - +
REGULATED-ENTITY - ENZRXN0-4381
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7443
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12980976
MODE - -
REGULATED-ENTITY - DEOXYRIBOSE-P-ALD-ENZRXN
REGULATOR - CPD-665
//
UNIQUE-ID - REG0-8062
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4901371]
COMMENT - cerulenin and
/thiolactomycin are antibiotics
MODE - -
REGULATED-ENTITY - 3-OXOACYL-ACP-SYNTHI-BASE-ENZRXN
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-8654
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6351926]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ACETOLACTSYNI-ENZRXN
REGULATOR - LEU
//
UNIQUE-ID - REG0-10568
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4572511
MODE - -
REGULATED-ENTITY - PEPSYNTH-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-9657
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11997136
CITATIONS - 3122832
CITATIONS - 10587449
MODE - -
REGULATED-ENTITY - NADH-DHI-ENZRXN
REGULATOR - CPD0-1233
//
UNIQUE-ID - REG0-11938
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 23769666
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ENZRXN0-6592
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-6824
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10634942
MODE - +
REGULATED-ENTITY - ENZRXN0-266
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-7417
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [14216423]
MODE - -
REGULATED-ENTITY - PHOSPHOGLUCMUT-ENZRXN
REGULATOR - MN+2
//
UNIQUE-ID - REG0-8035
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6337635
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PREPHENATEDEHYDRAT-ENZRXN
REGULATOR - CPD-225
//
UNIQUE-ID - REG0-8626
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10787409
CITATIONS - 23414808
MODE - -
REGULATED-ENTITY - DXPREDISOM-ENZRXN
REGULATOR - CPD0-441
//
UNIQUE-ID - REG0-10411
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19061856
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - NADH-DHI-ENZRXN
REGULATOR - NAD
//
UNIQUE-ID - REG0-9634
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2856144]
CITATIONS - [HandEnzInh]
CITATIONS - [6365921]
MODE - -
REGULATED-ENTITY - CYT-O-UBIOX-ENZRXN
REGULATOR - CPD0-1233
//
UNIQUE-ID - REG0-11917
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24214977
KI - 3
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7813
REGULATOR - GUANINE
//
UNIQUE-ID - REG0-6789
TYPES - Regulation-of-Enzyme-Activity
COMMENT - This inhibition is reversed by FAD.  |CITS: [MethEnz62-379]| 
MODE - -
REGULATED-ENTITY - ENZRXN-153
REGULATOR - ATABRINE
//
UNIQUE-ID - REG0-7397
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4966660]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTAMINA-ENZRXN
REGULATOR - GLT
//
UNIQUE-ID - REG0-7986
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1100621]
CITATIONS - 16593486
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - ENZRXN-17895
REGULATOR - |Phospholipids|
//
UNIQUE-ID - REG0-8585
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3910996]
MODE - +
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - F
//
UNIQUE-ID - REG0-10363
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - DIACYLGLYKIN-ENZRXN
REGULATOR - CPD0-1810
//
UNIQUE-ID - REG0-9612
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12813080
MODE - -
REGULATED-ENTITY - TRANS-ENZRXN-22
REGULATOR - CPD-5401
//
UNIQUE-ID - REG0-11850
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4568129
MODE - +
REGULATED-ENTITY - UGD-ENZRXN
REGULATOR - NADH
//
UNIQUE-ID - REG0-6750
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14245396
MODE - +
REGULATED-ENTITY - CYCPHOSDIESTER-ENZRXN
REGULATOR - CO+2
//
UNIQUE-ID - REG0-7378
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - CARBPSYN-ENZRXN
REGULATOR - CPD0-1628
//
UNIQUE-ID - REG0-7965
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7035170]
MODE - -
REGULATED-ENTITY - GLUTSEMIALDEHYDROG-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-8556
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - CPD-183
//
UNIQUE-ID - REG0-10255
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2007545
MODE - -
REGULATED-ENTITY - 7-ALPHA-HYDROXYSTEROID-DEH-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-9542
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 319747
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PHOSPHAGLYPSYN-ENZRXN
REGULATOR - L-GLYCERALDEHYDE-3-PHOSPHATE
//
UNIQUE-ID - REG0-11827
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 23844911
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7782
REGULATOR - BUTYRIC_ACID
//
UNIQUE-ID - REG0-6733
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [ColiSalII]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CHERTARM-ENZRXN
REGULATOR - TAR-GLUME
//
UNIQUE-ID - REG0-7361
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8955296
MODE - -
REGULATED-ENTITY - O-SUCCINYLBENZOATE-COA-LIG-ENZRXN
REGULATOR - FE+2
//
UNIQUE-ID - REG0-7920
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4290215]
MODE - -
REGULATED-ENTITY - NAD-SYNTH-NH3-ENZRXN
REGULATOR - ADENOSINE
//
UNIQUE-ID - REG0-8530
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8060125]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CROBETREDUCT-ENZRXN
REGULATOR - GAMMA-BUTYROBETAINE
//
UNIQUE-ID - REG0-10235
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6386817
MODE - -
REGULATED-ENTITY - CYTIDEAM-ENZRXN
REGULATOR - CPD0-1711
//
UNIQUE-ID - REG0-9496
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18459799
MODE - -
REGULATED-ENTITY - ENZRXN0-2802
REGULATOR - MN+2
//
UNIQUE-ID - REG0-11785
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2950851
MODE - -
REGULATED-ENTITY - 3-DEHYDROQUINATE-DEHYDRATASE-ENZRXN
REGULATOR - DEHYDROQUINATE
//
UNIQUE-ID - REG0-6711
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5543331]
MODE - +
REGULATED-ENTITY - ALPHAGALACTOSID-ENZRXN
REGULATOR - 2-MERCAPTOETHANOL
//
UNIQUE-ID - REG0-7326
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13844669
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - AMYLOMALT-ENZRXN
REGULATOR - CPD0-1669
//
UNIQUE-ID - REG0-7883
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7929317]
MODE - -
REGULATED-ENTITY - RIBONUCLEOSIDE-TRIP-REDUCT-ENZRXN
REGULATOR - DATP
//
UNIQUE-ID - REG0-8503
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [2856144]
CITATIONS - [6365921]
MODE - -
REGULATED-ENTITY - CYT-O-UBIOX-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-10198
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2194570
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - BADH-ENZRXN
REGULATOR - ACETALD
//
UNIQUE-ID - REG0-9432
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18328504
MODE - -
REGULATED-ENTITY - ENZRXN0-6517
REGULATOR - CU+2
//
UNIQUE-ID - REG0-11766
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - MALAMYBIOCHEM31893
MODE - -
REGULATED-ENTITY - ENZRXN0-7757
REGULATOR - CYS
//
UNIQUE-ID - REG0-6688
TYPES - Regulation-of-Enzyme-Activity
COMMENT - competitive with
/respect to glycine |CITS: [3117785]|
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - AKBLIG-ENZRXN
REGULATOR - AMINOMALONATE
//
UNIQUE-ID - REG0-7277
TYPES - Regulation-of-Enzyme-Activity
MODE - +
REGULATED-ENTITY - PEPCARBOX-ENZRXN
REGULATOR - CMP
//
UNIQUE-ID - REG0-7859
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15501829
MODE - -
REGULATED-ENTITY - ENZRXN0-6121
REGULATOR - 1-DEOXYXYLONOJIRIMYCIN
//
UNIQUE-ID - REG0-8479
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [214126]
COMMENT - with respect to ATP
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - NUCLEOSIDE-DIP-KIN-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-10161
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2495789
CITATIONS - HandEnzInh
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - CPD0-1594
//
UNIQUE-ID - REG0-9339
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - NIL
REGULATED-ENTITY - OHACYL-COA-DEHYDROG-ENZRXN
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-11728
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ACETOACETYL-COA-TRANSFER-ENZRXN
REGULATOR - ACETYL-COA
//
UNIQUE-ID - REG0-6657
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15951572
MODE - -
REGULATED-ENTITY - ENZRXN0-6153
REGULATOR - DIETHYLDITHIOCARBAMATE
//
UNIQUE-ID - REG0-7250
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6759855]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ALTRODEHYDRAT-ENZRXN
REGULATOR - CPD-1114
//
UNIQUE-ID - REG0-7835
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13794771
CITATIONS - 13628636
MODE - -
REGULATED-ENTITY - GALACTUROISOM-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-8455
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2542328
CITATIONS - 9125530
KI - 50
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PRPPSYN-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-10141
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2185839
MODE - -
REGULATED-ENTITY - GART-ENZRXN
REGULATOR - CPD0-1576
//
UNIQUE-ID - REG0-9220
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11563694
MODE - +
REGULATED-ENTITY - RIBOKIN-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-11679
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7893644
KI - 190
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIHYDROPICRED-ENZRXN
REGULATOR - NADP
//
UNIQUE-ID - REG0-6635
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16567800
MODE - -
REGULATED-ENTITY - ENZRXN0-6199
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-7221
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10769114
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUCARDEHYDRA-ENZRXN
REGULATOR - CPD0-1613
//
UNIQUE-ID - REG0-7819
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2211698
MODE - -
REGULATED-ENTITY - ENZRXN0-4521
REGULATOR - NITRITE
//
UNIQUE-ID - REG0-8441
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4878695
COMMENT - competitive with respect to glucose-1-phosphate. |CITS: [4878695]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLYCOPHOSPHORYL-ENZRXN
REGULATOR - UDP-GLUCOSE
//
UNIQUE-ID - REG0-10110
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [JAmChemSoc112-4932]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIAMINOPIMEPIM-ENZRXN
REGULATOR - CPD0-1536
//
UNIQUE-ID - REG0-9200
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10446288
MODE - -
REGULATED-ENTITY - ENZRXN0-6461
REGULATOR - SARCOSINE
//
UNIQUE-ID - REG0-11613
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1839607
MODE - -
REGULATED-ENTITY - ENZRXN0-1701
REGULATOR - BOROHYDRIDE
//
UNIQUE-ID - REG0-12474
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - -
REGULATED-ENTITY - ENZRXN0-8288
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7192
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3034883
COMMENT - The enzyme was markedly inhibited by several non-ionic detergents such as,
/Triton X-100, Lubrol PX, Brij 35, Brij 58 and Tween 20.  |CITS: [9134438]| 
COMMENT - Tunicamycin inhibits both the forward and reverse reactions.  |CITS: [3034883]| 
MODE - -
REGULATED-ENTITY - GLCNACPTRANS-ENZRXN
REGULATOR - CPD-5242
//
UNIQUE-ID - REG0-7798
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4943676
COMMENT - Competitive with respect to carbamoyl-phosphate, non-competitive with 
/L-aspartate.  |CITS: [4943676] [HandEnzInh]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ASPCARBTRANS-ENZRXN
REGULATOR - CPD0-1617
//
UNIQUE-ID - REG0-8418
TYPES - Regulation-of-Enzyme-Activity
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - DCTP-DEAM-ENZRXN
REGULATOR - DUTP
//
UNIQUE-ID - REG0-10075
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17470659
MODE - -
REGULATED-ENTITY - ENZRXN0-6573
REGULATOR - cefepime
//
UNIQUE-ID - REG0-9156
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4632320
MODE - -
REGULATED-ENTITY - DARABISOM-ENZRXN
REGULATOR - GALACTITOL
//
UNIQUE-ID - REG0-11570
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4552992
CITATIONS - 1993184
KI - 70
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - DALADALALIGB-ENZRXN
REGULATOR - D-ALA-D-ALA
//
UNIQUE-ID - REG0-9989
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10359647
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6603
REGULATOR - L-XYLOSE
//
UNIQUE-ID - REG0-12458
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - -
REGULATED-ENTITY - ENZRXN0-8283
REGULATOR - TRIS
//
UNIQUE-ID - REG0-7162
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - CD+2
//
UNIQUE-ID - REG0-7761
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2178550]
MODE - -
REGULATED-ENTITY - GABATRANSAM-ENZRXN
REGULATOR - DITHIO-NITROBENZOATE
//
UNIQUE-ID - REG0-8393
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8394006
MODE - -
REGULATED-ENTITY - PPPGPPHYDRO-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-10056
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 368067
MODE - -
REGULATED-ENTITY - GLYC3PDEHYDROGBIOSYN-ENZRXN
REGULATOR - |Long-Chain-Acyl-CoAs|
//
UNIQUE-ID - REG0-9121
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4562390
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - THREDEHYDSYN-ENZRXN
REGULATOR - LEU
//
UNIQUE-ID - REG0-11460
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 22344668
MODE - -
REGULATED-ENTITY - FUMARA-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-9925
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1097688
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PHES-ENZRXN
REGULATOR - CPD0-1430
//
UNIQUE-ID - REG0-12442
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8261
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7127
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5332197]
MODE - -
REGULATED-ENTITY - DARAB5PISOM-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-7737
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1577828]
COMMENT - an antibiotic
MODE - -
REGULATED-ENTITY - KDOTRANS2-ENZRXN
REGULATOR - CPD0-1277
//
UNIQUE-ID - REG0-8374
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5333666]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GUANYL-KIN-ENZRXN
REGULATOR - GUANOSINE
//
UNIQUE-ID - REG0-10037
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3303031
MODE - -
REGULATED-ENTITY - IGPSYN-ENZRXN
REGULATOR - CPD0-1486
//
UNIQUE-ID - REG0-9094
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12930982
MODE - -
REGULATED-ENTITY - MALSYNG-ENZRXN
REGULATOR - PYRUVATE
//
UNIQUE-ID - REG0-11363
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 372191
MODE - -
REGULATED-ENTITY - PRPPAMIDOTRANS-ENZRXN
REGULATOR - IMP
//
UNIQUE-ID - REG0-9906
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7918616
MODE - -
REGULATED-ENTITY - CARDIOLIPSYN-ENZRXN
REGULATOR - CPD0-1422
//
UNIQUE-ID - REG0-12426
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - ENZRXN0-8174
REGULATOR - HSCN
//
UNIQUE-ID - REG0-7101
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2148683]
COMMENT - noncompetitive with respect to ADP
MODE - -
REGULATED-ENTITY - GLYCEROL-KIN-ENZRXN
REGULATOR - GLYCEROL
//
UNIQUE-ID - REG0-7707
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 357894
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - RIBONUCLEOSIDE-DIP-REDUCTI-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-8349
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7797548
MODE - -
REGULATED-ENTITY - ADENYLOSUCCINATE-SYNTHASE-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-10017
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2045363]
MODE - -
REGULATED-ENTITY - GSAAMINOTRANS-ENZRXN
REGULATOR - CPD0-1467
//
UNIQUE-ID - REG0-8980
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11368768
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - HOMOSERDEHYDROGI-ENZRXN
REGULATOR - THR
//
UNIQUE-ID - REG0-11332
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3553189
MODE - -
REGULATED-ENTITY - ENZRXN0-1461
REGULATOR - ACET
//
UNIQUE-ID - REG0-9873
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6353153]
MODE - -
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - CPD0-1399
//
UNIQUE-ID - REG0-12371
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 26584540
MODE - +
REGULATED-ENTITY - ENZRXN0-255
REGULATOR - NH42SO4
//
UNIQUE-ID - REG0-7082
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4934182]
COMMENT - with respect to
/malonyl-CoA
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - MALONYL-COA-ACP-TRANSACYL-ENZRXN
REGULATOR - ACETYL-COA
//
UNIQUE-ID - REG0-7676
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 224913
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - MALIC-NAD-ENZRXN
REGULATOR - L-ASPARTATE
//
UNIQUE-ID - REG0-8327
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7918616
COMMENT - end-product inhibition
/|CITS: [7918616]|
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - CARDIOLIPSYN-ENZRXN
REGULATOR - CARDIOLIPIN
//
UNIQUE-ID - REG-15074
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8550422]
CREDITS - SRI
CREDITS - |caspi|
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ENZRXN-23884
REGULATOR - SER
//
UNIQUE-ID - REG0-8928
TYPES - Regulation-of-Enzyme-Activity
COMMENT - competitive with respect
/to hydroxymethylpyrimidine
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - OHMETPYRKIN-ENZRXN
REGULATOR - PYRIDOXINE
//
UNIQUE-ID - REG0-11302
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17557829
MODE - +
REGULATED-ENTITY - MALIC-NADP-ENZRXN
REGULATOR - GLT
//
UNIQUE-ID - REG0-9848
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [VogelAdvEnzym40-70]
MODE - -
REGULATED-ENTITY - ACETYLORNTRANSAM-ENZRXN
REGULATOR - |Sulfhydryl-Reagents|
//
UNIQUE-ID - REG0-12330
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9254614
KI - 5400
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ASNSYNB-ENZRXN
REGULATOR - 3-SULFINOALANINE
//
UNIQUE-ID - REG0-7062
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 30751
COMMENT - competitive with respect to dCTP
/|CITS: [30751]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CDPDIGLYSYN-ENZRXN
REGULATOR - CTP
//
UNIQUE-ID - REG0-7650
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13734750
MODE - -
REGULATED-ENTITY - SUCCINYLDIAMINOPIMTRANS-ENZRXN
REGULATOR - 2-KETOGLUTARATE
//
UNIQUE-ID - REG0-8289
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3291954
MODE - -
REGULATED-ENTITY - ISOCITLYASE-ENZRXN
REGULATOR - CIS-ACONITATE
//
UNIQUE-ID - REG-14657
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1646603]
CREDITS - SRI
CREDITS - |caspi|
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ENZRXN-22535
REGULATOR - CPD0-1551
//
UNIQUE-ID - REG0-8905
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4860415
COMMENT - Glutamine synthetase activity is subject to cumulative feedback
/inhibition by the products of glutamine metabolism. Each of the listed compounds inhibits glutamine synthetase partially together
COMMENT - these compounds can inhibit glutamine synthetase completely. Glutamine itself is not an inhibitor.
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUTAMINESYN-ENZRXN
REGULATOR - GLY
//
UNIQUE-ID - REG0-11284
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6369325
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - PYRUVFORMLY-ENZRXN
REGULATOR - OXYGEN-MOLECULE
//
UNIQUE-ID - REG0-9830
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - 3-DEHYDROQUINATE-SYNTHASE-ENZRXN
REGULATOR - CPD0-1374
//
UNIQUE-ID - REG0-12289
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2892828
MODE - -
REGULATED-ENTITY - ENZRXN0-4321
REGULATOR - DIISOPROPYL-FLUOROPHOSPHATE
//
UNIQUE-ID - REG0-7039
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [46]
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - CPD-3682
//
UNIQUE-ID - REG0-7625
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3297044
COMMENT - irreversible
/inhibitor  |CITS: [3157043]|
MODE - -
REGULATED-ENTITY - ARGDECARBOXBIO-ENZRXN
REGULATOR - CPD0-1663
//
UNIQUE-ID - REG0-8262
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14982633
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - TRANS-ENZRXN-68
REGULATOR - ARG
//
UNIQUE-ID - REG0-8861
TYPES - Regulation-of-Enzyme-Activity
COMMENT - all three bind at the same active
/site of the enzyme  |CITS: [NishiharaJBC247,5079]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - 4OH2OXOGLUTARALDOL-ENZRXN
REGULATOR - D-4-HYDROXY-2-KETO-GLUTARATE
//
UNIQUE-ID - REG0-11198
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11527707
MODE - -
REGULATED-ENTITY - TRANSKETOI-ENZRXN
REGULATOR - CPD0-2022
//
UNIQUE-ID - REG0-9805
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3486292
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - H2PTEROATESYNTH-ENZRXN
REGULATOR - |Diaryl-Sulfone-Derivatives|
//
UNIQUE-ID - REG0-12269
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 345275
MODE - -
REGULATED-ENTITY - ENZRXN0-7970
REGULATOR - CPD-9229
//
UNIQUE-ID - REG0-7008
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4567662]
MODE - -
REGULATED-ENTITY - THI-P-KIN-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-7601
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10625615
MODE - +
REGULATED-ENTITY - ICITDEHDEPHOSPH-ENZRXN
REGULATOR - G3P
//
UNIQUE-ID - REG0-8241
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6246070]
MODE - -
REGULATED-ENTITY - KDO-8PPHOSPHAT-ENZRXN
REGULATOR - CL-
//
UNIQUE-ID - REG0-8828
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10879466
COMMENT - mixed type
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - GUANOSINEKIN-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-11023
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21467222
MODE - -
REGULATED-ENTITY - ENZRXN0-7454
REGULATOR - CPD-5541
//
UNIQUE-ID - REG0-9786
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4861610]
CITATIONS - [357898]
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - THYKI-ENZRXN
REGULATOR - CPD0-1344
//
UNIQUE-ID - REG0-12252
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3898066
CITATIONS - 14693515
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - CPD-9195
//
UNIQUE-ID - REG0-6970
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 793612
MECHANISM - :UNCOMPETITIVE
MODE - -
REGULATED-ENTITY - PHOSPHAGLYPSYN-ENZRXN
REGULATOR - CDPDIACYLGLYCEROL
//
UNIQUE-ID - REG0-7571
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6794600
MODE - -
REGULATED-ENTITY - PHES-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-8209
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4312205
CITATIONS - 20236319
COMMENT - noncompetitive with respect to CoA
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - PHOSACETYLTRANS-ENZRXN
REGULATOR - NADH
//
UNIQUE-ID - REG0-8812
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6312898
MECHANISM - :NONCOMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - F16BDEPHOS-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-11005
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3091070
MODE - -
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - CPD0-1404
//
UNIQUE-ID - REG0-9762
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [211379]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - URKI-ENZRXN
REGULATOR - CPD0-1321
//
UNIQUE-ID - REG0-12236
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1482128
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - DQ-2556
//
UNIQUE-ID - REG0-6944
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16890
MODE - -
REGULATED-ENTITY - N-ACETYLTRANSFER-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7547
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1646603]
COMMENT - slight inhibition
MODE - -
REGULATED-ENTITY - ACNEULY-ENZRXN
REGULATOR - FE+2
//
UNIQUE-ID - REG0-8178
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [SaikusaAgBioChem51-1893]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - METHYLGLYREDUCT-ENZRXN
REGULATOR - CO+2
//
UNIQUE-ID - REG0-8783
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14245397
MODE - -
REGULATED-ENTITY - 3-NUCLEOTID-ENZRXN
REGULATOR - |RNAs|
//
UNIQUE-ID - REG0-10875
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1309518
MODE - -
REGULATED-ENTITY - ENZRXN0-7431
REGULATOR - HG+2
//
UNIQUE-ID - REG0-9741
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2651445
MODE - -
REGULATED-ENTITY - 3-OXOACYL-ACP-SYNTHII-BASE-ENZRXN
REGULATOR - CPD0-1242
//
UNIQUE-ID - REG0-12179
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3305505
CITATIONS - 8647136
MODE - -
REGULATED-ENTITY - ENZRXN0-7928
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-6926
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4936448]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - KDPGALDOL-ENZRXN
REGULATOR - CPD-2961
//
UNIQUE-ID - REG0-7524
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4351434
COMMENT - with respect
/to tagaturonate |CITS: [4402917]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ALTRO-OXIDOREDUCT-ENZRXN
REGULATOR - FRUCTURONATE
//
UNIQUE-ID - REG0-8157
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10437801
CITATIONS - 21187861
COMMENT - Vanadate strongly inhibits the enzyme.  |CITS: [10437801]| 
MODE - -
REGULATED-ENTITY - 3PGAREARR-ENZRXN
REGULATOR - CPD-4584
//
UNIQUE-ID - REG0-8757
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [776970]
MODE - +
REGULATED-ENTITY - GLUTAMINB-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-10849
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4555418
CITATIONS - 8075065
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - UDPNACETYLGLUCOSAMENOLPYRTRANS-ENZRXN
REGULATOR - CPD0-1113
//
UNIQUE-ID - REG0-9725
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [WallenfelsTheEnzymes7-617]
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - |RHg|
//
UNIQUE-ID - REG0-12155
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 25557370
MODE - -
REGULATED-ENTITY - ACETYL-COA-CARBOXYLMULTI-ENZRXN
REGULATOR - PIIPROTEIN-CPLX
//
UNIQUE-ID - REG0-6900
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4920894]
COMMENT - High levels of glycolytic and TCA cycle intermediates result in strong 
/inhibition of the adenylyltransferase reaction.  Pyruvate, glutarate, succinate
/and fumarate also inhibit to a lesser degree.  |CITS: [4920894]| 
MODE - -
REGULATED-ENTITY - GSADENYLATION-ENZRXN
REGULATOR - FRUCTOSE-16-DIPHOSPHATE
//
UNIQUE-ID - REG0-7507
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - 6PGLUCONDEHYDROG-ENZRXN
REGULATOR - DITHIO-NITROBENZOATE
//
UNIQUE-ID - REG0-8136
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4402996]
MODE - +
REGULATED-ENTITY - MANNONOXIDOREDUCT-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-8728
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [821948]
KI - 2.9    
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GTP-CYCLOHYDRO-I-ENZRXN
REGULATOR - UTP
//
UNIQUE-ID - REG0-10738
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [FishMethEnz9-529]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - 2-KETO-3-DEOXY-6-P-GLUCONATE
//
UNIQUE-ID - REG0-9707
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - GLUTACONATE
//
UNIQUE-ID - REG0-12115
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7639702
MODE - -
REGULATED-ENTITY - ENZRXN0-1314
REGULATOR - 6-SELENO-OCTANOATE
//
UNIQUE-ID - REG0-6880
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [40950]
MODE - -
REGULATED-ENTITY - GLYCDEH-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-7487
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4861610]
CITATIONS - [357898]
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - THYKI-ENZRXN
REGULATOR - DGTP
//
UNIQUE-ID - REG0-8106
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [33657]
MODE - -
REGULATED-ENTITY - ETHAMLY-ENZRXN
REGULATOR - PHMB
//
UNIQUE-ID - REG0-8703
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [FishMethEnz9-529]
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - BR-
//
UNIQUE-ID - REG0-10651
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18474219
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SUCCSEMIALDDEHYDROG-ENZRXN
REGULATOR - CPD-8774
//
UNIQUE-ID - REG0-9691
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - CPD0-1272
//
UNIQUE-ID - REG0-12026
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20350528
MODE - -
REGULATED-ENTITY - ENZRXN0-6304
REGULATOR - O-PHENANTHROLINE
//
UNIQUE-ID - REG0-6864
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1099093
MODE - -
REGULATED-ENTITY - FORMATEDEHYDROGN-ENZRXN
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7460
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - ASPARTASE-ENZRXN
REGULATOR - PROPANOL
//
UNIQUE-ID - REG0-8083
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10684608
COMMENT - Uncompetitive with respect to N-acetylornithine.
MECHANISM - :UNCOMPETITIVE
MODE - -
REGULATED-ENTITY - ACETYLORNDEACET-ENZRXN
REGULATOR - |NaF|
//
UNIQUE-ID - REG0-8677
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2269304]
COMMENT - Both potassium and phosphate ions present simultaneously
/cause the activation. 
MODE - +
REGULATED-ENTITY - UDP-NACMURALGLDAPLIG-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-10621
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4966660]
MODE - -
REGULATED-ENTITY - GLUTAMINA-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-9672
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1095054]
MODE - -
REGULATED-ENTITY - FOLYLPOLYGLUTAMATESYNTH-ENZRXN
REGULATOR - CPD0-1255
//
UNIQUE-ID - REG0-11967
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 368072
MODE - +
REGULATED-ENTITY - ENZRXN0-282
REGULATOR - ASOLECTIN
//
UNIQUE-ID - REG0-6846
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10986273]
MODE - -
REGULATED-ENTITY - ENZRXN0-402
REGULATOR - ADP
//
UNIQUE-ID - REG0-7440
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6365916
MODE - -
REGULATED-ENTITY - TETHYDPICSUCC-ENZRXN
REGULATOR - CO+2
//
UNIQUE-ID - REG0-8057
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [355248]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PROLDEHYDROG-ENZRXN
REGULATOR - PYRUVATE
//
UNIQUE-ID - REG0-8650
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12496243
CITATIONS - 3911944
MODE - -
REGULATED-ENTITY - ENZRXN0-2245
REGULATOR - 5-METHYLTHIOTUBERCIDIN
//
UNIQUE-ID - REG0-10525
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11157970
MODE - -
REGULATED-ENTITY - ACETYL-COA-CARBOXYLTRANSFER-ENZRXN
REGULATOR - ACYL-ACP
//
UNIQUE-ID - REG0-9653
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2651445]
MODE - -
REGULATED-ENTITY - 3-OXOACYL-ACP-COA-SYNTHIII-ENZRXN
REGULATOR - CPD0-1242
//
UNIQUE-ID - REG0-11934
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19375450
MODE - -
REGULATED-ENTITY - ENZRXN0-7818
REGULATOR - CPD-520
//
UNIQUE-ID - REG0-6819
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1729236
CITATIONS - 10428950
KI - 50
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-2621
REGULATOR - NOCARDICIN-A
//
UNIQUE-ID - REG0-7414
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [14216423]
MODE - -
REGULATED-ENTITY - PHOSPHOGLUCMUT-ENZRXN
REGULATOR - CPD-1484
//
UNIQUE-ID - REG0-8017
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5327100
COMMENT - As a competive substrate it inhibits the formation of the keto acid from 
/D-serine.  |CITS: [5327100]| 
KI - 3400
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DSERDEAM-ENZRXN
REGULATOR - D-THREONINE
//
UNIQUE-ID - REG0-8618
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7011505]
MODE - -
REGULATED-ENTITY - LSERINEDEAM1-ENZRXN
REGULATOR - O-PHENANTHROLINE
//
UNIQUE-ID - REG0-10408
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9384533
MODE - -
REGULATED-ENTITY - GSPAMID-ENZRXN
REGULATOR - CPD0-1891
//
UNIQUE-ID - REG0-9631
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18344567
MODE - -
REGULATED-ENTITY - ENZRXN0-6535
REGULATOR - CPD0-1229
//
UNIQUE-ID - REG0-11914
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24214977
KI - 154
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7813
REGULATOR - CPD0-1143
//
UNIQUE-ID - REG0-6783
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4899016]
CITATIONS - [HandEnzInh]
COMMENT - In high concentrations
MODE - -
REGULATED-ENTITY - DTMPKI-ENZRXN
REGULATOR - TTP
//
UNIQUE-ID - REG0-7393
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10683258
COMMENT - K<SUP>+</SUP> is the most effective activator,
/followed by Rb<SUP>+</SUP> and NH<SUB>4</SUB><SUP>+</SUP>.
/Cs<SUP>+</SUP> is the least effective activator. |CITS: [10683258]|
MODE - +
REGULATED-ENTITY - IMP-DEHYDROG-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-7983
TYPES - Regulation-of-Enzyme-Activity
COMMENT - competitive with respect to
/TPP  |CITS: [6752143]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN-17895
REGULATOR - PPI
//
UNIQUE-ID - REG0-8582
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-10337
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - DIACYLGLYKIN-ENZRXN
REGULATOR - CPD0-1759
//
UNIQUE-ID - REG0-9609
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13727223
MODE - -
REGULATED-ENTITY - DIHYDROXYMETVALDEHYDRAT-ENZRXN
REGULATOR - |NaF|
//
UNIQUE-ID - REG0-11842
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4575199
KI - 500
MECHANISM - :NONCOMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLYCEROL-KIN-ENZRXN
REGULATOR - FRUCTOSE-16-DIPHOSPHATE
//
UNIQUE-ID - REG0-6747
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14245396
MODE - -
REGULATED-ENTITY - CYCPHOSDIESTER-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-7375
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [5339592]
MODE - -
REGULATED-ENTITY - CARBPSYN-ENZRXN
REGULATOR - CPD0-1224
//
UNIQUE-ID - REG0-7954
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6337635
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CHORISMATEMUT2-ENZRXN
REGULATOR - CIT
//
UNIQUE-ID - REG0-8543
TYPES - Regulation-of-Enzyme-Activity
COMMENT - for
/the uridine synthesis reaction |CITS: [6357095]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - URPHOS-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-10252
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7011505]
MODE - -
REGULATED-ENTITY - LSERINEDEAM1-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-9535
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16682444
MODE - -
REGULATED-ENTITY - ENZRXN0-6576
REGULATOR - LI+
//
UNIQUE-ID - REG0-11807
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2540841
KI - 2.7    
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - HMP-KIN-ENZRXN
REGULATOR - PYRIDOXINE
//
UNIQUE-ID - REG0-6730
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15911379
CITATIONS - 20961145
CITATIONS - 19328201
MODE - -
REGULATED-ENTITY - BIOTIN-SYN-ENZRXN
REGULATOR - CH33ADO
//
UNIQUE-ID - REG0-7356
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8530465]
COMMENT - noncompetitive inhibitor when riboflavin
/concentration was varied and NADPH concentration was fixed
MECHANISM - :NONCOMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - FMNREDUCT-ENZRXN
REGULATOR - NADP
//
UNIQUE-ID - REG0-7908
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [42538]
MODE - +
REGULATED-ENTITY - THYMIDYLATESYN-ENZRXN
REGULATOR - 2-MERCAPTOETHANOL
//
UNIQUE-ID - REG0-8526
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8752345]
MODE - -
REGULATED-ENTITY - DHPDIOXYGEN-ENZRXN
REGULATOR - PHMB
//
UNIQUE-ID - REG0-10227
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19073594
MODE - -
REGULATED-ENTITY - ENZRXN0-6614
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-9493
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18321216
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - CYT-O-UBIOX-ENZRXN
REGULATOR - FORMAMIDE
//
UNIQUE-ID - REG0-11782
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2950851
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - 3-DEHYDROQUINATE-DEHYDRATASE-ENZRXN
REGULATOR - ACET
//
UNIQUE-ID - REG0-6707
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3024831
MODE - -
REGULATED-ENTITY - ALPHAGALACTOSID-ENZRXN
REGULATOR - 5-AMINO-5-DEOXY-D-GALACTOPYRANOSIDE
//
UNIQUE-ID - REG0-7305
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8798731]
COMMENT - dAMP is a weak competitive inhibitor.
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-442
REGULATOR - DAMP
//
UNIQUE-ID - REG0-6704
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5543331]
MODE - -
REGULATED-ENTITY - ALPHAGALACTOSID-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7297
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2005134
MODE - -
REGULATED-ENTITY - PSII-ENZRXN
REGULATOR - PICOLINATE
//
UNIQUE-ID - REG0-7877
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1463470
MODE - -
REGULATED-ENTITY - DIHYDRODIPICSYN-ENZRXN
REGULATOR - S-2-AMINOETHYL-L-CYSTEINE
//
UNIQUE-ID - REG0-8500
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11170472
COMMENT - Competitive with respect to <I>N</I>-methyltryptophan.  |CITS: [11170472]| 
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SARCOX-ENZRXN
REGULATOR - BENZOATE
//
UNIQUE-ID - REG0-10193
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2194570
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - BADH-ENZRXN
REGULATOR - CPD0-1675
//
UNIQUE-ID - REG0-9428
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12486048
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-268
REGULATOR - DITHIOTHREITOL
//
UNIQUE-ID - REG0-11763
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - MALAMYBIOCHEM31893
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7757
REGULATOR - THIOGLYCOLATE
//
UNIQUE-ID - REG0-6676
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6300054
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ADENYLATECYC-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-7273
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7040354
MECHANISM - :ALLOSTERIC
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PEPCARBOX-ENZRXN
REGULATOR - ACETYL-COA
//
UNIQUE-ID - REG0-7853
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - 3-P-SHIK-1-CARBOXYVINYLXFERASE-ENZRXN
REGULATOR - PYRIDOXAL_PHOSPHATE
//
UNIQUE-ID - REG0-8476
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6378898]
MODE - -
REGULATED-ENTITY - TRANSENOYLCOARED-ENZRXN
REGULATOR - DITHIO-NITROBENZOATE
//
UNIQUE-ID - REG0-10154
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [2495789]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - CPD0-1587
//
UNIQUE-ID - REG0-9314
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8439296
MODE - NIL
REGULATED-ENTITY - PORPHOBILSYNTH-ENZRXN
REGULATOR - MG+2
//
UNIQUE-ID - REG0-11705
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15133034
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7440
REGULATOR - CPD-15291
//
UNIQUE-ID - REG0-6653
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10486141
COMMENT - Shows noncompetitive inhibition in the succinate oxidase reaction.
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - FUMARATE-REDN-ENZRXN
REGULATOR - |2-Alkyl-Dinitrophenol-Derivatives|
//
UNIQUE-ID - REG0-7235
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4337557]
MODE - -
REGULATED-ENTITY - DHBAMPLIG-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-7832
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13794771
MODE - -
REGULATED-ENTITY - GALACTUROISOM-ENZRXN
REGULATOR - CPD0-1610
//
UNIQUE-ID - REG0-10134
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12485611
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PROLDEHYDROG-ENZRXN
REGULATOR - CPD0-1572
//
UNIQUE-ID - REG0-9215
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13727223
MODE - -
REGULATED-ENTITY - DIHYDROXYISOVALDEHYDRAT-ENZRXN
REGULATOR - |NaF|
//
UNIQUE-ID - REG0-11676
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1463470
CITATIONS - 9048556
KI - 11000
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIHYDRODIPICSYN-ENZRXN
REGULATOR - CPD-4841
//
UNIQUE-ID - REG0-6630
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6756470
CITATIONS - 3325036
MODE - +
REGULATED-ENTITY - ENZRXN0-6312
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7218
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6760815]
COMMENT - as well as other cations
MODE - +
REGULATED-ENTITY - GLYCEROL-3-P-ACYLTRANSFER-ENZRXN
REGULATOR - MG+2
//
UNIQUE-ID - REG0-7816
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1906883
CITATIONS - 2211698
COMMENT - Sodium azide also protects the enzyme from inactivation by oxygen.
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-4521
REGULATOR - CPD-2841
//
UNIQUE-ID - REG0-8438
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4878695
COMMENT - competitive with respect to glucose-1-phosphate. |CITS: [4878695]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLYCOPHOSPHORYL-ENZRXN
REGULATOR - DTDP-D-GLUCOSE
//
UNIQUE-ID - REG0-10107
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [JAmChemSoc112-4932]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIAMINOPIMEPIM-ENZRXN
REGULATOR - CPD0-1530
//
UNIQUE-ID - REG0-9193
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10504245]
MODE - -
REGULATED-ENTITY - NITRATREDUCTA-ENZRXN
REGULATOR - CPD-7975
//
UNIQUE-ID - REG0-11610
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7929223
MODE - -
REGULATED-ENTITY - ENZRXN0-4861
REGULATOR - CPD-13584
//
UNIQUE-ID - REG0-12471
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - -
REGULATED-ENTITY - ENZRXN0-8287
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7189
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2856144]
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - CYT-D-UBIOX-ENZRXN
REGULATOR - HYDROXYLAMINE
//
UNIQUE-ID - REG0-7794
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4870599]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ARGDECARBOXDEG-ENZRXN
REGULATOR - SPERMIDINE
//
UNIQUE-ID - REG0-8415
TYPES - Regulation-of-Enzyme-Activity
COMMENT - phosphate inhibition is
/competitve with MgATP  |CITS: [357895] [7000783]|
MECHANISM - :ALLOSTERIC
MODE - -
REGULATED-ENTITY - AMP-NUCLEOSID-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-10072
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - ENZRXN0-241
REGULATOR - CPD0-1512
//
UNIQUE-ID - REG0-9150
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4871199
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - ENZRXN0-6436
REGULATOR - DIISOPROPYL-FLUOROPHOSPHATE
//
UNIQUE-ID - REG0-11563
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15327942
MODE - -
REGULATED-ENTITY - ACS-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-9978
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2033383
MODE - -
REGULATED-ENTITY - S-ADENMETSYN-ENZRXN
REGULATOR - L-2-AMINOHEXANOATE
//
UNIQUE-ID - REG0-12455
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8267
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7158
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - OXALATE
//
UNIQUE-ID - REG0-7758
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2178550]
MODE - -
REGULATED-ENTITY - GABATRANSAM-ENZRXN
REGULATOR - CARBOXYMETHOXYLAMINE
//
UNIQUE-ID - REG0-8390
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6130093
COMMENT - slight inhibition  |CITS:
/[6130093]|
MODE - -
REGULATED-ENTITY - PPPGPPHYDRO-ENZRXN
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-10052
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3042781
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - DIAMINOPIMEPIM-ENZRXN
REGULATOR - CPD0-1500
//
UNIQUE-ID - REG0-9118
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4346334
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - THREDEHYDCAT-ENZRXN
REGULATOR - 2-OXOBUTANOATE
//
UNIQUE-ID - REG0-11450
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 340460
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6416
REGULATOR - DIHYDROXY-ACETONE-PHOSPHATE
//
UNIQUE-ID - REG0-9921
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - PHOSPHASERDECARB-ENZRXN
REGULATOR - HYDRAZINE
//
UNIQUE-ID - REG0-12439
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8259
REGULATOR - TRIS-HYDROCHLORIDE
//
UNIQUE-ID - REG0-7120
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - femsletbusch29-231-85
MODE - -
REGULATED-ENTITY - 1PFRUCTPHOSPHN-ENZRXN
REGULATOR - FRUCTOSE-16-DIPHOSPHATE
//
UNIQUE-ID - REG0-7729
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4893578]
MODE - +
REGULATED-ENTITY - GSDEADENYLATION-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-8371
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 234462
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PGLYCDEHYDROG-ENZRXN
REGULATOR - SER
//
UNIQUE-ID - REG0-10034
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1092682
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - DAPASYN-ENZRXN
REGULATOR - CPD0-1483
//
UNIQUE-ID - REG0-9065
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [BlumenthalMethEnz9-660]
MODE - -
REGULATED-ENTITY - GLUCARDEHYDRA-ENZRXN
REGULATOR - CPD0-1092
//
UNIQUE-ID - REG0-11360
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 372191
MODE - -
REGULATED-ENTITY - PRPPAMIDOTRANS-ENZRXN
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-9901
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8999955
MODE - -
REGULATED-ENTITY - GSPSYN-ENZRXN
REGULATOR - PHOSPHONATE
//
UNIQUE-ID - REG0-12399
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7024555]
MODE - +
REGULATED-ENTITY - ENZRXN0-8140
REGULATOR - ATP
//
UNIQUE-ID - REG0-7096
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2148683]
COMMENT - competitive versus both
/glycerol and ATP
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLYCEROL-KIN-ENZRXN
REGULATOR - GLYCEROL-3P
//
UNIQUE-ID - REG0-7699
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329757
MODE - -
REGULATED-ENTITY - ICITDEHKINASE-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-8346
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3029083
CITATIONS - 7929447
COMMENT - Competitive with respect to
/ATP. CoA thioesters are also inhibitors but to a lesser extent.
/|CITS: [3029083]|
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PANTOTHENATE-KIN-ENZRXN
REGULATOR - CO-A
//
UNIQUE-ID - REG0-10014
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2182115
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLYRIBONUCSYN-ENZRXN
REGULATOR - CPD0-1465
//
UNIQUE-ID - REG0-8977
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 28752
CITATIONS - 192265
CITATIONS - 6313682
CITATIONS - 3150686
CITATIONS - 11368768
KI - 167
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ASPARTATEKINI-ENZRXN
REGULATOR - THR
//
UNIQUE-ID - REG0-11329
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12603203
MODE - +
REGULATED-ENTITY - 5-NUCLEOTID-ENZRXN
REGULATOR - CO+2
//
UNIQUE-ID - REG0-9867
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [2667519]
MODE - -
REGULATED-ENTITY - RIBONUCLEOSIDE-DIP-REDUCTI-ENZRXN
REGULATOR - CPD0-1392
//
UNIQUE-ID - REG0-12359
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 26370943
MODE - +
REGULATED-ENTITY - ENZRXN0-7969
REGULATOR - EG11529-MONOMER
//
UNIQUE-ID - REG0-7076
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4879561]
CITATIONS - [4598072]
MODE - -
REGULATED-ENTITY - 7KAPSYN-ENZRXN
REGULATOR - CYS
//
UNIQUE-ID - REG0-7673
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17215140
MECHANISM - :UNCOMPETITIVE
MODE - -
REGULATED-ENTITY - MALIC-NAD-ENZRXN
REGULATOR - MAL
//
UNIQUE-ID - REG0-8316
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1765076
MODE - -
REGULATED-ENTITY - UDP-NACMURALA-GLU-LIG-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG-14994
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7002918
CREDITS - SRI
CREDITS - |caspi|
MODE - -
REGULATED-ENTITY - ENZRXN0-4761
REGULATOR - MG+2
//
UNIQUE-ID - REG0-8923
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8550422]
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - KETOGLUTREDUCT-ENZRXN
REGULATOR - SER
//
UNIQUE-ID - REG0-11299
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7765483
MODE - -
REGULATED-ENTITY - AMINEPHEN-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-9844
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4365537
MODE - -
REGULATED-ENTITY - N-ACETYLGLUTPREDUCT-ENZRXN
REGULATOR - |Sulfhydryl-Reagents|
//
UNIQUE-ID - REG0-12311
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - CHEN09WORDJMICRO
CITATIONS - 8226676
MODE - -
REGULATED-ENTITY - ENZRXN0-4502
REGULATOR - EDTA
//
UNIQUE-ID - REG0-7058
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3530323
COMMENT - ADP versus FGAM
MODE - -
REGULATED-ENTITY - AIRS-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-7647
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10026271]
MODE - -
REGULATED-ENTITY - UDPACYLGLCNACDEACETYL-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-8286
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3291954
COMMENT - An uncompetitive inhibitor with respect to isocitrate. 
MECHANISM - :UNCOMPETITIVE
MODE - -
REGULATED-ENTITY - ISOCITLYASE-ENZRXN
REGULATOR - SUC
//
UNIQUE-ID - REG0-8902
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4860415
COMMENT - Glutamine synthetase activity is subject to cumulative feedback
/inhibition by the products of glutamine metabolism. Each of the listed compounds inhibits glutamine synthetase partially together
COMMENT - these compounds can inhibit glutamine synthetase completely. Glutamine itself is not an inhibitor.
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUTAMINESYN-ENZRXN
REGULATOR - CTP
//
UNIQUE-ID - REG0-11270
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15855504
MODE - -
REGULATED-ENTITY - ENZRXN-802
REGULATOR - CPD-4501
//
UNIQUE-ID - REG0-9827
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [JAmChemSoc111-1861]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - 3-DEHYDROQUINATE-SYNTHASE-ENZRXN
REGULATOR - CPD0-1370
//
UNIQUE-ID - REG0-12286
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12198182
MODE - -
REGULATED-ENTITY - ENZRXN0-6402
REGULATOR - EDTA
//
UNIQUE-ID - REG0-7025
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [692401]
MODE - -
REGULATED-ENTITY - HYPOXANPRIBOSYLTRAN-ENZRXN
REGULATOR - BA+2
//
UNIQUE-ID - REG0-7621
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2549047
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ADENYLYLSULFKIN-ENZRXN
REGULATOR - CPD0-1651
//
UNIQUE-ID - REG0-8256
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1091651
COMMENT - Li+ and Na+ will inhibit the enzyme
/if added together with K+ or NH4+.   |CITS: [236639]|
MODE - -
REGULATED-ENTITY - TRYPTOPHAN-ENZRXN
REGULATOR - NA+
//
UNIQUE-ID - REG0-8848
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3891338]
CITATIONS - [8100227]
MODE - -
REGULATED-ENTITY - PYRNUTRANSHYDROGEN-ENZRXN
REGULATOR - CPD-10322
//
UNIQUE-ID - REG0-11195
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21696459
MODE - -
REGULATED-ENTITY - GLYOXIII-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-9801
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10684604
MODE - -
REGULATED-ENTITY - ENZRXN0-3802
REGULATOR - CPD0-1358
//
UNIQUE-ID - REG0-12266
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6389538
MODE - -
REGULATED-ENTITY - ENZRXN0-7969
REGULATOR - macarbomycin
//
UNIQUE-ID - REG0-7005
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4567662]
MODE - -
REGULATED-ENTITY - THI-P-KIN-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-7590
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2194570]
MODE - -
REGULATED-ENTITY - BADH-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-8238
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3042775
MODE - -
REGULATED-ENTITY - GLUTATHIONE-SYN-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-8825
TYPES - Regulation-of-Enzyme-Activity
COMMENT - GTP is competitive with ATP.  |CITS: [10879466]| 
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GUANOSINEKIN-ENZRXN
REGULATOR - GTP
//
UNIQUE-ID - REG0-11020
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21467222
MODE - -
REGULATED-ENTITY - ENZRXN0-7454
REGULATOR - HG+2
//
UNIQUE-ID - REG0-9777
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7601127]
MODE - -
REGULATED-ENTITY - UDP-NACMUR-ALA-LIG-ENZRXN
REGULATOR - CPD0-1335
//
UNIQUE-ID - REG0-12249
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14693515
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - CPD-9235
//
UNIQUE-ID - REG0-6966
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6233271
CITATIONS - [149128]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PFRUCTPHOS-ENZRXN
REGULATOR - FRUCTOSE-16-DIPHOSPHATE
//
UNIQUE-ID - REG0-7562
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6143811
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-2081
REGULATOR - S-TUBERCIDINYLHOMOCYSTEINE
//
UNIQUE-ID - REG0-8203
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - 15-DIDEOXY-15-IMINO-D-GALACTITOL
//
UNIQUE-ID - REG0-8808
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6767707
MODE - -
REGULATED-ENTITY - ENZRXN0-4281
REGULATOR - BH4NA
//
UNIQUE-ID - REG0-11000
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17567041
MODE - +
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - FE+2
//
UNIQUE-ID - REG0-9759
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [211379]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - URKI-ENZRXN
REGULATOR - CPD0-1320
//
UNIQUE-ID - REG0-12233
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 22995830
MODE - +
REGULATED-ENTITY - ENZRXN0-7967
REGULATOR - CPLX0-3964
//
UNIQUE-ID - REG0-6941
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4563643
COMMENT - Phosphoenolpyruvate and 3-phosphoglycerate were potent inhibitors of 
/the enzyme.   Arsenate was a less effective inhibitor. |CITS: [4563643]|
MODE - -
REGULATED-ENTITY - METHGLYSYN-ENZRXN
REGULATOR - ARSENATE
//
UNIQUE-ID - REG0-7544
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1646603]
MODE - -
REGULATED-ENTITY - ACNEULY-ENZRXN
REGULATOR - DIETHYLPYROCARBONATE
//
UNIQUE-ID - REG0-8172
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6351926]
MODE - -
REGULATED-ENTITY - ACETOOHBUTSYN-ENZRXN
REGULATOR - LEU
//
UNIQUE-ID - REG0-8778
TYPES - Regulation-of-Enzyme-Activity
COMMENT - and other nucleotides  |CITS: [15587]|
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ORNDECARBOX-BIO-ENZRXN
REGULATOR - GTP
//
UNIQUE-ID - REG0-10872
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7744829
MODE - -
REGULATED-ENTITY - ENZRXN0-6155
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-9738
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6463
MODE - -
REGULATED-ENTITY - 3-METHYL-2-OXOBUT-OHCH3XFER-ENZRXN
REGULATOR - CPD0-1307
//
UNIQUE-ID - REG0-12175
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 25670698
MODE - -
REGULATED-ENTITY - GLYOXII-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-6923
TYPES - Regulation-of-Enzyme-Activity
COMMENT - Competitive with respect to isocitrate, uncompetitive against NADP. This 
/inhibition is not considered physiologically significant.  |CITS: [3521584]| 
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ISOCITDEH-ENZRXN
REGULATOR - GLYOX
//
UNIQUE-ID - REG0-7521
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6780553]
CITATIONS - [3518793]
MODE - -
REGULATED-ENTITY - THREODEHYD-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-8153
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8077207]
KI - 1570
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SPERMACTRAN-ENZRXN
REGULATOR - CPD0-1685
//
UNIQUE-ID - REG0-8754
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [776969]
CITATIONS - 776970
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - GLUTAMINB-ENZRXN
REGULATOR - GLT
//
UNIQUE-ID - REG0-10796
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20643650
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - NAPHTHOATE-SYN-ENZRXN
REGULATOR - NITRATE
//
UNIQUE-ID - REG0-9720
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [237196]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - RHAMNULPALDOL-ENZRXN
REGULATOR - CPD0-1286
//
UNIQUE-ID - REG0-12145
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24479701
MODE - -
REGULATED-ENTITY - ENZRXN0-6222
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-6897
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [MethEnz17A-922]
CITATIONS - [HandEnzInh]
COMMENT - High levels of glycolytic and TCA cycle intermediates result in strong 
/inhibition of the adenylyltransferase reaction.  Pyruvate, glutarate, succinate
/and fumarate also inhibit to a lesser degree.  |CITS: [4920894]| 
MODE - -
REGULATED-ENTITY - GSADENYLATION-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-7504
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - 6PGLUCONDEHYDROG-ENZRXN
REGULATOR - RIBULOSE-5P
//
UNIQUE-ID - REG0-8126
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 217342
MODE - -
REGULATED-ENTITY - NITRITREDUCT-ENZRXN
REGULATOR - SO3
//
UNIQUE-ID - REG0-8724
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11697907
COMMENT - at high levels  |CITS:[BernsteinJBC240,391]|
MODE - -
REGULATED-ENTITY - DTDPGLUCOSEPP-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-10718
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17567041
MODE - +
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-9704
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1577828]
MODE - -
REGULATED-ENTITY - KDOTRANS-ENZRXN
REGULATOR - CPD0-1284
//
UNIQUE-ID - REG0-12112
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 25238255
MECHANISM - :MIXED
MODE - -
REGULATED-ENTITY - NADH-DHI-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-6877
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9733680]
MODE - -
REGULATED-ENTITY - GLUCOSAMINE1PACETYL-ENZRXN
REGULATOR - PHMB
//
UNIQUE-ID - REG0-7484
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - OkazakiJBC239,269
CITATIONS - 357898
CITATIONS - 4861610
COMMENT - competitive with respect to deoxythymidine|CITS:[OkazakiJBC239,275]|
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - THYKI-ENZRXN
REGULATOR - TTP
//
UNIQUE-ID - REG0-8097
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9257704]
MODE - +
REGULATED-ENTITY - GDPMANDEHYDRA-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-8700
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [FishMethEnz9-529]
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-10642
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10455035
MODE - -
REGULATED-ENTITY - FLAVINREDUCT-ENZRXN
REGULATOR - CPD0-2301
//
UNIQUE-ID - REG0-9688
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - CPD0-1269
//
UNIQUE-ID - REG0-12023
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11515538
MODE - -
REGULATED-ENTITY - ENZRXN0-7629
REGULATOR - EDTA
//
UNIQUE-ID - REG0-6861
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7657631]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - FLAVINREDUCT-ENZRXN
REGULATOR - NADP
//
UNIQUE-ID - REG0-7457
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - ASPARTASE-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-8076
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8226944]
MODE - -
REGULATED-ENTITY - CYTDEAM-ENZRXN
REGULATOR - O-PHENANTHROLINE
//
UNIQUE-ID - REG0-8671
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3905407]
MODE - -
REGULATED-ENTITY - UDP-NACMURALGLDAPLIG-ENZRXN
REGULATOR - CPD0-1456
//
UNIQUE-ID - REG0-10618
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7798192
MECHANISM - :ALLOSTERIC
MODE - -
REGULATED-ENTITY - ENZRXN0-6320
REGULATOR - CPD0-1614
//
UNIQUE-ID - REG0-9669
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6768963]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIHYDROFOLATESYNTH-ENZRXN
REGULATOR - CPD0-1252
//
UNIQUE-ID - REG0-11964
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 368072
MODE - +
REGULATED-ENTITY - ENZRXN0-282
REGULATOR - CARDIOLIPIN
//
UNIQUE-ID - REG0-6837
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16420038
MODE - -
REGULATED-ENTITY - ENZRXN0-3801
REGULATOR - THIABENDAZOLE
//
UNIQUE-ID - REG0-7431
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12952
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DAHPSYNPHE-ENZRXN
REGULATOR - 2-PG
//
UNIQUE-ID - REG0-8053
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14343156
MODE - +
REGULATED-ENTITY - DIAMINOPIMDECARB-ENZRXN
REGULATOR - 23-DIMERCAPTOPROPAN-1-OL
//
UNIQUE-ID - REG0-8647
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3911944
MODE - -
REGULATED-ENTITY - ENZRXN0-2245
REGULATOR - 5-METHYLTHIOFORMYCIN
//
UNIQUE-ID - REG0-10522
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8431434
MODE - -
REGULATED-ENTITY - GLUTATHIONE-SYN-ENZRXN
REGULATOR - CPD0-2275
//
UNIQUE-ID - REG0-9649
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [BlumenthalMethEnz9-665]
MODE - -
REGULATED-ENTITY - GALACTARDEHYDRA-ENZRXN
REGULATOR - CIT
//
UNIQUE-ID - REG0-11931
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2141983
MODE - -
REGULATED-ENTITY - ENZRXN0-7818
REGULATOR - CPD0-1250
//
UNIQUE-ID - REG0-6815
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8002619
CITATIONS - 10747806
COMMENT - Li<SUP>+</SUP> is a potent inhibitor.  |CITS: [10747806]| 
MODE - -
REGULATED-ENTITY - ENZRXN0-247
REGULATOR - LI+
//
UNIQUE-ID - REG0-7411
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4568817
CITATIONS - 4563765
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - PHOSPHOGLUCMUT-ENZRXN
REGULATOR - GTP
//
UNIQUE-ID - REG0-8014
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9011040]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - APHA-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-8613
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4150390]
MODE - -
REGULATED-ENTITY - SULFITE-REDUCT-ENZRXN
REGULATOR - CPD-5401
//
UNIQUE-ID - REG0-10399
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15895686
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLURS-ENZRXN
REGULATOR - CPD0-1883
//
UNIQUE-ID - REG0-9628
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10196195
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - ENOYL-ACP-REDUCT-NADH-ENZRXN
REGULATOR - CPD0-1227
//
UNIQUE-ID - REG0-11911
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24214977
KI - 4
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7811
REGULATOR - CPD-5721
//
UNIQUE-ID - REG0-6780
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - DTMPKI-ENZRXN
REGULATOR - AMMONIUM
//
UNIQUE-ID - REG0-7390
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10683258
COMMENT - K<SUP>+</SUP> is the most effective activator,
/followed by Rb<SUP>+</SUP> and NH<SUB>4</SUB><SUP>+</SUP>.
/Cs<SUP>+</SUP> is the least effective activator. 
/ |CITS: [10683258]| 
MODE - +
REGULATED-ENTITY - IMP-DEHYDROG-ENZRXN
REGULATOR - CPD-2
//
UNIQUE-ID - REG0-7980
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7042705]
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - ENZRXN-17895
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-8578
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - CD+2
//
UNIQUE-ID - REG0-10282
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329757
CITATIONS - 10625615
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ICITDEHKINASE-ENZRXN
REGULATOR - |Isocitrate|
//
UNIQUE-ID - REG0-9582
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4552540
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ADENYLATECYC-ENZRXN
REGULATOR - CPD0-1194
//
UNIQUE-ID - REG0-11839
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3009477
CITATIONS - 10954724
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PRPPSYN-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-6743
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - CITSYN-ENZRXN
REGULATOR - ACETYL-COA
//
UNIQUE-ID - REG0-7372
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [MalamyBiochem3-1893]
MODE - -
REGULATED-ENTITY - ALKAPHOSPHA-ENZRXN
REGULATOR - CYS
//
UNIQUE-ID - REG0-7934
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4364023]
CITATIONS - [177283]
COMMENT - linearly competitive with
/respect to homoserine, non-competitive with respect to ATP
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - HOMOSERKIN-ENZRXN
REGULATOR - CYS
//
UNIQUE-ID - REG0-8540
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 769833
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - URPHOS-ENZRXN
REGULATOR - RIBOSE-1P
//
UNIQUE-ID - REG0-10248
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16567800
MODE - -
REGULATED-ENTITY - ENZRXN0-6199
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-9522
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4557975
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - MANNKIN-ENZRXN
REGULATOR - |D-Mannosamines|
//
UNIQUE-ID - REG0-11803
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18422345
MODE - -
REGULATED-ENTITY - UDPHYDROXYMYRGLUCOSAMNACETYLTRANS-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-6725
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4895362
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ASNSYNA-ENZRXN
REGULATOR - AMMONIA
//
UNIQUE-ID - REG0-7353
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8530465]
COMMENT - competitive with respect to
/NADPH
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - FMNREDUCT-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-7905
TYPES - Regulation-of-Enzyme-Activity
MODE - +
REGULATED-ENTITY - THIKIN-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-8519
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7860596
COMMENT - probably functions as feedback inhibition  |CITS: [7860596]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PNP-PMPOXI-ENZRXN
REGULATOR - PYRIDOXAL_PHOSPHATE
//
UNIQUE-ID - REG0-10218
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19109926
MODE - -
REGULATED-ENTITY - ENZRXN0-6613
REGULATOR - ATP
//
UNIQUE-ID - REG0-9459
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9047371
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - ACNEULY-ENZRXN
REGULATOR - OH-PYR
//
UNIQUE-ID - REG0-11779
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9387
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - DAHPSYNTYR-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-6700
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4945113]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ALDOSE1EPIM-ENZRXN
REGULATOR - 2-DEOXY-D-GLUCOSE
//
UNIQUE-ID - REG0-7289
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1316760]
COMMENT - Mg++ was the best activator. |CITS: [1316760]| 
MODE - +
REGULATED-ENTITY - PPK-ENZRXN
REGULATOR - CO+2
//
UNIQUE-ID - REG0-7872
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13794771
MODE - -
REGULATED-ENTITY - GLUCUROISOM-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-8494
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4384650]
MODE - +
REGULATED-ENTITY - ENOYL-ACP-REDUCT-NADH-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-10180
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13844669
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - AMYLOMALT-ENZRXN
REGULATOR - CPD0-1668
//
UNIQUE-ID - REG0-9397
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18245280
MECHANISM - :UNCOMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-1702
REGULATOR - ACETYL-COA
//
UNIQUE-ID - REG0-11760
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3280015
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7757
REGULATOR - CPD-3
//
UNIQUE-ID - REG0-6672
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6282821]
COMMENT - Ethanol and dimethyl sulfoxide
/inhibit the model reaction using PNPP as a substrate analog.
MODE - -
REGULATED-ENTITY - ACID-PHOSPHAT-ENZRXN
REGULATOR - OXALATE
//
UNIQUE-ID - REG0-7269
TYPES - Regulation-of-Enzyme-Activity
COMMENT - with respect to
/phosphoenolpyruvate  |CITS: [42643]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PEPCARBOX-ENZRXN
REGULATOR - |DL-Phospholactate|
//
UNIQUE-ID - REG0-7848
TYPES - Regulation-of-Enzyme-Activity
COMMENT - competitive with
/L-ornithine,induces cooperative interactions between subunits of the
/enzyme.  |CITS: [7048313] [KuoPNAS80,3243]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ORNCARBAMTRANSFERF-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-8473
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15582453
MODE - -
REGULATED-ENTITY - ASPS-ENZRXN
REGULATOR - CPD0-915
//
UNIQUE-ID - REG0-10151
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [2495789]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - CPD0-1585
//
UNIQUE-ID - REG0-9305
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4581499
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - MANNONDEHYDRAT-ENZRXN
REGULATOR - CPD0-1656
//
UNIQUE-ID - REG0-11691
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21602303
KI - 34.7    
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6184
REGULATOR - ADENOSINE
//
UNIQUE-ID - REG0-6650
TYPES - Regulation-of-Enzyme-Activity
COMMENT - Shows competitive inhibition in the fumarate reduction reaction.  |CITS: [10486141]| 
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - FUMARATE-REDN-ENZRXN
REGULATOR - |2-Alkyl-Dinitrophenol-Derivatives|
//
UNIQUE-ID - REG0-7232
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [357906]
MODE - -
REGULATED-ENTITY - ADENPRIBOSYLTRAN-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-7829
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3651424
COMMENT - Along with several other dicaroxylic acids, displays `slow-binding'
/reversible inhibition, by binding at both sites.
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYANLY-ENZRXN
REGULATOR - OXALATE
//
UNIQUE-ID - REG0-8452
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4878695]
CITATIONS - [4878694]
MODE - +
REGULATED-ENTITY - GLYCOPHOSPHORYL-ENZRXN
REGULATOR - F-
//
UNIQUE-ID - REG0-10127
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12952
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DAHPSYNPHE-ENZRXN
REGULATOR - 23-DIPHOSPHOGLYCERATE
//
UNIQUE-ID - REG0-9212
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9150206
MODE - NIL
REGULATED-ENTITY - MENF-ENZRXN
REGULATOR - 2-MERCAPTOETHANOL
//
UNIQUE-ID - REG0-11673
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1463470
CITATIONS - 7832769
KI - 1600
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIHYDRODIPICSYN-ENZRXN
REGULATOR - 3-BROMOPYRUVATE
//
UNIQUE-ID - REG0-6626
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14982633
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6343
REGULATOR - PUTRESCINE
//
UNIQUE-ID - REG0-7210
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6383480]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLYCEROL-3-P-ACYLTRANSFER-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-7813
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 361681
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - LEUAMINOTRANS-ENZRXN
REGULATOR - LEU
//
UNIQUE-ID - REG0-8435
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14641112
MODE - -
REGULATED-ENTITY - ENZRXN0-6041
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-10104
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [JOrgChem54-2404]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PREPHENATEDEHYDRAT-ENZRXN
REGULATOR - CPD0-1525
//
UNIQUE-ID - REG0-9190
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 40956
MODE - -
REGULATED-ENTITY - LACTALDREDUCT-ENZRXN
REGULATOR - PROPANE-1-2-DIOL
//
UNIQUE-ID - REG0-11606
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8980649
MODE - -
REGULATED-ENTITY - HYDROPEROXIDII-ENZRXN
REGULATOR - CPD-13584
//
UNIQUE-ID - REG0-12468
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - -
REGULATED-ENTITY - ENZRXN0-8286
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7186
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6321507]
MODE - -
REGULATED-ENTITY - CYT-D-UBIOX-ENZRXN
REGULATOR - CPD-2841
//
UNIQUE-ID - REG0-7791
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3294837
MODE - -
REGULATED-ENTITY - 3-OXOACYL-ACP-SYNTHII-BASE-ENZRXN
REGULATOR - CPD-6901
//
UNIQUE-ID - REG0-8408
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1731613]
MODE - -
REGULATED-ENTITY - L-GLN-FRUCT-6-P-AMINOTRANS-ENZRXN
REGULATOR - DIETHYLPYROCARBONATE
//
UNIQUE-ID - REG0-10067
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4307450]
MODE - -
REGULATED-ENTITY - DTDPGLUCDEHYDRAT-ENZRXN
REGULATOR - |Sulfhydryls|
//
UNIQUE-ID - REG0-9138
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7774707
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - TRANS-ENZRXN-130
REGULATOR - CPD-10324
//
UNIQUE-ID - REG0-11560
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4323856
MODE - -
REGULATED-ENTITY - ENZRXN0-1304
REGULATOR - NADH
//
UNIQUE-ID - REG0-9975
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9770455
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - ENZRXN0-3801
REGULATOR - CPD0-1436
//
UNIQUE-ID - REG0-12452
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8266
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7153
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - MALEATE
//
UNIQUE-ID - REG0-7754
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1577828]
MODE - -
REGULATED-ENTITY - KDOTRANS-ENZRXN
REGULATOR - KDO2-LIPID-A
//
UNIQUE-ID - REG0-8386
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4365537
MODE - -
REGULATED-ENTITY - N-ACETYLGLUTPREDUCT-ENZRXN
REGULATOR - NI+2
//
UNIQUE-ID - REG0-10049
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ISOCITDEH-ENZRXN
REGULATOR - CPD-628
//
UNIQUE-ID - REG0-9111
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15155761
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - LSERINEDEAM1-ENZRXN
REGULATOR - CYS
//
UNIQUE-ID - REG0-11446
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 340460
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6416
REGULATOR - GAP
//
UNIQUE-ID - REG0-9917
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1391
MODE - -
REGULATED-ENTITY - ENZRXN0-6609
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-12436
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8258
REGULATOR - TRIS-HYDROCHLORIDE
//
UNIQUE-ID - REG0-7111
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4349042
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - HISTIDPHOS-ENZRXN
REGULATOR - HISTIDINOL
//
UNIQUE-ID - REG0-7724
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4893578]
MODE - -
REGULATED-ENTITY - GSDEADENYLATION-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-8368
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [189701]
MODE - -
REGULATED-ENTITY - GMP-SYN-GLUT-ENZRXN
REGULATOR - TRIS
//
UNIQUE-ID - REG0-10031
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7643397
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - TRPS-ENZRXN
REGULATOR - CPD0-1480
//
UNIQUE-ID - REG0-9057
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - femsletbusch29-231-85
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - 1PFRUCTPHOSPHN-ENZRXN
REGULATOR - CPD-5541
//
UNIQUE-ID - REG0-11357
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 372191
MODE - -
REGULATED-ENTITY - PRPPAMIDOTRANS-ENZRXN
REGULATOR - CPD0-1627
//
UNIQUE-ID - REG0-9898
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2005134
MODE - -
REGULATED-ENTITY - PSII-ENZRXN
REGULATOR - O-PHENANTHROLINE
//
UNIQUE-ID - REG0-12395
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 26678554
MODE - -
REGULATED-ENTITY - ENZRXN0-8126
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7092
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1576149
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - INOPHOSPHOR-ENZRXN
REGULATOR - FORMYCIN-A
//
UNIQUE-ID - REG0-7696
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329757
MODE - -
REGULATED-ENTITY - ICITDEHKINASE-ENZRXN
REGULATOR - 2-KETOGLUTARATE
//
UNIQUE-ID - REG0-8343
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6463
COMMENT - inhibited the forward reaction
/|CITS: [6463]|
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - 3-METHYL-2-OXOBUT-OHCH3XFER-ENZRXN
REGULATOR - CO-A
//
UNIQUE-ID - REG0-10011
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8440684
MODE - -
REGULATED-ENTITY - GLYOCARBOLIG-ENZRXN
REGULATOR - CPD0-1464
//
UNIQUE-ID - REG0-8974
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 163250
CITATIONS - 8460951
MODE - +
REGULATED-ENTITY - HOMOSERDEHYDROGI-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-11314
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1325457]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PFLDEACTIV-ENZRXN
REGULATOR - NADH
//
UNIQUE-ID - REG0-9864
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7929323
MODE - -
REGULATED-ENTITY - RIBONUCLEOSIDE-TRIP-REDUCT-ENZRXN
REGULATOR - CPD0-1390
//
UNIQUE-ID - REG0-12351
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16791965
MODE - -
REGULATED-ENTITY - SORB6PDEHYDROG-ENZRXN
REGULATOR - CPD-15979
//
UNIQUE-ID - REG0-7073
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4550559
COMMENT - GTP activates the first step of
/the glutamine reaction, and the ammonia reaction is unaffected.  ATP
/and UTP induce different conformational changes, induce formation of
/the tetramer and accelerate the glutaminase activity. |CITS:
/[3514618] [KoshlandLevitzkiEnzymes105391974]|
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - CTPSYN-ENZRXN
REGULATOR - GTP
//
UNIQUE-ID - REG0-7670
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 224913
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - MALIC-NAD-ENZRXN
REGULATOR - CO-A
//
UNIQUE-ID - REG0-8304
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3294837]
COMMENT - cerulenin and
/thiolactomycin are antibiotics
MODE - -
REGULATED-ENTITY - 3-OXOACYL-ACP-SYNTHI-ENZRXN
REGULATOR - CPD-6901
//
UNIQUE-ID - REG-14947
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9214294]
CREDITS - SRI
CREDITS - |caspi|
MODE - -
REGULATED-ENTITY - ENZRXN-23149
REGULATOR - ENTB-MONOMER
//
UNIQUE-ID - REG0-8920
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8550422
COMMENT - inhibits
/the reductase activity  |CITS: [8550422]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - KETOGLUTREDUCT-ENZRXN
REGULATOR - 2-HYDROXYGLUTARIC_ACID
//
UNIQUE-ID - REG0-11296
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7702553
MODE - -
REGULATED-ENTITY - AMINEPHEN-ENZRXN
REGULATOR - SEMICARBAZIDE
//
UNIQUE-ID - REG0-9841
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6368527]
MODE - -
REGULATED-ENTITY - PEPCARBOX-ENZRXN
REGULATOR - |DL-Phosphomalate|
//
UNIQUE-ID - REG0-12308
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - CHEN09WORDJMICRO
CITATIONS - 8226676
MODE - +
REGULATED-ENTITY - ENZRXN0-4502
REGULATOR - CO+2
//
UNIQUE-ID - REG0-7055
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4557653]
MODE - -
REGULATED-ENTITY - GLYCOLATEDEHYDRO-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-7644
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [11488932]
CITATIONS - [3025169]
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - NAD-KIN-ENZRXN
REGULATOR - NADH
//
UNIQUE-ID - REG0-8282
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3291954
COMMENT - Competitive with respect to isocitrate.  |CITS: [3291954]| 
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ISOCITLYASE-ENZRXN
REGULATOR - MALONATE
//
UNIQUE-ID - REG0-8899
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4860415
MODE - -
REGULATED-ENTITY - GLUTAMINESYN-ENZRXN
REGULATOR - CARBAMOYL-P
//
UNIQUE-ID - REG0-11231
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5329747
CITATIONS - 11009607
MODE - -
REGULATED-ENTITY - INORGPYROPHOSPHAT-ENZRXN
REGULATOR - F-
//
UNIQUE-ID - REG0-9824
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SUCCINATE-OXN-ENZRXN
REGULATOR - |2-Alkyl-Dinitrophenol-Derivatives|
//
UNIQUE-ID - REG0-12282
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2201947
KI - 2
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-1625
REGULATOR - SINEFUNGIN
//
UNIQUE-ID - REG0-7022
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [692401]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - HYPOXANPRIBOSYLTRAN-ENZRXN
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-7617
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4388614]
CITATIONS - [SpinaBiochem193794]
CITATIONS - 17557829
CITATIONS - 7016178
MODE - +
REGULATED-ENTITY - MALIC-NADP-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-8252
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3291856]
MODE - -
REGULATED-ENTITY - ACP-S-ACETYLTRANSFER-ENZRXN
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-8844
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12133
MODE - -
REGULATED-ENTITY - PYRROLINECARBREDUCT-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-11109
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21545144
MODE - -
REGULATED-ENTITY - CYTDEAM-ENZRXN
REGULATOR - CPD0-2458
//
UNIQUE-ID - REG0-9797
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14245401
MODE - -
REGULATED-ENTITY - THIOREDOXIN-REDUCT-NADPH-ENZRXN
REGULATOR - CPD0-1355
//
UNIQUE-ID - REG0-12263
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12714684
MODE - -
REGULATED-ENTITY - ENZRXN0-7969
REGULATOR - chlorobiphenyl vancomycin
//
UNIQUE-ID - REG0-6997
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2655695
COMMENT - At concn > 3.2 mM
/|CITS:  [2655695]|
MODE - -
REGULATED-ENTITY - PYRUVATEDEH-ENZRXN
REGULATOR - NAD
//
UNIQUE-ID - REG0-7583
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6384188]
MODE - -
REGULATED-ENTITY - SORB6PDEHYDROG-ENZRXN
REGULATOR - DIETHYLPYROCARBONATE
//
UNIQUE-ID - REG0-8229
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10736170
COMMENT - NADP<SUP>+</SUP> is competitive with respect to 
/NADPH but noncompetitive with respect to ketopantoate.
/
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - 2-DEHYDROPANTOATE-REDUCT-ENZRXN
REGULATOR - NADP
//
UNIQUE-ID - REG0-8822
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4992818
MODE - -
REGULATED-ENTITY - D-PPENTOMUT
REGULATOR - CD+2
//
UNIQUE-ID - REG0-11017
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21467222
MODE - -
REGULATED-ENTITY - ENZRXN0-7454
REGULATOR - AG+
//
UNIQUE-ID - REG0-9774
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3905407]
MODE - -
REGULATED-ENTITY - UDP-NACMURALGLDAPLIG-ENZRXN
REGULATOR - CPD0-1330
//
UNIQUE-ID - REG0-12246
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14693515
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - cefazolin
//
UNIQUE-ID - REG0-6962
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [376531]
MODE - -
REGULATED-ENTITY - ORNCARBAMTRANSFERI-ENZRXN
REGULATOR - N-DELTA-PHOSPHONOACETYL-L-ORNITHINE
//
UNIQUE-ID - REG0-7559
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4581499]
MODE - +
REGULATED-ENTITY - MANNONDEHYDRAT-ENZRXN
REGULATOR - GLUCURONATE
//
UNIQUE-ID - REG0-8195
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [WallenfelsTheEnzymes7-617]
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - PROPANOL
//
UNIQUE-ID - REG0-8803
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6767707
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-4281
REGULATOR - D-SERINE
//
UNIQUE-ID - REG0-10946
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7578154
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-1641
REGULATOR - CPD0-2400
//
UNIQUE-ID - REG0-9756
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2954322]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - URPHOS-ENZRXN
REGULATOR - |Acyclonucleoside-Analogues|
//
UNIQUE-ID - REG0-12210
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17314096
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - F16BDEPHOS-ENZRXN
REGULATOR - CIT
//
UNIQUE-ID - REG0-6938
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9665712]
CITATIONS - 11945670
CITATIONS - 4563643
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - METHGLYSYN-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-7540
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 164459
MODE - -
REGULATED-ENTITY - GMP-SYN-NH3-ENZRXN
REGULATOR - ADENOSINE
//
UNIQUE-ID - REG0-8169
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1646790
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PHEAMINOTRANS-ENZRXN
REGULATOR - 2-KETO-ISOVALERATE
//
UNIQUE-ID - REG0-8772
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3096379]
CITATIONS - [HandEnzInh]
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ORNDECARBOX-BIO-ENZRXN
REGULATOR - L-THREONINE-O-3-PHOSPHATE
//
UNIQUE-ID - REG0-10868
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13221579
MODE - -
REGULATED-ENTITY - ACETATEKINA-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-9735
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4721625]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - CPD0-1304
//
UNIQUE-ID - REG0-12169
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8836102
MODE - +
REGULATED-ENTITY - F16ALDOLASE-ENZRXN-CLASSII
REGULATOR - K+
//
UNIQUE-ID - REG0-6919
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12630859
MODE - -
REGULATED-ENTITY - IPPISOM-ENZRXN
REGULATOR - CPD0-1025
//
UNIQUE-ID - REG0-7518
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3518793]
MODE - -
REGULATED-ENTITY - THREODEHYD-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-8148
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7034777
COMMENT - inhibit the enzyme by competing
/for both the NAD+ and CoA binding sites.  |CITS: [7034777]|
MODE - -
REGULATED-ENTITY - ACETALD-DEHYDROG-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-8747
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [776970]
MODE - -
REGULATED-ENTITY - GLUTAMINB-ENZRXN
REGULATOR - CPD-607
//
UNIQUE-ID - REG0-10765
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20522491
MODE - +
REGULATED-ENTITY - ENZRXN0-7381
REGULATOR - MG+2
//
UNIQUE-ID - REG0-9717
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - CPD0-1271
//
UNIQUE-ID - REG0-12136
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2139607
MODE - -
REGULATED-ENTITY - NITRATREDUCTZ-ENZRXN
REGULATOR - CPD-7975
//
UNIQUE-ID - REG0-6894
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7848303
COMMENT - The
/enzyme is sensitive to thiol-blocking reagents.  Activity blocked by
/p-hydroxymercuribenzoate or 5,5'-dithiobis-(2-nitrobenzoate) could be
/restored by addition of dithiothreitol, 2-mercaptoethanol or GSH.
/|CITS: [7848303]|
MODE - -
REGULATED-ENTITY - GLYOXIII-ENZRXN
REGULATOR - PHMB
//
UNIQUE-ID - REG0-7501
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [WestwoodMicrobios9,143]
COMMENT - competitive in the presence
/and non-competitive in the absence of 2-mercaptoethanol with respect
/to NADP+, a mixed type inhibition is observed in both cases with
/respect to 6-phosphogluconate
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - 6PGLUCONDEHYDROG-ENZRXN
REGULATOR - NADP
//
UNIQUE-ID - REG0-8121
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [MethEnz17A-708]
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - ASP-SEMIALDEHYDE-DEHYDROGENASE-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-8721
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4630409]
COMMENT - slight inhibition
MODE - -
REGULATED-ENTITY - GALACTOACETYLTRAN-ENZRXN
REGULATOR - O-PHENANTHROLINE
//
UNIQUE-ID - REG0-10715
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17567041
MODE - +
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - CPD-1484
//
UNIQUE-ID - REG0-9701
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1577828]
MODE - -
REGULATED-ENTITY - KDOTRANS2-ENZRXN
REGULATOR - CPD0-1283
//
UNIQUE-ID - REG0-12097
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 25139244
MODE - -
REGULATED-ENTITY - ENZRXN0-7897
REGULATOR - CYS
//
UNIQUE-ID - REG0-6874
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9733680
COMMENT - inactivated the enzyme, but the presence of either acetyl-CoA or beta-mercaptoethanol at high concentrations could protect the enzyme from inactivation
MODE - -
REGULATED-ENTITY - GLUCOSAMINE1PACETYL-ENZRXN
REGULATOR - DITHIO-NITROBENZOATE
//
UNIQUE-ID - REG0-7475
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4229913
MECHANISM - :ALLOSTERIC
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - 6PFRUCTPHOS-ENZRXN
REGULATOR - GDP
//
UNIQUE-ID - REG0-8094
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [14299611]
MODE - -
REGULATED-ENTITY - GDPMANDEHYDRA-ENZRXN
REGULATOR - CPD-5401
//
UNIQUE-ID - REG0-8696
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - FishMethEnz9-529
COMMENT - inhibition is due to chelation and binding to the enzyme
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - D-GALACTARATE
//
UNIQUE-ID - REG0-10639
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7665468
MODE - -
REGULATED-ENTITY - GUANOSINEKIN-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-9685
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - GLUTACONATE
//
UNIQUE-ID - REG0-11999
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 37899
KI - 1600
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ARGS-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-6858
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 348198
MODE - +
REGULATED-ENTITY - F16ALDOLASE-ENZRXN-CLASSI
REGULATOR - GLYCEROL-3P
//
UNIQUE-ID - REG0-7454
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2853974]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ASPARTASE-ENZRXN
REGULATOR - CPD0-1615
//
UNIQUE-ID - REG0-8070
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10224113
MODE - -
REGULATED-ENTITY - ENZRXN0-3461
REGULATOR - ADENOSYL-HOMO-CYS
//
UNIQUE-ID - REG0-8667
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3905407]
MODE - -
REGULATED-ENTITY - UDP-NACMURALGLDAPLIG-ENZRXN
REGULATOR - UDP
//
UNIQUE-ID - REG0-10600
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 334530
MODE - -
REGULATED-ENTITY - CHORISMATEMUT2-ENZRXN
REGULATOR - CPD-12153
//
UNIQUE-ID - REG0-9666
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10556628]
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - PYRNUTRANSHYDROGEN-ENZRXN
REGULATOR - CPD0-1250
//
UNIQUE-ID - REG0-11960
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11527960
MODE - -
REGULATED-ENTITY - THREDEHYDSYN-ENZRXN
REGULATOR - D-CYSTEINE
//
UNIQUE-ID - REG0-6834
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3276686
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-3782
REGULATOR - TRNA
//
UNIQUE-ID - REG0-7427
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [357905]
MODE - -
REGULATED-ENTITY - ADENODEAMIN-ENZRXN
REGULATOR - COFORMYCIN
//
UNIQUE-ID - REG0-8044
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5332668
MODE - -
REGULATED-ENTITY - SERINE-O-ACETTRAN-ENZRXN
REGULATOR - SER
//
UNIQUE-ID - REG0-8643
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - 3-DEHYDROQUINATE-SYNTHASE-ENZRXN
REGULATOR - NAD
//
UNIQUE-ID - REG0-10450
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19815542
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CPM-KDOSYNTH-ENZRXN
REGULATOR - CPD0-2019
//
UNIQUE-ID - REG0-9643
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [821948]
KI - 0.13    
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GTP-CYCLOHYDRO-I-ENZRXN
REGULATOR - GUANOSINE_TETRAPHOSPHATE
//
UNIQUE-ID - REG0-11927
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - Treffry98
MODE - -
REGULATED-ENTITY - ENZRXN0-6577
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-6802
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [12147680]
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - ENZRXN0-1105
REGULATOR - EDTA
//
UNIQUE-ID - REG0-7408
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4568817
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - PHOSPHOGLUCMUT-ENZRXN
REGULATOR - TDP
//
UNIQUE-ID - REG0-8011
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9011040]
MODE - -
REGULATED-ENTITY - APHA-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-8610
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4150390]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SULFITE-REDUCT-ENZRXN
REGULATOR - HCN
//
UNIQUE-ID - REG0-10371
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - DIACYLGLYKIN-ENZRXN
REGULATOR - CPD0-1816
//
UNIQUE-ID - REG0-9623
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [MethEnz17A-708]
MODE - -
REGULATED-ENTITY - ASP-SEMIALDEHYDE-DEHYDROGENASE-ENZRXN
REGULATOR - TRIS
//
UNIQUE-ID - REG0-11908
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24214977
KI - 19
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7809
REGULATOR - CPD-16183
//
UNIQUE-ID - REG0-6776
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4899016]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DTMPKI-ENZRXN
REGULATOR - DUMP
//
UNIQUE-ID - REG0-7385
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 235552
MODE - -
REGULATED-ENTITY - GTP-CYCLOHYDRO-II-ENZRXN
REGULATOR - GUANOSINE_TETRAPHOSPHATE
//
UNIQUE-ID - REG0-7977
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1645722
MODE - -
REGULATED-ENTITY - THIOESTERII-ENZRXN
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-8573
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - SUC
//
UNIQUE-ID - REG0-10279
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8941345
MODE - -
REGULATED-ENTITY - ENZRXN0-6633
REGULATOR - 5-N-PROPYLTHIOADENOSINE
//
UNIQUE-ID - REG0-9562
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7925376
MODE - -
REGULATED-ENTITY - ENZRXN0-4822
REGULATOR - PENICILLIN-G
//
UNIQUE-ID - REG0-11835
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15489502
MODE - -
REGULATED-ENTITY - ENZRXN0-5221
REGULATOR - DGTP
//
UNIQUE-ID - REG0-6740
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :ALLOSTERIC
MODE - -
REGULATED-ENTITY - CITSYN-ENZRXN
REGULATOR - NAD
//
UNIQUE-ID - REG0-7369
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [MalamyBiochem3-1893]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ALKAPHOSPHA-ENZRXN
REGULATOR - THIOGLYCOLATE
//
UNIQUE-ID - REG0-7927
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3280546]
MODE - +
REGULATED-ENTITY - DIMESULFREDUCT-ENZRXN
REGULATOR - FE+2
//
UNIQUE-ID - REG0-8537
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10600526
COMMENT - Noncompetitive with respect to bicarbonate.
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - BIOTIN-CARBOXYL-ENZRXN
REGULATOR - CPD-764
//
UNIQUE-ID - REG0-10245
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4349042
MODE - -
REGULATED-ENTITY - IMIDPHOSDEHYD-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-9516
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15136582
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PANTOTHENATE-KIN-ENZRXN
REGULATOR - CPD0-1153
//
UNIQUE-ID - REG0-11799
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 23823238
MODE - -
REGULATED-ENTITY - PFRUCTPHOS-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-6718
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6365902]
MODE - -
REGULATED-ENTITY - AMINOPROPDEHYDROG-ENZRXN
REGULATOR - FE+2
//
UNIQUE-ID - REG0-7343
TYPES - Regulation-of-Enzyme-Activity
COMMENT - When GDP is the substrate ppGpp might
/cause end-product inhibition.  |CITS: [3015258]|
MODE - -
REGULATED-ENTITY - GDPPYPHOSKINI-ENZRXN
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-7898
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6305942]
COMMENT - 20% inhibition at 1mM
MODE - -
REGULATED-ENTITY - XANPRIBOSYLTRAN-ENZRXN
REGULATOR - XANTHOSINE-5-PHOSPHATE
//
UNIQUE-ID - REG0-8516
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6988389
MODE - -
REGULATED-ENTITY - KDO-8PSYNTH-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-10213
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2007545
MODE - -
REGULATED-ENTITY - 7-ALPHA-HYDROXYSTEROID-DEH-ENZRXN
REGULATOR - CPD0-1696
//
UNIQUE-ID - REG0-9456
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3886014
MODE - -
REGULATED-ENTITY - GUANPRIBOSYLTRAN-ENZRXN
REGULATOR - CPD-5721
//
UNIQUE-ID - REG0-11773
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6383480
MODE - -
REGULATED-ENTITY - GLYCEROL-3-P-ACYLTRANSFER-ENZRXN
REGULATOR - PHENYLGLYOXAL
//
UNIQUE-ID - REG0-10209
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2007545
MODE - -
REGULATED-ENTITY - 7-ALPHA-HYDROXYSTEROID-DEH-ENZRXN
REGULATOR - CPD0-1694
//
UNIQUE-ID - REG0-9439
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6338013
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PREPHENATEDEHYDROG-ENZRXN
REGULATOR - TYR
//
UNIQUE-ID - REG0-11770
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6383480
MECHANISM - :MIXED
MODE - -
REGULATED-ENTITY - GLYCEROL-3-P-ACYLTRANSFER-ENZRXN
REGULATOR - CPD0-1458
//
UNIQUE-ID - REG0-6695
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3117785]
MODE - -
REGULATED-ENTITY - AKBLIG-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-7285
TYPES - Regulation-of-Enzyme-Activity
COMMENT - inhibitory at high levels |CITS: [2164013]| 
MODE - -
REGULATED-ENTITY - PPK-ENZRXN
REGULATOR - NH42SO4
//
UNIQUE-ID - REG0-7869
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13794771
MODE - -
REGULATED-ENTITY - GLUCUROISOM-ENZRXN
REGULATOR - 2-MERCAPTOETHANOL
//
UNIQUE-ID - REG0-8491
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4384650]
MODE - -
REGULATED-ENTITY - ENOYL-ACP-REDUCT-NADH-ENZRXN
REGULATOR - IODOACETATE
//
UNIQUE-ID - REG0-10171
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4565667]
MODE - -
REGULATED-ENTITY - DLACTDEHYDROGFAD-ENZRXN
REGULATOR - CPD0-1604
//
UNIQUE-ID - REG0-9371
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 195622
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - MANNONOXIDOREDUCT-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-11741
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21957966
MODE - +
REGULATED-ENTITY - ORNDECARBOXDEG-ENZRXN
REGULATOR - GDP-TP
//
UNIQUE-ID - REG0-6665
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2007545
MODE - -
REGULATED-ENTITY - 7-ALPHA-HYDROXYSTEROID-DEH-ENZRXN
REGULATOR - N-BROMOSUCCINIMIDE
//
UNIQUE-ID - REG0-7842
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9143339
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - NAG6PDEACET-ENZRXN
REGULATOR - ACET
//
UNIQUE-ID - REG0-8470
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4198624
MODE - -
REGULATED-ENTITY - F16ALDOLASE-ENZRXN-CLASSII
REGULATOR - EDTA
//
UNIQUE-ID - REG0-10148
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4387360]
CITATIONS - [7005446]
CITATIONS - [HandEnzInh]
CITATIONS - [6814484]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - CPD0-1581
//
UNIQUE-ID - REG0-9302
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14401695
CITATIONS - 4402996
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - MANNONOXIDOREDUCT-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-11688
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15016358
MODE - -
REGULATED-ENTITY - ENZRXN0-7445
REGULATOR - MG+2
//
UNIQUE-ID - REG0-6647
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1581388
CITATIONS - 2124684
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6142
REGULATOR - CPD-11426
//
UNIQUE-ID - REG0-7229
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4328693
COMMENT - competition with
/PRPP may be cooperative
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ADENPRIBOSYLTRAN-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-7826
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3301828]
COMMENT - inhibits at both
/substrate sites
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYANLY-ENZRXN
REGULATOR - NITRATE
//
UNIQUE-ID - REG0-8449
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4878694]
CITATIONS - [4878695]
MODE - -
REGULATED-ENTITY - GLYCOPHOSPHORYL-ENZRXN
REGULATOR - CPD-387
//
UNIQUE-ID - REG0-10124
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3027060
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ADENYL-KIN-ENZRXN
REGULATOR - CPD0-1552
//
UNIQUE-ID - REG0-9208
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3308886
MODE - -
REGULATED-ENTITY - GLYCOLALD-DEHYDROG-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-11670
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24449932
MODE - -
REGULATED-ENTITY - ENZRXN0-7682
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-6623
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14982633
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6343
REGULATOR - AGMATHINE
//
UNIQUE-ID - REG0-7202
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 372191
COMMENT - AMP versus PRPP
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PRPPAMIDOTRANS-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-7805
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [350870]
MODE - -
REGULATED-ENTITY - METHYLENETHFDEHYDROG-NADP-ENZRXN
REGULATOR - IMP
//
UNIQUE-ID - REG0-8432
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [11422389]
MODE - -
REGULATED-ENTITY - ENZRXN0-1521
REGULATOR - CA+2
//
UNIQUE-ID - REG0-10082
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6368264
MODE - -
REGULATED-ENTITY - ENZRXN0-6563
REGULATOR - EDTA
//
UNIQUE-ID - REG0-9180
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4616949
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - ENZRXN0-6440
REGULATOR - IODOACETATE
//
UNIQUE-ID - REG0-11598
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 22984449
MODE - +
REGULATED-ENTITY - ENZRXN0-7608
REGULATOR - MG+2
//
UNIQUE-ID - REG0-12465
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - -
REGULATED-ENTITY - ENZRXN0-8285
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7175
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3157043]
CITATIONS - 3290196
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - SPERMIDINE
//
UNIQUE-ID - REG0-7784
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [237196]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - RHAMNULPALDOL-ENZRXN
REGULATOR - O-PHENANTHROLINE
//
UNIQUE-ID - REG0-8403
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3132968
CITATIONS - 8805567
COMMENT - Competitive with respect to glutamine.  |CITS: [3132968]| 
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - L-GLN-FRUCT-6-P-AMINOTRANS-ENZRXN
REGULATOR - GLT
//
UNIQUE-ID - REG0-10064
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - FishMethEnz9-529
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - |Xylarates|
//
UNIQUE-ID - REG0-9132
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7547881
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - L-GLN-FRUCT-6-P-AMINOTRANS-ENZRXN
REGULATOR - L-GLUTAMATE_GAMMA-SEMIALDEHYDE
//
UNIQUE-ID - REG0-11547
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11825618
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CHORPYRLY-ENZRXN
REGULATOR - VANILLATE
//
UNIQUE-ID - REG0-9971
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3081491
MODE - -
REGULATED-ENTITY - AGMATIN-ENZRXN
REGULATOR - EGTA
//
UNIQUE-ID - REG0-12449
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8264
REGULATOR - TRIS-HYDROCHLORIDE
//
UNIQUE-ID - REG0-7149
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - PHTHALATE
//
UNIQUE-ID - REG0-7747
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 241744
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUTDEHYD-ENZRXN
REGULATOR - GLN
//
UNIQUE-ID - REG0-8382
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5333666]
MODE - +
REGULATED-ENTITY - GUANYL-KIN-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-10044
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1033766]
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - IMP-DEHYDROG-ENZRXN
REGULATOR - CPD0-1493
//
UNIQUE-ID - REG0-9106
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4580841]
CITATIONS - [374983]
MODE - -
REGULATED-ENTITY - THI-P-SYN-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-11411
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7552727
KI - 2300
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - FUMARC-ENZRXN
REGULATOR - TUNGSTATE
//
UNIQUE-ID - REG0-9914
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1391
MODE - -
REGULATED-ENTITY - ENZRXN0-4761
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-12433
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8256
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7108
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2675968
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ACETOLACTSYNIII-ENZRXN
REGULATOR - VAL
//
UNIQUE-ID - REG0-7721
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4365537]
MODE - +
REGULATED-ENTITY - ARGSUCCINLYA-ENZRXN
REGULATOR - NI+2
//
UNIQUE-ID - REG0-8365
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 164459
CITATIONS - [189701]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GMP-SYN-GLUT-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-10026
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4364023]
CITATIONS - [177283]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - HOMOSERKIN-ENZRXN
REGULATOR - CPD0-1475
//
UNIQUE-ID - REG0-9054
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14726201
MODE - -
REGULATED-ENTITY - ASP-SEMIALDEHYDE-DEHYDROGENASE-ENZRXN
REGULATOR - DITHIO-NITROBENZOATE
//
UNIQUE-ID - REG0-11349
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5327101]
CITATIONS - 10601247
KI - 3000
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DSERDEAM-ENZRXN
REGULATOR - SER
//
UNIQUE-ID - REG0-9894
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 365225
MODE - -
REGULATED-ENTITY - PSII-ENZRXN
REGULATOR - LI+
//
UNIQUE-ID - REG0-12383
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18714089
KI - 650
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - MALATESYN-ENZRXN
REGULATOR - PYRUVATE
//
UNIQUE-ID - REG0-7089
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7711027]
CITATIONS - 18945668
MECHANISM - :ALLOSTERIC
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - UMPKI-ENZRXN
REGULATOR - GTP
//
UNIQUE-ID - REG0-7693
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329757
CITATIONS - 10625615
MODE - -
REGULATED-ENTITY - ICITDEHKINASE-ENZRXN
REGULATOR - PYRUVATE
//
UNIQUE-ID - REG0-8340
TYPES - Regulation-of-Enzyme-Activity
COMMENT - inhibited the forward reaction  |CITS:
/[6463]|
MODE - -
REGULATED-ENTITY - 3-METHYL-2-OXOBUT-OHCH3XFER-ENZRXN
REGULATOR - ISOVALERATE
//
UNIQUE-ID - REG0-10005
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8172902
CITATIONS - [7873525]
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUTRACE-ENZRXN
REGULATOR - CPD0-1456
//
UNIQUE-ID - REG0-8971
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16905770
CITATIONS - 11368768
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ASPARTATEKINIII-ENZRXN
REGULATOR - LYS
//
UNIQUE-ID - REG0-11311
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 22068497
MODE - -
REGULATED-ENTITY - MALIC-NADP-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-9860
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1460049
MODE - -
REGULATED-ENTITY - RIBONUCLEOSIDE-TRIP-REDUCT-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-12348
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 26350134
MODE - -
REGULATED-ENTITY - ENZRXN0-8073
REGULATOR - CPD0-1562
//
UNIQUE-ID - REG0-7070
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4862983
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - CTPSYN-ENZRXN
REGULATOR - CTP
//
UNIQUE-ID - REG0-7660
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [380648]
CITATIONS - 9409147
MODE - -
REGULATED-ENTITY - CFA-ENZRXN
REGULATOR - DITHIO-NITROBENZOATE
//
UNIQUE-ID - REG0-8299
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 342522
MODE - +
REGULATED-ENTITY - ENZRXN0-5101
REGULATOR - K+
//
UNIQUE-ID - REG-14664
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1646603]
CREDITS - SRI
CREDITS - |caspi|
MODE - -
REGULATED-ENTITY - ENZRXN-22535
REGULATOR - DIETHYLPYROCARBONATE
//
UNIQUE-ID - REG0-8914
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3013841
CITATIONS - 2162151
MECHANISM - :ALLOSTERIC
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUC1PADENYLTRANS-ENZRXN
REGULATOR - FRUCTOSE-16-DIPHOSPHATE
//
UNIQUE-ID - REG0-11291
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1444446
MODE - -
REGULATED-ENTITY - AKBLIG-ENZRXN
REGULATOR - PHENYLGLYOXAL
//
UNIQUE-ID - REG0-9837
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16054140
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SERS-ENZRXN
REGULATOR - CPD0-1379
//
UNIQUE-ID - REG0-12305
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - CHEN09WORDJMICRO
MODE - +
REGULATED-ENTITY - ENZRXN0-4502
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7048
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [46]
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-7637
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [211379]
MODE - -
REGULATED-ENTITY - URKI-ENZRXN
REGULATOR - UTP
//
UNIQUE-ID - REG0-8278
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8494895]
MODE - -
REGULATED-ENTITY - GLUTAMIDOTRANS-ENZRXN
REGULATOR - MG+2
//
UNIQUE-ID - REG0-8891
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4860415
CITATIONS - 14104
CITATIONS - 235974
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUTAMINESYN-ENZRXN
REGULATOR - L-ALPHA-ALANINE
//
UNIQUE-ID - REG0-11228
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3512553
KI - 10000
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLYOHMETRANS-ENZRXN
REGULATOR - CL-
//
UNIQUE-ID - REG0-9820
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4301680]
CITATIONS - [7034777]
MODE - +
REGULATED-ENTITY - ACETALD-DEHYDROG-ENZRXN
REGULATOR - |Thiols|
//
UNIQUE-ID - REG0-12276
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20300061
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - NACMURLALAAMI2-ENZRXN
REGULATOR - EG12297-MONOMER
//
UNIQUE-ID - REG0-7015
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4404056
MODE - -
REGULATED-ENTITY - TYRAMINOTRANS-ENZRXN
REGULATOR - TYR
//
UNIQUE-ID - REG0-7612
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4385340
CITATIONS - 17557829
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - MALIC-NADP-ENZRXN
REGULATOR - ACETYL-COA
//
UNIQUE-ID - REG0-8248
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3291856]
COMMENT - weak competitive inhibitor
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ACP-S-ACETYLTRANSFER-ENZRXN
REGULATOR - CPD-511
//
UNIQUE-ID - REG0-8841
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5337593
COMMENT - competitive with the substrate |CITS: [5337593]|
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - UDPSUGARHYDRO-ENZRXN
REGULATOR - GDP-D-GLUCOSE
//
UNIQUE-ID - REG0-11043
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8831789
MODE - -
REGULATED-ENTITY - CYSTATHIONINE-BETA-LYASE-ENZRXN
REGULATOR - CPD0-1636
//
UNIQUE-ID - REG0-9793
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7005225
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PYRUVATEDEH-ENZRXN
REGULATOR - OH-PYR
//
UNIQUE-ID - REG0-12260
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7001458
MODE - -
REGULATED-ENTITY - ENZRXN0-7969
REGULATOR - ristocetin
//
UNIQUE-ID - REG0-6992
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7005225
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PYRUVATEDEH-ENZRXN
REGULATOR - GLYOX
//
UNIQUE-ID - REG0-7580
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [346589]
COMMENT - 85% inhibition at 2.5mM
MODE - -
REGULATED-ENTITY - DUTP-PYROP-ENZRXN
REGULATOR - O-PHENANTHROLINE
//
UNIQUE-ID - REG0-8222
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - ACETOOHBUTSYNII-ENZRXN
REGULATOR - VAL
//
UNIQUE-ID - REG0-8819
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4992818
MODE - -
REGULATED-ENTITY - D-PPENTOMUT
REGULATOR - FE+2
//
UNIQUE-ID - REG0-11014
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3157043]
CITATIONS - 3091070
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - CPD0-1396
//
UNIQUE-ID - REG0-9770
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3513846]
MODE - -
REGULATED-ENTITY - URACIL-PRIBOSYLTRANS-ENZRXN
REGULATOR - |Uridine-Nucleotides|
//
UNIQUE-ID - REG0-12243
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14693515
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - cephadroxil
//
UNIQUE-ID - REG0-6955
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2857097
CITATIONS - 2885030
COMMENT - In concentrations of 2 to 50 microM, phosphatidylglycerol activated the enzyme.  Higher concentrations led to inactivation of the enzyme. The specifc identity of the amidase purified by these authors is not known.
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - NACMURLALAAMI1-ENZRXN
REGULATOR - L-1-PHOSPHATIDYL-GLYCEROL
//
UNIQUE-ID - REG0-7556
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4581499]
MODE - +
REGULATED-ENTITY - MANNONDEHYDRAT-ENZRXN
REGULATOR - D-ALTRONATE
//
UNIQUE-ID - REG0-8185
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6811114]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - GALACTOSE
//
UNIQUE-ID - REG0-8791
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8631920
COMMENT - Acyl-ACP showed a mixed type inhibition with respect to acetyl-CoA.
MECHANISM - :OTHER
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - 3-OXOACYL-ACP-COA-SYNTHIII-ENZRXN
REGULATOR - ACYL-ACP
//
UNIQUE-ID - REG0-10943
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9055203
MODE - -
REGULATED-ENTITY - ENZRXN0-1641
REGULATOR - METHYLMETHANETHIOSULFONATE
//
UNIQUE-ID - REG0-9752
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2186813
MODE - -
REGULATED-ENTITY - UDPGLUCEPIM-ENZRXN
REGULATOR - CPD0-1314
//
UNIQUE-ID - REG0-12186
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4592651
MODE - -
REGULATED-ENTITY - ENZRXN0-7912
REGULATOR - ADENOSINE
//
UNIQUE-ID - REG0-6935
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4590109
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - LYSDECARBOX-ENZRXN
REGULATOR - CPD-884
//
UNIQUE-ID - REG0-7536
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 189701
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - GMP-SYN-NH3-ENZRXN
REGULATOR - CPD0-1627
//
UNIQUE-ID - REG0-8166
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2653362
CITATIONS - 4588693
COMMENT - high concentrations of Mg+2 and ADP |CITS:[2653362]|
MODE - -
REGULATED-ENTITY - PEPDEPHOSI-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-8769
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [15587]
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ORNDECARBOX-BIO-ENZRXN
REGULATOR - SPERMIDINE
//
UNIQUE-ID - REG0-10865
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20236319
MODE - +
REGULATED-ENTITY - PHOSACETYLTRANS-ENZRXN
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-9732
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - CPD0-1300
//
UNIQUE-ID - REG0-12166
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 348198
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - F16ALDOLASE-ENZRXN-CLASSI
REGULATOR - BOROHYDRIDE
//
UNIQUE-ID - REG0-6908
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4867671]
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GSADENYLATION-ENZRXN
REGULATOR - GLN
//
UNIQUE-ID - REG0-7515
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6780553]
MODE - -
REGULATED-ENTITY - THREODEHYD-ENZRXN
REGULATOR - DITHIO-NITROBENZOATE
//
UNIQUE-ID - REG0-8145
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7034777]
COMMENT - with respect to NAD+ under steady
/state conditions
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ACETALD-DEHYDROG-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-8744
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [776970]
MODE - -
REGULATED-ENTITY - GLUTAMINB-ENZRXN
REGULATOR - NADP
//
UNIQUE-ID - REG0-10748
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19261245
MODE - +
REGULATED-ENTITY - NADH-DHI-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-9714
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - CPD0-1274
//
UNIQUE-ID - REG0-12133
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3311749]
MODE - -
REGULATED-ENTITY - NITRATREDUCTZ-ENZRXN
REGULATOR - CPD-7082
//
UNIQUE-ID - REG0-6887
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8226921
COMMENT - competes with ADP-glucose
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLYCOGENSYN-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-7498
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [14336062]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - MALSYNG-ENZRXN
REGULATOR - GLYCOLLATE
//
UNIQUE-ID - REG0-8117
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [MethEnz17A-708]
MODE - -
REGULATED-ENTITY - ASP-SEMIALDEHYDE-DEHYDROGENASE-ENZRXN
REGULATOR - BORATE
//
UNIQUE-ID - REG0-8718
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4630409]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GALACTOACETYLTRAN-ENZRXN
REGULATOR - CO-A
//
UNIQUE-ID - REG0-10705
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3072022
CITATIONS - 3907689
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - ORNCARBAMTRANSFERI-ENZRXN
REGULATOR - L-2-AMINOPENTANOIC-ACID
//
UNIQUE-ID - REG0-9698
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1577828]
MODE - -
REGULATED-ENTITY - KDOTRANS2-ENZRXN
REGULATOR - CPD0-1280
//
UNIQUE-ID - REG0-12040
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6792201
MODE - -
REGULATED-ENTITY - ENZRXN0-7868
REGULATOR - DITHIO-NITROBENZOATE
//
UNIQUE-ID - REG0-6871
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8083170]
COMMENT - weak inhibitor
MODE - -
REGULATED-ENTITY - GLUCOSAMINE1PACETYL-ENZRXN
REGULATOR - CPD0-1643
//
UNIQUE-ID - REG0-7467
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3900058
MODE - +
REGULATED-ENTITY - ASPARTASE-ENZRXN
REGULATOR - L-ASPARTATE
//
UNIQUE-ID - REG0-8091
TYPES - Regulation-of-Enzyme-Activity
MODE - +
REGULATED-ENTITY - ACETYLORNDEACET-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-8690
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5333199
COMMENT - Competitive with respect to chorismate|CITS:[4886289]|
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ANTHRANSYN-ENZRXN
REGULATOR - TRP
//
UNIQUE-ID - REG0-10636
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7665468
MODE - -
REGULATED-ENTITY - INOSINEKIN-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-9682
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - GLUTARATE
//
UNIQUE-ID - REG0-11975
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24479701
MODE - -
REGULATED-ENTITY - ENZRXN0-6222
REGULATOR - MG+2
//
UNIQUE-ID - REG0-6853
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15995192
MODE - -
REGULATED-ENTITY - ENZRXN0-5541
REGULATOR - CA+2
//
UNIQUE-ID - REG0-7448
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14004226
MODE - -
REGULATED-ENTITY - PYROXALTRANSAM-ENZRXN
REGULATOR - PYRIDOXAMINE-5P
//
UNIQUE-ID - REG0-8066
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3089333
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DEOXYGUANPHOSPHOR-ENZRXN
REGULATOR - ADENOSINE
//
UNIQUE-ID - REG0-8663
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 779849
MODE - -
REGULATED-ENTITY - ENZRXN0-2142
REGULATOR - IODOACETATE
//
UNIQUE-ID - REG0-10596
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 334529
MODE - -
REGULATED-ENTITY - PREPHENATEDEHYDRAT-ENZRXN
REGULATOR - DITHIO-NITROBENZOATE
//
UNIQUE-ID - REG0-9662
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1967948]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTAMINESYN-ENZRXN
REGULATOR - CPD0-1248
//
UNIQUE-ID - REG0-11957
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3908101
MODE - -
REGULATED-ENTITY - ALADEHYDCHLORO-ENZRXN
REGULATOR - PHENYLHYDRAZINE
//
UNIQUE-ID - REG0-6831
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [11120740]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-285
REGULATOR - ARABINOSE-5P
//
UNIQUE-ID - REG0-7424
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7592346
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - TRANSALDOLB-ENZRXN
REGULATOR - ARABINOSE-5P
//
UNIQUE-ID - REG0-8041
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12627979
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SERINE-O-ACETTRAN-ENZRXN
REGULATOR - GLY
//
UNIQUE-ID - REG0-8635
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1856235
COMMENT - Exhibits product inhibition.
/|CITS: [1856235]|
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - MALTACETYLTRAN-ENZRXN
REGULATOR - CO-A
//
UNIQUE-ID - REG0-10425
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7011505]
MODE - -
REGULATED-ENTITY - LSERINEDEAM1-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-9640
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3132968
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - L-GLN-FRUCT-6-P-AMINOTRANS-ENZRXN
REGULATOR - CPD0-1237
//
UNIQUE-ID - REG0-11921
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3298234
MODE - -
REGULATED-ENTITY - ENZRXN0-7814
REGULATOR - MG+2
//
UNIQUE-ID - REG0-6793
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9287300]
MODE - +
REGULATED-ENTITY - ENZRXN-203
REGULATOR - ASCORBATE
//
UNIQUE-ID - REG0-7405
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11083878
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ENZRXN0-5501
REGULATOR - MN+2
//
UNIQUE-ID - REG0-7990
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4878429]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ARABISOM-ENZRXN
REGULATOR - L-ARABITOL
//
UNIQUE-ID - REG0-8596
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7727397
COMMENT - The enzyme is activated by monovalent
/cations.  |CITS: [36973]|
MODE - +
REGULATED-ENTITY - UDPNACETYLMURAMATEDEHYDROG-ENZRXN
REGULATOR - AMMONIUM
//
UNIQUE-ID - REG0-10368
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - DIACYLGLYKIN-ENZRXN
REGULATOR - CPD0-1762
//
UNIQUE-ID - REG0-9617
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - DIACYLGLYKIN-ENZRXN
REGULATOR - DIACYLGLYCEROL
//
UNIQUE-ID - REG0-11905
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24214977
KI - 2
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7337
REGULATOR - CPD-16183
//
UNIQUE-ID - REG0-6768
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1993184]
KI - 27
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DALADALALIGB-ENZRXN
REGULATOR - CPD-2482
//
UNIQUE-ID - REG0-7382
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [189806]
CITATIONS - [4358555]
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - CARBPSYN-ENZRXN
REGULATOR - AMMONIUM
//
UNIQUE-ID - REG0-7972
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2182115
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLYRIBONUCSYN-ENZRXN
REGULATOR - 5-P-BETA-D-RIBOSYL-AMINE
//
UNIQUE-ID - REG0-8567
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - CPD-1831
//
UNIQUE-ID - REG0-10276
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329757
MODE - +
REGULATED-ENTITY - ICITDEHDEPHOSPH-ENZRXN
REGULATOR - |Isocitrate|
//
UNIQUE-ID - REG0-9550
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8561507
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - QUINOPRIBOTRANS-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-11832
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15489502
MODE - -
REGULATED-ENTITY - ENZRXN0-5221
REGULATOR - ADP
//
UNIQUE-ID - REG0-6737
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CITSYN-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-7366
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3280015]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ALKAPHOSPHA-ENZRXN
REGULATOR - CPD-3
//
UNIQUE-ID - REG0-7924
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4872726]
MODE - -
REGULATED-ENTITY - HOLO-ACP-SYNTH-ENZRXN
REGULATOR - KCL
//
UNIQUE-ID - REG0-8534
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8060125]
MODE - -
REGULATED-ENTITY - CROBETREDUCT-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-10241
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [237196]
MODE - -
REGULATED-ENTITY - RHAMNULPALDOL-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-9500
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18459799
MODE - -
REGULATED-ENTITY - ENZRXN0-2801
REGULATOR - MG+2
//
UNIQUE-ID - REG0-11789
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 381306
MODE - +
REGULATED-ENTITY - UDPMANNACADEHYDROG-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-6715
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6365902]
CITATIONS - 359547
MODE - -
REGULATED-ENTITY - AMINOPROPDEHYDROG-ENZRXN
REGULATOR - CO+2
//
UNIQUE-ID - REG0-7334
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13844669
MODE - -
REGULATED-ENTITY - AMYLOMALT-ENZRXN
REGULATOR - NI+2
//
UNIQUE-ID - REG0-7895
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7929317]
COMMENT - for GTP
/reduction
MECHANISM - :ALLOSTERIC
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - RIBONUCLEOSIDE-TRIP-REDUCT-ENZRXN
REGULATOR - TTP
//
UNIQUE-ID - REG0-8513
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10572007
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - KDO-8PSYNTH-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-8509
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6365921]
MODE - +
REGULATED-ENTITY - CYT-O-UBIOX-ENZRXN
REGULATOR - |Phospholipids|
//
UNIQUE-ID - REG0-10203
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2194570
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - BADH-ENZRXN
REGULATOR - CPD0-1678
//
UNIQUE-ID - REG0-9436
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18328504
MODE - -
REGULATED-ENTITY - ENZRXN0-6517
REGULATOR - CO+2
//
UNIQUE-ID - REG0-11767
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6383480
MECHANISM - :MIXED
MODE - -
REGULATED-ENTITY - GLYCEROL-3-P-ACYLTRANSFER-ENZRXN
REGULATOR - DIHYDROXY-ACETONE-PHOSPHATE
//
UNIQUE-ID - REG0-6692
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3117785]
MODE - -
REGULATED-ENTITY - AKBLIG-ENZRXN
REGULATOR - DITHIOTHREITOL
//
UNIQUE-ID - REG0-7282
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1316760]
MODE - -
REGULATED-ENTITY - PPK-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-7864
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8155731
MODE - -
REGULATED-ENTITY - 4OHBENZOATE-OCTAPRENYLTRANSFER-ENZRXN
REGULATOR - CPD-3563
//
UNIQUE-ID - REG0-8483
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [214126]
MODE - -
REGULATED-ENTITY - NUCLEOSIDE-DIP-KIN-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-10167
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15066985
MODE - -
REGULATED-ENTITY - ACETYL-COA-CARBOXYLTRANSFER-ENZRXN
REGULATOR - |Pyrrolidine-Diones|
//
UNIQUE-ID - REG0-9343
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7012144]
MODE - NIL
REGULATED-ENTITY - ENOYL-COA-DELTA-ISOM-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-11736
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4935199
MECHANISM - :MIXED
MODE - -
REGULATED-ENTITY - THYM-PHOSPH-ENZRXN
REGULATOR - DEOXY-RIBOSE-1P
//
UNIQUE-ID - REG0-6661
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16216582
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6179
REGULATOR - ATP
//
UNIQUE-ID - REG0-7266
TYPES - Regulation-of-Enzyme-Activity
COMMENT - allosterically inhibited in a synergistic way, representing
/cooperative effects of end products of a branched pathway |CITS: [5333667]|
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - HOMSUCTRAN-ENZRXN
REGULATOR - S-ADENOSYLMETHIONINE
//
UNIQUE-ID - REG0-7839
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9148919
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-1627
REGULATOR - ATP
//
UNIQUE-ID - REG0-8463
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6251075]
COMMENT - competitive with respect to ATP, noncompetitive with respect to
/methionine
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - S-ADENMETSYN-ENZRXN
REGULATOR - P3I
//
UNIQUE-ID - REG0-10145
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14343156
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIAMINOPIMDECARB-ENZRXN
REGULATOR - GLT
//
UNIQUE-ID - REG0-9247
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8313963
MODE - -
REGULATED-ENTITY - NADH-DHI-ENZRXN
REGULATOR - O-PHENANTHROLINE
//
UNIQUE-ID - REG0-11683
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10806332
COMMENT - N-Ethylmaleimide is competitive with o-aminobenzoic acid 
/and non-competitive with acetyl-CoA.  |CITS: [10806332]| 
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7688
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-6642
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7896726
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6320
REGULATOR - MALEATE
//
UNIQUE-ID - REG0-7226
TYPES - Regulation-of-Enzyme-Activity
COMMENT - at high concentrations
/|CITS: [BlumenthalMethEnz9-660]|
MODE - -
REGULATED-ENTITY - GLUCARDEHYDRA-ENZRXN
REGULATOR - CO+2
//
UNIQUE-ID - REG0-7823
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3301828]
COMMENT - competitive with respect to bicarbonate
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYANLY-ENZRXN
REGULATOR - ACET
//
UNIQUE-ID - REG0-8445
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4878694]
CITATIONS - [4878695]
MODE - -
REGULATED-ENTITY - GLYCOPHOSPHORYL-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-10121
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7925376
MODE - -
REGULATED-ENTITY - ENZRXN0-4822
REGULATOR - CPD0-1545
//
UNIQUE-ID - REG0-9204
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2653423
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ACETOLACTREDUCTOISOM-ENZRXN
REGULATOR - DIOH-ISOVALERATE
//
UNIQUE-ID - REG0-11647
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6998959
KI - 23
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ABC-27-ENZRXN
REGULATOR - ARSENATE
//
UNIQUE-ID - REG0-6619
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4555420
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6293
REGULATOR - CPD-2483
//
UNIQUE-ID - REG0-7197
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4297266]
MODE - +
REGULATED-ENTITY - DLACTDEHYDROGNAD-ENZRXN
REGULATOR - 2-OXOBUTANOATE
//
UNIQUE-ID - REG0-7802
TYPES - Regulation-of-Enzyme-Activity
COMMENT - competitive with NADP+ |CITS: [350870]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - METHYLENETHFDEHYDROG-NADP-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-8428
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [362128]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DLACTDEHYDROGFAD-ENZRXN
REGULATOR - OXAMATE
//
UNIQUE-ID - REG0-10079
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18390656
MODE - -
REGULATED-ENTITY - ENZRXN0-6573
REGULATOR - mecillinam
//
UNIQUE-ID - REG0-9177
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4616949
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - ENZRXN0-6440
REGULATOR - CPD-2841
//
UNIQUE-ID - REG0-11595
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9011040
MODE - -
REGULATED-ENTITY - APHA-ENZRXN
REGULATOR - GUANOSINE
//
UNIQUE-ID - REG0-12462
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - -
REGULATED-ENTITY - ENZRXN0-8284
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7167
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3910996]
MODE - +
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - CL
//
UNIQUE-ID - REG0-7776
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4572733]
MODE - -
REGULATED-ENTITY - SPERMIDINESYN-ENZRXN
REGULATOR - PHMB
//
UNIQUE-ID - REG0-8398
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - CooperMethEnz13309
CITATIONS - 4572511
MODE - -
REGULATED-ENTITY - PEPSYNTH-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-10061
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [FishMethEnz9-529]
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - |Pentaric-Acids|
//
UNIQUE-ID - REG0-9126
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 370104
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ACETOOHBUTSYNI-ENZRXN
REGULATOR - VAL
//
UNIQUE-ID - REG0-11540
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21084197
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - CPD-14445
//
UNIQUE-ID - REG0-9967
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10542235
MODE - -
REGULATED-ENTITY - ENZRXN0-6562
REGULATOR - MOENOMYCIN
//
UNIQUE-ID - REG0-12446
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8263
REGULATOR - TRIS-HYDROCHLORIDE
//
UNIQUE-ID - REG0-7134
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10406936
KI - 44
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ADHP-ENZRXN
REGULATOR - CPD0-1652
//
UNIQUE-ID - REG0-7744
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5328735
COMMENT - Stimulation by NH4Cl is greatest. |CITS: [5328735]|
MODE - +
REGULATED-ENTITY - GLYOCARBOLIG-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-8379
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5333666]
MODE - -
REGULATED-ENTITY - GUANYL-KIN-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-10041
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [MethEnzV-794]
MODE - -
REGULATED-ENTITY - IGPSYN-ENZRXN
REGULATOR - CPD0-1490
//
UNIQUE-ID - REG0-9103
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4580841]
CITATIONS - [374983]
MODE - -
REGULATED-ENTITY - THI-P-SYN-ENZRXN
REGULATOR - CTP
//
UNIQUE-ID - REG0-11400
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8203917]
CITATIONS - 1329945
MODE - -
REGULATED-ENTITY - FUMARA-ENZRXN
REGULATOR - CPD0-2489
//
UNIQUE-ID - REG0-9911
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1391
MODE - -
REGULATED-ENTITY - ENZRXN0-4761
REGULATOR - PENICILLIN-G
//
UNIQUE-ID - REG0-12430
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - ENZRXN0-8177
REGULATOR - HSCN
//
UNIQUE-ID - REG0-7105
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8380170
COMMENT - KCl stimulated activity but at high concentrations it was inhibitory. 
/ |CITS: [8380170]| 
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PPX-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-7716
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3516689]
MODE - -
REGULATED-ENTITY - FORMHYDROGI-ENZRXN
REGULATOR - N-BROMOSUCCINIMIDE
//
UNIQUE-ID - REG0-8362
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 189701
CITATIONS - 11170408
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - GMP-SYN-GLUT-ENZRXN
REGULATOR - CPD0-1627
//
UNIQUE-ID - REG0-10021
TYPES - Regulation-of-Enzyme-Activity
MODE - +
REGULATED-ENTITY - PPK-ENZRXN
REGULATOR - CPD0-1470
//
UNIQUE-ID - REG0-9022
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6393625]
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - GLUTATHIONE-REDUCT-NADPH-ENZRXN
REGULATOR - PHMB
//
UNIQUE-ID - REG0-11339
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15641804
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SAICARSYN-ENZRXN
REGULATOR - MALEATE
//
UNIQUE-ID - REG0-9890
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7860596]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PMPOXI-ENZRXN
REGULATOR - CPD0-1221
//
UNIQUE-ID - REG0-12380
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2673221
MODE - -
REGULATED-ENTITY - ISOCITLYASE-ENZRXN
REGULATOR - IODOACETATE
//
UNIQUE-ID - REG0-7086
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4584822]
MODE - -
REGULATED-ENTITY - MALONYL-COA-ACP-TRANSACYL-ENZRXN
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7689
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329757
MODE - -
REGULATED-ENTITY - ICITDEHKINASE-ENZRXN
REGULATOR - FRUCTOSE-6P
//
UNIQUE-ID - REG0-8336
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6463
COMMENT - inhibited
/the forward reaction  |CITS: [6463]|
MODE - -
REGULATED-ENTITY - 3-METHYL-2-OXOBUT-OHCH3XFER-ENZRXN
REGULATOR - CPD-3642
//
UNIQUE-ID - REG0-10002
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19029291
MODE - +
REGULATED-ENTITY - ADENYL-KIN-ENZRXN
REGULATOR - MG+2
//
UNIQUE-ID - REG0-8947
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 322702
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUCOSAMINE-6-P-DEAMIN-ENZRXN
REGULATOR - CPD-9051
//
UNIQUE-ID - REG0-11307
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7765483
MODE - -
REGULATED-ENTITY - AMINEPHEN-ENZRXN
REGULATOR - CPD-13898
//
UNIQUE-ID - REG0-9857
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - ACYLCOASYN-ENZRXN
REGULATOR - CPD0-1385
//
UNIQUE-ID - REG0-12345
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 25139244
MODE - -
REGULATED-ENTITY - ENZRXN0-8073
REGULATOR - CYS
//
UNIQUE-ID - REG0-7067
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 30751
COMMENT - Maximum stimulation was with CTP as a
/substrate, with dCTP stimulation was much less.  |CITS: [30751]|
MODE - +
REGULATED-ENTITY - CDPDIGLYSYN-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-7657
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9409147
CITATIONS - [380648]
CITATIONS - 15026045
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - CFA-ENZRXN
REGULATOR - ADENOSYL-HOMO-CYS
//
UNIQUE-ID - REG0-8296
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3291954]
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - ISOCITLYASE-ENZRXN
REGULATOR - HYDROXYMALONATE
//
UNIQUE-ID - REG-14661
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1646603]
COMMENT - slight inhibition
CREDITS - SRI
CREDITS - |caspi|
MODE - -
REGULATED-ENTITY - ENZRXN-22535
REGULATOR - FE+2
//
UNIQUE-ID - REG0-8911
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1648099
CITATIONS - 2162151
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUC1PADENYLTRANS-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-11288
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21957966
MODE - -
REGULATED-ENTITY - LDC2-ENZRXN
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-9834
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3157043]
CITATIONS - 6406265
MODE - -
REGULATED-ENTITY - SPERMIDINESYN-ENZRXN
REGULATOR - CPD0-1376
//
UNIQUE-ID - REG0-12301
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6214787
MODE - -
REGULATED-ENTITY - ENZRXN0-4263
REGULATOR - ADP
//
UNIQUE-ID - REG0-7045
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [46]
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - CPD-2
//
UNIQUE-ID - REG0-7630
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3297044
COMMENT - irreversible inhibitor  |CITS: [3297044] [HandEnzInh]|
MODE - -
REGULATED-ENTITY - ARGDECARBOXBIO-ENZRXN
REGULATOR - CPD0-1661
//
UNIQUE-ID - REG0-8272
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1092682
COMMENT - Competitive with Ado-Met, noncompetitive with
/7KAP
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DAPASYN-ENZRXN
REGULATOR - ADENOSINE
//
UNIQUE-ID - REG0-8866
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [1978721]
MODE - -
REGULATED-ENTITY - 4OH2OXOGLUTARALDOL-ENZRXN
REGULATOR - 3-BROMOPYRUVATE
//
UNIQUE-ID - REG0-11225
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3891721
MODE - -
REGULATED-ENTITY - GLYOHMETRANS-ENZRXN
REGULATOR - METHYLMETHANETHIOSULFONATE
//
UNIQUE-ID - REG0-9816
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12589497
MODE - -
REGULATED-ENTITY - METHYLMALONYL-COA-MUT-ENZRXN
REGULATOR - MN+2
//
UNIQUE-ID - REG0-12273
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7929087
MODE - -
REGULATED-ENTITY - ILES-ENZRXN
REGULATOR - CPD0-2581
//
UNIQUE-ID - REG0-7012
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4567662
COMMENT - The effect of K+ was partly replaceable by
/NH4+ and Rb+ |CITS: [4567662]|.
MODE - +
REGULATED-ENTITY - THI-P-KIN-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-7605
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329757
MODE - +
REGULATED-ENTITY - ICITDEHDEPHOSPH-ENZRXN
REGULATOR - OXALACETIC_ACID
//
UNIQUE-ID - REG0-8245
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6246070]
MODE - -
REGULATED-ENTITY - KDO-8PPHOSPHAT-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-8834
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10879466]
MODE - +
REGULATED-ENTITY - GUANOSINEKIN-ENZRXN
REGULATOR - TMP
//
UNIQUE-ID - REG0-11039
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 821948
MECHANISM - :UNCOMPETITIVE
MODE - -
REGULATED-ENTITY - GTP-CYCLOHYDRO-I-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-9790
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15507440
CITATIONS - 4883496
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - THRS-ENZRXN
REGULATOR - CPD0-1348
//
UNIQUE-ID - REG0-12256
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14693515
CITATIONS - 7001458
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - PENICILLIN-G
//
UNIQUE-ID - REG0-6975
TYPES - Regulation-of-Enzyme-Activity
COMMENT - probably functions as feedback inhibition  |CITS: [7860596]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PMPOXI-ENZRXN
REGULATOR - PYRIDOXAL_PHOSPHATE
//
UNIQUE-ID - REG0-7577
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 782527
MODE - +
REGULATED-ENTITY - 3-OCTPRNL-4-OHBENZOATE-DECARBOX-ENZRXN
REGULATOR - DITHIOTHREITOL
//
UNIQUE-ID - REG0-8218
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4312205]
CITATIONS - 20236319
MODE - +
REGULATED-ENTITY - PHOSACETYLTRANS-ENZRXN
REGULATOR - PYRUVATE
//
UNIQUE-ID - REG0-8816
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4992818
MODE - -
REGULATED-ENTITY - D-PPENTOMUT
REGULATOR - FE+3
//
UNIQUE-ID - REG0-11011
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3091070
MODE - -
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - CPD0-1402
//
UNIQUE-ID - REG0-9766
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8241178]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - UDPGLUCEPIM-ENZRXN
REGULATOR - CPD0-1324
//
UNIQUE-ID - REG0-12240
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14693515
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - CPD-9227
//
UNIQUE-ID - REG0-6948
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1089665
MODE - -
REGULATED-ENTITY - N-ACETYLTRANSFER-ENZRXN
REGULATOR - CPD0-1691
//
UNIQUE-ID - REG0-7551
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4581499]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - MANNONDEHYDRAT-ENZRXN
REGULATOR - GLUCONATE
//
UNIQUE-ID - REG0-8182
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [SaikusaAgBioChem51-1893]
MODE - +
REGULATED-ENTITY - METHYLGLYREDUCT-ENZRXN
REGULATOR - 2-MERCAPTOETHANOL
//
UNIQUE-ID - REG0-8787
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14245396
MODE - -
REGULATED-ENTITY - 3-NUCLEOTID-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-10935
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21247091
MODE - -
REGULATED-ENTITY - ENZRXN0-2583
REGULATOR - CPD0-2383
//
UNIQUE-ID - REG0-9745
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2692708]
KI - 3.500e-2
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYTIDEAM2-ENZRXN
REGULATOR - CPD0-1311
//
UNIQUE-ID - REG0-12183
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12177066
KI - 0.1    
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - FMNREDUCT-ENZRXN
REGULATOR - FAD
//
UNIQUE-ID - REG0-6931
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4310089]
CITATIONS - 3308886
MODE - -
REGULATED-ENTITY - LACTALDDEHYDROG-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-7529
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - CHEN09WORDJMICRO
CITATIONS - 8226676
MODE - -
REGULATED-ENTITY - ENZRXN0-4502
REGULATOR - CU+2
//
UNIQUE-ID - REG0-8163
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11092864
MODE - -
REGULATED-ENTITY - ENZRXN0-268
REGULATOR - CU+2
//
UNIQUE-ID - REG0-8766
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [BlumenthalMethEnz9-665]
CITATIONS - 4285952
MODE - -
REGULATED-ENTITY - GALACTARDEHYDRA-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-10861
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20961145
MODE - -
REGULATED-ENTITY - BIOTIN-SYN-ENZRXN
REGULATOR - MET
//
UNIQUE-ID - REG0-9729
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - CPD0-1296
//
UNIQUE-ID - REG0-12161
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4588693
MODE - -
REGULATED-ENTITY - PEPDEPHOSI-ENZRXN
REGULATOR - GTP
//
UNIQUE-ID - REG0-6904
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4920894]
COMMENT - High levels of glycolytic and TCA cycle intermediates result in strong 
/inhibition of the adenylyltransferase reaction.  Pyruvate, glutarate, succinate
/and fumarate also inhibit to a lesser degree.  |CITS: [4920894]| 
MODE - -
REGULATED-ENTITY - GSADENYLATION-ENZRXN
REGULATOR - OXALACETIC_ACID
//
UNIQUE-ID - REG0-7511
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2681195]
MODE - -
REGULATED-ENTITY - THREODEHYD-ENZRXN
REGULATOR - PHENYLGLYOXAL
//
UNIQUE-ID - REG0-8140
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3516690]
MODE - -
REGULATED-ENTITY - FORMHYDROG2-ENZRXN
REGULATOR - CO+2
//
UNIQUE-ID - REG0-8733
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1459137
COMMENT - The enzyme's activity can be modulated positively and negatively by allosteric effector molecules. |CITS: [1459137]|
MECHANISM - :ALLOSTERIC
MODE - -
REGULATED-ENTITY - GTP-CYCLOHYDRO-I-ENZRXN
REGULATOR - TETRA-H-BIOPTERIN
//
UNIQUE-ID - REG0-10745
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7004378
MODE - -
REGULATED-ENTITY - PGLUCISOM-ENZRXN
REGULATOR - CPD-2961
//
UNIQUE-ID - REG0-9711
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - CPD0-1269
//
UNIQUE-ID - REG0-12126
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 25401076
CITATIONS - 4297266
MECHANISM - :MIXED
MODE - -
REGULATED-ENTITY - DLACTDEHYDROGNAD-ENZRXN
REGULATOR - OXAMATE
//
UNIQUE-ID - REG0-6884
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [40950]
COMMENT - only for
/the dehydrogenase reaction
MODE - +
REGULATED-ENTITY - GLYCDEH-ENZRXN
REGULATOR - RB+
//
UNIQUE-ID - REG0-7493
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4861610]
CITATIONS - [357898]
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - THYKI-ENZRXN
REGULATOR - DGDP
//
UNIQUE-ID - REG0-8114
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - MethEnz17A-708
CITATIONS - HandEnzInh
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ASP-SEMIALDEHYDE-DEHYDROGENASE-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-8712
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10913105]
MODE - -
REGULATED-ENTITY - ENZRXN0-242
REGULATOR - O-PHENANTHROLINE
//
UNIQUE-ID - REG0-10699
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16678412
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DHBAMPLIG-ENZRXN
REGULATOR - CPD0-2332
//
UNIQUE-ID - REG0-9695
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1577828]
MODE - -
REGULATED-ENTITY - KDOTRANS-ENZRXN
REGULATOR - CPD0-1277
//
UNIQUE-ID - REG0-12032
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24127606
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ENZRXN0-7860
REGULATOR - C-DI-GMP
//
UNIQUE-ID - REG0-6868
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17049867
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLNS-ENZRXN
REGULATOR - CPD0-1086
//
UNIQUE-ID - REG0-7464
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [4584395]
MODE - -
REGULATED-ENTITY - ASPARTASE-ENZRXN
REGULATOR - DITHIO-NITROBENZOATE
//
UNIQUE-ID - REG0-8087
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [VogelAdvEnzym40-71]
CITATIONS - 10684608
MODE - -
REGULATED-ENTITY - ACETYLORNDEACET-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-8687
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4565085
MODE - -
REGULATED-ENTITY - GLUTAMATESYN-ENZRXN
REGULATOR - CPD-302
//
UNIQUE-ID - REG0-10625
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1748668]
MODE - -
REGULATED-ENTITY - METHYLENETHFDEHYDROG-NADP-ENZRXN
REGULATOR - TRIS
//
UNIQUE-ID - REG0-9679
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [319195]
CITATIONS - [33657]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ETHAMLY-ENZRXN
REGULATOR - CPD0-1258
//
UNIQUE-ID - REG0-11972
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 193572
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - PEPDEPHOSII-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-6850
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7988883
MODE - +
REGULATED-ENTITY - ENZRXN0-4381
REGULATOR - CO+2
//
UNIQUE-ID - REG0-7445
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12980976
MODE - -
REGULATED-ENTITY - DEOXYRIBOSE-P-ALD-ENZRXN
REGULATOR - OCTANOL
//
UNIQUE-ID - REG0-8063
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10480878
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6061
REGULATOR - GDP
//
UNIQUE-ID - REG0-8655
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - DeFeliceBBA5419
MODE - -
REGULATED-ENTITY - ACETOLACTSYNI-ENZRXN
REGULATOR - 2-OXOBUTANOATE
//
UNIQUE-ID - REG0-10569
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4572511
MODE - -
REGULATED-ENTITY - PEPSYNTH-ENZRXN
REGULATOR - 2-KETOGLUTARATE
//
UNIQUE-ID - REG0-9659
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1967948]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTAMINESYN-ENZRXN
REGULATOR - CPD0-1245
//
UNIQUE-ID - REG0-11954
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3908101
MODE - -
REGULATED-ENTITY - ALADEHYDCHLORO-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-6825
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8703024
MODE - -
REGULATED-ENTITY - ENZRXN0-2706
REGULATOR - CPD-10016
//
UNIQUE-ID - REG0-7418
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [14216423]
MODE - +
REGULATED-ENTITY - PHOSPHOGLUCMUT-ENZRXN
REGULATOR - ALPHA-GLUCOSE-16-BISPHOSPHATE
//
UNIQUE-ID - REG0-8036
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7030214
CITATIONS - 4261395
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PREPHENATEDEHYDRAT-ENZRXN
REGULATOR - PHE
//
UNIQUE-ID - REG0-8627
TYPES - Regulation-of-Enzyme-Activity
COMMENT - Acts as a slight inhibitor.  |CITS: [1377]| 
MODE - -
REGULATED-ENTITY - ENZRXN0-241
REGULATOR - N-ACETYL-D-GLUCOSAMINE
//
UNIQUE-ID - REG0-10412
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4578944
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - UDPGLUCEPIM-ENZRXN
REGULATOR - CPD0-1898
//
UNIQUE-ID - REG0-9635
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1099080
MODE - -
REGULATED-ENTITY - THREDEHYDSYN-ENZRXN
REGULATOR - CPD0-1234
//
UNIQUE-ID - REG0-11918
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24214977
KI - 4
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7811
REGULATOR - GUANINE
//
UNIQUE-ID - REG0-6790
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9287300]
MODE - -
REGULATED-ENTITY - ENZRXN-203
REGULATOR - CO+2
//
UNIQUE-ID - REG0-7398
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4966660]
MODE - -
REGULATED-ENTITY - GLUTAMINA-ENZRXN
REGULATOR - PHMB
//
UNIQUE-ID - REG0-7987
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6385860]
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - ENZRXN-17895
REGULATOR - |Long-Chain-Fatty-Acids|
//
UNIQUE-ID - REG0-8590
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2187483]
CITATIONS - 7033218
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - L-ASPARTATE-OXID-ENZRXN
REGULATOR - MESO-TARTRATE
//
UNIQUE-ID - REG0-10364
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - DIACYLGLYKIN-ENZRXN
REGULATOR - CPD0-1809
//
UNIQUE-ID - REG0-9614
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7860596
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PNP-PMPOXI-ENZRXN
REGULATOR - CPD0-1221
//
UNIQUE-ID - REG0-11887
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24210219
MODE - -
REGULATED-ENTITY - ENZRXN0-7799
REGULATOR - UTP
//
UNIQUE-ID - REG0-6763
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [211379]
MODE - -
REGULATED-ENTITY - CYTIDINEKIN-ENZRXN
REGULATOR - UTP
//
UNIQUE-ID - REG0-7379
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - CARBPSYN-ENZRXN
REGULATOR - CPD0-1036
//
UNIQUE-ID - REG0-7966
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7035170]
MODE - -
REGULATED-ENTITY - GLUTSEMIALDEHYDROG-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-8561
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - CPD-205
//
UNIQUE-ID - REG0-10256
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [MethEnz62-379]
MODE - -
REGULATED-ENTITY - ENZRXN-153
REGULATOR - MN+2
//
UNIQUE-ID - REG0-9544
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8706749
MODE - -
REGULATED-ENTITY - L-ASPARTATE-OXID-ENZRXN
REGULATOR - IMINOASPARTATE
//
UNIQUE-ID - REG0-11828
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 23844911
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7782
REGULATOR - BENZOATE
//
UNIQUE-ID - REG0-6734
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7559411
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CHORISMATE-SYNTHASE-ENZRXN
REGULATOR - 6S-6-FLUORO-EPSP
//
UNIQUE-ID - REG0-7362
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8955296
MODE - -
REGULATED-ENTITY - O-SUCCINYLBENZOATE-COA-LIG-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-7921
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4290215]
COMMENT - Shows slight inhibition.
MODE - -
REGULATED-ENTITY - NAD-SYNTH-NH3-ENZRXN
REGULATOR - CPD-10129
//
UNIQUE-ID - REG0-8531
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8060125]
MODE - -
REGULATED-ENTITY - CROBETREDUCT-ENZRXN
REGULATOR - D-CARNITINE
//
UNIQUE-ID - REG0-10237
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17142397
MECHANISM - :ALLOSTERIC
MODE - -
REGULATED-ENTITY - ISOCITDEH-ENZRXN
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-9497
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18459799
MODE - -
REGULATED-ENTITY - ENZRXN0-2802
REGULATOR - MG+2
//
UNIQUE-ID - REG0-11786
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1344882
MODE - +
REGULATED-ENTITY - 3-P-SHIK-1-CARBOXYVINYLXFERASE-ENZRXN
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-6712
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5543331
COMMENT -  The requirement of a
/hydrolytic enzyme for NAD+, usually a coenzyme for oxidoreduction is
/presently unexplained.  |CITS: [5543331] [2831880]|
MODE - +
REGULATED-ENTITY - ALPHAGALACTOSID-ENZRXN
REGULATOR - NAD
//
UNIQUE-ID - REG0-7331
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13844669
MODE - -
REGULATED-ENTITY - AMYLOMALT-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-7892
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1460049]
MODE - -
REGULATED-ENTITY - RIBONUCLEOSIDE-TRIP-REDUCT-ENZRXN
REGULATOR - ADENOSYL-HOMO-CYS
//
UNIQUE-ID - REG0-7889
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1460049
COMMENT - in high
/concentrations |CITS: [1460049]|
MODE - -
REGULATED-ENTITY - RIBONUCLEOSIDE-TRIP-REDUCT-ENZRXN
REGULATOR - DITHIOTHREITOL
//
UNIQUE-ID - REG0-8504
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6365921]
MODE - -
REGULATED-ENTITY - CYT-O-UBIOX-ENZRXN
REGULATOR - CPD-2841
//
UNIQUE-ID - REG0-10200
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2194570
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - BADH-ENZRXN
REGULATOR - BENZALDEHYDE
//
UNIQUE-ID - REG0-9433
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18328504
MODE - -
REGULATED-ENTITY - ENZRXN0-6517
REGULATOR - DATP
//
UNIQUE-ID - REG0-6689
TYPES - Regulation-of-Enzyme-Activity
COMMENT - exhibits strong product inhibition |CITS: [3117785]|
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - AKBLIG-ENZRXN
REGULATOR - CO-A
//
UNIQUE-ID - REG0-7278
TYPES - Regulation-of-Enzyme-Activity
MODE - +
REGULATED-ENTITY - PEPCARBOX-ENZRXN
REGULATOR - CDP
//
UNIQUE-ID - REG0-7861
TYPES - Regulation-of-Enzyme-Activity
COMMENT - slightly inhibitory  |CITS:
/[6115852]|
MODE - -
REGULATED-ENTITY - GUANYLCYC-ENZRXN
REGULATOR - F-
//
UNIQUE-ID - REG0-8480
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [214126]
COMMENT - with respect to ATP when GDP is phosphate acceptor; where ADP
/is acceptor, GTP is donor, GDP is competitive inhibitor of ADP
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - NUCLEOSIDE-DIP-KIN-ENZRXN
REGULATOR - GDP
//
UNIQUE-ID - REG0-10164
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1095054]
MODE - -
REGULATED-ENTITY - FOLYLPOLYGLUTAMATESYNTH-ENZRXN
REGULATOR - DIHYDROFOLATE
//
UNIQUE-ID - REG0-9340
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - NIL
REGULATED-ENTITY - OHACYL-COA-DEHYDROG-ENZRXN
REGULATOR - TRIS-HYDROCHLORIDE
//
UNIQUE-ID - REG0-11733
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4992818
MODE - +
REGULATED-ENTITY - D-PPENTOMUT
REGULATOR - CPD-16577
//
UNIQUE-ID - REG0-6658
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15951572
MODE - -
REGULATED-ENTITY - ENZRXN0-6153
REGULATOR - KOJIC-ACID
//
UNIQUE-ID - REG0-7252
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6759855]
CITATIONS - 13831814
CITATIONS - 3038546
MODE - +
REGULATED-ENTITY - ALTRODEHYDRAT-ENZRXN
REGULATOR - FE+2
//
UNIQUE-ID - REG0-7836
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13794771
MODE - -
REGULATED-ENTITY - GALACTUROISOM-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-8459
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3009477
CITATIONS - 9125530
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PRPPSYN-ENZRXN
REGULATOR - MG+2
//
UNIQUE-ID - REG0-10142
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11157970
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - ACETYL-COA-CARBOXYLMULTI-ENZRXN
REGULATOR - |apo-ACP|
//
UNIQUE-ID - REG0-9225
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10891278
MODE - -
REGULATED-ENTITY - RHAMNISOM-ENZRXN
REGULATOR - CPD0-1114
//
UNIQUE-ID - REG0-11680
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3056252
KI - 0.2    
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIAMINOPIMEPIM-ENZRXN
REGULATOR - CPD0-1502
//
UNIQUE-ID - REG0-6638
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16567800
MODE - -
REGULATED-ENTITY - ENZRXN0-6198
REGULATOR - IODOACETATE
//
UNIQUE-ID - REG0-7222
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [BlumenthalMethEnz9-660]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUCARDEHYDRA-ENZRXN
REGULATOR - TARTRATE
//
UNIQUE-ID - REG0-7820
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3518792
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYANLY-ENZRXN
REGULATOR - HCO3
//
UNIQUE-ID - REG0-8442
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4878695]
CITATIONS - [4878694]
MODE - -
REGULATED-ENTITY - GLYCOPHOSPHORYL-ENZRXN
REGULATOR - HCN
//
UNIQUE-ID - REG0-10111
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [JAmChemSoc112-4932]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIAMINOPIMEPIM-ENZRXN
REGULATOR - CPD0-1535
//
UNIQUE-ID - REG0-9201
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10446288
MODE - -
REGULATED-ENTITY - ENZRXN0-6461
REGULATOR - METHYLNICOTINATE
//
UNIQUE-ID - REG0-11614
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12941942
MODE - +
REGULATED-ENTITY - ENZRXN0-7642
REGULATOR - G6905-MONOMER
//
UNIQUE-ID - REG0-12475
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - -
REGULATED-ENTITY - ENZRXN0-8288
REGULATOR - TRIS
//
UNIQUE-ID - REG0-7193
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9134438
MODE - +
REGULATED-ENTITY - GLCNACPTRANS-ENZRXN
REGULATOR - CPD0-1088
//
UNIQUE-ID - REG0-7799
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4868539
COMMENT - competitive with respect to aspartate |CITS: [8060968]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ASPCARBTRANS-ENZRXN
REGULATOR - SUC
//
UNIQUE-ID - REG0-8419
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7727513
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - MALDEXPHOSPHORYL-ENZRXN
REGULATOR - CPD0-1029
//
UNIQUE-ID - REG0-10076
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17470659
MODE - -
REGULATED-ENTITY - ENZRXN0-6573
REGULATOR - CPD-12294
//
UNIQUE-ID - REG0-9157
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4632320
MODE - -
REGULATED-ENTITY - DARABISOM-ENZRXN
REGULATOR - L-ARABITOL
//
UNIQUE-ID - REG0-11573
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 22387619
MODE - +
REGULATED-ENTITY - ENZRXN0-5561
REGULATOR - HS
//
UNIQUE-ID - REG0-9990
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10359647
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6603
REGULATOR - CPD-227
//
UNIQUE-ID - REG0-12459
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - -
REGULATED-ENTITY - ENZRXN0-8283
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7163
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-7762
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2178550]
MODE - -
REGULATED-ENTITY - GABATRANSAM-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-8394
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14086727
MODE - -
REGULATED-ENTITY - PSERPHOSPHA-ENZRXN
REGULATOR - F-
//
UNIQUE-ID - REG0-10058
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [FishMethEnz9-529]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - KDO
//
UNIQUE-ID - REG0-9122
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4562390
CITATIONS - 13405870
CITATIONS - 13319259
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - THREDEHYDSYN-ENZRXN
REGULATOR - ILE
//
UNIQUE-ID - REG0-11461
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 22344668
MODE - -
REGULATED-ENTITY - FUMARA-ENZRXN
REGULATOR - CD+2
//
UNIQUE-ID - REG0-9926
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1097688
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PHES-ENZRXN
REGULATOR - CPD0-1431
//
UNIQUE-ID - REG0-12443
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8261
REGULATOR - TRIS-HYDROCHLORIDE
//
UNIQUE-ID - REG0-7128
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5332197]
MODE - -
REGULATED-ENTITY - DARAB5PISOM-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-7740
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5328735
MODE - -
REGULATED-ENTITY - GLYOCARBOLIG-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-8375
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5333666]
COMMENT - may be competing at
/both the ATP and  GMP sites
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GUANYL-KIN-ENZRXN
REGULATOR - GDP
//
UNIQUE-ID - REG0-10038
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [MethEnzV-794]
MODE - -
REGULATED-ENTITY - IGPSYN-ENZRXN
REGULATOR - CPD0-1487
//
UNIQUE-ID - REG0-9100
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4580841]
CITATIONS - [374983]
MODE - -
REGULATED-ENTITY - THI-P-SYN-ENZRXN
REGULATOR - CREATINE-P
//
UNIQUE-ID - REG0-11364
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 372191
MODE - -
REGULATED-ENTITY - PRPPAMIDOTRANS-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-9907
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7918616]
MODE - -
REGULATED-ENTITY - CARDIOLIPSYN-ENZRXN
REGULATOR - CPD0-1423
//
UNIQUE-ID - REG0-12427
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - ENZRXN0-8176
REGULATOR - HSCN
//
UNIQUE-ID - REG0-7102
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2148683]
MODE - +
REGULATED-ENTITY - GLYCEROL-KIN-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-7708
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [VogelAdvEnzym40-70]
MODE - -
REGULATED-ENTITY - ACETYLORNTRANSAM-ENZRXN
REGULATOR - FE+2
//
UNIQUE-ID - REG0-8350
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - JBC240-1711
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - THREDEHYDCAT-ENZRXN
REGULATOR - D-SERINE
//
UNIQUE-ID - REG0-10018
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4920894]
MODE - -
REGULATED-ENTITY - GSADENYLATION-ENZRXN
REGULATOR - MAL
//
UNIQUE-ID - REG0-9019
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9772162
MODE - +
REGULATED-ENTITY - GALACTARDEHYDRA-ENZRXN
REGULATOR - 2-MERCAPTOETHANOL
//
UNIQUE-ID - REG0-11333
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3553189
CITATIONS - 19088907
MODE - -
REGULATED-ENTITY - ENZRXN0-1461
REGULATOR - SULFATE
//
UNIQUE-ID - REG0-9885
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18500821
MECHANISM - :UNCOMPETITIVE
MODE - -
REGULATED-ENTITY - RIBOFLAVINSYNREDUC-ENZRXN
REGULATOR - CPD0-1407
//
UNIQUE-ID - REG0-12376
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10769150
CITATIONS - 14636073
MODE - -
REGULATED-ENTITY - ENZRXN0-7819
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7083
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4934182]
COMMENT - with respect to ACP
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - MALONYL-COA-ACP-TRANSACYL-ENZRXN
REGULATOR - CO-A
//
UNIQUE-ID - REG0-7682
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [MethEnz18B-765]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - H2PTEROATESYNTH-ENZRXN
REGULATOR - CPD0-889
//
UNIQUE-ID - REG0-8332
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7918616]
MODE - +
REGULATED-ENTITY - CARDIOLIPSYN-ENZRXN
REGULATOR - L-1-PHOSPHATIDYL-SERINE
//
UNIQUE-ID - REG-15075
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8550422
COMMENT - inhibits the reverse, dehydrogenase activity |CITS: [8550422]|
CREDITS - SRI
CREDITS - |caspi|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN-23884
REGULATOR - 3-P-HYDROXYPYRUVATE
//
UNIQUE-ID - REG0-8929
TYPES - Regulation-of-Enzyme-Activity
COMMENT - competitive with respect to pyridoxine
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - OHMETPYRKIN-ENZRXN
REGULATOR - HMP
//
UNIQUE-ID - REG0-11303
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17557829
MODE - +
REGULATED-ENTITY - MALIC-NADP-ENZRXN
REGULATOR - ACETYL-P
//
UNIQUE-ID - REG0-9849
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [VogelAdvEnzym40-71]
MODE - -
REGULATED-ENTITY - ACETYLORNDEACET-ENZRXN
REGULATOR - |Sulfhydryl-Reagents|
//
UNIQUE-ID - REG0-12331
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9748330
KI - 18000
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ASNSYNB-ENZRXN
REGULATOR - L-THREO-3-METHYL-ASPARTATE
//
UNIQUE-ID - REG0-7063
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 30751
COMMENT - competitive with respect to CTP
/|CITS: [30751]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CDPDIGLYSYN-ENZRXN
REGULATOR - DCTP
//
UNIQUE-ID - REG0-7651
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9214294]
CREDITS - SRI
CREDITS - |caspi|
CREDITS - |paley|
MODE - -
REGULATED-ENTITY - ENTDB-ENZRXN
REGULATOR - ENTB-MONOMER
//
UNIQUE-ID - REG0-8290
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3291954
MODE - -
REGULATED-ENTITY - ISOCITLYASE-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG-14658
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9047371
CREDITS - SRI
CREDITS - |caspi|
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - ENZRXN-22535
REGULATOR - OH-PYR
//
UNIQUE-ID - REG0-8906
TYPES - Regulation-of-Enzyme-Activity
COMMENT - Glutamine synthetase activity is subject to cumulative feedback
/inhibition by the products of glutamine metabolism. Each of the listed compounds inhibits glutamine synthetase partially together
COMMENT - these compounds can inhibit glutamine synthetase completely. Glutamine itself is not an inhibitor.
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUTAMINESYN-ENZRXN
REGULATOR - SER
//
UNIQUE-ID - REG0-11285
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6369325
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - PYRUVFORMLY-ENZRXN
REGULATOR - CPD-27
//
UNIQUE-ID - REG0-9831
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - 3-DEHYDROQUINATE-SYNTHASE-ENZRXN
REGULATOR - |Oxygen-Substituted-Quinates|
//
UNIQUE-ID - REG0-12290
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2892828
MODE - -
REGULATED-ENTITY - ENZRXN0-4321
REGULATOR - CPD-6301
//
UNIQUE-ID - REG0-7040
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [46]
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - SPERMIDINE
//
UNIQUE-ID - REG0-7626
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4571773
COMMENT - feedback inhibitor  |CITS:
/[4571773]|
MODE - -
REGULATED-ENTITY - ARGDECARBOXBIO-ENZRXN
REGULATOR - SPERMIDINE
//
UNIQUE-ID - REG0-8263
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14982633
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - TRANS-ENZRXN-68
REGULATOR - AGMATHINE
//
UNIQUE-ID - REG0-8862
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - 4OH2OXOGLUTARALDOL-ENZRXN
REGULATOR - OH-PYR
//
UNIQUE-ID - REG0-11199
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12517338
MODE - -
REGULATED-ENTITY - RIB5PISOMA-ENZRXN
REGULATOR - ARABINOSE-5P
//
UNIQUE-ID - REG0-9806
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3486292
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - H2PTEROATESYNTH-ENZRXN
REGULATOR - |5-Nitroisocytosine-Derivatives|
//
UNIQUE-ID - REG0-12270
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3898066
MODE - -
REGULATED-ENTITY - ENZRXN0-7970
REGULATOR - CPD-9195
//
UNIQUE-ID - REG0-7009
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4567662]
COMMENT - product inhibition
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - THI-P-KIN-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-7602
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329757
MODE - +
REGULATED-ENTITY - ICITDEHDEPHOSPH-ENZRXN
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-8242
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6246070]
MODE - -
REGULATED-ENTITY - KDO-8PPHOSPHAT-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-8829
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10879466
MODE - -
REGULATED-ENTITY - GUANOSINEKIN-ENZRXN
REGULATOR - GDP
//
UNIQUE-ID - REG0-11024
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21467222
MODE - -
REGULATED-ENTITY - ENZRXN0-7454
REGULATOR - IODOACETATE
//
UNIQUE-ID - REG0-9787
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4861610]
CITATIONS - [357898]
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - THYKI-ENZRXN
REGULATOR - CPD0-1343
//
UNIQUE-ID - REG0-12253
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17092918
CITATIONS - 16569861
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - MOENOMYCIN
//
UNIQUE-ID - REG0-6971
TYPES - Regulation-of-Enzyme-Activity
COMMENT - completely inhibits the reverse reaction |CITS: [793612]|
MODE - -
REGULATED-ENTITY - PHOSPHAGLYPSYN-ENZRXN
REGULATOR - GLYCEROL-3P
//
UNIQUE-ID - REG0-7573
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4349042
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - IMIDPHOSDEHYD-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-8210
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4312205
COMMENT - noncompetitive with respect to CoA
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - PHOSACETYLTRANS-ENZRXN
REGULATOR - NADPH
//
UNIQUE-ID - REG0-8813
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6312898
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - F16BDEPHOS-ENZRXN
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-11006
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3091070
MODE - -
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - CPD0-1405
//
UNIQUE-ID - REG0-9763
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [211379]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYTIDINEKIN-ENZRXN
REGULATOR - CPD0-1322
//
UNIQUE-ID - REG0-12237
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6427167
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - CPD-9231
//
UNIQUE-ID - REG0-6945
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16890
MODE - -
REGULATED-ENTITY - N-ACETYLTRANSFER-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-7548
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1646603]
CITATIONS - 6389524
MODE - -
REGULATED-ENTITY - ACNEULY-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-8179
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [SaikusaAgBioChem51-1893]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - METHYLGLYREDUCT-ENZRXN
REGULATOR - NI+2
//
UNIQUE-ID - REG0-8784
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14245396
MODE - -
REGULATED-ENTITY - 3-NUCLEOTID-ENZRXN
REGULATOR - CPD-7082
//
UNIQUE-ID - REG0-10879
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12731872
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-1661
REGULATOR - SINEFUNGIN
//
UNIQUE-ID - REG0-9742
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2651445]
MODE - -
REGULATED-ENTITY - 3-OXOACYL-ACP-SYNTHII-ENZRXN
REGULATOR - CPD0-1242
//
UNIQUE-ID - REG0-12180
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8530465
MODE - -
REGULATED-ENTITY - ENZRXN0-7928
REGULATOR - CPD-605
//
UNIQUE-ID - REG0-6927
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7012144]
MODE - -
REGULATED-ENTITY - KETOACYLCOATHIOL-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-7525
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14401695
CITATIONS - 6755169
COMMENT - non-competitive
/|CITS: [4402917]|
MODE - -
REGULATED-ENTITY - ALTRO-OXIDOREDUCT-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-8159
TYPES - Regulation-of-Enzyme-Activity
COMMENT - The enzyme
/is sensitive to a number of carbonyl reagents due to the fact that
/catalysis is mediated by the carbonyl moiety of the pyruvate
/prosthetic group.  |CITS: [1495415] [338609]|
MODE - -
REGULATED-ENTITY - PHOSPHASERDECARB-ENZRXN
REGULATOR - HYDROXYLAMINE
//
UNIQUE-ID - REG0-8758
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 776970
MODE - +
REGULATED-ENTITY - GLUTAMINB-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-10851
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20921376
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - UDPNACETYLGLUCOSAMENOLPYRTRANS-ENZRXN
REGULATOR - BROMOACETATE
//
UNIQUE-ID - REG0-9726
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [WallenfelsTheEnzymes7-617]
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - |Heavy-Metal-Ions|
//
UNIQUE-ID - REG0-12156
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9737855
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ENZRXN0-7916
REGULATOR - GLN
//
UNIQUE-ID - REG0-6901
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4920894]
COMMENT - High levels of glycolytic and TCA cycle intermediates result in strong 
/inhibition of the adenylyltransferase reaction.  Pyruvate, glutarate, succinate
/and fumarate also inhibit to a lesser degree.  |CITS: [4920894]| 
MODE - -
REGULATED-ENTITY - GSADENYLATION-ENZRXN
REGULATOR - G3P
//
UNIQUE-ID - REG0-7508
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - 6PGLUCONDEHYDROG-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-8137
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4402996]
MODE - +
REGULATED-ENTITY - MANNONOXIDOREDUCT-ENZRXN
REGULATOR - MN+2
//
UNIQUE-ID - REG0-8729
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [821948]
KI - 1.5    
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GTP-CYCLOHYDRO-I-ENZRXN
REGULATOR - GDP
//
UNIQUE-ID - REG0-10739
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4966660]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTAMINA-ENZRXN
REGULATOR - N5-METHYLGLUTAMINE
//
UNIQUE-ID - REG0-9708
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - CPD0-1265
//
UNIQUE-ID - REG0-12116
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7639702
MODE - -
REGULATED-ENTITY - ENZRXN0-1314
REGULATOR - CU+2
//
UNIQUE-ID - REG0-6881
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [40950]
MODE - -
REGULATED-ENTITY - GLYCDEH-ENZRXN
REGULATOR - O-PHENANTHROLINE
//
UNIQUE-ID - REG0-7488
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4861610]
CITATIONS - [357898]
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - THYKI-ENZRXN
REGULATOR - DCDP
//
UNIQUE-ID - REG0-8111
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14718529
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-3281
REGULATOR - CPD-660
//
UNIQUE-ID - REG0-8704
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [FishMethEnz9-529]
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - NITRATE
//
UNIQUE-ID - REG0-10661
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17307338
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUCOKIN-ENZRXN
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-9692
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - 3-4-DIHYDROXYBENZOATE
//
UNIQUE-ID - REG0-12027
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24914049
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ENZRXN0-7856
REGULATOR - CPLX0-248
//
UNIQUE-ID - REG0-6865
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1099093
MODE - -
REGULATED-ENTITY - FORMATEDEHYDROGN-ENZRXN
REGULATOR - PHMB
//
UNIQUE-ID - REG0-7461
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3289541
MODE - -
REGULATED-ENTITY - ASPARTASE-ENZRXN
REGULATOR - CPD0-1616
//
UNIQUE-ID - REG0-8084
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4607756]
COMMENT - in a
/concentration of 25 mg/ml
MODE - -
REGULATED-ENTITY - ACETYLORNDEACET-ENZRXN
REGULATOR - CPD0-1641
//
UNIQUE-ID - REG0-8684
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4565085
MODE - -
REGULATED-ENTITY - GLUTAMATESYN-ENZRXN
REGULATOR - MET
//
UNIQUE-ID - REG0-10622
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4966660]
MODE - -
REGULATED-ENTITY - GLUTAMINA-ENZRXN
REGULATOR - PB+2
//
UNIQUE-ID - REG0-9675
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [33657]
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ETHAMLY-ENZRXN
REGULATOR - CPD0-1256
//
UNIQUE-ID - REG0-11968
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 368072
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-282
REGULATOR - AMP
//
UNIQUE-ID - REG0-6847
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10986273]
MODE - +
REGULATED-ENTITY - ENZRXN0-402
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-7441
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6365916
MODE - -
REGULATED-ENTITY - TETHYDPICSUCC-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-8059
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6305659]
CITATIONS - [6321477]
MODE - -
REGULATED-ENTITY - PROLDEHYDROG-ENZRXN
REGULATOR - CPD-5742
//
UNIQUE-ID - REG0-8651
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3911944
MODE - -
REGULATED-ENTITY - ENZRXN0-2245
REGULATOR - S-TUBERCIDINYLHOMOCYSTEINE
//
UNIQUE-ID - REG0-10562
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5322808
CITATIONS - 25707819
MODE - -
REGULATED-ENTITY - PEPSYNTH-ENZRXN
REGULATOR - F-
//
UNIQUE-ID - REG0-9654
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1551888]
MODE - -
REGULATED-ENTITY - ACP-S-ACETYLTRANSFER-ENZRXN
REGULATOR - CPD0-1242
//
UNIQUE-ID - REG0-11935
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2141983
MODE - -
REGULATED-ENTITY - ENZRXN0-7818
REGULATOR - CPD0-1618
//
UNIQUE-ID - REG0-6822
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10634942
MODE - -
REGULATED-ENTITY - ENZRXN0-266
REGULATOR - L-PHOSPHATIDATE
//
UNIQUE-ID - REG0-7415
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [14216423]
MODE - -
REGULATED-ENTITY - PHOSPHOGLUCMUT-ENZRXN
REGULATOR - FE+2
//
UNIQUE-ID - REG0-8019
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5327101]
MODE - -
REGULATED-ENTITY - DSERDEAM-ENZRXN
REGULATOR - ALLO-THR
//
UNIQUE-ID - REG0-8619
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7011505]
MODE - -
REGULATED-ENTITY - LSERINEDEAM1-ENZRXN
REGULATOR - ETHANOL-AMINE
//
UNIQUE-ID - REG0-10409
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12975365
MODE - -
REGULATED-ENTITY - ENZRXN0-1822
REGULATOR - PROTOPORPHYRIN_IX
//
UNIQUE-ID - REG0-9632
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12517755
MODE - -
REGULATED-ENTITY - ENZRXN0-1141
REGULATOR - CPD0-1231
//
UNIQUE-ID - REG0-11915
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24214977
KI - 4
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7813
REGULATOR - CPD-5721
//
UNIQUE-ID - REG0-6787
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [MethEnz62-379]
MODE - -
REGULATED-ENTITY - ENZRXN-153
REGULATOR - CUSO4
//
UNIQUE-ID - REG0-7394
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4587126
CITATIONS - 4966660
COMMENT - Causes irreversible inhibition by alkylation of the enzyme.
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - GLUTAMINA-ENZRXN
REGULATOR - CPD0-1627
//
UNIQUE-ID - REG0-7984
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6385860]
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - ENZRXN-17895
REGULATOR - PALMITATE
//
UNIQUE-ID - REG0-8583
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3910996]
MODE - +
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - CL
//
UNIQUE-ID - REG0-10361
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - DIACYLGLYKIN-ENZRXN
REGULATOR - CPD0-1808
//
UNIQUE-ID - REG0-9610
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2189496
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - ACETOLACTREDUCTOISOM-ENZRXN
REGULATOR - CPD0-1218
//
UNIQUE-ID - REG0-11843
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4575199
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - GLYCEROL-KIN-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-6748
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14245396
MODE - -
REGULATED-ENTITY - CYCPHOSDIESTER-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7376
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [5339592]
MODE - -
REGULATED-ENTITY - CARBPSYN-ENZRXN
REGULATOR - L-AZASERINE
//
UNIQUE-ID - REG0-7955
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7030214
CITATIONS - 4261395
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - CHORISMATEMUT2-ENZRXN
REGULATOR - PHE
//
UNIQUE-ID - REG0-8546
TYPES - Regulation-of-Enzyme-Activity
COMMENT - with respect to uracil  |CITS:
/[6357095]|
MODE - -
REGULATED-ENTITY - URPHOS-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-10253
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2007545
MODE - -
REGULATED-ENTITY - 7-ALPHA-HYDROXYSTEROID-DEH-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-9536
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16682444
MODE - -
REGULATED-ENTITY - ENZRXN0-2681
REGULATOR - 3-5-ADP
//
UNIQUE-ID - REG0-11814
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13459890
MODE - +
REGULATED-ENTITY - PYRDAMPTRANS-ENZRXN
REGULATOR - MG+2
//
UNIQUE-ID - REG0-6731
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1740425
MODE - -
REGULATED-ENTITY - CARBODEHYDRAT-ENZRXN
REGULATOR - CPD0-1626
//
UNIQUE-ID - REG0-7357
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8530465]
COMMENT - noncompetitive with respect to
/NADPH
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - FMNREDUCT-ENZRXN
REGULATOR - CPD-605
//
UNIQUE-ID - REG0-7918
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4290215]
COMMENT - Exhibits mixed type inhibition.
MODE - -
REGULATED-ENTITY - NAD-SYNTH-NH3-ENZRXN
REGULATOR - CPD0-1033
//
UNIQUE-ID - REG0-8528
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1672127
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - DAHPSYNTRP-ENZRXN
REGULATOR - TRP
//
UNIQUE-ID - REG0-10228
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19073594
MODE - -
REGULATED-ENTITY - ENZRXN0-6614
REGULATOR - LI+
//
UNIQUE-ID - REG0-9494
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18321216
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - CYT-O-UBIOX-ENZRXN
REGULATOR - CPD-581
//
UNIQUE-ID - REG0-11783
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2950851
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - 3-DEHYDROQUINATE-DEHYDRATASE-ENZRXN
REGULATOR - CL-
//
UNIQUE-ID - REG0-6708
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3024831
MODE - -
REGULATED-ENTITY - ALPHAGALACTOSID-ENZRXN
REGULATOR - 15-DIDEOXY-15-IMINO-D-GALACTITOL
//
UNIQUE-ID - REG0-7306
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1846850]
MODE - -
REGULATED-ENTITY - PHOSNACMURPENTATRANS-ENZRXN
REGULATOR - CPD-5242
//
UNIQUE-ID - REG0-7303
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 340264
MODE - +
REGULATED-ENTITY - PSII-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-7881
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7929317
COMMENT - inhibits the reduction
/of the `incorrect' substrate |CITS: [7929317]|
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - RIBONUCLEOSIDE-TRIP-REDUCT-ENZRXN
REGULATOR - TTP
//
UNIQUE-ID - REG0-8501
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6365921]
MODE - -
REGULATED-ENTITY - CYT-O-UBIOX-ENZRXN
REGULATOR - CO+2
//
UNIQUE-ID - REG0-10195
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2194570
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - BADH-ENZRXN
REGULATOR - CHOLINE
//
UNIQUE-ID - REG0-9429
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15539408
MODE - -
REGULATED-ENTITY - DCTP-DEAM-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-11764
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3910843
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7757
REGULATOR - ARSENATE
//
UNIQUE-ID - REG0-6677
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6300054
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ADENYLATECYC-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-7274
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7040354
MECHANISM - :ALLOSTERIC
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PEPCARBOX-ENZRXN
REGULATOR - FRUCTOSE-16-DIPHOSPHATE
//
UNIQUE-ID - REG0-7854
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6229418
MODE - -
REGULATED-ENTITY - 3-P-SHIK-1-CARBOXYVINYLXFERASE-ENZRXN
REGULATOR - 3-ENOLPYRUVYL-SHIKIMATE-5P
//
UNIQUE-ID - REG0-8477
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6378898]
MODE - -
REGULATED-ENTITY - TRANSENOYLCOARED-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-10158
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [4378654]
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - CPD0-1590
//
UNIQUE-ID - REG0-9337
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - NIL
REGULATED-ENTITY - OHBUTYRYL-COA-EPIM-ENZRXN
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-11706
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11502177
MODE - -
REGULATED-ENTITY - 3-OXOACYL-ACP-SYNTHI-ENZRXN
REGULATOR - ACP
//
UNIQUE-ID - REG0-6654
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10373108]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - FUMARATE-REDN-ENZRXN
REGULATOR - OXALACETIC_ACID
//
UNIQUE-ID - REG0-7236
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2510713]
MODE - -
REGULATED-ENTITY - OHMETHYLBILANESYN-ENZRXN
REGULATOR - BH4NA
//
UNIQUE-ID - REG0-7833
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13794771
MODE - -
REGULATED-ENTITY - GALACTUROISOM-ENZRXN
REGULATOR - O-PHENANTHROLINE
//
UNIQUE-ID - REG0-8453
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4878695]
CITATIONS - [4878694]
MODE - +
REGULATED-ENTITY - GLYCOPHOSPHORYL-ENZRXN
REGULATOR - NA2SO4
//
UNIQUE-ID - REG0-10139
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2185839
MODE - -
REGULATED-ENTITY - GART-ENZRXN
REGULATOR - CPD0-1574
//
UNIQUE-ID - REG0-9216
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13727223
MODE - -
REGULATED-ENTITY - DIHYDROXYISOVALDEHYDRAT-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-11677
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18787203
MODE - -
REGULATED-ENTITY - DIHYDRODIPICSYN-ENZRXN
REGULATOR - OH-PYR
//
UNIQUE-ID - REG0-6631
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17134700
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6314
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-7219
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6760815]
MODE - +
REGULATED-ENTITY - GLYCEROL-3-P-ACYLTRANSFER-ENZRXN
REGULATOR - SPERMIDINE
//
UNIQUE-ID - REG0-7817
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2211698
MODE - -
REGULATED-ENTITY - ENZRXN0-4521
REGULATOR - CL-
//
UNIQUE-ID - REG0-8439
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4878695
COMMENT - competitive with respect to glucose-1-phosphate. |CITS: [4878695]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLYCOPHOSPHORYL-ENZRXN
REGULATOR - ADP-D-GLUCOSE
//
UNIQUE-ID - REG0-10108
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [JAmChemSoc112-4932]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIAMINOPIMEPIM-ENZRXN
REGULATOR - CPD0-1532
//
UNIQUE-ID - REG0-9194
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9851711
MODE - -
REGULATED-ENTITY - GLYCOLALDREDUCT-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-11611
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11948193
MODE - +
REGULATED-ENTITY - ENZRXN0-3101
REGULATOR - K+
//
UNIQUE-ID - REG0-12472
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7012144]
MODE - -
REGULATED-ENTITY - ENZRXN0-8287
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-7190
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [2856144]
MODE - -
REGULATED-ENTITY - CYT-D-UBIOX-ENZRXN
REGULATOR - CPD0-1633
//
UNIQUE-ID - REG0-7795
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4870599]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ARGDECARBOXDEG-ENZRXN
REGULATOR - LYS
//
UNIQUE-ID - REG0-8416
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [357895]
CITATIONS - [7000783]
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - AMP-NUCLEOSID-ENZRXN
REGULATOR - CPD0-1634
//
UNIQUE-ID - REG0-10073
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [30751]
MODE - +
REGULATED-ENTITY - CDPDIGLYSYN-ENZRXN
REGULATOR - |Phospholipids|
//
UNIQUE-ID - REG0-9153
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4632320
MODE - -
REGULATED-ENTITY - FUCISOM-ENZRXN
REGULATOR - CD+2
//
UNIQUE-ID - REG0-11564
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15327942
MODE - -
REGULATED-ENTITY - ACS-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-9979
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7629147
MODE - -
REGULATED-ENTITY - S-ADENMETSYN-ENZRXN
REGULATOR - CPD0-1437
//
UNIQUE-ID - REG0-12456
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8268
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7159
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - CPD-205
//
UNIQUE-ID - REG0-7759
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2178550]
MODE - -
REGULATED-ENTITY - GABATRANSAM-ENZRXN
REGULATOR - CPD0-1467
//
UNIQUE-ID - REG0-8391
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8394006
MODE - -
REGULATED-ENTITY - PPPGPPHYDRO-ENZRXN
REGULATOR - |NaF|
//
UNIQUE-ID - REG0-10053
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3042781]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIAMINOPIMEPIM-ENZRXN
REGULATOR - |Lanthionine-Isomers|
//
UNIQUE-ID - REG0-9119
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 381296
MODE - -
REGULATED-ENTITY - THREDEHYDCAT-ENZRXN
REGULATOR - GLYOX
//
UNIQUE-ID - REG0-11458
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 22344668
MODE - -
REGULATED-ENTITY - FUMARA-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-9922
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - PHOSPHASERDECARB-ENZRXN
REGULATOR - CPD0-1399
//
UNIQUE-ID - REG0-12440
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8260
REGULATOR - TRIS-HYDROCHLORIDE
//
UNIQUE-ID - REG0-7122
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7602590]
MODE - -
REGULATED-ENTITY - QOR-ENZRXN
REGULATOR - DICOUMAROL
//
UNIQUE-ID - REG0-7734
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1577828]
MODE - -
REGULATED-ENTITY - KDOTRANS2-ENZRXN
REGULATOR - KDO2-LIPID-IVA
//
UNIQUE-ID - REG0-8372
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8550422
CITATIONS - [320209]
CITATIONS - [4296829]
MECHANISM - :ALLOSTERIC
MODE - -
REGULATED-ENTITY - PGLYCDEHYDROG-ENZRXN
REGULATOR - GLY
//
UNIQUE-ID - REG0-10035
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1092682
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DAPASYN-ENZRXN
REGULATOR - CPD0-1484
//
UNIQUE-ID - REG0-9081
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5328735
MODE - -
REGULATED-ENTITY - GLYOCARBOLIG-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-11361
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 372191
MODE - +
REGULATED-ENTITY - PRPPAMIDOTRANS-ENZRXN
REGULATOR - GTP
//
UNIQUE-ID - REG0-9902
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1993184
CITATIONS - 1554356
CITATIONS - 8807826
MODE - -
REGULATED-ENTITY - DALADALALIGB-ENZRXN
REGULATOR - |Aminoalkylphosphinates|
//
UNIQUE-ID - REG0-12423
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2194570
MODE - +
REGULATED-ENTITY - BADH-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-7097
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2148683]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLYCEROL-KIN-ENZRXN
REGULATOR - CPD0-1054
//
UNIQUE-ID - REG0-7702
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1396671]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - RIBONUCLEOSIDE-DIP-REDUCTI-ENZRXN
REGULATOR - DCDP
//
UNIQUE-ID - REG0-8347
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6117328
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ADENYLOSUCCINATE-SYNTHASE-ENZRXN
REGULATOR - CPD0-1055
//
UNIQUE-ID - REG0-10015
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 164459
MODE - -
REGULATED-ENTITY - GMP-SYN-NH3-ENZRXN
REGULATOR - CPD0-1466
//
UNIQUE-ID - REG0-8978
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - Stadtman61
MODE - -
REGULATED-ENTITY - ASPARTATEKINI-ENZRXN
REGULATOR - LYS
//
UNIQUE-ID - REG0-11330
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5337593
MODE - +
REGULATED-ENTITY - UDPSUGARHYDRO-ENZRXN
REGULATOR - CO+2
//
UNIQUE-ID - REG0-9868
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10769119
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - RIBONUCLEOSIDE-DIP-REDUCTI-ENZRXN
REGULATOR - CPD0-1395
//
UNIQUE-ID - REG0-12360
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7001458
MODE - -
REGULATED-ENTITY - ENZRXN0-7969
REGULATOR - enduracidin
//
UNIQUE-ID - REG0-7077
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10486141]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SUCCINATE-OXN-ENZRXN
REGULATOR - PENTACHLOROPHENOL
//
UNIQUE-ID - REG0-7674
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 224913
MODE - -
REGULATED-ENTITY - MALIC-NAD-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-8318
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3301347
MODE - -
REGULATED-ENTITY - UDP-NACMURALA-GLU-LIG-ENZRXN
REGULATOR - UDP-AA-GLUTAMATE
//
UNIQUE-ID - REG-15072
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8550422
CREDITS - SRI
CREDITS - |caspi|
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN-23884
REGULATOR - G3P
//
UNIQUE-ID - REG0-8924
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8550422
MECHANISM - :ALLOSTERIC
MODE - -
REGULATED-ENTITY - KETOGLUTREDUCT-ENZRXN
REGULATOR - GLY
//
UNIQUE-ID - REG0-11300
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17557829
MODE - -
REGULATED-ENTITY - MALIC-NADP-ENZRXN
REGULATOR - FUM
//
UNIQUE-ID - REG0-9845
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [ColiSalII]
MODE - -
REGULATED-ENTITY - MCPMETEST-ENZRXN
REGULATOR - |Sulfhydryl-Reagents|
//
UNIQUE-ID - REG0-12319
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9261133
KI - 200
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PPX-ENZRXN
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-7059
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3530323
COMMENT - Pi versus FGAM
MODE - -
REGULATED-ENTITY - AIRS-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-7648
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10026271
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - UDPACYLGLCNACDEACETYL-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-8287
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3291954
COMMENT - Poor inhibitor  |CITS: [3291954]| 
MODE - -
REGULATED-ENTITY - ISOCITLYASE-ENZRXN
REGULATOR - GLYCOLLATE
//
UNIQUE-ID - REG0-8903
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4860415
COMMENT - Glutamine synthetase activity is subject to cumulative feedback
/inhibition by the products of glutamine metabolism. Each of the listed compounds inhibits glutamine synthetase partially together
COMMENT - these compounds can inhibit glutamine synthetase completely. Glutamine itself is not an inhibitor.
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUTAMINESYN-ENZRXN
REGULATOR - TRP
//
UNIQUE-ID - REG0-11273
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9315862
MODE - -
REGULATED-ENTITY - MHPCHYDROL-ENZRXN
REGULATOR - PHMB
//
UNIQUE-ID - REG0-9828
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [JAmChemSoc111-1861]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - 3-DEHYDROQUINATE-SYNTHASE-ENZRXN
REGULATOR - CPD0-1372
//
UNIQUE-ID - REG0-12287
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2892828
MODE - -
REGULATED-ENTITY - ENZRXN0-4321
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7026
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [692401]
CITATIONS - 12070315
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - HYPOXANPRIBOSYLTRAN-ENZRXN
REGULATOR - IMP
//
UNIQUE-ID - REG0-7622
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2549047
COMMENT - Both inhibited the enzyme in a
/noncompetitive manner at a subinhibitory concentration of APS.  PAPS
/was uncompetitive with MgATP when a high APS concentration was used.
MODE - -
REGULATED-ENTITY - ADENYLYLSULFKIN-ENZRXN
REGULATOR - PAPS
//
UNIQUE-ID - REG0-8258
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2502187
CITATIONS - 1091651
COMMENT - The enzyme requires a monovalent
/cation for activity. Rb+ will activate but less effectively than K+
/and Tl+ will replace K+ as an activator with greater affinity.  |CITS:
/[236639]|
MODE - +
REGULATED-ENTITY - TRYPTOPHAN-ENZRXN
REGULATOR - AMMONIUM
//
UNIQUE-ID - REG0-8859
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - 4OH2OXOGLUTARALDOL-ENZRXN
REGULATOR - PYRUVATE
//
UNIQUE-ID - REG0-11196
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21696459
MODE - -
REGULATED-ENTITY - GLYOXIII-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-9802
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10395747
MODE - -
REGULATED-ENTITY - ENZRXN0-3802
REGULATOR - CPD0-1359
//
UNIQUE-ID - REG0-12267
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16569861
MODE - -
REGULATED-ENTITY - ENZRXN0-7970
REGULATOR - PENICILLIN
//
UNIQUE-ID - REG0-7006
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4567662]
MODE - -
REGULATED-ENTITY - THI-P-KIN-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-7595
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4625870
MODE - -
REGULATED-ENTITY - GLUCONOLACT-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-8239
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3553173
MODE - -
REGULATED-ENTITY - GLUTATHIONE-SYN-ENZRXN
REGULATOR - CPD-6041
//
UNIQUE-ID - REG0-8826
TYPES - Regulation-of-Enzyme-Activity
COMMENT - When the guanosine concentration is varied GMP is
/a competitive inhibitor. When the Mg-ATP
/concentration is varied GMP shows a mixed 
/inhibition.  |CITS: [10879466]| 
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GUANOSINEKIN-ENZRXN
REGULATOR - GMP
//
UNIQUE-ID - REG0-11021
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21467222
MODE - -
REGULATED-ENTITY - ENZRXN0-7454
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-9778
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7601127]
MODE - -
REGULATED-ENTITY - UDP-NACMUR-ALA-LIG-ENZRXN
REGULATOR - CPD0-1336
//
UNIQUE-ID - REG0-12250
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14693515
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - amoxicillin
//
UNIQUE-ID - REG0-6967
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9748334
CITATIONS - [6456900]
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PFRUCTPHOS-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-7563
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6143811
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-2081
REGULATOR - ADENOSYL-HOMO-CYS
//
UNIQUE-ID - REG0-8205
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - D-GALACTOSYLAMINE
//
UNIQUE-ID - REG0-8809
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6767707
MODE - -
REGULATED-ENTITY - ENZRXN0-4281
REGULATOR - HYDROXYLAMINE
//
UNIQUE-ID - REG0-11001
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17567041
MODE - +
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - MN+2
//
UNIQUE-ID - REG0-9760
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [211379]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYTIDINEKIN-ENZRXN
REGULATOR - CPD0-1320
//
UNIQUE-ID - REG0-12234
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 147874
MODE - +
REGULATED-ENTITY - ENZRXN0-6150
REGULATOR - MG+2
//
UNIQUE-ID - REG0-6942
TYPES - Regulation-of-Enzyme-Activity
COMMENT - causes homotropic activation  |CITS: [9489667]| 
MODE - +
REGULATED-ENTITY - METHGLYSYN-ENZRXN
REGULATOR - DIHYDROXY-ACETONE-PHOSPHATE
//
UNIQUE-ID - REG0-7545
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1646603]
CITATIONS - 6389524
MODE - -
REGULATED-ENTITY - ACNEULY-ENZRXN
REGULATOR - N-BROMOSUCCINIMIDE
//
UNIQUE-ID - REG0-8173
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2675968
COMMENT - inhibition by
/valine is overcome by isoleucine
MODE - -
REGULATED-ENTITY - ACETOOHBUTSYN-ENZRXN
REGULATOR - VAL
//
UNIQUE-ID - REG0-8779
TYPES - Regulation-of-Enzyme-Activity
COMMENT - with respect to acyl-CoA
/substrate  |CITS: [332081]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ACETOACETYL-COA-TRANSFER-ENZRXN
REGULATOR - CO-A
//
UNIQUE-ID - REG0-10873
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1309518
MODE - -
REGULATED-ENTITY - ENZRXN0-7431
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-9739
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2651445]
MODE - -
REGULATED-ENTITY - 3-OXOACYL-ACP-SYNTHI-BASE-ENZRXN
REGULATOR - CPD0-1242
//
UNIQUE-ID - REG0-12177
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3334241
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ASPARAGHYDB-ENZRXN
REGULATOR - L-ASPARTATE
//
UNIQUE-ID - REG0-6924
TYPES - Regulation-of-Enzyme-Activity
COMMENT - Phenylglyoxal inactivates the unphosphorylated form of the enzyme. 
/ |CITS: [2673216]| 
MODE - -
REGULATED-ENTITY - ISOCITDEH-ENZRXN
REGULATOR - PHENYLGLYOXAL
//
UNIQUE-ID - REG0-7522
TYPES - Regulation-of-Enzyme-Activity
COMMENT - Mn++ can be replaced by Cd++.  |CITS:
/[3518793]|
MODE - +
REGULATED-ENTITY - THREODEHYD-ENZRXN
REGULATOR - MN+2
//
UNIQUE-ID - REG0-8154
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6319365
CITATIONS - 2567735
KI - 60
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUTKIN-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-8755
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 776970
MODE - +
REGULATED-ENTITY - GLUTAMINB-ENZRXN
REGULATOR - P3I
//
UNIQUE-ID - REG0-10830
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 115862
MODE - -
REGULATED-ENTITY - ENZRXN0-7396
REGULATOR - MG+2
//
UNIQUE-ID - REG0-9721
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [237196]
CITATIONS - SCHWARTZ72
MODE - -
REGULATED-ENTITY - RHAMNULPALDOL-ENZRXN
REGULATOR - CPD0-1288
//
UNIQUE-ID - REG0-12146
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24479701
MODE - -
REGULATED-ENTITY - ENZRXN0-6222
REGULATOR - CA+2
//
UNIQUE-ID - REG0-6898
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [MethEnz17A-922]
CITATIONS - [HandEnzInh]
COMMENT - High levels of glycolytic and TCA cycle intermediates result in strong 
/inhibition of the adenylyltransferase reaction.  Pyruvate, glutarate, succinate
/and fumarate also inhibit to a lesser degree.  |CITS: [4920894]| 
MODE - -
REGULATED-ENTITY - GSADENYLATION-ENZRXN
REGULATOR - SULFATE
//
UNIQUE-ID - REG0-7505
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - 6PGLUCONDEHYDROG-ENZRXN
REGULATOR - CO-A
//
UNIQUE-ID - REG0-8127
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 217342
MODE - -
REGULATED-ENTITY - NITRITREDUCT-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-8726
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [821948]
KI - 10
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GTP-CYCLOHYDRO-I-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-10719
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20434458
MODE - +
REGULATED-ENTITY - ENZRXN0-7341
REGULATOR - EG11835-MONOMER
//
UNIQUE-ID - REG0-9705
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - TEREPHTHALATE
//
UNIQUE-ID - REG0-12113
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7639702
MODE - -
REGULATED-ENTITY - ENZRXN0-1314
REGULATOR - 8-SELENO-OCTANOATE
//
UNIQUE-ID - REG0-6878
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9733680]
MODE - -
REGULATED-ENTITY - GLUCOSAMINE1PACETYL-ENZRXN
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7485
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4861610]
CITATIONS - [357898]
MECHANISM - :ALLOSTERIC
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - THYKI-ENZRXN
REGULATOR - DCTP
//
UNIQUE-ID - REG0-8102
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [33657]
CITATIONS - 784902
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ETHAMLY-ENZRXN
REGULATOR - CPD-315
//
UNIQUE-ID - REG0-8701
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [FishMethEnz9-529]
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-10648
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2271698
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - HOMOCYSMETB12-ENZRXN
REGULATOR - THF
//
UNIQUE-ID - REG0-9689
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - CPD-7673
//
UNIQUE-ID - REG0-12024
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11515538
MODE - +
REGULATED-ENTITY - ENZRXN0-7629
REGULATOR - NI+2
//
UNIQUE-ID - REG0-6862
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1099093
MODE - -
REGULATED-ENTITY - FORMATEDEHYDROGN-ENZRXN
REGULATOR - HCN
//
UNIQUE-ID - REG0-7458
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - ASPARTASE-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-8081
TYPES - Regulation-of-Enzyme-Activity
COMMENT - Competitive with respect to N-acetylornithine.  |CITS: [10684608]| 
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ACETYLORNDEACET-ENZRXN
REGULATOR - ACET
//
UNIQUE-ID - REG0-8672
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3905407]
MODE - -
REGULATED-ENTITY - UDP-NACMURALGLDAPLIG-ENZRXN
REGULATOR - UDP-AAGM-DIAMINOHEPTANEDIOATE
//
UNIQUE-ID - REG0-10619
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7798192
MECHANISM - :ALLOSTERIC
MODE - -
REGULATED-ENTITY - ASPAMINOTRANS-ENZRXN
REGULATOR - CPD0-1614
//
UNIQUE-ID - REG0-9670
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6768963]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIHYDROFOLATESYNTH-ENZRXN
REGULATOR - CPD0-1253
//
UNIQUE-ID - REG0-11965
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 368072
MODE - +
REGULATED-ENTITY - ENZRXN0-282
REGULATOR - L-1-PHOSPHATIDYL-GLYCEROL-P
//
UNIQUE-ID - REG0-6839
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10700392
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-3802
REGULATOR - CPD0-1708
//
UNIQUE-ID - REG0-7438
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 26682
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - DAHPSYNPHE-ENZRXN
REGULATOR - PHE
//
UNIQUE-ID - REG0-8055
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [355248]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PROLDEHYDROG-ENZRXN
REGULATOR - L-LACTATE
//
UNIQUE-ID - REG0-8648
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3911944
MODE - -
REGULATED-ENTITY - ENZRXN0-2245
REGULATOR - 5-CHLOROFORMYCIN
//
UNIQUE-ID - REG0-10523
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19994913
MODE - -
REGULATED-ENTITY - PROLDEHYDROG-ENZRXN
REGULATOR - CPD0-2281
//
UNIQUE-ID - REG0-9650
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [BlumenthalMethEnz9-665]
MODE - -
REGULATED-ENTITY - GALACTARDEHYDRA-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-11932
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2141983
MODE - -
REGULATED-ENTITY - ENZRXN0-7818
REGULATOR - CPD0-1624
//
UNIQUE-ID - REG0-6817
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8144648
COMMENT - Competitive with respect to ATP.  Several nucleotide
/analogues act as inhibitors as well.  |CITS: [JBC269-10597] [9482859]| 
KI - 170
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-253
REGULATOR - AMP
//
UNIQUE-ID - REG0-7412
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4960829
MODE - -
REGULATED-ENTITY - PHOSPHOGLUCMUT-ENZRXN
REGULATOR - CPD-1492
//
UNIQUE-ID - REG0-8015
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9011040]
MODE - +
REGULATED-ENTITY - APHA-ENZRXN
REGULATOR - ETOH
//
UNIQUE-ID - REG0-8614
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - SULFITE-REDUCT-ENZRXN
REGULATOR - CO+2
//
UNIQUE-ID - REG0-10406
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10978324]
MODE - -
REGULATED-ENTITY - ENZRXN0-241
REGULATOR - CPD0-1888
//
UNIQUE-ID - REG0-9629
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8119879
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ENOYL-ACP-REDUCT-NADH-ENZRXN
REGULATOR - CPD0-1228
//
UNIQUE-ID - REG0-11912
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24214977
KI - 33
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7811
REGULATOR - CPD0-1932
//
UNIQUE-ID - REG0-6781
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4899016]
CITATIONS - [HandEnzInh]
COMMENT - In high concentrations
MODE - -
REGULATED-ENTITY - DTMPKI-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-7391
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10683258
COMMENT - K<SUP>+</SUP> is the most effective activator,
/followed by Rb<SUP>+</SUP> and NH<SUB>4</SUB><SUP>+</SUP>.
/Cs<SUP>+</SUP> is the least effective activator. 
/ |CITS: [10683258]| 
MODE - +
REGULATED-ENTITY - IMP-DEHYDROG-ENZRXN
REGULATOR - AMMONIUM
//
UNIQUE-ID - REG0-7981
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6990987]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN-17895
REGULATOR - CPD-551
//
UNIQUE-ID - REG0-8579
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-10328
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11389594
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - METHGLYSYN-ENZRXN
REGULATOR - CPD0-1102
//
UNIQUE-ID - REG0-9591
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18519036
MODE - -
REGULATED-ENTITY - CYT-D-UBIOX-ENZRXN
REGULATOR - |Gramicidins|
//
UNIQUE-ID - REG0-11840
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3009477
CITATIONS - 9125530
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PRPPSYN-ENZRXN
REGULATOR - CPD0-1651
//
UNIQUE-ID - REG0-6744
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :OTHER
MODE - +
REGULATED-ENTITY - CITSYN-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-7373
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
COMMENT - Cyanate is believed to be a competitive inhibitor due to its reversibility,
/although kinetically it behaves as a noncompetitive inhibitor.
/ |CITS: [240389]| 
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CARBPSYN-ENZRXN
REGULATOR - CPD-69
//
UNIQUE-ID - REG0-7937
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6097184
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - HOMOSERKIN-ENZRXN
REGULATOR - HOMO-SER
//
UNIQUE-ID - REG0-8541
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 769833
COMMENT - for the
/phosphorolysis reaction, with uridine levels varied and phosphate at a
/nonsaturating level |CITS: [6357095]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - URPHOS-ENZRXN
REGULATOR - URACIL
//
UNIQUE-ID - REG0-10250
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16567800
MODE - -
REGULATED-ENTITY - ENZRXN0-6198
REGULATOR - CU+2
//
UNIQUE-ID - REG0-9523
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11926828
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GDPMANMANHYDRO-ENZRXN
REGULATOR - GDP
//
UNIQUE-ID - REG0-11804
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8366125
MODE - -
REGULATED-ENTITY - UDPHYDROXYMYRGLUCOSAMNACETYLTRANS-ENZRXN
REGULATOR - ACP
//
UNIQUE-ID - REG0-6726
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4895362
COMMENT - with respect to aspartate
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ASNSYNA-ENZRXN
REGULATOR - ASN
//
UNIQUE-ID - REG0-7354
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8530465]
COMMENT - competitive with respect to
/riboflavin
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - FMNREDUCT-ENZRXN
REGULATOR - CPD-605
//
UNIQUE-ID - REG0-7906
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [350870]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - METHENYLTHFCYCLOHYDRO-ENZRXN
REGULATOR - 10-FORMYL-THF
//
UNIQUE-ID - REG0-8521
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7860596
COMMENT - demonstrates substrate inhibition  |CITS: [7860596]|
MODE - -
REGULATED-ENTITY - PNP-PMPOXI-ENZRXN
REGULATOR - PYRIDOXINE-5P
//
UNIQUE-ID - REG0-10225
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19073594
MODE - -
REGULATED-ENTITY - ENZRXN0-402
REGULATOR - LI+
//
UNIQUE-ID - REG0-9477
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12517755
MODE - -
REGULATED-ENTITY - ENZRXN0-1141
REGULATOR - CPD-520
//
UNIQUE-ID - REG0-11780
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2950851
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - 3-DEHYDROQUINATE-DEHYDRATASE-ENZRXN
REGULATOR - DIETHYLPYROCARBONATE
//
UNIQUE-ID - REG0-6705
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5543331]
MODE - -
REGULATED-ENTITY - ALPHAGALACTOSID-ENZRXN
REGULATOR - CD+2
//
UNIQUE-ID - REG0-6702
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5543331]
MODE - -
REGULATED-ENTITY - ALPHAGALACTOSID-ENZRXN
REGULATOR - PHMB
//
UNIQUE-ID - REG0-7290
TYPES - Regulation-of-Enzyme-Activity
COMMENT - Mg++ was the best activator. |CITS: [1316760]| 
COMMENT - Pyrophosphate inhibits
/polyphosphate synthesis and the NDK reaction but
/stimulates ppppG synthesis.  |CITS: [10660553]| 
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PPK-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-7873
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13794771
MODE - -
REGULATED-ENTITY - GLUCUROISOM-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-8497
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4565667]
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - L-LACTDEHYDROGFMN-ENZRXN
REGULATOR - CPD0-1604
//
UNIQUE-ID - REG0-10191
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2194570
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - BADH-ENZRXN
REGULATOR - CPD-5601
//
UNIQUE-ID - REG0-9398
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18245280
MODE - -
REGULATED-ENTITY - ENZRXN0-1702
REGULATOR - OXALATE
//
UNIQUE-ID - REG0-11761
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3280015
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7757
REGULATOR - CPD-4422
//
UNIQUE-ID - REG0-6673
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6300054]
MECHANISM - :ALLOSTERIC
MODE - -
REGULATED-ENTITY - ADENYLATECYC-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-7270
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7040354
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PEPCARBOX-ENZRXN
REGULATOR - L-ASPARTATE
//
UNIQUE-ID - REG0-7849
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [376531]
MODE - -
REGULATED-ENTITY - ORNCARBAMTRANSFERF-ENZRXN
REGULATOR - N-DELTA-PHOSPHONOACETYL-L-ORNITHINE
//
UNIQUE-ID - REG0-8474
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6378898]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - TRANSENOYLCOARED-ENZRXN
REGULATOR - saturated acyl-CoA
//
UNIQUE-ID - REG0-10152
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [2495789]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - CPD0-1586
//
UNIQUE-ID - REG0-9306
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3038546
MODE - -
REGULATED-ENTITY - MANNONDEHYDRAT-ENZRXN
REGULATOR - O-PHENANTHROLINE
//
UNIQUE-ID - REG0-11692
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21602303
KI - 0.62    
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6184
REGULATOR - SINEFUNGIN
//
UNIQUE-ID - REG0-6651
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10486141]
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - FUMARATE-REDN-ENZRXN
REGULATOR - MALONATE
//
UNIQUE-ID - REG0-7233
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [357906]
MODE - -
REGULATED-ENTITY - ADENPRIBOSYLTRAN-ENZRXN
REGULATOR - BA+2
//
UNIQUE-ID - REG0-7830
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13794771
MODE - -
REGULATED-ENTITY - GALACTUROISOM-ENZRXN
REGULATOR - CYS
//
UNIQUE-ID - REG0-10128
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 26682
MODE - -
REGULATED-ENTITY - DAHPSYNPHE-ENZRXN
REGULATOR - CPD0-1557
//
UNIQUE-ID - REG0-9213
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9150206
MODE - NIL
REGULATED-ENTITY - MENF-ENZRXN
REGULATOR - DITHIOTHREITOL
//
UNIQUE-ID - REG0-11674
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8993314
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - DIHYDRODIPICSYN-ENZRXN
REGULATOR - CPD-291
//
UNIQUE-ID - REG0-6627
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6270288
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6350
REGULATOR - CPD0-1605
//
UNIQUE-ID - REG0-7216
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7026564]
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - GLYCEROL-3-P-ACYLTRANSFER-ENZRXN
REGULATOR - ACP-MONOMER
//
UNIQUE-ID - REG0-7814
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4404056
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - LEUAMINOTRANS-ENZRXN
REGULATOR - TYR
//
UNIQUE-ID - REG0-8436
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14641112
MODE - +
REGULATED-ENTITY - ENZRXN0-6041
REGULATOR - NI+2
//
UNIQUE-ID - REG0-10105
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [JOrgChem54-2404]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PREPHENATEDEHYDRAT-ENZRXN
REGULATOR - CPD0-1524
//
UNIQUE-ID - REG0-9191
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4151408]
MODE - -
REGULATED-ENTITY - NITRATREDUCTA-ENZRXN
REGULATOR - HCN
//
UNIQUE-ID - REG0-11608
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12392545
MODE - -
REGULATED-ENTITY - SUPEROX-DISMUTFE-ENZRXN
REGULATOR - HYDROGEN-PEROXIDE
//
UNIQUE-ID - REG0-12469
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - -
REGULATED-ENTITY - ENZRXN0-8286
REGULATOR - TRIS
//
UNIQUE-ID - REG0-7187
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6321507]
MODE - -
REGULATED-ENTITY - CYT-D-UBIOX-ENZRXN
REGULATOR - CPD-7082
//
UNIQUE-ID - REG0-7792
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4870599]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ARGDECARBOXDEG-ENZRXN
REGULATOR - |Guanido-Compounds|
//
UNIQUE-ID - REG0-8409
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1915361
COMMENT - shows mixed-type inhibition when
/glutamine is the variable substrate  |CITS: [1915361]|
MODE - -
REGULATED-ENTITY - L-GLN-FRUCT-6-P-AMINOTRANS-ENZRXN
REGULATOR - PYRIDOXAL_PHOSPHATE
//
UNIQUE-ID - REG0-10068
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - DTDPGLUCOSEPP-ENZRXN
REGULATOR - DTDP-RHAMNOSE
//
UNIQUE-ID - REG0-9139
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8496184
MODE - -
REGULATED-ENTITY - TRANS-ENZRXN-144B
REGULATOR - MG+2
//
UNIQUE-ID - REG0-11561
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20821193
MODE - -
REGULATED-ENTITY - PYRUVATEDEH-ENZRXN
REGULATOR - CPD-4544
//
UNIQUE-ID - REG0-9976
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6251075]
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - S-ADENMETSYN-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-12453
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8266
REGULATOR - TRIS-HYDROCHLORIDE
//
UNIQUE-ID - REG0-7156
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - SUC
//
UNIQUE-ID - REG0-7756
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2178550]
MODE - -
REGULATED-ENTITY - GABATRANSAM-ENZRXN
REGULATOR - PHENYLHYDRAZINE
//
UNIQUE-ID - REG0-8387
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4365537
MODE - -
REGULATED-ENTITY - N-ACETYLGLUTPREDUCT-ENZRXN
REGULATOR - MN+2
//
UNIQUE-ID - REG0-10050
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3042781]
MODE - -
REGULATED-ENTITY - DIAMINOPIMEPIM-ENZRXN
REGULATOR - CPD0-1498
//
UNIQUE-ID - REG0-9116
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4889010
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - ENZRXN0-6427
REGULATOR - AMP
//
UNIQUE-ID - REG0-11448
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 340460
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6416
REGULATOR - 2-PG
//
UNIQUE-ID - REG0-9918
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4567662]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - THI-P-KIN-ENZRXN
REGULATOR - CPD0-1426
//
UNIQUE-ID - REG0-12437
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8258
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7112
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4349042
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - HISTIDPHOS-ENZRXN
REGULATOR - HIS
//
UNIQUE-ID - REG0-7725
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4893578]
CITATIONS - [4866293]
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GSDEADENYLATION-ENZRXN
REGULATOR - 2-KETOGLUTARATE
//
UNIQUE-ID - REG0-8369
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [189701]
MODE - -
REGULATED-ENTITY - GMP-SYN-GLUT-ENZRXN
REGULATOR - DITHIO-NITROBENZOATE
//
UNIQUE-ID - REG0-10032
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12218056
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - DAPASYN-ENZRXN
REGULATOR - CPD0-1481
//
UNIQUE-ID - REG0-9060
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 781521
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ENZRXN0-6423
REGULATOR - HIS
//
UNIQUE-ID - REG0-11358
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 372191
MODE - -
REGULATED-ENTITY - PRPPAMIDOTRANS-ENZRXN
REGULATOR - CPD0-1224
//
UNIQUE-ID - REG0-9899
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 340264
MODE - -
REGULATED-ENTITY - PSII-ENZRXN
REGULATOR - CPD0-1415
//
UNIQUE-ID - REG0-12396
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19923213
MODE - -
REGULATED-ENTITY - ENZRXN0-7345
REGULATOR - GLYOX
//
UNIQUE-ID - REG0-7093
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17123542
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - XYLULOKIN-ENZRXN
REGULATOR - CPD0-1054
//
UNIQUE-ID - REG0-7697
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329757
MODE - -
REGULATED-ENTITY - ICITDEHKINASE-ENZRXN
REGULATOR - OXALACETIC_ACID
//
UNIQUE-ID - REG0-8344
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6463
COMMENT - inhibited the forward reaction
/|CITS: [6463]|
MODE - -
REGULATED-ENTITY - 3-METHYL-2-OXOBUT-OHCH3XFER-ENZRXN
REGULATOR - THF
//
UNIQUE-ID - REG0-10012
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5328735
MODE - +
REGULATED-ENTITY - GLYOCARBOLIG-ENZRXN
REGULATOR - |SH-Compounds|
//
UNIQUE-ID - REG0-8975
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 163250
MODE - +
REGULATED-ENTITY - HOMOSERDEHYDROGI-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-11315
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10612730
MODE - -
REGULATED-ENTITY - ACETALD-DEHYDROG-ENZRXN
REGULATOR - CPD-400
//
UNIQUE-ID - REG0-9865
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2407066
MODE - -
REGULATED-ENTITY - RIBONUCLEOSIDE-DIP-REDUCTI-ENZRXN
REGULATOR - CPD0-1394
//
UNIQUE-ID - REG0-12352
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16791965
MODE - -
REGULATED-ENTITY - SORB6PDEHYDROG-ENZRXN
REGULATOR - CPD-15157
//
UNIQUE-ID - REG0-7074
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 769831
MODE - +
REGULATED-ENTITY - DHHB-METHYLTRANSFER-ENZRXN
REGULATOR - DITHIOTHREITOL
//
UNIQUE-ID - REG0-7671
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4294855]
CITATIONS - [4313705]
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - MALIC-NAD-ENZRXN
REGULATOR - ACETYL-COA
//
UNIQUE-ID - REG0-8305
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4901371]
COMMENT - cerulenin and
/thiolactomycin are antibiotics
MODE - -
REGULATED-ENTITY - 3-OXOACYL-ACP-SYNTHI-ENZRXN
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG-14948
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16678412
CREDITS - SRI
CREDITS - |caspi|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN-23156
REGULATOR - CPD0-2332
//
UNIQUE-ID - REG0-8921
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8550422
COMMENT - inhibits the reverse, dehydrogenase
/activity |CITS: [8550422]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - KETOGLUTREDUCT-ENZRXN
REGULATOR - 2-KETOGLUTARATE
//
UNIQUE-ID - REG0-11297
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7765483
MODE - -
REGULATED-ENTITY - AMINEPHEN-ENZRXN
REGULATOR - ISONIAZIDE
//
UNIQUE-ID - REG0-9842
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4365537]
MODE - -
REGULATED-ENTITY - ORNCARBAMTRANSFERI-ENZRXN
REGULATOR - |Sulfhydryl-Reagents|
//
UNIQUE-ID - REG0-12309
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - CHEN09WORDJMICRO
CITATIONS - 8226676
MODE - +
REGULATED-ENTITY - ENZRXN0-4502
REGULATOR - CA+2
//
UNIQUE-ID - REG0-7056
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4557653]
MODE - -
REGULATED-ENTITY - GLYCOLATEDEHYDRO-ENZRXN
REGULATOR - CUSO4
//
UNIQUE-ID - REG0-7645
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3288280]
MODE - -
REGULATED-ENTITY - UDPACYLGLCNACDEACETYL-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-8283
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2673042
COMMENT - For the condensation reaction with respect to succinate,
/for the cleavage reaction, and with repect to glyoxylate|CITS:[2673042]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ISOCITLYASE-ENZRXN
REGULATOR - G3P
//
UNIQUE-ID - REG0-8900
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4860415
COMMENT - Glutamine synthetase activity is subject to cumulative feedback
/inhibition by the products of glutamine metabolism. Each of the listed compounds inhibits glutamine synthetase partially together
COMMENT - these compounds can inhibit glutamine synthetase completely. Glutamine itself is not an inhibitor.
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUTAMINESYN-ENZRXN
REGULATOR - D-GLUCOSAMINE-6-P
//
UNIQUE-ID - REG0-11262
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17451745
MECHANISM - :ALLOSTERIC
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ASPARAGHYDA-ENZRXN
REGULATOR - ASN
//
UNIQUE-ID - REG0-9825
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14973029
CITATIONS - 15466596
MODE - +
REGULATED-ENTITY - ENZRXN0-1181
REGULATOR - CPLX0-3953
//
UNIQUE-ID - REG0-12284
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2197276
MODE - -
REGULATED-ENTITY - ENZRXN0-4561
REGULATOR - DIISOPROPYL-FLUOROPHOSPHATE
//
UNIQUE-ID - REG0-7023
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [692401]
MODE - -
REGULATED-ENTITY - HYPOXANPRIBOSYLTRAN-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7618
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4307450
COMMENT - structural
/analogue  |CITS: [4307450]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DTDPGLUCDEHYDRAT-ENZRXN
REGULATOR - TDP-6-DEOXY-D-GLUCOSE
//
UNIQUE-ID - REG0-8253
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9125514
CITATIONS - 12392545
COMMENT - 73% inhibition  |CITS: [213023]|
MODE - -
REGULATED-ENTITY - SUPEROX-DISMUTFE-ENZRXN
REGULATOR - CPD-2841
//
UNIQUE-ID - REG0-8845
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [21941]
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ACS-ENZRXN
REGULATOR - PROPIONATE
//
UNIQUE-ID - REG0-11165
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13844669
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - AMYLOMALT-ENZRXN
REGULATOR - CPD-3570
//
UNIQUE-ID - REG0-9799
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1099080
MODE - -
REGULATED-ENTITY - ILES-ENZRXN
REGULATOR - CPD0-1234
//
UNIQUE-ID - REG0-12264
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12714684
MODE - -
REGULATED-ENTITY - ENZRXN0-7969
REGULATOR - CPD-12251
//
UNIQUE-ID - REG0-6999
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1104357
MODE - -
REGULATED-ENTITY - RIB5PISOMA-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-7584
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6384188]
MODE - -
REGULATED-ENTITY - SORB6PDEHYDROG-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-8230
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10736170
COMMENT - Pantoate was noncompetitive with respect to both
/ketopantoate and NADPH. 
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - 2-DEHYDROPANTOATE-REDUCT-ENZRXN
REGULATOR - L-PANTOATE
//
UNIQUE-ID - REG0-8823
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4992818
MODE - -
REGULATED-ENTITY - D-PPENTOMUT
REGULATOR - CU+2
//
UNIQUE-ID - REG0-11018
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21467222
MODE - -
REGULATED-ENTITY - ENZRXN0-7454
REGULATOR - FE+2
//
UNIQUE-ID - REG0-9775
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - UDP-NACMURALGLDAPAALIG-ENZRXN
REGULATOR - |DDP-NAcMur-Peptides|
//
UNIQUE-ID - REG0-12247
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14693515
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - cepharpirin
//
UNIQUE-ID - REG0-6964
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3311153
COMMENT - strong inhibitor of the pabB
/subunit activity  |CITS: [3311153]|
MODE - -
REGULATED-ENTITY - PABASYN-ENZRXN
REGULATOR - CPD0-1681
//
UNIQUE-ID - REG0-7560
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4581499
CITATIONS - 3038546
MODE - +
REGULATED-ENTITY - MANNONDEHYDRAT-ENZRXN
REGULATOR - MN+2
//
UNIQUE-ID - REG0-8196
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [WallenfelsTheEnzymes7-617]
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - 2-MERCAPTOETHANOL
//
UNIQUE-ID - REG0-8806
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6767707
MODE - -
REGULATED-ENTITY - ENZRXN0-4281
REGULATOR - HYDRAZINE
//
UNIQUE-ID - REG0-10947
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8323579
MODE - -
REGULATED-ENTITY - ENZRXN0-1641
REGULATOR - DIMETHYLSUBERIMIDATE
//
UNIQUE-ID - REG0-9757
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [211379]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - URKI-ENZRXN
REGULATOR - CPD0-1319
//
UNIQUE-ID - REG0-12215
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19073594
MODE - -
REGULATED-ENTITY - ENZRXN0-6614
REGULATOR - ATP
//
UNIQUE-ID - REG0-6939
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11945670
CITATIONS - 4563643
COMMENT - Phosphoenolpyruvate and 3-phosphoglycerate were potent inhibitors of 
/the enzyme.   Arsenate was a less effective inhibitor. |CITS: [4563643]|
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - METHGLYSYN-ENZRXN
REGULATOR - G3P
//
UNIQUE-ID - REG0-7541
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1646603]
CITATIONS - 6389524
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ACNEULY-ENZRXN
REGULATOR - PYRUVATE
//
UNIQUE-ID - REG0-8170
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 361681
MODE - -
REGULATED-ENTITY - PHEAMINOTRANS-ENZRXN
REGULATOR - LEU
//
UNIQUE-ID - REG0-8775
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3542048]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ORNDECARBOX-BIO-ENZRXN
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-10870
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9692922
MODE - +
REGULATED-ENTITY - ENZRXN0-6310
REGULATOR - CPD-8855
//
UNIQUE-ID - REG0-9736
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - CPD0-1305
//
UNIQUE-ID - REG0-12173
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21332126
MODE - +
REGULATED-ENTITY - ENZRXN0-7923
REGULATOR - NAD
//
UNIQUE-ID - REG0-6920
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3519603
COMMENT - Showed slight inhibition
/|CITS: [3519603]|
MODE - -
REGULATED-ENTITY - IPPISOM-ENZRXN
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7519
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3518793]
MODE - -
REGULATED-ENTITY - THREODEHYD-ENZRXN
REGULATOR - CPD-1492
//
UNIQUE-ID - REG0-8151
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7034777]
MODE - +
REGULATED-ENTITY - ACETALD-DEHYDROG-ENZRXN
REGULATOR - NAD
//
UNIQUE-ID - REG0-8748
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [776970]
MODE - -
REGULATED-ENTITY - GLUTAMINB-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-10779
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20424759
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - OROTPDECARB-ENZRXN
REGULATOR - CPD0-2358
//
UNIQUE-ID - REG0-9718
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - CPD0-1276
//
UNIQUE-ID - REG0-12143
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24479701
MODE - -
REGULATED-ENTITY - ENZRXN0-6222
REGULATOR - NI+2
//
UNIQUE-ID - REG0-6895
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4920894]
CITATIONS - [MethEnz17A-922]
CITATIONS - [HandEnzInh]
COMMENT - High levels of glycolytic and TCA cycle intermediates result in strong 
/inhibition of the adenylyltransferase reaction.  Pyruvate, glutarate, succinate
/and fumarate also inhibit to a lesser degree.  |CITS: [4920894]| 
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GSADENYLATION-ENZRXN
REGULATOR - 2-KETOGLUTARATE
//
UNIQUE-ID - REG0-7502
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [WestwoodMicrobios9,143]
COMMENT - competitive for both
/substrate and coenzyme
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - 6PGLUCONDEHYDROG-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-8124
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 217342
MODE - -
REGULATED-ENTITY - NITRITREDUCT-ENZRXN
REGULATOR - HCN
//
UNIQUE-ID - REG0-8722
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4630409]
COMMENT - 40% inhibition
MODE - -
REGULATED-ENTITY - GALACTOACETYLTRAN-ENZRXN
REGULATOR - CPD0-1608
//
UNIQUE-ID - REG0-10716
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17567041
MODE - +
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - LI+
//
UNIQUE-ID - REG0-9702
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1577828]
MODE - -
REGULATED-ENTITY - KDOTRANS-ENZRXN
REGULATOR - CPD0-1283
//
UNIQUE-ID - REG0-12098
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 25139244
MODE - -
REGULATED-ENTITY - ENZRXN0-7897
REGULATOR - MESO-DIAMINOPIMELATE
//
UNIQUE-ID - REG0-6875
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9733680
COMMENT - inactivated the enzyme, but the presence of either acetyl-CoA or beta-mercaptoethanol at high concentrations could protect the enzyme from inactivation
MODE - -
REGULATED-ENTITY - GLUCOSAMINE1PACETYL-ENZRXN
REGULATOR - CPD0-1642
//
UNIQUE-ID - REG0-7476
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4268865
MECHANISM - :OTHER
MODE - +
REGULATED-ENTITY - 6PFRUCTPHOS-ENZRXN
REGULATOR - FRUCTOSE-6P
//
UNIQUE-ID - REG0-8095
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9257704
COMMENT - Exhibits a low level of inhibition. |CITS: [9257704]|
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GDPMANDEHYDRA-ENZRXN
REGULATOR - GDP-D-GLUCOSE
//
UNIQUE-ID - REG0-8697
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - FishMethEnz9-529
COMMENT - inhibition is due to chelation and binding to the enzyme
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - D-GLUCARATE
//
UNIQUE-ID - REG0-10640
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2559948
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GUANOSINEKIN-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-9686
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - CPD0-1267
//
UNIQUE-ID - REG0-12000
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 37899
KI - 2400
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ARGS-ENZRXN
REGULATOR - HOMOARGININE
//
UNIQUE-ID - REG0-6859
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 348198
MODE - +
REGULATED-ENTITY - F16ALDOLASE-ENZRXN-CLASSI
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-7455
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2853974]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ASPARTASE-ENZRXN
REGULATOR - CPD-3722
//
UNIQUE-ID - REG0-8074
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8226944
COMMENT - In excess Zn<SUP>2+</SUP> inhibits the enzyme.  |CITS: [8226944]| 
KI - 5.8    
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYTDEAM-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-8669
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3905407]
MODE - -
REGULATED-ENTITY - UDP-NACMURALGLDAPLIG-ENZRXN
REGULATOR - UDP-N-ACETYL-D-GLUCOSAMINE
//
UNIQUE-ID - REG0-10616
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4578095
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PHES-ENZRXN
REGULATOR - 3-PHENYLPROPIONATE
//
UNIQUE-ID - REG0-9667
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6768963]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIHYDROFOLATESYNTH-ENZRXN
REGULATOR - DIHYDROFOLATE
//
UNIQUE-ID - REG0-11962
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10383414
MODE - +
REGULATED-ENTITY - ENZRXN0-2401
REGULATOR - MG+2
//
UNIQUE-ID - REG0-6835
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16142902
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - ENZRXN0-3801
REGULATOR - 5-IODOPENTAPHOSPHONATE
//
UNIQUE-ID - REG0-7428
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 357905
MODE - -
REGULATED-ENTITY - ADENODEAMIN-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-8050
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14343156
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIAMINOPIMDECARB-ENZRXN
REGULATOR - CYSTINE
//
UNIQUE-ID - REG0-8645
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 782530
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-2245
REGULATOR - 5-N-PROPYLTHIOADENOSINE
//
UNIQUE-ID - REG0-10498
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [46]
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - CADAVERINE
//
UNIQUE-ID - REG0-9646
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3157043]
MODE - -
REGULATED-ENTITY - ORNDECARBOX-BIO-ENZRXN
REGULATOR - CPD0-1239
//
UNIQUE-ID - REG0-11929
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2141983
MODE - -
REGULATED-ENTITY - ENZRXN0-7818
REGULATOR - CPD0-1620
//
UNIQUE-ID - REG0-6808
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2461858
MODE - +
REGULATED-ENTITY - ENZRXN0-1584
REGULATOR - MG+2
//
UNIQUE-ID - REG0-7409
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4568817
CITATIONS - 4563765
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - PHOSPHOGLUCMUT-ENZRXN
REGULATOR - CO-A
//
UNIQUE-ID - REG0-8012
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9011040]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - APHA-ENZRXN
REGULATOR - URIDINE
//
UNIQUE-ID - REG0-8611
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4150390]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SULFITE-REDUCT-ENZRXN
REGULATOR - CPD-763
//
UNIQUE-ID - REG0-10372
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - DIACYLGLYKIN-ENZRXN
REGULATOR - CPD0-1815
//
UNIQUE-ID - REG0-9624
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6365921]
MODE - -
REGULATED-ENTITY - CYT-O-UBIOX-ENZRXN
REGULATOR - CPD-7082
//
UNIQUE-ID - REG0-11909
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24214977
KI - 18
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7811
REGULATOR - CPD-15916
//
UNIQUE-ID - REG0-6778
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - DTMPKI-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-7386
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 235552
MODE - -
REGULATED-ENTITY - GTP-CYCLOHYDRO-II-ENZRXN
REGULATOR - XTP
//
UNIQUE-ID - REG0-7978
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7046791]
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - ENZRXN-17895
REGULATOR - PHENYLGLYOXAL
//
UNIQUE-ID - REG0-8574
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - MALONATE
//
UNIQUE-ID - REG0-10280
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329757
CITATIONS - 10625615
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ICITDEHDEPHOSPH-ENZRXN
REGULATOR - NADPH
//
UNIQUE-ID - REG0-9564
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7925376
MODE - -
REGULATED-ENTITY - ENZRXN0-4822
REGULATOR - NACL
//
UNIQUE-ID - REG0-11836
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15489502
MODE - -
REGULATED-ENTITY - ENZRXN0-5221
REGULATOR - DCTP
//
UNIQUE-ID - REG0-6741
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7612655
MODE - -
REGULATED-ENTITY - CITSYN-ENZRXN
REGULATOR - CPD0-1673
//
UNIQUE-ID - REG0-7370
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3910843]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ALKAPHOSPHA-ENZRXN
REGULATOR - ARSENATE
//
UNIQUE-ID - REG0-7932
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4364023
CITATIONS - 177283
COMMENT - linearly competitive with
/respect to homoserine, non-competitive with respect to ATP
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - HOMOSERKIN-ENZRXN
REGULATOR - THR
//
UNIQUE-ID - REG0-8538
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10600526
COMMENT - Biotin exhibits noncompetitive substrate inhibition.
MECHANISM - :NONCOMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - BIOTIN-CARBOXYL-ENZRXN
REGULATOR - BIOTIN
//
UNIQUE-ID - REG0-10246
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4557653]
MODE - -
REGULATED-ENTITY - GLYCOLATEDEHYDRO-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-9517
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15136582
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PANTOTHENATE-KIN-ENZRXN
REGULATOR - CPD0-1152
//
UNIQUE-ID - REG0-11800
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21445328
MODE - -
REGULATED-ENTITY - UDPNACETYLGLUCOSAMENOLPYRTRANS-ENZRXN
REGULATOR - CPD0-2537
//
UNIQUE-ID - REG0-6719
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6365902]
CITATIONS - 359547
MODE - -
REGULATED-ENTITY - AMINOPROPDEHYDROG-ENZRXN
REGULATOR - NI+2
//
UNIQUE-ID - REG0-7344
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 115862
CITATIONS - 80103
MODE - -
REGULATED-ENTITY - ENZRXN0-4901
REGULATOR - MG+2
//
UNIQUE-ID - REG0-7899
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6305942]
CITATIONS - 3886014
MODE - -
REGULATED-ENTITY - XANPRIBOSYLTRAN-ENZRXN
REGULATOR - GMP
//
UNIQUE-ID - REG0-8517
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6988389
MODE - -
REGULATED-ENTITY - KDO-8PSYNTH-ENZRXN
REGULATOR - CD+2
//
UNIQUE-ID - REG0-10214
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1460049
MODE - -
REGULATED-ENTITY - RIBONUCLEOSIDE-TRIP-REDUCT-ENZRXN
REGULATOR - FE+2
//
UNIQUE-ID - REG0-9457
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12070315
MODE - -
REGULATED-ENTITY - HYPOXANPRIBOSYLTRAN-ENZRXN
REGULATOR - GMP
//
UNIQUE-ID - REG0-11774
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 30751
MODE - -
REGULATED-ENTITY - CDPDIGLYSYN-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-9454
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3886014
MODE - -
REGULATED-ENTITY - XANPRIBOSYLTRAN-ENZRXN
REGULATOR - CPD0-1143
//
UNIQUE-ID - REG0-11771
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6383480
MECHANISM - :MIXED
MODE - -
REGULATED-ENTITY - GLYCEROL-3-P-ACYLTRANSFER-ENZRXN
REGULATOR - CPD0-1457
//
UNIQUE-ID - REG0-6696
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3117785]
MODE - -
REGULATED-ENTITY - AKBLIG-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-7287
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2164013]
CITATIONS - [1316760]
COMMENT - Mg++ was the best activator. |CITS: [1316760]| 
MODE - +
REGULATED-ENTITY - PPK-ENZRXN
REGULATOR - MG+2
//
UNIQUE-ID - REG0-7870
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13794771
MODE - -
REGULATED-ENTITY - GLUCUROISOM-ENZRXN
REGULATOR - O-PHENANTHROLINE
//
UNIQUE-ID - REG0-8492
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4384650
MODE - -
REGULATED-ENTITY - ENOYL-ACP-REDUCT-NADH-ENZRXN
REGULATOR - PHMB
//
UNIQUE-ID - REG0-10172
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6282821]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ACID-PHOSPHAT-ENZRXN
REGULATOR - CPD0-1606
//
UNIQUE-ID - REG0-9394
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18247525
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ENZRXN0-6510
REGULATOR - CO-A
//
UNIQUE-ID - REG0-11742
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21957966
MODE - +
REGULATED-ENTITY - ORNDECARBOXDEG-ENZRXN
REGULATOR - GDP
//
UNIQUE-ID - REG0-6669
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6282821]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ACID-PHOSPHAT-ENZRXN
REGULATOR - TARTRATE
//
UNIQUE-ID - REG0-7843
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9143339
CITATIONS - 4861885
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - NAG6PDEACET-ENZRXN
REGULATOR - D-GLUCOSAMINE-6-P
//
UNIQUE-ID - REG0-8471
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15582453
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ASPS-ENZRXN
REGULATOR - CPD0-914
//
UNIQUE-ID - REG0-10149
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6814484]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - CPD0-1583
//
UNIQUE-ID - REG0-9303
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4581499
MODE - -
REGULATED-ENTITY - MANNONDEHYDRAT-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-11689
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15016358
MODE - -
REGULATED-ENTITY - ENZRXN0-7445
REGULATOR - CA+2
//
UNIQUE-ID - REG0-6648
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10486141]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - FUMARATE-REDN-ENZRXN
REGULATOR - PENTACHLOROPHENOL
//
UNIQUE-ID - REG0-7230
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4328693
COMMENT - with respect to PRPP
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ADENPRIBOSYLTRAN-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-7827
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3301828]
COMMENT - inhibits at both substrate sites
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYANLY-ENZRXN
REGULATOR - NITRITE
//
UNIQUE-ID - REG0-8450
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4878694]
CITATIONS - [4878695]
MODE - -
REGULATED-ENTITY - GLYCOPHOSPHORYL-ENZRXN
REGULATOR - NITRATE
//
UNIQUE-ID - REG0-10125
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12952
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DAHPSYNPHE-ENZRXN
REGULATOR - CPD0-1554
//
UNIQUE-ID - REG0-9209
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3308886
MODE - -
REGULATED-ENTITY - LACTALDDEHYDROG-ENZRXN
REGULATOR - LACTALD
//
UNIQUE-ID - REG0-11671
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24449932
MODE - -
REGULATED-ENTITY - ENZRXN0-7682
REGULATOR - NI+2
//
UNIQUE-ID - REG0-6624
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14982633
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6343
REGULATOR - L-ORNITHINE
//
UNIQUE-ID - REG0-7207
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6363415
MECHANISM - :NONCOMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - DIENOYLCOAREDUCT-ENZRXN
REGULATOR - NADH
//
UNIQUE-ID - REG0-7807
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1748668]
MODE - -
REGULATED-ENTITY - METHYLENETHFDEHYDROG-NADP-ENZRXN
REGULATOR - 2-MERCAPTOETHANOL
//
UNIQUE-ID - REG0-8433
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [11422389]
MODE - -
REGULATED-ENTITY - ENZRXN0-1521
REGULATOR - 3-BROMOPYRUVATE
//
UNIQUE-ID - REG0-10083
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6368264
MODE - -
REGULATED-ENTITY - ENZRXN0-6563
REGULATOR - CPD-12245
//
UNIQUE-ID - REG0-9182
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8676381
CITATIONS - FESSNER96
MODE - -
REGULATED-ENTITY - DARABALDOL-ENZRXN
REGULATOR - CPD0-1102
//
UNIQUE-ID - REG0-11599
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 22970852
MODE - -
REGULATED-ENTITY - ENZRXN0-1101
REGULATOR - EDTA
//
UNIQUE-ID - REG0-12466
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7012144]
MODE - -
REGULATED-ENTITY - ENZRXN0-8285
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-7184
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6749853
MODE - -
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - BOROHYDRIDE
//
UNIQUE-ID - REG0-7785
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - SCHWARTZ72
COMMENT - Inhibition is instantly relieved by the addition of Co++,
/Zn++, Mn++ or Ni++ |CITS: [237196]| 
MODE - -
REGULATED-ENTITY - RHAMNULPALDOL-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-8404
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [GhoshJBC235-1265]
CITATIONS - 3297136
COMMENT - Competitive with respect to glutamine.  |CITS: [3132968]| 
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - L-GLN-FRUCT-6-P-AMINOTRANS-ENZRXN
REGULATOR - CPD0-1627
//
UNIQUE-ID - REG0-10065
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - FishMethEnz9-529
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - CPD0-1506
//
UNIQUE-ID - REG0-9133
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - BADET95
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - L-GLN-FRUCT-6-P-AMINOTRANS-ENZRXN
REGULATOR - CPD-9051
//
UNIQUE-ID - REG0-11551
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17367808
MODE - -
REGULATED-ENTITY - ENZRXN0-1318
REGULATOR - OXALACETIC_ACID
//
UNIQUE-ID - REG0-9972
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3081491
MODE - -
REGULATED-ENTITY - AGMATIN-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-12450
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8265
REGULATOR - TRIS-HYDROCHLORIDE
//
UNIQUE-ID - REG0-7150
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - CPD-1831
//
UNIQUE-ID - REG0-7748
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 241744
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUTDEHYD-ENZRXN
REGULATOR - HOMO-SER
//
UNIQUE-ID - REG0-8384
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4365537
MODE - -
REGULATED-ENTITY - N-ACETYLGLUTPREDUCT-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-10047
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [MethEnz62-379]
MODE - -
REGULATED-ENTITY - ENZRXN-153
REGULATOR - CPD0-1496
//
UNIQUE-ID - REG0-9107
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4580841]
CITATIONS - [374983]
COMMENT - uncompetitive for either HMP-PP or THZ-P
MODE - -
REGULATED-ENTITY - THI-P-SYN-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-11444
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 340460
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6416
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-9915
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1391
MODE - -
REGULATED-ENTITY - ENZRXN0-4761
REGULATOR - amidino penicillin
//
UNIQUE-ID - REG0-12434
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8257
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7109
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3071721]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ACETOLACTSYNIII-ENZRXN
REGULATOR - ILE
//
UNIQUE-ID - REG0-7722
TYPES - Regulation-of-Enzyme-Activity
MODE - +
REGULATED-ENTITY - ARGSUCCINLYA-ENZRXN
REGULATOR - CO+2
//
UNIQUE-ID - REG0-8366
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11170408
MODE - -
REGULATED-ENTITY - GMP-SYN-GLUT-ENZRXN
REGULATOR - CPD0-1036
//
UNIQUE-ID - REG0-10027
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4364023]
CITATIONS - [177283]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - HOMOSERKIN-ENZRXN
REGULATOR - |2-Aminobutyrate|
//
UNIQUE-ID - REG0-9055
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14726201
MODE - -
REGULATED-ENTITY - ASP-SEMIALDEHYDE-DEHYDROGENASE-ENZRXN
REGULATOR - GLUTATHIONE
//
UNIQUE-ID - REG0-11355
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 372191
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PRPPAMIDOTRANS-ENZRXN
REGULATOR - GMP
//
UNIQUE-ID - REG0-9895
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 340264
MODE - -
REGULATED-ENTITY - PSII-ENZRXN
REGULATOR - CPD0-1413
//
UNIQUE-ID - REG0-12388
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19109926
CITATIONS - 19824612
MODE - +
REGULATED-ENTITY - ENZRXN0-6613
REGULATOR - CPLX0-3962
//
UNIQUE-ID - REG0-7090
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1576149
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - INOPHOSPHOR-ENZRXN
REGULATOR - CPD0-1045
//
UNIQUE-ID - REG0-7694
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10625615
MODE - -
REGULATED-ENTITY - ICITDEHKINASE-ENZRXN
REGULATOR - G3P
//
UNIQUE-ID - REG0-8341
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6463
COMMENT - inhibited
/both the forward and reverse reactions |CITS: [6463]|
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - 3-METHYL-2-OXOBUT-OHCH3XFER-ENZRXN
REGULATOR - L-PANTOATE
//
UNIQUE-ID - REG0-10009
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2826434]
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - GLYCEROL-KIN-ENZRXN
REGULATOR - CPD0-1461
//
UNIQUE-ID - REG0-8972
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8155731
MODE - -
REGULATED-ENTITY - 4OHBENZOATE-OCTAPRENYLTRANSFER-ENZRXN
REGULATOR - DEOXYCHOLATE
//
UNIQUE-ID - REG0-11312
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7016178
CITATIONS - 4388614
CITATIONS - 4388615
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - MALIC-NADP-ENZRXN
REGULATOR - NADH
//
UNIQUE-ID - REG0-9862
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7929323
MODE - -
REGULATED-ENTITY - RIBONUCLEOSIDE-TRIP-REDUCT-ENZRXN
REGULATOR - CPD0-1388
//
UNIQUE-ID - REG0-12349
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16740960
KI - 1300
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PYRIDOXKIN-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-7071
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6751817
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CTPSYN-ENZRXN
REGULATOR - CPD0-1037
//
UNIQUE-ID - REG0-7661
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [380648]
CITATIONS - 9409147
MODE - -
REGULATED-ENTITY - CFA-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-8300
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11825618
COMMENT - Shows strong
/product inhibition, with a competitive mechanism.  |CITS:
/[8012607]|
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - CHORPYRLY-ENZRXN
REGULATOR - |4-hydroxybenzoate|
//
UNIQUE-ID - REG-14665
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1646603]
CREDITS - SRI
CREDITS - |caspi|
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ENZRXN-22535
REGULATOR - DIHYDROXYACETONE
//
UNIQUE-ID - REG0-8915
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8940025
MODE - -
REGULATED-ENTITY - ENZRXN0-5861
REGULATOR - MN+2
//
UNIQUE-ID - REG0-11292
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1444446
MODE - -
REGULATED-ENTITY - AKBLIG-ENZRXN
REGULATOR - CPD0-1349
//
UNIQUE-ID - REG0-9838
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11170472
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SARCOX-ENZRXN
REGULATOR - CPD0-1380
//
UNIQUE-ID - REG0-12306
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - CHEN09WORDJMICRO
MODE - -
REGULATED-ENTITY - ENZRXN0-4502
REGULATOR - HG+2
//
UNIQUE-ID - REG0-7052
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4557653]
MODE - -
REGULATED-ENTITY - GLYCOLATEDEHYDRO-ENZRXN
REGULATOR - CPD-7082
//
UNIQUE-ID - REG0-7638
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [211379]
MODE - -
REGULATED-ENTITY - URKI-ENZRXN
REGULATOR - CTP
//
UNIQUE-ID - REG0-8279
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1104357
MODE - -
REGULATED-ENTITY - RIB5PISOMB-ENZRXN
REGULATOR - IODOACETATE
//
UNIQUE-ID - REG0-8892
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1967948]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTAMINESYN-ENZRXN
REGULATOR - L-PHOSPHINOTHRICIN
//
UNIQUE-ID - REG0-11229
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6985897
CITATIONS - 28326
KI - 4.4    
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLYC3PDEHYDROGBIOSYN-ENZRXN
REGULATOR - GLYCEROL-3P
//
UNIQUE-ID - REG0-9822
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10486141
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - SUCCINATE-OXN-ENZRXN
REGULATOR - CPD0-1366
//
UNIQUE-ID - REG0-12277
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20300061
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ENZRXN0-3507
REGULATOR - EG12111-MONOMER
//
UNIQUE-ID - REG0-7019
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3513846]
CITATIONS - 8856065
MODE - +
REGULATED-ENTITY - URACIL-PRIBOSYLTRANS-ENZRXN
REGULATOR - GTP
//
UNIQUE-ID - REG0-7615
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4388614]
CITATIONS - [4388615]
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - MALIC-NADP-ENZRXN
REGULATOR - CAMP
//
UNIQUE-ID - REG0-8249
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3291856]
COMMENT - with respect to varied acetyl-CoA concentration
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ACP-S-ACETYLTRANSFER-ENZRXN
REGULATOR - CO-A
//
UNIQUE-ID - REG0-8842
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12133
KI - 15000
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PYRROLINECARBREDUCT-ENZRXN
REGULATOR - PRO
//
UNIQUE-ID - REG0-11044
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4904482
MODE - -
REGULATED-ENTITY - HOMOCYSMET-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-9795
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7011811
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PYRUVATEDEH-ENZRXN
REGULATOR - CPD0-1353
//
UNIQUE-ID - REG0-12261
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16569861
MODE - -
REGULATED-ENTITY - ENZRXN0-7969
REGULATOR - CPD-5242
//
UNIQUE-ID - REG0-6993
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7011811]
CITATIONS - 7005225
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PYRUVATEDEH-ENZRXN
REGULATOR - 2-OXOBUTANOATE
//
UNIQUE-ID - REG0-7581
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [346589]
COMMENT - 85% inhibition at 1mM
MODE - -
REGULATED-ENTITY - DUTP-PYROP-ENZRXN
REGULATOR - EGTA
//
UNIQUE-ID - REG0-8223
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - ACETOOHBUTSYNII-ENZRXN
REGULATOR - LEU
//
UNIQUE-ID - REG0-8820
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4992818
MODE - -
REGULATED-ENTITY - D-PPENTOMUT
REGULATOR - CA+2
//
UNIQUE-ID - REG0-11015
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21467222
MODE - -
REGULATED-ENTITY - ENZRXN0-7454
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-9771
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3905407]
MODE - -
REGULATED-ENTITY - UDP-NACMURALGLDAPLIG-ENZRXN
REGULATOR - CPD0-1328
//
UNIQUE-ID - REG0-12244
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14693515
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - cefaclor
//
UNIQUE-ID - REG0-6957
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4151408]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - NITRATREDUCTA-ENZRXN
REGULATOR - CPD-2841
//
UNIQUE-ID - REG0-7557
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4581499]
MODE - +
REGULATED-ENTITY - MANNONDEHYDRAT-ENZRXN
REGULATOR - D-TAGATURONATE
//
UNIQUE-ID - REG0-8193
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [WallenfelsTheEnzymes7-617]
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - CPD-3682
//
UNIQUE-ID - REG0-8793
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8573592
CITATIONS - 2118334
MODE - -
REGULATED-ENTITY - NADH-DHI-ENZRXN
REGULATOR - CAPSAICIN
//
UNIQUE-ID - REG0-10944
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9055203
MODE - -
REGULATED-ENTITY - ENZRXN0-1641
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-9753
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17123542
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - XYLULOKIN-ENZRXN
REGULATOR - CPD0-1316
//
UNIQUE-ID - REG0-12195
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9442062
KI - 6000
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - TRIOSEPISOMERIZATION-ENZRXN
REGULATOR - CPD-67
//
UNIQUE-ID - REG0-6936
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9665712]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - METHGLYSYN-ENZRXN
REGULATOR - CPD-67
//
UNIQUE-ID - REG0-7537
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 164459
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GMP-SYN-NH3-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-8167
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7011316
MECHANISM - :ALLOSTERIC
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PEPDEPHOSI-ENZRXN
REGULATOR - FRUCTOSE-16-DIPHOSPHATE
//
UNIQUE-ID - REG0-8770
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3096379]
CITATIONS - [HandEnzInh]
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ORNDECARBOX-BIO-ENZRXN
REGULATOR - 3-P-SERINE
//
UNIQUE-ID - REG0-10866
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20236319
MODE - -
REGULATED-ENTITY - PHOSACETYLTRANS-ENZRXN
REGULATOR - PYRUVATE
//
UNIQUE-ID - REG0-9733
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4947657]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - CPD0-1302
//
UNIQUE-ID - REG0-12167
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 22014167
MODE - -
REGULATED-ENTITY - F16ALDOLASE-ENZRXN-CLASSII
REGULATOR - NI+2
//
UNIQUE-ID - REG0-6911
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3886014
MODE - -
REGULATED-ENTITY - GUANPRIBOSYLTRAN-ENZRXN
REGULATOR - GMP
//
UNIQUE-ID - REG0-7516
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6780553]
MODE - -
REGULATED-ENTITY - THREODEHYD-ENZRXN
REGULATOR - CPD-7388
//
UNIQUE-ID - REG0-8146
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7034777]
COMMENT - with respect to
/acetaldehyde, uncompetitive with respect to NAD+ and CoA
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ACETALD-DEHYDROG-ENZRXN
REGULATOR - BENZALDEHYDE
//
UNIQUE-ID - REG0-8745
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [776970]
MODE - -
REGULATED-ENTITY - GLUTAMINB-ENZRXN
REGULATOR - NADH
//
UNIQUE-ID - REG0-10749
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20553497
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7377
REGULATOR - CO-A
//
UNIQUE-ID - REG0-9715
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - 3-4-DIHYDROXYBENZOATE
//
UNIQUE-ID - REG0-12134
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2139607
MODE - -
REGULATED-ENTITY - NITRATREDUCTZ-ENZRXN
REGULATOR - CPD-2841
//
UNIQUE-ID - REG0-6892
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7848303
COMMENT - The
/enzyme is sensitive to thiol-blocking reagents.  Activity blocked by
/p-hydroxymercuribenzoate or 5,5'-dithiobis-(2-nitrobenzoate) could be
/restored by addition of dithiothreitol, 2-mercaptoethanol or GSH.
/|CITS: [7848303]|
MODE - -
REGULATED-ENTITY - GLYOXIII-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-7499
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [14336062]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - MALSYNG-ENZRXN
REGULATOR - OXALATE
//
UNIQUE-ID - REG0-8119
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [MethEnz17A-708]
MODE - -
REGULATED-ENTITY - ASP-SEMIALDEHYDE-DEHYDROGENASE-ENZRXN
REGULATOR - AMMONIUM
//
UNIQUE-ID - REG0-8719
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4630409]
COMMENT - noncompetitive inhibitor
MODE - -
REGULATED-ENTITY - GALACTOACETYLTRAN-ENZRXN
REGULATOR - CPD0-1607
//
UNIQUE-ID - REG0-10707
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 368795
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ORNDECARBOX-BIO-ENZRXN
REGULATOR - CPD0-1515
//
UNIQUE-ID - REG0-9699
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1577828]
MODE - -
REGULATED-ENTITY - KDOTRANS2-ENZRXN
REGULATOR - CPD0-1281
//
UNIQUE-ID - REG0-12041
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6792201
MODE - -
REGULATED-ENTITY - ENZRXN0-7868
REGULATOR - CPD-5401
//
UNIQUE-ID - REG0-6872
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8083170]
COMMENT - weak inhibitor
MODE - -
REGULATED-ENTITY - GLUCOSAMINE1PACETYL-ENZRXN
REGULATOR - CPD0-1337
//
UNIQUE-ID - REG0-7473
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4268865
CITATIONS - 4229913
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - 6PFRUCTPHOS-ENZRXN
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-8092
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10684608
COMMENT - When Co(II) is added to the enzyme already 
/containing a single mole of zinc, the activity
/is increased.  |CITS: [10684608]| 
MODE - +
REGULATED-ENTITY - ACETYLORNDEACET-ENZRXN
REGULATOR - CO+2
//
UNIQUE-ID - REG0-8691
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5333199
COMMENT - Noncompetitive with respect to ammonium sulfate concentration
MECHANISM - :NONCOMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ANTHRANSYN-ENZRXN
REGULATOR - TRP
//
UNIQUE-ID - REG0-10637
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7665468
MODE - -
REGULATED-ENTITY - INOSINEKIN-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-9683
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - CPD0-1264
//
UNIQUE-ID - REG0-11976
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6427236
MODE - -
REGULATED-ENTITY - TRANS-ENZRXN-166
REGULATOR - SORBITOL
//
UNIQUE-ID - REG0-6854
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7929099
MODE - -
REGULATED-ENTITY - ENZRXN0-5762
REGULATOR - ADP
//
UNIQUE-ID - REG0-7449
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14004226
MODE - -
REGULATED-ENTITY - PYROXALTRANSAM-ENZRXN
REGULATOR - PYRIDOXAL_PHOSPHATE
//
UNIQUE-ID - REG0-8068
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - CITLY-ENZRXN
REGULATOR - OXALACETIC_ACID
//
UNIQUE-ID - REG0-8665
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 779849
MODE - -
REGULATED-ENTITY - ENZRXN0-2142
REGULATOR - CUSO4
//
UNIQUE-ID - REG0-10597
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3881132
MODE - -
REGULATED-ENTITY - PREPHENATEDEHYDRAT-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-9663
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1967948]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTAMINESYN-ENZRXN
REGULATOR - CPD0-1249
//
UNIQUE-ID - REG0-11958
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3908101
MODE - -
REGULATED-ENTITY - ALADEHYDCHLORO-ENZRXN
REGULATOR - HYDROXYLAMINE
//
UNIQUE-ID - REG0-6832
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [11120740]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-285
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-7425
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7592346
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - TRANSALDOLB-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-8042
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5332668
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - SERINE-O-ACETTRAN-ENZRXN
REGULATOR - CYS
//
UNIQUE-ID - REG0-8636
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14243758
MODE - -
REGULATED-ENTITY - RHAMNISOM-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-10448
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1645722
MODE - -
REGULATED-ENTITY - THIOESTERII-ENZRXN
REGULATOR - DIETHYLPYROCARBONATE
//
UNIQUE-ID - REG0-9641
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [776969]
MODE - -
REGULATED-ENTITY - GLUTAMINB-ENZRXN
REGULATOR - BORATE
//
UNIQUE-ID - REG0-11925
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 22411989
MODE - -
REGULATED-ENTITY - CYTDEAM-ENZRXN
REGULATOR - HYDROGEN-PEROXIDE
//
UNIQUE-ID - REG0-6800
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [12147680]
MODE - -
REGULATED-ENTITY - ENZRXN0-1105
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7406
TYPES - Regulation-of-Enzyme-Activity
COMMENT - competitive at high concentrations with
/respect to glucose-1-P and vice versa |CITS: [RayJBC239,1228]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PHOSPHOGLUCMUT-ENZRXN
REGULATOR - ALPHA-GLUCOSE-16-BISPHOSPHATE
//
UNIQUE-ID - REG0-7991
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4878429]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ARABISOM-ENZRXN
REGULATOR - RIBITOL
//
UNIQUE-ID - REG0-8597
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7727397
CITATIONS - 22068704
COMMENT - The enzyme is activated by monovalent
/cations.  |CITS: [36973]|
MODE - +
REGULATED-ENTITY - UDPNACETYLMURAMATEDEHYDROG-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-10369
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - DIACYLGLYKIN-ENZRXN
REGULATOR - CPD0-1761
//
UNIQUE-ID - REG0-9618
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1204631
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6423
REGULATOR - CPD-8179
//
UNIQUE-ID - REG0-11906
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24214977
KI - 1
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7337
REGULATOR - CPD0-2060
//
UNIQUE-ID - REG0-6771
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13563461
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DGTPTRIPHYDRO-ENZRXN
REGULATOR - GTP
//
UNIQUE-ID - REG0-7383
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10089390]
MODE - +
REGULATED-ENTITY - CARBPSYN-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-7973
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2182115
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLYRIBONUCSYN-ENZRXN
REGULATOR - B-ALANINE
//
UNIQUE-ID - REG0-8569
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - FUM
//
UNIQUE-ID - REG0-10277
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9524204
MODE - -
REGULATED-ENTITY - ENZRXN0-6633
REGULATOR - ADENOSYL-HOMO-CYS
//
UNIQUE-ID - REG0-9551
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8561507
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - QUINOPRIBOTRANS-ENZRXN
REGULATOR - NICOTINATE_NUCLEOTIDE
//
UNIQUE-ID - REG0-11833
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15489502
MODE - -
REGULATED-ENTITY - ENZRXN0-5221
REGULATOR - ATP
//
UNIQUE-ID - REG0-6738
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - CITSYN-ENZRXN
REGULATOR - NADH
//
UNIQUE-ID - REG0-7367
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3280015]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ALKAPHOSPHA-ENZRXN
REGULATOR - CPD-4422
//
UNIQUE-ID - REG0-7925
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4872726]
MODE - -
REGULATED-ENTITY - HOLO-ACP-SYNTH-ENZRXN
REGULATOR - NH42SO4
//
UNIQUE-ID - REG0-8535
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8060125]
MODE - -
REGULATED-ENTITY - CROBETREDUCT-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-10242
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - HANDENZINH
CITATIONS - 3291954
MODE - -
REGULATED-ENTITY - ISOCITLYASE-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-9501
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18459799
MODE - -
REGULATED-ENTITY - ENZRXN0-2801
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-11790
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11697907
MODE - -
REGULATED-ENTITY - DTDPGLUCOSEPP-ENZRXN
REGULATOR - DTDP-D-GLUCOSE
//
UNIQUE-ID - REG0-6716
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6365902]
CITATIONS - 359547
MODE - -
REGULATED-ENTITY - AMINOPROPDEHYDROG-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-7335
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13844669
MODE - -
REGULATED-ENTITY - AMYLOMALT-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-7896
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7751290]
MODE - +
REGULATED-ENTITY - GAPDH-A-ENZRXN
REGULATOR - ARSENATE
//
UNIQUE-ID - REG0-8514
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6988389
COMMENT - The inhibition
/by Hg++ can be reversed by dthiothreitol.  |CITS: [6988389]|
MODE - -
REGULATED-ENTITY - KDO-8PSYNTH-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-10210
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2007545
MODE - -
REGULATED-ENTITY - 7-ALPHA-HYDROXYSTEROID-DEH-ENZRXN
REGULATOR - CPD0-1693
//
UNIQUE-ID - REG0-10205
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6368527]
MODE - +
REGULATED-ENTITY - PEPCARBOX-ENZRXN
REGULATOR - |Alcohols|
//
UNIQUE-ID - REG0-9437
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18328504
MODE - -
REGULATED-ENTITY - ENZRXN0-6517
REGULATOR - FE+3
//
UNIQUE-ID - REG0-11768
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6383480
MECHANISM - :MIXED
MODE - -
REGULATED-ENTITY - GLYCEROL-3-P-ACYLTRANSFER-ENZRXN
REGULATOR - CPD0-2032
//
UNIQUE-ID - REG0-6693
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3117785]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - AKBLIG-ENZRXN
REGULATOR - CYS
//
UNIQUE-ID - REG0-7283
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1316760]
MODE - -
REGULATED-ENTITY - PPK-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7867
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13794771
MODE - -
REGULATED-ENTITY - GLUCUROISOM-ENZRXN
REGULATOR - CPD0-1610
//
UNIQUE-ID - REG0-8484
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9387
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - DAHPSYNTYR-ENZRXN
REGULATOR - TYR
//
UNIQUE-ID - REG0-10168
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13670940
MODE - -
REGULATED-ENTITY - ENZRXN0-5441
REGULATOR - CPD0-1601
//
UNIQUE-ID - REG0-9344
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - NIL
REGULATED-ENTITY - ENOYL-COA-DELTA-ISOM-ENZRXN
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-11737
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4935199
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - THYM-PHOSPH-ENZRXN
REGULATOR - THYMINE
//
UNIQUE-ID - REG0-6662
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4829932
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ENZRXN0-6250
REGULATOR - LEU
//
UNIQUE-ID - REG0-7267
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [JgMic52223]
MODE - -
REGULATED-ENTITY - HOMSUCTRAN-ENZRXN
REGULATOR - ALPHA-METHYLMETHIONINE
//
UNIQUE-ID - REG0-7840
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4341485
MODE - -
REGULATED-ENTITY - ENZRXN0-1627
REGULATOR - PPI
//
UNIQUE-ID - REG0-8467
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4362677]
COMMENT - somewhat inhibitory
MODE - -
REGULATED-ENTITY - H2NEOPTERINP3PYROPHOSPHOHYDRO-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-10146
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14343156
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIAMINOPIMDECARB-ENZRXN
REGULATOR - CPD-9793
//
UNIQUE-ID - REG0-9297
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3038546
MODE - +
REGULATED-ENTITY - ALTRODEHYDRAT-ENZRXN
REGULATOR - MN+2
//
UNIQUE-ID - REG0-11685
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7023711
MODE - -
REGULATED-ENTITY - ENZRXN0-6205
REGULATOR - PHMB
//
UNIQUE-ID - REG0-6644
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3298234
MODE - -
REGULATED-ENTITY - ENZRXN0-6244
REGULATOR - MG+2
//
UNIQUE-ID - REG0-7227
TYPES - Regulation-of-Enzyme-Activity
COMMENT - at high concentrations  |CITS:
/[BlumenthalMethEnz9-660]|
MODE - -
REGULATED-ENTITY - GLUCARDEHYDRA-ENZRXN
REGULATOR - MN+2
//
UNIQUE-ID - REG0-7824
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3301828]
COMMENT - inhibits at both substrate sites
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYANLY-ENZRXN
REGULATOR - CL-
//
UNIQUE-ID - REG0-8446
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4878694]
CITATIONS - [4878695]
MODE - -
REGULATED-ENTITY - GLYCOPHOSPHORYL-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-10122
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7925376
MODE - -
REGULATED-ENTITY - ENZRXN0-4822
REGULATOR - CPD0-1546
//
UNIQUE-ID - REG0-9205
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2653423
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ACETOLACTREDUCTOISOM-ENZRXN
REGULATOR - NADP
//
UNIQUE-ID - REG0-11653
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21058398
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - MANNPISOM-ENZRXN
REGULATOR - CPD-15157
//
UNIQUE-ID - REG0-6620
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4555420
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6293
REGULATOR - CPD-2482
//
UNIQUE-ID - REG0-7199
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6991069]
MODE - -
REGULATED-ENTITY - PEPCARBOXYKIN-ENZRXN
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-7803
TYPES - Regulation-of-Enzyme-Activity
COMMENT - noncompetitive with respect to both substrates |CITS: [350870]|
MODE - -
REGULATED-ENTITY - METHYLENETHFDEHYDROG-NADP-ENZRXN
REGULATOR - 10-FORMYL-THF
//
UNIQUE-ID - REG0-8429
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [362128]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DLACTDEHYDROGFAD-ENZRXN
REGULATOR - OXALATE
//
UNIQUE-ID - REG0-10080
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12709336
MODE - -
REGULATED-ENTITY - ENZRXN0-6573
REGULATOR - AM-112
//
UNIQUE-ID - REG0-9178
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4616949
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - ENZRXN0-6440
REGULATOR - CPD-7970
//
UNIQUE-ID - REG0-11596
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1663113
CITATIONS - 7918616
MODE - +
REGULATED-ENTITY - CARDIOLIPSYN-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-12463
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - -
REGULATED-ENTITY - ENZRXN0-8284
REGULATOR - TRIS
//
UNIQUE-ID - REG0-7168
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3910996]
MODE - +
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - BR
//
UNIQUE-ID - REG0-7777
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4572733
COMMENT - The reaction is partially
/inhibited by the end products |CITS: [4572733] [6312268]|
MODE - -
REGULATED-ENTITY - SPERMIDINESYN-ENZRXN
REGULATOR - SPERMIDINE
//
UNIQUE-ID - REG0-8399
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - CooperMethEnz13309
CITATIONS - 4319237
MODE - -
REGULATED-ENTITY - PEPSYNTH-ENZRXN
REGULATOR - PHMB
//
UNIQUE-ID - REG0-10062
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [FishMethEnz9-529]
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - |Hexonic-Acids|
//
UNIQUE-ID - REG0-9130
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3297136]
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - L-GLN-FRUCT-6-P-AMINOTRANS-ENZRXN
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-11545
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11825618
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CHORPYRLY-ENZRXN
REGULATOR - CPD-14463
//
UNIQUE-ID - REG0-9968
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6272307]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PGLYCEROLTRANSII-ENZRXN
REGULATOR - CPD-3605
//
UNIQUE-ID - REG0-12447
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8263
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7135
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10406936
KI - 0.2    
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ADHP-ENZRXN
REGULATOR - PYRAZOLE
//
UNIQUE-ID - REG0-7745
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5328735
COMMENT - Stimulation by NH4Cl is greatest. |CITS: [5328735]|
MODE - +
REGULATED-ENTITY - GLYOCARBOLIG-ENZRXN
REGULATOR - NA+
//
UNIQUE-ID - REG0-8380
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5333666]
MODE - -
REGULATED-ENTITY - GUANYL-KIN-ENZRXN
REGULATOR - IMP
//
UNIQUE-ID - REG0-10042
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4349042
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - IMIDPHOSDEHYD-ENZRXN
REGULATOR - CPD0-1491
//
UNIQUE-ID - REG0-9104
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4580841]
CITATIONS - [374983]
MODE - -
REGULATED-ENTITY - THI-P-SYN-ENZRXN
REGULATOR - UTP
//
UNIQUE-ID - REG0-11401
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8226748
CITATIONS - 11849539
MODE - -
REGULATED-ENTITY - FUMARB-ENZRXN
REGULATOR - SUPER-OXIDE
//
UNIQUE-ID - REG0-9912
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1391
MODE - -
REGULATED-ENTITY - ENZRXN0-4761
REGULATOR - 6-APA
//
UNIQUE-ID - REG0-12431
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8002619
CITATIONS - 10747806
COMMENT - Li<SUP>+</SUP> is a potent inhibitor.  |CITS: [10747806]| 
MODE - -
REGULATED-ENTITY - ENZRXN0-8180
REGULATOR - LI+
//
UNIQUE-ID - REG0-7106
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8380170]
MODE - +
REGULATED-ENTITY - PPX-ENZRXN
REGULATOR - NH42SO4
//
UNIQUE-ID - REG0-7717
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3516689]
MODE - -
REGULATED-ENTITY - FORMHYDROGI-ENZRXN
REGULATOR - CPD-2841
//
UNIQUE-ID - REG0-8363
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 235520
CITATIONS - [189701]
CITATIONS - 3907701
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - GMP-SYN-GLUT-ENZRXN
REGULATOR - CPD0-1033
//
UNIQUE-ID - REG0-10023
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4904482
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - HOMOCYSMET-ENZRXN
REGULATOR - CPD0-1472
//
UNIQUE-ID - REG0-9024
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14245401
COMMENT - moderate inhibition |CITS: [14245401]|
MODE - -
REGULATED-ENTITY - THIOREDOXIN-REDUCT-NADPH-ENZRXN
REGULATOR - CPD-763
//
UNIQUE-ID - REG0-11340
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15641804
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SAICARSYN-ENZRXN
REGULATOR - IMP
//
UNIQUE-ID - REG0-9892
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6130093
MODE - -
REGULATED-ENTITY - PPPGPPHYDRO-ENZRXN
REGULATOR - CPD0-1410
//
UNIQUE-ID - REG0-12381
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17142397
MECHANISM - :UNCOMPETITIVE
MODE - -
REGULATED-ENTITY - ISOCITLYASE-ENZRXN
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-7087
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4584822]
MODE - -
REGULATED-ENTITY - MALONYL-COA-ACP-TRANSACYL-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-7690
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329757
MODE - -
REGULATED-ENTITY - ICITDEHKINASE-ENZRXN
REGULATOR - CIT
//
UNIQUE-ID - REG0-8337
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6463
COMMENT - inhibited the
/forward reaction  |CITS: [6463]|
MODE - -
REGULATED-ENTITY - 3-METHYL-2-OXOBUT-OHCH3XFER-ENZRXN
REGULATOR - VAL
//
UNIQUE-ID - REG0-10003
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6337636
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTSEMIALDEHYDROG-ENZRXN
REGULATOR - CPD0-1454
//
UNIQUE-ID - REG0-8969
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8290655
MODE - -
REGULATED-ENTITY - ASPARTATEKINIII-ENZRXN
REGULATOR - S-2-AMINOETHYL-L-CYSTEINE
//
UNIQUE-ID - REG0-11308
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17557829
MODE - +
REGULATED-ENTITY - MALIC-NADP-ENZRXN
REGULATOR - GLC-6-P
//
UNIQUE-ID - REG0-9858
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6251075]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - S-ADENMETSYN-ENZRXN
REGULATOR - CPD0-1386
//
UNIQUE-ID - REG0-12346
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 25139244
MODE - -
REGULATED-ENTITY - ENZRXN0-8073
REGULATOR - CPD0-1564
//
UNIQUE-ID - REG0-7068
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [13977183]
MODE - +
REGULATED-ENTITY - GALACTOKIN-ENZRXN
REGULATOR - 2-MERCAPTOETHANOL
//
UNIQUE-ID - REG0-7658
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18501724
COMMENT - An antifungal drug.
MODE - -
REGULATED-ENTITY - CFA-ENZRXN
REGULATOR - SINEFUNGIN
//
UNIQUE-ID - REG0-8297
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [3291954]
MODE - -
REGULATED-ENTITY - ISOCITLYASE-ENZRXN
REGULATOR - CPD-8147
//
UNIQUE-ID - REG-14662
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1646603]
CITATIONS - 6389524
CREDITS - SRI
CREDITS - |caspi|
MODE - -
REGULATED-ENTITY - ENZRXN-22535
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-8912
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6312996
MODE - -
REGULATED-ENTITY - GLUC1PADENYLTRANS-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-11289
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3056527
MODE - +
REGULATED-ENTITY - THREODEHYD-ENZRXN
REGULATOR - CD+2
//
UNIQUE-ID - REG0-9835
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16054140
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SERS-ENZRXN
REGULATOR - CPD0-1377
//
UNIQUE-ID - REG0-12302
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - CHEN09WORDJMICRO
CITATIONS - 8226676
MODE - -
REGULATED-ENTITY - ENZRXN0-4502
REGULATOR - O-PHENANTHROLINE
//
UNIQUE-ID - REG0-7046
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [46]
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - RB+
//
UNIQUE-ID - REG0-7631
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3297044
COMMENT - The inhibition is partially reversible  |CITS: [3297044] [HandEnzInh]|
MODE - -
REGULATED-ENTITY - ARGDECARBOXBIO-ENZRXN
REGULATOR - CPD0-1660
//
UNIQUE-ID - REG0-8274
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1092682
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - DAPASYN-ENZRXN
REGULATOR - ADENINE
//
UNIQUE-ID - REG0-8867
TYPES - Regulation-of-Enzyme-Activity
COMMENT - partially inhibit enzyme activity  |CITS:
/[NishiharaJBC247,5079]|
MODE - -
REGULATED-ENTITY - 4OH2OXOGLUTARALDOL-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-11226
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2113366
CITATIONS - 3891721
MODE - -
REGULATED-ENTITY - GLYOHMETRANS-ENZRXN
REGULATOR - DITHIO-NITROBENZOATE
//
UNIQUE-ID - REG0-9817
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12589497
MODE - -
REGULATED-ENTITY - METHYLMALONYL-COA-MUT-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-12274
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 23258706
MODE - +
REGULATED-ENTITY - ENZRXN0-7983
REGULATOR - HCO3
//
UNIQUE-ID - REG0-7013
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1646790
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - TYRAMINOTRANS-ENZRXN
REGULATOR - 2-KETO-ISOVALERATE
//
UNIQUE-ID - REG0-7606
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329757
MODE - +
REGULATED-ENTITY - ICITDEHDEPHOSPH-ENZRXN
REGULATOR - 2-KETOGLUTARATE
//
UNIQUE-ID - REG0-8246
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6246070]
MODE - -
REGULATED-ENTITY - KDO-8PPHOSPHAT-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-8839
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5337593
COMMENT - competitive with the substrate |CITS: [5337593]|
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - UDPSUGARHYDRO-ENZRXN
REGULATOR - ADP-D-GLUCOSE
//
UNIQUE-ID - REG0-11040
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1459137
MODE - +
REGULATED-ENTITY - GTP-CYCLOHYDRO-I-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-9791
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2681195]
MODE - -
REGULATED-ENTITY - THREODEHYD-ENZRXN
REGULATOR - CPD0-1349
//
UNIQUE-ID - REG0-12257
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7001458
MODE - -
REGULATED-ENTITY - ENZRXN0-7969
REGULATOR - MOENOMYCIN
//
UNIQUE-ID - REG0-6981
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 22848564
CITATIONS - 4917899
COMMENT - noncompetitive
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PYRIDOXKIN-ENZRXN
REGULATOR - PYRIDOXAL_PHOSPHATE
//
UNIQUE-ID - REG0-7578
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7961955]
MODE - -
REGULATED-ENTITY - LYXK-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-8220
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9398217
MODE - -
REGULATED-ENTITY - GSPAMID-ENZRXN
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-8817
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4992818
MODE - -
REGULATED-ENTITY - D-PPENTOMUT
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-11012
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3091070
MODE - -
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - CPD0-1401
//
UNIQUE-ID - REG0-9767
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8241177]
MODE - -
REGULATED-ENTITY - UDPGLUCEPIM-ENZRXN
REGULATOR - CPD0-1325
//
UNIQUE-ID - REG0-12241
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14693515
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - CPD0-2068
//
UNIQUE-ID - REG0-6949
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16890
MODE - -
REGULATED-ENTITY - N-ACETYLTRANSFER-ENZRXN
REGULATOR - L-CITRULLINE
//
UNIQUE-ID - REG0-7552
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4581499]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - MANNONDEHYDRAT-ENZRXN
REGULATOR - MANNITOL
//
UNIQUE-ID - REG0-8183
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [SaikusaAgBioChem51-1893]
MODE - +
REGULATED-ENTITY - METHYLGLYREDUCT-ENZRXN
REGULATOR - DITHIOTHREITOL
//
UNIQUE-ID - REG0-8788
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14245396
MODE - +
REGULATED-ENTITY - 3-NUCLEOTID-ENZRXN
REGULATOR - CO+2
//
UNIQUE-ID - REG0-10941
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8323579
MODE - -
REGULATED-ENTITY - ENZRXN0-1641
REGULATOR - ETHYLACETIMIDATE
//
UNIQUE-ID - REG0-9747
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2692708]
KI - 0.36    
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYTIDEAM2-ENZRXN
REGULATOR - CPD0-1312
//
UNIQUE-ID - REG0-12184
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17306798
MODE - +
REGULATED-ENTITY - ENZRXN0-5803
REGULATOR - UDP-GLUCOSE
//
UNIQUE-ID - REG0-6933
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6349639]
MODE - -
REGULATED-ENTITY - LDC2-ENZRXN
REGULATOR - SPERMIDINE
//
UNIQUE-ID - REG0-7530
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8226676
MODE - -
REGULATED-ENTITY - ENZRXN0-4502
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-8164
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2653362
COMMENT - high concentrations of Mg+2 and ADP |CITS:[2653362]|
MODE - -
REGULATED-ENTITY - PEPDEPHOSI-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-8767
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [BlumenthalMethEnz9-665]
CITATIONS - 4285952
MODE - -
REGULATED-ENTITY - GALACTARDEHYDRA-ENZRXN
REGULATOR - CPD-7082
//
UNIQUE-ID - REG0-10862
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 20961145
MODE - -
REGULATED-ENTITY - BIOTIN-SYN-ENZRXN
REGULATOR - SINEFUNGIN
//
UNIQUE-ID - REG0-9730
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3286645]
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - CPD0-1297
//
UNIQUE-ID - REG0-12164
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4326214
MODE - -
REGULATED-ENTITY - GAPDH-A-ENZRXN
REGULATOR - IODOACETATE
//
UNIQUE-ID - REG0-6905
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4920894]
COMMENT - High levels of glycolytic and TCA cycle intermediates result in strong 
/inhibition of the adenylyltransferase reaction.  Pyruvate, glutarate, succinate
/and fumarate also inhibit to a lesser degree.  |CITS: [4920894]| 
MODE - -
REGULATED-ENTITY - GSADENYLATION-ENZRXN
REGULATOR - CIT
//
UNIQUE-ID - REG0-7513
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2681195]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - THREODEHYD-ENZRXN
REGULATOR - DIACETYL
//
UNIQUE-ID - REG0-8141
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3516690]
MODE - -
REGULATED-ENTITY - FORMHYDROG2-ENZRXN
REGULATOR - N-BROMOSUCCINIMIDE
//
UNIQUE-ID - REG0-8740
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 776969
COMMENT - partially competitive
/|CITS: [776969]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTAMINB-ENZRXN
REGULATOR - GLT
//
UNIQUE-ID - REG0-10746
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18501724
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CFA-ENZRXN
REGULATOR - CPD0-2355
//
UNIQUE-ID - REG0-9712
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - CPD0-1263
//
UNIQUE-ID - REG0-12131
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11004177
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN-42
REGULATOR - DMSO
//
UNIQUE-ID - REG0-6885
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [40950]
COMMENT - for the reaction in both directions
MODE - +
REGULATED-ENTITY - GLYCDEH-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-7494
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4861610]
CITATIONS - [357898]
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - THYKI-ENZRXN
REGULATOR - GDP
//
UNIQUE-ID - REG0-8115
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - MethEnz17A-708
CITATIONS - HandEnzInh
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ASP-SEMIALDEHYDE-DEHYDROGENASE-ENZRXN
REGULATOR - PHMB
//
UNIQUE-ID - REG0-8715
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 122902
CITATIONS - 193572
MECHANISM - :ALLOSTERIC
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PEPDEPHOSII-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-10702
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10684608
MODE - -
REGULATED-ENTITY - ACETYLORNDEACET-ENZRXN
REGULATOR - CD+2
//
UNIQUE-ID - REG0-9696
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1577828]
MODE - -
REGULATED-ENTITY - KDOTRANS2-ENZRXN
REGULATOR - BISOHMYR-GLC
//
UNIQUE-ID - REG0-12033
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21296885
MODE - -
REGULATED-ENTITY - ENZRXNMETA-19626
REGULATOR - CPD0-2558
//
UNIQUE-ID - REG0-6869
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8083170]
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUCOSAMINE1PACETYL-ENZRXN
REGULATOR - N-ACETYL-D-GLUCOSAMINE-1-P
//
UNIQUE-ID - REG0-7465
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3900058
MODE - +
REGULATED-ENTITY - ASPARTASE-ENZRXN
REGULATOR - CPD0-1614
//
UNIQUE-ID - REG0-8088
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [VogelAdvEnzym40-71]
MODE - -
REGULATED-ENTITY - ACETYLORNDEACET-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-8688
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12374823
MODE - -
REGULATED-ENTITY - ENZRXN0-2041
REGULATOR - OXYGEN-MOLECULE
//
UNIQUE-ID - REG0-10626
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - -
REGULATED-ENTITY - KETOACYLCOATHIOL-ENZRXN
REGULATOR - TRIS
//
UNIQUE-ID - REG0-9680
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - CPD0-1262
//
UNIQUE-ID - REG0-11973
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 193572
MODE - +
REGULATED-ENTITY - PEPDEPHOSII-ENZRXN
REGULATOR - RIBOSE-5P
//
UNIQUE-ID - REG0-6851
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2659585
MODE - +
REGULATED-ENTITY - ENZRXN0-4481
REGULATOR - MN+2
//
UNIQUE-ID - REG0-7446
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14004226
COMMENT - inhibits the initial rate of transamination
MODE - -
REGULATED-ENTITY - PYROXALTRANSAM-ENZRXN
REGULATOR - GLT
//
UNIQUE-ID - REG0-8064
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10480878
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6061
REGULATOR - NADP
//
UNIQUE-ID - REG0-8658
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14419794
COMMENT - AMP and IMP are also inhibitors to a much
/lesser extent  |CITS: [14419794]|
MODE - -
REGULATED-ENTITY - GMP-REDUCT-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-10570
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17713924
MODE - -
REGULATED-ENTITY - ASPAMINOTRANS-ENZRXN
REGULATOR - CPD-12132
//
UNIQUE-ID - REG0-9660
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1967948]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTAMINESYN-ENZRXN
REGULATOR - CPD0-1246
//
UNIQUE-ID - REG0-11955
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3908101
MODE - -
REGULATED-ENTITY - ALADEHYDCHLORO-ENZRXN
REGULATOR - L-PENICILLAMINE
//
UNIQUE-ID - REG0-6826
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9558330
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - ENZRXN0-2708
REGULATOR - HYDROXYNAPHTHOQUINONE
//
UNIQUE-ID - REG0-7419
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [14216423]
MODE - +
REGULATED-ENTITY - PHOSPHOGLUCMUT-ENZRXN
REGULATOR - CYS
//
UNIQUE-ID - REG0-8037
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 334530
MODE - -
REGULATED-ENTITY - PREPHENATEDEHYDRAT-ENZRXN
REGULATOR - TETRANITROMETHANE
//
UNIQUE-ID - REG0-8628
TYPES - Regulation-of-Enzyme-Activity
COMMENT - Acts as a slight inhibitor.  |CITS: [1377]| 
MODE - -
REGULATED-ENTITY - ENZRXN0-241
REGULATOR - NACMUR
//
UNIQUE-ID - REG0-10413
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 189796
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - UDPGLUCEPIM-ENZRXN
REGULATOR - UMP
//
UNIQUE-ID - REG0-9636
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8621700
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - L-GLN-FRUCT-6-P-AMINOTRANS-ENZRXN
REGULATOR - CPD0-1235
//
UNIQUE-ID - REG0-11919
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24214977
KI - 330
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7809
REGULATOR - HYPOXANTHINE
//
UNIQUE-ID - REG0-6791
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9287300]
MODE - -
REGULATED-ENTITY - ENZRXN-203
REGULATOR - CU+2
//
UNIQUE-ID - REG0-7401
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4966660]
MODE - -
REGULATED-ENTITY - GLUTAMINA-ENZRXN
REGULATOR - AG+
//
UNIQUE-ID - REG0-7988
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7868604]
MODE - -
REGULATED-ENTITY - FORMYLTHFDEFORMYL-ENZRXN
REGULATOR - GLY
//
UNIQUE-ID - REG0-8591
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 238844
CITATIONS - 7033218
CITATIONS - 10103021
COMMENT - competitive with respect to FAD |CITS: [7033218]|
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - L-ASPARTATE-OXID-ENZRXN
REGULATOR - NAD
//
UNIQUE-ID - REG0-10365
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - DIACYLGLYKIN-ENZRXN
REGULATOR - CPD0-1812
//
UNIQUE-ID - REG0-9615
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [40956]
MODE - -
REGULATED-ENTITY - LACTALDREDUCT-ENZRXN
REGULATOR - CPD0-1222
//
UNIQUE-ID - REG0-11888
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24210219
MODE - -
REGULATED-ENTITY - ENZRXN0-7799
REGULATOR - ATP
//
UNIQUE-ID - REG0-6764
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [211379]
MODE - -
REGULATED-ENTITY - CYTIDINEKIN-ENZRXN
REGULATOR - CTP
//
UNIQUE-ID - REG0-7380
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [189806]
CITATIONS - [4358555]
MECHANISM - :ALLOSTERIC
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - CARBPSYN-ENZRXN
REGULATOR - L-ORNITHINE
//
UNIQUE-ID - REG0-7967
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2185038
MODE - -
REGULATED-ENTITY - GST-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-8563
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - ADIPATE
//
UNIQUE-ID - REG0-10257
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [MethEnz62-379]
MODE - -
REGULATED-ENTITY - ENZRXN-153
REGULATOR - IODOACETATE
//
UNIQUE-ID - REG0-9548
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8561507
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - QUINOPRIBOTRANS-ENZRXN
REGULATOR - FRUCTOSE-16-DIPHOSPHATE
//
UNIQUE-ID - REG0-11829
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 23844911
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7782
REGULATOR - PROPIONATE
//
UNIQUE-ID - REG0-6735
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10956653
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CHORISMATE-SYNTHASE-ENZRXN
REGULATOR - 6R-6-FLUORO-EPSP
//
UNIQUE-ID - REG0-7363
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9324253
COMMENT - The enzyme was partially protected from inactivation by either o-succinylbenzoate,
/ATP, or ATP plus Mg++.  The enzyme was completely protected from inactivation
/by the presence of the combination of o-succinylbenzoate, ATP and Mg++.
MODE - -
REGULATED-ENTITY - O-SUCCINYLBENZOATE-COA-LIG-ENZRXN
REGULATOR - DIETHYLPYROCARBONATE
//
UNIQUE-ID - REG0-7922
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4290215]
COMMENT - Shows slight inhibition.
MODE - -
REGULATED-ENTITY - NAD-SYNTH-NH3-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-8532
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8060125]
MODE - -
REGULATED-ENTITY - CROBETREDUCT-ENZRXN
REGULATOR - CHOLINE
//
UNIQUE-ID - REG0-10238
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2194570]
MODE - -
REGULATED-ENTITY - BADH-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-9498
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18459799
MODE - -
REGULATED-ENTITY - ENZRXN0-2802
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-11787
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1599467
MODE - -
REGULATED-ENTITY - 3-P-SHIK-1-CARBOXYVINYLXFERASE-ENZRXN
REGULATOR - PYRUVATE
//
UNIQUE-ID - REG0-6713
TYPES - Regulation-of-Enzyme-Activity
COMMENT - inhibits the activated enzyme
/|CITS: [7702553]|
MODE - -
REGULATED-ENTITY - AMINEOXID-ENZRXN
REGULATOR - SEMICARBAZIDE
//
UNIQUE-ID - REG0-7332
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13844669
MODE - -
REGULATED-ENTITY - AMYLOMALT-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7893
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7929317]
COMMENT - for ATP reduction
MECHANISM - :ALLOSTERIC
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - RIBONUCLEOSIDE-TRIP-REDUCT-ENZRXN
REGULATOR - DGTP
//
UNIQUE-ID - REG0-8511
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8223657
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - KDO-8PSYNTH-ENZRXN
REGULATOR - KDO-8P
//
UNIQUE-ID - REG0-7890
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1460049
COMMENT - in high
/concentrations |CITS: [1460049]|
MODE - -
REGULATED-ENTITY - RIBONUCLEOSIDE-TRIP-REDUCT-ENZRXN
REGULATOR - MG+2
//
UNIQUE-ID - REG0-8507
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [2856144]
CITATIONS - [6365921]
MODE - -
REGULATED-ENTITY - CYT-O-UBIOX-ENZRXN
REGULATOR - CPD-7975
//
UNIQUE-ID - REG0-10201
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2194570
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - BADH-ENZRXN
REGULATOR - GLYCERALD
//
UNIQUE-ID - REG0-9434
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18328504
MODE - -
REGULATED-ENTITY - ENZRXN0-6517
REGULATOR - ADP
//
UNIQUE-ID - REG0-6690
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3117785]
MODE - -
REGULATED-ENTITY - AKBLIG-ENZRXN
REGULATOR - CPD0-1074
//
UNIQUE-ID - REG0-7280
TYPES - Regulation-of-Enzyme-Activity
COMMENT - Strong product inhibitor of polyphosphate synthesis.  |CITS: [2164013] [1316760]| 
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PPK-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-7862
TYPES - Regulation-of-Enzyme-Activity
COMMENT - Inhibition can be overcome by addition
/of ACP. LiCl appears to affect the enzyme's ability to utilize ACP.
/|CITS: [6373752]|
MODE - -
REGULATED-ENTITY - ACYLGPEACYLTRANS-ENZRXN
REGULATOR - LI+
//
UNIQUE-ID - REG0-8481
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [214126]
COMMENT - inhibitor of ATP for ADP production
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - NUCLEOSIDE-DIP-KIN-ENZRXN
REGULATOR - GTP
//
UNIQUE-ID - REG0-10165
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1095054]
MODE - -
REGULATED-ENTITY - FOLYLPOLYGLUTAMATESYNTH-ENZRXN
REGULATOR - CPD0-1596
//
UNIQUE-ID - REG0-9341
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - NIL
REGULATED-ENTITY - ENOYL-COA-HYDRAT-ENZRXN
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-11734
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4992818
MODE - +
REGULATED-ENTITY - D-PPENTOMUT
REGULATOR - RIBOSE-15-BISPHOSPHATE
//
UNIQUE-ID - REG0-6659
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16216582
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6179
REGULATOR - THIAMINE-PYROPHOSPHATE
//
UNIQUE-ID - REG0-7255
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4289778
MODE - -
REGULATED-ENTITY - TYRS-ENZRXN
REGULATOR - DATP
//
UNIQUE-ID - REG0-7837
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13794771
MODE - -
REGULATED-ENTITY - GALACTUROISOM-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-8461
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6251075]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - S-ADENMETSYN-ENZRXN
REGULATOR - S-ADENOSYLMETHIONINE
//
UNIQUE-ID - REG0-10143
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14343156
MODE - -
REGULATED-ENTITY - DIAMINOPIMDECARB-ENZRXN
REGULATOR - CPD0-1577
//
UNIQUE-ID - REG0-9228
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [237196]
CITATIONS - SCHWARTZ72A
MODE - -
REGULATED-ENTITY - RHAMNULPALDOL-ENZRXN
REGULATOR - CPD-7388
//
UNIQUE-ID - REG0-11681
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2197412]
CITATIONS - 2689171
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - DIAMINOPIMEPIM-ENZRXN
REGULATOR - CPD0-1537
//
UNIQUE-ID - REG0-6639
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16567800
MODE - -
REGULATED-ENTITY - ENZRXN0-6198
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-7224
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [BlumenthalMethEnz9-660]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUCARDEHYDRA-ENZRXN
REGULATOR - D-GALACTARATE
//
UNIQUE-ID - REG0-7821
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3518792
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYANLY-ENZRXN
REGULATOR - CPD-69
//
UNIQUE-ID - REG0-8443
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4878694]
CITATIONS - [4878695]
MODE - -
REGULATED-ENTITY - GLYCOPHOSPHORYL-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-10113
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8752345]
MODE - -
REGULATED-ENTITY - DHPDIOXYGEN-ENZRXN
REGULATOR - DITHIO-NITROBENZOATE
//
UNIQUE-ID - REG0-9202
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10446288
MODE - -
REGULATED-ENTITY - ENZRXN0-6461
REGULATOR - L-ALPHA-ALANINE
//
UNIQUE-ID - REG0-11615
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 23202856
MECHANISM - :ALLOSTERIC
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ENZRXN0-7644
REGULATOR - C-DI-GMP
//
UNIQUE-ID - REG0-12476
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - ENZRXN0-8297
REGULATOR - CPD0-1385
//
UNIQUE-ID - REG0-7195
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4297266]
MODE - -
REGULATED-ENTITY - DLACTDEHYDROGNAD-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-7800
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1939236]
CITATIONS - [6302686]
CITATIONS - 5333198
CITATIONS - 13897943
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ASPCARBTRANS-ENZRXN
REGULATOR - CTP
//
UNIQUE-ID - REG0-8420
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3081491
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - AGMATIN-ENZRXN
REGULATOR - ARG
//
UNIQUE-ID - REG0-10077
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17470659
MODE - -
REGULATED-ENTITY - ENZRXN0-6573
REGULATOR - ceftobiprole
//
UNIQUE-ID - REG0-9158
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4632320
MODE - -
REGULATED-ENTITY - DARABISOM-ENZRXN
REGULATOR - RIBITOL
//
UNIQUE-ID - REG0-11593
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6986370]
CITATIONS - 12837799
MODE - +
REGULATED-ENTITY - PEPCARBOXYKIN-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-9991
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10359647
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6603
REGULATOR - D-ARABINOSE
//
UNIQUE-ID - REG0-12460
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7012144]
MODE - -
REGULATED-ENTITY - ENZRXN0-8283
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-7165
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-7766
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 357904
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - THYM-PHOSPH-ENZRXN
REGULATOR - RIBOSE-1P
//
UNIQUE-ID - REG0-8395
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14086727
COMMENT - uncompetitive with respect to phosphoserine, noncompetitive with respect to water |CITS: [14086727]|. 
/Appreciable inhibition is observed only when concentration of serine approaches that required for 
/saturation by substrate.  |CITS: [14047241]|
MODE - -
REGULATED-ENTITY - PSERPHOSPHA-ENZRXN
REGULATOR - SER
//
UNIQUE-ID - REG0-10059
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [FishMethEnz9-529]
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - |Hexaric-Acids|
//
UNIQUE-ID - REG0-9123
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7007336
MECHANISM - :OTHER
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - THREDEHYDSYN-ENZRXN
REGULATOR - CYS
//
UNIQUE-ID - REG0-11499
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 22511334
MODE - +
REGULATED-ENTITY - ENZRXN0-7548
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-9927
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1097688
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PHES-ENZRXN
REGULATOR - CPD0-1432
//
UNIQUE-ID - REG0-12444
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8262
REGULATOR - TRIS-HYDROCHLORIDE
//
UNIQUE-ID - REG0-7129
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12805358
CITATIONS - [5332197]
MODE - -
REGULATED-ENTITY - DARAB5PISOM-ENZRXN
REGULATOR - CD+2
//
UNIQUE-ID - REG0-7741
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5328735
COMMENT - inhibition relieved by O2 and
/FAD  |CITS: [5328735]|
MODE - -
REGULATED-ENTITY - GLYOCARBOLIG-ENZRXN
REGULATOR - S2O4
//
UNIQUE-ID - REG0-8376
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5333666]
COMMENT - may be competing at
/both the ATP and  GMP sites
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GUANYL-KIN-ENZRXN
REGULATOR - GTP
//
UNIQUE-ID - REG0-10039
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [MethEnzV-794]
MODE - -
REGULATED-ENTITY - IGPSYN-ENZRXN
REGULATOR - CPD0-1488
//
UNIQUE-ID - REG0-9101
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4580841]
CITATIONS - [374983]
MODE - -
REGULATED-ENTITY - THI-P-SYN-ENZRXN
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-11365
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 372191
MODE - -
REGULATED-ENTITY - PRPPAMIDOTRANS-ENZRXN
REGULATOR - XANTHOSINE-5-PHOSPHATE
//
UNIQUE-ID - REG0-9909
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7918616]
MODE - -
REGULATED-ENTITY - CARDIOLIPSYN-ENZRXN
REGULATOR - CPD0-1425
//
UNIQUE-ID - REG0-12428
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - ENZRXN0-8176
REGULATOR - CPD0-1385
//
UNIQUE-ID - REG0-7103
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9261133]
KI - 10
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PPX-ENZRXN
REGULATOR - GDP-TP
//
UNIQUE-ID - REG0-7709
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [VogelAdvEnzym40-70]
MODE - -
REGULATED-ENTITY - ACETYLORNTRANSAM-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-8351
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - JBC240-1711
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - THREDEHYDCAT-ENZRXN
REGULATOR - D-THREONINE
//
UNIQUE-ID - REG0-10019
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5333666]
MODE - -
REGULATED-ENTITY - GUANYL-KIN-ENZRXN
REGULATOR - CPD0-1468
//
UNIQUE-ID - REG0-9020
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6393625
COMMENT - shows substrate inhibition at high concentrations  |CITS: [6393625]|
MODE - -
REGULATED-ENTITY - GLUTATHIONE-REDUCT-NADPH-ENZRXN
REGULATOR - OXIDIZED-GLUTATHIONE
//
UNIQUE-ID - REG0-11334
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19088907
MODE - -
REGULATED-ENTITY - ENZRXN0-1461
REGULATOR - SO3
//
UNIQUE-ID - REG0-9886
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18500821
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - RIBOFLAVINSYNREDUC-ENZRXN
REGULATOR - CPD0-1407
//
UNIQUE-ID - REG0-12378
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 25712150
MODE - +
REGULATED-ENTITY - ENZRXN0-8114
REGULATOR - CPLX0-3964
//
UNIQUE-ID - REG0-7084
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4934182]
COMMENT - with respect to malonyl-CoA
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - MALONYL-COA-ACP-TRANSACYL-ENZRXN
REGULATOR - MALONYL-ACP
//
UNIQUE-ID - REG0-7683
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4304228]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - H2PTEROATESYNTH-ENZRXN
REGULATOR - 7-8-DIHYDROPTEROATE
//
UNIQUE-ID - REG0-8333
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7918616]
MODE - +
REGULATED-ENTITY - CARDIOLIPSYN-ENZRXN
REGULATOR - L-1-PHOSPHATIDYL-ETHANOLAMINE
//
UNIQUE-ID - REG-15076
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8550422
COMMENT - inhibits the reverse, dehydrogenase
/activity |CITS: [8550422]|
CREDITS - SRI
CREDITS - |caspi|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN-23884
REGULATOR - 2-KETOGLUTARATE
//
UNIQUE-ID - REG0-8930
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9109378
COMMENT - Inhibits at high concentration. |CITS: [9109378]|
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PHENDEHYD-ENZRXN
REGULATOR - PHENYLACETALDEHYDE
//
UNIQUE-ID - REG0-11304
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7765483
MODE - -
REGULATED-ENTITY - AMINEPHEN-ENZRXN
REGULATOR - CPD-13895
//
UNIQUE-ID - REG0-9854
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - ACYLACPSYNTH-ENZRXN
REGULATOR - |Salts|
//
UNIQUE-ID - REG0-12332
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9748330
KI - 910
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ASNSYNB-ENZRXN
REGULATOR - CPD0-1054
//
UNIQUE-ID - REG0-7064
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [30751]
MODE - +
REGULATED-ENTITY - CDPDIGLYSYN-ENZRXN
REGULATOR - BRIJ97
//
UNIQUE-ID - REG0-7652
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6756470
CITATIONS - 3325036
MODE - -
REGULATED-ENTITY - LYSU-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-8294
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3291954
CITATIONS - 3281659
MODE - -
REGULATED-ENTITY - ISOCITLYASE-ENZRXN
REGULATOR - 2-KETOGLUTARATE
//
UNIQUE-ID - REG-14659
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2896604
CREDITS - SRI
CREDITS - |caspi|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN-22535
REGULATOR - CPD0-1144
//
UNIQUE-ID - REG0-8907
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6378902
MODE - -
REGULATED-ENTITY - ACETOLACTSYNII-ENZRXN
REGULATOR - CPD0-1692
//
UNIQUE-ID - REG0-11286
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10648809
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - PYRUVFORMLY-ENZRXN
REGULATOR - CPD-13859
//
UNIQUE-ID - REG0-9832
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4572733]
MODE - -
REGULATED-ENTITY - SPERMIDINESYN-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-12299
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3900067
MODE - -
REGULATED-ENTITY - ENZRXN0-4263
REGULATOR - DIISOPROPYL-FLUOROPHOSPHATE
//
UNIQUE-ID - REG0-7041
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [46]
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - SPERMINE
//
UNIQUE-ID - REG0-7628
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3297044
MODE - -
REGULATED-ENTITY - ARGDECARBOXBIO-ENZRXN
REGULATOR - CPD0-1664
//
UNIQUE-ID - REG0-8264
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14982633
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - TRANS-ENZRXN-68
REGULATOR - L-ORNITHINE
//
UNIQUE-ID - REG0-8863
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - 4OH2OXOGLUTARALDOL-ENZRXN
REGULATOR - CIT
//
UNIQUE-ID - REG0-11200
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21754980
KI - 42
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-5481
REGULATOR - CPD0-2464
//
UNIQUE-ID - REG0-9807
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 368012
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - H2PTEROATESYNTH-ENZRXN
REGULATOR - |Sulfonamides|
//
UNIQUE-ID - REG0-12271
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16569861
MODE - -
REGULATED-ENTITY - ENZRXN0-7971
REGULATOR - MOENOMYCIN
//
UNIQUE-ID - REG0-7010
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4567662
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - THI-P-KIN-ENZRXN
REGULATOR - RB+
//
UNIQUE-ID - REG0-7603
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329757
CITATIONS - 10625615
MODE - +
REGULATED-ENTITY - ICITDEHDEPHOSPH-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-8243
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6246070]
MODE - -
REGULATED-ENTITY - KDO-8PPHOSPHAT-ENZRXN
REGULATOR - CD+2
//
UNIQUE-ID - REG0-8832
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10879466]
MODE - +
REGULATED-ENTITY - GUANOSINEKIN-ENZRXN
REGULATOR - CMP
//
UNIQUE-ID - REG0-11025
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21467222
MODE - -
REGULATED-ENTITY - ENZRXN0-7454
REGULATOR - DIISOPROPYL-FLUOROPHOSPHATE
//
UNIQUE-ID - REG0-9788
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4861610]
CITATIONS - [357898]
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - THYKI-ENZRXN
REGULATOR - CPD0-1345
//
UNIQUE-ID - REG0-12254
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14693515
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - CPD-12245
//
UNIQUE-ID - REG0-6972
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - PHOSPHAGLYPSYN-ENZRXN
REGULATOR - CDPDIACYLGLYCEROL
//
UNIQUE-ID - REG0-7575
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 782527
COMMENT - The inhibition could be overcome by the
/addition of divalent metal ions, of which Mn++ was the most effective.
/|CITS: [782527]|
MODE - -
REGULATED-ENTITY - 3-OCTPRNL-4-OHBENZOATE-DECARBOX-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-8211
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4312205
COMMENT - noncompetitive with respect to CoA
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - PHOSACETYLTRANS-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-8814
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16670087
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - F16BDEPHOS-ENZRXN
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-11008
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3091070
MODE - -
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - CPD0-1406
//
UNIQUE-ID - REG0-9764
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [211379]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYTIDINEKIN-ENZRXN
REGULATOR - CPD0-1321
//
UNIQUE-ID - REG0-12238
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14692773
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - compound 6
//
UNIQUE-ID - REG0-6946
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16890
MODE - -
REGULATED-ENTITY - N-ACETYLTRANSFER-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-7549
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15489439
MODE - -
REGULATED-ENTITY - ENZRXN0-5681
REGULATOR - ADP
//
UNIQUE-ID - REG0-8180
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [SaikusaAgBioChem51-1893]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - METHYLGLYREDUCT-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-8785
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14245396
MODE - -
REGULATED-ENTITY - 3-NUCLEOTID-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-10880
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12731872
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-1661
REGULATOR - ADENOSYL-HOMO-CYS
//
UNIQUE-ID - REG0-9743
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6229418
KI - 1
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - 3-P-SHIK-1-CARBOXYVINYLXFERASE-ENZRXN
REGULATOR - CPD0-1308
//
UNIQUE-ID - REG0-12181
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8530465
CITATIONS - 10373427
MODE - -
REGULATED-ENTITY - ENZRXN0-7928
REGULATOR - AMP
//
UNIQUE-ID - REG0-6928
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - -
REGULATED-ENTITY - KETOACYLCOATHIOL-ENZRXN
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7527
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 786633
KI - 8.5    
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - TRPS-ENZRXN
REGULATOR - CPD0-920
//
UNIQUE-ID - REG0-8161
TYPES - Regulation-of-Enzyme-Activity
COMMENT - The enzyme
/is sensitive to a number of carbonyl reagents due to the fact that
/catalysis is mediated by the carbonyl moiety of the pyruvate
/prosthetic group.  |CITS: [1495415] [338609]|
MODE - -
REGULATED-ENTITY - PHOSPHASERDECARB-ENZRXN
REGULATOR - BOROHYDRIDE
//
UNIQUE-ID - REG0-8759
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 776970
MODE - +
REGULATED-ENTITY - GLUTAMINB-ENZRXN
REGULATOR - MN+2
//
UNIQUE-ID - REG0-10852
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15751977
CITATIONS - 22378791
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - UDPNACETYLGLUCOSAMENOLPYRTRANS-ENZRXN
REGULATOR - UDP-N-ACETYLMURAMATE
//
UNIQUE-ID - REG0-9727
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - CPD0-1293
//
UNIQUE-ID - REG0-12159
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [46]
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-6902
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4920894]
COMMENT - High levels of glycolytic and TCA cycle intermediates result in strong 
/inhibition of the adenylyltransferase reaction.  Pyruvate, glutarate, succinate
/and fumarate also inhibit to a lesser degree.  |CITS: [4920894]| 
MODE - -
REGULATED-ENTITY - GSADENYLATION-ENZRXN
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-7509
TYPES - Regulation-of-Enzyme-Activity
COMMENT - activates at low concentrations, inhibits
/at high, 6-PGD has no absolute requirement for Mg++  |CITS:
/[WestwoodMicrobios9,143]|
MODE - +
REGULATED-ENTITY - 6PGLUCONDEHYDROG-ENZRXN
REGULATOR - MG+2
//
UNIQUE-ID - REG0-8138
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4402996]
MODE - +
REGULATED-ENTITY - MANNONOXIDOREDUCT-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-8731
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [821948]
KI - 0.24    
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GTP-CYCLOHYDRO-I-ENZRXN
REGULATOR - DGTP
//
UNIQUE-ID - REG0-10743
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19762342
MODE - -
REGULATED-ENTITY - ETHAMLY-ENZRXN
REGULATOR - CPD0-2347
//
UNIQUE-ID - REG0-9709
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - CPD0-1264
//
UNIQUE-ID - REG0-12117
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12591875
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-1085
REGULATOR - LIPOL-AMP
//
UNIQUE-ID - REG0-6882
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [40950]
MODE - -
REGULATED-ENTITY - GLYCDEH-ENZRXN
REGULATOR - 8-HYDROXYQUINOLINE
//
UNIQUE-ID - REG0-7491
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4861610]
CITATIONS - [357898]
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - THYKI-ENZRXN
REGULATOR - GTP
//
UNIQUE-ID - REG0-8112
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14718529
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-3281
REGULATOR - TARTRATE
//
UNIQUE-ID - REG0-8705
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [FishMethEnz9-529]
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - CL-
//
UNIQUE-ID - REG0-10663
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19123216
MODE - -
REGULATED-ENTITY - TREHALAPERI-ENZRXN
REGULATOR - CPD0-2306
//
UNIQUE-ID - REG0-9693
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - CPD0-1274
//
UNIQUE-ID - REG0-12028
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24914049
MODE - +
REGULATED-ENTITY - ENZRXN0-7856
REGULATOR - ATP
//
UNIQUE-ID - REG0-6866
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1099093
MODE - -
REGULATED-ENTITY - FORMATEDEHYDROGN-ENZRXN
REGULATOR - CPD-2841
//
UNIQUE-ID - REG0-7462
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [6396297]
MODE - -
REGULATED-ENTITY - ASPARTASE-ENZRXN
REGULATOR - DIETHYLPYROCARBONATE
//
UNIQUE-ID - REG0-8085
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [VogelAdvEnzym40-71]
MODE - -
REGULATED-ENTITY - ACETYLORNDEACET-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-8685
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4565085
MODE - -
REGULATED-ENTITY - GLUTAMATESYN-ENZRXN
REGULATOR - D-GLT
//
UNIQUE-ID - REG0-10623
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4966660]
MODE - -
REGULATED-ENTITY - GLUTAMINA-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-9676
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [319195]
CITATIONS - [33657]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ETHAMLY-ENZRXN
REGULATOR - 1-AMINO-PROPAN-2-OL
//
UNIQUE-ID - REG0-11969
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 368072
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-282
REGULATOR - ADP
//
UNIQUE-ID - REG0-6848
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1317461
MODE - -
REGULATED-ENTITY - ENZRXN0-4101
REGULATOR - ATP
//
UNIQUE-ID - REG0-7442
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6365916
MODE - -
REGULATED-ENTITY - TETHYDPICSUCC-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-8061
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3294837]
COMMENT - cerulenin and
/thiolactomycin are antibiotics
MODE - -
REGULATED-ENTITY - 3-OXOACYL-ACP-SYNTHI-BASE-ENZRXN
REGULATOR - CPD-6901
//
UNIQUE-ID - REG0-8653
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12496243
MODE - -
REGULATED-ENTITY - ENZRXN0-2245
REGULATOR - FORMYCIN-A
//
UNIQUE-ID - REG0-10567
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4572511
MODE - -
REGULATED-ENTITY - PEPSYNTH-ENZRXN
REGULATOR - OXALACETIC_ACID
//
UNIQUE-ID - REG0-9656
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3122832]
MODE - -
REGULATED-ENTITY - NADH-DHI-ENZRXN
REGULATOR - CPD0-1244
//
UNIQUE-ID - REG0-11936
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2141983
MODE - -
REGULATED-ENTITY - ENZRXN0-7818
REGULATOR - CPD-11925
//
UNIQUE-ID - REG0-6823
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10634942
MODE - -
REGULATED-ENTITY - ENZRXN0-266
REGULATOR - CARDIOLIPIN
//
UNIQUE-ID - REG0-7416
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [14216423]
MODE - -
REGULATED-ENTITY - PHOSPHOGLUCMUT-ENZRXN
REGULATOR - CU+
//
UNIQUE-ID - REG0-8034
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6337635
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PREPHENATEDEHYDRAT-ENZRXN
REGULATOR - CIS-ACONITATE
//
UNIQUE-ID - REG0-8620
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7011505]
CITATIONS - 15155761
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - LSERINEDEAM1-ENZRXN
REGULATOR - D-SERINE
//
UNIQUE-ID - REG0-10410
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4893578]
MODE - +
REGULATED-ENTITY - GSDEADENYLATION-ENZRXN
REGULATOR - UTP
//
UNIQUE-ID - REG0-9633
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18321216
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - CYT-O-UBIOX-ENZRXN
REGULATOR - CPD0-1232
//
UNIQUE-ID - REG0-11916
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24214977
KI - 105
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7813
REGULATOR - CPD0-1932
//
UNIQUE-ID - REG0-6788
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [MethEnz62-379]
MODE - -
REGULATED-ENTITY - ENZRXN-153
REGULATOR - EDTA
//
UNIQUE-ID - REG0-7396
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4966660]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTAMINA-ENZRXN
REGULATOR - CPD-9384
//
UNIQUE-ID - REG0-7985
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7046791]
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - ENZRXN-17895
REGULATOR - DIACETYL
//
UNIQUE-ID - REG0-8584
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3910996]
MODE - +
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - BR
//
UNIQUE-ID - REG0-10362
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - DIACYLGLYKIN-ENZRXN
REGULATOR - CPD0-1807
//
UNIQUE-ID - REG0-9611
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - 3049163
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ACETOLACTREDUCTOISOM-ENZRXN
REGULATOR - CPD0-1220
//
UNIQUE-ID - REG0-11849
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8631677
MODE - +
REGULATED-ENTITY - SUCCCOASYN-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-6749
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14245396
MODE - -
REGULATED-ENTITY - CYCPHOSDIESTER-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-7377
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [5339592]
MODE - -
REGULATED-ENTITY - CARBPSYN-ENZRXN
REGULATOR - CPD0-1627
//
UNIQUE-ID - REG0-7958
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1459486
CITATIONS - 1846509
MODE - -
REGULATED-ENTITY - QUINOLINATE-SYNTHA-ENZRXN
REGULATOR - OXYGEN-MOLECULE
//
UNIQUE-ID - REG0-8547
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4862197
COMMENT - for the phosphorolysis reaction, with
/variable concentrations of phosphate, and a constant nonsaturating
/level of uridine, the inhibition is noncompetitive  |CITS:
/[6357095]|
MODE - -
REGULATED-ENTITY - URPHOS-ENZRXN
REGULATOR - URACIL
//
UNIQUE-ID - REG0-10254
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2007545
MODE - -
REGULATED-ENTITY - 7-ALPHA-HYDROXYSTEROID-DEH-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-9541
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 319747
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLYCEROL-3-P-ACYLTRANSFER-ENZRXN
REGULATOR - L-GLYCERALDEHYDE-3-PHOSPHATE
//
UNIQUE-ID - REG0-11815
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15489502
MODE - -
REGULATED-ENTITY - ENZRXN0-7651
REGULATOR - ATP
//
UNIQUE-ID - REG0-6732
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1740425
MODE - -
REGULATED-ENTITY - CARBODEHYDRAT-ENZRXN
REGULATOR - CPD-69
//
UNIQUE-ID - REG0-7358
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8530465]
COMMENT - noncompetitive with respect to
/riboflavin
MECHANISM - :NONCOMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - FMNREDUCT-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-7919
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4290215]
MODE - -
REGULATED-ENTITY - NAD-SYNTH-NH3-ENZRXN
REGULATOR - DECOYININE
//
UNIQUE-ID - REG0-8529
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1672127
MODE - +
REGULATED-ENTITY - DAHPSYNTRP-ENZRXN
REGULATOR - FE+2
//
UNIQUE-ID - REG0-10229
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19073594
MODE - -
REGULATED-ENTITY - ENZRXN0-6614
REGULATOR - KCL
//
UNIQUE-ID - REG0-9495
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18459799
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-2802
REGULATOR - CPD-9195
//
UNIQUE-ID - REG0-11784
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2950851
MODE - -
REGULATED-ENTITY - 3-DEHYDROQUINATE-DEHYDRATASE-ENZRXN
REGULATOR - BH4NA
//
UNIQUE-ID - REG0-6710
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5543331]
MODE - +
REGULATED-ENTITY - ALPHAGALACTOSID-ENZRXN
REGULATOR - |Thiols|
//
UNIQUE-ID - REG0-7315
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1325457]
MODE - -
REGULATED-ENTITY - PFLDEACTIV-ENZRXN
REGULATOR - PYRUVATE
//
UNIQUE-ID - REG0-7882
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7929317
COMMENT - inhibits the reduction of the `incorrect'
/substrate |CITS: [7929317]|
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - RIBONUCLEOSIDE-TRIP-REDUCT-ENZRXN
REGULATOR - DGTP
//
UNIQUE-ID - REG0-8502
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6365921]
MODE - -
REGULATED-ENTITY - CYT-O-UBIOX-ENZRXN
REGULATOR - CD+2
//
UNIQUE-ID - REG0-10197
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2194570
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - BADH-ENZRXN
REGULATOR - PHENYLACETALDEHYDE
//
UNIQUE-ID - REG0-9430
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16990935
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PANTOATE-BETA-ALANINE-LIG-ENZRXN
REGULATOR - CPD0-1141
//
UNIQUE-ID - REG0-11765
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2010919
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7757
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-6681
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6300054
COMMENT - Ca++ is a strong inhibitor when added in
/the presence of Mg++.  |CITS: [6300054]|
MODE - -
REGULATED-ENTITY - ADENYLATECYC-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-7275
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7040354
MECHANISM - :ALLOSTERIC
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PEPCARBOX-ENZRXN
REGULATOR - GTP
//
UNIQUE-ID - REG0-7856
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4861885
CITATIONS - 1734962
COMMENT - activates the reaction in both directions  |CITS: [6375729]
/[8125098]|
MECHANISM - :ALLOSTERIC
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUCOSAMINE-6-P-DEAMIN-ENZRXN
REGULATOR - N-ACETYL-D-GLUCOSAMINE-6-P
//
UNIQUE-ID - REG0-8478
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6378898]
MODE - -
REGULATED-ENTITY - TRANSENOYLCOARED-ENZRXN
REGULATOR - PHMB
//
UNIQUE-ID - REG0-10160
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3276891]
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - CPD0-1591
//
UNIQUE-ID - REG0-9338
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - NIL
REGULATED-ENTITY - OHBUTYRYL-COA-EPIM-ENZRXN
REGULATOR - TRIS-HYDROCHLORIDE
//
UNIQUE-ID - REG0-11707
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16710421
MODE - -
REGULATED-ENTITY - 3-OXOACYL-ACP-SYNTHII-ENZRXN
REGULATOR - CPD-15302
//
UNIQUE-ID - REG0-6655
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16199563
MODE - -
REGULATED-ENTITY - ENZRXN0-6149
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7237
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2510713]
MODE - -
REGULATED-ENTITY - OHMETHYLBILANESYN-ENZRXN
REGULATOR - PYRIDOXAL_PHOSPHATE
//
UNIQUE-ID - REG0-7834
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13794771
MODE - -
REGULATED-ENTITY - GALACTUROISOM-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-8454
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3047129
CITATIONS - [4878694]
CITATIONS - [4878695]
MODE - +
REGULATED-ENTITY - GLYCOPHOSPHORYL-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-10140
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2709379
MODE - -
REGULATED-ENTITY - GART-ENZRXN
REGULATOR - CPD0-1575
//
UNIQUE-ID - REG0-9218
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13727223
MODE - -
REGULATED-ENTITY - DIHYDROXYMETVALDEHYDRAT-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-11678
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15194235
CITATIONS - 9048556
CITATIONS - [1463470]
CITATIONS - 3514578
MECHANISM - :MIXED
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - DIHYDRODIPICSYN-ENZRXN
REGULATOR - LYS
//
UNIQUE-ID - REG0-6634
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16567800
MODE - -
REGULATED-ENTITY - ENZRXN0-6199
REGULATOR - IODOACETATE
//
UNIQUE-ID - REG0-7220
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10769114
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUCARDEHYDRA-ENZRXN
REGULATOR - CPD0-1612
//
UNIQUE-ID - REG0-7818
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2211698
MODE - -
REGULATED-ENTITY - ENZRXN0-4521
REGULATOR - OXYGEN-MOLECULE
//
UNIQUE-ID - REG0-8440
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4878695
COMMENT - competitive with respect to glucose-1-phosphate. |CITS: [4878695]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLYCOPHOSPHORYL-ENZRXN
REGULATOR - GLC
//
UNIQUE-ID - REG0-10109
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [JAmChemSoc112-4932]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIAMINOPIMEPIM-ENZRXN
REGULATOR - CPD0-1533
//
UNIQUE-ID - REG0-9195
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9851711
CITATIONS - 15995211
MODE - -
REGULATED-ENTITY - LACTALDREDUCT-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-11612
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1839607
MODE - -
REGULATED-ENTITY - ENZRXN0-1701
REGULATOR - CPD-13584
//
UNIQUE-ID - REG0-12473
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7012144]
MODE - -
REGULATED-ENTITY - ENZRXN0-8288
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-7191
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6321507]
MODE - +
REGULATED-ENTITY - CYT-D-UBIOX-ENZRXN
REGULATOR - |Phospholipids|
//
UNIQUE-ID - REG0-7796
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4870599]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ARGDECARBOXDEG-ENZRXN
REGULATOR - L-ORNITHINE
//
UNIQUE-ID - REG0-8417
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17651436
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - DCTP-DEAM-ENZRXN
REGULATOR - TTP
//
UNIQUE-ID - REG0-10074
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17470659
MODE - -
REGULATED-ENTITY - ENZRXN0-6573
REGULATOR - CPD-9231
//
UNIQUE-ID - REG0-9155
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4632320
MODE - -
REGULATED-ENTITY - DARABISOM-ENZRXN
REGULATOR - CD+2
//
UNIQUE-ID - REG0-11569
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4552992
CITATIONS - 1993184
KI - 49
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - DALADALALIGA-ENZRXN
REGULATOR - D-ALA-D-ALA
//
UNIQUE-ID - REG0-9982
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10413480
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - S-ADENMETSYN-ENZRXN
REGULATOR - CPD0-1438
//
UNIQUE-ID - REG0-12457
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8268
REGULATOR - TRIS-HYDROCHLORIDE
//
UNIQUE-ID - REG0-7161
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - ADIPATE
//
UNIQUE-ID - REG0-7760
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2178550]
MODE - -
REGULATED-ENTITY - GABATRANSAM-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-8392
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8394006
MODE - -
REGULATED-ENTITY - PPPGPPHYDRO-ENZRXN
REGULATOR - NA+
//
UNIQUE-ID - REG0-10054
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [JAmChemSoc112-4932]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIAMINOPIMEPIM-ENZRXN
REGULATOR - CPD0-1501
//
UNIQUE-ID - REG0-9120
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 378926
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - THREDEHYDCAT-ENZRXN
REGULATOR - PYRUVATE
//
UNIQUE-ID - REG0-11459
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 22344668
MODE - -
REGULATED-ENTITY - FUMARA-ENZRXN
REGULATOR - AG+
//
UNIQUE-ID - REG0-9923
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4578095
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PHES-ENZRXN
REGULATOR - CPD0-1428
//
UNIQUE-ID - REG0-12441
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8260
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7126
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12805358
MODE - -
REGULATED-ENTITY - DARAB5PISOM-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-7736
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1577828]
MODE - -
REGULATED-ENTITY - KDOTRANS2-ENZRXN
REGULATOR - KDO2-LIPID-A
//
UNIQUE-ID - REG0-8373
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3519603
MODE - -
REGULATED-ENTITY - GPPSYN-ENZRXN
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-10036
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1092682
CITATIONS - 4945185
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DAPASYN-ENZRXN
REGULATOR - 8-AMINO-7-OXONONANOATE
//
UNIQUE-ID - REG0-9083
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4362677]
MODE - -
REGULATED-ENTITY - H2NEOPTERINP3PYROPHOSPHOHYDRO-ENZRXN
REGULATOR - DIHYDRONEOPTERIN-P
//
UNIQUE-ID - REG0-11362
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 372191
MODE - +
REGULATED-ENTITY - PRPPAMIDOTRANS-ENZRXN
REGULATOR - GDP
//
UNIQUE-ID - REG0-9903
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1993184
MODE - -
REGULATED-ENTITY - DALADALALIGA-ENZRXN
REGULATOR - |Aminoalkylphosphinates|
//
UNIQUE-ID - REG0-12425
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - ENZRXN0-8174
REGULATOR - CPD0-1385
//
UNIQUE-ID - REG0-7100
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2148683]
MODE - -
REGULATED-ENTITY - GLYCEROL-KIN-ENZRXN
REGULATOR - CPD0-1054
//
UNIQUE-ID - REG0-7705
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4896737]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - RIBONUCLEOSIDE-DIP-REDUCTI-ENZRXN
REGULATOR - DATP
//
UNIQUE-ID - REG0-8348
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6117328
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ADENYLOSUCCINATE-SYNTHASE-ENZRXN
REGULATOR - GUANOSINE-5DP-3DP
//
UNIQUE-ID - REG0-10016
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4310089
MODE - +
REGULATED-ENTITY - LACTALDDEHYDROG-ENZRXN
REGULATOR - |Sulfhydryl-Groups|
//
UNIQUE-ID - REG0-8979
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - Stadtman61
MODE - +
REGULATED-ENTITY - ASPARTATEKINI-ENZRXN
REGULATOR - HOMO-SER
//
UNIQUE-ID - REG0-11331
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3553189
CITATIONS - 19088907
MODE - -
REGULATED-ENTITY - ENZRXN0-1461
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-9872
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6351843
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - CPD0-1398
//
UNIQUE-ID - REG0-12367
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16326011
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ACETOLACTSYNI-ENZRXN
REGULATOR - VAL
//
UNIQUE-ID - REG0-7080
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10486141]
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - SUCCINATE-OXN-ENZRXN
REGULATOR - MALONATE
//
UNIQUE-ID - REG0-7675
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4144085]
COMMENT - inhibits the malate
/decarboxylating activity
MODE - -
REGULATED-ENTITY - MALIC-NAD-ENZRXN
REGULATOR - OXALACETIC_ACID
//
UNIQUE-ID - REG0-8323
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [238647]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUTCYSLIG-ENZRXN
REGULATOR - GLUTATHIONE
//
UNIQUE-ID - REG-15073
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8550422
CREDITS - SRI
CREDITS - |caspi|
MECHANISM - :ALLOSTERIC
MODE - -
REGULATED-ENTITY - ENZRXN-23884
REGULATOR - GLY
//
UNIQUE-ID - REG0-8925
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8550422
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - KETOGLUTREDUCT-ENZRXN
REGULATOR - G3P
//
UNIQUE-ID - REG0-11301
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7765483
MODE - -
REGULATED-ENTITY - AMINEPHEN-ENZRXN
REGULATOR - IPRONIAZID
//
UNIQUE-ID - REG0-9846
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4365537]
MODE - -
REGULATED-ENTITY - ARGSUCCINLYA-ENZRXN
REGULATOR - |Sulfhydryl-Reagents|
//
UNIQUE-ID - REG0-12325
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19748470
MODE - -
REGULATED-ENTITY - ENZRXN0-6292
REGULATOR - CPD-2482
//
UNIQUE-ID - REG0-7060
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3530323
COMMENT - AIR versus FGAM
MODE - -
REGULATED-ENTITY - AIRS-ENZRXN
REGULATOR - 5-PHOSPHORIBOSYL-5-AMINOIMIDAZOLE
//
UNIQUE-ID - REG0-7649
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13734750
MODE - -
REGULATED-ENTITY - SUCCINYLDIAMINOPIMTRANS-ENZRXN
REGULATOR - HYDROXYLAMINE
//
UNIQUE-ID - REG0-8288
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3281659
MODE - -
REGULATED-ENTITY - ISOCITLYASE-ENZRXN
REGULATOR - CL-
//
UNIQUE-ID - REG0-8904
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4860415
CITATIONS - 14104
COMMENT - Glutamine synthetase activity is subject to cumulative feedback
/inhibition by the products of glutamine metabolism. Each of the listed compounds inhibits glutamine synthetase partially together
COMMENT - these compounds can inhibit glutamine synthetase completely. Glutamine itself is not an inhibitor.
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUTAMINESYN-ENZRXN
REGULATOR - HIS
//
UNIQUE-ID - REG0-11274
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9492273
MODE - -
REGULATED-ENTITY - MHPDHYDROL-ENZRXN
REGULATOR - OXALATE
//
UNIQUE-ID - REG0-9829
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [JAmChemSoc111-1861]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - 3-DEHYDROQUINATE-SYNTHASE-ENZRXN
REGULATOR - CPD0-1373
//
UNIQUE-ID - REG0-12288
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2892828
MODE - -
REGULATED-ENTITY - ENZRXN0-4321
REGULATOR - CPD-5541
//
UNIQUE-ID - REG0-7033
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6814484]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - CPD-6041
//
UNIQUE-ID - REG0-7623
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2549047
MODE - -
REGULATED-ENTITY - ADENYLYLSULFKIN-ENZRXN
REGULATOR - CPD0-1651
//
UNIQUE-ID - REG0-8259
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2502187
CITATIONS - 1091651
COMMENT - The enzyme requires a monovalent
/cation for activity. Rb+ will activate but less effectively than K+
/and Tl+ will replace K+ as an activator with greater affinity.  |CITS:
/[236639]|
MODE - +
REGULATED-ENTITY - TRYPTOPHAN-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-8860
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - GradyBch202497
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - 4OH2OXOGLUTARALDOL-ENZRXN
REGULATOR - GLYOX
//
UNIQUE-ID - REG0-11197
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9933617
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - ENZRXN0-7468
REGULATOR - SUPER-OXIDE
//
UNIQUE-ID - REG0-9803
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11032420
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-3802
REGULATOR - CPD0-1360
//
UNIQUE-ID - REG0-12268
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 345275
MODE - -
REGULATED-ENTITY - ENZRXN0-7970
REGULATOR - CPD-9228
//
UNIQUE-ID - REG0-7007
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4567662]
MODE - -
REGULATED-ENTITY - THI-P-KIN-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-7600
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329757
CITATIONS - 10625615
COMMENT - sensitivity to 3-phosphoglycerate is a strong function of the concentration of isocitrate dehydrogenase
MODE - +
REGULATED-ENTITY - ICITDEHDEPHOSPH-ENZRXN
REGULATOR - PYRUVATE
//
UNIQUE-ID - REG0-8240
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [238647]
MODE - -
REGULATED-ENTITY - GLUTATHIONE-SYN-ENZRXN
REGULATOR - OXIDIZED-GLUTATHIONE
//
UNIQUE-ID - REG0-8827
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10879466
COMMENT - noncompetitive with respect to Mg-ATP
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - GUANOSINEKIN-ENZRXN
REGULATOR - GDP
//
UNIQUE-ID - REG0-11022
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21467222
MODE - -
REGULATED-ENTITY - ENZRXN0-7454
REGULATOR - DITHIO-NITROBENZOATE
//
UNIQUE-ID - REG0-9779
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3301347
MODE - -
REGULATED-ENTITY - UDP-NACMURALA-GLU-LIG-ENZRXN
REGULATOR - CPD0-1331
//
UNIQUE-ID - REG0-12251
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3898066
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - cefsulodin
//
UNIQUE-ID - REG0-6968
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16866375
MODE - -
REGULATED-ENTITY - PFRUCTPHOS-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-7569
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4578095
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PHES-ENZRXN
REGULATOR - BENZYL-ALCOHOL
//
UNIQUE-ID - REG0-8207
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7588765
COMMENT - competitive with respect to PAPS |CITS: [7588765]|
KI - 4
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PAPSSULFOTRANS-ENZRXN
REGULATOR - 3-5-ADP
//
UNIQUE-ID - REG0-8811
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11825604
CITATIONS - 6324777
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - F16BDEPHOS-ENZRXN
REGULATOR - CPD-535
//
UNIQUE-ID - REG0-11002
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17567041
MODE - +
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - CO+2
//
UNIQUE-ID - REG0-9761
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [211379]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - URKI-ENZRXN
REGULATOR - CPD0-1322
//
UNIQUE-ID - REG0-12235
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7001458
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - CPD-9228
//
UNIQUE-ID - REG0-6943
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1089665
MODE - -
REGULATED-ENTITY - N-ACETYLTRANSFER-ENZRXN
REGULATOR - CPD0-1690
//
UNIQUE-ID - REG0-7546
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1646603]
CITATIONS - 6389524
MODE - -
REGULATED-ENTITY - ACNEULY-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-8177
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [SaikusaAgBioChem51-1893]
MODE - -
REGULATED-ENTITY - METHYLGLYREDUCT-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-8781
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1103739]
MODE - -
REGULATED-ENTITY - ACETOACETYL-COA-TRANSFER-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-10874
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1309518
MODE - -
REGULATED-ENTITY - ENZRXN0-7431
REGULATOR - |NaF|
//
UNIQUE-ID - REG0-9740
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2651445]
MODE - -
REGULATED-ENTITY - 3-OXOACYL-ACP-SYNTHI-ENZRXN
REGULATOR - CPD0-1242
//
UNIQUE-ID - REG0-12178
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3305505
MODE - -
REGULATED-ENTITY - ENZRXN0-7928
REGULATOR - IODOACETATE
//
UNIQUE-ID - REG0-6925
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - KDPGALDOL-ENZRXN
REGULATOR - GAP
//
UNIQUE-ID - REG0-7523
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4351434
COMMENT - with respect to
/tagaturonate |CITS: [4402917]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ALTRO-OXIDOREDUCT-ENZRXN
REGULATOR - D-MANNONATE
//
UNIQUE-ID - REG0-8155
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17069808
CITATIONS - 6319365
CITATIONS - 2567735
CITATIONS - 15502337
CITATIONS - 20970428
COMMENT - exhibits feedback inhibition |CITS: [4904678]| 
/
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUTKIN-ENZRXN
REGULATOR - PRO
//
UNIQUE-ID - REG0-8756
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 776970
MODE - +
REGULATED-ENTITY - GLUTAMINB-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-10831
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 80103
MODE - -
REGULATED-ENTITY - ENZRXN0-7396
REGULATOR - CA+2
//
UNIQUE-ID - REG0-9723
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [WallenfelsTheEnzymes7-617]
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - CPD-239
//
UNIQUE-ID - REG0-12147
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24479701
MODE - -
REGULATED-ENTITY - ENZRXN0-6222
REGULATOR - CU+2
//
UNIQUE-ID - REG0-6899
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4920894]
COMMENT - High levels of glycolytic and TCA cycle intermediates result in strong 
/inhibition of the adenylyltransferase reaction.  Pyruvate, glutarate, succinate
/and fumarate also inhibit to a lesser degree.  |CITS: [4920894]| 
MODE - -
REGULATED-ENTITY - GSADENYLATION-ENZRXN
REGULATOR - FRUCTOSE-6P
//
UNIQUE-ID - REG0-7506
TYPES - Regulation-of-Enzyme-Activity
COMMENT - mixed type inhibition with respect to both substrate and coenzyme
/|CITS: [WestwoodMicrobios9,143]|
MODE - -
REGULATED-ENTITY - 6PGLUCONDEHYDROG-ENZRXN
REGULATOR - FRUCTOSE-16-DIPHOSPHATE
//
UNIQUE-ID - REG0-8128
TYPES - Regulation-of-Enzyme-Activity
COMMENT - substrate inhibition detected at low
/concentrations, mixed product inhibition with respect to NADH and
/mixed or uncompetitive inhibition with respect to hydroxylamine
/|CITS: [6279095]|
MODE - -
REGULATED-ENTITY - NITRITREDUCT-ENZRXN
REGULATOR - NAD
//
UNIQUE-ID - REG0-8727
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [821948]
KI - 1.6    
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GTP-CYCLOHYDRO-I-ENZRXN
REGULATOR - TTP
//
UNIQUE-ID - REG0-10736
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15951572
MODE - -
REGULATED-ENTITY - ENZRXN0-6153
REGULATOR - O-PHENANTHROLINE
//
UNIQUE-ID - REG0-9706
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - CPD0-1267
//
UNIQUE-ID - REG0-12114
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7639702
MODE - -
REGULATED-ENTITY - ENZRXN0-1314
REGULATOR - 8-THIO-OCTANOATE
//
UNIQUE-ID - REG0-6879
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [40950]
MODE - -
REGULATED-ENTITY - GLYCDEH-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-7486
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4861610]
CITATIONS - [357898]
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - THYKI-ENZRXN
REGULATOR - DATP
//
UNIQUE-ID - REG0-8103
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [33657]
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ETHAMLY-ENZRXN
REGULATOR - CPD-9037
//
UNIQUE-ID - REG0-8702
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [FishMethEnz9-529]
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - F-
//
UNIQUE-ID - REG0-10649
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2271698
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - HOMOCYSMETB12-ENZRXN
REGULATOR - MET
//
UNIQUE-ID - REG0-9690
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1883399]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - CPD0-1271
//
UNIQUE-ID - REG0-12025
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11515538
MODE - +
REGULATED-ENTITY - ENZRXN0-7629
REGULATOR - MN+2
//
UNIQUE-ID - REG0-6863
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1099093]
MODE - -
REGULATED-ENTITY - FORMATEDEHYDROGN-ENZRXN
REGULATOR - OXYGEN-MOLECULE
//
UNIQUE-ID - REG0-7459
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :OTHER
MODE - -
REGULATED-ENTITY - ASPARTASE-ENZRXN
REGULATOR - CIT
//
UNIQUE-ID - REG0-8082
TYPES - Regulation-of-Enzyme-Activity
COMMENT - Competitive with respect to N-acetylornithine.  |CITS: [10684608]| 
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ACETYLORNDEACET-ENZRXN
REGULATOR - L-ORNITHINE
//
UNIQUE-ID - REG0-8676
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2269304]
COMMENT - Both potassium and phosphate ions present simultaneously
/cause the activation. 
MODE - +
REGULATED-ENTITY - UDP-NACMURALGLDAPLIG-ENZRXN
REGULATOR - K+
//
UNIQUE-ID - REG0-10620
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [46]
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - PUTRESCINE
//
UNIQUE-ID - REG0-9671
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1095054]
MODE - -
REGULATED-ENTITY - FOLYLPOLYGLUTAMATESYNTH-ENZRXN
REGULATOR - 5-METHYL-THF
//
UNIQUE-ID - REG0-11966
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 368072
MODE - +
REGULATED-ENTITY - ENZRXN0-282
REGULATOR - L-1-PHOSPHATIDYL-GLYCEROL
//
UNIQUE-ID - REG0-6842
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7896716
MODE - -
REGULATED-ENTITY - ENZRXN0-3802
REGULATOR - O-PHENANTHROLINE
//
UNIQUE-ID - REG0-7439
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - DAHPSYNPHE-ENZRXN
REGULATOR - L-ALPHA-ALANINE
//
UNIQUE-ID - REG0-8056
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [355248]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PROLDEHYDROG-ENZRXN
REGULATOR - D-LACTATE
//
UNIQUE-ID - REG0-8649
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3911944
MODE - -
REGULATED-ENTITY - ENZRXN0-2245
REGULATOR - S-FORMYCINYLHOMOCYSTEINE
//
UNIQUE-ID - REG0-10524
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9668099
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ACETYL-COA-CARBOXYLTRANSFER-ENZRXN
REGULATOR - DETHIOBIOTIN
//
UNIQUE-ID - REG0-9652
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [BlumenthalMethEnz9-665]
MODE - -
REGULATED-ENTITY - GALACTARDEHYDRA-ENZRXN
REGULATOR - DIMETHYLARSINATE
//
UNIQUE-ID - REG0-11933
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19375450
MODE - -
REGULATED-ENTITY - ENZRXN0-7818
REGULATOR - CPD-83
//
UNIQUE-ID - REG0-6818
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8144648
CITATIONS - 8262938
CITATIONS - 8041789
MODE - -
REGULATED-ENTITY - ENZRXN0-253
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7413
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [14216423]
MODE - -
REGULATED-ENTITY - PHOSPHOGLUCMUT-ENZRXN
REGULATOR - CPD-29
//
UNIQUE-ID - REG0-8016
TYPES - Regulation-of-Enzyme-Activity
COMMENT - inhibits both the
/pterin-dependent and pterin-independent reactions; competitive with
/respect to quinoid 6-methyl-7,8-dihydro-(6H)-pterin  |CITS:
/[3060113]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIHYDROPTERIREDUCT-ENZRXN
REGULATOR - CPD-6041
//
UNIQUE-ID - REG0-8615
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1712632
MODE - -
REGULATED-ENTITY - ALAS-ENZRXN
REGULATOR - O-PHENANTHROLINE
//
UNIQUE-ID - REG0-10407
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1325457]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - PFLDEACTIV-ENZRXN
REGULATOR - CPD0-1889
//
UNIQUE-ID - REG0-9630
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18344567
MODE - -
REGULATED-ENTITY - ENZRXN0-6535
REGULATOR - CPD0-1230
//
UNIQUE-ID - REG0-11913
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24214977
KI - 51
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7813
REGULATOR - CPD-15916
//
UNIQUE-ID - REG0-6782
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [4899016]
COMMENT - In high concentrations
MODE - -
REGULATED-ENTITY - DTMPKI-ENZRXN
REGULATOR - DCTP
//
UNIQUE-ID - REG0-7392
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10683258
COMMENT - K<SUP>+</SUP> is the most effective activator,
/followed by Rb<SUP>+</SUP> and NH<SUB>4</SUB><SUP>+</SUP>.
/Cs<SUP>+</SUP> is the least effective activator. 
/ |CITS: [10683258]| 
MODE - +
REGULATED-ENTITY - IMP-DEHYDROG-ENZRXN
REGULATOR - RB+
//
UNIQUE-ID - REG0-7982
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6990987]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN-17895
REGULATOR - METHYL-ACETYLPHOSPHONATE
//
UNIQUE-ID - REG0-8581
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - HG+2
//
UNIQUE-ID - REG0-10336
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - DIACYLGLYKIN-ENZRXN
REGULATOR - CPD0-1760
//
UNIQUE-ID - REG0-9594
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14730018
MODE - -
REGULATED-ENTITY - ENZRXN0-6364
REGULATOR - |RNA-Containing-5-Fluorouridines|
//
UNIQUE-ID - REG0-11841
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2542328
CITATIONS - 9125530
MECHANISM - :UNCOMPETITIVE
MODE - -
REGULATED-ENTITY - PRPPSYN-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-6746
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14245396
MODE - -
REGULATED-ENTITY - CYCPHOSDIESTER-ENZRXN
REGULATOR - CPD-7082
//
UNIQUE-ID - REG0-7374
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4358555]
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - CARBPSYN-ENZRXN
REGULATOR - UMP
//
UNIQUE-ID - REG0-7953
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 334529
CITATIONS - 348236
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CHORISMATEMUT2-ENZRXN
REGULATOR - PREPHENATE
//
UNIQUE-ID - REG0-8542
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4862197
COMMENT - for the
/uridine synthesis reaction |CITS: [6357095]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - URPHOS-ENZRXN
REGULATOR - URIDINE
//
UNIQUE-ID - REG0-10251
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16567800
MODE - -
REGULATED-ENTITY - ENZRXN0-6199
REGULATOR - CU+2
//
UNIQUE-ID - REG0-9534
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16682444
MODE - -
REGULATED-ENTITY - ENZRXN0-6576
REGULATOR - CA+2
//
UNIQUE-ID - REG0-11805
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18422345
MODE - -
REGULATED-ENTITY - UDPHYDROXYMYRGLUCOSAMNACETYLTRANS-ENZRXN
REGULATOR - MG+2
//
UNIQUE-ID - REG0-6727
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4895362
COMMENT - with respect to ATP
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ASNSYNA-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-7355
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8530465]
COMMENT - competitive with respect to NADPH when
/NADPH concentration was varied and riboflavin concentration was
/fixed
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - FMNREDUCT-ENZRXN
REGULATOR - NADP
//
UNIQUE-ID - REG0-7907
TYPES - Regulation-of-Enzyme-Activity
COMMENT - competitive inhibition with respect to (+)CH2H4folate |CITS:
/[42538]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - THYMIDYLATESYN-ENZRXN
REGULATOR - stereoisomer (-)CH2H4folate
//
UNIQUE-ID - REG0-8523
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1323028]
MODE - -
REGULATED-ENTITY - DIACYLGLYKIN-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-10226
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19073594
CITATIONS - 10986273
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-402
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-9488
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16390452
MODE - -
REGULATED-ENTITY - ENZRXN0-1201
REGULATOR - CPLX0-1242
//
UNIQUE-ID - REG0-11781
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2950851
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - 3-DEHYDROQUINATE-DEHYDRATASE-ENZRXN
REGULATOR - SUC
//
UNIQUE-ID - REG0-6706
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5543331]
MODE - -
REGULATED-ENTITY - ALPHAGALACTOSID-ENZRXN
REGULATOR - NI+2
//
UNIQUE-ID - REG0-7304
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8798731]
COMMENT - Pyrophosphate is a strong inhibitor.
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-442
REGULATOR - PPI
//
UNIQUE-ID - REG0-6703
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [5543331]
MODE - -
REGULATED-ENTITY - ALPHAGALACTOSID-ENZRXN
REGULATOR - CPD-1490
//
UNIQUE-ID - REG0-7292
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15901686
MODE - -
REGULATED-ENTITY - ENZRXN0-5901
REGULATOR - ADP
//
UNIQUE-ID - REG0-7874
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13794771
MODE - -
REGULATED-ENTITY - GLUCUROISOM-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-8498
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [342518]
MODE - +
REGULATED-ENTITY - L-LACTDEHYDROGFMN-ENZRXN
REGULATOR - |Phospholipids|
//
UNIQUE-ID - REG0-10192
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2194570
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - BADH-ENZRXN
REGULATOR - CPD-5602
//
UNIQUE-ID - REG0-9417
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6311616]
CITATIONS - [1548697]
MODE - -
REGULATED-ENTITY - ADENYL-KIN-ENZRXN
REGULATOR - CPD0-1137
//
UNIQUE-ID - REG0-11762
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3280015
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7757
REGULATOR - CPD-4584
//
UNIQUE-ID - REG0-6675
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6300054
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ADENYLATECYC-ENZRXN
REGULATOR - GTP
//
UNIQUE-ID - REG0-7271
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7040354
MECHANISM - :ALLOSTERIC
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PEPCARBOX-ENZRXN
REGULATOR - MAL
//
UNIQUE-ID - REG0-7852
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1899181]
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - 3-P-SHIK-1-CARBOXYVINYLXFERASE-ENZRXN
REGULATOR - 3-BROMOPYRUVATE
//
UNIQUE-ID - REG0-8475
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6378898]
COMMENT - slightly
/competitive inhibitor
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - TRANSENOYLCOARED-ENZRXN
REGULATOR - NADP
//
UNIQUE-ID - REG0-10153
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [2495789]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIHYDROFOLATEREDUCT-ENZRXN
REGULATOR - CPD0-1588
//
UNIQUE-ID - REG0-9313
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8424649
MODE - NIL
REGULATED-ENTITY - PORPHOBILSYNTH-ENZRXN
REGULATOR - O-PHENANTHROLINE
//
UNIQUE-ID - REG0-11704
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9022698
MODE - -
REGULATED-ENTITY - ENZRXN0-7438
REGULATOR - PALMITYL-COA
//
UNIQUE-ID - REG0-6652
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10486141
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - FUMARATE-REDN-ENZRXN
REGULATOR - CPD-7975
//
UNIQUE-ID - REG0-7234
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [357906]
MODE - -
REGULATED-ENTITY - ADENPRIBOSYLTRAN-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7831
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 13794771
MODE - -
REGULATED-ENTITY - GALACTUROISOM-ENZRXN
REGULATOR - 2-MERCAPTOETHANOL
//
UNIQUE-ID - REG0-10129
TYPES - Regulation-of-Enzyme-Activity
MODE - -
REGULATED-ENTITY - DAHPSYNPHE-ENZRXN
REGULATOR - CPD0-1558
//
UNIQUE-ID - REG0-9214
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3275622
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - LACTALDDEHYDROG-ENZRXN
REGULATOR - NADH
//
UNIQUE-ID - REG0-11675
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8993314
CITATIONS - 9048556
KI - 300
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIHYDRODIPICSYN-ENZRXN
REGULATOR - SUCC-S-ALD
//
UNIQUE-ID - REG0-6629
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6756470
MODE - +
REGULATED-ENTITY - ENZRXN0-6313
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7217
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7026564]
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - GLYCEROL-3-P-ACYLTRANSFER-ENZRXN
REGULATOR - CO-A
//
UNIQUE-ID - REG0-7815
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1906883
CITATIONS - 2211698
COMMENT - competitive with respect to formate
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-4521
REGULATOR - NITRATE
//
UNIQUE-ID - REG0-8437
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4942326
MODE - -
REGULATED-ENTITY - 2PGADEHYDRAT-ENZRXN
REGULATOR - F-
//
UNIQUE-ID - REG0-10106
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3540965
MODE - -
REGULATED-ENTITY - THREDEHYDCAT-ENZRXN
REGULATOR - |2-Oxo-Acids|
//
UNIQUE-ID - REG0-9192
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10504245]
MODE - -
REGULATED-ENTITY - NITRATREDUCTA-ENZRXN
REGULATOR - CPD0-1686
//
UNIQUE-ID - REG0-11609
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7929223
MODE - -
REGULATED-ENTITY - ENZRXN0-4861
REGULATOR - DIETHYLDITHIOCARBAMATE
//
UNIQUE-ID - REG0-12470
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - -
REGULATED-ENTITY - ENZRXN0-8287
REGULATOR - TRIS
//
UNIQUE-ID - REG0-7188
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
CITATIONS - [2856144]
CITATIONS - [6321507]
MODE - -
REGULATED-ENTITY - CYT-D-UBIOX-ENZRXN
REGULATOR - CPD0-1233
//
UNIQUE-ID - REG0-7793
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4870599]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ARGDECARBOXDEG-ENZRXN
REGULATOR - |Ureido-Compounds|
//
UNIQUE-ID - REG0-8414
TYPES - Regulation-of-Enzyme-Activity
COMMENT - competitive with
/respect to AMP  |CITS: [7000783]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - AMP-NUCLEOSID-ENZRXN
REGULATOR - CPD0-1635
//
UNIQUE-ID - REG0-10069
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4899016]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DTMPKI-ENZRXN
REGULATOR - CPD0-1508
//
UNIQUE-ID - REG0-9149
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8132479
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - ENZRXN0-6437
REGULATOR - DIISOPROPYL-FLUOROPHOSPHATE
//
UNIQUE-ID - REG0-11562
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 22343352
MODE - -
REGULATED-ENTITY - PYRUVATEDEH-ENZRXN
REGULATOR - NADH
//
UNIQUE-ID - REG0-9977
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6251075]
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - S-ADENMETSYN-ENZRXN
REGULATOR - PPI
//
UNIQUE-ID - REG0-12454
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368024]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8267
REGULATOR - TRIS-HYDROCHLORIDE
//
UNIQUE-ID - REG0-7157
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - MALONATE
//
UNIQUE-ID - REG0-7757
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2178550]
MODE - -
REGULATED-ENTITY - GABATRANSAM-ENZRXN
REGULATOR - HYDROXYLAMINE
//
UNIQUE-ID - REG0-8388
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4365537
MODE - -
REGULATED-ENTITY - N-ACETYLGLUTPREDUCT-ENZRXN
REGULATOR - FE+2
//
UNIQUE-ID - REG0-10051
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3042781]
KI - 5.6    
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIAMINOPIMEPIM-ENZRXN
REGULATOR - CPD0-1499
//
UNIQUE-ID - REG0-9117
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4889010
MECHANISM - :ALLOSTERIC
MODE - +
REGULATED-ENTITY - THREDEHYDCAT-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-11449
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 340460
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6416
REGULATOR - G3P
//
UNIQUE-ID - REG0-9919
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6150934
CITATIONS - 7907888
MODE - -
REGULATED-ENTITY - THRESYN-ENZRXN
REGULATOR - 4-PHOSPHONOOXY-THREONINE
//
UNIQUE-ID - REG0-12438
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6350283]
MODE - NIL
REGULATED-ENTITY - ENZRXN0-8259
REGULATOR - IODOACETAMIDE
//
UNIQUE-ID - REG0-7119
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - femsletbusch29-231-85
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - 1PFRUCTPHOSPHN-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-7728
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4893578]
MODE - +
REGULATED-ENTITY - GSDEADENYLATION-ENZRXN
REGULATOR - ARSENATE
//
UNIQUE-ID - REG0-8370
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [189701]
MODE - -
REGULATED-ENTITY - GMP-SYN-GLUT-ENZRXN
REGULATOR - 3-BROMOPYRUVATE
//
UNIQUE-ID - REG0-10033
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1092682
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - DAPASYN-ENZRXN
REGULATOR - CPD0-1482
//
UNIQUE-ID - REG0-9061
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 781521
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ENZRXN0-6423
REGULATOR - AMP
//
UNIQUE-ID - REG0-11359
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 372191
MODE - -
REGULATED-ENTITY - PRPPAMIDOTRANS-ENZRXN
REGULATOR - CPD-7388
//
UNIQUE-ID - REG0-9900
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [692401]
MODE - -
REGULATED-ENTITY - HYPOXANPRIBOSYLTRAN-ENZRXN
REGULATOR - |6-Hydroxy-Purine-Nucleotides|
//
UNIQUE-ID - REG0-12398
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7512955
MODE - -
REGULATED-ENTITY - ENZRXN0-8135
REGULATOR - HG+2
//
UNIQUE-ID - REG0-7095
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
COMMENT - Competitive inhibitor at high concentrations of MgATP. ADP is noncompetitive
/with respect to glycerol at limiting MgATP concentration.  |CITS: [4575199]| 
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLYCEROL-KIN-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-7698
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329757
CITATIONS - 10625615
MODE - -
REGULATED-ENTITY - ICITDEHKINASE-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-8345
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6463
COMMENT - inhibited the forward reaction
/|CITS: [6463]|
MODE - -
REGULATED-ENTITY - 3-METHYL-2-OXOBUT-OHCH3XFER-ENZRXN
REGULATOR - FORMALDEHYDE
//
UNIQUE-ID - REG0-10013
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 5328735
MODE - -
REGULATED-ENTITY - GLYOCARBOLIG-ENZRXN
REGULATOR - PHMB
//
UNIQUE-ID - REG0-8976
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 236185
MODE - -
REGULATED-ENTITY - HOMOSERDEHYDROGI-ENZRXN
REGULATOR - CPD0-1224
//
UNIQUE-ID - REG0-11316
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 22089136
MODE - +
REGULATED-ENTITY - ENZRXN0-7496
REGULATOR - S2O4
//
UNIQUE-ID - REG0-9866
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2407066
CITATIONS - 3307907
MODE - -
REGULATED-ENTITY - RIBONUCLEOSIDE-DIP-REDUCTI-ENZRXN
REGULATOR - CPD0-1393
//
UNIQUE-ID - REG0-12353
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16791965
MODE - -
REGULATED-ENTITY - SORB6PDEHYDROG-ENZRXN
REGULATOR - CPD-18734
//
UNIQUE-ID - REG0-7075
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16557306
MODE - -
REGULATED-ENTITY - 7KAPSYN-ENZRXN
REGULATOR - CPD0-1636
//
UNIQUE-ID - REG0-7672
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17215140
MECHANISM - :UNCOMPETITIVE
MODE - -
REGULATED-ENTITY - MALIC-NAD-ENZRXN
REGULATOR - NAD
//
UNIQUE-ID - REG0-8315
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7024555]
MODE - +
REGULATED-ENTITY - BIOTINLIG-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG-14949
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4337557]
CREDITS - SRI
CREDITS - |caspi|
MODE - -
REGULATED-ENTITY - ENZRXN-23156
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-8922
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8550422
COMMENT - inhibits the reverse, dehydrogenase activity |CITS: [8550422]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - KETOGLUTREDUCT-ENZRXN
REGULATOR - 3-P-HYDROXYPYRUVATE
//
UNIQUE-ID - REG0-11298
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7765483
MODE - -
REGULATED-ENTITY - AMINEPHEN-ENZRXN
REGULATOR - HYDROXYLAMINE
//
UNIQUE-ID - REG0-9843
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4365537]
MODE - -
REGULATED-ENTITY - ORNCARBAMTRANSFERF-ENZRXN
REGULATOR - |Sulfhydryl-Reagents|
//
UNIQUE-ID - REG0-12310
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - CHEN09WORDJMICRO
CITATIONS - 8226676
MODE - +
REGULATED-ENTITY - ENZRXN0-4502
REGULATOR - MG+2
//
UNIQUE-ID - REG0-7057
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3530323
COMMENT - versus ATP
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - AIRS-ENZRXN
REGULATOR - ADP
//
UNIQUE-ID - REG0-7646
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [10026271]
MODE - -
REGULATED-ENTITY - UDPACYLGLCNACDEACETYL-ENZRXN
REGULATOR - CPD-4841
//
UNIQUE-ID - REG0-8285
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3291954
COMMENT - An uncompetitive inhibitor with respect to isocitrate.
MECHANISM - :UNCOMPETITIVE
MODE - -
REGULATED-ENTITY - ISOCITLYASE-ENZRXN
REGULATOR - ITACONATE
//
UNIQUE-ID - REG0-8901
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4860415
CITATIONS - 14104
COMMENT - Glutamine synthetase activity is subject to cumulative feedback
/inhibition by the products of glutamine metabolism. Each of the listed compounds inhibits glutamine synthetase partially together
COMMENT - these compounds can inhibit glutamine synthetase completely. Glutamine itself is not an inhibitor.
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - GLUTAMINESYN-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-11263
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4595199
KI - 2600
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ASPARAGHYDA-ENZRXN
REGULATOR - CPD0-1541
//
UNIQUE-ID - REG0-9826
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [JAmChemSoc111-1861]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - 3-DEHYDROQUINATE-SYNTHASE-ENZRXN
REGULATOR - 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-P
//
UNIQUE-ID - REG0-12285
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12198182
MODE - +
REGULATED-ENTITY - ENZRXN0-6402
REGULATOR - PAMIDRONATE
//
UNIQUE-ID - REG0-7024
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [692401]
MODE - -
REGULATED-ENTITY - HYPOXANPRIBOSYLTRAN-ENZRXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-7620
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2549047
COMMENT - in the forward direction,
/competitve with ATP
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ADENYLYLSULFKIN-ENZRXN
REGULATOR - APS
//
UNIQUE-ID - REG0-8255
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14617668
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-3061
REGULATOR - CPD-6041
//
UNIQUE-ID - REG0-8846
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [21941]
MODE - -
REGULATED-ENTITY - ACS-ENZRXN
REGULATOR - EDTA
//
UNIQUE-ID - REG0-11192
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21627110
KI - 1.5    
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - NAPHTHOATE-SYN-ENZRXN
REGULATOR - CPD-9925
//
UNIQUE-ID - REG0-9800
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12643918
MODE - -
REGULATED-ENTITY - ILES-ENZRXN
REGULATOR - CPD0-1357
//
UNIQUE-ID - REG0-12265
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11731300
MODE - -
REGULATED-ENTITY - ENZRXN0-7969
REGULATOR - DCB-PV
//
UNIQUE-ID - REG0-7004
TYPES - Regulation-of-Enzyme-Activity
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - THI-P-KIN-ENZRXN
REGULATOR - AMP
//
UNIQUE-ID - REG0-7585
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4941574
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-4921
REGULATOR - NA+
//
UNIQUE-ID - REG0-8237
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 3042775
MODE - -
REGULATED-ENTITY - GLUTATHIONE-SYN-ENZRXN
REGULATOR - DITHIO-NITROBENZOATE
//
UNIQUE-ID - REG0-8824
TYPES - Regulation-of-Enzyme-Activity
COMMENT - Competitive with
/respect to erythrose 4-phosphate, however this inhibition may not be
/physiologically significant due to normal low intracellular
/concentration.  |CITS: [7751290]|
MODE - -
REGULATED-ENTITY - ERYTH4PDEHYDROG-ENZRXN
REGULATOR - PYRIDOXAL_PHOSPHATE
//
UNIQUE-ID - REG0-11019
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21467222
MODE - -
REGULATED-ENTITY - ENZRXN0-7454
REGULATOR - CU+2
//
UNIQUE-ID - REG0-9776
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7601127]
MODE - -
REGULATED-ENTITY - UDP-NACMUR-ALA-LIG-ENZRXN
REGULATOR - CHLORALAN-CPD
//
UNIQUE-ID - REG0-12248
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14693515
MODE - -
REGULATED-ENTITY - ENZRXN0-7968
REGULATOR - meropenem
//
UNIQUE-ID - REG0-6965
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1637823
COMMENT - inhibits the pabA/pabB
/complex's glutaminase activity  |CITS: [1637823]|
MODE - -
REGULATED-ENTITY - PABASYN-ENZRXN
REGULATOR - CPD0-1627
//
UNIQUE-ID - REG0-7561
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4581499
CITATIONS - 3038546
MODE - +
REGULATED-ENTITY - MANNONDEHYDRAT-ENZRXN
REGULATOR - FE+2
//
UNIQUE-ID - REG0-8200
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - BETAGALACTOSID-ENZRXN
REGULATOR - 5-AMINO-5-DEOXY-D-GALACTOPYRANOSIDE
//
UNIQUE-ID - REG0-8807
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6767707
MODE - -
REGULATED-ENTITY - ENZRXN0-4281
REGULATOR - CPD-2482
//
UNIQUE-ID - REG0-10999
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17567041
MODE - +
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - FE+3
//
UNIQUE-ID - REG0-9758
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [211379]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYTIDINEKIN-ENZRXN
REGULATOR - CPD0-1319
//
UNIQUE-ID - REG0-12216
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 19073594
MODE - +
REGULATED-ENTITY - ENZRXN0-6614
REGULATOR - DITHIOTHREITOL
//
UNIQUE-ID - REG0-6940
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11945670
COMMENT - Phosphoenolpyruvate and 3-phosphoglycerate were potent inhibitors of 
/the enzyme.   Arsenate was a less effective inhibitor. |CITS: [4563643]|
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - METHGLYSYN-ENZRXN
REGULATOR - PHOSPHO-ENOL-PYRUVATE
//
UNIQUE-ID - REG0-7542
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1646603]
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ACNEULY-ENZRXN
REGULATOR - DIHYDROXYACETONE
//
UNIQUE-ID - REG0-8171
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4404056
MODE - -
REGULATED-ENTITY - PHEAMINOTRANS-ENZRXN
REGULATOR - TYR
//
UNIQUE-ID - REG0-8777
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [368795]
MODE - +
REGULATED-ENTITY - ORNDECARBOX-BIO-ENZRXN
REGULATOR - anti-antizyme
//
UNIQUE-ID - REG0-10871
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11368768
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - HOMOSERKIN-ENZRXN
REGULATOR - LYS
//
UNIQUE-ID - REG0-9737
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2832401
MODE - -
REGULATED-ENTITY - 3-HYDROXYDECANOYL-ACP-DEHYDR-ENZRXN
REGULATOR - CPD0-1306
//
UNIQUE-ID - REG0-12174
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 25670698
MODE - -
REGULATED-ENTITY - ENZRXN0-7926
REGULATOR - CU+2
//
UNIQUE-ID - REG0-6922
TYPES - Regulation-of-Enzyme-Activity
COMMENT - Competitive with respect to isocitrate, uncompetitive against NADP. This 
/inhibition is not considered physiologically significant.  |CITS: [3521584]| 
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ISOCITDEH-ENZRXN
REGULATOR - OXALACETIC_ACID
//
UNIQUE-ID - REG0-7520
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6780553]
CITATIONS - [3518793]
MODE - -
REGULATED-ENTITY - THREODEHYD-ENZRXN
REGULATOR - NI+2
//
UNIQUE-ID - REG0-8152
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [8077207]
KI - 645
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SPERMACTRAN-ENZRXN
REGULATOR - CPD0-1684
//
UNIQUE-ID - REG0-8749
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [776970]
MODE - -
REGULATED-ENTITY - GLUTAMINB-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-10781
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10074342
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIHYDROOROTOX-ENZRXN
REGULATOR - OROTATE
//
UNIQUE-ID - REG0-9719
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
CITATIONS - [HandEnzInh]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - GLUTARATE
//
UNIQUE-ID - REG0-12144
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24479701
MODE - -
REGULATED-ENTITY - ENZRXN0-6222
REGULATOR - CO+2
//
UNIQUE-ID - REG0-6896
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [MethEnz17A-922]
CITATIONS - [HandEnzInh]
COMMENT - High levels of glycolytic and TCA cycle intermediates result in strong 
/inhibition of the adenylyltransferase reaction.  Pyruvate, glutarate, succinate
/and fumarate also inhibit to a lesser degree.  |CITS: [4920894]| 
MODE - -
REGULATED-ENTITY - GSADENYLATION-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-7503
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - WestwoodMicrobios9143
MODE - -
REGULATED-ENTITY - 6PGLUCONDEHYDROG-ENZRXN
REGULATOR - |Heavy-Metal-Ions|
//
UNIQUE-ID - REG0-8125
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [217342]
MODE - -
REGULATED-ENTITY - NITRITREDUCT-ENZRXN
REGULATOR - CPD-763
//
UNIQUE-ID - REG0-8723
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - BernsteinJBC240391
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DTDPGLUCOSEPP-ENZRXN
REGULATOR - UDP-GLUCOSE
//
UNIQUE-ID - REG0-10717
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17567041
MODE - -
REGULATED-ENTITY - SAMDECARB-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-9703
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [1577828]
MODE - -
REGULATED-ENTITY - KDOTRANS2-ENZRXN
REGULATOR - CPD0-1284
//
UNIQUE-ID - REG0-12108
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10922365
CITATIONS - 25193663
MODE - -
REGULATED-ENTITY - ENZRXN-802
REGULATOR - CARBON-MONOXIDE
//
UNIQUE-ID - REG0-6876
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9733680]
MODE - -
REGULATED-ENTITY - GLUCOSAMINE1PACETYL-ENZRXN
REGULATOR - N-ETHYLMALEIMIDE
//
UNIQUE-ID - REG0-7483
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 11278255
COMMENT - At high concentrations 4'-phosphopantothenate exhibits substrate inhibition.  |CITS: [11278255]| 
MODE - -
REGULATED-ENTITY - P-PANTOCYSLIG-ENZRXN
REGULATOR - 4-P-PANTOTHENATE
//
UNIQUE-ID - REG0-8096
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9257704]
MODE - +
REGULATED-ENTITY - GDPMANDEHYDRA-ENZRXN
REGULATOR - MG+2
//
UNIQUE-ID - REG0-8699
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [FishMethEnz9-529]
MODE - -
REGULATED-ENTITY - KDGALDOL-ENZRXN
REGULATOR - HCN
//
UNIQUE-ID - REG0-10641
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2559948
MODE - +
REGULATED-ENTITY - INOSINEKIN-ENZRXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-9687
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXA-ENZRXN
REGULATOR - TEREPHTHALATE
//
UNIQUE-ID - REG0-12012
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3516689]
MODE - -
REGULATED-ENTITY - FORMHYDROGI-ENZRXN
REGULATOR - CARBON-MONOXIDE
//
UNIQUE-ID - REG0-6860
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 348198
MODE - +
REGULATED-ENTITY - F16ALDOLASE-ENZRXN-CLASSI
REGULATOR - CIT
//
UNIQUE-ID - REG0-7456
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2853974]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ASPARTASE-ENZRXN
REGULATOR - CPD-660
//
UNIQUE-ID - REG0-8075
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 8226944
COMMENT - In excess Cu<SUP>2+</SUP> inhibits the enzyme.  |CITS: [8226944]| 
KI - 1.8    
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - CYTDEAM-ENZRXN
REGULATOR - CU+2
//
UNIQUE-ID - REG0-8670
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3905407]
MODE - -
REGULATED-ENTITY - UDP-NACMURALGLDAPLIG-ENZRXN
REGULATOR - UDP-N-ACETYLMURAMATE
//
UNIQUE-ID - REG0-10617
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7798192
MECHANISM - :ALLOSTERIC
MODE - -
REGULATED-ENTITY - ENZRXN0-6321
REGULATOR - CPD0-1614
//
UNIQUE-ID - REG0-9668
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6768963]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - DIHYDROFOLATESYNTH-ENZRXN
REGULATOR - CPD0-1251
//
UNIQUE-ID - REG0-11963
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 368072
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-282
REGULATOR - ATP
//
UNIQUE-ID - REG0-6836
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16300729
MODE - -
REGULATED-ENTITY - ENZRXN0-3801
REGULATOR - N-QUINOLIN-8-YLMETHANESULFONAMI
//
UNIQUE-ID - REG0-7429
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2045363]
MODE - -
REGULATED-ENTITY - GSAAMINOTRANS-ENZRXN
REGULATOR - CARBOXYMETHOXYLAMINE
//
UNIQUE-ID - REG0-8051
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 14343156
MODE - -
REGULATED-ENTITY - DIAMINOPIMDECARB-ENZRXN
REGULATOR - LYS
//
UNIQUE-ID - REG0-8646
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 782530
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-2245
REGULATOR - 5-ETHYLTHIOADENOSINE
//
UNIQUE-ID - REG0-10521
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2895925
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - GLUTCYSLIG-ENZRXN
REGULATOR - BUTHIONINE-SULFOXIMINE
//
UNIQUE-ID - REG0-9647
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [3157043]
MODE - -
REGULATED-ENTITY - ORNDECARBOX-BIO-ENZRXN
REGULATOR - CPD0-1240
//
UNIQUE-ID - REG0-11930
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2141983
MODE - -
REGULATED-ENTITY - ENZRXN0-7818
REGULATOR - CPD-10322
//
UNIQUE-ID - REG0-6809
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6337136
CITATIONS - 21602303
KI - 6
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-6184
REGULATOR - ADENOSYL-HOMO-CYS
//
UNIQUE-ID - REG0-7410
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4568817
CITATIONS - 4563765
MECHANISM - :NONCOMPETITIVE
MODE - -
REGULATED-ENTITY - PHOSPHOGLUCMUT-ENZRXN
REGULATOR - ACETYL-COA
//
UNIQUE-ID - REG0-8013
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [9011040]
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - APHA-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-8612
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 4150390
COMMENT - competitively inhibited all
/NADPH-dependent activites  |CITS: [4150390]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - SULFITE-REDUCT-ENZRXN
REGULATOR - NADP
//
UNIQUE-ID - REG0-10398
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17049867
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLURS-ENZRXN
REGULATOR - CPD0-1884
//
UNIQUE-ID - REG0-9627
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 9387
MODE - -
REGULATED-ENTITY - DAHPSYNTYR-ENZRXN
REGULATOR - 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-P
//
UNIQUE-ID - REG0-11910
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 24214977
KI - 44
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ENZRXN0-7811
REGULATOR - CPD0-1143
//
UNIQUE-ID - REG0-6779
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [HandEnzInh]
MODE - -
REGULATED-ENTITY - DTMPKI-ENZRXN
REGULATOR - NA+
//
UNIQUE-ID - REG0-7387
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 44191
COMMENT - with respect to IMP  |CITS:
/[44191] [2860637]|
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - IMP-DEHYDROG-ENZRXN
REGULATOR - GMP
//
UNIQUE-ID - REG0-7979
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [7042705]
MECHANISM - :IRREVERSIBLE
MODE - -
REGULATED-ENTITY - ENZRXN-17895
REGULATOR - METHYLMETHANETHIOSULFONATE
//
UNIQUE-ID - REG0-8575
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4552052]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - GLUTDECARBOXB-ENZRXN
REGULATOR - OXALATE
//
UNIQUE-ID - REG0-10281
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 6329757
CITATIONS - 10625615
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ICITDEHKINASE-ENZRXN
REGULATOR - NADPH
//
UNIQUE-ID - REG0-9579
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 12813065
MODE - -
REGULATED-ENTITY - ENZRXN0-4782
REGULATOR - CPD-9227
//
UNIQUE-ID - REG0-11837
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 15489502
MODE - -
REGULATED-ENTITY - ENZRXN0-5221
REGULATOR - DATP
//
UNIQUE-ID - REG0-6742
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 7612655
MODE - -
REGULATED-ENTITY - CITSYN-ENZRXN
REGULATOR - PROPIONYL-COA
//
UNIQUE-ID - REG0-7371
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [2010919]
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ALKAPHOSPHA-ENZRXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-7933
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4364023]
CITATIONS - [177283]
COMMENT - linearly competitive with
/respect to homoserine, non-competitive with respect to ATP
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - HOMOSERKIN-ENZRXN
REGULATOR - HOMO-CYS
//
UNIQUE-ID - REG0-8539
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [ColiSalII]
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - CHER-ENZRXN
REGULATOR - ADENOSYL-HOMO-CYS
//
UNIQUE-ID - REG0-10247
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 16567800
MODE - -
REGULATED-ENTITY - ENZRXN0-6198
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-9520
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 17873050
MECHANISM - :COMPETITIVE
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PANTEPADENYLYLTRAN-ENZRXN
REGULATOR - CO-A
//
UNIQUE-ID - REG0-11801
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 18656959
MODE - -
REGULATED-ENTITY - LAUROYLACYLTRAN-ENZRXN
REGULATOR - LAUROYLCOA-CPD
//
UNIQUE-ID - REG0-6720
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [6365902]
CITATIONS - 359547
MODE - -
REGULATED-ENTITY - AMINOPROPDEHYDROG-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-7345
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 80103
MODE - -
REGULATED-ENTITY - ENZRXN0-4901
REGULATOR - CA+2
//
UNIQUE-ID - REG0-7904
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - [4550803]
MODE - +
REGULATED-ENTITY - THIKIN-ENZRXN
REGULATOR - AMMONIUM
//
UNIQUE-ID - REG0-8518
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 10572007
CITATIONS - 6988389
COMMENT - PEP protects the enzyme from inactivation by DEPC and
/D-arabinose 5-phosphate partially protects it.  |CITS: [10572007]| 
MODE - -
REGULATED-ENTITY - KDO-8PSYNTH-ENZRXN
REGULATOR - DIETHYLPYROCARBONATE
//
UNIQUE-ID - REG0-10216
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 1460049
MODE - -
REGULATED-ENTITY - RIBONUCLEOSIDE-TRIP-REDUCT-ENZRXN
REGULATOR - CO+2
//
UNIQUE-ID - REG0-9458
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 2896604
MECHANISM - :COMPETITIVE
MODE - -
REGULATED-ENTITY - ACNEULY-ENZRXN
REGULATOR - CPD0-1144
//
UNIQUE-ID - REG0-11775
TYPES - Regulation-of-Enzyme-Activity
CITATIONS - 21545646
MODE - -
REGULATED-ENTITY - UDHA-ENZRXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-10790
TYPES - Regulation-of-Translation
ASSOCIATED-BINDING-SITE - RBS0-80
CITATIONS - 19933154
CITATIONS - 19933154:EV-EXP-IDA:3489774624:keseler
COMMENT - Expression of <i>alx</i> is controlled by a novel pH-responsive riboregulator.  The <i>alx</i> 5' UTR can form alternative secondary structures depending on the pH; under extreme alkaline conditions, the secondary structure that forms during transcription leaves the ribosome binding site and start codon accessible to the ribosome, thus enabling translation.  The formation of this secondary structure is kinetically controlled by RNA polymerase pausing |CITS: [19933154]|.  pH is here indicated by a proton, |FRAME: PROTON|.
/
MECHANISM - :TRANSLATION-BLOCKING
REGULATED-ENTITY - TU0-13859
REGULATOR - PROTON
//
UNIQUE-ID - REG0-12199
TYPES - Regulation-of-Translation
CITATIONS - 25898225
CITATIONS - 25898225:EV-EXP-IEP:3639926918:keseler
MODE - +
REGULATED-ENTITY - TU0-13714
REGULATOR - PUTRESCINE
//
UNIQUE-ID - REG0-12200
TYPES - Regulation-of-Translation
CITATIONS - 25898225
CITATIONS - 25898225:EV-EXP-IEP:3639927399:keseler
MODE - +
REGULATED-ENTITY - TU00456
REGULATOR - PUTRESCINE
//
UNIQUE-ID - REG0-10653
TYPES - Regulation-of-Translation
ASSOCIATED-BINDING-SITE - RBS0-70
CITATIONS - 20129052:EV-EXP-IDA:3477086765:keseler
CITATIONS - 20129052:EV-EXP-IMP-SITE-MUTATION:3477086765:keseler
COMMENT - The <i>cspA</i> mRNA undergoes a temperature-dependent structural rearrangement which determines the accessibility of the ribosome binding site.  At optimal growth temperatures (37&deg;C), the mRNA forms a secondary structure that occludes the ribosome binding site.  At lower growth temperatures, an entirely different secondary structure forms, resulting in more efficient translation of the <i>cspA</i> ORF |CITS: [20129052]|.
MECHANISM - :TRANSLATION-BLOCKING
REGULATED-ENTITY - TU0-1581
//
UNIQUE-ID - REG0-12201
TYPES - Regulation-of-Translation
CITATIONS - 25898225
CITATIONS - 25898225:EV-EXP-IEP:3639927877:keseler
MODE - +
REGULATED-ENTITY - EG10603
REGULATOR - PUTRESCINE
//
UNIQUE-ID - REG0-11713
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-119
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IEP:3575666044:keseler
MODE - -
REGULATED-ENTITY - EG12434
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-11426
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-102
CITATIONS - 22289118
CITATIONS - 22289118:EV-EXP-IEP:3538232701:keseler
CITATIONS - 22289118:EV-EXP-IMP-SITE-MUTATION:3538232701:keseler
MODE - +
REGULATED-ENTITY - TU00136
REGULATOR - IS061-RNA
//
UNIQUE-ID - REG0-10725
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-75
CITATIONS - 20407422:EV-EXP-IMP-SITE-MUTATION:3482695094:keseler
CITATIONS - 20407422:EV-EXP-IDA:3482698727:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00392
REGULATOR - SRAE-RNA
//
UNIQUE-ID - REG0-10499
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-58
CITATIONS - 19889087:EV-COMP-HINF:3467037122:keseler
MODE - -
REGULATED-ENTITY - TU0-13748
REGULATOR - RNA0-348
//
UNIQUE-ID - REG0-9540
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-17
CITATIONS - 18619465:EV-COMP-HINF:3425905959:keseler
CITATIONS - 18978044:EV-EXP-IMP:3435425691:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-8812
REGULATOR - RYEE-RNA
//
UNIQUE-ID - REG0-12362
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-186
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IMP-SITE-MUTATION:3656356921:keseler
CITATIONS - 21768388:EV-EXP-IEP:3656356985:keseler
CITATIONS - 25891076:EV-EXP-IPI:3656360143:keseler
MODE - -
REGULATED-ENTITY - TU00050
REGULATOR - RYBB-RNA
//
UNIQUE-ID - REG0-11928
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-170
CITATIONS - 23659637
CITATIONS - 23659637:EV-EXP-IMP-SITE-MUTATION:3598901361:keseler
MODE - -
REGULATED-ENTITY - TU0-13975
REGULATOR - SRAH-RNA
//
UNIQUE-ID - REG0-11871
TYPES - RNA-Mediated-Translation-Regulation
CITATIONS - 21292161
CITATIONS - 21292161:EV-EXP-IEP:3593794521:keseler
MODE - -
REGULATED-ENTITY - EG10253
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11854
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-145
CITATIONS - 24188714
CITATIONS - 24188714:EV-EXP-IEP:3593366304:keseler
CITATIONS - 24188714:EV-COMP:3593366731:keseler
MODE - -
REGULATED-ENTITY - TU0-12908
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-11777
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-133
CITATIONS - 23671689
CITATIONS - 23671689:EV-EXP-IEP:3580144416:keseler
CITATIONS - 23671689:EV-EXP-IDA:3580144416:keseler
CITATIONS - 23671689:EV-EXP-IMP-SITE-MUTATION:3580144416:keseler
COMMENT - RNase E and Hfq are required for RyhB-induced degradation of the <i>msrB</i> mRNA |CITS: [23671689]|.
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-41857
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-11726
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-129
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IEP:3575908212:keseler
CITATIONS - 25891076:EV-EXP-IPI:3656359991:keseler
MODE - -
REGULATED-ENTITY - TU00450
REGULATOR - RYBB-RNA
//
UNIQUE-ID - REG0-11709
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-116
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IEP:3575665306:keseler
MODE - -
REGULATED-ENTITY - TU0-8813
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-11394
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-99
CITATIONS - 22250746
CITATIONS - 22250746:EV-EXP-IEP:3536680225:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU00392
REGULATOR - GCVB-RNA
//
UNIQUE-ID - REG0-10690
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-73
CITATIONS - 18619465:EV-EXP-IMP:3479498062:keseler
CITATIONS - 21768388:EV-EXP-IMP-SITE-MUTATION:3575907884:keseler
MODE - -
REGULATED-ENTITY - TU0-8812
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-10420
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-55
CITATIONS - 15466019
CITATIONS - 15466019:EV-EXP-IMP-SITE-MUTATION:3457962344:keseler
CITATIONS - 15466019:EV-EXP-IEP:3457962344:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00049
REGULATOR - TKE8-RNA
//
UNIQUE-ID - REG0-9531
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-14
CITATIONS - 17499044
CITATIONS - 17499044:EV-EXP-IDA:3424111520:keseler
CITATIONS - 17499044:EV-EXP-IMP:3424111520:keseler
CITATIONS - 15620655:EV-EXP-IMP-SITE-MUTATION:3435937465:keseler
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-6241
REGULATOR - RNA0-282
//
UNIQUE-ID - REG0-12357
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-185
CITATIONS - 16513633
CITATIONS - 16513633:EV-EXP-IEP:3656191974:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU00476
REGULATOR - RNA0-327
//
UNIQUE-ID - REG0-11884
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-167
CITATIONS - 22474262
CITATIONS - 22474262:EV-EXP-IEP:3593817299:keseler
CITATIONS - 22474262:EV-EXP-IMP-SITE-MUTATION:3593817299:keseler
COMMENT - RybB induces RNase E-dependent degradation of the mRNA |CITS: [22474262]|.
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - EG10933
REGULATOR - RYBB-RNA
//
UNIQUE-ID - REG0-11868
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-157
CITATIONS - 21292161
CITATIONS - 21292161:EV-EXP-IEP:3593794013:keseler
CITATIONS - 21292161:EV-EXP-IMP-SITE-MUTATION:3593794013:keseler
MODE - -
REGULATED-ENTITY - G7921
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11851
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-142
CITATIONS - 23980183
CITATIONS - 23980183:EV-COMP:3593362967:keseler
CITATIONS - 23980183:EV-EXP-IMP-SITE-MUTATION:3593362967:keseler
CITATIONS - 23980183:EV-EXP-IEP:3593363206:keseler
DOWNSTREAM-GENES-ONLY? - T
MODE - -
REGULATED-ENTITY - EG10653
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-11723
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-126
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IEP:3575719229:keseler
DOWNSTREAM-GENES-ONLY? - T
MODE - -
REGULATED-ENTITY - EG12854
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-11607
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-113
CITATIONS - 22393021
CITATIONS - 22393021:EV-EXP-IEP:3563639338:keseler
MODE - -
REGULATED-ENTITY - TU00064
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-11391
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-96
CITATIONS - 22250746
CITATIONS - 22250746:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3536501504:keseler
CITATIONS - 22250746:EV-EXP-IMP-SITE-MUTATION:3536501504:keseler
CITATIONS - 22250746:EV-EXP-IPI:3536501504:keseler
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU00392
REGULATOR - IS061-RNA
//
UNIQUE-ID - REG0-10591
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-67
CITATIONS - 20070527
CITATIONS - 20070527:EV-EXP-IEP:3472847449:keseler
MODE - -
REGULATED-ENTITY - TU0-13589
REGULATOR - RNA0-349
//
UNIQUE-ID - REG0-10401
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-52
CITATIONS - 11917098
CITATIONS - 14739933:EV-EXP-IPI:3455298874:keseler
CITATIONS - 11917098:EV-EXP-IMP:3455298874:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU00524
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-9887
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-17
CITATIONS - 18619465:EV-COMP-HINF:3435424325:keseler
CITATIONS - 18978044:EV-EXP-IMP:3435425824:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-14688
REGULATOR - RYEE-RNA
//
UNIQUE-ID - REG0-9511
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-11
CITATIONS - 10972807
CITATIONS - 18312576
CITATIONS - 18312576:EV-EXP-IGI:3421590821:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00222
REGULATOR - GCVB-RNA
//
UNIQUE-ID - REG0-12354
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-184
CITATIONS - 16513633
CITATIONS - 16513633:EV-EXP-IEP:3656181345:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU00048
REGULATOR - RNA0-327
//
UNIQUE-ID - REG0-11881
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-164
CITATIONS - 22388518
CITATIONS - 22388518:EV-EXP-IEP:3593812751:keseler
MODE - -
REGULATED-ENTITY - EG11669
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11865
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-155
CITATIONS - 21292161
CITATIONS - 21292161:EV-EXP-IEP:3593792112:keseler
CITATIONS - 21292161:EV-EXP-IMP:3593792112:keseler
MODE - -
REGULATED-ENTITY - EG10349
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11796
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-139
CITATIONS - 22925049
CITATIONS - 22925049:EV-EXP-IMP:3582550389:keseler
CITATIONS - 22925049:EV-EXP-IMP-SITE-MUTATION:3582550389:keseler
DOWNSTREAM-GENES-ONLY? - T
MODE - -
REGULATED-ENTITY - TU00136
REGULATOR - SRAE-RNA
//
UNIQUE-ID - REG0-11720
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-125
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IEP:3575718575:keseler
DOWNSTREAM-GENES-ONLY? - T
MODE - -
REGULATED-ENTITY - TU21
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-11439
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-110
CITATIONS - 22356413
CITATIONS - 22356413:EV-EXP-IMP-SITE-MUTATION:3539632637:keseler
CITATIONS - 22356413:EV-EXP-IEP:3539632637:keseler
MODE - -
REGULATED-ENTITY - TU0-8697
REGULATOR - RPRA-RNA
//
UNIQUE-ID - REG0-10837
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-82
CITATIONS - 20696910
CITATIONS - 20696910:EV-EXP-IPI:3493745306:keseler
CITATIONS - 20696910:EV-EXP-IEP:3493745306:keseler
CITATIONS - 20696910:EV-EXP-IMP-SITE-MUTATION:3493745306:keseler
MODE - -
REGULATED-ENTITY - TU0-6501
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-10588
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-64
CITATIONS - 20070527
CITATIONS - 20070527:EV-EXP-IEP:3472847250:keseler
CITATIONS - 20070527:EV-EXP-IMP-SITE-MUTATION:3472847821:keseler
MODE - -
REGULATED-ENTITY - TU0-13287
REGULATOR - RNA0-349
//
UNIQUE-ID - REG0-10283
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-49
CITATIONS - 19426207
CITATIONS - 19426207:EV-EXP-IMP-SITE-MUTATION:3452611460:keseler
CITATIONS - 19426207:EV-EXP-IGI:3452611460:keseler
MODE - -
REGULATED-ENTITY - TU0-13000
REGULATOR - RNA0-123
//
UNIQUE-ID - REG0-9812
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-26
CITATIONS - 18953042:EV-EXP-IMP-SITE-MUTATION:3434815043:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU00014
REGULATOR - RYGB-RNA
//
UNIQUE-ID - REG0-12377
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
CITATIONS - 11917098
CITATIONS - 11917098:EV-EXP-IEP:3658773718:keseler
MODE - -
REGULATED-ENTITY - EG10113
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-12339
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-180
CITATIONS - 26411266
CITATIONS - 26411266:EV-EXP-IMP:3653143249:keseler
CITATIONS - 26411266:EV-EXP-IMP-SITE-MUTATION:3653143249:keseler
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU821
REGULATOR - RNA0-241
//
UNIQUE-ID - REG0-11878
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-161
CITATIONS - 22388518
CITATIONS - 22388518:EV-EXP-IEP:3593808560:keseler
CITATIONS - 22388518:EV-EXP-IMP-SITE-MUTATION:3593808560:keseler
MODE - -
REGULATED-ENTITY - EG10352
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11862
TYPES - RNA-Mediated-Translation-Regulation
CITATIONS - 21292161
CITATIONS - 21292161:EV-EXP-IEP:3593790966:keseler
MODE - -
REGULATED-ENTITY - EG10948
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11793
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-136
CITATIONS - 10903857
CITATIONS - 11804582
CITATIONS - 20927406
CITATIONS - 10903857:EV-EXP-IDA:3582397086:keseler
CITATIONS - 10903857:EV-EXP-IMP:3582397086:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - EG10301
REGULATOR - OXYS-RNA
//
UNIQUE-ID - REG0-11717
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-122
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IEP:3575666825:keseler
MODE - -
REGULATED-ENTITY - TU00409
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-11436
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-107
CITATIONS - 22324810
CITATIONS - 22324810:EV-EXP-IMP:3539619159:keseler
MODE - -
REGULATED-ENTITY - TU0-3
REGULATOR - MICF-RNA
//
UNIQUE-ID - REG0-10770
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-78
CITATIONS - 17007876
CITATIONS - 17007876:EV-EXP-IEP:3487704323:keseler
CITATIONS - 17007876:EV-AS-HYPO:3487704323:keseler
CITATIONS - 25891076:EV-EXP-IPI:3656360065:keseler
MODE - -
REGULATED-ENTITY - TU00476
REGULATOR - RYBB-RNA
//
UNIQUE-ID - REG0-10585
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-63
CITATIONS - 20075074
CITATIONS - 20075074:EV-EXP-IEP:3472843356:keseler
MODE - -
REGULATED-ENTITY - TU0-13432
REGULATOR - RNA0-349
//
UNIQUE-ID - REG0-10097
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-37
CITATIONS - 18978044
CITATIONS - 18978044:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3440510756:keseler
CITATIONS - 18978044:EV-EXP-IMP-SITE-MUTATION:3440510756:keseler
MODE - -
REGULATED-ENTITY - TU0-13709
REGULATOR - RYEE-RNA
//
UNIQUE-ID - REG0-9809
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-23
CITATIONS - 18953042:EV-EXP-IMP-SITE-MUTATION:3434816718:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-7823
REGULATOR - SRAE-RNA
//
UNIQUE-ID - REG0-12366
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-190
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IMP:3656358943:keseler
CITATIONS - 21768388:EV-EXP-IEP:3656358943:keseler
CITATIONS - 25891076:EV-EXP-IPI:3656359851:keseler
MODE - -
REGULATED-ENTITY - TU00080
REGULATOR - RYBB-RNA
//
UNIQUE-ID - REG0-12011
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-174
CITATIONS - 24600026
CITATIONS - 24600026:EV-EXP-IEP:3608560347:keseler
MODE - +
REGULATED-ENTITY - TU0-14736
REGULATOR - RNA0-351
//
UNIQUE-ID - REG0-11875
TYPES - RNA-Mediated-Translation-Regulation
CITATIONS - 21292161
CITATIONS - 21292161:EV-EXP-IEP:3593795295:keseler
MODE - +
REGULATED-ENTITY - EG12882
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11859
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-150
CITATIONS - 23980183
CITATIONS - 23980183:EV-EXP-IMP-SITE-MUTATION:3593445877:keseler
CITATIONS - 23980183:EV-EXP-IEP:3593445877:keseler
MODE - -
REGULATED-ENTITY - G7326
REGULATOR - RNA0-349
//
UNIQUE-ID - REG0-11714
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-120
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IEP:3575666259:keseler
DOWNSTREAM-GENES-ONLY? - T
MODE - -
REGULATED-ENTITY - G7260
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-11427
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-103
CITATIONS - 22289118
CITATIONS - 22289118:EV-EXP-IEP:3538232854:keseler
CITATIONS - 22289118:EV-EXP-IMP:3538232854:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - +
REGULATED-ENTITY - TU00136
REGULATOR - IS061-RNA
//
UNIQUE-ID - REG0-10726
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-76
CITATIONS - 20407422:EV-EXP-IMP-SITE-MUTATION:3482699625:keseler
CITATIONS - 20407422:EV-EXP-IDA:3482699625:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00392
REGULATOR - RYGB-RNA
//
UNIQUE-ID - REG0-10500
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-59
CITATIONS - 19889087:EV-COMP-HINF:3467037323:keseler
CITATIONS - 23659637:EV-EXP-IMP:3598897133:keseler
MODE - -
REGULATED-ENTITY - TU0-13975
REGULATOR - RNA0-348
//
UNIQUE-ID - REG0-9569
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - EG10215-MONOMER
ASSOCIATED-BINDING-SITE - RBS0-19
CITATIONS - 18658123
CITATIONS - 20683441:EV-EXP-IEP:3490710178:keseler
COMMENT - In a <i>deaD</i> mutant strain, DsrA-<i>rpoS</i> duplex formation does not occur |CITS: [21045550]|.
MECHANISM - :TRANSLATION-BLOCKING
MODE - +
REGULATED-ENTITY - TU00442
REGULATOR - DSRA-RNA
//
UNIQUE-ID - REG0-12363
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-187
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IMP-SITE-MUTATION:3656357198:keseler
MODE - -
REGULATED-ENTITY - TU356
REGULATOR - RYBB-RNA
//
UNIQUE-ID - REG0-11971
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-171
CITATIONS - 24489123
CITATIONS - 24489123:EV-EXP-IEP:3601305262:keseler
CITATIONS - 24489123:EV-EXP-IMP:3601305262:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00392
REGULATOR - RNA0-328
//
UNIQUE-ID - REG0-11872
TYPES - RNA-Mediated-Translation-Regulation
CITATIONS - 21292161
CITATIONS - 21292161:EV-EXP-IEP:3593794750:keseler
MODE - -
REGULATED-ENTITY - EG10021
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11855
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-146
CITATIONS - 24188714
CITATIONS - 24188714:EV-EXP-IEP:3593367428:keseler
CITATIONS - 24188714:EV-COMP:3593367428:keseler
MODE - -
REGULATED-ENTITY - TU0-12951
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-11778
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-134
CITATIONS - 22474262
CITATIONS - 22474262:EV-EXP-IMP-SITE-MUTATION:3580146937:keseler
CITATIONS - 22474262:EV-EXP-IEP:3580146937:keseler
CITATIONS - 22474262:EV-EXP-IPI:3580146937:keseler
COMMENT - RyhB induces RNase E-dependent degradation of the mRNA |CITS: [22474262]|.
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU00524
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-11710
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-117
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IEP:3575665578:keseler
CITATIONS - 21768388:EV-EXP-IMP-SITE-MUTATION:3575907802:keseler
MODE - -
REGULATED-ENTITY - TU00450
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-11395
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-100
CITATIONS - 17542919
CITATIONS - 17542919:EV-EXP-IEP:3536683729:keseler
CITATIONS - 17542919:EV-EXP-IMP-SITE-MUTATION:3536683729:keseler
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - +
REGULATED-ENTITY - TU0-42474
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-10691
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-73
CITATIONS - 18619465:EV-EXP-IMP:3479498126:keseler
CITATIONS - 21768388:EV-EXP-IMP-SITE-MUTATION:3575907865:keseler
MODE - -
REGULATED-ENTITY - TU0-14688
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-10421
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-55
CITATIONS - 15466019:EV-EXP-IMP-SITE-MUTATION:3457962421:keseler
CITATIONS - 15466019:EV-EXP-IEP:3457962421:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00476
REGULATOR - TKE8-RNA
//
UNIQUE-ID - REG0-9538
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-15
CITATIONS - 15522088
CITATIONS - 16859494:EV-EXP-IDA:3425827065:keseler
CITATIONS - 16859494:EV-EXP-IMP-SITE-MUTATION:3479490626:keseler
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-1141
REGULATOR - RNA0-241
//
UNIQUE-ID - REG0-12358
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-185
CITATIONS - 16513633
CITATIONS - 16513633:EV-EXP-IEP:3656192050:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU00477
REGULATOR - RNA0-327
//
UNIQUE-ID - REG0-11885
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-168
CITATIONS - 23980183
CITATIONS - 23980183:EV-EXP-IMP-SITE-MUTATION:3593818597:keseler
MODE - -
REGULATED-ENTITY - EG10372
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11869
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-160
CITATIONS - 21292161
CITATIONS - 22388518
CITATIONS - 21292161:EV-EXP-IEP:3593794212:keseler
CITATIONS - 22388518:EV-EXP-IMP-SITE-MUTATION:3593808194:keseler
MODE - -
REGULATED-ENTITY - G436
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11852
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-143
CITATIONS - 23980183
CITATIONS - 23980183:EV-EXP-IMP:3593364174:keseler
CITATIONS - 23980183:EV-EXP-IEP:3593364174:keseler
MODE - -
REGULATED-ENTITY - EG12332
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-11727
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-129
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IEP:3575908270:keseler
CITATIONS - 25891076:EV-EXP-IPI:3656360012:keseler
MODE - -
REGULATED-ENTITY - TU00449
REGULATOR - RYBB-RNA
//
UNIQUE-ID - REG0-11724
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-127
CITATIONS - 23300478
CITATIONS - 23300478:EV-EXP-IEP:3575828582:keseler
CITATIONS - 23300478:EV-EXP-IMP-SITE-MUTATION:3575828582:keseler
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU00319
REGULATOR - GCVB-RNA
//
UNIQUE-ID - REG0-11686
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-114
CITATIONS - 23511474
CITATIONS - 23511474:EV-EXP-IPI:3573492337:keseler
MODE - -
REGULATED-ENTITY - TU723
REGULATOR - RYEB-RNA
//
UNIQUE-ID - REG0-11392
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-97
CITATIONS - 22250746
CITATIONS - 22356413
CITATIONS - 22250746:EV-EXP-IMP:3536524121:keseler
CITATIONS - 22250746:EV-EXP-IDA:3536524121:keseler
CITATIONS - 22356413:EV-EXP-IMP-SITE-MUTATION:3539638074:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00392
REGULATOR - RPRA-RNA
//
UNIQUE-ID - REG0-10688
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-72
CITATIONS - 16204185:EV-EXP-IMP-SITE-MUTATION:3479494570:keseler
CITATIONS - 16204185:EV-EXP-IDA:3479494570:keseler
CITATIONS - 16313626:EV-EXP-IDA:3479495813:keseler
COMMENT - Glucose increases Hfq protein levels, which decreases <i>ompA</i> mRNA stability, with a half-life of ~11.5 to ~8.1 min. On the other hand, in the absence of glucose, cAMP represses <i>hfq</i> and thereby stabilizes <i>ompA</i> mRNA |CITS:[21840983]|.
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00048
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-10402
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-53
CITATIONS - 17268550:EV-EXP-IMP-SITE-MUTATION:3455304741:keseler
CITATIONS - 17268550:EV-EXP-IEP:3455305172:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU0-1281
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-9974
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-31
CITATIONS - 12410838:EV-EXP-IMP-SITE-MUTATION:3436102012:keseler
CITATIONS - 11251852:EV-EXP-IMP:3436102012:keseler
CITATIONS - 20683441:EV-EXP-IEP:3490710142:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - +
REGULATED-ENTITY - TU00442
REGULATOR - RPRA-RNA
//
UNIQUE-ID - REG0-9512
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-12
CITATIONS - 17264113
CITATIONS - 18312576
CITATIONS - 18312576:EV-EXP-IGI:3421591101:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00262
REGULATOR - GCVB-RNA
//
UNIQUE-ID - REG0-12355
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-185
CITATIONS - 16513633
CITATIONS - 16513633:EV-EXP-IEP:3656181605:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU00049
REGULATOR - RNA0-327
//
UNIQUE-ID - REG0-11882
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-165
CITATIONS - 22388518
CITATIONS - 22388518:EV-EXP-IEP:3593813200:keseler
MODE - -
REGULATED-ENTITY - EG11560
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11866
TYPES - RNA-Mediated-Translation-Regulation
CITATIONS - 21292161
CITATIONS - 21292161:EV-EXP-IEP:3593792962:keseler
MODE - -
REGULATED-ENTITY - EG10350
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11797
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-140
CITATIONS - 22925049
CITATIONS - 22925049:EV-EXP-IMP:3582550488:keseler
CITATIONS - 22925049:EV-EXP-IMP-SITE-MUTATION:3582550488:keseler
DOWNSTREAM-GENES-ONLY? - T
MODE - -
REGULATED-ENTITY - TU00136
REGULATOR - RYGB-RNA
//
UNIQUE-ID - REG0-11721
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-125
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IEP:3575718728:keseler
DOWNSTREAM-GENES-ONLY? - T
MODE - -
REGULATED-ENTITY - EG10684
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-11440
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-111
CITATIONS - 22356413
CITATIONS - 22356413:EV-EXP-IMP-SITE-MUTATION:3539640932:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00392
REGULATOR - RPRA-RNA
//
UNIQUE-ID - REG0-10916
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-83
CITATIONS - 21245045
CITATIONS - 22988087
CITATIONS - 21245045:EV-EXP-IEP:3504902473:keseler
CITATIONS - 21245045:EV-EXP-IPI:3504902473:keseler
CITATIONS - 21245045:EV-EXP-IMP-SITE-MUTATION:3504902473:keseler
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - EG10567
REGULATOR - RNA0-241
//
UNIQUE-ID - REG0-10589
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-65
CITATIONS - 20070527
CITATIONS - 20070527:EV-EXP-IEP:3472847323:keseler
CITATIONS - 20070527:EV-EXP-IMP-SITE-MUTATION:3472847860:keseler
MODE - -
REGULATED-ENTITY - TU0-3382
REGULATOR - RNA0-349
//
UNIQUE-ID - REG0-10284
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-50
CITATIONS - 19400782
CITATIONS - 19400782:EV-EXP-IMP-SITE-MUTATION:3452616153:keseler
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-13021
REGULATOR - RNA0-123
//
UNIQUE-ID - REG0-9813
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-26
CITATIONS - 18953042:EV-EXP-IMP-SITE-MUTATION:3434815177:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU00015
REGULATOR - RYGB-RNA
//
UNIQUE-ID - REG0-9489
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-9
CITATIONS - 18351803
CITATIONS - 18334534
CITATIONS - 18351803:EV-EXP-IMP:3419971342:keseler
CITATIONS - 18351803:EV-EXP-IDA:3419971342:keseler
COMMENT - The GlmZ small RNA binds to the upstream UTR of <i>glmS</i>, prohibiting formation of a secondary
/structure that occludes the ribosome binding site, thus allowing translation |CITS: [18351803]|.
DOWNSTREAM-GENES-ONLY? - T
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - +
REGULATED-ENTITY - TU00488
REGULATOR - SRAJ-RNA
//
UNIQUE-ID - REG0-12340
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-181
CITATIONS - 26411266
CITATIONS - 26411266:EV-EXP-IMP:3653144480:keseler
CITATIONS - 26411266:EV-EXP-IMP-SITE-MUTATION:3653144480:keseler
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-13539
REGULATOR - RNA0-241
//
UNIQUE-ID - REG0-11879
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-162
CITATIONS - 22388518
CITATIONS - 22388518:EV-EXP-IEP:3593808877:keseler
MODE - -
REGULATED-ENTITY - EG10396
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11863
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-153
CITATIONS - 21292161
CITATIONS - 21292161:EV-EXP-IEP:3593791167:keseler
CITATIONS - 21292161:EV-EXP-IMP-SITE-MUTATION:3593791167:keseler
MODE - -
REGULATED-ENTITY - EG11428
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11794
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-137
CITATIONS - 22925049
CITATIONS - 22925049:EV-EXP-IMP:3582491200:keseler
CITATIONS - 22925049:EV-EXP-IMP-SITE-MUTATION:3582491200:keseler
DOWNSTREAM-GENES-ONLY? - T
MODE - -
REGULATED-ENTITY - TU00136
REGULATOR - OXYS-RNA
//
UNIQUE-ID - REG0-11718
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-123
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IEP:3575667322:keseler
DOWNSTREAM-GENES-ONLY? - T
MODE - -
REGULATED-ENTITY - G7146
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-11437
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-108
CITATIONS - 22324810
CITATIONS - 22324810:EV-EXP-IMP:3539619352:keseler
MODE - -
REGULATED-ENTITY - TU00086
REGULATOR - MICF-RNA
//
UNIQUE-ID - REG0-10771
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-78
CITATIONS - 17007876
CITATIONS - 17007876:EV-EXP-IEP:3487704399:keseler
CITATIONS - 17007876:EV-AS-HYPO:3487704399:keseler
CITATIONS - 25891076:EV-EXP-IPI:3656360090:keseler
MODE - -
REGULATED-ENTITY - TU00477
REGULATOR - RYBB-RNA
//
UNIQUE-ID - REG0-10586
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-61
CITATIONS - 20075074
CITATIONS - 20075074:EV-EXP-IDA:3472843846:keseler
CITATIONS - 20075074:EV-EXP-IEP:3472843846:keseler
MODE - -
REGULATED-ENTITY - TU00064
REGULATOR - RNA0-349
//
UNIQUE-ID - REG0-10098
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-38
CITATIONS - 18978044
CITATIONS - 18978044:EV-EXP-IEP:3440511605:keseler
CITATIONS - 18978044:EV-EXP-IMP-SITE-MUTATION:3440511605:keseler
MODE - -
REGULATED-ENTITY - TU0-8849
REGULATOR - RYEE-RNA
//
UNIQUE-ID - REG0-9810
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-24
CITATIONS - 18953042:EV-EXP-IMP-SITE-MUTATION:3434752331:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU00014
REGULATOR - SRAE-RNA
//
UNIQUE-ID - REG0-12368
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-191
CITATIONS - 16199566
CITATIONS - 25092924
CITATIONS - 16199566:EV-EXP-IMP:3656962002:keseler
CITATIONS - 25092924:EV-EXP-IMP:3656963626:keseler
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU796
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-12105
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-175
CITATIONS - 25030700
CITATIONS - 25030700:EV-EXP-IMP-SITE-MUTATION:3621772839:keseler
CITATIONS - 25030700:EV-EXP-IEP:3621772839:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - EG10544
REGULATOR - RNA0-386
//
UNIQUE-ID - REG0-11876
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-158
CITATIONS - 22388518
CITATIONS - 22388518:EV-EXP-IEP:3593806682:keseler
CITATIONS - 22388518:EV-EXP-IMP-SITE-MUTATION:3593806682:keseler
MODE - -
REGULATED-ENTITY - G6646
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11860
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-151
CITATIONS - 23980183
CITATIONS - 23980183:EV-EXP-IEP:3593446395:keseler
CITATIONS - 23980183:EV-EXP-IMP:3593446395:keseler
MODE - -
REGULATED-ENTITY - EG11434
REGULATOR - RNA0-349
//
UNIQUE-ID - REG0-11715
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-121
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IEP:3575666455:keseler
MODE - -
REGULATED-ENTITY - TU0-14682
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-11432
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-105
CITATIONS - 6201848
CITATIONS - 6201848:EV-EXP-IEP:3539100941:keseler
CITATIONS - 1702997:EV-EXP-IPI:3539100941:keseler
CITATIONS - 7534474:EV-EXP-IDA:3539112500:keseler
CITATIONS - 17264113:EV-EXP-IDA:3539118212:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00050
REGULATOR - MICF-RNA
//
UNIQUE-ID - REG0-10768
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-77
CITATIONS - 20457943
CITATIONS - 20457943:EV-EXP-IEP:3487622935:keseler
CITATIONS - 20683441:EV-EXP-IEP:3490710253:keseler
CITATIONS - 20683441:EV-EXP-IMP-SITE-MUTATION:3490710739:keseler
COMMENT - Stimulation of translation by ArcZ is dependent on Hfq binding to the <i>rpoS</i> mRNA leader region |CITS: [20457943]|.
MECHANISM - :TRANSLATION-BLOCKING
MODE - +
REGULATED-ENTITY - TU00442
REGULATOR - SRAH-RNA
//
UNIQUE-ID - REG0-10583
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-60
CITATIONS - 20075074
CITATIONS - 20070527
CITATIONS - 20075074:EV-EXP-IDA:3472842838:keseler
CITATIONS - 20075074:EV-EXP-IEP:3472842838:keseler
CITATIONS - 20070527:EV-EXP-IEP:3472847142:keseler
CITATIONS - 20070527:EV-EXP-IMP-SITE-MUTATION:3472847789:keseler
MODE - -
REGULATED-ENTITY - TU0-1681
REGULATOR - RNA0-349
//
UNIQUE-ID - REG0-9590
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-21
CITATIONS - 18710431:EV-EXP-IMP:3428934005:keseler
COMMENT - In an <i>ohsC</i> deletion mutant, expression of ShoB is more than two-fold higher under all tested
/conditions |CITS: [18710431]|.
MODE - -
REGULATED-ENTITY - TU0-14422
REGULATOR - RNA0-330
//
UNIQUE-ID - REG0-12364
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-188
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IMP-SITE-MUTATION:3656358314:keseler
CITATIONS - 21768388:EV-EXP-IEP:3656358314:keseler
MODE - -
REGULATED-ENTITY - TU0-2521
REGULATOR - RYBB-RNA
//
UNIQUE-ID - REG0-11994
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-172
CITATIONS - 24593230
CITATIONS - 19682266
CITATIONS - 24593230:EV-EXP-IEP:3606741312:keseler
CITATIONS - 19682266:EV-EXP-IEP:3606747125:keseler
MODE - -
REGULATED-ENTITY - EG10141
REGULATOR - RNA0-123
//
UNIQUE-ID - REG0-11873
TYPES - RNA-Mediated-Translation-Regulation
CITATIONS - 21292161
CITATIONS - 21292161:EV-EXP-IEP:3593794837:keseler
MODE - -
REGULATED-ENTITY - G7871
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11856
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-147
CITATIONS - 24065131
CITATIONS - 24065131:EV-EXP-IMP-SITE-MUTATION:3593369140:keseler
CITATIONS - 24065131:EV-EXP-IEP:3593369140:keseler
CITATIONS - 24065131:EV-EXP-IPI:3593376509:keseler
COMMENT - Binding of Hfq blocks translation initiation; binding of RyhB leads to changes in the mRNA secondary structure, thereby displacing Hfq |CITS: [24065131]|.
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - +
REGULATED-ENTITY - EG10155
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-11791
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
CITATIONS - 9774349
CITATIONS - 21889623
CITATIONS - 22040174
CITATIONS - 9774349:EV-EXP-IMP:3582395009:keseler
COMMENT - While its interaction with Hfq is strong, OxyS only shows weak affinity for the <i>rpoS</i> leader region.  Thus, regulation of <i>rpoS</i> translation by OxyS may be due to sequestration of Hfq rather than by binding to <i>rpoS</i> mRNA |CITS: [21889623][22040174]|.
DOWNSTREAM-GENES-ONLY? - T
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00442
REGULATOR - OXYS-RNA
//
UNIQUE-ID - REG0-11711
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-118
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IEP:3575665674:keseler
CITATIONS - 21768388:EV-EXP-IMP-SITE-MUTATION:3575907816:keseler
MODE - -
REGULATED-ENTITY - TU00449
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-11396
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-101
CITATIONS - 21289064
CITATIONS - 11917098
CITATIONS - 21289064:EV-EXP-IPI:3536687155:keseler
CITATIONS - 11917098:EV-EXP-IEP:3536687717:keseler
CITATIONS - 16199566:EV-EXP-IEP:3536687717:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU00104
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-10692
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-74
CITATIONS - 20345657
CITATIONS - 23300478
CITATIONS - 20345657:EV-EXP-IMP-SITE-MUTATION:3479499108:keseler
CITATIONS - 23300478:EV-EXP-IPI:3575823492:keseler
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU00319
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-10422
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-55
CITATIONS - 15466019:EV-EXP-IMP-SITE-MUTATION:3457962479:keseler
CITATIONS - 15466019:EV-EXP-IEP:3457962479:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00477
REGULATOR - TKE8-RNA
//
UNIQUE-ID - REG0-9539
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-15
CITATIONS - 16859494:EV-EXP-IDA:3425827032:keseler
CITATIONS - 16859494:EV-EXP-IMP-SITE-MUTATION:3479490639:keseler
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-1142
REGULATOR - RNA0-241
//
UNIQUE-ID - REG0-12361
TYPES - RNA-Mediated-Translation-Regulation
CITATIONS - 25891076
CITATIONS - 25891076:EV-EXP-IDA:3656266775:keseler
CITATIONS - 25891076:EV-EXP-IEP:3656266775:keseler
CITATIONS - 25891076:EV-EXP-IPI:3656359955:keseler
MODE - +
REGULATED-ENTITY - TU0-8603
REGULATOR - RYBB-RNA
//
UNIQUE-ID - REG0-11886
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-169
CITATIONS - 23980183
CITATIONS - 23980183:EV-EXP-IMP:3593818858:keseler
MODE - -
REGULATED-ENTITY - EG10981
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11870
TYPES - RNA-Mediated-Translation-Regulation
CITATIONS - 21292161
CITATIONS - 21292161:EV-EXP-IEP:3593794368:keseler
MODE - -
REGULATED-ENTITY - EG11961
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11853
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-144
CITATIONS - 23980183
CITATIONS - 23980183:EV-COMP:3593365106:keseler
CITATIONS - 23980183:EV-EXP-IEP:3593365476:keseler
MODE - -
REGULATED-ENTITY - EG11434
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-11776
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-132
CITATIONS - 23671689
CITATIONS - 23671689:EV-EXP-IEP:3580144215:keseler
CITATIONS - 23671689:EV-EXP-IDA:3580144215:keseler
CITATIONS - 23671689:EV-EXP-IMP-SITE-MUTATION:3580144215:keseler
COMMENT - RNase E and Hfq are required for RyhB-induced degradation of the <i>msrB</i> mRNA |CITS: [23671689]|.
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-41857
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-11725
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-128
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IEP:3575906372:keseler
MODE - -
REGULATED-ENTITY - G6891
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-11708
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-115
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IEP:3575664945:keseler
DOWNSTREAM-GENES-ONLY? - T
MODE - -
REGULATED-ENTITY - EG10528
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-11393
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-98
CITATIONS - 21876160
CITATIONS - 21876160:EV-EXP-IEP:3536679108:keseler
CITATIONS - 21876160:EV-EXP-IMP-SITE-MUTATION:3536679108:keseler
MODE - -
REGULATED-ENTITY - TU00181
REGULATOR - GCVB-RNA
//
UNIQUE-ID - REG0-10689
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-72
CITATIONS - 16204185:EV-EXP-IMP-SITE-MUTATION:3479494720:keseler
CITATIONS - 16204185:EV-EXP-IDA:3479494720:keseler
CITATIONS - 16313626:EV-EXP-IDA:3479495790:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU0-4742
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-10403
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-54
CITATIONS - 21289064
CITATIONS - 19407815:EV-EXP-IPI:3455378403:keseler
CITATIONS - 19407815:EV-EXP-IMP-SITE-MUTATION:3455378403:keseler
CITATIONS - 19407815:EV-EXP-IEP:3455378403:keseler
COMMENT - RyhB interaction with the <i>iscRSUA</i> mRNA at a site between the <i>iscR</i> and <i>iscS</i> open reading frames leads to cleavage of the mRNA and subsequent degradation of the 3' <i>iscSUA</i> mRNA, while the IscR-encoding 5' end of the mRNA remains stable |CITS: [19407815]|.
DOWNSTREAM-GENES-ONLY? - T
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-1881
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-9529
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-86
CITATIONS - 15466020
CITATIONS - 15466020:EV-EXP-IMP:3424092878:keseler
CITATIONS - 21147125
MECHANISM - :MRNA-DEGRADATION
MODE - +
REGULATED-ENTITY - TU0-14433
REGULATOR - IS183-RNA
//
UNIQUE-ID - REG0-12356
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-184
CITATIONS - 16513633
CITATIONS - 16513633:EV-EXP-IEP:3656191849:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-4742
REGULATOR - RNA0-327
//
UNIQUE-ID - REG0-11883
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-166
CITATIONS - 22474262
CITATIONS - 22474262:EV-EXP-IEP:3593814605:keseler
CITATIONS - 22474262:EV-EXP-IDA:3593814605:keseler
COMMENT - Here, Spot 42 RNA appears to recruit Hfq binding to a site overlapping the ribosome binding site, thereby inhibiting binding of the 30S subunit of the ribosome and initiation of translation |CITS: [22474262]|.
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - EG10933
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11867
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-156
CITATIONS - 21292161
CITATIONS - 21292161:EV-EXP-IEP:3593793642:keseler
CITATIONS - 21292161:EV-EXP-IMP:3593793642:keseler
MODE - -
REGULATED-ENTITY - EG20252
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11806
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-141
CITATIONS - 23873911
CITATIONS - 23873911:EV-EXP-IEP:3584131205:keseler
MODE - +
REGULATED-ENTITY - EG11470
REGULATOR - RNA0-241
//
UNIQUE-ID - REG0-11722
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-126
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IEP:3575719137:keseler
DOWNSTREAM-GENES-ONLY? - T
MODE - -
REGULATED-ENTITY - EG12854
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-11601
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-112
CITATIONS - 22988087
CITATIONS - 22988087:EV-EXP-IPI:3561493321:keseler
CITATIONS - 22988087:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3561493321:keseler
CITATIONS - 22988087:EV-EXP-IMP-SITE-MUTATION:3561493321:keseler
DOWNSTREAM-GENES-ONLY? - T
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU00196
REGULATOR - RNA0-241
//
UNIQUE-ID - REG0-11003
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-84
CITATIONS - 12101127
CITATIONS - 11804583
CITATIONS - 26045496
CITATIONS - 12101127:EV-EXP-IDA:3511209471:keseler
CITATIONS - 12101127:EV-EXP-IEP:3511209471:keseler
CITATIONS - 26045496:EV-EXP-IMP:3643723684:keseler
DOWNSTREAM-GENES-ONLY? - T
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - EG10363
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-10590
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-66
CITATIONS - 20070527
CITATIONS - 20070527:EV-EXP-IEP:3472847389:keseler
CITATIONS - 20070527:EV-EXP-IMP:3472847577:keseler
MODE - -
REGULATED-ENTITY - TU0-13539
REGULATOR - RNA0-349
//
UNIQUE-ID - REG0-10400
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-51
CITATIONS - 14617150
CITATIONS - 21289064
CITATIONS - 14617150:EV-EXP-IMP-SITE-MUTATION:3455297638:keseler
CITATIONS - 15781494:EV-EXP-IPI:3455300934:keseler
CITATIONS - 17264113:EV-EXP-IEP:3455304270:keseler
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-1681
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-9814
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-28
CITATIONS - 18953042:EV-EXP-IMP-SITE-MUTATION:3434815304:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-7823
REGULATOR - RYGB-RNA
//
UNIQUE-ID - REG0-9490
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-9
CITATIONS - 18351803
CITATIONS - 18334534
CITATIONS - :EV-EXP:3419962555:keseler
DOWNSTREAM-GENES-ONLY? - T
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - +
REGULATED-ENTITY - TU00280
REGULATOR - SRAJ-RNA
//
UNIQUE-ID - REG0-12341
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-182
CITATIONS - 26411266
CITATIONS - 26411266:EV-EXP-IMP:3653144739:keseler
CITATIONS - 26411266:EV-EXP-IMP-SITE-MUTATION:3653144739:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00059
REGULATOR - RNA0-241
//
UNIQUE-ID - REG0-11880
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-163
CITATIONS - 22388518
CITATIONS - 22388518:EV-EXP-IEP:3593809078:keseler
MODE - -
REGULATED-ENTITY - G6719
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11864
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-154
CITATIONS - 21292161
CITATIONS - 21292161:EV-EXP-IEP:3593791536:keseler
CITATIONS - 21292161:EV-EXP-IMP-SITE-MUTATION:3593791536:keseler
MODE - -
REGULATED-ENTITY - G8210
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11795
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-138
CITATIONS - 22925049
CITATIONS - 22925049:EV-EXP-IMP:3582494049:keseler
CITATIONS - 22925049:EV-EXP-IMP-SITE-MUTATION:3582494049:keseler
DOWNSTREAM-GENES-ONLY? - T
MODE - -
REGULATED-ENTITY - TU00136
REGULATOR - SRAH-RNA
//
UNIQUE-ID - REG0-11719
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-124
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IEP:3575667790:keseler
MODE - -
REGULATED-ENTITY - TU0-13138
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-11438
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-109
CITATIONS - 17462020
CITATIONS - 17462020:EV-EXP-IMP:3539623764:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-8264
REGULATOR - RNA0-334
//
UNIQUE-ID - REG0-10772
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-79
CITATIONS - 17007876
CITATIONS - 17007876:EV-EXP-IEP:3487704548:keseler
CITATIONS - 17007876:EV-AS-HYPO:3487704548:keseler
CITATIONS - 25891076:EV-EXP-IPI:3656359920:keseler
MODE - -
REGULATED-ENTITY - TU0-8813
REGULATOR - RYBB-RNA
//
UNIQUE-ID - REG0-10587
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-62
CITATIONS - 20075074
CITATIONS - 20075074:EV-EXP-IEP:3472844438:keseler
MODE - -
REGULATED-ENTITY - TU0-8221
REGULATOR - RNA0-349
//
UNIQUE-ID - REG0-10101
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-39
CITATIONS - 19118351
CITATIONS - 19118351:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3441111807:keseler
MODE - -
REGULATED-ENTITY - TU0-14159
REGULATOR - GCVB-RNA
//
UNIQUE-ID - REG0-9811
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-24
CITATIONS - 18953042:EV-EXP-IMP-SITE-MUTATION:3434752473:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU00015
REGULATOR - SRAE-RNA
//
UNIQUE-ID - REG0-12369
TYPES - RNA-Mediated-Translation-Regulation
CITATIONS - 25891076
CITATIONS - 25891076:EV-EXP-IMP:3656973031:keseler
MODE - -
REGULATED-ENTITY - TU0-8805
REGULATOR - SRAI-RNA
//
UNIQUE-ID - REG0-12338
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-179
CITATIONS - 26411266
CITATIONS - 26411266:EV-EXP-IMP:3653142868:keseler
CITATIONS - 26411266:EV-EXP-IMP-SITE-MUTATION:3653142868:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-13935
REGULATOR - RNA0-241
//
UNIQUE-ID - REG0-11877
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-159
CITATIONS - 22388518
CITATIONS - 22388518:EV-EXP-IEP:3593807660:keseler
CITATIONS - 22388518:EV-EXP-IMP-SITE-MUTATION:3593807660:keseler
MODE - -
REGULATED-ENTITY - EG10086
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11861
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-152
CITATIONS - 21292161
CITATIONS - 21292161:EV-EXP-IEP:3593790170:keseler
CITATIONS - 21292161:EV-EXP-IMP:3593790170:keseler
MODE - -
REGULATED-ENTITY - EG10402
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11792
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-135
CITATIONS - 9774350
CITATIONS - 11804582
CITATIONS - 20927406
CITATIONS - 9774350:EV-EXP-IMP-SITE-MUTATION:3582395502:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - EG10301
REGULATOR - OXYS-RNA
//
UNIQUE-ID - REG0-11716
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-122
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IEP:3575666670:keseler
MODE - -
REGULATED-ENTITY - TU00410
REGULATOR - SRAD-RNA
//
UNIQUE-ID - REG0-11433
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-106
CITATIONS - 22324810
CITATIONS - 22324810:EV-EXP-IMP-SITE-MUTATION:3539120241:keseler
CITATIONS - 22324810:EV-EXP-IEP:3539120241:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00181
REGULATOR - MICF-RNA
//
UNIQUE-ID - REG0-10769
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-78
CITATIONS - 17007876
CITATIONS - 17007876:EV-EXP-IEP:3487703000:keseler
CITATIONS - 17007876:EV-AS-HYPO:3487703000:keseler
CITATIONS - 25891076:EV-EXP-IPI:3656360037:keseler
MODE - -
REGULATED-ENTITY - TU00049
REGULATOR - RYBB-RNA
//
UNIQUE-ID - REG0-10584
TYPES - RNA-Mediated-Translation-Regulation
CITATIONS - 20075074
CITATIONS - 20075074:EV-EXP-IEP:3472843157:keseler
MODE - -
REGULATED-ENTITY - TU00254
REGULATOR - RNA0-349
//
UNIQUE-ID - REG0-10096
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-36
CITATIONS - 18978044
CITATIONS - 18978044:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3440510556:keseler
CITATIONS - 18978044:EV-EXP-IMP-SITE-MUTATION:3440510556:keseler
MODE - -
REGULATED-ENTITY - TU0-13386
REGULATOR - RYEE-RNA
//
UNIQUE-ID - REG0-9794
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-22
CITATIONS - 18952787
CITATIONS - 18952787:EV-EXP-IMP:3434727715:keseler
CITATIONS - 18952787:EV-EXP-IEP:3434727715:keseler
COMMENT - Site-directed mutagenesis of both the GcvB small RNA and the regulatory region of <i>sstT</i> have been
/performed, but a precise binding region has not been defined |CITS: [18952787]|.
MODE - -
REGULATED-ENTITY - TU0-13860
REGULATOR - GCVB-RNA
//
UNIQUE-ID - REG0-12365
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-189
CITATIONS - 21768388
CITATIONS - 21768388:EV-EXP-IMP-SITE-MUTATION:3656358498:keseler
CITATIONS - 21768388:EV-EXP-IEP:3656358498:keseler
MODE - -
REGULATED-ENTITY - EG12098
REGULATOR - RYBB-RNA
//
UNIQUE-ID - REG0-12010
TYPES - RNA-Mediated-Translation-Regulation
ACCESSORY-PROTEINS - CPLX0-1461
ASSOCIATED-BINDING-SITE - RBS0-173
CITATIONS - 24748661
CITATIONS - 24748661:EV-EXP-IMP-SITE-MUTATION:3608556363:keseler
MODE - -
REGULATED-ENTITY - EG11900
REGULATOR - RNA0-385
//
UNIQUE-ID - REG0-11874
TYPES - RNA-Mediated-Translation-Regulation
CITATIONS - 21292161
CITATIONS - 21292161:EV-EXP-IEP:3593795183:keseler
MODE - +
REGULATED-ENTITY - EG12625
REGULATOR - SPF-RNA
//
UNIQUE-ID - REG0-11858
TYPES - RNA-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-149
CITATIONS - 23980183
CITATIONS - 23980183:EV-EXP-IMP-SITE-MUTATION:3593441832:keseler
CITATIONS - 23980183:EV-EXP-IEP:3593441832:keseler
MODE - -
REGULATED-ENTITY - G7000
REGULATOR - RYEE-RNA
//
UNIQUE-ID - REG0-9970
TYPES - Compound-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-30
CITATIONS - 18824545:EV-EXP:3436039060:keseler
COMMENT - The <i>oppA</i> mRNA appears to undergo a change in secondary structure in the presence of polyamines such as spermidine |CITS: [10428855]|.  The structural change stimulates translation of the mRNA |CITS: [18824545]|.
MODE - +
REGULATED-ENTITY - TU00222
REGULATOR - SPERMIDINE
//
UNIQUE-ID - REG0-9515
TYPES - Compound-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-13
CITATIONS - 18506875:EV-EXP-IPI:3421766350:keseler
CITATIONS - 10852957:EV-EXP-IDA:3421766350:keseler
MODE - -
REGULATED-ENTITY - TU0-6281
REGULATOR - ADENOSYLCOBALAMIN
//
UNIQUE-ID - REG0-9483
TYPES - Compound-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-8
CITATIONS - 18363797
CITATIONS - 18363797:EV-EXP-IMP-SITE-MUTATION:3419860482:keseler
MODE - -
REGULATED-ENTITY - TU0-1123
REGULATOR - CPD-4
//
UNIQUE-ID - REG0-12171
TYPES - Compound-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-176
CITATIONS - 25661987
CITATIONS - 25661987:EV-EXP-IEP-GENE-EXPRESSION-ANALYSIS:3635776478:keseler
MODE - -
REGULATED-ENTITY - EG10465
REGULATOR - FMN
//
UNIQUE-ID - REG0-11544
TYPES - Compound-Mediated-Translation-Regulation
CITATIONS - 20628056
CITATIONS - 20628056:EV-EXP-IEP:3547572943:keseler
CITATIONS - 20628056:EV-EXP-IMP:3547572943:keseler
MODE - +
REGULATED-ENTITY - TU0-42483
REGULATOR - PUTRESCINE
//
UNIQUE-ID - REG0-10644
TYPES - Compound-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-69
CITATIONS - 12410317:EV-EXP-IEP:3475511738:keseler
CITATIONS - 12410317:EV-EXP-IDA:3475511856:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00365
REGULATOR - THIAMINE-PYROPHOSPHATE
//
UNIQUE-ID - REG0-10643
TYPES - Compound-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-68
CITATIONS - 12410317:EV-EXP-IEP:3475449390:keseler
CITATIONS - 12410317:EV-EXP-IMP-SITE-MUTATION:3475449390:keseler
CITATIONS - 12410317:EV-EXP-IDA:3475450719:keseler
CITATIONS - 18179415:EV-EXP-IMP-SITE-MUTATION:3475450719:keseler
COMMENT - Binding of TPP to <i>thiM</i> mRNA stabilizes a secondary structure that includes base pairing of the ribosome binding site, sequestering the site and inhibiting translation |CITS: [12410317]|.
/
/Crystal structures of the <i>thiM</i> riboswitch have been solved |CITS: [16728979][16962976][19948769]|, and phosphate group recognition was studied by NMR |CITS: [16871614]|.  The change in secondary structure of the TPP-free and TPP-bound forms was studied by enzymatic probing |CITS: [17517779]|, and a model for ligand-induced folding was proposed |CITS: [17693433]|.  The nucleotides involved in TPP recognition were confirmed by site-directed mutagenesis |CITS: [18179415]|.
/
/Review: |CITS: [17355861]|
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU0-13512
REGULATOR - THIAMINE-PYROPHOSPHATE
//
UNIQUE-ID - REG0-9994
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-32
CITATIONS - 18713317:EV-EXP-IPI:3436729617:keseler
CITATIONS - 18713317:EV-EXP-IEP:3436729617:keseler
COMMENT - The precise position of the CsrA binding site is inferred by its similarity to the consensus sequence; binding
/of CsrA was confirmed by gel shift assay |CITS: [18713317]|.
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-8682
REGULATOR - CPLX0-7956
//
UNIQUE-ID - REG0-11279
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-93
CITATIONS - 6379605
CITATIONS - 6379605:EV-COMP-HINF:3529420290:keseler
MODE - -
REGULATED-ENTITY - EG10878
REGULATOR - EG10903-MONOMER
//
UNIQUE-ID - REG0-10220
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-41
CITATIONS - 12067347:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3445626313:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00469
REGULATOR - CPLX0-7956
//
UNIQUE-ID - REG0-9453
TYPES - Protein-Mediated-Translation-Regulation
CITATIONS - 15916613
CITATIONS - 15916613:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3417546085:keseler
MODE - -
REGULATED-ENTITY - TU0-8471
REGULATOR - CPLX0-7956
//
UNIQUE-ID - REG0-10952
TYPES - Protein-Mediated-Translation-Regulation
CITATIONS - 8576033
CITATIONS - 8576033:EV-EXP-IEP:3510430430:keseler
MODE - -
REGULATED-ENTITY - TU00420
REGULATOR - CPLX0-7956
//
UNIQUE-ID - REG0-10093
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-34
CITATIONS - 18713317:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3440455456:keseler
CITATIONS - 18713317:EV-EXP-IEP:3440455456:keseler
COMMENT - The precise position of the CsrA binding site is inferred by similarity to the consensus sequence; binding of
/CsrA was confirmed by gel shift assay |CITS: [18713317]|.
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-13308
REGULATOR - CPLX0-7956
//
UNIQUE-ID - REG0-12194
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-178
CITATIONS - 25749694
CITATIONS - 25749694:EV-EXP-IMP-SITE-MUTATION:3639169412:keseler
MODE - -
REGULATED-ENTITY - TU0-13557
REGULATOR - EG10885-MONOMER
//
UNIQUE-ID - REG0-10656
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-71
CITATIONS - 12486013:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3477239510:keseler
CITATIONS - 12486013:EV-EXP-IMP-SITE-MUTATION:3477239510:keseler
MODE - -
REGULATED-ENTITY - TU00355
REGULATOR - CPLX0-8053
//
UNIQUE-ID - REG0-11996
TYPES - Protein-Mediated-Translation-Regulation
CITATIONS - 24708042
CITATIONS - 24708042:EV-EXP-IMP:3607102417:keseler
MODE - +
REGULATED-ENTITY - EG10935
REGULATOR - EG10215-MONOMER
//
UNIQUE-ID - REG0-10232
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-46
CITATIONS - 19320830
CITATIONS - 19320830:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3447431062:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-14273
REGULATOR - CPLX0-3461
//
UNIQUE-ID - REG0-11283
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-95
CITATIONS - 22037401
CITATIONS - 22037401:EV-EXP-IDA:3529758977:keseler
CITATIONS - 22037401:EV-EXP-IMP-SITE-MUTATION:3529758977:keseler
CITATIONS - 22037401:EV-EXP-IEP:3529758977:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - EG11078
REGULATOR - CPLX0-7956
//
UNIQUE-ID - REG0-10224
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-41
CITATIONS - 12067347:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3445628777:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00470
REGULATOR - CPLX0-7956
//
UNIQUE-ID - REGECOLI-11233
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBSECOLI-88
CITATIONS - 21908661
CITATIONS - 21908661:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3526244780:keseler
CITATIONS - 21908661:EV-EXP-IEP:3526244780:keseler
CITATIONS - 21908661:EV-EXP-IMP-SITE-MUTATION:3526245186:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU0-41901
REGULATOR - CPLX0-7956
//
UNIQUE-ID - REG0-11280
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-92
CITATIONS - 6445562
CITATIONS - 6445562:EV-EXP-IEP:3529423413:keseler
CITATIONS - 2443719:EV-EXP-IDA:3529423413:keseler
CITATIONS - 3309351:EV-EXP-IMP:3529423413:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - EG10910
REGULATOR - EG10903-MONOMER
//
UNIQUE-ID - REG0-10221
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-41
CITATIONS - 12067347:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3445626542:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00122
REGULATOR - CPLX0-7956
//
UNIQUE-ID - REG0-9543
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-18
CITATIONS - 18648071
CITATIONS - 18648071:EV-EXP-IEP:3426262220:keseler
CITATIONS - 18648071:EV-EXP-IMP:3426262220:keseler
MODE - -
REGULATED-ENTITY - TU00345
REGULATOR - EG10901-MONOMER
//
UNIQUE-ID - REG0-11232
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-87
CITATIONS - 11483525:EV-EXP-IMP-SITE-MUTATION:3525028039:keseler
CITATIONS - 6267426:EV-EXP-IEP:3525028228:keseler
CITATIONS - 2120211:EV-EXP-IEP:3525028228:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - EG10900
REGULATOR - EG10900-MONOMER
//
UNIQUE-ID - REG0-10094
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-35
CITATIONS - 18713317:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3440455559:keseler
CITATIONS - 18713317:EV-EXP-IEP:3440455559:keseler
COMMENT - The precise position of the CsrA binding site is inferred by similarity to the consensus sequence; binding of
/CsrA was confirmed by gel shift assay |CITS: [18713317]|.
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-13308
REGULATOR - CPLX0-7956
//
UNIQUE-ID - REG0-12343
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-183
CITATIONS - 25092924
CITATIONS - 25092924:EV-EXP-IDA:3653414375:keseler
MODE - +
REGULATED-ENTITY - TU796
REGULATOR - ACONITATEDEHYDRB-MONOMER
//
UNIQUE-ID - REG0-10836
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-81
CITATIONS - 7016341
CITATIONS - 7016341:EV-EXP-IDA:3493731832:keseler
CITATIONS - 17027976:EV-EXP-IPI:3493731832:keseler
MODE - -
REGULATED-ENTITY - TU00348
REGULATOR - EG10906-MONOMER
//
UNIQUE-ID - REG0-11997
TYPES - Protein-Mediated-Translation-Regulation
CITATIONS - 24708042
CITATIONS - 24708042:EV-EXP-IMP:3607102535:keseler
MODE - +
REGULATED-ENTITY - G6420
REGULATOR - EG10215-MONOMER
//
UNIQUE-ID - REG0-10526
TYPES - Protein-Mediated-Translation-Regulation
CITATIONS - 19965770:EV-EXP-IDA:3470098045:keseler
MODE - -
REGULATED-ENTITY - TU00230
REGULATOR - ACETYL-COA-CARBOXYLTRANSFER-CPLX
//
UNIQUE-ID - REG0-11857
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-148
CITATIONS - 24065131
CITATIONS - 24065131:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3593377077:keseler
COMMENT - Binding of Hfq blocks translation initiation; binding of the small RNA RyhB leads to changes in the mRNA secondary structure, thereby displacing Hfq |CITS: [24065131]|.
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - EG10155
REGULATOR - CPLX0-1461
//
UNIQUE-ID - REG0-10230
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-46
CITATIONS - 19320830
CITATIONS - 19320830:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3447430882:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU-8407
REGULATOR - CPLX0-3461
//
UNIQUE-ID - REGECOLI-11234
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBSECOLI-89
CITATIONS - 21908661
CITATIONS - 21908661:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3526244862:keseler
CITATIONS - 21908661:EV-EXP-IEP:3526244862:keseler
CITATIONS - 21908661:EV-EXP-IMP-SITE-MUTATION:3526245165:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU0-41901
REGULATOR - CPLX0-7956
//
UNIQUE-ID - REG0-11281
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-92
CITATIONS - 6445562
CITATIONS - 6445562:EV-EXP-IEP:3529423654:keseler
CITATIONS - 2443719:EV-EXP-IDA:3529423654:keseler
CITATIONS - 3309351:EV-EXP-IMP:3529423654:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - EG10903
REGULATOR - EG10903-MONOMER
//
UNIQUE-ID - REG0-10222
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-40
CITATIONS - 12067347:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3445626595:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00122
REGULATOR - CPLX0-7956
//
UNIQUE-ID - REG0-9572
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-20
CITATIONS - 6354472:EV-EXP-IDA:3427143789:keseler
CITATIONS - 6382263:EV-EXP-IMP:3427143789:keseler
MODE - -
REGULATED-ENTITY - TU0-6512
REGULATOR - EG10864-MONOMER
//
UNIQUE-ID - REG0-11275
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-92
CITATIONS - 6445562
CITATIONS - 6445562:EV-EXP-IEP:3529340454:keseler
CITATIONS - 3309351:EV-EXP-IMP:3529346089:keseler
CITATIONS - 2443719:EV-EXP-IDA:3529349173:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - EG10912
REGULATOR - EG10903-MONOMER
//
UNIQUE-ID - REG0-10219
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-40
CITATIONS - 12067347
CITATIONS - 12067347:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3445626213:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00469
REGULATOR - CPLX0-7956
//
UNIQUE-ID - REG0-12390
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-192
CITATIONS - 26447183
CITATIONS - 23980204:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3662242777:keseler
CITATIONS - 26447183:EV-EXP-IMP-SITE-MUTATION:3662242777:keseler
CITATIONS - 26447183:EV-EXP-IEP:3662242777:keseler
CITATIONS - 26447183:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3662242777:keseler
MODE - -
REGULATED-ENTITY - TU00346
REGULATOR - CPLX0-8208
//
UNIQUE-ID - REG0-10951
TYPES - Protein-Mediated-Translation-Regulation
CITATIONS - 8576033
CITATIONS - 8576033:EV-EXP-IEP:3510430381:keseler
MODE - -
REGULATED-ENTITY - TU00279
REGULATOR - CPLX0-7956
//
UNIQUE-ID - REG0-10092
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-33
CITATIONS - 18713317
CITATIONS - 18713317:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3440454747:keseler
CITATIONS - 18713317:EV-EXP-IEP:3440454962:keseler
COMMENT - The precise position of the CsrA binding site is inferred by its similarity to the consensus sequence; binding
/of CsrA was confirmed by gel shift assay |CITS: [18713317]|.
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-8682
REGULATOR - CPLX0-7956
//
UNIQUE-ID - REG0-12176
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-177
CITATIONS - 6445562
CITATIONS - 6450328
CITATIONS - 2464692
CITATIONS - 3049533
CITATIONS - 2643112
CITATIONS - 6445562:EV-EXP-IDA:3636826410:keseler
CITATIONS - 6450328:EV-EXP-IDA:3636826410:keseler
CITATIONS - 2464692:EV-EXP-IMP-SITE-MUTATION:3636826410:keseler
COMMENT - S5 regulates translation of the genes encoded by the <i>spc</i> operon by binding to a sequence at the 5' end of the L5 (RplE) coding sequence.  Regulation of expression of genes downstream of <i>rplE</i> is achieved by translational coupling |CITS: [3049533]|.  Translation of proteins encoded upstream of <i>rplE</i> is regulated by "retroregulation" involving degradation of the <i>spc</i> operon mRNA |CITS: [2643112]|.
MECHANISM - :TRANSLATION-BLOCKING
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU00337
REGULATOR - EG10907-MONOMER
//
UNIQUE-ID - REG0-10527
TYPES - Protein-Mediated-Translation-Regulation
CITATIONS - 19965770:EV-EXP-IDA:3470098111:keseler
MODE - -
REGULATED-ENTITY - TU00232
REGULATOR - ACETYL-COA-CARBOXYLTRANSFER-CPLX
//
UNIQUE-ID - REG0-11995
TYPES - Protein-Mediated-Translation-Regulation
CITATIONS - 24708042
CITATIONS - 24708042:EV-EXP-IMP:3607101714:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - +
REGULATED-ENTITY - EG11140
REGULATOR - EG10215-MONOMER
//
UNIQUE-ID - REG0-10231
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-46
CITATIONS - 19320830
CITATIONS - 19320830:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3447430990:keseler
MECHANISM - :MRNA-DEGRADATION
MODE - -
REGULATED-ENTITY - TU0-14272
REGULATOR - CPLX0-3461
//
UNIQUE-ID - REG0-11282
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-94
CITATIONS - 22037401
CITATIONS - 22037401:EV-EXP-IDA:3529758381:keseler
CITATIONS - 22037401:EV-EXP-IEP:3529758381:keseler
CITATIONS - 22037401:EV-EXP-IMP-SITE-MUTATION:3529758381:keseler
DOWNSTREAM-GENES-ONLY? - T
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - EG11078
REGULATOR - CPLX0-7956
//
UNIQUE-ID - REG0-10223
TYPES - Protein-Mediated-Translation-Regulation
ASSOCIATED-BINDING-SITE - RBS0-40
CITATIONS - 12067347:EV-EXP-IDA-BINDING-OF-PURIFIED-PROTEINS:3445628729:keseler
MECHANISM - :TRANSLATION-BLOCKING
MODE - -
REGULATED-ENTITY - TU00470
REGULATOR - CPLX0-7956
//
UNIQUE-ID - REG0-10650
TYPES - Regulation-of-Reactions
MODE - -
REGULATED-ENTITY - PHOQ-RXN
REGULATOR - MG+2
//
UNIQUE-ID - REG0-12037
TYPES - Regulation-of-Reactions
MODE - +
REGULATED-ENTITY - RXN0-6493
//
UNIQUE-ID - REG0-10314
TYPES - Regulation-of-Reactions
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - NRIDEPHOS-RXN
REGULATOR - PIIPROTEIN-CPLX
//
UNIQUE-ID - REG0-10822
TYPES - Regulation-of-Reactions
MODE - -
REGULATED-ENTITY - ARCB-RXN
REGULATOR - |Quinones|
//
UNIQUE-ID - REG0-10793
TYPES - Regulation-of-Reactions
MODE - +
REGULATED-ENTITY - HYDH-RXN
REGULATOR - ZN+2
//
UNIQUE-ID - REG0-10750
TYPES - Regulation-of-Reactions
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - PHOR-RXN
REGULATOR - |Pi|
//
UNIQUE-ID - REG0-12107
TYPES - Regulation-of-Reactions
MODE - NIL
REGULATED-ENTITY - CPXA-RXN
REGULATOR - EG12137-MONOMER
//
UNIQUE-ID - REG0-10321
TYPES - Regulation-of-Reactions
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - ARCA-RXN
REGULATOR - unphosphorylated receiver module of sensor kinase-phosphotransferase ArcB
//
UNIQUE-ID - REG0-10835
TYPES - Regulation-of-Reactions
MODE - -
REGULATED-ENTITY - RXN0-6532
REGULATOR - PROTEIN-PII
//
UNIQUE-ID - REG0-10312
TYPES - Regulation-of-Reactions
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - NRIDEPHOS-RXN
REGULATOR - PROTEIN-NRII
//
UNIQUE-ID - REG0-10794
TYPES - Regulation-of-Reactions
MODE - +
REGULATED-ENTITY - HYDH-RXN
REGULATOR - PB+2
//
UNIQUE-ID - REG0-10791
TYPES - Regulation-of-Reactions
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - RXN0-6502
REGULATOR - SPERMIDINE
//
UNIQUE-ID - REG0-10322
TYPES - Regulation-of-Reactions
COMMENT - Inhibits the phosphatase reaction, presumably by competing with Mg++. |CITS: [2201404]|
MODE - -
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - CHEYDEPHOS-RXN
REGULATOR - CA+2
//
UNIQUE-ID - REG0-10847
TYPES - Regulation-of-Reactions
MODE - -
REGULATED-ENTITY - CPXA-RXN
REGULATOR - G7816-MONOMER
//
UNIQUE-ID - REG0-10313
TYPES - Regulation-of-Reactions
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - NRIDEPHOS-RXN
REGULATOR - ATP
//
UNIQUE-ID - REG0-10795
TYPES - Regulation-of-Reactions
MODE - +
REGULATED-ENTITY - RXN0-6271
REGULATOR - CIT
//
UNIQUE-ID - REG0-10792
TYPES - Regulation-of-Reactions
MODE - +
PHYSIOLOGICALLY-RELEVANT? - T
REGULATED-ENTITY - RXN0-6502
REGULATOR - 3-KETOBUTYRATE
//
